Gene;EnsembleID;Trait_Id;Trait_Description;rsID;Allele;Imputation_Score;Beta;std_Beta;P_value;AA_Consequences;Transcript_ID
CXCR2;ENSG00000180871;23128-0.0;Trunk fat mass;rs200413041;A;1.0;0.9715600000000001;0.35431999999999997;0.0061062;A195D;ENST00000318507
CXCR2;ENSG00000180871;23128-0.0;Trunk fat mass;rs200413041;A;1.0;0.9715600000000001;0.35431999999999997;0.0061062;A195D;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs61733609;A;0.627677;0.014131;0.0033574;2.5669e-05;R248Q;ENST00000318507
CXCR2;ENSG00000180871;30090-0.0;Platelet crit;rs10201766;T;1.0;0.004058099999999999;0.0014282;0.0044903;R236C;ENST00000318507
CXCR2;ENSG00000180871;1727-0.0;Ease of skin tanning;rs149364972;A;0.639012;0.99375;0.32641;0.0023309;G79S;ENST00000318507
CXCR2;ENSG00000180871;1727-0.0;Ease of skin tanning;rs149364972;A;0.639012;0.99375;0.32641;0.0023309;G79S;ENST00000415392
CXCR2;ENSG00000180871;1727-0.0;Ease of skin tanning;rs149364972;A;0.639012;0.99375;0.32641;0.0023309;G79S;ENST00000428565
CXCR2;ENSG00000180871;1727-0.0;Ease of skin tanning;rs149364972;A;0.639012;0.99375;0.32641;0.0023309;G79S;ENST00000453237
CXCR2;ENSG00000180871;1727-0.0;Ease of skin tanning;rs149364972;A;0.639012;0.99375;0.32641;0.0023309;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_Block_M15-M19;M15-M19 Arthrosis;rs61733608;A;0.928919;0.41055;0.15512;0.0081308;A241T;ENST00000318507
CXCR2;ENSG00000180871;30160-0.0;Basophill count;rs55799208;A;1.0;-0.005693899999999999;0.00071855;2.3025e-15;R153H;ENST00000318507
CXCR2;ENSG00000180871;30160-0.0;Basophill count;rs55799208;A;1.0;-0.005693899999999999;0.00071855;2.3025e-15;R153H;ENST00000428565
CXCR2;ENSG00000180871;30160-0.0;Basophill count;rs55799208;A;1.0;-0.005693899999999999;0.00071855;2.3025e-15;R153H;ENST00000453237
CXCR2;ENSG00000180871;cancer_c_Block_C15-C26;C15-C26 Malignant neoplasms of digestive organs;rs55799208;A;1.0;0.0069756;0.0022089;0.0015886;R153H;ENST00000318507
CXCR2;ENSG00000180871;cancer_c_Block_C15-C26;C15-C26 Malignant neoplasms of digestive organs;rs55799208;A;1.0;0.0069756;0.0022089;0.0015886;R153H;ENST00000428565
CXCR2;ENSG00000180871;cancer_c_Block_C15-C26;C15-C26 Malignant neoplasms of digestive organs;rs55799208;A;1.0;0.0069756;0.0022089;0.0015886;R153H;ENST00000453237
CXCR2;ENSG00000180871;selfReported_n_1268;eye/eyelid problem;rs149364972;A;0.639012;0.20205;0.07812899999999999;0.009708;G79S;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1268;eye/eyelid problem;rs149364972;A;0.639012;0.20205;0.07812899999999999;0.009708;G79S;ENST00000415392
CXCR2;ENSG00000180871;selfReported_n_1268;eye/eyelid problem;rs149364972;A;0.639012;0.20205;0.07812899999999999;0.009708;G79S;ENST00000428565
CXCR2;ENSG00000180871;selfReported_n_1268;eye/eyelid problem;rs149364972;A;0.639012;0.20205;0.07812899999999999;0.009708;G79S;ENST00000453237
CXCR2;ENSG00000180871;selfReported_n_1268;eye/eyelid problem;rs149364972;A;0.639012;0.20205;0.07812899999999999;0.009708;G79S;ENST00000454148
CXCR2;ENSG00000180871;30210-0.0;Eosinophill percentage;rs55799208;A;1.0;0.12722999999999998;0.028696;9.2585e-06;R153H;ENST00000318507
CXCR2;ENSG00000180871;30210-0.0;Eosinophill percentage;rs55799208;A;1.0;0.12722999999999998;0.028696;9.2585e-06;R153H;ENST00000428565
CXCR2;ENSG00000180871;30210-0.0;Eosinophill percentage;rs55799208;A;1.0;0.12722999999999998;0.028696;9.2585e-06;R153H;ENST00000453237
CXCR2;ENSG00000180871;30210-0.0;Eosinophill percentage;rs61733609;A;0.627677;0.24818;0.089031;0.0053114;R248Q;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_I26;I26 Pulmonary embolism;rs10201766;T;1.0;0.015263999999999998;0.0036735;3.2516e-05;R236C;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs199632317;G;0.516455;0.009985299999999999;0.0037290999999999995;0.007413500000000001;H332R;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_K07;K07 Dentofacial anomalies [including malocclusion];rs10201766;T;1.0;0.0047301;0.0015071;0.0016985;R236C;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_I26-I28;I26-I28 Pulmonary heart disease and diseases of pulmonary circulation;rs10201766;T;1.0;0.019978;0.0040476999999999996;7.9876e-07;R236C;ENST00000318507
CXCR2;ENSG00000180871;23127-0.0;Trunk fat percentage;rs200413041;A;1.0;1.5181;0.50439;0.0026138999999999997;A195D;ENST00000318507
CXCR2;ENSG00000180871;23127-0.0;Trunk fat percentage;rs200413041;A;1.0;1.5181;0.50439;0.0026138999999999997;A195D;ENST00000453237
CXCR2;ENSG00000180871;selfReported_n_1223;urinary frequency / incontinence;rs199632317;G;0.516455;0.019825;0.0056286999999999995;0.00042812;H332R;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs149364972;A;0.639012;0.24602;0.0442;2.6083e-08;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs149364972;A;0.639012;0.24602;0.0442;2.6083e-08;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs149364972;A;0.639012;0.24602;0.0442;2.6083e-08;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs149364972;A;0.639012;0.24602;0.0442;2.6083e-08;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs149364972;A;0.639012;0.24602;0.0442;2.6083e-08;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs61733608;A;0.928919;0.22984000000000002;0.057510000000000006;6.4288e-05;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_N03;N03 Chronic nephritic syndrome;rs200413041;A;1.0;0.012342;0.0038683;0.0014202;A195D;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_N03;N03 Chronic nephritic syndrome;rs200413041;A;1.0;0.012342;0.0038683;0.0014202;A195D;ENST00000453237
CXCR2;ENSG00000180871;30220-0.0;Basophill percentage;rs55799208;A;1.0;-0.030843000000000002;0.0079955;0.00011459;R153H;ENST00000318507
CXCR2;ENSG00000180871;30220-0.0;Basophill percentage;rs55799208;A;1.0;-0.030843000000000002;0.0079955;0.00011459;R153H;ENST00000428565
CXCR2;ENSG00000180871;30220-0.0;Basophill percentage;rs55799208;A;1.0;-0.030843000000000002;0.0079955;0.00011459;R153H;ENST00000453237
CXCR2;ENSG00000180871;selfReported_n_1301;retinal problem;rs61733608;A;0.928919;0.26514;0.040662000000000004;7.0021e-11;A241T;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1265;neurology;rs55799208;A;1.0;0.019653;0.0047794;3.9242e-05;R153H;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1265;neurology;rs55799208;A;1.0;0.019653;0.0047794;3.9242e-05;R153H;ENST00000428565
CXCR2;ENSG00000180871;selfReported_n_1265;neurology;rs55799208;A;1.0;0.019653;0.0047794;3.9242e-05;R153H;ENST00000453237
CXCR2;ENSG00000180871;selfReported_n_1414;sarcoidosis;rs149364972;A;0.639012;0.045819;0.017648;0.0094259;G79S;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1414;sarcoidosis;rs149364972;A;0.639012;0.045819;0.017648;0.0094259;G79S;ENST00000415392
CXCR2;ENSG00000180871;selfReported_n_1414;sarcoidosis;rs149364972;A;0.639012;0.045819;0.017648;0.0094259;G79S;ENST00000428565
CXCR2;ENSG00000180871;selfReported_n_1414;sarcoidosis;rs149364972;A;0.639012;0.045819;0.017648;0.0094259;G79S;ENST00000453237
CXCR2;ENSG00000180871;selfReported_n_1414;sarcoidosis;rs149364972;A;0.639012;0.045819;0.017648;0.0094259;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs149364972;A;0.639012;0.17705;0.052651;0.00077198;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs149364972;A;0.639012;0.17705;0.052651;0.00077198;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs149364972;A;0.639012;0.17705;0.052651;0.00077198;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs149364972;A;0.639012;0.17705;0.052651;0.00077198;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs149364972;A;0.639012;0.17705;0.052651;0.00077198;G79S;ENST00000454148
CXCR2;ENSG00000180871;1438-0.0;Bread intake;rs149364972;A;0.639012;9.967;3.1376;0.0014902000000000001;G79S;ENST00000318507
CXCR2;ENSG00000180871;1438-0.0;Bread intake;rs149364972;A;0.639012;9.967;3.1376;0.0014902000000000001;G79S;ENST00000415392
CXCR2;ENSG00000180871;1438-0.0;Bread intake;rs149364972;A;0.639012;9.967;3.1376;0.0014902000000000001;G79S;ENST00000428565
CXCR2;ENSG00000180871;1438-0.0;Bread intake;rs149364972;A;0.639012;9.967;3.1376;0.0014902000000000001;G79S;ENST00000453237
CXCR2;ENSG00000180871;1438-0.0;Bread intake;rs149364972;A;0.639012;9.967;3.1376;0.0014902000000000001;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_J92;J92 Pleural plaque;rs10201766;T;1.0;0.0048357;0.0016940000000000002;0.0043091;R236C;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1249;thyroid problem (not cancer);rs200413041;A;1.0;0.055799;0.018606;0.0027093000000000004;A195D;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1249;thyroid problem (not cancer);rs200413041;A;1.0;0.055799;0.018606;0.0027093000000000004;A195D;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_M24;M24 Other specific joint derangements;rs61733608;A;0.928919;0.22121999999999997;0.041552;1.0163e-07;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs149364972;A;0.639012;0.054258;0.020569999999999998;0.008345299999999998;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs149364972;A;0.639012;0.054258;0.020569999999999998;0.008345299999999998;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs149364972;A;0.639012;0.054258;0.020569999999999998;0.008345299999999998;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs149364972;A;0.639012;0.054258;0.020569999999999998;0.008345299999999998;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs149364972;A;0.639012;0.054258;0.020569999999999998;0.008345299999999998;G79S;ENST00000454148
CXCR2;ENSG00000180871;1319-0.0;Dried fruit intake;rs199632317;G;0.516455;0.35345;0.13210999999999998;0.0074643999999999995;H332R;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_G47;G47 Sleep disorders;rs10201766;T;1.0;0.014088;0.0044301;0.0014720999999999998;R236C;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1291;migraine;rs55799208;A;1.0;0.012276;0.0031697;0.00010762;R153H;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1291;migraine;rs55799208;A;1.0;0.012276;0.0031697;0.00010762;R153H;ENST00000428565
CXCR2;ENSG00000180871;selfReported_n_1291;migraine;rs55799208;A;1.0;0.012276;0.0031697;0.00010762;R153H;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_I12;I12 Hypertensive renal disease;rs61733608;A;0.928919;0.08666599999999999;0.031856;0.0065169;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs149364972;A;0.639012;0.1781;0.051984;0.00061259;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs149364972;A;0.639012;0.1781;0.051984;0.00061259;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs149364972;A;0.639012;0.1781;0.051984;0.00061259;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs149364972;A;0.639012;0.1781;0.051984;0.00061259;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs149364972;A;0.639012;0.1781;0.051984;0.00061259;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_D68;D68 Other coagulation defects;rs10201766;T;1.0;0.005688;0.0018751999999999998;0.0024198;R236C;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_D86;D86 Sarcoidosis;rs149364972;A;0.639012;0.048085;0.014519999999999998;0.00092732;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_D86;D86 Sarcoidosis;rs149364972;A;0.639012;0.048085;0.014519999999999998;0.00092732;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_D86;D86 Sarcoidosis;rs149364972;A;0.639012;0.048085;0.014519999999999998;0.00092732;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_D86;D86 Sarcoidosis;rs149364972;A;0.639012;0.048085;0.014519999999999998;0.00092732;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_D86;D86 Sarcoidosis;rs149364972;A;0.639012;0.048085;0.014519999999999998;0.00092732;G79S;ENST00000454148
CXCR2;ENSG00000180871;30020-0.0;Haemoglobin concentration;rs200413041;A;1.0;-0.18625999999999998;0.07002;0.0078119;A195D;ENST00000318507
CXCR2;ENSG00000180871;30020-0.0;Haemoglobin concentration;rs200413041;A;1.0;-0.18625999999999998;0.07002;0.0078119;A195D;ENST00000453237
CXCR2;ENSG00000180871;30200-0.0;Neutrophill percentage;rs10201766;T;1.0;-1.2348;0.28763;1.7621e-05;R236C;ENST00000318507
CXCR2;ENSG00000180871;30200-0.0;Neutrophill percentage;rs55799208;A;1.0;-2.4873;0.13932999999999998;2.9161999999999996e-71;R153H;ENST00000318507
CXCR2;ENSG00000180871;30200-0.0;Neutrophill percentage;rs55799208;A;1.0;-2.4873;0.13932999999999998;2.9161999999999996e-71;R153H;ENST00000428565
CXCR2;ENSG00000180871;30200-0.0;Neutrophill percentage;rs55799208;A;1.0;-2.4873;0.13932999999999998;2.9161999999999996e-71;R153H;ENST00000453237
CXCR2;ENSG00000180871;30200-0.0;Neutrophill percentage;rs61733609;A;0.627677;-2.4848;0.4324;9.1167e-09;R248Q;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_K76;K76 Other diseases of liver;rs61733608;A;0.928919;0.23634000000000002;0.047629000000000005;6.9783e-07;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_L29;L29 Pruritus;rs199632317;G;0.516455;0.011404000000000001;0.0040875;0.0052718999999999995;H332R;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_O03;O03 Spontaneous abortion;rs149364972;A;0.639012;0.15935;0.046431;0.00059923;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_O03;O03 Spontaneous abortion;rs149364972;A;0.639012;0.15935;0.046431;0.00059923;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_O03;O03 Spontaneous abortion;rs149364972;A;0.639012;0.15935;0.046431;0.00059923;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_O03;O03 Spontaneous abortion;rs149364972;A;0.639012;0.15935;0.046431;0.00059923;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_O03;O03 Spontaneous abortion;rs149364972;A;0.639012;0.15935;0.046431;0.00059923;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_I08;I08 Multiple valve diseases;rs200413041;A;1.0;0.017651;0.0053506;0.00097037;A195D;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_I08;I08 Multiple valve diseases;rs200413041;A;1.0;0.017651;0.0053506;0.00097037;A195D;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_I08;I08 Multiple valve diseases;rs61733609;A;0.627677;0.010394;0.0037608000000000003;0.0057161;R248Q;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1540;psoriatic arthropathy;rs200413041;A;1.0;0.012412999999999999;0.0037275999999999998;0.00086809;A195D;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1540;psoriatic arthropathy;rs200413041;A;1.0;0.012412999999999999;0.0037275999999999998;0.00086809;A195D;ENST00000453237
CXCR2;ENSG00000180871;30100-0.0;Mean platelet (thrombocyte) volume;rs55799208;A;1.0;-0.042462;0.014524;0.0034611999999999993;R153H;ENST00000318507
CXCR2;ENSG00000180871;30100-0.0;Mean platelet (thrombocyte) volume;rs55799208;A;1.0;-0.042462;0.014524;0.0034611999999999993;R153H;ENST00000428565
CXCR2;ENSG00000180871;30100-0.0;Mean platelet (thrombocyte) volume;rs55799208;A;1.0;-0.042462;0.014524;0.0034611999999999993;R153H;ENST00000453237
CXCR2;ENSG00000180871;30070-0.0;Red blood cell (erythrocyte) distribution width;rs149364972;A;0.639012;0.9742799999999999;0.31840999999999997;0.002215;G79S;ENST00000318507
CXCR2;ENSG00000180871;30070-0.0;Red blood cell (erythrocyte) distribution width;rs149364972;A;0.639012;0.9742799999999999;0.31840999999999997;0.002215;G79S;ENST00000415392
CXCR2;ENSG00000180871;30070-0.0;Red blood cell (erythrocyte) distribution width;rs149364972;A;0.639012;0.9742799999999999;0.31840999999999997;0.002215;G79S;ENST00000428565
CXCR2;ENSG00000180871;30070-0.0;Red blood cell (erythrocyte) distribution width;rs149364972;A;0.639012;0.9742799999999999;0.31840999999999997;0.002215;G79S;ENST00000453237
CXCR2;ENSG00000180871;30070-0.0;Red blood cell (erythrocyte) distribution width;rs149364972;A;0.639012;0.9742799999999999;0.31840999999999997;0.002215;G79S;ENST00000454148
CXCR2;ENSG00000180871;30000-0.0;White blood cell (leukocyte) count;rs10201766;T;1.0;-0.28665999999999997;0.058865999999999995;1.1179000000000001e-06;R236C;ENST00000318507
CXCR2;ENSG00000180871;30000-0.0;White blood cell (leukocyte) count;rs55799208;A;1.0;-0.5287;0.028513999999999998;1.0173999999999999e-76;R153H;ENST00000318507
CXCR2;ENSG00000180871;30000-0.0;White blood cell (leukocyte) count;rs55799208;A;1.0;-0.5287;0.028513999999999998;1.0173999999999999e-76;R153H;ENST00000428565
CXCR2;ENSG00000180871;30000-0.0;White blood cell (leukocyte) count;rs55799208;A;1.0;-0.5287;0.028513999999999998;1.0173999999999999e-76;R153H;ENST00000453237
CXCR2;ENSG00000180871;30000-0.0;White blood cell (leukocyte) count;rs61733609;A;0.627677;-0.5444100000000001;0.088496;7.667300000000001e-10;R248Q;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs149364972;A;0.639012;0.19564;0.018037;2.098e-27;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs149364972;A;0.639012;0.19564;0.018037;2.098e-27;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs149364972;A;0.639012;0.19564;0.018037;2.098e-27;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs149364972;A;0.639012;0.19564;0.018037;2.098e-27;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs149364972;A;0.639012;0.19564;0.018037;2.098e-27;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs61733608;A;0.928919;0.22373;0.023469;1.5339e-21;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_B15-B19;B15-B19 Viral hepatitis;rs61733608;A;0.928919;0.22324000000000002;0.019597;4.6612e-30;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_G00-G09;G00-G09 Inflammatory diseases of the central nervous system;rs61733609;A;0.627677;0.0071078999999999995;0.0023011999999999998;0.0020096;R248Q;ENST00000318507
CXCR2;ENSG00000180871;30190-0.0;Monocyte percentage;rs55799208;A;1.0;0.40826999999999997;0.034658;5.0006e-32;R153H;ENST00000318507
CXCR2;ENSG00000180871;30190-0.0;Monocyte percentage;rs55799208;A;1.0;0.40826999999999997;0.034658;5.0006e-32;R153H;ENST00000428565
CXCR2;ENSG00000180871;30190-0.0;Monocyte percentage;rs55799208;A;1.0;0.40826999999999997;0.034658;5.0006e-32;R153H;ENST00000453237
CXCR2;ENSG00000180871;30190-0.0;Monocyte percentage;rs61733609;A;0.627677;0.3714;0.10754000000000001;0.00055344;R248Q;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_M50;M50 Cervical disk disorders;rs200413041;A;1.0;0.017513;0.0051032;0.00059964;A195D;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_M50;M50 Cervical disk disorders;rs200413041;A;1.0;0.017513;0.0051032;0.00059964;A195D;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_D69;D69 Purpura and other haemorrhagic conditions;rs61733608;A;0.928919;0.08747;0.03324;0.0085013;A241T;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1519;colitis/not crohns or ulcerative colitis;rs200413041;A;1.0;0.011823;0.004313399999999999;0.0061259999999999995;A195D;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1519;colitis/not crohns or ulcerative colitis;rs200413041;A;1.0;0.011823;0.004313399999999999;0.0061259999999999995;A195D;ENST00000453237
CXCR2;ENSG00000180871;23099-0.0;Body fat percentage;rs200413041;A;1.0;1.2458;0.43811000000000005;0.0044597000000000005;A195D;ENST00000318507
CXCR2;ENSG00000180871;23099-0.0;Body fat percentage;rs200413041;A;1.0;1.2458;0.43811000000000005;0.0044597000000000005;A195D;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_I27;I27 Other pulmonary heart diseases;rs10201766;T;1.0;0.0045831000000000005;0.0017765;0.009884100000000002;R236C;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_M05;M05 Seropositive rheumatoid arthritis;rs199632317;G;0.516455;0.009918000000000001;0.0035654000000000003;0.005407100000000001;H332R;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1443;pneumonia;rs61733609;A;0.627677;0.018732;0.0070593;0.0079647;R248Q;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_D63;D63 Anaemia in chronic diseases classified elsewhere;rs199632317;G;0.516455;0.011644;0.0039327;0.0030685;H332R;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_M75;M75 Shoulder lesions;rs61733608;A;0.928919;0.22351999999999997;0.076616;0.0035299;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_I05-I09;I05-I09 Chronic rheumatic heart diseases;rs200413041;A;1.0;0.016403;0.006159;0.007738299999999999;A195D;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_I05-I09;I05-I09 Chronic rheumatic heart diseases;rs200413041;A;1.0;0.016403;0.006159;0.007738299999999999;A195D;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_Block_I95-I99;I95-I99 Other and unspecified disorders of the circulatory system;rs61733608;A;0.928919;0.20498000000000002;0.060110000000000004;0.00064949;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_H11;H11 Other disorders of conjunctiva;rs149364972;A;0.639012;0.07939299999999999;0.017291;4.4026e-06;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_H11;H11 Other disorders of conjunctiva;rs149364972;A;0.639012;0.07939299999999999;0.017291;4.4026e-06;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_H11;H11 Other disorders of conjunctiva;rs149364972;A;0.639012;0.07939299999999999;0.017291;4.4026e-06;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_H11;H11 Other disorders of conjunctiva;rs149364972;A;0.639012;0.07939299999999999;0.017291;4.4026e-06;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_H11;H11 Other disorders of conjunctiva;rs149364972;A;0.639012;0.07939299999999999;0.017291;4.4026e-06;G79S;ENST00000454148
CXCR2;ENSG00000180871;cancer_c_C20;C20 Malignant neoplasm of rectum;rs55799208;A;1.0;0.003926099999999999;0.0010077;9.7766e-05;R153H;ENST00000318507
CXCR2;ENSG00000180871;cancer_c_C20;C20 Malignant neoplasm of rectum;rs55799208;A;1.0;0.003926099999999999;0.0010077;9.7766e-05;R153H;ENST00000428565
CXCR2;ENSG00000180871;cancer_c_C20;C20 Malignant neoplasm of rectum;rs55799208;A;1.0;0.003926099999999999;0.0010077;9.7766e-05;R153H;ENST00000453237
CXCR2;ENSG00000180871;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs61733608;A;0.928919;0.08528999999999999;0.023556999999999998;0.00029394;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_E27;E27 Other disorders of adrenal gland;rs199632317;G;0.516455;0.011384;0.003204;0.00038069;H332R;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1428;allergy or anaphylactic reaction to food;rs55799208;A;1.0;0.0042518;0.0012874;0.00095805;R153H;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1428;allergy or anaphylactic reaction to food;rs55799208;A;1.0;0.0042518;0.0012874;0.00095805;R153H;ENST00000428565
CXCR2;ENSG00000180871;selfReported_n_1428;allergy or anaphylactic reaction to food;rs55799208;A;1.0;0.0042518;0.0012874;0.00095805;R153H;ENST00000453237
CXCR2;ENSG00000180871;selfReported_n_1467;nasal/sinus disorder;rs149364972;A;0.639012;0.16185;0.047675;0.00068684;G79S;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1467;nasal/sinus disorder;rs149364972;A;0.639012;0.16185;0.047675;0.00068684;G79S;ENST00000415392
CXCR2;ENSG00000180871;selfReported_n_1467;nasal/sinus disorder;rs149364972;A;0.639012;0.16185;0.047675;0.00068684;G79S;ENST00000428565
CXCR2;ENSG00000180871;selfReported_n_1467;nasal/sinus disorder;rs149364972;A;0.639012;0.16185;0.047675;0.00068684;G79S;ENST00000453237
CXCR2;ENSG00000180871;selfReported_n_1467;nasal/sinus disorder;rs149364972;A;0.639012;0.16185;0.047675;0.00068684;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_D50;D50 Iron deficiency anaemia;rs149364972;A;0.639012;0.14475;0.054454999999999996;0.007857;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_D50;D50 Iron deficiency anaemia;rs149364972;A;0.639012;0.14475;0.054454999999999996;0.007857;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_D50;D50 Iron deficiency anaemia;rs149364972;A;0.639012;0.14475;0.054454999999999996;0.007857;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_D50;D50 Iron deficiency anaemia;rs149364972;A;0.639012;0.14475;0.054454999999999996;0.007857;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_D50;D50 Iron deficiency anaemia;rs149364972;A;0.639012;0.14475;0.054454999999999996;0.007857;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_K30;K30 Dyspepsia;rs149364972;A;0.639012;0.18084;0.06751;0.0073915000000000005;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_K30;K30 Dyspepsia;rs149364972;A;0.639012;0.18084;0.06751;0.0073915000000000005;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_K30;K30 Dyspepsia;rs149364972;A;0.639012;0.18084;0.06751;0.0073915000000000005;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_K30;K30 Dyspepsia;rs149364972;A;0.639012;0.18084;0.06751;0.0073915000000000005;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_K30;K30 Dyspepsia;rs149364972;A;0.639012;0.18084;0.06751;0.0073915000000000005;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs149364972;A;0.639012;0.077296;0.020007;0.00011182;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs149364972;A;0.639012;0.077296;0.020007;0.00011182;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs149364972;A;0.639012;0.077296;0.020007;0.00011182;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs149364972;A;0.639012;0.077296;0.020007;0.00011182;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs149364972;A;0.639012;0.077296;0.020007;0.00011182;G79S;ENST00000454148
CXCR2;ENSG00000180871;selfReported_n_1317;mania/bipolar disorder/manic depression;rs200413041;A;1.0;0.0115;0.0044613;0.0099461;A195D;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1317;mania/bipolar disorder/manic depression;rs200413041;A;1.0;0.0115;0.0044613;0.0099461;A195D;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_K22;K22 Other diseases of oesophagus;rs61733609;A;0.627677;0.028602;0.008987700000000001;0.0014611;R248Q;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_G70-G73;G70-G73 Diseases of myoneural junction and muscle;rs199632317;G;0.516455;0.010009;0.0033913000000000003;0.0031654;H332R;ENST00000318507
CXCR2;ENSG00000180871;30140-0.0;Neutrophill count;rs10201766;T;1.0;-0.26381;0.047501999999999996;2.7969999999999998e-08;R236C;ENST00000318507
CXCR2;ENSG00000180871;30140-0.0;Neutrophill count;rs55799208;A;1.0;-0.48571000000000003;0.023007;6.911299999999998e-99;R153H;ENST00000318507
CXCR2;ENSG00000180871;30140-0.0;Neutrophill count;rs55799208;A;1.0;-0.48571000000000003;0.023007;6.911299999999998e-99;R153H;ENST00000428565
CXCR2;ENSG00000180871;30140-0.0;Neutrophill count;rs55799208;A;1.0;-0.48571000000000003;0.023007;6.911299999999998e-99;R153H;ENST00000453237
CXCR2;ENSG00000180871;30140-0.0;Neutrophill count;rs61733609;A;0.627677;-0.49007;0.071411;6.7674e-12;R248Q;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_M19;M19 Other arthrosis;rs61733608;A;0.928919;0.44148000000000004;0.1013;1.3107e-05;A241T;ENST00000318507
CXCR2;ENSG00000180871;20116-0.0;Smoking status;rs55799208;A;1.0;-0.035246;0.011789;0.002793;R153H;ENST00000318507
CXCR2;ENSG00000180871;20116-0.0;Smoking status;rs55799208;A;1.0;-0.035246;0.011789;0.002793;R153H;ENST00000428565
CXCR2;ENSG00000180871;20116-0.0;Smoking status;rs55799208;A;1.0;-0.035246;0.011789;0.002793;R153H;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_N84;N84 Polyp of female genital tract;rs199632317;G;0.516455;0.082665;0.02649;0.0018046;H332R;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_N30;N30 Cystitis;rs55799208;A;1.0;0.004720899999999999;0.0016143000000000002;0.0034516;R153H;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_N30;N30 Cystitis;rs55799208;A;1.0;0.004720899999999999;0.0016143000000000002;0.0034516;R153H;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_N30;N30 Cystitis;rs55799208;A;1.0;0.004720899999999999;0.0016143000000000002;0.0034516;R153H;ENST00000453237
CXCR2;ENSG00000180871;selfReported_n_1516;malabsorption/coeliac disease;rs199632317;G;0.516455;0.027583999999999997;0.0061442;7.145e-06;H332R;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_F40-F48;F40-F48 Neurotic, stress-related and somatoform disorders;rs199632317;G;0.516455;0.03581;0.012578;0.004414199999999999;H332R;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs149364972;A;0.639012;0.24924;0.0809;0.0020646;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs149364972;A;0.639012;0.24924;0.0809;0.0020646;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs149364972;A;0.639012;0.24924;0.0809;0.0020646;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs149364972;A;0.639012;0.24924;0.0809;0.0020646;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs149364972;A;0.639012;0.24924;0.0809;0.0020646;G79S;ENST00000454148
CXCR2;ENSG00000180871;30040-0.0;Mean corpuscular volume;rs200413041;A;1.0;-1.1202;0.28784;9.9558e-05;A195D;ENST00000318507
CXCR2;ENSG00000180871;30040-0.0;Mean corpuscular volume;rs200413041;A;1.0;-1.1202;0.28784;9.9558e-05;A195D;ENST00000453237
CXCR2;ENSG00000180871;30040-0.0;Mean corpuscular volume;rs55799208;A;1.0;-0.20778000000000002;0.065211;0.0014412000000000001;R153H;ENST00000318507
CXCR2;ENSG00000180871;30040-0.0;Mean corpuscular volume;rs55799208;A;1.0;-0.20778000000000002;0.065211;0.0014412000000000001;R153H;ENST00000428565
CXCR2;ENSG00000180871;30040-0.0;Mean corpuscular volume;rs55799208;A;1.0;-0.20778000000000002;0.065211;0.0014412000000000001;R153H;ENST00000453237
CXCR2;ENSG00000180871;30130-0.0;Monocyte count;rs55799208;A;1.0;-0.012058;0.0025933;3.3243e-06;R153H;ENST00000318507
CXCR2;ENSG00000180871;30130-0.0;Monocyte count;rs55799208;A;1.0;-0.012058;0.0025933;3.3243e-06;R153H;ENST00000428565
CXCR2;ENSG00000180871;30130-0.0;Monocyte count;rs55799208;A;1.0;-0.012058;0.0025933;3.3243e-06;R153H;ENST00000453237
CXCR2;ENSG00000180871;selfReported_n_1502;haematology;rs10201766;T;1.0;0.013127000000000002;0.0046436;0.004700500000000001;R236C;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_G51;G51 Facial nerve disorders;rs199632317;G;0.516455;0.0155;0.0043551;0.00037224;H332R;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs149364972;A;0.639012;0.052989999999999995;0.020171;0.008612;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs149364972;A;0.639012;0.052989999999999995;0.020171;0.008612;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs149364972;A;0.639012;0.052989999999999995;0.020171;0.008612;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs149364972;A;0.639012;0.052989999999999995;0.020171;0.008612;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs149364972;A;0.639012;0.052989999999999995;0.020171;0.008612;G79S;ENST00000454148
CXCR2;ENSG00000180871;selfReported_n_1720;fracture pelvis & lower limb;rs61733608;A;0.928919;0.25564000000000003;0.047994;1.0014e-07;A241T;ENST00000318507
CXCR2;ENSG00000180871;49-0.0;Hip circumference;rs200413041;A;1.0;1.7662;0.64722;0.0063547;A195D;ENST00000318507
CXCR2;ENSG00000180871;49-0.0;Hip circumference;rs200413041;A;1.0;1.7662;0.64722;0.0063547;A195D;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_E05;E05 Thyrotoxicosis [hyperthyroidism];rs200413041;A;1.0;0.017383000000000003;0.0056261;0.0020039000000000003;A195D;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_E05;E05 Thyrotoxicosis [hyperthyroidism];rs200413041;A;1.0;0.017383000000000003;0.0056261;0.0020039000000000003;A195D;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs149364972;A;0.639012;0.087328;0.028976;0.0025800999999999997;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs149364972;A;0.639012;0.087328;0.028976;0.0025800999999999997;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs149364972;A;0.639012;0.087328;0.028976;0.0025800999999999997;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs149364972;A;0.639012;0.087328;0.028976;0.0025800999999999997;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs149364972;A;0.639012;0.087328;0.028976;0.0025800999999999997;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_G43;G43 Migraine;rs61733608;A;0.928919;0.27149;0.042685;2.0150999999999998e-10;A241T;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1348;osteoporosis;rs200413041;A;1.0;0.028515;0.010508;0.0066568;A195D;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1348;osteoporosis;rs200413041;A;1.0;0.028515;0.010508;0.0066568;A195D;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_I61;I61 Intracerebral haemorrhage;rs149364972;A;0.639012;0.084095;0.016738;5.054500000000001e-07;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_I61;I61 Intracerebral haemorrhage;rs149364972;A;0.639012;0.084095;0.016738;5.054500000000001e-07;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_I61;I61 Intracerebral haemorrhage;rs149364972;A;0.639012;0.084095;0.016738;5.054500000000001e-07;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_I61;I61 Intracerebral haemorrhage;rs149364972;A;0.639012;0.084095;0.016738;5.054500000000001e-07;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_I61;I61 Intracerebral haemorrhage;rs149364972;A;0.639012;0.084095;0.016738;5.054500000000001e-07;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_Block_G40-G47;G40-G47 Episodic and paroxysmal disorders;rs61733608;A;0.928919;0.24658000000000002;0.09519;0.009587299999999998;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_J90;J90 Pleural effusion, not elsewhere classified;rs149364972;A;0.639012;0.12165999999999999;0.044802999999999996;0.0066191;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_J90;J90 Pleural effusion, not elsewhere classified;rs149364972;A;0.639012;0.12165999999999999;0.044802999999999996;0.0066191;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_J90;J90 Pleural effusion, not elsewhere classified;rs149364972;A;0.639012;0.12165999999999999;0.044802999999999996;0.0066191;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_J90;J90 Pleural effusion, not elsewhere classified;rs149364972;A;0.639012;0.12165999999999999;0.044802999999999996;0.0066191;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_J90;J90 Pleural effusion, not elsewhere classified;rs149364972;A;0.639012;0.12165999999999999;0.044802999999999996;0.0066191;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_I60;I60 Subarachnoid haemorrhage;rs149364972;A;0.639012;0.084775;0.017916;2.225e-06;G79S;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_I60;I60 Subarachnoid haemorrhage;rs149364972;A;0.639012;0.084775;0.017916;2.225e-06;G79S;ENST00000415392
CXCR2;ENSG00000180871;clinical_c_I60;I60 Subarachnoid haemorrhage;rs149364972;A;0.639012;0.084775;0.017916;2.225e-06;G79S;ENST00000428565
CXCR2;ENSG00000180871;clinical_c_I60;I60 Subarachnoid haemorrhage;rs149364972;A;0.639012;0.084775;0.017916;2.225e-06;G79S;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_I60;I60 Subarachnoid haemorrhage;rs149364972;A;0.639012;0.084775;0.017916;2.225e-06;G79S;ENST00000454148
CXCR2;ENSG00000180871;clinical_c_K42;K42 Umbilical hernia;rs61733608;A;0.928919;0.25895;0.049453;1.6395e-07;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_L92;L92 Granulomatous disorders of skin and subcutaneous tissue;rs10201766;T;1.0;0.0080033;0.0014870999999999999;7.382000000000001e-08;R236C;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_K60;K60 Fissure and fistula of anal and rectal regions;rs61733608;A;0.928919;0.26861999999999997;0.045732;4.2621e-09;A241T;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1592;dry eyes;rs149364972;A;0.639012;0.14342;0.015341;8.8783e-21;G79S;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1592;dry eyes;rs149364972;A;0.639012;0.14342;0.015341;8.8783e-21;G79S;ENST00000415392
CXCR2;ENSG00000180871;selfReported_n_1592;dry eyes;rs149364972;A;0.639012;0.14342;0.015341;8.8783e-21;G79S;ENST00000428565
CXCR2;ENSG00000180871;selfReported_n_1592;dry eyes;rs149364972;A;0.639012;0.14342;0.015341;8.8783e-21;G79S;ENST00000453237
CXCR2;ENSG00000180871;selfReported_n_1592;dry eyes;rs149364972;A;0.639012;0.14342;0.015341;8.8783e-21;G79S;ENST00000454148
CXCR2;ENSG00000180871;selfReported_n_1592;dry eyes;rs61733608;A;0.928919;0.27526999999999996;0.019958;2.8768e-43;A241T;ENST00000318507
CXCR2;ENSG00000180871;1160-0.0;Sleep duration;rs10201766;T;1.0;-0.11279000000000002;0.040505;0.005361100000000001;R236C;ENST00000318507
CXCR2;ENSG00000180871;1160-0.0;Sleep duration;rs200413041;A;1.0;0.22549;0.086636;0.0092496;A195D;ENST00000318507
CXCR2;ENSG00000180871;1160-0.0;Sleep duration;rs200413041;A;1.0;0.22549;0.086636;0.0092496;A195D;ENST00000453237
CXCR2;ENSG00000180871;1160-0.0;Sleep duration;rs61733608;A;0.928919;-1.4781;0.5374800000000001;0.0059583;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_K31;K31 Other diseases of stomach and duodenum;rs61733608;A;0.928919;0.20775;0.068774;0.0025219;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_H02;H02 Other disorders of eyelid;rs61733608;A;0.928919;0.25589;0.061382000000000006;3.0618000000000004e-05;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_H00-H06;H00-H06 Disorders of eyelid, lacrimal system and orbit;rs61733608;A;0.928919;0.24006;0.079575;0.002555;A241T;ENST00000318507
CXCR2;ENSG00000180871;30180-0.0;Lymphocyte percentage;rs10201766;T;1.0;1.037;0.24664;2.6172e-05;R236C;ENST00000318507
CXCR2;ENSG00000180871;30180-0.0;Lymphocyte percentage;rs55799208;A;1.0;1.9949;0.11947;1.4381999999999998e-62;R153H;ENST00000318507
CXCR2;ENSG00000180871;30180-0.0;Lymphocyte percentage;rs55799208;A;1.0;1.9949;0.11947;1.4381999999999998e-62;R153H;ENST00000428565
CXCR2;ENSG00000180871;30180-0.0;Lymphocyte percentage;rs55799208;A;1.0;1.9949;0.11947;1.4381999999999998e-62;R153H;ENST00000453237
CXCR2;ENSG00000180871;30180-0.0;Lymphocyte percentage;rs61733609;A;0.627677;1.9036;0.37078;2.8361e-07;R248Q;ENST00000318507
CXCR2;ENSG00000180871;30110-0.0;Platelet distribution width;rs61733608;A;0.928919;0.9104;0.2166;2.6335e-05;A241T;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_B25-B34;B25-B34 Other viral diseases;rs61733609;A;0.627677;0.010839;0.0040625999999999995;0.007630500000000001;R248Q;ENST00000318507
CXCR2;ENSG00000180871;selfReported_n_1695;fracture;rs61733608;A;0.928919;0.22599;0.069458;0.0011397;A241T;ENST00000318507
CXCR2;ENSG00000180871;30050-0.0;Mean corpuscular haemoglobin;rs200413041;A;1.0;-0.42768;0.11653;0.00024243;A195D;ENST00000318507
CXCR2;ENSG00000180871;30050-0.0;Mean corpuscular haemoglobin;rs200413041;A;1.0;-0.42768;0.11653;0.00024243;A195D;ENST00000453237
CXCR2;ENSG00000180871;30050-0.0;Mean corpuscular haemoglobin;rs55799208;A;1.0;-0.07335;0.026399000000000002;0.0054621;R153H;ENST00000318507
CXCR2;ENSG00000180871;30050-0.0;Mean corpuscular haemoglobin;rs55799208;A;1.0;-0.07335;0.026399000000000002;0.0054621;R153H;ENST00000428565
CXCR2;ENSG00000180871;30050-0.0;Mean corpuscular haemoglobin;rs55799208;A;1.0;-0.07335;0.026399000000000002;0.0054621;R153H;ENST00000453237
CXCR2;ENSG00000180871;clinical_c_N90;N90 Other noninflammatory disorders of vulva and perineum;rs61733609;A;0.627677;0.024861;0.007401100000000002;0.00078201;R248Q;ENST00000318507
CXCR2;ENSG00000180871;728-0.0;Number of vehicles in household;rs199632317;G;0.516455;0.20185999999999998;0.076852;0.008623100000000002;H332R;ENST00000318507
CXCR2;ENSG00000180871;clinical_c_Block_J60-J70;J60-J70 Lung diseases due to external agents;rs61733609;A;0.627677;0.009206;0.002885;0.0014182;R248Q;ENST00000318507
CXCR2;ENSG00000180871;cancer_c_C56;C56 Malignant neoplasm of ovary;rs149364972;A;0.639012;0.11955;0.035409;0.00073521;G79S;ENST00000318507
CXCR2;ENSG00000180871;cancer_c_C56;C56 Malignant neoplasm of ovary;rs149364972;A;0.639012;0.11955;0.035409;0.00073521;G79S;ENST00000415392
CXCR2;ENSG00000180871;cancer_c_C56;C56 Malignant neoplasm of ovary;rs149364972;A;0.639012;0.11955;0.035409;0.00073521;G79S;ENST00000428565
CXCR2;ENSG00000180871;cancer_c_C56;C56 Malignant neoplasm of ovary;rs149364972;A;0.639012;0.11955;0.035409;0.00073521;G79S;ENST00000453237
CXCR2;ENSG00000180871;cancer_c_C56;C56 Malignant neoplasm of ovary;rs149364972;A;0.639012;0.11955;0.035409;0.00073521;G79S;ENST00000454148
CXCR1;ENSG00000163464;clinical_c_G93;G93 Other disorders of brain;rs140349292;A;0.23156100000000002;0.070823;0.013028;5.4482e-08;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L08;L08 Other local infections of skin and subcutaneous tissue;rs140349292;A;0.23156100000000002;0.031192;0.011558;0.0069616;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L08;L08 Other local infections of skin and subcutaneous tissue;rs146380244;T;0.661995;0.0124;0.003553;0.00048297;V133M;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N20;N20 Calculus of kidney and ureter;rs16858808;A;1.0;0.0017192999999999998;0.00065757;0.0089341;R335C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N20;N20 Calculus of kidney and ureter;rs575757254;A;0.714495;0.022062000000000002;0.0074449;0.0030430999999999995;R175C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1560;pneumothorax;rs142978743;A;0.9582639999999999;0.05902;0.013005000000000001;5.670499999999999e-06;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs111741549;A;0.702565;0.038704;0.010823;0.00034861;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_I60-I69;I60-I69 Cerebrovascular diseases;rs140349292;A;0.23156100000000002;0.097335;0.029133;0.00083466;R333C;ENST00000295683
CXCR1;ENSG00000163464;30090-0.0;Platelet crit;rs142978743;A;0.9582639999999999;0.030036;0.0088836;0.00072195;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I44;I44 Atrioventricular and left bundle-branch block;rs16858808;A;1.0;-0.001517;0.00057764;0.0086332;R335C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_H25;H25 Senile cataract;rs199933392;A;0.44469;0.07441299999999999;0.028272000000000002;0.0084875;P214L;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1740;benign breast lump;rs111741549;A;0.702565;0.040975;0.013426;0.0022733;R144C;ENST00000295683
CXCR1;ENSG00000163464;30210-0.0;Eosinophill percentage;rs16858808;A;1.0;0.023999;0.009298899999999999;0.0098544;R335C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1089;essential hypertension;rs140349292;A;0.23156100000000002;0.055926;0.014109;7.373899999999999e-05;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_M18;M18 Arthrosis of first carpometacarpal joint;rs146445859;T;1.0;0.008767299999999999;0.0024885000000000003;0.00042647;R199Q;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N19;N19 Unspecified renal failure;rs140349292;A;0.23156100000000002;0.040313;0.012263;0.0010114;R333C;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_C18;C18 Malignant neoplasm of colon;rs575757254;A;0.714495;0.013935;0.0052985;0.00854;R175C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I26;I26 Pulmonary embolism;rs9282752;G;0.922323;0.12024000000000001;0.024761000000000002;1.1995000000000001e-06;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs16858806;A;0.86606;0.0095728;0.0026941999999999995;0.00038082;S342L;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_C50;C50 Malignant neoplasm of breast;rs111741549;A;0.702565;0.1118;0.036837;0.0024057;R144C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1098;stroke;rs142076386;T;0.788538;0.088292;0.024874;0.00038599;F211L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_J40-J47;J40-J47 Chronic lower respiratory diseases;rs146380244;T;0.661995;0.044631;0.017049;0.0088512;V133M;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_J40-J47;J40-J47 Chronic lower respiratory diseases;rs16858808;A;1.0;0.004348899999999999;0.0016308;0.0076577;R335C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_J40-J47;J40-J47 Chronic lower respiratory diseases;rs16858811;C;1.0;0.0043164;0.0016251999999999998;0.0079103;M31R;ENST00000295683
CXCR1;ENSG00000163464;50-0.0;Standing height;rs16858808;A;1.0;-0.075922;0.025095;0.0024833999999999998;R335C;ENST00000295683
CXCR1;ENSG00000163464;50-0.0;Standing height;rs16858811;C;1.0;-0.074186;0.02501;0.0030145;M31R;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_L40-L45;L40-L45 Papulosquamous disorders;rs142978743;A;0.9582639999999999;0.052830999999999996;0.020162;0.008786200000000001;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_L40-L45;L40-L45 Papulosquamous disorders;rs9282752;G;0.922323;0.062655;0.021849;0.0041351999999999995;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_I26-I28;I26-I28 Pulmonary heart disease and diseases of pulmonary circulation;rs9282752;G;0.922323;0.11732000000000001;0.027284;1.708e-05;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L82;L82 Seborrhoeic keratosis;rs9282752;G;0.922323;0.072056;0.022985;0.001719;M268L;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1284;chronic/degenerative neurological problem;rs142978743;A;0.9582639999999999;0.054587000000000004;0.019138;0.0043401;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J40;J40 Bronchitis, not specified as acute or chronic;rs111741549;A;0.702565;0.016676;0.0050712;0.0010079000000000002;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J03;J03 Acute tonsillitis;rs111741549;A;0.702565;0.014218999999999999;0.0048035;0.0030745;R144C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1223;urinary frequency / incontinence;rs2234671;G;1.0;0.00069336;0.00026866;0.0098581;S276T;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I95;I95 Hypotension;rs61755739;A;0.554509;0.041835000000000004;0.013744999999999999;0.0023375;R280C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_M95-M99;M95-M99 Other disorders of the musculoskeletal system and connective tissue;rs9282752;G;0.922323;0.067557;0.012384000000000001;4.8905e-08;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_M86;M86 Osteomyelitis;rs140349292;A;0.23156100000000002;0.042796;0.007535600000000001;1.3545e-08;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs9282752;G;0.922323;0.12495999999999999;0.029213999999999997;1.8903e-05;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K66;K66 Other disorders of peritoneum;rs140349292;A;0.23156100000000002;0.089671;0.018294;9.5044e-07;R333C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1301;retinal problem;rs142978743;A;0.9582639999999999;0.058151999999999995;0.019062;0.0022835;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K26;K26 Duodenal ulcer;rs142978743;A;0.9582639999999999;0.095557;0.021294999999999998;7.2139e-06;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N63;N63 Unspecified lump in breast;rs61752206;T;0.614703;0.0098777;0.0036924999999999996;0.007471899999999999;R313H;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1092;heart attack/myocardial infarction;rs575757254;A;0.714495;0.026858;0.010236;0.008695;R175C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N64;N64 Other disorders of breast;rs111741549;A;0.702565;0.054517;0.013713;7.022300000000001e-05;R144C;ENST00000295683
CXCR1;ENSG00000163464;30290-0.0;High light scatter reticulocyte percentage;rs9282752;G;0.922323;0.12222000000000001;0.045506;0.0072354;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_H65-H75;H65-H75 Diseases of middle ear and mastoid;rs142978743;A;0.9582639999999999;0.056885000000000005;0.021631;0.0085429;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N47;N47 Redundant prepuce, phimosis and paraphimosis;rs9282752;G;0.922323;0.20914;0.046874;8.1345e-06;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K52;K52 Other non-infective gastro-enteritis and colitis;rs140349292;A;0.23156100000000002;0.15194000000000002;0.040837;0.00019879;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_L20-L30;L20-L30 Dermatitis and eczema;rs140349292;A;0.23156100000000002;0.059119000000000005;0.018347;0.0012715;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J93;J93 Pneumothorax;rs575757254;A;0.714495;0.008330200000000001;0.0031719;0.008634399999999999;R175C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J92;J92 Pleural plaque;rs140349292;A;0.23156100000000002;0.023418;0.0090464;0.0096364;R333C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1085;venous thromboembolic disease;rs140349292;A;0.23156100000000002;0.11977;0.032993;0.0002833;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J96;J96 Respiratory failure, not elsewhere classified;rs140349292;A;0.23156100000000002;0.047596;0.014782;0.0012828;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L60;L60 Nail disorders;rs9282752;G;0.922323;0.072203;0.0141;3.0453000000000004e-07;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_A30-A49;A30-A49 Other bacterial diseases;rs140349292;A;0.23156100000000002;0.094338;0.022769;3.4235e-05;R333C;ENST00000295683
CXCR1;ENSG00000163464;1777-0.0;Part of a multiple birth;rs142978743;A;0.9582639999999999;0.09686900000000001;0.036445;0.007861799999999999;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K70;K70 Alcoholic liver disease;rs9282752;G;0.922323;0.068935;0.012043;1.0411e-08;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_B35-B49;B35-B49 Mycoses;rs111741549;A;0.702565;0.034703;0.010394;0.00084188;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_B35-B49;B35-B49 Mycoses;rs140349292;A;0.23156100000000002;0.056502;0.016947;0.00085623;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_B35-B49;B35-B49 Mycoses;rs146445859;T;1.0;0.011349;0.0035426999999999998;0.0013578;R199Q;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1457;muscle or soft tissue injuries;rs9282752;G;0.922323;0.06163300000000001;0.022596;0.0063788000000000004;M268L;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1761;tuberculosis (tb);rs9282752;G;0.922323;0.061747;0.018688;0.00095306;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I12;I12 Hypertensive renal disease;rs140349292;A;0.23156100000000002;0.043191;0.012821;0.0007547999999999999;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I12;I12 Hypertensive renal disease;rs9282752;G;0.922323;0.06411900000000001;0.016182;7.424600000000001e-05;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K20;K20 Oesophagitis;rs140349292;A;0.23156100000000002;0.11784000000000001;0.031044;0.0001471;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K20;K20 Oesophagitis;rs16858806;A;0.86606;0.026638;0.010117000000000001;0.0084635;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_D68;D68 Other coagulation defects;rs16858806;A;0.86606;0.012475;0.0032635999999999997;0.00013208;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_O63;O63 Long labour;rs9282752;G;0.922323;0.10001;0.030272000000000007;0.00095479;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_A09;A09 Diarrhoea and gastro-enteritis of presumed infectious origin;rs140349292;A;0.23156100000000002;0.060725;0.023365;0.009351700000000001;R333C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1460;substance abuse/dependency;rs111741549;A;0.702565;0.026648;0.005278;4.4468000000000004e-07;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_I30-I52;I30-I52 Other forms of heart disease;rs111741549;A;0.702565;0.083536;0.031751;0.0085148;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs142978743;A;0.9582639999999999;0.12270999999999999;0.047102;0.0091793;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs111741549;A;0.702565;0.042453;0.016380000000000002;0.0095519;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs9282752;G;0.922323;0.086714;0.029103;0.0028869;M268L;ENST00000295683
CXCR1;ENSG00000163464;30200-0.0;Neutrophill percentage;rs16858808;A;1.0;-0.17708;0.045163;8.8266e-05;R335C;ENST00000295683
CXCR1;ENSG00000163464;30200-0.0;Neutrophill percentage;rs16858811;C;1.0;-0.17907;0.04501;6.9394e-05;M31R;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1503;clotting disorder/excessive bleeding;rs61755739;A;0.554509;0.018369;0.0056255;0.0010936;R280C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_G31;G31 Other degenerative diseases of nervous system, not elsewhere classified;rs140349292;A;0.23156100000000002;0.026570999999999997;0.0081055;0.0010449;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L29;L29 Pruritus;rs140349292;A;0.23156100000000002;0.067334;0.0090615;1.0812999999999999e-13;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N72;N72 Inflammatory disease of cervix uteri;rs61755739;A;0.554509;0.066139;0.013218;5.629600000000001e-07;R280C;ENST00000295683
CXCR1;ENSG00000163464;136-0.0;Number of operations, self-reported;rs142978743;A;0.9582639999999999;1.2064;0.35099;0.00058765;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs199933392;A;0.44469;0.042486;0.0092536;4.4063e-06;P214L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_L80-L99;L80-L99 Other disorders of the skin and subcutaneous tissue;rs140349292;A;0.23156100000000002;0.1248;0.040655000000000004;0.0021429;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_L80-L99;L80-L99 Other disorders of the skin and subcutaneous tissue;rs9282752;G;0.922323;0.14092000000000002;0.051315999999999994;0.0060301;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs140349292;A;0.23156100000000002;0.10197;0.035758;0.0043479;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J06;J06 Acute upper respiratory infections of multiple and unspecified sites;rs2234671;G;1.0;0.00053794;0.00020368;0.0082639;S276T;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_M06;M06 Other rheumatoid arthritis;rs9282752;G;0.922323;0.10799;0.026949;6.145e-05;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_N99-N99;N99-N99 Other disorders of the genitourinary system;rs16858806;A;0.86606;0.0096221;0.0036655999999999998;0.0086664;S342L;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_D04;D04 Carcinoma in situ of skin;rs61752206;T;0.614703;0.0082272;0.0028249000000000004;0.0035868000000000002;R313H;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I63;I63 Cerebral infarction;rs140349292;A;0.23156100000000002;0.05809500000000001;0.018536;0.0017230999999999998;R333C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1081;hypertension;rs16858808;A;1.0;-0.0072572;0.0023874;0.0023675000000000002;R335C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1081;hypertension;rs16858811;C;1.0;-0.0071166;0.0023793000000000004;0.0027800999999999998;M31R;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I08;I08 Multiple valve diseases;rs16858806;A;0.86606;0.015588999999999999;0.0043536;0.00034269;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I65;I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction;rs16858808;A;1.0;0.00082654;0.00030785;0.0072556;R335C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I65;I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction;rs16858811;C;1.0;0.00080556;0.00030680000000000003;0.0086483;M31R;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1266;neurological injury/trauma;rs9282752;G;0.922323;0.067764;0.019804;0.0006223;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_F20-F29;F20-F29 Schizophrenia, schizotypal and delusional disorders;rs142076386;T;0.788538;0.032638;0.010206999999999999;0.0013864;F211L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_F31;F31 Bipolar affective disorder;rs142076386;T;0.788538;0.036663999999999995;0.010206999999999999;0.00032828;F211L;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1540;psoriatic arthropathy;rs9282752;G;0.922323;0.06840800000000001;0.011747;5.7701e-09;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J44;J44 Other chronic obstructive pulmonary disease;rs16858806;A;0.86606;0.039252999999999996;0.0095704;4.1046999999999995e-05;S342L;ENST00000295683
CXCR1;ENSG00000163464;30100-0.0;Mean platelet (thrombocyte) volume;rs140349292;A;0.23156100000000002;-0.41531999999999997;0.16007000000000002;0.0094708;R333C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1091;angina;rs16858808;A;1.0;-0.0030101;0.0010550999999999998;0.004331399999999999;R335C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1091;angina;rs16858811;C;1.0;-0.0030285;0.0010515000000000001;0.0039741;M31R;ENST00000295683
CXCR1;ENSG00000163464;30070-0.0;Red blood cell (erythrocyte) distribution width;rs140349292;A;0.23156100000000002;0.44472;0.16673;0.0076472;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K57;K57 Diverticular disease of intestine;rs9282752;G;0.922323;0.28013000000000005;0.063775;1.1212e-05;M268L;ENST00000295683
CXCR1;ENSG00000163464;30260-0.0;Mean reticulocyte volume;rs575757254;A;0.714495;-1.3763;0.43941;0.0017356;R175C;ENST00000295683
CXCR1;ENSG00000163464;30000-0.0;White blood cell (leukocyte) count;rs142978743;A;0.9582639999999999;1.0883;0.36617;0.0029578000000000004;I283F;ENST00000295683
CXCR1;ENSG00000163464;30000-0.0;White blood cell (leukocyte) count;rs16858808;A;1.0;-0.026677999999999997;0.0092433;0.0038997;R335C;ENST00000295683
CXCR1;ENSG00000163464;30000-0.0;White blood cell (leukocyte) count;rs16858811;C;1.0;-0.027299;0.0092118;0.0030416;M31R;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_E21;E21 Hyperparathyroidism and other disorders of parathyroid gland;rs111741549;A;0.702565;0.016912;0.0057278;0.0031504000000000002;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_E21;E21 Hyperparathyroidism and other disorders of parathyroid gland;rs575757254;A;0.714495;0.008327;0.0031089000000000004;0.0073964;R175C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_B15-B19;B15-B19 Viral hepatitis;rs111741549;A;0.702565;0.029751;0.0048376999999999995;7.7699e-10;R144C;ENST00000295683
CXCR1;ENSG00000163464;30080-0.0;Platelet count;rs142978743;A;0.9582639999999999;38.445;10.724;0.00033731;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_G00-G09;G00-G09 Inflammatory diseases of the central nervous system;rs9282752;G;0.922323;0.051448;0.010318;6.152399999999999e-07;M268L;ENST00000295683
CXCR1;ENSG00000163464;30060-0.0;Mean corpuscular haemoglobin concentration;rs142076386;T;0.788538;0.52261;0.17985;0.0036631;F211L;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1702;fracture upper limb & shoulder;rs142978743;A;0.9582639999999999;0.11394000000000001;0.023168;8.7352e-07;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_M50;M50 Cervical disk disorders;rs199933392;A;0.44469;0.034605000000000004;0.012336;0.0050283;P214L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N62;N62 Hypertrophy of breast;rs16858808;A;1.0;0.00077521;0.00027695;0.0051251000000000005;R335C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N62;N62 Hypertrophy of breast;rs16858811;C;1.0;0.00075448;0.00027601;0.006266300000000001;M31R;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K21;K21 Gastro-oesophageal reflux disease;rs146445859;T;1.0;0.029085000000000003;0.0099982;0.0036260999999999997;R199Q;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1131;chronic obstructive airways disease/copd;rs575757254;A;0.714495;0.013594;0.004150399999999999;0.0010554;R175C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_H35;H35 Other retinal disorders;rs140349292;A;0.23156100000000002;0.051135;0.019259000000000002;0.0079282;R333C;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs140349292;A;0.23156100000000002;0.048192;0.0082532;5.2483000000000006e-09;R333C;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_Block_C50-C50;C50-C50 Malignant neoplasm of breast;rs111741549;A;0.702565;0.1118;0.036837;0.0024057;R144C;ENST00000295683
CXCR1;ENSG00000163464;1548-0.0;Variation in diet;rs142076386;T;0.788538;0.33879000000000004;0.11995;0.0047378;F211L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I27;I27 Other pulmonary heart diseases;rs9282752;G;0.922323;0.050044;0.011974;2.9254e-05;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K83;K83 Other diseases of biliary tract;rs9282752;G;0.922323;0.055875;0.01817;0.0021041999999999996;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L97;L97 Ulcer of lower limb, not elsewhere classified;rs140349292;A;0.23156100000000002;0.035668;0.010664;0.00082394;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L97;L97 Ulcer of lower limb, not elsewhere classified;rs61752206;T;0.614703;0.012034;0.0030421;7.629e-05;R313H;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N99;N99 Postprocedural disorders of genito-urinary system, not elsewhere classified;rs16858806;A;0.86606;0.0096221;0.0036655999999999998;0.0086664;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I45;I45 Other conduction disorders;rs142978743;A;0.9582639999999999;0.055211;0.017866999999999997;0.0020012;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_I05-I09;I05-I09 Chronic rheumatic heart diseases;rs16858806;A;0.86606;0.013951;0.0050114;0.0053711;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_O70;O70 Perineal laceration during delivery;rs9282752;G;0.922323;0.25581;0.048164;1.0892e-07;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_O02;O02 Other abnormal products of conception;rs146380244;T;0.661995;0.028704;0.006544;1.1533e-05;V133M;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_Block_C64-C68;C64-C68 Malignant neoplasms of urinary tract;rs9282752;G;0.922323;0.06551799999999999;0.016987000000000002;0.00011483;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_M05-M14;M05-M14 Inflammatory polyarthropathies;rs9282752;G;0.922323;0.16430999999999998;0.054903999999999994;0.0027653;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_I95-I99;I95-I99 Other and unspecified disorders of the circulatory system;rs61755739;A;0.554509;0.03975;0.014500999999999998;0.0061213000000000005;R280C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_I95-I99;I95-I99 Other and unspecified disorders of the circulatory system;rs9282752;G;0.922323;0.10705999999999999;0.030535000000000003;0.00045481;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_N60-N64;N60-N64 Disorders of breast;rs111741549;A;0.702565;0.040332;0.014634999999999999;0.005853;R144C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1112;deep venous thrombosis (dvt);rs140349292;A;0.23156100000000002;0.12715;0.029299000000000002;1.4281e-05;R333C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1094;heart arrhythmia;rs142978743;A;0.9582639999999999;0.17240999999999998;0.029930000000000002;8.4051e-09;I283F;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1094;heart arrhythmia;rs9282752;G;0.922323;0.1218;0.032434;0.00017312;M268L;ENST00000295683
CXCR1;ENSG00000163464;134-0.0;Number of self-reported cancers;rs111741549;A;0.702565;0.10378;0.039726;0.0089888;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L02;L02 Cutaneous abscess, furuncle and carbuncle;rs61752206;T;0.614703;0.016314;0.0045241000000000005;0.00031085;R313H;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1760;helicobacter pylori;rs142978743;A;0.9582639999999999;0.03816;0.013175999999999998;0.0037768;I283F;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1760;helicobacter pylori;rs16858806;A;0.86606;0.010537999999999999;0.0036863;0.0042555;S342L;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1760;helicobacter pylori;rs2234671;G;1.0;0.00070697;0.00024353;0.0036964;S276T;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J33;J33 Nasal polyp;rs142978743;A;0.9582639999999999;0.055387;0.021491999999999997;0.0099632;I283F;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_Block_C00-C14;C00-C14 Malignant neoplasms of lip, oral cavity and pharynx;rs142978743;A;0.9582639999999999;0.059503;0.010361;9.316399999999999e-09;I283F;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_Block_C00-C14;C00-C14 Malignant neoplasms of lip, oral cavity and pharynx;rs575757254;A;0.714495;0.007709100000000001;0.0029613000000000005;0.0092324;R175C;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs9282752;G;0.922323;0.069399;0.011966;6.652600000000001e-09;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_H54;H54 Blindness and low vision;rs9282752;G;0.922323;0.051974;0.012256999999999999;2.2306e-05;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I73;I73 Other peripheral vascular diseases;rs140349292;A;0.23156100000000002;0.10580999999999999;0.019819;9.351200000000001e-08;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_E27;E27 Other disorders of adrenal gland;rs16858806;A;0.86606;0.0098949;0.0023149;1.9163e-05;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_E03;E03 Other hypothyroidism;rs142978743;A;0.9582639999999999;0.13165;0.043095999999999995;0.0022513999999999998;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_E83;E83 Disorders of mineral metabolism;rs140349292;A;0.23156100000000002;0.092052;0.015041999999999998;9.3942e-10;R333C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1428;allergy or anaphylactic reaction to food;rs142978743;A;0.9582639999999999;0.054457000000000005;0.016527;0.00098388;I283F;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1213;renal/kidney failure;rs575757254;A;0.714495;0.0079182;0.0028909;0.006163;R175C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_D50;D50 Iron deficiency anaemia;rs2234671;G;1.0;-0.0016006;0.0006138999999999999;0.009126700000000001;S276T;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_D70;D70 Agranulocytosis;rs9282752;G;0.922323;0.06475700000000001;0.023508;0.005874600000000001;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K25;K25 Gastric ulcer;rs199933392;A;0.44469;0.079638;0.02075;0.00012411;P214L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K92;K92 Other diseases of digestive system;rs9282752;G;0.922323;0.20234000000000002;0.039501999999999995;3.0198e-07;M268L;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1317;mania/bipolar disorder/manic depression;rs142076386;T;0.788538;0.033924;0.011073999999999999;0.0021885000000000003;F211L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N40;N40 Hyperplasia of prostate;rs111741549;A;0.702565;0.10811;0.040582;0.0077197;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_G70-G73;G70-G73 Diseases of myoneural junction and muscle;rs16858806;A;0.86606;0.0088618;0.0024502;0.00029839;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_E86;E86 Volume depletion;rs140349292;A;0.23156100000000002;0.046577;0.017415;0.0074831;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_E86;E86 Volume depletion;rs9282752;G;0.922323;0.12805999999999998;0.021981;5.6803999999999995e-09;M268L;ENST00000295683
CXCR1;ENSG00000163464;30140-0.0;Neutrophill count;rs142076386;T;0.788538;0.6854399999999999;0.2522;0.0065717;F211L;ENST00000295683
CXCR1;ENSG00000163464;30140-0.0;Neutrophill count;rs142978743;A;0.9582639999999999;0.88208;0.29548;0.002834;I283F;ENST00000295683
CXCR1;ENSG00000163464;30140-0.0;Neutrophill count;rs16858808;A;1.0;-0.029688;0.0074587;6.8835e-05;R335C;ENST00000295683
CXCR1;ENSG00000163464;30140-0.0;Neutrophill count;rs16858811;C;1.0;-0.030159;0.007433400000000001;4.9666e-05;M31R;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1082;heart/cardiac problem;rs16858808;A;1.0;-0.0041270000000000005;0.0015435;0.007501300000000001;R335C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1082;heart/cardiac problem;rs16858811;C;1.0;-0.004036199999999999;0.0015382999999999998;0.0086953;M31R;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N31;N31 Neuromuscular dysfunction of bladder, not elsewhere classified;rs9282752;G;0.922323;0.067949;0.016626;4.3706000000000005e-05;M268L;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1133;bronchiectasis;rs111741549;A;0.702565;0.017501;0.0062637;0.0052045;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J69;J69 Pneumonitis due to solids and liquids;rs16858806;A;0.86606;0.0080679;0.0026209;0.0020824000000000003;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_O04;O04 Medical abortion;rs146445859;T;1.0;0.012144;0.0043492;0.0052356;R199Q;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1217;urinary tract infection/kidney infection;rs142978743;A;0.9582639999999999;0.11559000000000001;0.018521;4.3557e-10;I283F;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1217;urinary tract infection/kidney infection;rs575757254;A;0.714495;0.017501;0.0052933;0.00094548;R175C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N30;N30 Cystitis;rs16858806;A;0.86606;0.015316;0.0057981000000000005;0.0082534;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_M10;M10 Gout;rs9282752;G;0.922323;0.076552;0.023275;0.0010057;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs142978743;A;0.9582639999999999;0.055004;0.016922;0.0011525;I283F;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1083;cerebrovascular disease;rs142076386;T;0.788538;0.077796;0.028227;0.0058506999999999995;F211L;ENST00000295683
CXCR1;ENSG00000163464;884-0.0;Number of days/week of moderate physical activity 10+ minutes;rs2234671;G;1.0;0.030566000000000003;0.009981299999999999;0.0021965;S276T;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_F40-F48;F40-F48 Neurotic, stress-related and somatoform disorders;rs146445859;T;1.0;0.015934;0.0058293;0.0062669;R199Q;ENST00000295683
CXCR1;ENSG00000163464;30250-0.0;Reticulocyte count;rs575757254;A;0.714495;0.004340999999999999;0.0014777999999999998;0.0033090000000000003;R175C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I84;I84 Haemorrhoids;rs9282752;G;0.922323;0.15771;0.061154999999999994;0.009913799999999999;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_G57;G57 Mononeuropathies of lower limb;rs16858806;A;0.86606;0.015234000000000001;0.004360899999999999;0.00047707;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I80;I80 Phlebitis and thrombophlebitis;rs140349292;A;0.23156100000000002;0.059165999999999996;0.020128;0.0032872;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K02;K02 Dental caries;rs9282752;G;0.922323;0.064184;0.023033;0.005327;M268L;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1270;infection of nervous system;rs142076386;T;0.788538;0.091599;0.014936000000000001;8.6436e-10;F211L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J43;J43 Emphysema;rs199933392;A;0.44469;0.035885;0.013151;0.0063581;P214L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_K65-K67;K65-K67 Diseases of peritoneum;rs140349292;A;0.23156100000000002;0.083133;0.020119;3.5971e-05;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_G51;G51 Facial nerve disorders;rs16858806;A;0.86606;0.0083811;0.0031466;0.007731699999999999;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_H65;H65 Nonsuppurative otitis media;rs140349292;A;0.23156100000000002;0.033417;0.010633;0.0016734999999999999;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_H65;H65 Nonsuppurative otitis media;rs142978743;A;0.9582639999999999;0.06026;0.012385;1.1416e-06;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_K50-K52;K50-K52 Noninfective enteritis and colitis;rs140349292;A;0.23156100000000002;0.14023;0.044169;0.0014999;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_H36;H36 Retinal disorders in diseases classified elsewhere;rs140349292;A;0.23156100000000002;0.036043;0.011902;0.0024592;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_H36;H36 Retinal disorders in diseases classified elsewhere;rs61752206;T;0.614703;0.009114200000000001;0.0033951999999999997;0.0072661;R313H;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N45;N45 Orchitis and epididymitis;rs199933392;A;0.44469;0.089543;0.020822;1.7057e-05;P214L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_A41;A41 Other septicaemia;rs140349292;A;0.23156100000000002;0.1049;0.020040000000000002;1.6572e-07;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_G90-G99;G90-G99 Other disorders of the nervous system;rs140349292;A;0.23156100000000002;0.10726;0.020924;2.9598000000000003e-07;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs9282752;G;0.922323;0.057962;0.01065;5.2569e-08;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J31;J31 Chronic rhinitis, nasopharyngitis and pharyngitis;rs142076386;T;0.788538;0.032705;0.0096447;0.00069653;F211L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_J00-J06;J00-J06 Acute upper respiratory infections;rs111741549;A;0.702565;0.031152;0.010936;0.0043921;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_J00-J06;J00-J06 Acute upper respiratory infections;rs61755739;A;0.554509;0.029735;0.010688;0.0054018;R280C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1292;head injury;rs9282752;G;0.922323;0.070377;0.015340000000000001;4.4817e-06;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_E50-E64;E50-E64 Other nutritional deficiencies;rs9282752;G;0.922323;0.054499;0.015474000000000002;0.00042851;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_E05;E05 Thyrotoxicosis [hyperthyroidism];rs61755739;A;0.554509;0.026216000000000003;0.00842;0.0018487000000000002;R280C;ENST00000295683
CXCR1;ENSG00000163464;1478-0.0;Salt added to food;rs142978743;A;0.9582639999999999;0.56082;0.19582;0.0041845;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J32;J32 Chronic sinusitis;rs111741549;A;0.702565;0.042155;0.0099843;2.421e-05;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_M21;M21 Other acquired deformities of limbs;rs140349292;A;0.23156100000000002;0.040272;0.013526;0.0029068;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_M21;M21 Other acquired deformities of limbs;rs142978743;A;0.9582639999999999;0.057201999999999996;0.015755;0.00028263;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L81;L81 Other disorders of pigmentation;rs9282752;G;0.922323;0.051664;0.011646;9.1614e-06;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K11;K11 Diseases of salivary glands;rs16858808;A;1.0;0.0010074;0.00030751;0.0010527999999999998;R335C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K11;K11 Diseases of salivary glands;rs16858811;C;1.0;0.001024;0.00030647;0.00083368;M31R;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J02;J02 Acute pharyngitis;rs61755739;A;0.554509;0.016163999999999998;0.0057615;0.0050235;R280C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_K90-K93;K90-K93 Other diseases of the digestive system;rs9282752;G;0.922323;0.18552000000000002;0.045696;4.9121000000000006e-05;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_I70-I79;I70-I79 Diseases of arteries, arterioles and capillaries;rs140349292;A;0.23156100000000002;0.09565599999999999;0.028014999999999998;0.00063906;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_E14;E14 Unspecified diabetes mellitus;rs575757254;A;0.714495;0.01594;0.0052485;0.0023897;R175C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_M86-M90;M86-M90 Other osteopathies;rs140349292;A;0.23156100000000002;0.09175;0.018365;5.8606e-07;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_M86-M90;M86-M90 Other osteopathies;rs16858808;A;1.0;0.0015555;0.00054;0.0039697;R335C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_M86-M90;M86-M90 Other osteopathies;rs16858811;C;1.0;0.0015682;0.00053816;0.0035684;M31R;ENST00000295683
CXCR1;ENSG00000163464;1697-0.0;Comparative height size at age 10;rs16858808;A;1.0;-0.011817;0.0034035;0.00051683;R335C;ENST00000295683
CXCR1;ENSG00000163464;1697-0.0;Comparative height size at age 10;rs16858811;C;1.0;-0.011523;0.0033919;0.00068093;M31R;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_D75;D75 Other diseases of blood and blood-forming organs;rs575757254;A;0.714495;0.013096;0.0027334;1.6588e-06;R175C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_G91;G91 Hydrocephalus;rs140349292;A;0.23156100000000002;0.025512;0.0069827;0.00025860000000000005;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_G91;G91 Hydrocephalus;rs61755739;A;0.554509;0.014309;0.0041855;0.0006291000000000001;R280C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_M35;M35 Other systemic involvement of connective tissue;rs146445859;T;1.0;0.0094952;0.0029806999999999998;0.0014448;R199Q;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K90;K90 Intestinal malabsorption;rs140349292;A;0.23156100000000002;0.051434;0.014787;0.00050442;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K90;K90 Intestinal malabsorption;rs142978743;A;0.9582639999999999;0.053923;0.017223;0.0017433;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_J90-J94;J90-J94 Other diseases of pleura;rs140349292;A;0.23156100000000002;0.096243;0.026517000000000002;0.00028396;R333C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1512;psoriasis;rs2234671;G;1.0;-0.0019412;0.00047412;4.2337e-05;S276T;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J45;J45 Asthma;rs146380244;T;0.661995;0.043373;0.015299;0.0045836;V133M;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K65;K65 Peritonitis;rs61752206;T;0.614703;0.007951399999999999;0.0026724;0.0029261;R313H;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1616;cervical problem;rs199933392;A;0.44469;0.069025;0.018969;0.00027385;P214L;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1616;cervical problem;rs61755739;A;0.554509;0.065116;0.012963;5.0883e-07;R280C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_M41;M41 Scoliosis;rs16858806;A;0.86606;0.011512999999999999;0.0034625999999999997;0.00088457;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L90;L90 Atrophic disorders of skin;rs142978743;A;0.9582639999999999;0.054558;0.020285;0.0071552;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_O00-O08;O00-O08 Pregnancy with abortive outcome;rs146380244;T;0.661995;0.037633;0.010786;0.000485;V133M;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_O60-O75;O60-O75 Complications of labour and delivery;rs9282752;G;0.922323;0.222;0.059866;0.00020865;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_F20;F20 Schizophrenia;rs142076386;T;0.788538;0.034856;0.0076138;4.6969e-06;F211L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_N83;N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament;rs142978743;A;0.9582639999999999;0.14819000000000002;0.043955;0.00074811;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_G20;G20 Parkinson's disease;rs142978743;A;0.9582639999999999;0.057359;0.012882;8.4792e-06;I283F;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1592;dry eyes;rs61755739;A;0.554509;0.017455000000000002;0.0048154;0.00028911;R280C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1302;diabetic eye disease;rs142076386;T;0.788538;0.042158999999999995;0.0091137;3.7316000000000004e-06;F211L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K51;K51 Ulcerative colitis;rs16858806;A;0.86606;0.016291;0.005986399999999999;0.0065009;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_G45;G45 Transient cerebral ischaemic attacks and related syndromes;rs140349292;A;0.23156100000000002;0.049385000000000005;0.016531999999999998;0.002816;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_I47;I47 Paroxysmal tachycardia;rs9282752;G;0.922323;0.066827;0.023503;0.0044648000000000005;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L40;L40 Psoriasis;rs142978743;A;0.9582639999999999;0.053958000000000006;0.017866;0.0025271;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L40;L40 Psoriasis;rs9282752;G;0.922323;0.06502899999999999;0.019361;0.0007827999999999999;M268L;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1176;hepatitis;rs199933392;A;0.44469;0.03914;0.014412000000000001;0.0066113;P214L;ENST00000295683
CXCR1;ENSG00000163464;30180-0.0;Lymphocyte percentage;rs16858808;A;1.0;0.13813;0.038726;0.00036151;R335C;ENST00000295683
CXCR1;ENSG00000163464;30180-0.0;Lymphocyte percentage;rs16858811;C;1.0;0.14245;0.038595;0.00022338;M31R;ENST00000295683
CXCR1;ENSG00000163464;30110-0.0;Platelet distribution width;rs2234671;G;1.0;0.0053558;0.0018768;0.004322100000000001;S276T;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_K63;K63 Other diseases of intestine;rs140349292;A;0.23156100000000002;0.11917;0.038362;0.0018929000000000003;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_M67;M67 Other disorders of synovium and tendon;rs111741549;A;0.702565;0.058337;0.012408;2.5825e-06;R144C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1695;fracture;rs142978743;A;0.9582639999999999;0.10407999999999999;0.032561;0.0013911;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L89;L89 Decubitus ulcer;rs140349292;A;0.23156100000000002;0.03714;0.0082413;6.5891999999999995e-06;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J98;J98 Other respiratory disorders;rs9282752;G;0.922323;0.09879099999999999;0.02344;2.5024e-05;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_M80-M85;M80-M85 Disorders of bone density and structure;rs16858806;A;0.86606;0.027989;0.009972100000000001;0.0050048;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L98;L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified;rs140349292;A;0.23156100000000002;0.11513;0.02429;2.1387e-06;R333C;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_Block_D10-D36;D10-D36 Benign neoplasms;rs142076386;T;0.788538;0.023886;0.008562299999999998;0.0052753;F211L;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_Block_D10-D36;D10-D36 Benign neoplasms;rs16858806;A;0.86606;0.007779899999999999;0.0028066999999999996;0.0055728999999999996;S342L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs140349292;A;0.23156100000000002;0.036944;0.008791799999999999;2.6445e-05;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs61755739;A;0.554509;0.013609999999999999;0.0052699;0.0098051;R280C;ENST00000295683
CXCR1;ENSG00000163464;1329-0.0;Oily fish intake;rs9282752;G;0.922323;0.65787;0.22914;0.004091;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_B37;B37 Candidiasis;rs111741549;A;0.702565;0.03708;0.0093476;7.2851e-05;R144C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_B37;B37 Candidiasis;rs140349292;A;0.23156100000000002;0.049477;0.015241;0.0011694000000000001;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L85;L85 Other epidermal thickening;rs140349292;A;0.23156100000000002;0.034688;0.008615799999999998;5.6704e-05;R333C;ENST00000295683
CXCR1;ENSG00000163464;selfReported_n_1713;other fractures;rs142978743;A;0.9582639999999999;0.059729;0.0099517;1.9512e-09;I283F;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_J95-J99;J95-J99 Other diseases of the respiratory system;rs140349292;A;0.23156100000000002;0.096126;0.023872;5.6572e-05;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_Block_J95-J99;J95-J99 Other diseases of the respiratory system;rs9282752;G;0.922323;0.09468700000000001;0.030132;0.0016757000000000002;M268L;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_L91;L91 Hypertrophic disorders of skin;rs16858808;A;1.0;0.00083618;0.00032108;0.0092074;R335C;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_D05;D05 Carcinoma in situ of breast;rs9282752;G;0.922323;0.096699;0.028618;0.00072759;M268L;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_C56;C56 Malignant neoplasm of ovary;rs142978743;A;0.9582639999999999;0.083327;0.017269999999999997;1.4001e-06;I283F;ENST00000295683
CXCR1;ENSG00000163464;cancer_c_C56;C56 Malignant neoplasm of ovary;rs146380244;T;0.661995;0.021482;0.005125800000000001;2.7793000000000006e-05;V133M;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_E87;E87 Other disorders of fluid, electrolyte and acid-base balance;rs140349292;A;0.23156100000000002;0.066788;0.023737;0.0048979;R333C;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_E87;E87 Other disorders of fluid, electrolyte and acid-base balance;rs2234671;G;1.0;-0.0014295999999999998;0.00051103;0.0051505000000000006;S276T;ENST00000295683
CXCR1;ENSG00000163464;clinical_c_E87;E87 Other disorders of fluid, electrolyte and acid-base balance;rs9282752;G;0.922323;0.11284000000000001;0.029961;0.00016577;M268L;ENST00000295683
CCR10;ENSG00000184451;selfReported_n_1099;transient ischaemic attack (tia);rs140554625;G;0.903185;0.32625;0.035901;1.0171e-19;S357T;ENST00000332438
CCR10;ENSG00000184451;selfReported_n_1099;transient ischaemic attack (tia);rs140554625;G;0.903185;0.32625;0.035901;1.0171e-19;S135T;ENST00000591765
CCR10;ENSG00000184451;selfReported_n_1098;stroke;rs140554625;G;0.903185;0.30580999999999997;0.069704;1.1480999999999999e-05;S357T;ENST00000332438
CCR10;ENSG00000184451;selfReported_n_1098;stroke;rs140554625;G;0.903185;0.30580999999999997;0.069704;1.1480999999999999e-05;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_Block_B95-B98;B95-B98 Bacterial, viral and other infectious agents;rs140554625;G;0.903185;0.29725;0.10267000000000001;0.0037903;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_Block_B95-B98;B95-B98 Bacterial, viral and other infectious agents;rs140554625;G;0.903185;0.29725;0.10267000000000001;0.0037903;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs140554625;G;0.903185;0.44798000000000004;0.064447;3.6280000000000003e-12;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs140554625;G;0.903185;0.44798000000000004;0.064447;3.6280000000000003e-12;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_K08;K08 Other disorders of teeth and supporting structures;rs140554625;G;0.903185;0.13362000000000002;0.047007;0.0044748;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_K08;K08 Other disorders of teeth and supporting structures;rs140554625;G;0.903185;0.13362000000000002;0.047007;0.0044748;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_K52;K52 Other non-infective gastro-enteritis and colitis;rs140554625;G;0.903185;0.33052;0.11366;0.0036368999999999998;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_K52;K52 Other non-infective gastro-enteritis and colitis;rs140554625;G;0.903185;0.33052;0.11366;0.0036368999999999998;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs140554625;G;0.903185;0.32958000000000004;0.029992;4.3469e-28;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs140554625;G;0.903185;0.32958000000000004;0.029992;4.3469e-28;S135T;ENST00000591765
CCR10;ENSG00000184451;cancer_c_C61;C61 Malignant neoplasm of prostate;rs140554625;G;0.903185;0.96932;0.17683;4.2154e-08;S357T;ENST00000332438
CCR10;ENSG00000184451;cancer_c_C61;C61 Malignant neoplasm of prostate;rs140554625;G;0.903185;0.96932;0.17683;4.2154e-08;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_K86;K86 Other diseases of pancreas;rs61730696;A;1.0;0.0035361999999999993;0.0013587999999999999;0.009259;R326W;ENST00000332438
CCR10;ENSG00000184451;clinical_c_K86;K86 Other diseases of pancreas;rs61730696;A;1.0;0.0035361999999999993;0.0013587999999999999;0.009259;R104W;ENST00000591765
CCR10;ENSG00000184451;selfReported_n_1510;dermatology;rs140554625;G;0.903185;0.31085;0.11648;0.0076173000000000005;S357T;ENST00000332438
CCR10;ENSG00000184451;selfReported_n_1510;dermatology;rs140554625;G;0.903185;0.31085;0.11648;0.0076173000000000005;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_H81;H81 Disorders of vestibular function;rs61730696;A;1.0;0.0038635999999999996;0.0012735;0.0024139;R326W;ENST00000332438
CCR10;ENSG00000184451;clinical_c_H81;H81 Disorders of vestibular function;rs61730696;A;1.0;0.0038635999999999996;0.0012735;0.0024139;R104W;ENST00000591765
CCR10;ENSG00000184451;1319-0.0;Dried fruit intake;rs61730696;A;1.0;0.09358;0.036047;0.0094299;R326W;ENST00000332438
CCR10;ENSG00000184451;1319-0.0;Dried fruit intake;rs61730696;A;1.0;0.09358;0.036047;0.0094299;R104W;ENST00000591765
CCR10;ENSG00000184451;30280-0.0;Immature reticulocyte fraction;rs61730696;A;1.0;-0.0043225;0.0013289;0.0011432;R326W;ENST00000332438
CCR10;ENSG00000184451;30280-0.0;Immature reticulocyte fraction;rs61730696;A;1.0;-0.0043225;0.0013289;0.0011432;R104W;ENST00000591765
CCR10;ENSG00000184451;clinical_c_Block_B35-B49;B35-B49 Mycoses;rs140554625;G;0.903185;0.31883;0.047187;1.414e-11;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_Block_B35-B49;B35-B49 Mycoses;rs140554625;G;0.903185;0.31883;0.047187;1.414e-11;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_G47;G47 Sleep disorders;rs140554625;G;0.903185;0.3102;0.065853;2.4715e-06;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_G47;G47 Sleep disorders;rs140554625;G;0.903185;0.3102;0.065853;2.4715e-06;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_J18;J18 Pneumonia, organism unspecified;rs140554625;G;0.903185;0.30157;0.08541599999999999;0.00041464;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_J18;J18 Pneumonia, organism unspecified;rs140554625;G;0.903185;0.30157;0.08541599999999999;0.00041464;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_K75;K75 Other inflammatory liver diseases;rs140554625;G;0.903185;0.46369;0.023795;1.5378999999999998e-84;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_K75;K75 Other inflammatory liver diseases;rs140554625;G;0.903185;0.46369;0.023795;1.5378999999999998e-84;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_M70;M70 Soft tissue disorders related to use, overuse and pressure;rs201963186;G;0.382842;0.011427;0.0039433;0.0037566;T112P;ENST00000332438
CCR10;ENSG00000184451;selfReported_n_1519;colitis/not crohns or ulcerative colitis;rs201963186;G;0.382842;0.010156;0.0032128;0.0015723;T112P;ENST00000332438
CCR10;ENSG00000184451;clinical_c_N32;N32 Other disorders of bladder;rs140554625;G;0.903185;0.32326;0.084103;0.00012124;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_N32;N32 Other disorders of bladder;rs140554625;G;0.903185;0.32326;0.084103;0.00012124;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_M75;M75 Shoulder lesions;rs140554625;G;0.903185;0.33228;0.08581699999999999;0.00010800000000000001;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_M75;M75 Shoulder lesions;rs140554625;G;0.903185;0.33228;0.08581699999999999;0.00010800000000000001;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_H54;H54 Blindness and low vision;rs201963186;G;0.382842;0.007588500000000001;0.0028973000000000002;0.008814200000000001;T112P;ENST00000332438
CCR10;ENSG00000184451;clinical_c_E27;E27 Other disorders of adrenal gland;rs61730696;A;1.0;0.0023561999999999997;0.00087598;0.0071507;R326W;ENST00000332438
CCR10;ENSG00000184451;clinical_c_E27;E27 Other disorders of adrenal gland;rs61730696;A;1.0;0.0023561999999999997;0.00087598;0.0071507;R104W;ENST00000591765
CCR10;ENSG00000184451;clinical_c_K30;K30 Dyspepsia;rs140554625;G;0.903185;0.29696999999999996;0.09842200000000001;0.0025507;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_K30;K30 Dyspepsia;rs140554625;G;0.903185;0.29696999999999996;0.09842200000000001;0.0025507;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_B95;B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters;rs140554625;G;0.903185;0.31621;0.058172;5.4573e-08;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_B95;B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters;rs140554625;G;0.903185;0.31621;0.058172;5.4573e-08;S135T;ENST00000591765
CCR10;ENSG00000184451;selfReported_n_1083;cerebrovascular disease;rs140554625;G;0.903185;0.3008;0.07908899999999999;0.00014281;S357T;ENST00000332438
CCR10;ENSG00000184451;selfReported_n_1083;cerebrovascular disease;rs140554625;G;0.903185;0.3008;0.07908899999999999;0.00014281;S135T;ENST00000591765
CCR10;ENSG00000184451;selfReported_n_1605;fibromyalgia;rs201963186;G;0.382842;0.0097314;0.002402;5.0915e-05;T112P;ENST00000332438
CCR10;ENSG00000184451;30230-0.0;Nucleated red blood cell percentage;rs140554625;G;0.903185;0.81371;0.23337;0.00048881;S357T;ENST00000332438
CCR10;ENSG00000184451;30230-0.0;Nucleated red blood cell percentage;rs140554625;G;0.903185;0.81371;0.23337;0.00048881;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_M46;M46 Other inflammatory spondylopathies;rs140554625;G;0.903185;0.3462;0.032576999999999995;2.2396e-26;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_M46;M46 Other inflammatory spondylopathies;rs140554625;G;0.903185;0.3462;0.032576999999999995;2.2396e-26;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_Block_J09-J18;J09-J18 Influenza and pneumonia;rs140554625;G;0.903185;0.29803;0.089384;0.00085534;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_Block_J09-J18;J09-J18 Influenza and pneumonia;rs140554625;G;0.903185;0.29803;0.089384;0.00085534;S135T;ENST00000591765
CCR10;ENSG00000184451;1873-0.0;Number of full brothers;rs140554625;G;0.903185;1.8334;0.6675399999999999;0.0060235;S357T;ENST00000332438
CCR10;ENSG00000184451;1873-0.0;Number of full brothers;rs140554625;G;0.903185;1.8334;0.6675399999999999;0.0060235;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_Block_G90-G99;G90-G99 Other disorders of the nervous system;rs140554625;G;0.903185;0.3173;0.058285000000000003;5.213199999999999e-08;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_Block_G90-G99;G90-G99 Other disorders of the nervous system;rs140554625;G;0.903185;0.3173;0.058285000000000003;5.213199999999999e-08;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_N13;N13 Obstructive and reflux uropathy;rs140554625;G;0.903185;0.3204;0.046836;7.8762e-12;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_N13;N13 Obstructive and reflux uropathy;rs140554625;G;0.903185;0.3204;0.046836;7.8762e-12;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_N94;N94 Pain and other conditions associated with female genital organs and menstrual cycle;rs140554625;G;0.903185;0.41927;0.087005;1.4442e-06;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_N94;N94 Pain and other conditions associated with female genital organs and menstrual cycle;rs140554625;G;0.903185;0.41927;0.087005;1.4442e-06;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_Block_N10-N16;N10-N16 Renal tubulo-interstitial diseases;rs140554625;G;0.903185;0.3146;0.055934000000000005;1.8628e-08;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_Block_N10-N16;N10-N16 Renal tubulo-interstitial diseases;rs140554625;G;0.903185;0.3146;0.055934000000000005;1.8628e-08;S135T;ENST00000591765
CCR10;ENSG00000184451;selfReported_n_1511;eczema/dermatitis;rs140554625;G;0.903185;0.31296999999999997;0.091843;0.0006553999999999999;S357T;ENST00000332438
CCR10;ENSG00000184451;selfReported_n_1511;eczema/dermatitis;rs140554625;G;0.903185;0.31296999999999997;0.091843;0.0006553999999999999;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_Block_M45-M49;M45-M49 Spondylopathies;rs140554625;G;0.903185;0.36338000000000004;0.096558;0.00016769999999999998;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_Block_M45-M49;M45-M49 Spondylopathies;rs140554625;G;0.903185;0.36338000000000004;0.096558;0.00016769999999999998;S135T;ENST00000591765
CCR10;ENSG00000184451;clinical_c_Block_G40-G47;G40-G47 Episodic and paroxysmal disorders;rs140554625;G;0.903185;0.27507;0.10662999999999999;0.009892299999999998;S357T;ENST00000332438
CCR10;ENSG00000184451;clinical_c_Block_G40-G47;G40-G47 Episodic and paroxysmal disorders;rs140554625;G;0.903185;0.27507;0.10662999999999999;0.009892299999999998;S135T;ENST00000591765
CCR10;ENSG00000184451;1309-0.0;Fresh fruit intake;rs61730696;A;1.0;0.12727;0.036172;0.00043403;R326W;ENST00000332438
CCR10;ENSG00000184451;1309-0.0;Fresh fruit intake;rs61730696;A;1.0;0.12727;0.036172;0.00043403;R104W;ENST00000591765
CCR10;ENSG00000184451;cancer_c_Block_C60-C63;C60-C63 Malignant neoplasms of male genital organs;rs140554625;G;0.903185;0.96731;0.18261;1.1778e-07;S357T;ENST00000332438
CCR10;ENSG00000184451;cancer_c_Block_C60-C63;C60-C63 Malignant neoplasms of male genital organs;rs140554625;G;0.903185;0.96731;0.18261;1.1778e-07;S135T;ENST00000591765
CCR8;ENSG00000179934;clinical_c_L08;L08 Other local infections of skin and subcutaneous tissue;rs144913149;T;1.0;0.004894699999999999;0.0016801;0.0035765000000000003;S110F;ENST00000326306
CCR8;ENSG00000179934;3079-0.0;Pace-maker;rs200735175;T;0.774352;0.0078486;0.0022697;0.00054443;T191I;ENST00000326306
CCR8;ENSG00000179934;selfReported_n_1163;gastric/stomach ulcers;rs200735175;T;0.774352;0.0090721;0.0035052;0.0096479;T191I;ENST00000326306
CCR8;ENSG00000179934;clinical_c_K13;K13 Other diseases of lip and oral mucosa;rs2853699;G;1.0;0.00049626;0.00018778;0.0082226;A27G;ENST00000326306
CCR8;ENSG00000179934;clinical_c_K13;K13 Other diseases of lip and oral mucosa;rs2853699;G;1.0;0.00049626;0.00018778;0.0082226;A27G;ENST00000414803
CCR8;ENSG00000179934;clinical_c_L82;L82 Seborrhoeic keratosis;rs200735175;T;0.774352;0.01314;0.0035691000000000004;0.00023182;T191I;ENST00000326306
CCR8;ENSG00000179934;selfReported_n_1293;spinal injury;rs200735175;T;0.774352;0.0047558;0.0016281;0.0034884;T191I;ENST00000326306
CCR8;ENSG00000179934;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs144913149;T;1.0;0.015955;0.0036059;9.663e-06;S110F;ENST00000326306
CCR8;ENSG00000179934;clinical_c_E78;E78 Disorders of lipoprotein metabolism and other lipidaemias;rs200735175;T;0.774352;0.029992;0.011018;0.0064895;T191I;ENST00000326306
CCR8;ENSG00000179934;clinical_c_D51;D51 Vitamin B12 deficiency anaemia;rs144913149;T;1.0;0.0045562;0.0014164000000000002;0.0012961;S110F;ENST00000326306
CCR8;ENSG00000179934;clinical_c_J93;J93 Pneumothorax;rs144913149;T;1.0;0.0036909;0.0013849;0.0076958;S110F;ENST00000326306
CCR8;ENSG00000179934;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs2853699;G;1.0;0.00029743;0.00011508;0.0097515;A27G;ENST00000326306
CCR8;ENSG00000179934;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs2853699;G;1.0;0.00029743;0.00011508;0.0097515;A27G;ENST00000414803
CCR8;ENSG00000179934;clinical_c_Block_I10-I15;I10-I15 Hypertensive diseases;rs2853699;G;1.0;0.0021884;0.00079081;0.005653899999999999;A27G;ENST00000326306
CCR8;ENSG00000179934;clinical_c_Block_I10-I15;I10-I15 Hypertensive diseases;rs2853699;G;1.0;0.0021884;0.00079081;0.005653899999999999;A27G;ENST00000414803
CCR8;ENSG00000179934;clinical_c_Block_E70-E90;E70-E90 Metabolic disorders;rs200735175;T;0.774352;0.032415;0.01209;0.0073348;T191I;ENST00000326306
CCR8;ENSG00000179934;1777-0.0;Part of a multiple birth;rs144913149;T;1.0;-0.011784000000000001;0.0045493;0.0095899;S110F;ENST00000326306
CCR8;ENSG00000179934;cancer_c_C34;C34 Malignant neoplasm of bronchus and lung;rs144913149;T;1.0;0.005021800000000001;0.0018584;0.006888200000000001;S110F;ENST00000326306
CCR8;ENSG00000179934;selfReported_n_1291;migraine;rs200735175;T;0.774352;0.017935;0.006845100000000001;0.0087906;T191I;ENST00000326306
CCR8;ENSG00000179934;clinical_c_K20;K20 Oesophagitis;rs200735175;T;0.774352;0.017490000000000002;0.0060831;0.0040384;T191I;ENST00000326306
CCR8;ENSG00000179934;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs144913149;T;1.0;0.016146;0.0035601;5.760800000000002e-06;S110F;ENST00000326306
CCR8;ENSG00000179934;selfReported_n_1660;respiratory infection;rs144913149;T;1.0;0.011401;0.0036801000000000004;0.0019474;S110F;ENST00000326306
CCR8;ENSG00000179934;136-0.0;Number of operations, self-reported;rs2853699;G;1.0;0.0090118;0.003218;0.0051031;A27G;ENST00000326306
CCR8;ENSG00000179934;136-0.0;Number of operations, self-reported;rs2853699;G;1.0;0.0090118;0.003218;0.0051031;A27G;ENST00000414803
CCR8;ENSG00000179934;clinical_c_Block_L80-L99;L80-L99 Other disorders of the skin and subcutaneous tissue;rs200735175;T;0.774352;0.030385000000000002;0.007963600000000001;0.00013593;T191I;ENST00000326306
CCR8;ENSG00000179934;selfReported_n_1081;hypertension;rs2853699;G;1.0;0.0026107;0.00086537;0.0025542;A27G;ENST00000326306
CCR8;ENSG00000179934;selfReported_n_1081;hypertension;rs2853699;G;1.0;0.0026107;0.00086537;0.0025542;A27G;ENST00000414803
CCR8;ENSG00000179934;clinical_c_N87;N87 Dysplasia of cervix uteri;rs140996751;C;0.944853;0.029147000000000006;0.010478;0.0054073;C43S;ENST00000326306
CCR8;ENSG00000179934;clinical_c_O48;O48 Prolonged pregnancy;rs2853699;G;1.0;-0.00060236;0.00022174;0.006597100000000001;A27G;ENST00000326306
CCR8;ENSG00000179934;clinical_c_O48;O48 Prolonged pregnancy;rs2853699;G;1.0;-0.00060236;0.00022174;0.006597100000000001;A27G;ENST00000414803
CCR8;ENSG00000179934;selfReported_n_1443;pneumonia;rs144913149;T;1.0;0.011673000000000001;0.0036443000000000005;0.0013594000000000002;S110F;ENST00000326306
CCR8;ENSG00000179934;134-0.0;Number of self-reported cancers;rs144913149;T;1.0;-0.024733;0.0094125;0.008598399999999999;S110F;ENST00000326306
CCR8;ENSG00000179934;clinical_c_O36;O36 Maternal care for other known or suspected foetal problems;rs144913149;T;1.0;0.010363;0.0036993;0.0050897;S110F;ENST00000326306
CCR8;ENSG00000179934;135-0.0;Number of self-reported non-cancer illnesses;rs2853699;G;1.0;0.013685;0.0037990000000000003;0.00031562;A27G;ENST00000326306
CCR8;ENSG00000179934;135-0.0;Number of self-reported non-cancer illnesses;rs2853699;G;1.0;0.013685;0.0037990000000000003;0.00031562;A27G;ENST00000414803
CCR8;ENSG00000179934;selfReported_n_1317;mania/bipolar disorder/manic depression;rs2853699;G;1.0;0.00035894;0.00011909999999999998;0.0025815;A27G;ENST00000326306
CCR8;ENSG00000179934;selfReported_n_1317;mania/bipolar disorder/manic depression;rs2853699;G;1.0;0.00035894;0.00011909999999999998;0.0025815;A27G;ENST00000414803
CCR8;ENSG00000179934;clinical_c_I10;I10 Essential (primary) hypertension;rs2853699;G;1.0;0.0021656999999999996;0.00078996;0.0061167;A27G;ENST00000326306
CCR8;ENSG00000179934;clinical_c_I10;I10 Essential (primary) hypertension;rs2853699;G;1.0;0.0021656999999999996;0.00078996;0.0061167;A27G;ENST00000414803
CCR8;ENSG00000179934;clinical_c_H65;H65 Nonsuppurative otitis media;rs140996751;C;0.944853;0.018009999999999998;0.0050971;0.00041047;C43S;ENST00000326306
CCR8;ENSG00000179934;selfReported_n_1314;nervous breakdown;rs200735175;T;0.774352;0.0050093;0.0015957;0.0016935;T191I;ENST00000326306
CCR8;ENSG00000179934;clinical_c_Block_F30-F39;F30-F39 Mood [affective] disorders;rs2853699;G;1.0;0.0010236000000000002;0.00038537;0.007902;A27G;ENST00000326306
CCR8;ENSG00000179934;clinical_c_Block_F30-F39;F30-F39 Mood [affective] disorders;rs2853699;G;1.0;0.0010236000000000002;0.00038537;0.007902;A27G;ENST00000414803
CCR8;ENSG00000179934;clinical_c_Block_J90-J94;J90-J94 Other diseases of pleura;rs200735175;T;0.774352;0.0178;0.0051998;0.0006189;T191I;ENST00000326306
CCR8;ENSG00000179934;clinical_c_J90;J90 Pleural effusion, not elsewhere classified;rs200735175;T;0.774352;0.014961000000000002;0.0046004;0.0011459;T191I;ENST00000326306
CCR8;ENSG00000179934;clinical_c_I60;I60 Subarachnoid haemorrhage;rs144913149;T;1.0;0.005642899999999999;0.0013637;3.5071e-05;S110F;ENST00000326306
CCR8;ENSG00000179934;selfReported_n_1156;liver/biliary/pancreas problem;rs140996751;C;0.944853;0.043692;0.016594;0.008463600000000002;C43S;ENST00000326306
CCR8;ENSG00000179934;clinical_c_N17;N17 Acute renal failure;rs200735175;T;0.774352;0.012501;0.0042931;0.0035919000000000003;T191I;ENST00000326306
CCR8;ENSG00000179934;1458-0.0;Cereal intake;rs2853699;G;1.0;0.017487;0.0059658;0.0033763000000000005;A27G;ENST00000326306
CCR8;ENSG00000179934;1458-0.0;Cereal intake;rs2853699;G;1.0;0.017487;0.0059658;0.0033763000000000005;A27G;ENST00000414803
CCR8;ENSG00000179934;clinical_c_L90;L90 Atrophic disorders of skin;rs200735175;T;0.774352;0.010925;0.0034132;0.0013709000000000002;T191I;ENST00000326306
CCR8;ENSG00000179934;selfReported_n_1305;eye trauma;rs144913149;T;1.0;0.0034484000000000003;0.001149;0.0026888000000000003;S110F;ENST00000326306
CCR8;ENSG00000179934;clinical_c_H60;H60 Otitis externa;rs144913149;T;1.0;0.0035152;0.0011036;0.0014460999999999999;S110F;ENST00000326306
CCR8;ENSG00000179934;selfReported_n_1269;psychological/psychiatric problem;rs2853699;G;1.0;0.0016190000000000002;0.00058758;0.0058617;A27G;ENST00000326306
CCR8;ENSG00000179934;selfReported_n_1269;psychological/psychiatric problem;rs2853699;G;1.0;0.0016190000000000002;0.00058758;0.0058617;A27G;ENST00000414803
CCR8;ENSG00000179934;clinical_c_I50;I50 Heart failure;rs200735175;T;0.774352;0.012928;0.004667899999999999;0.005614899999999999;T191I;ENST00000326306
CCR8;ENSG00000179934;clinical_c_Block_J95-J99;J95-J99 Other diseases of the respiratory system;rs200735175;T;0.774352;0.012489;0.0046773000000000006;0.0075804;T191I;ENST00000326306
CXCR6;ENSG00000172215;30240-0.0;Reticulocyte percentage;rs151224196;A;0.873088;0.089187;0.032736;0.0064411;G107D;ENST00000304552
CXCR6;ENSG00000172215;30240-0.0;Reticulocyte percentage;rs151224196;A;0.873088;0.089187;0.032736;0.0064411;G107D;ENST00000438735
CXCR6;ENSG00000172215;30240-0.0;Reticulocyte percentage;rs151224196;A;0.873088;0.089187;0.032736;0.0064411;G107D;ENST00000457814
CXCR6;ENSG00000172215;30240-0.0;Reticulocyte percentage;rs151224196;A;0.873088;0.089187;0.032736;0.0064411;G107D;ENST00000458629
CXCR6;ENSG00000172215;clinical_c_O72;O72 Postpartum haemorrhage;rs2234355;A;1.0;0.0097966;0.0030241;0.0011973;E3K;ENST00000304552
CXCR6;ENSG00000172215;clinical_c_O72;O72 Postpartum haemorrhage;rs2234355;A;1.0;0.0097966;0.0030241;0.0011973;E3K;ENST00000438735
CXCR6;ENSG00000172215;clinical_c_O72;O72 Postpartum haemorrhage;rs2234355;A;1.0;0.0097966;0.0030241;0.0011973;E3K;ENST00000457814
CXCR6;ENSG00000172215;clinical_c_O72;O72 Postpartum haemorrhage;rs2234355;A;1.0;0.0097966;0.0030241;0.0011973;E3K;ENST00000458629
CXCR6;ENSG00000172215;30290-0.0;High light scatter reticulocyte percentage;rs151224196;A;0.873088;0.032826999999999995;0.012081;0.0065844;G107D;ENST00000304552
CXCR6;ENSG00000172215;30290-0.0;High light scatter reticulocyte percentage;rs151224196;A;0.873088;0.032826999999999995;0.012081;0.0065844;G107D;ENST00000438735
CXCR6;ENSG00000172215;30290-0.0;High light scatter reticulocyte percentage;rs151224196;A;0.873088;0.032826999999999995;0.012081;0.0065844;G107D;ENST00000457814
CXCR6;ENSG00000172215;30290-0.0;High light scatter reticulocyte percentage;rs151224196;A;0.873088;0.032826999999999995;0.012081;0.0065844;G107D;ENST00000458629
CXCR6;ENSG00000172215;clinical_c_O42;O42 Premature rupture of membranes;rs2234355;A;1.0;0.010821;0.0027377;7.729899999999999e-05;E3K;ENST00000304552
CXCR6;ENSG00000172215;clinical_c_O42;O42 Premature rupture of membranes;rs2234355;A;1.0;0.010821;0.0027377;7.729899999999999e-05;E3K;ENST00000438735
CXCR6;ENSG00000172215;clinical_c_O42;O42 Premature rupture of membranes;rs2234355;A;1.0;0.010821;0.0027377;7.729899999999999e-05;E3K;ENST00000457814
CXCR6;ENSG00000172215;clinical_c_O42;O42 Premature rupture of membranes;rs2234355;A;1.0;0.010821;0.0027377;7.729899999999999e-05;E3K;ENST00000458629
CXCR6;ENSG00000172215;30300-0.0;High light scatter reticulocyte count;rs151224196;A;0.873088;0.0015005;0.00054036;0.0054873000000000005;G107D;ENST00000304552
CXCR6;ENSG00000172215;30300-0.0;High light scatter reticulocyte count;rs151224196;A;0.873088;0.0015005;0.00054036;0.0054873000000000005;G107D;ENST00000438735
CXCR6;ENSG00000172215;30300-0.0;High light scatter reticulocyte count;rs151224196;A;0.873088;0.0015005;0.00054036;0.0054873000000000005;G107D;ENST00000457814
CXCR6;ENSG00000172215;30300-0.0;High light scatter reticulocyte count;rs151224196;A;0.873088;0.0015005;0.00054036;0.0054873000000000005;G107D;ENST00000458629
CXCR6;ENSG00000172215;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs2234355;A;1.0;0.0030134;0.0010577;0.0043861;E3K;ENST00000304552
CXCR6;ENSG00000172215;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs2234355;A;1.0;0.0030134;0.0010577;0.0043861;E3K;ENST00000438735
CXCR6;ENSG00000172215;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs2234355;A;1.0;0.0030134;0.0010577;0.0043861;E3K;ENST00000457814
CXCR6;ENSG00000172215;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs2234355;A;1.0;0.0030134;0.0010577;0.0043861;E3K;ENST00000458629
CXCR6;ENSG00000172215;clinical_c_H35;H35 Other retinal disorders;rs151224196;A;0.873088;0.017228;0.006476600000000001;0.007814699999999999;G107D;ENST00000304552
CXCR6;ENSG00000172215;clinical_c_H35;H35 Other retinal disorders;rs151224196;A;0.873088;0.017228;0.006476600000000001;0.007814699999999999;G107D;ENST00000438735
CXCR6;ENSG00000172215;clinical_c_H35;H35 Other retinal disorders;rs151224196;A;0.873088;0.017228;0.006476600000000001;0.007814699999999999;G107D;ENST00000457814
CXCR6;ENSG00000172215;clinical_c_H35;H35 Other retinal disorders;rs151224196;A;0.873088;0.017228;0.006476600000000001;0.007814699999999999;G107D;ENST00000458629
CXCR6;ENSG00000172215;30250-0.0;Reticulocyte count;rs151224196;A;0.873088;0.0039773000000000005;0.0014872;0.0074875;G107D;ENST00000304552
CXCR6;ENSG00000172215;30250-0.0;Reticulocyte count;rs151224196;A;0.873088;0.0039773000000000005;0.0014872;0.0074875;G107D;ENST00000438735
CXCR6;ENSG00000172215;30250-0.0;Reticulocyte count;rs151224196;A;0.873088;0.0039773000000000005;0.0014872;0.0074875;G107D;ENST00000457814
CXCR6;ENSG00000172215;30250-0.0;Reticulocyte count;rs151224196;A;0.873088;0.0039773000000000005;0.0014872;0.0074875;G107D;ENST00000458629
CXCR6;ENSG00000172215;selfReported_n_1175;irritable bowel syndrome;rs151224196;A;0.873088;0.034239;0.010739;0.0014311;G107D;ENST00000304552
CXCR6;ENSG00000172215;selfReported_n_1175;irritable bowel syndrome;rs151224196;A;0.873088;0.034239;0.010739;0.0014311;G107D;ENST00000438735
CXCR6;ENSG00000172215;selfReported_n_1175;irritable bowel syndrome;rs151224196;A;0.873088;0.034239;0.010739;0.0014311;G107D;ENST00000457814
CXCR6;ENSG00000172215;selfReported_n_1175;irritable bowel syndrome;rs151224196;A;0.873088;0.034239;0.010739;0.0014311;G107D;ENST00000458629
CXCR6;ENSG00000172215;20117-0.0;Alcohol drinker status;rs151224196;A;0.873088;0.07131599999999999;0.027099;0.0084965;G107D;ENST00000304552
CXCR6;ENSG00000172215;20117-0.0;Alcohol drinker status;rs151224196;A;0.873088;0.07131599999999999;0.027099;0.0084965;G107D;ENST00000438735
CXCR6;ENSG00000172215;20117-0.0;Alcohol drinker status;rs151224196;A;0.873088;0.07131599999999999;0.027099;0.0084965;G107D;ENST00000457814
CXCR6;ENSG00000172215;20117-0.0;Alcohol drinker status;rs151224196;A;0.873088;0.07131599999999999;0.027099;0.0084965;G107D;ENST00000458629
CXCR6;ENSG00000172215;clinical_c_I61;I61 Intracerebral haemorrhage;rs2234355;A;1.0;0.0035995;0.0012122;0.0029839000000000003;E3K;ENST00000304552
CXCR6;ENSG00000172215;clinical_c_I61;I61 Intracerebral haemorrhage;rs2234355;A;1.0;0.0035995;0.0012122;0.0029839000000000003;E3K;ENST00000438735
CXCR6;ENSG00000172215;clinical_c_I61;I61 Intracerebral haemorrhage;rs2234355;A;1.0;0.0035995;0.0012122;0.0029839000000000003;E3K;ENST00000457814
CXCR6;ENSG00000172215;clinical_c_I61;I61 Intracerebral haemorrhage;rs2234355;A;1.0;0.0035995;0.0012122;0.0029839000000000003;E3K;ENST00000458629
CXCR6;ENSG00000172215;clinical_c_H01;H01 Other inflammation of eyelid;rs151224196;A;0.873088;0.0089084;0.0026878;0.00091847;G107D;ENST00000304552
CXCR6;ENSG00000172215;clinical_c_H01;H01 Other inflammation of eyelid;rs151224196;A;0.873088;0.0089084;0.0026878;0.00091847;G107D;ENST00000438735
CXCR6;ENSG00000172215;clinical_c_H01;H01 Other inflammation of eyelid;rs151224196;A;0.873088;0.0089084;0.0026878;0.00091847;G107D;ENST00000457814
CXCR6;ENSG00000172215;clinical_c_H01;H01 Other inflammation of eyelid;rs151224196;A;0.873088;0.0089084;0.0026878;0.00091847;G107D;ENST00000458629
CXCR4;ENSG00000121966;clinical_c_A04;A04 Other bacterial intestinal infections;rs56400844;G;0.623492;0.024527;0.007611100000000001;0.0012709000000000002;I53L;ENST00000241393
CXCR4;ENSG00000121966;clinical_c_A04;A04 Other bacterial intestinal infections;rs56400844;G;0.623492;0.024527;0.007611100000000001;0.0012709000000000002;I57L;ENST00000409817
CXCR4;ENSG00000121966;30280-0.0;Immature reticulocyte fraction;rs56400844;G;0.623492;-0.013518;0.0049177;0.005980600000000001;I53L;ENST00000241393
CXCR4;ENSG00000121966;30280-0.0;Immature reticulocyte fraction;rs56400844;G;0.623492;-0.013518;0.0049177;0.005980600000000001;I57L;ENST00000409817
CXCR4;ENSG00000121966;30080-0.0;Platelet count;rs56400844;G;0.623492;13.342;4.183;0.0014245999999999998;I53L;ENST00000241393
CXCR4;ENSG00000121966;30080-0.0;Platelet count;rs56400844;G;0.623492;13.342;4.183;0.0014245999999999998;I57L;ENST00000409817
CXCR4;ENSG00000121966;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs56400844;G;0.623492;0.016216;0.0034757;3.0786e-06;I53L;ENST00000241393
CXCR4;ENSG00000121966;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs56400844;G;0.623492;0.016216;0.0034757;3.0786e-06;I57L;ENST00000409817
CXCR4;ENSG00000121966;clinical_c_H35;H35 Other retinal disorders;rs56400844;G;0.623492;0.024621;0.0087499;0.0048955;I53L;ENST00000241393
CXCR4;ENSG00000121966;clinical_c_H35;H35 Other retinal disorders;rs56400844;G;0.623492;0.024621;0.0087499;0.0048955;I57L;ENST00000409817
CXCR4;ENSG00000121966;selfReported_n_1133;bronchiectasis;rs56400844;G;0.623492;0.013474000000000002;0.00464;0.0036868;I53L;ENST00000241393
CXCR4;ENSG00000121966;selfReported_n_1133;bronchiectasis;rs56400844;G;0.623492;0.013474000000000002;0.00464;0.0036868;I57L;ENST00000409817
CXCR4;ENSG00000121966;clinical_c_Block_J20-J22;J20-J22 Other acute lower respiratory infections;rs56400844;G;0.623492;0.034545;0.012959;0.0076833;I53L;ENST00000241393
CXCR4;ENSG00000121966;clinical_c_Block_J20-J22;J20-J22 Other acute lower respiratory infections;rs56400844;G;0.623492;0.034545;0.012959;0.0076833;I57L;ENST00000409817
CXCR4;ENSG00000121966;clinical_c_K50;K50 Crohn's disease [regional enteritis];rs56400844;G;0.623492;0.020096;0.006161600000000001;0.0011083;I53L;ENST00000241393
CXCR4;ENSG00000121966;clinical_c_K50;K50 Crohn's disease [regional enteritis];rs56400844;G;0.623492;0.020096;0.006161600000000001;0.0011083;I57L;ENST00000409817
CXCR4;ENSG00000121966;clinical_c_K41;K41 Femoral hernia;rs56400844;G;0.623492;0.012237;0.0037527000000000003;0.0011105;I53L;ENST00000241393
CXCR4;ENSG00000121966;clinical_c_K41;K41 Femoral hernia;rs56400844;G;0.623492;0.012237;0.0037527000000000003;0.0011105;I57L;ENST00000409817
CXCR4;ENSG00000121966;clinical_c_J22;J22 Unspecified acute lower respiratory infection;rs56400844;G;0.623492;0.03522;0.012832;0.006058600000000001;I53L;ENST00000241393
CXCR4;ENSG00000121966;clinical_c_J22;J22 Unspecified acute lower respiratory infection;rs56400844;G;0.623492;0.03522;0.012832;0.006058600000000001;I57L;ENST00000409817
CXCR4;ENSG00000121966;clinical_c_H52;H52 Disorders of refraction and accommodation;rs56400844;G;0.623492;0.019909;0.006352;0.0017233;I53L;ENST00000241393
CXCR4;ENSG00000121966;clinical_c_H52;H52 Disorders of refraction and accommodation;rs56400844;G;0.623492;0.019909;0.006352;0.0017233;I57L;ENST00000409817
CXCR4;ENSG00000121966;clinical_c_K82;K82 Other diseases of gallbladder;rs56400844;G;0.623492;0.017031;0.0063111999999999994;0.006963600000000001;I53L;ENST00000241393
CXCR4;ENSG00000121966;clinical_c_K82;K82 Other diseases of gallbladder;rs56400844;G;0.623492;0.017031;0.0063111999999999994;0.006963600000000001;I57L;ENST00000409817
CXCR4;ENSG00000121966;30110-0.0;Platelet distribution width;rs56400844;G;0.623492;-0.16037;0.039605;5.1385e-05;I53L;ENST00000241393
CXCR4;ENSG00000121966;30110-0.0;Platelet distribution width;rs56400844;G;0.623492;-0.16037;0.039605;5.1385e-05;I57L;ENST00000409817
ACKR4;ENSG00000129048;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs147449210;C;0.9464870000000001;0.042116;0.012069;0.0004837;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_I44;I44 Atrioventricular and left bundle-branch block;rs147449210;C;0.9464870000000001;0.074675;0.019888;0.00017346;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_Block_L40-L45;L40-L45 Papulosquamous disorders;rs147449210;C;0.9464870000000001;0.074611;0.017506;2.0253e-05;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_Block_L50-L54;L50-L54 Urticaria and erythema;rs147449210;C;0.9464870000000001;0.042916;0.010740000000000001;6.4438e-05;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_Block_M95-M99;M95-M99 Other disorders of the musculoskeletal system and connective tissue;rs147449210;C;0.9464870000000001;0.042998;0.009926899999999999;1.4818e-05;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_H61;H61 Other disorders of external ear;rs147449210;C;0.9464870000000001;0.035291;0.010397;0.00068772;V78L;ENST00000249887
ACKR4;ENSG00000129048;cancer_c_C54;C54 Malignant neoplasm of corpus uteri;rs147449210;C;0.9464870000000001;0.073908;0.020275;0.00026717;V78L;ENST00000249887
ACKR4;ENSG00000129048;selfReported_n_1085;venous thromboembolic disease;rs138269944;A;0.513152;0.022294;0.0080811;0.005801;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_J96;J96 Respiratory failure, not elsewhere classified;rs147449210;C;0.9464870000000001;0.04106;0.014952000000000002;0.006032;V78L;ENST00000249887
ACKR4;ENSG00000129048;selfReported_n_1621;obstetric problem;rs147449210;C;0.9464870000000001;0.057944;0.019871;0.0035457;V78L;ENST00000249887
ACKR4;ENSG00000129048;selfReported_n_1513;blistering/desquamating skin disorder;rs138269944;A;0.513152;0.0066006;0.0022146;0.0028784;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_O63;O63 Long labour;rs138269944;A;0.513152;0.018406;0.0066417;0.0055842;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_O68;O68 Labour and delivery complicated by foetal stress [distress];rs138269944;A;0.513152;0.023674;0.0085491;0.0056201;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_L53;L53 Other erythematous conditions;rs147449210;C;0.9464870000000001;0.044685;0.0076801000000000005;5.9463e-09;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_F31;F31 Bipolar affective disorder;rs147449210;C;0.9464870000000001;0.042963999999999995;0.010388;3.5379e-05;V78L;ENST00000249887
ACKR4;ENSG00000129048;selfReported_n_1540;psoriatic arthropathy;rs147449210;C;0.9464870000000001;0.044318;0.009412100000000001;2.4945e-06;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_O48;O48 Prolonged pregnancy;rs138269944;A;0.513152;0.016062;0.0052475;0.0022067;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_H92;H92 Otalgia and effusion of ear;rs147449210;C;0.9464870000000001;0.036666000000000004;0.007663;1.7125e-06;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_L97;L97 Ulcer of lower limb, not elsewhere classified;rs138269944;A;0.513152;0.0094568;0.0026128;0.00029529;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_L97;L97 Ulcer of lower limb, not elsewhere classified;rs147449210;C;0.9464870000000001;0.043335000000000005;0.010787;5.8896999999999995e-05;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_F33;F33 Recurrent depressive disorder;rs147449210;C;0.9464870000000001;0.04406;0.008973899999999998;9.117100000000001e-07;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_I35;I35 Nonrheumatic aortic valve disorders;rs138269944;A;0.513152;0.010985;0.0040476999999999996;0.0066492999999999995;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_I78;I78 Diseases of capillaries;rs147449210;C;0.9464870000000001;0.045636;0.0086883;1.5003e-07;V78L;ENST00000249887
ACKR4;ENSG00000129048;selfReported_n_1317;mania/bipolar disorder/manic depression;rs147449210;C;0.9464870000000001;0.044812;0.01127;7.0059e-05;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_Block_H90-H95;H90-H95 Other disorders of ear;rs147449210;C;0.9464870000000001;0.066087;0.022333000000000002;0.0030853;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_O82;O82 Single delivery by Caesarean section;rs138269944;A;0.513152;0.011331;0.0035927;0.0016117;V150E;ENST00000249887
ACKR4;ENSG00000129048;30130-0.0;Monocyte count;rs138269944;A;0.513152;0.021192;0.0069859;0.0024168;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_H65;H65 Nonsuppurative otitis media;rs147449210;C;0.9464870000000001;0.035243000000000003;0.010759999999999999;0.0010554;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs147449210;C;0.9464870000000001;0.043941;0.0085325;2.6082e-07;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_N23;N23 Unspecified renal colic;rs138269944;A;0.513152;0.0093855;0.0034915;0.007186;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_O46;O46 Antepartum haemorrhage, not elsewhere classified;rs138269944;A;0.513152;0.010034;0.0038671;0.0094695;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_H66;H66 Suppurative and unspecified otitis media;rs147449210;C;0.9464870000000001;0.045854;0.009324200000000001;8.757600000000001e-07;V78L;ENST00000249887
ACKR4;ENSG00000129048;selfReported_n_1218;kidney stone/ureter stone/bladder stone;rs138269944;A;0.513152;0.011726;0.0045284;0.009615700000000001;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs147449210;C;0.9464870000000001;0.035602999999999996;0.01031;0.00055415;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_K41;K41 Femoral hernia;rs138269944;A;0.513152;0.0059421000000000005;0.0020239;0.0033251999999999995;V150E;ENST00000249887
ACKR4;ENSG00000129048;selfReported_n_1292;head injury;rs147449210;C;0.9464870000000001;0.039367;0.012294;0.001364;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_Block_E50-E64;E50-E64 Other nutritional deficiencies;rs147449210;C;0.9464870000000001;0.041783999999999995;0.012397;0.00075083;V78L;ENST00000249887
ACKR4;ENSG00000129048;selfReported_n_1262;disorder or pituitary gland;rs147449210;C;0.9464870000000001;0.043591000000000005;0.0080011;5.0919e-08;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_E14;E14 Unspecified diabetes mellitus;rs147449210;C;0.9464870000000001;0.051604;0.015947;0.0012124;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs147449210;C;0.9464870000000001;0.033592000000000004;0.012652;0.0079315;V78L;ENST00000249887
ACKR4;ENSG00000129048;selfReported_n_1696;fracture head & neck;rs147449210;C;0.9464870000000001;0.037582;0.011229000000000001;0.00081739;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_K55;K55 Vascular disorders of intestine;rs147449210;C;0.9464870000000001;0.044972000000000005;0.010657;2.4449000000000003e-05;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_Block_O60-O75;O60-O75 Complications of labour and delivery;rs138269944;A;0.513152;0.047385;0.013116999999999998;0.00030338;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_E04;E04 Other non-toxic goitre;rs147449210;C;0.9464870000000001;0.040776;0.013543000000000001;0.0026043000000000004;V78L;ENST00000249887
ACKR4;ENSG00000129048;selfReported_n_1623;miscarriage;rs147449210;C;0.9464870000000001;0.05998600000000001;0.017066;0.00043992;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_K56;K56 Paralytic ileus and intestinal obstruction without hernia;rs147449210;C;0.9464870000000001;0.07331;0.020793;0.0004224;V78L;ENST00000249887
ACKR4;ENSG00000129048;selfReported_n_1695;fracture;rs147449210;C;0.9464870000000001;0.09121;0.028267;0.0012522;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_M53;M53 Other dorsopathies, not elsewhere classified;rs138269944;A;0.513152;0.0084372;0.0018827000000000002;7.419500000000001e-06;V150E;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_I50;I50 Heart failure;rs147449210;C;0.9464870000000001;0.066986;0.024094;0.005433299999999999;V78L;ENST00000249887
ACKR4;ENSG00000129048;clinical_c_L43;L43 Lichen planus;rs147449210;C;0.9464870000000001;0.036313;0.0078444;3.6723e-06;V78L;ENST00000249887
ACKR2;ENSG00000144648;clinical_c_G93;G93 Other disorders of brain;rs6779520;G;0.9810700000000001;0.085102;0.029598000000000003;0.0040371;L311V;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_G93;G93 Other disorders of brain;rs6779520;G;0.9810700000000001;0.085102;0.029598000000000003;0.0040371;L311V;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_A04;A04 Other bacterial intestinal infections;rs201310570;C;0.742383;0.014784;0.0051951;0.004431;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_A04;A04 Other bacterial intestinal infections;rs201310570;C;0.742383;0.014784;0.0051951;0.004431;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_A04;A04 Other bacterial intestinal infections;rs201310570;C;0.742383;0.014784;0.0051951;0.004431;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_K40;K40 Inguinal hernia;rs150050911;G;1.0;-0.011812000000000001;0.0045506999999999995;0.009439399999999999;S172C;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_K40;K40 Inguinal hernia;rs150050911;G;1.0;-0.011812000000000001;0.0045506999999999995;0.009439399999999999;S172C;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_K40;K40 Inguinal hernia;rs150050911;G;1.0;-0.011812000000000001;0.0045506999999999995;0.009439399999999999;S172C;ENST00000493193
ACKR2;ENSG00000144648;30030-0.0;Haematocrit percentage;rs2228467;C;1.0;-0.029476;0.010563;0.0052607;V41A;ENST00000422265
ACKR2;ENSG00000144648;30030-0.0;Haematocrit percentage;rs2228467;C;1.0;-0.029476;0.010563;0.0052607;V41A;ENST00000442925
ACKR2;ENSG00000144648;30030-0.0;Haematocrit percentage;rs2228467;C;1.0;-0.029476;0.010563;0.0052607;V41A;ENST00000492609
ACKR2;ENSG00000144648;30030-0.0;Haematocrit percentage;rs2228467;C;1.0;-0.029476;0.010563;0.0052607;V41A;ENST00000493193
ACKR2;ENSG00000144648;30030-0.0;Haematocrit percentage;rs2228467;C;1.0;-0.029476;0.010563;0.0052607;V41A;ENST00000494619
ACKR2;ENSG00000144648;30030-0.0;Haematocrit percentage;rs2228467;C;1.0;-0.029476;0.010563;0.0052607;V41A;ENST00000497921
ACKR2;ENSG00000144648;selfReported_n_1740;benign breast lump;rs147684121;C;1.0;0.0055555;0.0020501;0.0067313;G218A;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1740;benign breast lump;rs147684121;C;1.0;0.0055555;0.0020501;0.0067313;G218A;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1740;benign breast lump;rs147684121;C;1.0;0.0055555;0.0020501;0.0067313;G218A;ENST00000493193
ACKR2;ENSG00000144648;30210-0.0;Eosinophill percentage;rs2228467;C;1.0;0.05685;0.0064876000000000005;1.91e-18;V41A;ENST00000422265
ACKR2;ENSG00000144648;30210-0.0;Eosinophill percentage;rs2228467;C;1.0;0.05685;0.0064876000000000005;1.91e-18;V41A;ENST00000442925
ACKR2;ENSG00000144648;30210-0.0;Eosinophill percentage;rs2228467;C;1.0;0.05685;0.0064876000000000005;1.91e-18;V41A;ENST00000492609
ACKR2;ENSG00000144648;30210-0.0;Eosinophill percentage;rs2228467;C;1.0;0.05685;0.0064876000000000005;1.91e-18;V41A;ENST00000493193
ACKR2;ENSG00000144648;30210-0.0;Eosinophill percentage;rs2228467;C;1.0;0.05685;0.0064876000000000005;1.91e-18;V41A;ENST00000494619
ACKR2;ENSG00000144648;30210-0.0;Eosinophill percentage;rs2228467;C;1.0;0.05685;0.0064876000000000005;1.91e-18;V41A;ENST00000497921
ACKR2;ENSG00000144648;clinical_c_Block_G35-G37;G35-G37 Demyelinating diseases of the central nervous system;rs138890782;A;0.9652139999999999;0.039831;0.012291;0.0011929;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_G35-G37;G35-G37 Demyelinating diseases of the central nervous system;rs138890782;A;0.9652139999999999;0.039831;0.012291;0.0011929;R320H;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_G35-G37;G35-G37 Demyelinating diseases of the central nervous system;rs201310570;C;0.742383;0.011848000000000001;0.003912;0.0024574;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_G35-G37;G35-G37 Demyelinating diseases of the central nervous system;rs201310570;C;0.742383;0.011848000000000001;0.003912;0.0024574;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_G35-G37;G35-G37 Demyelinating diseases of the central nervous system;rs201310570;C;0.742383;0.011848000000000001;0.003912;0.0024574;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_A08;A08 Viral and other specified intestinal infections;rs138890782;A;0.9652139999999999;0.025258000000000003;0.0092645;0.0064054;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_A08;A08 Viral and other specified intestinal infections;rs138890782;A;0.9652139999999999;0.025258000000000003;0.0092645;0.0064054;R320H;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_N75;N75 Diseases of Bartholin's gland;rs138890782;A;0.9652139999999999;0.078903;0.016259;1.2172e-06;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_N75;N75 Diseases of Bartholin's gland;rs138890782;A;0.9652139999999999;0.078903;0.016259;1.2172e-06;R320H;ENST00000442925
ACKR2;ENSG00000144648;1359-0.0;Poultry intake;rs150050911;G;1.0;0.055188;0.020926;0.008356299999999999;S172C;ENST00000422265
ACKR2;ENSG00000144648;1359-0.0;Poultry intake;rs150050911;G;1.0;0.055188;0.020926;0.008356299999999999;S172C;ENST00000442925
ACKR2;ENSG00000144648;1359-0.0;Poultry intake;rs150050911;G;1.0;0.055188;0.020926;0.008356299999999999;S172C;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_N80;N80 Endometriosis;rs201310570;C;0.742383;0.045886;0.011597;7.6018e-05;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_N80;N80 Endometriosis;rs201310570;C;0.742383;0.045886;0.011597;7.6018e-05;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_N80;N80 Endometriosis;rs201310570;C;0.742383;0.045886;0.011597;7.6018e-05;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_Block_N00-N08;N00-N08 Glomerular diseases;rs147684121;C;1.0;0.0040996;0.0014884;0.0058801;G218A;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_N00-N08;N00-N08 Glomerular diseases;rs147684121;C;1.0;0.0040996;0.0014884;0.0058801;G218A;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_N00-N08;N00-N08 Glomerular diseases;rs147684121;C;1.0;0.0040996;0.0014884;0.0058801;G218A;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_N88;N88 Other noninflammatory disorders of cervix uteri;rs147684121;C;1.0;-0.0080454;0.0025344;0.0015014000000000002;G218A;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_N88;N88 Other noninflammatory disorders of cervix uteri;rs147684121;C;1.0;-0.0080454;0.0025344;0.0015014000000000002;G218A;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_N88;N88 Other noninflammatory disorders of cervix uteri;rs147684121;C;1.0;-0.0080454;0.0025344;0.0015014000000000002;G218A;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_H34;H34 Retinal vascular occlusions;rs201310570;C;0.742383;0.0067412999999999995;0.0023377;0.0039307;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_H34;H34 Retinal vascular occlusions;rs201310570;C;0.742383;0.0067412999999999995;0.0023377;0.0039307;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_H34;H34 Retinal vascular occlusions;rs201310570;C;0.742383;0.0067412999999999995;0.0023377;0.0039307;I233T;ENST00000493193
ACKR2;ENSG00000144648;selfReported_n_1275;cranial nerve problem/palsy;rs138890782;A;0.9652139999999999;0.040415;0.0091413;9.8213e-06;R320H;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1275;cranial nerve problem/palsy;rs138890782;A;0.9652139999999999;0.040415;0.0091413;9.8213e-06;R320H;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_M62;M62 Other disorders of muscle;rs138890782;A;0.9652139999999999;0.040225;0.0095778;2.6715e-05;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_M62;M62 Other disorders of muscle;rs138890782;A;0.9652139999999999;0.040225;0.0095778;2.6715e-05;R320H;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_J92;J92 Pleural plaque;rs201310570;C;0.742383;0.010681999999999999;0.0028054;0.00014029;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_J92;J92 Pleural plaque;rs201310570;C;0.742383;0.010681999999999999;0.0028054;0.00014029;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_J92;J92 Pleural plaque;rs201310570;C;0.742383;0.010681999999999999;0.0028054;0.00014029;I233T;ENST00000493193
ACKR2;ENSG00000144648;selfReported_n_1249;thyroid problem (not cancer);rs2228467;C;1.0;-0.0028634;0.00095509;0.0027177;V41A;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1249;thyroid problem (not cancer);rs2228467;C;1.0;-0.0028634;0.00095509;0.0027177;V41A;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1249;thyroid problem (not cancer);rs2228467;C;1.0;-0.0028634;0.00095509;0.0027177;V41A;ENST00000492609
ACKR2;ENSG00000144648;selfReported_n_1249;thyroid problem (not cancer);rs2228467;C;1.0;-0.0028634;0.00095509;0.0027177;V41A;ENST00000493193
ACKR2;ENSG00000144648;selfReported_n_1249;thyroid problem (not cancer);rs2228467;C;1.0;-0.0028634;0.00095509;0.0027177;V41A;ENST00000494619
ACKR2;ENSG00000144648;selfReported_n_1249;thyroid problem (not cancer);rs2228467;C;1.0;-0.0028634;0.00095509;0.0027177;V41A;ENST00000497921
ACKR2;ENSG00000144648;selfReported_n_1566;anal problem;rs201310570;C;0.742383;0.013787;0.0037198;0.00021018;I233T;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1566;anal problem;rs201310570;C;0.742383;0.013787;0.0037198;0.00021018;I233T;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1566;anal problem;rs201310570;C;0.742383;0.013787;0.0037198;0.00021018;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs147684121;C;1.0;0.0049305;0.0018088;0.0064149;G218A;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs147684121;C;1.0;0.0049305;0.0018088;0.0064149;G218A;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs147684121;C;1.0;0.0049305;0.0018088;0.0064149;G218A;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs201310570;C;0.742383;0.039349;0.0056895;4.6558e-12;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs201310570;C;0.742383;0.039349;0.0056895;4.6558e-12;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs201310570;C;0.742383;0.039349;0.0056895;4.6558e-12;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_I69;I69 Sequelae of cerebrovascular disease;rs201310570;C;0.742383;0.013231;0.0036018;0.00023927;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_I69;I69 Sequelae of cerebrovascular disease;rs201310570;C;0.742383;0.013231;0.0036018;0.00023927;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_I69;I69 Sequelae of cerebrovascular disease;rs201310570;C;0.742383;0.013231;0.0036018;0.00023927;I233T;ENST00000493193
ACKR2;ENSG00000144648;cancer_c_C67;C67 Malignant neoplasm of bladder;rs6779520;G;0.9810700000000001;0.22973000000000002;0.020692;1.2318e-28;L311V;ENST00000422265
ACKR2;ENSG00000144648;cancer_c_C67;C67 Malignant neoplasm of bladder;rs6779520;G;0.9810700000000001;0.22973000000000002;0.020692;1.2318e-28;L311V;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_K70;K70 Alcoholic liver disease;rs150050911;G;1.0;0.002878;0.0011172;0.0099929;S172C;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_K70;K70 Alcoholic liver disease;rs150050911;G;1.0;0.002878;0.0011172;0.0099929;S172C;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_K70;K70 Alcoholic liver disease;rs150050911;G;1.0;0.002878;0.0011172;0.0099929;S172C;ENST00000493193
ACKR2;ENSG00000144648;selfReported_n_1761;tuberculosis (tb);rs150050911;G;1.0;0.0060942;0.0017332;0.00043789;S172C;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1761;tuberculosis (tb);rs150050911;G;1.0;0.0060942;0.0017332;0.00043789;S172C;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1761;tuberculosis (tb);rs150050911;G;1.0;0.0060942;0.0017332;0.00043789;S172C;ENST00000493193
ACKR2;ENSG00000144648;selfReported_n_1761;tuberculosis (tb);rs2228467;C;1.0;0.00081474;0.0003047;0.0074983;V41A;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1761;tuberculosis (tb);rs2228467;C;1.0;0.00081474;0.0003047;0.0074983;V41A;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1761;tuberculosis (tb);rs2228467;C;1.0;0.00081474;0.0003047;0.0074983;V41A;ENST00000492609
ACKR2;ENSG00000144648;selfReported_n_1761;tuberculosis (tb);rs2228467;C;1.0;0.00081474;0.0003047;0.0074983;V41A;ENST00000493193
ACKR2;ENSG00000144648;selfReported_n_1761;tuberculosis (tb);rs2228467;C;1.0;0.00081474;0.0003047;0.0074983;V41A;ENST00000494619
ACKR2;ENSG00000144648;selfReported_n_1761;tuberculosis (tb);rs2228467;C;1.0;0.00081474;0.0003047;0.0074983;V41A;ENST00000497921
ACKR2;ENSG00000144648;clinical_c_K20;K20 Oesophagitis;rs150050911;G;1.0;0.011008;0.0036344999999999997;0.002456;S172C;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_K20;K20 Oesophagitis;rs150050911;G;1.0;0.011008;0.0036344999999999997;0.002456;S172C;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_K20;K20 Oesophagitis;rs150050911;G;1.0;0.011008;0.0036344999999999997;0.002456;S172C;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_D68;D68 Other coagulation defects;rs138890782;A;0.9652139999999999;0.051387;0.009755;1.3815e-07;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_D68;D68 Other coagulation defects;rs138890782;A;0.9652139999999999;0.051387;0.009755;1.3815e-07;R320H;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_O63;O63 Long labour;rs138890782;A;0.9652139999999999;0.089837;0.02619;0.00060334;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_O63;O63 Long labour;rs138890782;A;0.9652139999999999;0.089837;0.02619;0.00060334;R320H;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_J18;J18 Pneumonia, organism unspecified;rs201310570;C;0.742383;0.026187000000000002;0.0095108;0.0058988999999999995;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_J18;J18 Pneumonia, organism unspecified;rs201310570;C;0.742383;0.026187000000000002;0.0095108;0.0058988999999999995;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_J18;J18 Pneumonia, organism unspecified;rs201310570;C;0.742383;0.026187000000000002;0.0095108;0.0058988999999999995;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_Block_I30-I52;I30-I52 Other forms of heart disease;rs201310570;C;0.742383;0.064452;0.016056;5.9677e-05;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_I30-I52;I30-I52 Other forms of heart disease;rs201310570;C;0.742383;0.064452;0.016056;5.9677e-05;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_I30-I52;I30-I52 Other forms of heart disease;rs201310570;C;0.742383;0.064452;0.016056;5.9677e-05;I233T;ENST00000493193
ACKR2;ENSG00000144648;30020-0.0;Haemoglobin concentration;rs2228467;C;1.0;-0.010006000000000001;0.0035805;0.005196;V41A;ENST00000422265
ACKR2;ENSG00000144648;30020-0.0;Haemoglobin concentration;rs2228467;C;1.0;-0.010006000000000001;0.0035805;0.005196;V41A;ENST00000442925
ACKR2;ENSG00000144648;30020-0.0;Haemoglobin concentration;rs2228467;C;1.0;-0.010006000000000001;0.0035805;0.005196;V41A;ENST00000492609
ACKR2;ENSG00000144648;30020-0.0;Haemoglobin concentration;rs2228467;C;1.0;-0.010006000000000001;0.0035805;0.005196;V41A;ENST00000493193
ACKR2;ENSG00000144648;30020-0.0;Haemoglobin concentration;rs2228467;C;1.0;-0.010006000000000001;0.0035805;0.005196;V41A;ENST00000494619
ACKR2;ENSG00000144648;30020-0.0;Haemoglobin concentration;rs2228467;C;1.0;-0.010006000000000001;0.0035805;0.005196;V41A;ENST00000497921
ACKR2;ENSG00000144648;30200-0.0;Neutrophill percentage;rs2228467;C;1.0;-0.081219;0.031529;0.0099949;V41A;ENST00000422265
ACKR2;ENSG00000144648;30200-0.0;Neutrophill percentage;rs2228467;C;1.0;-0.081219;0.031529;0.0099949;V41A;ENST00000442925
ACKR2;ENSG00000144648;30200-0.0;Neutrophill percentage;rs2228467;C;1.0;-0.081219;0.031529;0.0099949;V41A;ENST00000492609
ACKR2;ENSG00000144648;30200-0.0;Neutrophill percentage;rs2228467;C;1.0;-0.081219;0.031529;0.0099949;V41A;ENST00000493193
ACKR2;ENSG00000144648;30200-0.0;Neutrophill percentage;rs2228467;C;1.0;-0.081219;0.031529;0.0099949;V41A;ENST00000494619
ACKR2;ENSG00000144648;30200-0.0;Neutrophill percentage;rs2228467;C;1.0;-0.081219;0.031529;0.0099949;V41A;ENST00000497921
ACKR2;ENSG00000144648;selfReported_n_1503;clotting disorder/excessive bleeding;rs201310570;C;0.742383;0.0080528;0.0029107;0.005665;I233T;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1503;clotting disorder/excessive bleeding;rs201310570;C;0.742383;0.0080528;0.0029107;0.005665;I233T;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1503;clotting disorder/excessive bleeding;rs201310570;C;0.742383;0.0080528;0.0029107;0.005665;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_G31;G31 Other degenerative diseases of nervous system, not elsewhere classified;rs201310570;C;0.742383;0.0080615;0.0025144000000000004;0.0013455;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_G31;G31 Other degenerative diseases of nervous system, not elsewhere classified;rs201310570;C;0.742383;0.0080615;0.0025144000000000004;0.0013455;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_G31;G31 Other degenerative diseases of nervous system, not elsewhere classified;rs201310570;C;0.742383;0.0080615;0.0025144000000000004;0.0013455;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_L53;L53 Other erythematous conditions;rs201310570;C;0.742383;0.0063606999999999995;0.0023545000000000003;0.0069027;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_L53;L53 Other erythematous conditions;rs201310570;C;0.742383;0.0063606999999999995;0.0023545000000000003;0.0069027;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_L53;L53 Other erythematous conditions;rs201310570;C;0.742383;0.0063606999999999995;0.0023545000000000003;0.0069027;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs2228467;C;1.0;-0.0023108;0.00073592;0.0016896;V41A;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs2228467;C;1.0;-0.0023108;0.00073592;0.0016896;V41A;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs2228467;C;1.0;-0.0023108;0.00073592;0.0016896;V41A;ENST00000492609
ACKR2;ENSG00000144648;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs2228467;C;1.0;-0.0023108;0.00073592;0.0016896;V41A;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs2228467;C;1.0;-0.0023108;0.00073592;0.0016896;V41A;ENST00000494619
ACKR2;ENSG00000144648;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs2228467;C;1.0;-0.0023108;0.00073592;0.0016896;V41A;ENST00000497921
ACKR2;ENSG00000144648;30000-0.0;White blood cell (leukocyte) count;rs147684121;C;1.0;0.12499;0.030986;5.4924e-05;G218A;ENST00000422265
ACKR2;ENSG00000144648;30000-0.0;White blood cell (leukocyte) count;rs147684121;C;1.0;0.12499;0.030986;5.4924e-05;G218A;ENST00000442925
ACKR2;ENSG00000144648;30000-0.0;White blood cell (leukocyte) count;rs147684121;C;1.0;0.12499;0.030986;5.4924e-05;G218A;ENST00000493193
ACKR2;ENSG00000144648;30000-0.0;White blood cell (leukocyte) count;rs2228467;C;1.0;0.048604;0.006443300000000001;4.5893000000000003e-14;V41A;ENST00000422265
ACKR2;ENSG00000144648;30000-0.0;White blood cell (leukocyte) count;rs2228467;C;1.0;0.048604;0.006443300000000001;4.5893000000000003e-14;V41A;ENST00000442925
ACKR2;ENSG00000144648;30000-0.0;White blood cell (leukocyte) count;rs2228467;C;1.0;0.048604;0.006443300000000001;4.5893000000000003e-14;V41A;ENST00000492609
ACKR2;ENSG00000144648;30000-0.0;White blood cell (leukocyte) count;rs2228467;C;1.0;0.048604;0.006443300000000001;4.5893000000000003e-14;V41A;ENST00000493193
ACKR2;ENSG00000144648;30000-0.0;White blood cell (leukocyte) count;rs2228467;C;1.0;0.048604;0.006443300000000001;4.5893000000000003e-14;V41A;ENST00000494619
ACKR2;ENSG00000144648;30000-0.0;White blood cell (leukocyte) count;rs2228467;C;1.0;0.048604;0.006443300000000001;4.5893000000000003e-14;V41A;ENST00000497921
ACKR2;ENSG00000144648;selfReported_n_1758;bacterial infection;rs150050911;G;1.0;0.0064475999999999995;0.0024756;0.009201799999999998;S172C;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1758;bacterial infection;rs150050911;G;1.0;0.0064475999999999995;0.0024756;0.009201799999999998;S172C;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1758;bacterial infection;rs150050911;G;1.0;0.0064475999999999995;0.0024756;0.009201799999999998;S172C;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs2228467;C;1.0;-0.00047162;0.00015743;0.0027377;V41A;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs2228467;C;1.0;-0.00047162;0.00015743;0.0027377;V41A;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs2228467;C;1.0;-0.00047162;0.00015743;0.0027377;V41A;ENST00000492609
ACKR2;ENSG00000144648;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs2228467;C;1.0;-0.00047162;0.00015743;0.0027377;V41A;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs2228467;C;1.0;-0.00047162;0.00015743;0.0027377;V41A;ENST00000494619
ACKR2;ENSG00000144648;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs2228467;C;1.0;-0.00047162;0.00015743;0.0027377;V41A;ENST00000497921
ACKR2;ENSG00000144648;30190-0.0;Monocyte percentage;rs201310570;C;0.742383;0.43331000000000003;0.11818;0.0002458;I233T;ENST00000422265
ACKR2;ENSG00000144648;30190-0.0;Monocyte percentage;rs201310570;C;0.742383;0.43331000000000003;0.11818;0.0002458;I233T;ENST00000442925
ACKR2;ENSG00000144648;30190-0.0;Monocyte percentage;rs201310570;C;0.742383;0.43331000000000003;0.11818;0.0002458;I233T;ENST00000493193
ACKR2;ENSG00000144648;30190-0.0;Monocyte percentage;rs2228467;C;1.0;0.25556999999999996;0.007835300000000002;4.218499999999998e-233;V41A;ENST00000422265
ACKR2;ENSG00000144648;30190-0.0;Monocyte percentage;rs2228467;C;1.0;0.25556999999999996;0.007835300000000002;4.218499999999998e-233;V41A;ENST00000442925
ACKR2;ENSG00000144648;30190-0.0;Monocyte percentage;rs2228467;C;1.0;0.25556999999999996;0.007835300000000002;4.218499999999998e-233;V41A;ENST00000492609
ACKR2;ENSG00000144648;30190-0.0;Monocyte percentage;rs2228467;C;1.0;0.25556999999999996;0.007835300000000002;4.218499999999998e-233;V41A;ENST00000493193
ACKR2;ENSG00000144648;30190-0.0;Monocyte percentage;rs2228467;C;1.0;0.25556999999999996;0.007835300000000002;4.218499999999998e-233;V41A;ENST00000494619
ACKR2;ENSG00000144648;30190-0.0;Monocyte percentage;rs2228467;C;1.0;0.25556999999999996;0.007835300000000002;4.218499999999998e-233;V41A;ENST00000497921
ACKR2;ENSG00000144648;clinical_c_M50;M50 Cervical disk disorders;rs150050911;G;1.0;0.003879;0.0014923;0.009342399999999999;S172C;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_M50;M50 Cervical disk disorders;rs150050911;G;1.0;0.003879;0.0014923;0.009342399999999999;S172C;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_M50;M50 Cervical disk disorders;rs150050911;G;1.0;0.003879;0.0014923;0.009342399999999999;S172C;ENST00000493193
ACKR2;ENSG00000144648;selfReported_n_1251;hypothyroidism/myxoedema;rs2228467;C;1.0;-0.0033873000000000006;0.00087831;0.00011498;V41A;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1251;hypothyroidism/myxoedema;rs2228467;C;1.0;-0.0033873000000000006;0.00087831;0.00011498;V41A;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1251;hypothyroidism/myxoedema;rs2228467;C;1.0;-0.0033873000000000006;0.00087831;0.00011498;V41A;ENST00000492609
ACKR2;ENSG00000144648;selfReported_n_1251;hypothyroidism/myxoedema;rs2228467;C;1.0;-0.0033873000000000006;0.00087831;0.00011498;V41A;ENST00000493193
ACKR2;ENSG00000144648;selfReported_n_1251;hypothyroidism/myxoedema;rs2228467;C;1.0;-0.0033873000000000006;0.00087831;0.00011498;V41A;ENST00000494619
ACKR2;ENSG00000144648;selfReported_n_1251;hypothyroidism/myxoedema;rs2228467;C;1.0;-0.0033873000000000006;0.00087831;0.00011498;V41A;ENST00000497921
ACKR2;ENSG00000144648;clinical_c_Block_O20-O29;O20-O29 Other maternal disorders predominantly related to pregnancy;rs201310570;C;0.742383;0.035539;0.010117;0.0004436;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_O20-O29;O20-O29 Other maternal disorders predominantly related to pregnancy;rs201310570;C;0.742383;0.035539;0.010117;0.0004436;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_O20-O29;O20-O29 Other maternal disorders predominantly related to pregnancy;rs201310570;C;0.742383;0.035539;0.010117;0.0004436;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_I45;I45 Other conduction disorders;rs6779520;G;0.9810700000000001;0.22434;0.034828;1.1846e-10;L311V;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_I45;I45 Other conduction disorders;rs6779520;G;0.9810700000000001;0.22434;0.034828;1.1846e-10;L311V;ENST00000442925
ACKR2;ENSG00000144648;30150-0.0;Eosinophill count;rs150050911;G;1.0;0.0070182000000000005;0.0026559;0.0082286;S172C;ENST00000422265
ACKR2;ENSG00000144648;30150-0.0;Eosinophill count;rs150050911;G;1.0;0.0070182000000000005;0.0026559;0.0082286;S172C;ENST00000442925
ACKR2;ENSG00000144648;30150-0.0;Eosinophill count;rs150050911;G;1.0;0.0070182000000000005;0.0026559;0.0082286;S172C;ENST00000493193
ACKR2;ENSG00000144648;30150-0.0;Eosinophill count;rs2228467;C;1.0;0.0053403999999999995;0.00046684;2.681e-30;V41A;ENST00000422265
ACKR2;ENSG00000144648;30150-0.0;Eosinophill count;rs2228467;C;1.0;0.0053403999999999995;0.00046684;2.681e-30;V41A;ENST00000442925
ACKR2;ENSG00000144648;30150-0.0;Eosinophill count;rs2228467;C;1.0;0.0053403999999999995;0.00046684;2.681e-30;V41A;ENST00000492609
ACKR2;ENSG00000144648;30150-0.0;Eosinophill count;rs2228467;C;1.0;0.0053403999999999995;0.00046684;2.681e-30;V41A;ENST00000493193
ACKR2;ENSG00000144648;30150-0.0;Eosinophill count;rs2228467;C;1.0;0.0053403999999999995;0.00046684;2.681e-30;V41A;ENST00000494619
ACKR2;ENSG00000144648;30150-0.0;Eosinophill count;rs2228467;C;1.0;0.0053403999999999995;0.00046684;2.681e-30;V41A;ENST00000497921
ACKR2;ENSG00000144648;clinical_c_Block_H49-H52;H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction;rs201310570;C;0.742383;0.014308000000000001;0.0055427;0.009838600000000001;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_H49-H52;H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction;rs201310570;C;0.742383;0.014308000000000001;0.0055427;0.009838600000000001;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_H49-H52;H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction;rs201310570;C;0.742383;0.014308000000000001;0.0055427;0.009838600000000001;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_N32;N32 Other disorders of bladder;rs6779520;G;0.9810700000000001;0.19265;0.068563;0.004956100000000001;L311V;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_N32;N32 Other disorders of bladder;rs6779520;G;0.9810700000000001;0.19265;0.068563;0.004956100000000001;L311V;ENST00000442925
ACKR2;ENSG00000144648;cancer_c_Block_C64-C68;C64-C68 Malignant neoplasms of urinary tract;rs6779520;G;0.9810700000000001;0.22626;0.030560000000000004;1.3256e-13;L311V;ENST00000422265
ACKR2;ENSG00000144648;cancer_c_Block_C64-C68;C64-C68 Malignant neoplasms of urinary tract;rs6779520;G;0.9810700000000001;0.22626;0.030560000000000004;1.3256e-13;L311V;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1094;heart arrhythmia;rs6779520;G;0.9810700000000001;0.21606999999999998;0.058349;0.00021306;L311V;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1094;heart arrhythmia;rs6779520;G;0.9810700000000001;0.21606999999999998;0.058349;0.00021306;L311V;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_E03;E03 Other hypothyroidism;rs2228467;C;1.0;-0.0022394000000000003;0.00076091;0.0032501999999999995;V41A;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_E03;E03 Other hypothyroidism;rs2228467;C;1.0;-0.0022394000000000003;0.00076091;0.0032501999999999995;V41A;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_E03;E03 Other hypothyroidism;rs2228467;C;1.0;-0.0022394000000000003;0.00076091;0.0032501999999999995;V41A;ENST00000492609
ACKR2;ENSG00000144648;clinical_c_E03;E03 Other hypothyroidism;rs2228467;C;1.0;-0.0022394000000000003;0.00076091;0.0032501999999999995;V41A;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_E03;E03 Other hypothyroidism;rs2228467;C;1.0;-0.0022394000000000003;0.00076091;0.0032501999999999995;V41A;ENST00000494619
ACKR2;ENSG00000144648;clinical_c_E03;E03 Other hypothyroidism;rs2228467;C;1.0;-0.0022394000000000003;0.00076091;0.0032501999999999995;V41A;ENST00000497921
ACKR2;ENSG00000144648;clinical_c_D50;D50 Iron deficiency anaemia;rs147684121;C;1.0;0.0083389;0.0028209;0.0031149999999999997;G218A;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_D50;D50 Iron deficiency anaemia;rs147684121;C;1.0;0.0083389;0.0028209;0.0031149999999999997;G218A;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_D50;D50 Iron deficiency anaemia;rs147684121;C;1.0;0.0083389;0.0028209;0.0031149999999999997;G218A;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_I78;I78 Diseases of capillaries;rs138890782;A;0.9652139999999999;0.025544;0.0083688;0.0022716;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_I78;I78 Diseases of capillaries;rs138890782;A;0.9652139999999999;0.025544;0.0083688;0.0022716;R320H;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1416;connective tissue disorder;rs201310570;C;0.742383;0.014324000000000002;0.005290100000000001;0.006776100000000001;I233T;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1416;connective tissue disorder;rs201310570;C;0.742383;0.014324000000000002;0.005290100000000001;0.006776100000000001;I233T;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1416;connective tissue disorder;rs201310570;C;0.742383;0.014324000000000002;0.005290100000000001;0.006776100000000001;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_Block_D50-D53;D50-D53 Nutritional anaemias;rs147684121;C;1.0;0.0089134;0.0029753;0.0027372;G218A;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_D50-D53;D50-D53 Nutritional anaemias;rs147684121;C;1.0;0.0089134;0.0029753;0.0027372;G218A;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_D50-D53;D50-D53 Nutritional anaemias;rs147684121;C;1.0;0.0089134;0.0029753;0.0027372;G218A;ENST00000493193
ACKR2;ENSG00000144648;30140-0.0;Neutrophill count;rs147684121;C;1.0;0.10095;0.025016999999999998;5.4558e-05;G218A;ENST00000422265
ACKR2;ENSG00000144648;30140-0.0;Neutrophill count;rs147684121;C;1.0;0.10095;0.025016999999999998;5.4558e-05;G218A;ENST00000442925
ACKR2;ENSG00000144648;30140-0.0;Neutrophill count;rs147684121;C;1.0;0.10095;0.025016999999999998;5.4558e-05;G218A;ENST00000493193
ACKR2;ENSG00000144648;30140-0.0;Neutrophill count;rs2228467;C;1.0;0.026452;0.0052023;3.6853000000000003e-07;V41A;ENST00000422265
ACKR2;ENSG00000144648;30140-0.0;Neutrophill count;rs2228467;C;1.0;0.026452;0.0052023;3.6853000000000003e-07;V41A;ENST00000442925
ACKR2;ENSG00000144648;30140-0.0;Neutrophill count;rs2228467;C;1.0;0.026452;0.0052023;3.6853000000000003e-07;V41A;ENST00000492609
ACKR2;ENSG00000144648;30140-0.0;Neutrophill count;rs2228467;C;1.0;0.026452;0.0052023;3.6853000000000003e-07;V41A;ENST00000493193
ACKR2;ENSG00000144648;30140-0.0;Neutrophill count;rs2228467;C;1.0;0.026452;0.0052023;3.6853000000000003e-07;V41A;ENST00000494619
ACKR2;ENSG00000144648;30140-0.0;Neutrophill count;rs2228467;C;1.0;0.026452;0.0052023;3.6853000000000003e-07;V41A;ENST00000497921
ACKR2;ENSG00000144648;clinical_c_G35;G35 Multiple sclerosis;rs201310570;C;0.742383;0.012502;0.0036333;0.00057969;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_G35;G35 Multiple sclerosis;rs201310570;C;0.742383;0.012502;0.0036333;0.00057969;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_G35;G35 Multiple sclerosis;rs201310570;C;0.742383;0.012502;0.0036333;0.00057969;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_M19;M19 Other arthrosis;rs201310570;C;0.742383;0.034;0.012638;0.0071408999999999995;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_M19;M19 Other arthrosis;rs201310570;C;0.742383;0.034;0.012638;0.0071408999999999995;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_M19;M19 Other arthrosis;rs201310570;C;0.742383;0.034;0.012638;0.0071408999999999995;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_H18;H18 Other disorders of cornea;rs150050911;G;1.0;0.0027623;0.00097293;0.0045236;S172C;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_H18;H18 Other disorders of cornea;rs150050911;G;1.0;0.0027623;0.00097293;0.0045236;S172C;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_H18;H18 Other disorders of cornea;rs150050911;G;1.0;0.0027623;0.00097293;0.0045236;S172C;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_I72;I72 Other aneurysm;rs201310570;C;0.742383;0.0059960000000000005;0.0022286;0.0071367;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_I72;I72 Other aneurysm;rs201310570;C;0.742383;0.0059960000000000005;0.0022286;0.0071367;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_I72;I72 Other aneurysm;rs201310570;C;0.742383;0.0059960000000000005;0.0022286;0.0071367;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_J69;J69 Pneumonitis due to solids and liquids;rs201310570;C;0.742383;0.008357;0.0024929;0.00080127;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_J69;J69 Pneumonitis due to solids and liquids;rs201310570;C;0.742383;0.008357;0.0024929;0.00080127;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_J69;J69 Pneumonitis due to solids and liquids;rs201310570;C;0.742383;0.008357;0.0024929;0.00080127;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_O04;O04 Medical abortion;rs138890782;A;0.9652139999999999;0.076173;0.019748;0.00011467;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_O04;O04 Medical abortion;rs138890782;A;0.9652139999999999;0.076173;0.019748;0.00011467;R320H;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_N30;N30 Cystitis;rs6779520;G;0.9810700000000001;0.2294;0.040389999999999995;1.3504e-08;L311V;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_N30;N30 Cystitis;rs6779520;G;0.9810700000000001;0.2294;0.040389999999999995;1.3504e-08;L311V;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_H90-H95;H90-H95 Other disorders of ear;rs201310570;C;0.742383;0.018287;0.0068466;0.0075649;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_H90-H95;H90-H95 Other disorders of ear;rs201310570;C;0.742383;0.018287;0.0068466;0.0075649;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_H90-H95;H90-H95 Other disorders of ear;rs201310570;C;0.742383;0.018287;0.0068466;0.0075649;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_H72;H72 Perforation of tympanic membrane;rs6779520;G;0.9810700000000001;0.069391;0.023413;0.0030391;L311V;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_H72;H72 Perforation of tympanic membrane;rs6779520;G;0.9810700000000001;0.069391;0.023413;0.0030391;L311V;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_F40-F48;F40-F48 Neurotic, stress-related and somatoform disorders;rs201310570;C;0.742383;0.025738;0.0086468;0.0029146000000000003;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_F40-F48;F40-F48 Neurotic, stress-related and somatoform disorders;rs201310570;C;0.742383;0.025738;0.0086468;0.0029146000000000003;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_F40-F48;F40-F48 Neurotic, stress-related and somatoform disorders;rs201310570;C;0.742383;0.025738;0.0086468;0.0029146000000000003;I233T;ENST00000493193
ACKR2;ENSG00000144648;30130-0.0;Monocyte count;rs147684121;C;1.0;0.0082301;0.0028223000000000002;0.0035448999999999997;G218A;ENST00000422265
ACKR2;ENSG00000144648;30130-0.0;Monocyte count;rs147684121;C;1.0;0.0082301;0.0028223000000000002;0.0035448999999999997;G218A;ENST00000442925
ACKR2;ENSG00000144648;30130-0.0;Monocyte count;rs147684121;C;1.0;0.0082301;0.0028223000000000002;0.0035448999999999997;G218A;ENST00000493193
ACKR2;ENSG00000144648;30130-0.0;Monocyte count;rs201310570;C;0.742383;0.045482;0.008841700000000001;2.6909000000000004e-07;I233T;ENST00000422265
ACKR2;ENSG00000144648;30130-0.0;Monocyte count;rs201310570;C;0.742383;0.045482;0.008841700000000001;2.6909000000000004e-07;I233T;ENST00000442925
ACKR2;ENSG00000144648;30130-0.0;Monocyte count;rs201310570;C;0.742383;0.045482;0.008841700000000001;2.6909000000000004e-07;I233T;ENST00000493193
ACKR2;ENSG00000144648;30130-0.0;Monocyte count;rs2228467;C;1.0;0.020406;0.00058614;3.2654999999999984e-265;V41A;ENST00000422265
ACKR2;ENSG00000144648;30130-0.0;Monocyte count;rs2228467;C;1.0;0.020406;0.00058614;3.2654999999999984e-265;V41A;ENST00000442925
ACKR2;ENSG00000144648;30130-0.0;Monocyte count;rs2228467;C;1.0;0.020406;0.00058614;3.2654999999999984e-265;V41A;ENST00000492609
ACKR2;ENSG00000144648;30130-0.0;Monocyte count;rs2228467;C;1.0;0.020406;0.00058614;3.2654999999999984e-265;V41A;ENST00000493193
ACKR2;ENSG00000144648;30130-0.0;Monocyte count;rs2228467;C;1.0;0.020406;0.00058614;3.2654999999999984e-265;V41A;ENST00000494619
ACKR2;ENSG00000144648;30130-0.0;Monocyte count;rs2228467;C;1.0;0.020406;0.00058614;3.2654999999999984e-265;V41A;ENST00000497921
ACKR2;ENSG00000144648;selfReported_n_1454;other renal/kidney problem;rs2228467;C;1.0;0.0009258;0.00032022;0.0038383000000000002;V41A;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1454;other renal/kidney problem;rs2228467;C;1.0;0.0009258;0.00032022;0.0038383000000000002;V41A;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1454;other renal/kidney problem;rs2228467;C;1.0;0.0009258;0.00032022;0.0038383000000000002;V41A;ENST00000492609
ACKR2;ENSG00000144648;selfReported_n_1454;other renal/kidney problem;rs2228467;C;1.0;0.0009258;0.00032022;0.0038383000000000002;V41A;ENST00000493193
ACKR2;ENSG00000144648;selfReported_n_1454;other renal/kidney problem;rs2228467;C;1.0;0.0009258;0.00032022;0.0038383000000000002;V41A;ENST00000494619
ACKR2;ENSG00000144648;selfReported_n_1454;other renal/kidney problem;rs2228467;C;1.0;0.0009258;0.00032022;0.0038383000000000002;V41A;ENST00000497921
ACKR2;ENSG00000144648;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs201310570;C;0.742383;0.0086861;0.0031608;0.0059943999999999996;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs201310570;C;0.742383;0.0086861;0.0031608;0.0059943999999999996;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs201310570;C;0.742383;0.0086861;0.0031608;0.0059943999999999996;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs201310570;C;0.742383;0.01349;0.0047052;0.0041421999999999995;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs201310570;C;0.742383;0.01349;0.0047052;0.0041421999999999995;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs201310570;C;0.742383;0.01349;0.0047052;0.0041421999999999995;I233T;ENST00000493193
ACKR2;ENSG00000144648;selfReported_n_1517;duodenal ulcer;rs150050911;G;1.0;0.0043805;0.0015895;0.0058543;S172C;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1517;duodenal ulcer;rs150050911;G;1.0;0.0043805;0.0015895;0.0058543;S172C;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1517;duodenal ulcer;rs150050911;G;1.0;0.0043805;0.0015895;0.0058543;S172C;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_Block_D65-D69;D65-D69 Coagulation defects, purpura and other haemorrhagic conditions;rs138890782;A;0.9652139999999999;0.046312;0.01634;0.004594300000000001;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_D65-D69;D65-D69 Coagulation defects, purpura and other haemorrhagic conditions;rs138890782;A;0.9652139999999999;0.046312;0.01634;0.004594300000000001;R320H;ENST00000442925
ACKR2;ENSG00000144648;30010-0.0;Red blood cell (erythrocyte) count;rs2228467;C;1.0;-0.0038211;0.0012202;0.0017387999999999998;V41A;ENST00000422265
ACKR2;ENSG00000144648;30010-0.0;Red blood cell (erythrocyte) count;rs2228467;C;1.0;-0.0038211;0.0012202;0.0017387999999999998;V41A;ENST00000442925
ACKR2;ENSG00000144648;30010-0.0;Red blood cell (erythrocyte) count;rs2228467;C;1.0;-0.0038211;0.0012202;0.0017387999999999998;V41A;ENST00000492609
ACKR2;ENSG00000144648;30010-0.0;Red blood cell (erythrocyte) count;rs2228467;C;1.0;-0.0038211;0.0012202;0.0017387999999999998;V41A;ENST00000493193
ACKR2;ENSG00000144648;30010-0.0;Red blood cell (erythrocyte) count;rs2228467;C;1.0;-0.0038211;0.0012202;0.0017387999999999998;V41A;ENST00000494619
ACKR2;ENSG00000144648;30010-0.0;Red blood cell (erythrocyte) count;rs2228467;C;1.0;-0.0038211;0.0012202;0.0017387999999999998;V41A;ENST00000497921
ACKR2;ENSG00000144648;clinical_c_Block_J90-J94;J90-J94 Other diseases of pleura;rs201310570;C;0.742383;0.025443;0.0082281;0.0019868999999999998;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_J90-J94;J90-J94 Other diseases of pleura;rs201310570;C;0.742383;0.025443;0.0082281;0.0019868999999999998;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_J90-J94;J90-J94 Other diseases of pleura;rs201310570;C;0.742383;0.025443;0.0082281;0.0019868999999999998;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_M43;M43 Other deforming dorsopathies;rs2228467;C;1.0;-0.00073676;0.00027997;0.008500299999999999;V41A;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_M43;M43 Other deforming dorsopathies;rs2228467;C;1.0;-0.00073676;0.00027997;0.008500299999999999;V41A;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_M43;M43 Other deforming dorsopathies;rs2228467;C;1.0;-0.00073676;0.00027997;0.008500299999999999;V41A;ENST00000492609
ACKR2;ENSG00000144648;clinical_c_M43;M43 Other deforming dorsopathies;rs2228467;C;1.0;-0.00073676;0.00027997;0.008500299999999999;V41A;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_M43;M43 Other deforming dorsopathies;rs2228467;C;1.0;-0.00073676;0.00027997;0.008500299999999999;V41A;ENST00000494619
ACKR2;ENSG00000144648;clinical_c_M43;M43 Other deforming dorsopathies;rs2228467;C;1.0;-0.00073676;0.00027997;0.008500299999999999;V41A;ENST00000497921
ACKR2;ENSG00000144648;clinical_c_J90;J90 Pleural effusion, not elsewhere classified;rs201310570;C;0.742383;0.021123;0.0072797;0.003713;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_J90;J90 Pleural effusion, not elsewhere classified;rs201310570;C;0.742383;0.021123;0.0072797;0.003713;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_J90;J90 Pleural effusion, not elsewhere classified;rs201310570;C;0.742383;0.021123;0.0072797;0.003713;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_Block_K00-K14;K00-K14 Diseases of oral cavity, salivary glands and jaws;rs2228467;C;1.0;0.0023008000000000004;0.0008271000000000001;0.0054066;V41A;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_K00-K14;K00-K14 Diseases of oral cavity, salivary glands and jaws;rs2228467;C;1.0;0.0023008000000000004;0.0008271000000000001;0.0054066;V41A;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_K00-K14;K00-K14 Diseases of oral cavity, salivary glands and jaws;rs2228467;C;1.0;0.0023008000000000004;0.0008271000000000001;0.0054066;V41A;ENST00000492609
ACKR2;ENSG00000144648;clinical_c_Block_K00-K14;K00-K14 Diseases of oral cavity, salivary glands and jaws;rs2228467;C;1.0;0.0023008000000000004;0.0008271000000000001;0.0054066;V41A;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_Block_K00-K14;K00-K14 Diseases of oral cavity, salivary glands and jaws;rs2228467;C;1.0;0.0023008000000000004;0.0008271000000000001;0.0054066;V41A;ENST00000494619
ACKR2;ENSG00000144648;clinical_c_Block_K00-K14;K00-K14 Diseases of oral cavity, salivary glands and jaws;rs2228467;C;1.0;0.0023008000000000004;0.0008271000000000001;0.0054066;V41A;ENST00000497921
ACKR2;ENSG00000144648;clinical_c_F43;F43 Reaction to severe stress, and adjustment disorders;rs201310570;C;0.742383;0.012653;0.0023190999999999997;4.8715e-08;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_F43;F43 Reaction to severe stress, and adjustment disorders;rs201310570;C;0.742383;0.012653;0.0023190999999999997;4.8715e-08;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_F43;F43 Reaction to severe stress, and adjustment disorders;rs201310570;C;0.742383;0.012653;0.0023190999999999997;4.8715e-08;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_K55;K55 Vascular disorders of intestine;rs147684121;C;1.0;0.004018;0.0010429;0.00011677;G218A;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_K55;K55 Vascular disorders of intestine;rs147684121;C;1.0;0.004018;0.0010429;0.00011677;G218A;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_K55;K55 Vascular disorders of intestine;rs147684121;C;1.0;0.004018;0.0010429;0.00011677;G218A;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_H52;H52 Disorders of refraction and accommodation;rs138890782;A;0.9652139999999999;0.037382;0.013628;0.0060882;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_H52;H52 Disorders of refraction and accommodation;rs138890782;A;0.9652139999999999;0.037382;0.013628;0.0060882;R320H;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_O85-O92;O85-O92 Complications predominantly related to the puerperium;rs138890782;A;0.9652139999999999;0.048134;0.015050999999999997;0.0013838;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_O85-O92;O85-O92 Complications predominantly related to the puerperium;rs138890782;A;0.9652139999999999;0.048134;0.015050999999999997;0.0013838;R320H;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_L90;L90 Atrophic disorders of skin;rs138890782;A;0.9652139999999999;0.062578;0.01697;0.00022640000000000003;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_L90;L90 Atrophic disorders of skin;rs138890782;A;0.9652139999999999;0.062578;0.01697;0.00022640000000000003;R320H;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_G20;G20 Parkinson's disease;rs201310570;C;0.742383;0.0094707;0.0034286;0.0057402;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_G20;G20 Parkinson's disease;rs201310570;C;0.742383;0.0094707;0.0034286;0.0057402;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_G20;G20 Parkinson's disease;rs201310570;C;0.742383;0.0094707;0.0034286;0.0057402;I233T;ENST00000493193
ACKR2;ENSG00000144648;selfReported_n_1592;dry eyes;rs150050911;G;1.0;0.0028979;0.00094088;0.0020702;S172C;ENST00000422265
ACKR2;ENSG00000144648;selfReported_n_1592;dry eyes;rs150050911;G;1.0;0.0028979;0.00094088;0.0020702;S172C;ENST00000442925
ACKR2;ENSG00000144648;selfReported_n_1592;dry eyes;rs150050911;G;1.0;0.0028979;0.00094088;0.0020702;S172C;ENST00000493193
ACKR2;ENSG00000144648;30180-0.0;Lymphocyte percentage;rs147684121;C;1.0;-0.37146;0.12991;0.0042436999999999996;G218A;ENST00000422265
ACKR2;ENSG00000144648;30180-0.0;Lymphocyte percentage;rs147684121;C;1.0;-0.37146;0.12991;0.0042436999999999996;G218A;ENST00000442925
ACKR2;ENSG00000144648;30180-0.0;Lymphocyte percentage;rs147684121;C;1.0;-0.37146;0.12991;0.0042436999999999996;G218A;ENST00000493193
ACKR2;ENSG00000144648;30180-0.0;Lymphocyte percentage;rs2228467;C;1.0;-0.21769000000000002;0.027013;7.7304e-16;V41A;ENST00000422265
ACKR2;ENSG00000144648;30180-0.0;Lymphocyte percentage;rs2228467;C;1.0;-0.21769000000000002;0.027013;7.7304e-16;V41A;ENST00000442925
ACKR2;ENSG00000144648;30180-0.0;Lymphocyte percentage;rs2228467;C;1.0;-0.21769000000000002;0.027013;7.7304e-16;V41A;ENST00000492609
ACKR2;ENSG00000144648;30180-0.0;Lymphocyte percentage;rs2228467;C;1.0;-0.21769000000000002;0.027013;7.7304e-16;V41A;ENST00000493193
ACKR2;ENSG00000144648;30180-0.0;Lymphocyte percentage;rs2228467;C;1.0;-0.21769000000000002;0.027013;7.7304e-16;V41A;ENST00000494619
ACKR2;ENSG00000144648;30180-0.0;Lymphocyte percentage;rs2228467;C;1.0;-0.21769000000000002;0.027013;7.7304e-16;V41A;ENST00000497921
ACKR2;ENSG00000144648;clinical_c_H50;H50 Other strabismus;rs138890782;A;0.9652139999999999;0.040533;0.0097345;3.1303e-05;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_H50;H50 Other strabismus;rs138890782;A;0.9652139999999999;0.040533;0.0097345;3.1303e-05;R320H;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_J60-J70;J60-J70 Lung diseases due to external agents;rs201310570;C;0.742383;0.015939;0.0031769000000000003;5.2514e-07;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_J60-J70;J60-J70 Lung diseases due to external agents;rs201310570;C;0.742383;0.015939;0.0031769000000000003;5.2514e-07;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_J60-J70;J60-J70 Lung diseases due to external agents;rs201310570;C;0.742383;0.015939;0.0031769000000000003;5.2514e-07;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_Block_F00-F09;F00-F09 Organic, including symptomatic, mental disorders;rs201310570;C;0.742383;0.019448;0.0040411;1.4908000000000002e-06;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_F00-F09;F00-F09 Organic, including symptomatic, mental disorders;rs201310570;C;0.742383;0.019448;0.0040411;1.4908000000000002e-06;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_F00-F09;F00-F09 Organic, including symptomatic, mental disorders;rs201310570;C;0.742383;0.019448;0.0040411;1.4908000000000002e-06;I233T;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs138890782;A;0.9652139999999999;0.039656;0.010781;0.00023481;R320H;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs138890782;A;0.9652139999999999;0.039656;0.010781;0.00023481;R320H;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_L43;L43 Lichen planus;rs150050911;G;1.0;0.0023752;0.00090802;0.0089027;S172C;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_L43;L43 Lichen planus;rs150050911;G;1.0;0.0023752;0.00090802;0.0089027;S172C;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_L43;L43 Lichen planus;rs150050911;G;1.0;0.0023752;0.00090802;0.0089027;S172C;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_Block_H55-H59;H55-H59 Other disorders of eye and adnexa;rs150050911;G;1.0;0.0031638;0.0012084;0.0088377;S172C;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_Block_H55-H59;H55-H59 Other disorders of eye and adnexa;rs150050911;G;1.0;0.0031638;0.0012084;0.0088377;S172C;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_Block_H55-H59;H55-H59 Other disorders of eye and adnexa;rs150050911;G;1.0;0.0031638;0.0012084;0.0088377;S172C;ENST00000493193
ACKR2;ENSG00000144648;clinical_c_N86;N86 Erosion and ectropion of cervix uteri;rs201310570;C;0.742383;0.020224;0.0056991;0.00038738;I233T;ENST00000422265
ACKR2;ENSG00000144648;clinical_c_N86;N86 Erosion and ectropion of cervix uteri;rs201310570;C;0.742383;0.020224;0.0056991;0.00038738;I233T;ENST00000442925
ACKR2;ENSG00000144648;clinical_c_N86;N86 Erosion and ectropion of cervix uteri;rs201310570;C;0.742383;0.020224;0.0056991;0.00038738;I233T;ENST00000493193
CCR1;ENSG00000163823;clinical_c_G93;G93 Other disorders of brain;rs76628634;T;0.954284;0.11714000000000001;0.021371;4.2229e-08;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs76628634;T;0.954284;0.22658000000000006;0.02808;7.1186e-16;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs143491674;T;1.0;0.010655;0.0026954;7.722399999999999e-05;A290T;ENST00000296140
CCR1;ENSG00000163823;3079-0.0;Pace-maker;rs138822282;G;0.808747;0.040708999999999995;0.011498999999999999;0.00039977;K94Q;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1465;bronchitis;rs143491674;T;1.0;0.010918;0.0040961999999999995;0.007689699999999999;A290T;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_E15-E16;E15-E16 Other disorders of glucose regulation and pancreatic internal secretion;rs138822282;G;0.808747;0.034351;0.0099317;0.00054268;K94Q;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1410;breast cysts;rs143491674;T;1.0;0.015563;0.0057045;0.0063676;A290T;ENST00000296140
CCR1;ENSG00000163823;clinical_c_H40;H40 Glaucoma;rs76628634;T;0.954284;0.10908;0.035387;0.0020524000000000002;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_N89;N89 Other noninflammatory disorders of vagina;rs76628634;T;0.954284;0.22589;0.040298;2.0786e-08;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_E16;E16 Other disorders of pancreatic internal secretion;rs138822282;G;0.808747;0.034357;0.0099165;0.00053105;K94Q;ENST00000296140
CCR1;ENSG00000163823;1359-0.0;Poultry intake;rs138822282;G;0.808747;-0.48494;0.17743;0.0062745;K94Q;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1685;osteopenia;rs138822282;G;0.808747;0.027233999999999998;0.010413;0.0089113;K94Q;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1280;peripheral nerve disorder;rs76628634;T;0.954284;0.11673;0.025568;4.985e-06;S70N;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1312;depression;rs76628634;T;0.954284;0.40212;0.079674;4.4879e-07;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_K58;K58 Irritable bowel syndrome;rs76628634;T;0.954284;0.10554000000000001;0.039697;0.0078443;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_K08;K08 Other disorders of teeth and supporting structures;rs76628634;T;0.954284;0.11623;0.027672000000000002;2.6677e-05;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_N88;N88 Other noninflammatory disorders of cervix uteri;rs138822282;G;0.808747;0.074586;0.025595;0.003566900000000001;K94Q;ENST00000296140
CCR1;ENSG00000163823;clinical_c_O34;O34 Maternal care for known or suspected abnormality of pelvic organs;rs138822282;G;0.808747;0.065152;0.023261;0.005096;K94Q;ENST00000296140
CCR1;ENSG00000163823;clinical_c_O34;O34 Maternal care for known or suspected abnormality of pelvic organs;rs41393844;G;0.864658;0.034414;0.010702;0.0013018;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_N95;N95 Menopausal and other perimenopausal disorders;rs41393844;G;0.864658;0.094632;0.027607;0.00060858;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_J92;J92 Pleural plaque;rs138822282;G;0.808747;0.042824;0.008981600000000001;1.8612999999999999e-06;K94Q;ENST00000296140
CCR1;ENSG00000163823;cancer_c_C34;C34 Malignant neoplasm of bronchus and lung;rs41393844;G;0.864658;0.015818000000000002;0.006036;0.0087771;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_G47;G47 Sleep disorders;rs41393844;G;0.864658;0.030503;0.011164;0.0062915;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_O68;O68 Labour and delivery complicated by foetal stress [distress];rs76628634;T;0.954284;0.20496;0.05698300000000001;0.00032208;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_A09;A09 Diarrhoea and gastro-enteritis of presumed infectious origin;rs76628634;T;0.954284;0.11093;0.038314;0.0037898000000000003;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs76628634;T;0.954284;0.32235;0.099273;0.0011661;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_O03;O03 Spontaneous abortion;rs76628634;T;0.954284;0.22208000000000006;0.037322;2.6787e-09;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_A49;A49 Bacterial infection of unspecified site;rs138822282;G;0.808747;0.042441;0.0089501;2.1177e-06;K94Q;ENST00000296140
CCR1;ENSG00000163823;clinical_c_I08;I08 Multiple valve diseases;rs143491674;T;1.0;0.0096023;0.0030198;0.0014738;A290T;ENST00000296140
CCR1;ENSG00000163823;clinical_c_I65;I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction;rs112927319;T;0.676298;0.010329000000000001;0.0024576999999999997;2.6407e-05;R319H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_M70;M70 Soft tissue disorders related to use, overuse and pressure;rs76628634;T;0.954284;0.11679;0.021661;6.9698e-08;S70N;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1290;epilepsy;rs41393844;G;0.864658;0.02945;0.009045000000000001;0.0011302999999999999;Y291H;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1136;other respiratory problems;rs138822282;G;0.808747;0.067813;0.022112;0.0021631999999999997;K94Q;ENST00000296140
CCR1;ENSG00000163823;clinical_c_N62;N62 Hypertrophy of breast;rs138822282;G;0.808747;0.0345;0.009354000000000001;0.00022586;K94Q;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1131;chronic obstructive airways disease/copd;rs138822282;G;0.808747;0.040094;0.012375;0.0011956;K94Q;ENST00000296140
CCR1;ENSG00000163823;clinical_c_G44;G44 Other headache syndromes;rs41393844;G;0.864658;0.016797;0.0035518;2.2565e-06;Y291H;ENST00000296140
CCR1;ENSG00000163823;30270-0.0;Mean sphered cell volume;rs143491674;T;1.0;-0.5978600000000001;0.19467;0.0021329;A290T;ENST00000296140
CCR1;ENSG00000163823;clinical_c_O70;O70 Perineal laceration during delivery;rs138822282;G;0.808747;0.15058;0.041771;0.00031237;K94Q;ENST00000296140
CCR1;ENSG00000163823;clinical_c_O02;O02 Other abnormal products of conception;rs143491674;T;1.0;0.013427;0.005090600000000001;0.008348600000000001;A290T;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_M05-M14;M05-M14 Inflammatory polyarthropathies;rs76628634;T;0.954284;0.19793;0.071309;0.0055083;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_H11;H11 Other disorders of conjunctiva;rs76628634;T;0.954284;0.05608;0.014844;0.00015816;S70N;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1574;abdominal hernia;rs76628634;T;0.954284;0.11141;0.026066000000000002;1.9194e-05;S70N;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1304;cataract;rs61752589;A;1.0;0.012015000000000001;0.0043531;0.0057782;A159V;ENST00000296140
CCR1;ENSG00000163823;cancer_c_C20;C20 Malignant neoplasm of rectum;rs138822282;G;0.808747;0.041014;0.011025;0.00019907;K94Q;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs76628634;T;0.954284;0.055471000000000006;0.017174000000000002;0.0012382;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_H00;H00 Hordeolum and chalazion;rs143491674;T;1.0;0.0093306;0.0031921999999999996;0.0034674;A290T;ENST00000296140
CCR1;ENSG00000163823;clinical_c_M84;M84 Disorders of continuity of bone;rs112927319;T;0.676298;0.0091262;0.002986;0.0022405000000000003;R319H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_M84;M84 Disorders of continuity of bone;rs138822282;G;0.808747;0.040923;0.012631999999999999;0.0011964;K94Q;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1545;chronic fatigue syndrome;rs76628634;T;0.954284;0.11535999999999999;0.023141;6.1911e-07;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_N30;N30 Cystitis;rs138822282;G;0.808747;0.072948;0.017658;3.6092e-05;K94Q;ENST00000296140
CCR1;ENSG00000163823;clinical_c_M10;M10 Gout;rs41393844;G;0.864658;0.026456;0.0087006;0.0023605;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_I24;I24 Other acute ischaemic heart diseases;rs138822282;G;0.808747;0.041059;0.012102;0.000692;K94Q;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1083;cerebrovascular disease;rs112927319;T;0.676298;0.018639;0.006665899999999999;0.0051722;R319H;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1734;rosacea;rs41393844;G;0.864658;0.010674;0.0039724;0.0072081;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_J38;J38 Diseases of vocal cords and larynx, not elsewhere classified;rs76628634;T;0.954284;0.11855999999999998;0.022479;1.3322e-07;S70N;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1182;gall bladder disease;rs41393844;G;0.864658;0.036895;0.013096;0.0048446999999999995;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_J20-J22;J20-J22 Other acute lower respiratory infections;rs41393844;G;0.864658;0.036425;0.013465000000000001;0.006827600000000001;Y291H;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1158;other abdominal problem;rs76628634;T;0.954284;0.10440999999999999;0.039113999999999996;0.0075967;S70N;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1352;ankylosing spondylitis;rs112927319;T;0.676298;0.0099965;0.0025769;0.00010481;R319H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs76628634;T;0.954284;0.21137;0.064939;0.0011343;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_G57;G57 Mononeuropathies of lower limb;rs76628634;T;0.954284;0.11707000000000001;0.021934;9.432800000000001e-08;S70N;ENST00000296140
CCR1;ENSG00000163823;cancer_c_D06;D06 Carcinoma in situ of cervix uteri;rs76628634;T;0.954284;0.21989;0.043210000000000005;3.605300000000001e-07;S70N;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1747;viral infection;rs76628634;T;0.954284;0.10857;0.030454000000000002;0.00036395;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_M66;M66 Spontaneous rupture of synovium and tendon;rs41393844;G;0.864658;0.012889;0.0035681999999999997;0.0003037;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_H36;H36 Retinal disorders in diseases classified elsewhere;rs138822282;G;0.808747;0.032007;0.011821;0.006776100000000001;K94Q;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1314;nervous breakdown;rs61752589;A;1.0;0.0056715;0.0014499;9.1686e-05;A159V;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_G90-G99;G90-G99 Other disorders of the nervous system;rs76628634;T;0.954284;0.10869000000000001;0.034296;0.0015294;S70N;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1142;sleep apnoea;rs138822282;G;0.808747;0.076785;0.011925;1.2045e-10;K94Q;ENST00000296140
CCR1;ENSG00000163823;clinical_c_J22;J22 Unspecified acute lower respiratory infection;rs41393844;G;0.864658;0.037147;0.013332;0.0053318;Y291H;ENST00000296140
CCR1;ENSG00000163823;1478-0.0;Salt added to food;rs61752589;A;1.0;0.077622;0.029887999999999998;0.009401399999999999;A159V;ENST00000296140
CCR1;ENSG00000163823;clinical_c_K11;K11 Diseases of salivary glands;rs143491674;T;1.0;0.0068066;0.0023628;0.003968;A290T;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1262;disorder or pituitary gland;rs143491674;T;1.0;0.0055812;0.0017870000000000002;0.001789;A290T;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_H15-H22;H15-H22 Disorders of sclera, cornea, iris and ciliary body;rs61752589;A;1.0;0.006122600000000001;0.0023669;0.0096877;A159V;ENST00000296140
CCR1;ENSG00000163823;clinical_c_G91;G91 Hydrocephalus;rs41393844;G;0.864658;0.009007799999999998;0.0032966000000000002;0.0062869;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_I61;I61 Intracerebral haemorrhage;rs61752589;A;1.0;0.004139899999999999;0.0015607999999999998;0.0079922;A159V;ENST00000296140
CCR1;ENSG00000163823;clinical_c_I61;I61 Intracerebral haemorrhage;rs76628634;T;0.954284;0.11937;0.014372;9.9447e-17;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_G40-G47;G40-G47 Episodic and paroxysmal disorders;rs41393844;G;0.864658;0.08010199999999999;0.018078999999999998;9.3996e-06;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_G40;G40 Epilepsy;rs41393844;G;0.864658;0.035848000000000005;0.0093913;0.000135;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_H04;H04 Disorders of lachrymal system;rs76628634;T;0.954284;0.1147;0.025312;5.8625999999999996e-06;S70N;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1319;bone disorder;rs138822282;G;0.808747;0.082957;0.030535000000000003;0.006592;K94Q;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_O85-O92;O85-O92 Complications predominantly related to the puerperium;rs76628634;T;0.954284;0.23;0.025437;1.5492e-19;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_O00-O08;O00-O08 Pregnancy with abortive outcome;rs76628634;T;0.954284;0.20016;0.059862;0.00082704;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_G81;G81 Hemiplegia;rs138822282;G;0.808747;0.039932999999999996;0.012496;0.0013959;K94Q;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_O60-O75;O60-O75 Complications of labour and delivery;rs138822282;G;0.808747;0.15025;0.051911;0.0038004;K94Q;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1592;dry eyes;rs61752589;A;1.0;0.0042823;0.0014309000000000001;0.0027648000000000004;A159V;ENST00000296140
CCR1;ENSG00000163823;clinical_c_H02;H02 Other disorders of eyelid;rs76628634;T;0.954284;0.10778;0.040503;0.007791299999999999;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_H00-H06;H00-H06 Disorders of eyelid, lacrimal system and orbit;rs143491674;T;1.0;0.024995;0.0072312;0.00054717;A290T;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_H40-H42;H40-H42 Glaucoma;rs76628634;T;0.954284;0.10905999999999999;0.03539;0.0020587;S70N;ENST00000296140
CCR1;ENSG00000163823;1389-0.0;Pork intake;rs61752589;A;1.0;0.07002699999999999;0.025726;0.0064877;A159V;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1269;psychological/psychiatric problem;rs76628634;T;0.954284;0.38195;0.09013;2.2576999999999997e-05;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_M13;M13 Other arthritis;rs76628634;T;0.954284;0.21902;0.056549;0.0001075;S70N;ENST00000296140
CCR1;ENSG00000163823;clinical_c_Block_J60-J70;J60-J70 Lung diseases due to external agents;rs41393844;G;0.864658;0.017291;0.004836399999999999;0.00035009;Y291H;ENST00000296140
CCR1;ENSG00000163823;selfReported_n_1248;type 2 diabetes;rs41393844;G;0.864658;0.020388;0.007904099999999999;0.0098973;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_L91;L91 Hypertrophic disorders of skin;rs41393844;G;0.864658;0.014509000000000001;0.005155399999999999;0.0048868;Y291H;ENST00000296140
CCR1;ENSG00000163823;cancer_c_D05;D05 Carcinoma in situ of breast;rs138822282;G;0.808747;0.074024;0.024815;0.0028544;K94Q;ENST00000296140
CCR1;ENSG00000163823;clinical_c_L43;L43 Lichen planus;rs143491674;T;1.0;0.0057442;0.0017519999999999999;0.0010432;A290T;ENST00000296140
CCR1;ENSG00000163823;clinical_c_N86;N86 Erosion and ectropion of cervix uteri;rs61752589;A;1.0;0.0094092;0.0032759;0.0040764;A159V;ENST00000296140
CCR1;ENSG00000163823;clinical_c_H01;H01 Other inflammation of eyelid;rs41393844;G;0.864658;0.018092;0.0037729;1.6255000000000001e-06;Y291H;ENST00000296140
CCR1;ENSG00000163823;clinical_c_I83;I83 Varicose veins of lower extremities;rs76628634;T;0.954284;0.25765;0.054402;2.18e-06;S70N;ENST00000296140
CXCR5;ENSG00000160683;clinical_c_N12;N12 Tubulo-interstitial nephritis, not specified as acute or chronic;rs200959025;A;0.8845719999999999;0.020686000000000003;0.0073006;0.004604;R201S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_A04;A04 Other bacterial intestinal infections;rs200959025;A;0.8845719999999999;0.032070999999999995;0.012320000000000001;0.0092389;R201S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_Block_I60-I69;I60-I69 Cerebrovascular diseases;rs665648;A;0.9450430000000001;-0.002802;0.0010714000000000001;0.0089142;G344S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_I42;I42 Cardiomyopathy;rs144650313;A;0.737841;0.014283;0.0045425;0.0016648;V108M;ENST00000292174
CXCR5;ENSG00000160683;30090-0.0;Platelet crit;rs665648;A;0.9450430000000001;-0.001431;0.00027969999999999997;3.1194e-07;G344S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_Block_M15-M19;M15-M19 Arthrosis;rs148564775;T;0.669849;-0.058116999999999995;0.021677000000000002;0.007339;V54L;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_H25;H25 Senile cataract;rs200959025;A;0.8845719999999999;0.065555;0.021465;0.002258;R201S;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1268;eye/eyelid problem;rs148564775;T;0.669849;0.037909;0.014228999999999999;0.0077167;V54L;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_A08;A08 Viral and other specified intestinal infections;rs200959025;A;0.8845719999999999;0.019916;0.0069947;0.0044091;R201S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_N89;N89 Other noninflammatory disorders of vagina;rs376334978;A;0.530338;0.030212;0.011417;0.0081409;D10N;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_Block_G30-G32;G30-G32 Other degenerative diseases of the nervous system;rs376334978;A;0.530338;0.016503999999999998;0.005010499999999999;0.00098835;D10N;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_Block_G30-G32;G30-G32 Other degenerative diseases of the nervous system;rs665648;A;0.9450430000000001;-0.00097887;0.00037894;0.009790299999999998;G344S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_I74;I74 Arterial embolism and thrombosis;rs200959025;A;0.8845719999999999;0.019002;0.0073199;0.0094348;R201S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_I74;I74 Arterial embolism and thrombosis;rs376334978;A;0.530338;0.013096;0.0048408;0.0068247;D10N;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_J47;J47 Bronchiectasis;rs144650313;A;0.737841;0.015572999999999998;0.0055395;0.004935800000000001;V108M;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1301;retinal problem;rs148564775;T;0.669849;0.022527000000000002;0.0056957;7.6524e-05;V54L;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1429;allergy or anaphylactic reaction to drug;rs144650313;A;0.737841;0.027466;0.007651600000000001;0.00033121;V108M;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_K05;K05 Gingivitis and periodontal diseases;rs148564775;T;0.669849;0.010908;0.0032871000000000003;0.00090558;V54L;ENST00000292174
CXCR5;ENSG00000160683;1319-0.0;Dried fruit intake;rs376334978;A;0.530338;-0.46028;0.1423;0.0012184000000000001;D10N;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1761;tuberculosis (tb);rs200959025;A;0.8845719999999999;0.043155;0.010887;7.3779e-05;R201S;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1526;gout;rs144650313;A;0.737841;0.029459;0.0094825;0.0018920999999999999;V108M;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_I46;I46 Cardiac arrest;rs200959025;A;0.8845719999999999;0.021407;0.0074458;0.0040388;R201S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_Block_K20-K31;K20-K31 Diseases of oesophagus, stomach and duodenum;rs665648;A;0.9450430000000001;0.007360600000000001;0.0026644999999999998;0.0057361999999999995;G344S;ENST00000292174
CXCR5;ENSG00000160683;1488-0.0;Tea intake;rs665648;A;0.9450430000000001;-0.07386799999999999;0.020824000000000002;0.00038925;G344S;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1503;clotting disorder/excessive bleeding;rs200959025;A;0.8845719999999999;0.019674;0.0069029;0.0043701;R201S;ENST00000292174
CXCR5;ENSG00000160683;cancer_c_D04;D04 Carcinoma in situ of skin;rs144650313;A;0.737841;0.010740000000000001;0.0038608000000000006;0.0054074;V108M;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_H92;H92 Otalgia and effusion of ear;rs200959025;A;0.8845719999999999;0.01725;0.0055722;0.0019635;R201S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_Block_B15-B19;B15-B19 Viral hepatitis;rs148564775;T;0.669849;0.0089831;0.0027443000000000003;0.0010630000000000001;V54L;ENST00000292174
CXCR5;ENSG00000160683;30080-0.0;Platelet count;rs665648;A;0.9450430000000001;-1.4568;0.33758;1.5937e-05;G344S;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1758;bacterial infection;rs200959025;A;0.8845719999999999;0.051616999999999996;0.015549;0.00090108;R201S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_Block_G00-G09;G00-G09 Inflammatory diseases of the central nervous system;rs200959025;A;0.8845719999999999;0.020752;0.006012;0.00055705;R201S;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1702;fracture upper limb & shoulder;rs144650313;A;0.737841;0.020016;0.007751899999999999;0.0098221;V108M;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_N50;N50 Other disorders of male genital organs;rs665648;A;0.9450430000000001;-0.003742;0.0013903;0.007115899999999999;G344S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_H91;H91 Other hearing loss;rs665648;A;0.9450430000000001;0.0020238;0.00064157;0.0016085000000000001;G344S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_G44;G44 Other headache syndromes;rs148564775;T;0.669849;0.0092134;0.0026173999999999998;0.00043141;V54L;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_G44;G44 Other headache syndromes;rs200959025;A;0.8845719999999999;0.01696;0.0055331;0.0021754;R201S;ENST00000292174
CXCR5;ENSG00000160683;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs665648;A;0.9450430000000001;0.00083635;0.00030359;0.0058723;G344S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_Block_H49-H52;H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction;rs200959025;A;0.8845719999999999;0.053045;0.013143;5.4421999999999995e-05;R201S;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1304;cataract;rs144650313;A;0.737841;0.029015;0.0095277;0.0023246;V108M;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_J34;J34 Other disorders of nose and nasal sinuses;rs200959025;A;0.8845719999999999;0.070243;0.019441999999999997;0.00030289;R201S;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1321;joint disorder;rs148564775;T;0.669849;-0.071873;0.023591;0.0023147;V54L;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1321;joint disorder;rs665648;A;0.9450430000000001;-0.0070134;0.0024944000000000003;0.0049286;G344S;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1133;bronchiectasis;rs144650313;A;0.737841;0.013728;0.0039816;0.00056507;V108M;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_I72;I72 Other aneurysm;rs200959025;A;0.8845719999999999;0.02054;0.0052858;0.00010198;R201S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_M22;M22 Disorders of patella;rs148564775;T;0.669849;0.012418;0.0034955999999999997;0.00038154;V54L;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_M89;M89 Other disorders of bone;rs376334978;A;0.530338;0.018665;0.006256800000000001;0.0028533;D10N;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1350;spine arthritis/spondylitis;rs200959025;A;0.8845719999999999;0.048337;0.014500999999999998;0.00085816;R201S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_N97;N97 Female infertility;rs200959025;A;0.8845719999999999;0.040002;0.0152;0.0084976;R201S;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1314;nervous breakdown;rs200959025;A;0.8845719999999999;0.020694;0.0059887000000000004;0.00054938;R201S;ENST00000292174
CXCR5;ENSG00000160683;20117-0.0;Alcohol drinker status;rs665648;A;0.9450430000000001;-0.0077664000000000006;0.0029621;0.0087435;G344S;ENST00000292174
CXCR5;ENSG00000160683;cancer_c_D41;D41 Neoplasm of uncertain or unknown behaviour of urinary organs;rs200959025;A;0.8845719999999999;0.022955;0.0060979;0.00016701;R201S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_Block_A00-A09;A00-A09 Intestinal infectious diseases;rs200959025;A;0.8845719999999999;0.060264;0.022483000000000003;0.007353;R201S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_D75;D75 Other diseases of blood and blood-forming organs;rs148564775;T;0.669849;0.015886;0.0028572;2.7006999999999998e-08;V54L;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_H52;H52 Disorders of refraction and accommodation;rs200959025;A;0.8845719999999999;0.056205;0.010284999999999999;4.6414e-08;R201S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_N43;N43 Hydrocele and spermatocele;rs376334978;A;0.530338;0.043541;0.013008;0.00081621;D10N;ENST00000292174
CXCR5;ENSG00000160683;selfReported_n_1592;dry eyes;rs665648;A;0.9450430000000001;0.00080742;0.00029554;0.0062957;G344S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_G45;G45 Transient cerebral ischaemic attacks and related syndromes;rs665648;A;0.9450430000000001;-0.0016600000000000002;0.00060812;0.0063394;G344S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_Block_H00-H06;H00-H06 Disorders of eyelid, lacrimal system and orbit;rs144650313;A;0.737841;0.035512;0.012477;0.0044245;V108M;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_M54;M54 Dorsalgia;rs665648;A;0.9450430000000001;0.0049847;0.001407;0.00039595;G344S;ENST00000292174
CXCR5;ENSG00000160683;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs200959025;A;0.8845719999999999;0.016734;0.0064657;0.009648499999999999;R201S;ENST00000292174
CXCR8;ENSG00000178623;clinical_c_M85;M85 Other disorders of bone density and structure;rs35146537;A;1.0;0.0012651;0.00043902;0.0039554;A25T;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_M85;M85 Other disorders of bone density and structure;rs35146537;A;1.0;0.0012651;0.00043902;0.0039554;A25T;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_M85;M85 Other disorders of bone density and structure;rs35146537;A;1.0;0.0012651;0.00043902;0.0039554;A25T;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_M85;M85 Other disorders of bone density and structure;rs35146537;A;1.0;0.0012651;0.00043902;0.0039554;A56T;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_M85;M85 Other disorders of bone density and structure;rs35146537;A;1.0;0.0012651;0.00043902;0.0039554;A25T;ENST00000438013
CXCR8;ENSG00000178623;23128-0.0;Trunk fat mass;rs34778053;A;0.997334;-0.077834;0.025677;0.0024358;R125S;ENST00000319838
CXCR8;ENSG00000178623;23128-0.0;Trunk fat mass;rs34778053;A;0.997334;-0.077834;0.025677;0.0024358;R125S;ENST00000403859
CXCR8;ENSG00000178623;23128-0.0;Trunk fat mass;rs34778053;A;0.997334;-0.077834;0.025677;0.0024358;R125S;ENST00000407714
CXCR8;ENSG00000178623;23128-0.0;Trunk fat mass;rs34778053;A;0.997334;-0.077834;0.025677;0.0024358;R156S;ENST00000430267
CXCR8;ENSG00000178623;23128-0.0;Trunk fat mass;rs34778053;A;0.997334;-0.077834;0.025677;0.0024358;R125S;ENST00000438013
CXCR8;ENSG00000178623;cancer_c_Block_C30-C39;C30-C39 Malignant neoplasms of respiratory and intrathoracic organs;rs61734453;A;0.9567;0.002107;0.00075334;0.0051608;G126R;ENST00000319838
CXCR8;ENSG00000178623;cancer_c_Block_C30-C39;C30-C39 Malignant neoplasms of respiratory and intrathoracic organs;rs61734453;A;0.9567;0.002107;0.00075334;0.0051608;G126R;ENST00000403859
CXCR8;ENSG00000178623;cancer_c_Block_C30-C39;C30-C39 Malignant neoplasms of respiratory and intrathoracic organs;rs61734453;A;0.9567;0.002107;0.00075334;0.0051608;G126R;ENST00000407714
CXCR8;ENSG00000178623;cancer_c_Block_C30-C39;C30-C39 Malignant neoplasms of respiratory and intrathoracic organs;rs61734453;A;0.9567;0.002107;0.00075334;0.0051608;G157R;ENST00000430267
CXCR8;ENSG00000178623;cancer_c_Block_C30-C39;C30-C39 Malignant neoplasms of respiratory and intrathoracic organs;rs61734453;A;0.9567;0.002107;0.00075334;0.0051608;G126R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_N12;N12 Tubulo-interstitial nephritis, not specified as acute or chronic;rs201441371;A;0.900618;0.009212999999999999;0.0035564999999999998;0.009585399999999999;V206M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_N12;N12 Tubulo-interstitial nephritis, not specified as acute or chronic;rs201441371;A;0.900618;0.009212999999999999;0.0035564999999999998;0.009585399999999999;V206M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_N12;N12 Tubulo-interstitial nephritis, not specified as acute or chronic;rs201441371;A;0.900618;0.009212999999999999;0.0035564999999999998;0.009585399999999999;V206M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_N12;N12 Tubulo-interstitial nephritis, not specified as acute or chronic;rs201441371;A;0.900618;0.009212999999999999;0.0035564999999999998;0.009585399999999999;V237M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_N12;N12 Tubulo-interstitial nephritis, not specified as acute or chronic;rs201441371;A;0.900618;0.009212999999999999;0.0035564999999999998;0.009585399999999999;V206M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_A04;A04 Other bacterial intestinal infections;rs3749172;C;1.0;-0.00044217;0.00016744;0.0082734;S294R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_A04;A04 Other bacterial intestinal infections;rs3749172;C;1.0;-0.00044217;0.00016744;0.0082734;S294R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_A04;A04 Other bacterial intestinal infections;rs3749172;C;1.0;-0.00044217;0.00016744;0.0082734;S294R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_A04;A04 Other bacterial intestinal infections;rs3749172;C;1.0;-0.00044217;0.00016744;0.0082734;S325R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_A04;A04 Other bacterial intestinal infections;rs3749172;C;1.0;-0.00044217;0.00016744;0.0082734;S294R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_K40;K40 Inguinal hernia;rs61734452;G;1.0;-0.008583;0.0033058999999999996;0.0094251;N169D;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_K40;K40 Inguinal hernia;rs61734452;G;1.0;-0.008583;0.0033058999999999996;0.0094251;N169D;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_K40;K40 Inguinal hernia;rs61734452;G;1.0;-0.008583;0.0033058999999999996;0.0094251;N169D;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_K40;K40 Inguinal hernia;rs61734452;G;1.0;-0.008583;0.0033058999999999996;0.0094251;N200D;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_K40;K40 Inguinal hernia;rs61734452;G;1.0;-0.008583;0.0033058999999999996;0.0094251;N169D;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_L30;L30 Other dermatitis;rs6437353;A;1.0;0.00049818;0.00012697;8.722600000000001e-05;R13H;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs13387859;A;0.976353;0.021331;0.0050139;2.0965e-05;V76M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs13387859;A;0.976353;0.021331;0.0050139;2.0965e-05;V76M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs13387859;A;0.976353;0.021331;0.0050139;2.0965e-05;V76M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs13387859;A;0.976353;0.021331;0.0050139;2.0965e-05;V107M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs13387859;A;0.976353;0.021331;0.0050139;2.0965e-05;V76M;ENST00000438013
CXCR8;ENSG00000178623;30090-0.0;Platelet crit;rs6437353;A;1.0;-0.00020766;7.5715e-05;0.0060953000000000005;R13H;ENST00000430267
CXCR8;ENSG00000178623;23104-0.0;Body mass index (BMI);rs34778053;A;0.997334;-0.084961;0.023647;0.00032706;R125S;ENST00000319838
CXCR8;ENSG00000178623;23104-0.0;Body mass index (BMI);rs34778053;A;0.997334;-0.084961;0.023647;0.00032706;R125S;ENST00000403859
CXCR8;ENSG00000178623;23104-0.0;Body mass index (BMI);rs34778053;A;0.997334;-0.084961;0.023647;0.00032706;R125S;ENST00000407714
CXCR8;ENSG00000178623;23104-0.0;Body mass index (BMI);rs34778053;A;0.997334;-0.084961;0.023647;0.00032706;R156S;ENST00000430267
CXCR8;ENSG00000178623;23104-0.0;Body mass index (BMI);rs34778053;A;0.997334;-0.084961;0.023647;0.00032706;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_M51;M51 Other intervertebral disk disorders;rs6437353;A;1.0;0.00071907;0.00027492;0.0089081;R13H;ENST00000430267
CXCR8;ENSG00000178623;30210-0.0;Eosinophill percentage;rs139197368;A;1.0;0.042852999999999995;0.015178;0.0047534;V29I;ENST00000319838
CXCR8;ENSG00000178623;30210-0.0;Eosinophill percentage;rs139197368;A;1.0;0.042852999999999995;0.015178;0.0047534;V29I;ENST00000403859
CXCR8;ENSG00000178623;30210-0.0;Eosinophill percentage;rs139197368;A;1.0;0.042852999999999995;0.015178;0.0047534;V29I;ENST00000407714
CXCR8;ENSG00000178623;30210-0.0;Eosinophill percentage;rs139197368;A;1.0;0.042852999999999995;0.015178;0.0047534;V60I;ENST00000430267
CXCR8;ENSG00000178623;30210-0.0;Eosinophill percentage;rs139197368;A;1.0;0.042852999999999995;0.015178;0.0047534;V29I;ENST00000438013
CXCR8;ENSG00000178623;30210-0.0;Eosinophill percentage;rs3749171;T;1.0;-0.016659999999999998;0.004047;3.8465e-05;T108M;ENST00000319838
CXCR8;ENSG00000178623;30210-0.0;Eosinophill percentage;rs3749171;T;1.0;-0.016659999999999998;0.004047;3.8465e-05;T108M;ENST00000403859
CXCR8;ENSG00000178623;30210-0.0;Eosinophill percentage;rs3749171;T;1.0;-0.016659999999999998;0.004047;3.8465e-05;T108M;ENST00000407714
CXCR8;ENSG00000178623;30210-0.0;Eosinophill percentage;rs3749171;T;1.0;-0.016659999999999998;0.004047;3.8465e-05;T139M;ENST00000430267
CXCR8;ENSG00000178623;30210-0.0;Eosinophill percentage;rs3749171;T;1.0;-0.016659999999999998;0.004047;3.8465e-05;T108M;ENST00000438013
CXCR8;ENSG00000178623;1408-0.0;Cheese intake;rs6437353;A;1.0;0.0067631;0.0020819000000000002;0.00116;R13H;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs115880579;T;0.9268069999999999;0.014378;0.0048832;0.0032359000000000003;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs115880579;T;0.9268069999999999;0.014378;0.0048832;0.0032359000000000003;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs115880579;T;0.9268069999999999;0.014378;0.0048832;0.0032359000000000003;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs115880579;T;0.9268069999999999;0.014378;0.0048832;0.0032359000000000003;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs115880579;T;0.9268069999999999;0.014378;0.0048832;0.0032359000000000003;R56C;ENST00000438013
CXCR8;ENSG00000178623;50-0.0;Standing height;rs139197368;A;1.0;0.1904;0.040962;3.3486e-06;V29I;ENST00000319838
CXCR8;ENSG00000178623;50-0.0;Standing height;rs139197368;A;1.0;0.1904;0.040962;3.3486e-06;V29I;ENST00000403859
CXCR8;ENSG00000178623;50-0.0;Standing height;rs139197368;A;1.0;0.1904;0.040962;3.3486e-06;V29I;ENST00000407714
CXCR8;ENSG00000178623;50-0.0;Standing height;rs139197368;A;1.0;0.1904;0.040962;3.3486e-06;V60I;ENST00000430267
CXCR8;ENSG00000178623;50-0.0;Standing height;rs139197368;A;1.0;0.1904;0.040962;3.3486e-06;V29I;ENST00000438013
CXCR8;ENSG00000178623;50-0.0;Standing height;rs201441371;A;0.900618;0.9291299999999999;0.30573;0.0023729;V206M;ENST00000319838
CXCR8;ENSG00000178623;50-0.0;Standing height;rs201441371;A;0.900618;0.9291299999999999;0.30573;0.0023729;V206M;ENST00000403859
CXCR8;ENSG00000178623;50-0.0;Standing height;rs201441371;A;0.900618;0.9291299999999999;0.30573;0.0023729;V206M;ENST00000407714
CXCR8;ENSG00000178623;50-0.0;Standing height;rs201441371;A;0.900618;0.9291299999999999;0.30573;0.0023729;V237M;ENST00000430267
CXCR8;ENSG00000178623;50-0.0;Standing height;rs201441371;A;0.900618;0.9291299999999999;0.30573;0.0023729;V206M;ENST00000438013
CXCR8;ENSG00000178623;50-0.0;Standing height;rs35146537;A;1.0;0.11127999999999999;0.034575;0.0012885;A25T;ENST00000319838
CXCR8;ENSG00000178623;50-0.0;Standing height;rs35146537;A;1.0;0.11127999999999999;0.034575;0.0012885;A25T;ENST00000403859
CXCR8;ENSG00000178623;50-0.0;Standing height;rs35146537;A;1.0;0.11127999999999999;0.034575;0.0012885;A25T;ENST00000407714
CXCR8;ENSG00000178623;50-0.0;Standing height;rs35146537;A;1.0;0.11127999999999999;0.034575;0.0012885;A56T;ENST00000430267
CXCR8;ENSG00000178623;50-0.0;Standing height;rs35146537;A;1.0;0.11127999999999999;0.034575;0.0012885;A25T;ENST00000438013
CXCR8;ENSG00000178623;30120-0.0;Lymphocyte count;rs201441371;A;0.900618;0.12183;0.03985;0.0022346;V206M;ENST00000319838
CXCR8;ENSG00000178623;30120-0.0;Lymphocyte count;rs201441371;A;0.900618;0.12183;0.03985;0.0022346;V206M;ENST00000403859
CXCR8;ENSG00000178623;30120-0.0;Lymphocyte count;rs201441371;A;0.900618;0.12183;0.03985;0.0022346;V206M;ENST00000407714
CXCR8;ENSG00000178623;30120-0.0;Lymphocyte count;rs201441371;A;0.900618;0.12183;0.03985;0.0022346;V237M;ENST00000430267
CXCR8;ENSG00000178623;30120-0.0;Lymphocyte count;rs201441371;A;0.900618;0.12183;0.03985;0.0022346;V206M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_L40-L45;L40-L45 Papulosquamous disorders;rs61734453;A;0.9567;0.0025519;0.00094247;0.0067756;G126R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_L40-L45;L40-L45 Papulosquamous disorders;rs61734453;A;0.9567;0.0025519;0.00094247;0.0067756;G126R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_L40-L45;L40-L45 Papulosquamous disorders;rs61734453;A;0.9567;0.0025519;0.00094247;0.0067756;G126R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_L40-L45;L40-L45 Papulosquamous disorders;rs61734453;A;0.9567;0.0025519;0.00094247;0.0067756;G157R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_L40-L45;L40-L45 Papulosquamous disorders;rs61734453;A;0.9567;0.0025519;0.00094247;0.0067756;G126R;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1685;osteopenia;rs6437353;A;1.0;-0.00035987;0.00010409;0.00054561;R13H;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_G30-G32;G30-G32 Other degenerative diseases of the nervous system;rs3749172;C;1.0;0.00030193;0.00010295;0.0033608000000000006;S294R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_G30-G32;G30-G32 Other degenerative diseases of the nervous system;rs3749172;C;1.0;0.00030193;0.00010295;0.0033608000000000006;S294R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_G30-G32;G30-G32 Other degenerative diseases of the nervous system;rs3749172;C;1.0;0.00030193;0.00010295;0.0033608000000000006;S294R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_G30-G32;G30-G32 Other degenerative diseases of the nervous system;rs3749172;C;1.0;0.00030193;0.00010295;0.0033608000000000006;S325R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_G30-G32;G30-G32 Other degenerative diseases of the nervous system;rs3749172;C;1.0;0.00030193;0.00010295;0.0033608000000000006;S294R;ENST00000438013
CXCR8;ENSG00000178623;23127-0.0;Trunk fat percentage;rs34778053;A;0.997334;-0.10513;0.036552999999999995;0.0040268;R125S;ENST00000319838
CXCR8;ENSG00000178623;23127-0.0;Trunk fat percentage;rs34778053;A;0.997334;-0.10513;0.036552999999999995;0.0040268;R125S;ENST00000403859
CXCR8;ENSG00000178623;23127-0.0;Trunk fat percentage;rs34778053;A;0.997334;-0.10513;0.036552999999999995;0.0040268;R125S;ENST00000407714
CXCR8;ENSG00000178623;23127-0.0;Trunk fat percentage;rs34778053;A;0.997334;-0.10513;0.036552999999999995;0.0040268;R156S;ENST00000430267
CXCR8;ENSG00000178623;23127-0.0;Trunk fat percentage;rs34778053;A;0.997334;-0.10513;0.036552999999999995;0.0040268;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_O16;O16 Unspecified maternal hypertension;rs115880579;T;0.9268069999999999;0.023057;0.0086694;0.0078236;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_O16;O16 Unspecified maternal hypertension;rs115880579;T;0.9268069999999999;0.023057;0.0086694;0.0078236;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_O16;O16 Unspecified maternal hypertension;rs115880579;T;0.9268069999999999;0.023057;0.0086694;0.0078236;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_O16;O16 Unspecified maternal hypertension;rs115880579;T;0.9268069999999999;0.023057;0.0086694;0.0078236;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_O16;O16 Unspecified maternal hypertension;rs115880579;T;0.9268069999999999;0.023057;0.0086694;0.0078236;R56C;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1757;mumps / epidemic parotitis;rs13387859;A;0.976353;0.022288;0.004111600000000001;5.9361e-08;V76M;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1757;mumps / epidemic parotitis;rs13387859;A;0.976353;0.022288;0.004111600000000001;5.9361e-08;V76M;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1757;mumps / epidemic parotitis;rs13387859;A;0.976353;0.022288;0.004111600000000001;5.9361e-08;V76M;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1757;mumps / epidemic parotitis;rs13387859;A;0.976353;0.022288;0.004111600000000001;5.9361e-08;V107M;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1757;mumps / epidemic parotitis;rs13387859;A;0.976353;0.022288;0.004111600000000001;5.9361e-08;V76M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_M86;M86 Osteomyelitis;rs61734453;A;0.9567;0.0010655;0.0004103;0.009410600000000002;G126R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_M86;M86 Osteomyelitis;rs61734453;A;0.9567;0.0010655;0.0004103;0.009410600000000002;G126R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_M86;M86 Osteomyelitis;rs61734453;A;0.9567;0.0010655;0.0004103;0.009410600000000002;G126R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_M86;M86 Osteomyelitis;rs61734453;A;0.9567;0.0010655;0.0004103;0.009410600000000002;G157R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_M86;M86 Osteomyelitis;rs61734453;A;0.9567;0.0010655;0.0004103;0.009410600000000002;G126R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_H61;H61 Other disorders of external ear;rs34778053;A;0.997334;0.00082322;0.00029831;0.0057873;R125S;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_H61;H61 Other disorders of external ear;rs34778053;A;0.997334;0.00082322;0.00029831;0.0057873;R125S;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_H61;H61 Other disorders of external ear;rs34778053;A;0.997334;0.00082322;0.00029831;0.0057873;R125S;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_H61;H61 Other disorders of external ear;rs34778053;A;0.997334;0.00082322;0.00029831;0.0057873;R156S;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_H61;H61 Other disorders of external ear;rs34778053;A;0.997334;0.00082322;0.00029831;0.0057873;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs139042901;G;0.701167;0.013671;0.005286600000000001;0.009709;E252G;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs139042901;G;0.701167;0.013671;0.005286600000000001;0.009709;E252G;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs139042901;G;0.701167;0.013671;0.005286600000000001;0.009709;E252G;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs139042901;G;0.701167;0.013671;0.005286600000000001;0.009709;E283G;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs139042901;G;0.701167;0.013671;0.005286600000000001;0.009709;E252G;ENST00000438013
CXCR8;ENSG00000178623;23113-0.0;Leg fat-free mass (right);rs34778053;A;0.997334;-0.015097999999999999;0.005855600000000001;0.009925100000000001;R125S;ENST00000319838
CXCR8;ENSG00000178623;23113-0.0;Leg fat-free mass (right);rs34778053;A;0.997334;-0.015097999999999999;0.005855600000000001;0.009925100000000001;R125S;ENST00000403859
CXCR8;ENSG00000178623;23113-0.0;Leg fat-free mass (right);rs34778053;A;0.997334;-0.015097999999999999;0.005855600000000001;0.009925100000000001;R125S;ENST00000407714
CXCR8;ENSG00000178623;23113-0.0;Leg fat-free mass (right);rs34778053;A;0.997334;-0.015097999999999999;0.005855600000000001;0.009925100000000001;R156S;ENST00000430267
CXCR8;ENSG00000178623;23113-0.0;Leg fat-free mass (right);rs34778053;A;0.997334;-0.015097999999999999;0.005855600000000001;0.009925100000000001;R125S;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1524;rheumatoid arthritis;rs35146537;A;1.0;-0.0025755;0.00089499;0.0040067;A25T;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1524;rheumatoid arthritis;rs35146537;A;1.0;-0.0025755;0.00089499;0.0040067;A25T;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1524;rheumatoid arthritis;rs35146537;A;1.0;-0.0025755;0.00089499;0.0040067;A25T;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1524;rheumatoid arthritis;rs35146537;A;1.0;-0.0025755;0.00089499;0.0040067;A56T;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1524;rheumatoid arthritis;rs35146537;A;1.0;-0.0025755;0.00089499;0.0040067;A25T;ENST00000438013
CXCR8;ENSG00000178623;21001-0.0;Body mass index (BMI);rs34778053;A;0.997334;-0.088536;0.023832;0.00020322;R125S;ENST00000319838
CXCR8;ENSG00000178623;21001-0.0;Body mass index (BMI);rs34778053;A;0.997334;-0.088536;0.023832;0.00020322;R125S;ENST00000403859
CXCR8;ENSG00000178623;21001-0.0;Body mass index (BMI);rs34778053;A;0.997334;-0.088536;0.023832;0.00020322;R125S;ENST00000407714
CXCR8;ENSG00000178623;21001-0.0;Body mass index (BMI);rs34778053;A;0.997334;-0.088536;0.023832;0.00020322;R156S;ENST00000430267
CXCR8;ENSG00000178623;21001-0.0;Body mass index (BMI);rs34778053;A;0.997334;-0.088536;0.023832;0.00020322;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs35146537;A;1.0;-0.0026445;0.001015;0.0091753;A25T;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs35146537;A;1.0;-0.0026445;0.001015;0.0091753;A25T;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs35146537;A;1.0;-0.0026445;0.001015;0.0091753;A25T;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs35146537;A;1.0;-0.0026445;0.001015;0.0091753;A56T;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs35146537;A;1.0;-0.0026445;0.001015;0.0091753;A25T;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1249;thyroid problem (not cancer);rs3749172;C;1.0;-0.0014174;0.00046433;0.0022686;S294R;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1249;thyroid problem (not cancer);rs3749172;C;1.0;-0.0014174;0.00046433;0.0022686;S294R;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1249;thyroid problem (not cancer);rs3749172;C;1.0;-0.0014174;0.00046433;0.0022686;S294R;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1249;thyroid problem (not cancer);rs3749172;C;1.0;-0.0014174;0.00046433;0.0022686;S325R;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1249;thyroid problem (not cancer);rs3749172;C;1.0;-0.0014174;0.00046433;0.0022686;S294R;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1566;anal problem;rs61734452;G;1.0;0.0029619;0.0010195;0.0036681999999999995;N169D;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1566;anal problem;rs61734452;G;1.0;0.0029619;0.0010195;0.0036681999999999995;N169D;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1566;anal problem;rs61734452;G;1.0;0.0029619;0.0010195;0.0036681999999999995;N169D;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1566;anal problem;rs61734452;G;1.0;0.0029619;0.0010195;0.0036681999999999995;N200D;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1566;anal problem;rs61734452;G;1.0;0.0029619;0.0010195;0.0036681999999999995;N169D;ENST00000438013
CXCR8;ENSG00000178623;23107-0.0;Impedance of leg (right);rs34778053;A;0.997334;0.43858;0.1587;0.0057161;R125S;ENST00000319838
CXCR8;ENSG00000178623;23107-0.0;Impedance of leg (right);rs34778053;A;0.997334;0.43858;0.1587;0.0057161;R125S;ENST00000403859
CXCR8;ENSG00000178623;23107-0.0;Impedance of leg (right);rs34778053;A;0.997334;0.43858;0.1587;0.0057161;R125S;ENST00000407714
CXCR8;ENSG00000178623;23107-0.0;Impedance of leg (right);rs34778053;A;0.997334;0.43858;0.1587;0.0057161;R156S;ENST00000430267
CXCR8;ENSG00000178623;23107-0.0;Impedance of leg (right);rs34778053;A;0.997334;0.43858;0.1587;0.0057161;R125S;ENST00000438013
CXCR8;ENSG00000178623;23107-0.0;Impedance of leg (right);rs35146537;A;1.0;0.59719;0.22149000000000002;0.0070142;A25T;ENST00000319838
CXCR8;ENSG00000178623;23107-0.0;Impedance of leg (right);rs35146537;A;1.0;0.59719;0.22149000000000002;0.0070142;A25T;ENST00000403859
CXCR8;ENSG00000178623;23107-0.0;Impedance of leg (right);rs35146537;A;1.0;0.59719;0.22149000000000002;0.0070142;A25T;ENST00000407714
CXCR8;ENSG00000178623;23107-0.0;Impedance of leg (right);rs35146537;A;1.0;0.59719;0.22149000000000002;0.0070142;A56T;ENST00000430267
CXCR8;ENSG00000178623;23107-0.0;Impedance of leg (right);rs35146537;A;1.0;0.59719;0.22149000000000002;0.0070142;A25T;ENST00000438013
CXCR8;ENSG00000178623;23112-0.0;Leg fat mass (right);rs34778053;A;0.997334;-0.022438;0.007937600000000001;0.0047012;R125S;ENST00000319838
CXCR8;ENSG00000178623;23112-0.0;Leg fat mass (right);rs34778053;A;0.997334;-0.022438;0.007937600000000001;0.0047012;R125S;ENST00000403859
CXCR8;ENSG00000178623;23112-0.0;Leg fat mass (right);rs34778053;A;0.997334;-0.022438;0.007937600000000001;0.0047012;R125S;ENST00000407714
CXCR8;ENSG00000178623;23112-0.0;Leg fat mass (right);rs34778053;A;0.997334;-0.022438;0.007937600000000001;0.0047012;R156S;ENST00000430267
CXCR8;ENSG00000178623;23112-0.0;Leg fat mass (right);rs34778053;A;0.997334;-0.022438;0.007937600000000001;0.0047012;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_L60;L60 Nail disorders;rs139197368;A;1.0;0.0016686;0.00053614;0.0018566;V29I;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_L60;L60 Nail disorders;rs139197368;A;1.0;0.0016686;0.00053614;0.0018566;V29I;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_L60;L60 Nail disorders;rs139197368;A;1.0;0.0016686;0.00053614;0.0018566;V29I;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_L60;L60 Nail disorders;rs139197368;A;1.0;0.0016686;0.00053614;0.0018566;V60I;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_L60;L60 Nail disorders;rs139197368;A;1.0;0.0016686;0.00053614;0.0018566;V29I;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_H43;H43 Disorders of vitreous body;rs35146537;A;1.0;-0.0013448;0.00048947;0.0060066;A25T;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_H43;H43 Disorders of vitreous body;rs35146537;A;1.0;-0.0013448;0.00048947;0.0060066;A25T;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_H43;H43 Disorders of vitreous body;rs35146537;A;1.0;-0.0013448;0.00048947;0.0060066;A25T;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_H43;H43 Disorders of vitreous body;rs35146537;A;1.0;-0.0013448;0.00048947;0.0060066;A56T;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_H43;H43 Disorders of vitreous body;rs35146537;A;1.0;-0.0013448;0.00048947;0.0060066;A25T;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1407;breast disease (not cancer);rs139042901;G;0.701167;0.020902;0.007562;0.0057095;E252G;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1407;breast disease (not cancer);rs139042901;G;0.701167;0.020902;0.007562;0.0057095;E252G;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1407;breast disease (not cancer);rs139042901;G;0.701167;0.020902;0.007562;0.0057095;E252G;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1407;breast disease (not cancer);rs139042901;G;0.701167;0.020902;0.007562;0.0057095;E283G;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1407;breast disease (not cancer);rs139042901;G;0.701167;0.020902;0.007562;0.0057095;E252G;ENST00000438013
CXCR8;ENSG00000178623;1289-0.0;Cooked vegetable intake;rs3749171;T;1.0;-0.011884;0.004220600000000001;0.004866;T108M;ENST00000319838
CXCR8;ENSG00000178623;1289-0.0;Cooked vegetable intake;rs3749171;T;1.0;-0.011884;0.004220600000000001;0.004866;T108M;ENST00000403859
CXCR8;ENSG00000178623;1289-0.0;Cooked vegetable intake;rs3749171;T;1.0;-0.011884;0.004220600000000001;0.004866;T108M;ENST00000407714
CXCR8;ENSG00000178623;1289-0.0;Cooked vegetable intake;rs3749171;T;1.0;-0.011884;0.004220600000000001;0.004866;T139M;ENST00000430267
CXCR8;ENSG00000178623;1289-0.0;Cooked vegetable intake;rs3749171;T;1.0;-0.011884;0.004220600000000001;0.004866;T108M;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1621;obstetric problem;rs139042901;G;0.701167;0.017419;0.0045382;0.00012395;E252G;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1621;obstetric problem;rs139042901;G;0.701167;0.017419;0.0045382;0.00012395;E252G;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1621;obstetric problem;rs139042901;G;0.701167;0.017419;0.0045382;0.00012395;E252G;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1621;obstetric problem;rs139042901;G;0.701167;0.017419;0.0045382;0.00012395;E283G;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1621;obstetric problem;rs139042901;G;0.701167;0.017419;0.0045382;0.00012395;E252G;ENST00000438013
CXCR8;ENSG00000178623;30280-0.0;Immature reticulocyte fraction;rs34778053;A;0.997334;-0.00083793;0.00031417;0.007651100000000001;R125S;ENST00000319838
CXCR8;ENSG00000178623;30280-0.0;Immature reticulocyte fraction;rs34778053;A;0.997334;-0.00083793;0.00031417;0.007651100000000001;R125S;ENST00000403859
CXCR8;ENSG00000178623;30280-0.0;Immature reticulocyte fraction;rs34778053;A;0.997334;-0.00083793;0.00031417;0.007651100000000001;R125S;ENST00000407714
CXCR8;ENSG00000178623;30280-0.0;Immature reticulocyte fraction;rs34778053;A;0.997334;-0.00083793;0.00031417;0.007651100000000001;R156S;ENST00000430267
CXCR8;ENSG00000178623;30280-0.0;Immature reticulocyte fraction;rs34778053;A;0.997334;-0.00083793;0.00031417;0.007651100000000001;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_D86;D86 Sarcoidosis;rs13387859;A;0.976353;0.0086711;0.0031964000000000003;0.0066721;V76M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_D86;D86 Sarcoidosis;rs13387859;A;0.976353;0.0086711;0.0031964000000000003;0.0066721;V76M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_D86;D86 Sarcoidosis;rs13387859;A;0.976353;0.0086711;0.0031964000000000003;0.0066721;V76M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_D86;D86 Sarcoidosis;rs13387859;A;0.976353;0.0086711;0.0031964000000000003;0.0066721;V107M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_D86;D86 Sarcoidosis;rs13387859;A;0.976353;0.0086711;0.0031964000000000003;0.0066721;V76M;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1460;substance abuse/dependency;rs35146537;A;1.0;-0.0011297;0.00034862;0.0011935000000000001;A25T;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1460;substance abuse/dependency;rs35146537;A;1.0;-0.0011297;0.00034862;0.0011935000000000001;A25T;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1460;substance abuse/dependency;rs35146537;A;1.0;-0.0011297;0.00034862;0.0011935000000000001;A25T;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1460;substance abuse/dependency;rs35146537;A;1.0;-0.0011297;0.00034862;0.0011935000000000001;A56T;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1460;substance abuse/dependency;rs35146537;A;1.0;-0.0011297;0.00034862;0.0011935000000000001;A25T;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs115880579;T;0.9268069999999999;0.039355;0.014822;0.0079273;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs115880579;T;0.9268069999999999;0.039355;0.014822;0.0079273;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs115880579;T;0.9268069999999999;0.039355;0.014822;0.0079273;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs115880579;T;0.9268069999999999;0.039355;0.014822;0.0079273;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs115880579;T;0.9268069999999999;0.039355;0.014822;0.0079273;R56C;ENST00000438013
CXCR8;ENSG00000178623;23100-0.0;Whole body fat mass;rs34778053;A;0.997334;-0.14356;0.046268000000000004;0.0019165;R125S;ENST00000319838
CXCR8;ENSG00000178623;23100-0.0;Whole body fat mass;rs34778053;A;0.997334;-0.14356;0.046268000000000004;0.0019165;R125S;ENST00000403859
CXCR8;ENSG00000178623;23100-0.0;Whole body fat mass;rs34778053;A;0.997334;-0.14356;0.046268000000000004;0.0019165;R125S;ENST00000407714
CXCR8;ENSG00000178623;23100-0.0;Whole body fat mass;rs34778053;A;0.997334;-0.14356;0.046268000000000004;0.0019165;R156S;ENST00000430267
CXCR8;ENSG00000178623;23100-0.0;Whole body fat mass;rs34778053;A;0.997334;-0.14356;0.046268000000000004;0.0019165;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_M91-M94;M91-M94 Chondropathies;rs13387859;A;0.976353;0.015622;0.0048043;0.0011472000000000001;V76M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_M91-M94;M91-M94 Chondropathies;rs13387859;A;0.976353;0.015622;0.0048043;0.0011472000000000001;V76M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_M91-M94;M91-M94 Chondropathies;rs13387859;A;0.976353;0.015622;0.0048043;0.0011472000000000001;V76M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_M91-M94;M91-M94 Chondropathies;rs13387859;A;0.976353;0.015622;0.0048043;0.0011472000000000001;V107M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_M91-M94;M91-M94 Chondropathies;rs13387859;A;0.976353;0.015622;0.0048043;0.0011472000000000001;V76M;ENST00000438013
CXCR8;ENSG00000178623;30200-0.0;Neutrophill percentage;rs3749171;T;1.0;0.07832599999999999;0.019656;6.7547e-05;T108M;ENST00000319838
CXCR8;ENSG00000178623;30200-0.0;Neutrophill percentage;rs3749171;T;1.0;0.07832599999999999;0.019656;6.7547e-05;T108M;ENST00000403859
CXCR8;ENSG00000178623;30200-0.0;Neutrophill percentage;rs3749171;T;1.0;0.07832599999999999;0.019656;6.7547e-05;T108M;ENST00000407714
CXCR8;ENSG00000178623;30200-0.0;Neutrophill percentage;rs3749171;T;1.0;0.07832599999999999;0.019656;6.7547e-05;T139M;ENST00000430267
CXCR8;ENSG00000178623;30200-0.0;Neutrophill percentage;rs3749171;T;1.0;0.07832599999999999;0.019656;6.7547e-05;T108M;ENST00000438013
CXCR8;ENSG00000178623;30200-0.0;Neutrophill percentage;rs3749172;C;1.0;-0.052030999999999994;0.015353;0.00070159;S294R;ENST00000319838
CXCR8;ENSG00000178623;30200-0.0;Neutrophill percentage;rs3749172;C;1.0;-0.052030999999999994;0.015353;0.00070159;S294R;ENST00000403859
CXCR8;ENSG00000178623;30200-0.0;Neutrophill percentage;rs3749172;C;1.0;-0.052030999999999994;0.015353;0.00070159;S294R;ENST00000407714
CXCR8;ENSG00000178623;30200-0.0;Neutrophill percentage;rs3749172;C;1.0;-0.052030999999999994;0.015353;0.00070159;S325R;ENST00000430267
CXCR8;ENSG00000178623;30200-0.0;Neutrophill percentage;rs3749172;C;1.0;-0.052030999999999994;0.015353;0.00070159;S294R;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1750;measles / morbillivirus;rs13387859;A;0.976353;0.013853;0.0051143000000000004;0.006756999999999999;V76M;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1750;measles / morbillivirus;rs13387859;A;0.976353;0.013853;0.0051143000000000004;0.006756999999999999;V76M;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1750;measles / morbillivirus;rs13387859;A;0.976353;0.013853;0.0051143000000000004;0.006756999999999999;V76M;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1750;measles / morbillivirus;rs13387859;A;0.976353;0.013853;0.0051143000000000004;0.006756999999999999;V107M;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1750;measles / morbillivirus;rs13387859;A;0.976353;0.013853;0.0051143000000000004;0.006756999999999999;V76M;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1750;measles / morbillivirus;rs139197368;A;1.0;0.0017167000000000003;0.00058385;0.0032790999999999996;V29I;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1750;measles / morbillivirus;rs139197368;A;1.0;0.0017167000000000003;0.00058385;0.0032790999999999996;V29I;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1750;measles / morbillivirus;rs139197368;A;1.0;0.0017167000000000003;0.00058385;0.0032790999999999996;V29I;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1750;measles / morbillivirus;rs139197368;A;1.0;0.0017167000000000003;0.00058385;0.0032790999999999996;V60I;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1750;measles / morbillivirus;rs139197368;A;1.0;0.0017167000000000003;0.00058385;0.0032790999999999996;V29I;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1503;clotting disorder/excessive bleeding;rs201441371;A;0.900618;0.008954299999999998;0.0033618000000000003;0.007732200000000001;V206M;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1503;clotting disorder/excessive bleeding;rs201441371;A;0.900618;0.008954299999999998;0.0033618000000000003;0.007732200000000001;V206M;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1503;clotting disorder/excessive bleeding;rs201441371;A;0.900618;0.008954299999999998;0.0033618000000000003;0.007732200000000001;V206M;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1503;clotting disorder/excessive bleeding;rs201441371;A;0.900618;0.008954299999999998;0.0033618000000000003;0.007732200000000001;V237M;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1503;clotting disorder/excessive bleeding;rs201441371;A;0.900618;0.008954299999999998;0.0033618000000000003;0.007732200000000001;V206M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_K76;K76 Other diseases of liver;rs139042901;G;0.701167;0.011681;0.0043783;0.0076337;E252G;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_K76;K76 Other diseases of liver;rs139042901;G;0.701167;0.011681;0.0043783;0.0076337;E252G;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_K76;K76 Other diseases of liver;rs139042901;G;0.701167;0.011681;0.0043783;0.0076337;E252G;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_K76;K76 Other diseases of liver;rs139042901;G;0.701167;0.011681;0.0043783;0.0076337;E283G;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_K76;K76 Other diseases of liver;rs139042901;G;0.701167;0.011681;0.0043783;0.0076337;E252G;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs139042901;G;0.701167;0.0059418;0.0021831;0.006494499999999999;E252G;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs139042901;G;0.701167;0.0059418;0.0021831;0.006494499999999999;E252G;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs139042901;G;0.701167;0.0059418;0.0021831;0.006494499999999999;E252G;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs139042901;G;0.701167;0.0059418;0.0021831;0.006494499999999999;E283G;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs139042901;G;0.701167;0.0059418;0.0021831;0.006494499999999999;E252G;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs61734453;A;0.9567;-0.0051416000000000005;0.0019469;0.0082692;G126R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs61734453;A;0.9567;-0.0051416000000000005;0.0019469;0.0082692;G126R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs61734453;A;0.9567;-0.0051416000000000005;0.0019469;0.0082692;G126R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs61734453;A;0.9567;-0.0051416000000000005;0.0019469;0.0082692;G157R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs61734453;A;0.9567;-0.0051416000000000005;0.0019469;0.0082692;G126R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_N87;N87 Dysplasia of cervix uteri;rs201441371;A;0.900618;0.033725;0.008277799999999998;4.619e-05;V206M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_N87;N87 Dysplasia of cervix uteri;rs201441371;A;0.900618;0.033725;0.008277799999999998;4.619e-05;V206M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_N87;N87 Dysplasia of cervix uteri;rs201441371;A;0.900618;0.033725;0.008277799999999998;4.619e-05;V206M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_N87;N87 Dysplasia of cervix uteri;rs201441371;A;0.900618;0.033725;0.008277799999999998;4.619e-05;V237M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_N87;N87 Dysplasia of cervix uteri;rs201441371;A;0.900618;0.033725;0.008277799999999998;4.619e-05;V206M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_J44;J44 Other chronic obstructive pulmonary disease;rs3749171;T;1.0;-0.00098449;0.00037581;0.008801799999999999;T108M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_J44;J44 Other chronic obstructive pulmonary disease;rs3749171;T;1.0;-0.00098449;0.00037581;0.008801799999999999;T108M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_J44;J44 Other chronic obstructive pulmonary disease;rs3749171;T;1.0;-0.00098449;0.00037581;0.008801799999999999;T108M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_J44;J44 Other chronic obstructive pulmonary disease;rs3749171;T;1.0;-0.00098449;0.00037581;0.008801799999999999;T139M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_J44;J44 Other chronic obstructive pulmonary disease;rs3749171;T;1.0;-0.00098449;0.00037581;0.008801799999999999;T108M;ENST00000438013
CXCR8;ENSG00000178623;23120-0.0;Arm fat mass (right);rs34778053;A;0.997334;-0.009956999999999999;0.0031138000000000003;0.0013851;R125S;ENST00000319838
CXCR8;ENSG00000178623;23120-0.0;Arm fat mass (right);rs34778053;A;0.997334;-0.009956999999999999;0.0031138000000000003;0.0013851;R125S;ENST00000403859
CXCR8;ENSG00000178623;23120-0.0;Arm fat mass (right);rs34778053;A;0.997334;-0.009956999999999999;0.0031138000000000003;0.0013851;R125S;ENST00000407714
CXCR8;ENSG00000178623;23120-0.0;Arm fat mass (right);rs34778053;A;0.997334;-0.009956999999999999;0.0031138000000000003;0.0013851;R156S;ENST00000430267
CXCR8;ENSG00000178623;23120-0.0;Arm fat mass (right);rs34778053;A;0.997334;-0.009956999999999999;0.0031138000000000003;0.0013851;R125S;ENST00000438013
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs139197368;A;1.0;0.024493;0.0076823;0.0014318;V29I;ENST00000319838
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs139197368;A;1.0;0.024493;0.0076823;0.0014318;V29I;ENST00000403859
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs139197368;A;1.0;0.024493;0.0076823;0.0014318;V29I;ENST00000407714
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs139197368;A;1.0;0.024493;0.0076823;0.0014318;V60I;ENST00000430267
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs139197368;A;1.0;0.024493;0.0076823;0.0014318;V29I;ENST00000438013
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs34778053;A;0.997334;0.014431999999999999;0.004646;0.0018948;R125S;ENST00000319838
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs34778053;A;0.997334;0.014431999999999999;0.004646;0.0018948;R125S;ENST00000403859
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs34778053;A;0.997334;0.014431999999999999;0.004646;0.0018948;R125S;ENST00000407714
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs34778053;A;0.997334;0.014431999999999999;0.004646;0.0018948;R156S;ENST00000430267
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs34778053;A;0.997334;0.014431999999999999;0.004646;0.0018948;R125S;ENST00000438013
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs35146537;A;1.0;0.018253;0.0064845;0.0048796;A25T;ENST00000319838
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs35146537;A;1.0;0.018253;0.0064845;0.0048796;A25T;ENST00000403859
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs35146537;A;1.0;0.018253;0.0064845;0.0048796;A25T;ENST00000407714
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs35146537;A;1.0;0.018253;0.0064845;0.0048796;A56T;ENST00000430267
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs35146537;A;1.0;0.018253;0.0064845;0.0048796;A25T;ENST00000438013
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs3749171;T;1.0;-0.017348;0.0020482;2.4641e-17;T108M;ENST00000319838
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs3749171;T;1.0;-0.017348;0.0020482;2.4641e-17;T108M;ENST00000403859
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs3749171;T;1.0;-0.017348;0.0020482;2.4641e-17;T108M;ENST00000407714
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs3749171;T;1.0;-0.017348;0.0020482;2.4641e-17;T139M;ENST00000430267
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs3749171;T;1.0;-0.017348;0.0020482;2.4641e-17;T108M;ENST00000438013
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs3749172;C;1.0;-0.0056841;0.0015999;0.00038137;S294R;ENST00000319838
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs3749172;C;1.0;-0.0056841;0.0015999;0.00038137;S294R;ENST00000403859
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs3749172;C;1.0;-0.0056841;0.0015999;0.00038137;S294R;ENST00000407714
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs3749172;C;1.0;-0.0056841;0.0015999;0.00038137;S325R;ENST00000430267
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs3749172;C;1.0;-0.0056841;0.0015999;0.00038137;S294R;ENST00000438013
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs61734453;A;0.9567;-0.06478300000000001;0.008715;1.0590999999999999e-13;G126R;ENST00000319838
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs61734453;A;0.9567;-0.06478300000000001;0.008715;1.0590999999999999e-13;G126R;ENST00000403859
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs61734453;A;0.9567;-0.06478300000000001;0.008715;1.0590999999999999e-13;G126R;ENST00000407714
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs61734453;A;0.9567;-0.06478300000000001;0.008715;1.0590999999999999e-13;G157R;ENST00000430267
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs61734453;A;0.9567;-0.06478300000000001;0.008715;1.0590999999999999e-13;G126R;ENST00000438013
CXCR8;ENSG00000178623;30100-0.0;Mean platelet (thrombocyte) volume;rs6437353;A;1.0;-0.028291000000000004;0.0015886;6.3552999999999995e-71;R13H;ENST00000430267
CXCR8;ENSG00000178623;30070-0.0;Red blood cell (erythrocyte) distribution width;rs6437353;A;1.0;-0.0061454;0.0016552;0.00020508;R13H;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1211;peritonitis;rs115880579;T;0.9268069999999999;0.024402;0.0072537999999999995;0.00076817;R56C;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1211;peritonitis;rs115880579;T;0.9268069999999999;0.024402;0.0072537999999999995;0.00076817;R56C;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1211;peritonitis;rs115880579;T;0.9268069999999999;0.024402;0.0072537999999999995;0.00076817;R56C;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1211;peritonitis;rs115880579;T;0.9268069999999999;0.024402;0.0072537999999999995;0.00076817;R87C;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1211;peritonitis;rs115880579;T;0.9268069999999999;0.024402;0.0072537999999999995;0.00076817;R56C;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_E21;E21 Hyperparathyroidism and other disorders of parathyroid gland;rs61734453;A;0.9567;0.0015819;0.00050849;0.0018645;G126R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_E21;E21 Hyperparathyroidism and other disorders of parathyroid gland;rs61734453;A;0.9567;0.0015819;0.00050849;0.0018645;G126R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_E21;E21 Hyperparathyroidism and other disorders of parathyroid gland;rs61734453;A;0.9567;0.0015819;0.00050849;0.0018645;G126R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_E21;E21 Hyperparathyroidism and other disorders of parathyroid gland;rs61734453;A;0.9567;0.0015819;0.00050849;0.0018645;G157R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_E21;E21 Hyperparathyroidism and other disorders of parathyroid gland;rs61734453;A;0.9567;0.0015819;0.00050849;0.0018645;G126R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_B34;B34 Viral infection of unspecified site;rs13387859;A;0.976353;0.020298;0.0057532;0.00041854;V76M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_B34;B34 Viral infection of unspecified site;rs13387859;A;0.976353;0.020298;0.0057532;0.00041854;V76M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_B34;B34 Viral infection of unspecified site;rs13387859;A;0.976353;0.020298;0.0057532;0.00041854;V76M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_B34;B34 Viral infection of unspecified site;rs13387859;A;0.976353;0.020298;0.0057532;0.00041854;V107M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_B34;B34 Viral infection of unspecified site;rs13387859;A;0.976353;0.020298;0.0057532;0.00041854;V76M;ENST00000438013
CXCR8;ENSG00000178623;30080-0.0;Platelet count;rs3749171;T;1.0;0.44643999999999995;0.11782000000000001;0.00015116;T108M;ENST00000319838
CXCR8;ENSG00000178623;30080-0.0;Platelet count;rs3749171;T;1.0;0.44643999999999995;0.11782000000000001;0.00015116;T108M;ENST00000403859
CXCR8;ENSG00000178623;30080-0.0;Platelet count;rs3749171;T;1.0;0.44643999999999995;0.11782000000000001;0.00015116;T108M;ENST00000407714
CXCR8;ENSG00000178623;30080-0.0;Platelet count;rs3749171;T;1.0;0.44643999999999995;0.11782000000000001;0.00015116;T139M;ENST00000430267
CXCR8;ENSG00000178623;30080-0.0;Platelet count;rs3749171;T;1.0;0.44643999999999995;0.11782000000000001;0.00015116;T108M;ENST00000438013
CXCR8;ENSG00000178623;30080-0.0;Platelet count;rs61734453;A;0.9567;1.6225;0.50129;0.00121;G126R;ENST00000319838
CXCR8;ENSG00000178623;30080-0.0;Platelet count;rs61734453;A;0.9567;1.6225;0.50129;0.00121;G126R;ENST00000403859
CXCR8;ENSG00000178623;30080-0.0;Platelet count;rs61734453;A;0.9567;1.6225;0.50129;0.00121;G126R;ENST00000407714
CXCR8;ENSG00000178623;30080-0.0;Platelet count;rs61734453;A;0.9567;1.6225;0.50129;0.00121;G157R;ENST00000430267
CXCR8;ENSG00000178623;30080-0.0;Platelet count;rs61734453;A;0.9567;1.6225;0.50129;0.00121;G126R;ENST00000438013
CXCR8;ENSG00000178623;30080-0.0;Platelet count;rs6437353;A;1.0;0.58117;0.0914;2.0393000000000001e-10;R13H;ENST00000430267
CXCR8;ENSG00000178623;20015-0.0;Sitting height;rs35146537;A;1.0;0.06819700000000001;0.023150999999999998;0.0032223;A25T;ENST00000319838
CXCR8;ENSG00000178623;20015-0.0;Sitting height;rs35146537;A;1.0;0.06819700000000001;0.023150999999999998;0.0032223;A25T;ENST00000403859
CXCR8;ENSG00000178623;20015-0.0;Sitting height;rs35146537;A;1.0;0.06819700000000001;0.023150999999999998;0.0032223;A25T;ENST00000407714
CXCR8;ENSG00000178623;20015-0.0;Sitting height;rs35146537;A;1.0;0.06819700000000001;0.023150999999999998;0.0032223;A56T;ENST00000430267
CXCR8;ENSG00000178623;20015-0.0;Sitting height;rs35146537;A;1.0;0.06819700000000001;0.023150999999999998;0.0032223;A25T;ENST00000438013
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs34778053;A;0.997334;-0.041775;0.011087999999999999;0.00016486;R125S;ENST00000319838
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs34778053;A;0.997334;-0.041775;0.011087999999999999;0.00016486;R125S;ENST00000403859
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs34778053;A;0.997334;-0.041775;0.011087999999999999;0.00016486;R125S;ENST00000407714
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs34778053;A;0.997334;-0.041775;0.011087999999999999;0.00016486;R156S;ENST00000430267
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs34778053;A;0.997334;-0.041775;0.011087999999999999;0.00016486;R125S;ENST00000438013
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs3749171;T;1.0;-0.055238;0.004888;1.3103e-29;T108M;ENST00000319838
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs3749171;T;1.0;-0.055238;0.004888;1.3103e-29;T108M;ENST00000403859
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs3749171;T;1.0;-0.055238;0.004888;1.3103e-29;T108M;ENST00000407714
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs3749171;T;1.0;-0.055238;0.004888;1.3103e-29;T139M;ENST00000430267
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs3749171;T;1.0;-0.055238;0.004888;1.3103e-29;T108M;ENST00000438013
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs3749172;C;1.0;0.029039999999999996;0.0038180999999999996;2.8395e-14;S294R;ENST00000319838
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs3749172;C;1.0;0.029039999999999996;0.0038180999999999996;2.8395e-14;S294R;ENST00000403859
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs3749172;C;1.0;0.029039999999999996;0.0038180999999999996;2.8395e-14;S294R;ENST00000407714
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs3749172;C;1.0;0.029039999999999996;0.0038180999999999996;2.8395e-14;S325R;ENST00000430267
CXCR8;ENSG00000178623;30190-0.0;Monocyte percentage;rs3749172;C;1.0;0.029039999999999996;0.0038180999999999996;2.8395e-14;S294R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_H91;H91 Other hearing loss;rs115880579;T;0.9268069999999999;0.036229000000000004;0.0103;0.00043559;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_H91;H91 Other hearing loss;rs115880579;T;0.9268069999999999;0.036229000000000004;0.0103;0.00043559;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_H91;H91 Other hearing loss;rs115880579;T;0.9268069999999999;0.036229000000000004;0.0103;0.00043559;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_H91;H91 Other hearing loss;rs115880579;T;0.9268069999999999;0.036229000000000004;0.0103;0.00043559;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_H91;H91 Other hearing loss;rs115880579;T;0.9268069999999999;0.036229000000000004;0.0103;0.00043559;R56C;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_I67;I67 Other cerebrovascular diseases;rs115880579;T;0.9268069999999999;0.032756;0.009470600000000001;0.00054279;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_I67;I67 Other cerebrovascular diseases;rs115880579;T;0.9268069999999999;0.032756;0.009470600000000001;0.00054279;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_I67;I67 Other cerebrovascular diseases;rs115880579;T;0.9268069999999999;0.032756;0.009470600000000001;0.00054279;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_I67;I67 Other cerebrovascular diseases;rs115880579;T;0.9268069999999999;0.032756;0.009470600000000001;0.00054279;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_I67;I67 Other cerebrovascular diseases;rs115880579;T;0.9268069999999999;0.032756;0.009470600000000001;0.00054279;R56C;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_I67;I67 Other cerebrovascular diseases;rs34778053;A;0.997334;0.0012046;0.00046538;0.009643500000000001;R125S;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_I67;I67 Other cerebrovascular diseases;rs34778053;A;0.997334;0.0012046;0.00046538;0.009643500000000001;R125S;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_I67;I67 Other cerebrovascular diseases;rs34778053;A;0.997334;0.0012046;0.00046538;0.009643500000000001;R125S;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_I67;I67 Other cerebrovascular diseases;rs34778053;A;0.997334;0.0012046;0.00046538;0.009643500000000001;R156S;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_I67;I67 Other cerebrovascular diseases;rs34778053;A;0.997334;0.0012046;0.00046538;0.009643500000000001;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_I67;I67 Other cerebrovascular diseases;rs6437353;A;1.0;-0.0004202;0.00015918;0.008296;R13H;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1251;hypothyroidism/myxoedema;rs3749171;T;1.0;0.0016293;0.00054647;0.0028689;T108M;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1251;hypothyroidism/myxoedema;rs3749171;T;1.0;0.0016293;0.00054647;0.0028689;T108M;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1251;hypothyroidism/myxoedema;rs3749171;T;1.0;0.0016293;0.00054647;0.0028689;T108M;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1251;hypothyroidism/myxoedema;rs3749171;T;1.0;0.0016293;0.00054647;0.0028689;T139M;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1251;hypothyroidism/myxoedema;rs3749171;T;1.0;0.0016293;0.00054647;0.0028689;T108M;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1251;hypothyroidism/myxoedema;rs3749172;C;1.0;-0.0015128;0.00042683;0.00039383;S294R;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1251;hypothyroidism/myxoedema;rs3749172;C;1.0;-0.0015128;0.00042683;0.00039383;S294R;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1251;hypothyroidism/myxoedema;rs3749172;C;1.0;-0.0015128;0.00042683;0.00039383;S294R;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1251;hypothyroidism/myxoedema;rs3749172;C;1.0;-0.0015128;0.00042683;0.00039383;S325R;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1251;hypothyroidism/myxoedema;rs3749172;C;1.0;-0.0015128;0.00042683;0.00039383;S294R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_D69;D69 Purpura and other haemorrhagic conditions;rs201441371;A;0.900618;0.013238;0.0047918;0.005735499999999999;V206M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_D69;D69 Purpura and other haemorrhagic conditions;rs201441371;A;0.900618;0.013238;0.0047918;0.005735499999999999;V206M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_D69;D69 Purpura and other haemorrhagic conditions;rs201441371;A;0.900618;0.013238;0.0047918;0.005735499999999999;V206M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_D69;D69 Purpura and other haemorrhagic conditions;rs201441371;A;0.900618;0.013238;0.0047918;0.005735499999999999;V237M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_D69;D69 Purpura and other haemorrhagic conditions;rs201441371;A;0.900618;0.013238;0.0047918;0.005735499999999999;V206M;ENST00000438013
CXCR8;ENSG00000178623;23118-0.0;Leg predicted mass (left);rs34778053;A;0.997334;-0.015106;0.0055183;0.0061903;R125S;ENST00000319838
CXCR8;ENSG00000178623;23118-0.0;Leg predicted mass (left);rs34778053;A;0.997334;-0.015106;0.0055183;0.0061903;R125S;ENST00000403859
CXCR8;ENSG00000178623;23118-0.0;Leg predicted mass (left);rs34778053;A;0.997334;-0.015106;0.0055183;0.0061903;R125S;ENST00000407714
CXCR8;ENSG00000178623;23118-0.0;Leg predicted mass (left);rs34778053;A;0.997334;-0.015106;0.0055183;0.0061903;R156S;ENST00000430267
CXCR8;ENSG00000178623;23118-0.0;Leg predicted mass (left);rs34778053;A;0.997334;-0.015106;0.0055183;0.0061903;R125S;ENST00000438013
CXCR8;ENSG00000178623;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs139197368;A;1.0;0.0010657;0.00039611;0.007139100000000001;V29I;ENST00000319838
CXCR8;ENSG00000178623;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs139197368;A;1.0;0.0010657;0.00039611;0.007139100000000001;V29I;ENST00000403859
CXCR8;ENSG00000178623;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs139197368;A;1.0;0.0010657;0.00039611;0.007139100000000001;V29I;ENST00000407714
CXCR8;ENSG00000178623;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs139197368;A;1.0;0.0010657;0.00039611;0.007139100000000001;V60I;ENST00000430267
CXCR8;ENSG00000178623;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs139197368;A;1.0;0.0010657;0.00039611;0.007139100000000001;V29I;ENST00000438013
CXCR8;ENSG00000178623;23099-0.0;Body fat percentage;rs34778053;A;0.997334;-0.094928;0.031749;0.0027906999999999997;R125S;ENST00000319838
CXCR8;ENSG00000178623;23099-0.0;Body fat percentage;rs34778053;A;0.997334;-0.094928;0.031749;0.0027906999999999997;R125S;ENST00000403859
CXCR8;ENSG00000178623;23099-0.0;Body fat percentage;rs34778053;A;0.997334;-0.094928;0.031749;0.0027906999999999997;R125S;ENST00000407714
CXCR8;ENSG00000178623;23099-0.0;Body fat percentage;rs34778053;A;0.997334;-0.094928;0.031749;0.0027906999999999997;R156S;ENST00000430267
CXCR8;ENSG00000178623;23099-0.0;Body fat percentage;rs34778053;A;0.997334;-0.094928;0.031749;0.0027906999999999997;R125S;ENST00000438013
CXCR8;ENSG00000178623;21002-0.0;Weight;rs34778053;A;0.997334;-0.21943000000000001;0.069391;0.0015660000000000001;R125S;ENST00000319838
CXCR8;ENSG00000178623;21002-0.0;Weight;rs34778053;A;0.997334;-0.21943000000000001;0.069391;0.0015660000000000001;R125S;ENST00000403859
CXCR8;ENSG00000178623;21002-0.0;Weight;rs34778053;A;0.997334;-0.21943000000000001;0.069391;0.0015660000000000001;R125S;ENST00000407714
CXCR8;ENSG00000178623;21002-0.0;Weight;rs34778053;A;0.997334;-0.21943000000000001;0.069391;0.0015660000000000001;R156S;ENST00000430267
CXCR8;ENSG00000178623;21002-0.0;Weight;rs34778053;A;0.997334;-0.21943000000000001;0.069391;0.0015660000000000001;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_K83;K83 Other diseases of biliary tract;rs61734453;A;0.9567;0.0026011999999999997;0.00078378;0.00090416;G126R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_K83;K83 Other diseases of biliary tract;rs61734453;A;0.9567;0.0026011999999999997;0.00078378;0.00090416;G126R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_K83;K83 Other diseases of biliary tract;rs61734453;A;0.9567;0.0026011999999999997;0.00078378;0.00090416;G126R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_K83;K83 Other diseases of biliary tract;rs61734453;A;0.9567;0.0026011999999999997;0.00078378;0.00090416;G157R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_K83;K83 Other diseases of biliary tract;rs61734453;A;0.9567;0.0026011999999999997;0.00078378;0.00090416;G126R;ENST00000438013
CXCR8;ENSG00000178623;30270-0.0;Mean sphered cell volume;rs35146537;A;1.0;0.11085999999999999;0.034982;0.0015295;A25T;ENST00000319838
CXCR8;ENSG00000178623;30270-0.0;Mean sphered cell volume;rs35146537;A;1.0;0.11085999999999999;0.034982;0.0015295;A25T;ENST00000403859
CXCR8;ENSG00000178623;30270-0.0;Mean sphered cell volume;rs35146537;A;1.0;0.11085999999999999;0.034982;0.0015295;A25T;ENST00000407714
CXCR8;ENSG00000178623;30270-0.0;Mean sphered cell volume;rs35146537;A;1.0;0.11085999999999999;0.034982;0.0015295;A56T;ENST00000430267
CXCR8;ENSG00000178623;30270-0.0;Mean sphered cell volume;rs35146537;A;1.0;0.11085999999999999;0.034982;0.0015295;A25T;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_I45;I45 Other conduction disorders;rs139042901;G;0.701167;0.009861799999999999;0.0035036;0.004882;E252G;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_I45;I45 Other conduction disorders;rs139042901;G;0.701167;0.009861799999999999;0.0035036;0.004882;E252G;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_I45;I45 Other conduction disorders;rs139042901;G;0.701167;0.009861799999999999;0.0035036;0.004882;E252G;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_I45;I45 Other conduction disorders;rs139042901;G;0.701167;0.009861799999999999;0.0035036;0.004882;E283G;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_I45;I45 Other conduction disorders;rs139042901;G;0.701167;0.009861799999999999;0.0035036;0.004882;E252G;ENST00000438013
CXCR8;ENSG00000178623;30150-0.0;Eosinophill count;rs3749171;T;1.0;-0.0012450999999999999;0.00029124;1.9092e-05;T108M;ENST00000319838
CXCR8;ENSG00000178623;30150-0.0;Eosinophill count;rs3749171;T;1.0;-0.0012450999999999999;0.00029124;1.9092e-05;T108M;ENST00000403859
CXCR8;ENSG00000178623;30150-0.0;Eosinophill count;rs3749171;T;1.0;-0.0012450999999999999;0.00029124;1.9092e-05;T108M;ENST00000407714
CXCR8;ENSG00000178623;30150-0.0;Eosinophill count;rs3749171;T;1.0;-0.0012450999999999999;0.00029124;1.9092e-05;T139M;ENST00000430267
CXCR8;ENSG00000178623;30150-0.0;Eosinophill count;rs3749171;T;1.0;-0.0012450999999999999;0.00029124;1.9092e-05;T108M;ENST00000438013
CXCR8;ENSG00000178623;1498-0.0;Coffee intake;rs61734453;A;0.9567;0.065421;0.022779;0.0040794;G126R;ENST00000319838
CXCR8;ENSG00000178623;1498-0.0;Coffee intake;rs61734453;A;0.9567;0.065421;0.022779;0.0040794;G126R;ENST00000403859
CXCR8;ENSG00000178623;1498-0.0;Coffee intake;rs61734453;A;0.9567;0.065421;0.022779;0.0040794;G126R;ENST00000407714
CXCR8;ENSG00000178623;1498-0.0;Coffee intake;rs61734453;A;0.9567;0.065421;0.022779;0.0040794;G157R;ENST00000430267
CXCR8;ENSG00000178623;1498-0.0;Coffee intake;rs61734453;A;0.9567;0.065421;0.022779;0.0040794;G126R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_M05-M14;M05-M14 Inflammatory polyarthropathies;rs6437353;A;1.0;-0.0011627;0.00043183;0.0070924;R13H;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1521;inflammatory bowel disease;rs3749171;T;1.0;0.001186;0.00024713;1.5955e-06;T108M;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1521;inflammatory bowel disease;rs3749171;T;1.0;0.001186;0.00024713;1.5955e-06;T108M;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1521;inflammatory bowel disease;rs3749171;T;1.0;0.001186;0.00024713;1.5955e-06;T108M;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1521;inflammatory bowel disease;rs3749171;T;1.0;0.001186;0.00024713;1.5955e-06;T139M;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1521;inflammatory bowel disease;rs3749171;T;1.0;0.001186;0.00024713;1.5955e-06;T108M;ENST00000438013
CXCR8;ENSG00000178623;48-0.0;Waist circumference;rs34778053;A;0.997334;-0.17942;0.06150599999999999;0.0035334000000000003;R125S;ENST00000319838
CXCR8;ENSG00000178623;48-0.0;Waist circumference;rs34778053;A;0.997334;-0.17942;0.06150599999999999;0.0035334000000000003;R125S;ENST00000403859
CXCR8;ENSG00000178623;48-0.0;Waist circumference;rs34778053;A;0.997334;-0.17942;0.06150599999999999;0.0035334000000000003;R125S;ENST00000407714
CXCR8;ENSG00000178623;48-0.0;Waist circumference;rs34778053;A;0.997334;-0.17942;0.06150599999999999;0.0035334000000000003;R156S;ENST00000430267
CXCR8;ENSG00000178623;48-0.0;Waist circumference;rs34778053;A;0.997334;-0.17942;0.06150599999999999;0.0035334000000000003;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_J33;J33 Nasal polyp;rs13387859;A;0.976353;0.025722000000000002;0.007756900000000001;0.00091341;V76M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_J33;J33 Nasal polyp;rs13387859;A;0.976353;0.025722000000000002;0.007756900000000001;0.00091341;V76M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_J33;J33 Nasal polyp;rs13387859;A;0.976353;0.025722000000000002;0.007756900000000001;0.00091341;V76M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_J33;J33 Nasal polyp;rs13387859;A;0.976353;0.025722000000000002;0.007756900000000001;0.00091341;V107M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_J33;J33 Nasal polyp;rs13387859;A;0.976353;0.025722000000000002;0.007756900000000001;0.00091341;V76M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_L05;L05 Pilonidal cyst;rs115880579;T;0.9268069999999999;0.014337;0.004292;0.00083678;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_L05;L05 Pilonidal cyst;rs115880579;T;0.9268069999999999;0.014337;0.004292;0.00083678;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_L05;L05 Pilonidal cyst;rs115880579;T;0.9268069999999999;0.014337;0.004292;0.00083678;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_L05;L05 Pilonidal cyst;rs115880579;T;0.9268069999999999;0.014337;0.004292;0.00083678;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_L05;L05 Pilonidal cyst;rs115880579;T;0.9268069999999999;0.014337;0.004292;0.00083678;R56C;ENST00000438013
CXCR8;ENSG00000178623;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs201441371;A;0.900618;0.0095055;0.003396;0.0051256999999999995;V206M;ENST00000319838
CXCR8;ENSG00000178623;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs201441371;A;0.900618;0.0095055;0.003396;0.0051256999999999995;V206M;ENST00000403859
CXCR8;ENSG00000178623;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs201441371;A;0.900618;0.0095055;0.003396;0.0051256999999999995;V206M;ENST00000407714
CXCR8;ENSG00000178623;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs201441371;A;0.900618;0.0095055;0.003396;0.0051256999999999995;V237M;ENST00000430267
CXCR8;ENSG00000178623;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs201441371;A;0.900618;0.0095055;0.003396;0.0051256999999999995;V206M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_H54;H54 Blindness and low vision;rs13387859;A;0.976353;0.013729;0.0040824;0.00077098;V76M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_H54;H54 Blindness and low vision;rs13387859;A;0.976353;0.013729;0.0040824;0.00077098;V76M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_H54;H54 Blindness and low vision;rs13387859;A;0.976353;0.013729;0.0040824;0.00077098;V76M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_H54;H54 Blindness and low vision;rs13387859;A;0.976353;0.013729;0.0040824;0.00077098;V107M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_H54;H54 Blindness and low vision;rs13387859;A;0.976353;0.013729;0.0040824;0.00077098;V76M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_E27;E27 Other disorders of adrenal gland;rs115880579;T;0.9268069999999999;0.011526;0.0041957;0.0060139;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_E27;E27 Other disorders of adrenal gland;rs115880579;T;0.9268069999999999;0.011526;0.0041957;0.0060139;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_E27;E27 Other disorders of adrenal gland;rs115880579;T;0.9268069999999999;0.011526;0.0041957;0.0060139;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_E27;E27 Other disorders of adrenal gland;rs115880579;T;0.9268069999999999;0.011526;0.0041957;0.0060139;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_E27;E27 Other disorders of adrenal gland;rs115880579;T;0.9268069999999999;0.011526;0.0041957;0.0060139;R56C;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_K92;K92 Other diseases of digestive system;rs6437353;A;1.0;0.00085703;0.00031069999999999996;0.0058088;R13H;ENST00000430267
CXCR8;ENSG00000178623;23116-0.0;Leg fat mass (left);rs34778053;A;0.997334;-0.022947;0.007758800000000001;0.0031011999999999997;R125S;ENST00000319838
CXCR8;ENSG00000178623;23116-0.0;Leg fat mass (left);rs34778053;A;0.997334;-0.022947;0.007758800000000001;0.0031011999999999997;R125S;ENST00000403859
CXCR8;ENSG00000178623;23116-0.0;Leg fat mass (left);rs34778053;A;0.997334;-0.022947;0.007758800000000001;0.0031011999999999997;R125S;ENST00000407714
CXCR8;ENSG00000178623;23116-0.0;Leg fat mass (left);rs34778053;A;0.997334;-0.022947;0.007758800000000001;0.0031011999999999997;R156S;ENST00000430267
CXCR8;ENSG00000178623;23116-0.0;Leg fat mass (left);rs34778053;A;0.997334;-0.022947;0.007758800000000001;0.0031011999999999997;R125S;ENST00000438013
CXCR8;ENSG00000178623;23098-0.0;Weight;rs34778053;A;0.997334;-0.21463000000000002;0.068877;0.0018320999999999997;R125S;ENST00000319838
CXCR8;ENSG00000178623;23098-0.0;Weight;rs34778053;A;0.997334;-0.21463000000000002;0.068877;0.0018320999999999997;R125S;ENST00000403859
CXCR8;ENSG00000178623;23098-0.0;Weight;rs34778053;A;0.997334;-0.21463000000000002;0.068877;0.0018320999999999997;R125S;ENST00000407714
CXCR8;ENSG00000178623;23098-0.0;Weight;rs34778053;A;0.997334;-0.21463000000000002;0.068877;0.0018320999999999997;R156S;ENST00000430267
CXCR8;ENSG00000178623;23098-0.0;Weight;rs34778053;A;0.997334;-0.21463000000000002;0.068877;0.0018320999999999997;R125S;ENST00000438013
CXCR8;ENSG00000178623;cancer_c_Block_D37-D48;D37-D48 Neoplasms of uncertain or unknown behaviour;rs139042901;G;0.701167;0.0092774;0.0031809;0.0035385;E252G;ENST00000319838
CXCR8;ENSG00000178623;cancer_c_Block_D37-D48;D37-D48 Neoplasms of uncertain or unknown behaviour;rs139042901;G;0.701167;0.0092774;0.0031809;0.0035385;E252G;ENST00000403859
CXCR8;ENSG00000178623;cancer_c_Block_D37-D48;D37-D48 Neoplasms of uncertain or unknown behaviour;rs139042901;G;0.701167;0.0092774;0.0031809;0.0035385;E252G;ENST00000407714
CXCR8;ENSG00000178623;cancer_c_Block_D37-D48;D37-D48 Neoplasms of uncertain or unknown behaviour;rs139042901;G;0.701167;0.0092774;0.0031809;0.0035385;E283G;ENST00000430267
CXCR8;ENSG00000178623;cancer_c_Block_D37-D48;D37-D48 Neoplasms of uncertain or unknown behaviour;rs139042901;G;0.701167;0.0092774;0.0031809;0.0035385;E252G;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_M31;M31 Other necrotising vasculopathies;rs115880579;T;0.9268069999999999;0.014647;0.004684300000000001;0.0017674;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_M31;M31 Other necrotising vasculopathies;rs115880579;T;0.9268069999999999;0.014647;0.004684300000000001;0.0017674;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_M31;M31 Other necrotising vasculopathies;rs115880579;T;0.9268069999999999;0.014647;0.004684300000000001;0.0017674;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_M31;M31 Other necrotising vasculopathies;rs115880579;T;0.9268069999999999;0.014647;0.004684300000000001;0.0017674;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_M31;M31 Other necrotising vasculopathies;rs115880579;T;0.9268069999999999;0.014647;0.004684300000000001;0.0017674;R56C;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_H18;H18 Other disorders of cornea;rs34778053;A;0.997334;0.00078031;0.00024121;0.0012167999999999999;R125S;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_H18;H18 Other disorders of cornea;rs34778053;A;0.997334;0.00078031;0.00024121;0.0012167999999999999;R125S;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_H18;H18 Other disorders of cornea;rs34778053;A;0.997334;0.00078031;0.00024121;0.0012167999999999999;R125S;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_H18;H18 Other disorders of cornea;rs34778053;A;0.997334;0.00078031;0.00024121;0.0012167999999999999;R156S;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_H18;H18 Other disorders of cornea;rs34778053;A;0.997334;0.00078031;0.00024121;0.0012167999999999999;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_M84;M84 Disorders of continuity of bone;rs201441371;A;0.900618;0.014697;0.0045592;0.001266;V206M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_M84;M84 Disorders of continuity of bone;rs201441371;A;0.900618;0.014697;0.0045592;0.001266;V206M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_M84;M84 Disorders of continuity of bone;rs201441371;A;0.900618;0.014697;0.0045592;0.001266;V206M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_M84;M84 Disorders of continuity of bone;rs201441371;A;0.900618;0.014697;0.0045592;0.001266;V237M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_M84;M84 Disorders of continuity of bone;rs201441371;A;0.900618;0.014697;0.0045592;0.001266;V206M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_N84;N84 Polyp of female genital tract;rs6437353;A;1.0;0.0018916;0.0006058;0.0017934;R13H;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1545;chronic fatigue syndrome;rs139042901;G;0.701167;0.009274;0.0032256;0.0040388;E252G;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1545;chronic fatigue syndrome;rs139042901;G;0.701167;0.009274;0.0032256;0.0040388;E252G;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1545;chronic fatigue syndrome;rs139042901;G;0.701167;0.009274;0.0032256;0.0040388;E252G;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1545;chronic fatigue syndrome;rs139042901;G;0.701167;0.009274;0.0032256;0.0040388;E283G;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1545;chronic fatigue syndrome;rs139042901;G;0.701167;0.009274;0.0032256;0.0040388;E252G;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1545;chronic fatigue syndrome;rs3749172;C;1.0;0.00043444;0.00014115;0.0020854;S294R;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1545;chronic fatigue syndrome;rs3749172;C;1.0;0.00043444;0.00014115;0.0020854;S294R;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1545;chronic fatigue syndrome;rs3749172;C;1.0;0.00043444;0.00014115;0.0020854;S294R;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1545;chronic fatigue syndrome;rs3749172;C;1.0;0.00043444;0.00014115;0.0020854;S325R;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1545;chronic fatigue syndrome;rs3749172;C;1.0;0.00043444;0.00014115;0.0020854;S294R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_N80-N98;N80-N98 Noninflammatory disorders of female genital tract;rs12468485;T;1.0;-0.0063185;0.0021026;0.0026559;T253M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_N80-N98;N80-N98 Noninflammatory disorders of female genital tract;rs12468485;T;1.0;-0.0063185;0.0021026;0.0026559;T253M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_N80-N98;N80-N98 Noninflammatory disorders of female genital tract;rs12468485;T;1.0;-0.0063185;0.0021026;0.0026559;T253M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_N80-N98;N80-N98 Noninflammatory disorders of female genital tract;rs12468485;T;1.0;-0.0063185;0.0021026;0.0026559;T284M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_N80-N98;N80-N98 Noninflammatory disorders of female genital tract;rs12468485;T;1.0;-0.0063185;0.0021026;0.0026559;T253M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_N80-N98;N80-N98 Noninflammatory disorders of female genital tract;rs6437353;A;1.0;0.0032345;0.0011499;0.0049096;R13H;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs34778053;A;0.997334;-0.0011939;0.00042167;0.0046372;R125S;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs34778053;A;0.997334;-0.0011939;0.00042167;0.0046372;R125S;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs34778053;A;0.997334;-0.0011939;0.00042167;0.0046372;R125S;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs34778053;A;0.997334;-0.0011939;0.00042167;0.0046372;R156S;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs34778053;A;0.997334;-0.0011939;0.00042167;0.0046372;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs3749172;C;1.0;0.00046031;0.00014521;0.0015248;S294R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs3749172;C;1.0;0.00046031;0.00014521;0.0015248;S294R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs3749172;C;1.0;0.00046031;0.00014521;0.0015248;S294R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs3749172;C;1.0;0.00046031;0.00014521;0.0015248;S325R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs3749172;C;1.0;0.00046031;0.00014521;0.0015248;S294R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs61734452;G;1.0;0.003507;0.0012345999999999998;0.004504600000000001;N169D;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs61734452;G;1.0;0.003507;0.0012345999999999998;0.004504600000000001;N169D;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs61734452;G;1.0;0.003507;0.0012345999999999998;0.004504600000000001;N169D;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs61734452;G;1.0;0.003507;0.0012345999999999998;0.004504600000000001;N200D;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_G20-G26;G20-G26 Extrapyramidal and movement disorders;rs61734452;G;1.0;0.003507;0.0012345999999999998;0.004504600000000001;N169D;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1083;cerebrovascular disease;rs34778053;A;0.997334;0.0023401;0.00082409;0.004516600000000001;R125S;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1083;cerebrovascular disease;rs34778053;A;0.997334;0.0023401;0.00082409;0.004516600000000001;R125S;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1083;cerebrovascular disease;rs34778053;A;0.997334;0.0023401;0.00082409;0.004516600000000001;R125S;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1083;cerebrovascular disease;rs34778053;A;0.997334;0.0023401;0.00082409;0.004516600000000001;R156S;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1083;cerebrovascular disease;rs34778053;A;0.997334;0.0023401;0.00082409;0.004516600000000001;R125S;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1083;cerebrovascular disease;rs35146537;A;1.0;0.0036058;0.0011502;0.0017187;A25T;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1083;cerebrovascular disease;rs35146537;A;1.0;0.0036058;0.0011502;0.0017187;A25T;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1083;cerebrovascular disease;rs35146537;A;1.0;0.0036058;0.0011502;0.0017187;A25T;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1083;cerebrovascular disease;rs35146537;A;1.0;0.0036058;0.0011502;0.0017187;A56T;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1083;cerebrovascular disease;rs35146537;A;1.0;0.0036058;0.0011502;0.0017187;A25T;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1734;rosacea;rs3749172;C;1.0;0.00028079;8.411e-05;0.00084279;S294R;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1734;rosacea;rs3749172;C;1.0;0.00028079;8.411e-05;0.00084279;S294R;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1734;rosacea;rs3749172;C;1.0;0.00028079;8.411e-05;0.00084279;S294R;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1734;rosacea;rs3749172;C;1.0;0.00028079;8.411e-05;0.00084279;S325R;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1734;rosacea;rs3749172;C;1.0;0.00028079;8.411e-05;0.00084279;S294R;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1605;fibromyalgia;rs201441371;A;0.900618;0.010195000000000001;0.0028837;0.00040743;V206M;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1605;fibromyalgia;rs201441371;A;0.900618;0.010195000000000001;0.0028837;0.00040743;V206M;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1605;fibromyalgia;rs201441371;A;0.900618;0.010195000000000001;0.0028837;0.00040743;V206M;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1605;fibromyalgia;rs201441371;A;0.900618;0.010195000000000001;0.0028837;0.00040743;V237M;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1605;fibromyalgia;rs201441371;A;0.900618;0.010195000000000001;0.0028837;0.00040743;V206M;ENST00000438013
CXCR8;ENSG00000178623;30230-0.0;Nucleated red blood cell percentage;rs13387859;A;0.976353;0.10098;0.035218;0.0041402;V76M;ENST00000319838
CXCR8;ENSG00000178623;30230-0.0;Nucleated red blood cell percentage;rs13387859;A;0.976353;0.10098;0.035218;0.0041402;V76M;ENST00000403859
CXCR8;ENSG00000178623;30230-0.0;Nucleated red blood cell percentage;rs13387859;A;0.976353;0.10098;0.035218;0.0041402;V76M;ENST00000407714
CXCR8;ENSG00000178623;30230-0.0;Nucleated red blood cell percentage;rs13387859;A;0.976353;0.10098;0.035218;0.0041402;V107M;ENST00000430267
CXCR8;ENSG00000178623;30230-0.0;Nucleated red blood cell percentage;rs13387859;A;0.976353;0.10098;0.035218;0.0041402;V76M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_M46;M46 Other inflammatory spondylopathies;rs115880579;T;0.9268069999999999;0.028803;0.0069071;3.046e-05;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_M46;M46 Other inflammatory spondylopathies;rs115880579;T;0.9268069999999999;0.028803;0.0069071;3.046e-05;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_M46;M46 Other inflammatory spondylopathies;rs115880579;T;0.9268069999999999;0.028803;0.0069071;3.046e-05;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_M46;M46 Other inflammatory spondylopathies;rs115880579;T;0.9268069999999999;0.028803;0.0069071;3.046e-05;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_M46;M46 Other inflammatory spondylopathies;rs115880579;T;0.9268069999999999;0.028803;0.0069071;3.046e-05;R56C;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs139042901;G;0.701167;0.02534;0.008571299999999999;0.0031133000000000003;E252G;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs139042901;G;0.701167;0.02534;0.008571299999999999;0.0031133000000000003;E252G;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs139042901;G;0.701167;0.02534;0.008571299999999999;0.0031133000000000003;E252G;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs139042901;G;0.701167;0.02534;0.008571299999999999;0.0031133000000000003;E283G;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs139042901;G;0.701167;0.02534;0.008571299999999999;0.0031133000000000003;E252G;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_O82;O82 Single delivery by Caesarean section;rs115880579;T;0.9268069999999999;0.022372;0.008352600000000002;0.0073967;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_O82;O82 Single delivery by Caesarean section;rs115880579;T;0.9268069999999999;0.022372;0.008352600000000002;0.0073967;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_O82;O82 Single delivery by Caesarean section;rs115880579;T;0.9268069999999999;0.022372;0.008352600000000002;0.0073967;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_O82;O82 Single delivery by Caesarean section;rs115880579;T;0.9268069999999999;0.022372;0.008352600000000002;0.0073967;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_O82;O82 Single delivery by Caesarean section;rs115880579;T;0.9268069999999999;0.022372;0.008352600000000002;0.0073967;R56C;ENST00000438013
CXCR8;ENSG00000178623;30040-0.0;Mean corpuscular volume;rs6437353;A;1.0;0.020083;0.007134899999999999;0.004880699999999999;R13H;ENST00000430267
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs34778053;A;0.997334;-0.0030031;0.00082955;0.00029447;R125S;ENST00000319838
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs34778053;A;0.997334;-0.0030031;0.00082955;0.00029447;R125S;ENST00000403859
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs34778053;A;0.997334;-0.0030031;0.00082955;0.00029447;R125S;ENST00000407714
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs34778053;A;0.997334;-0.0030031;0.00082955;0.00029447;R156S;ENST00000430267
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs34778053;A;0.997334;-0.0030031;0.00082955;0.00029447;R125S;ENST00000438013
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs3749171;T;1.0;-0.0043151000000000005;0.00036569;3.9462999999999996e-32;T108M;ENST00000319838
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs3749171;T;1.0;-0.0043151000000000005;0.00036569;3.9462999999999996e-32;T108M;ENST00000403859
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs3749171;T;1.0;-0.0043151000000000005;0.00036569;3.9462999999999996e-32;T108M;ENST00000407714
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs3749171;T;1.0;-0.0043151000000000005;0.00036569;3.9462999999999996e-32;T139M;ENST00000430267
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs3749171;T;1.0;-0.0043151000000000005;0.00036569;3.9462999999999996e-32;T108M;ENST00000438013
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs3749172;C;1.0;0.0024343000000000004;0.00028565;1.5714e-17;S294R;ENST00000319838
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs3749172;C;1.0;0.0024343000000000004;0.00028565;1.5714e-17;S294R;ENST00000403859
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs3749172;C;1.0;0.0024343000000000004;0.00028565;1.5714e-17;S294R;ENST00000407714
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs3749172;C;1.0;0.0024343000000000004;0.00028565;1.5714e-17;S325R;ENST00000430267
CXCR8;ENSG00000178623;30130-0.0;Monocyte count;rs3749172;C;1.0;0.0024343000000000004;0.00028565;1.5714e-17;S294R;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1747;viral infection;rs13387859;A;0.976353;0.032173;0.007805800000000001;3.7616e-05;V76M;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1747;viral infection;rs13387859;A;0.976353;0.032173;0.007805800000000001;3.7616e-05;V76M;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1747;viral infection;rs13387859;A;0.976353;0.032173;0.007805800000000001;3.7616e-05;V76M;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1747;viral infection;rs13387859;A;0.976353;0.032173;0.007805800000000001;3.7616e-05;V107M;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1747;viral infection;rs13387859;A;0.976353;0.032173;0.007805800000000001;3.7616e-05;V76M;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1747;viral infection;rs139197368;A;1.0;0.0023086;0.00089111;0.0095776;V29I;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1747;viral infection;rs139197368;A;1.0;0.0023086;0.00089111;0.0095776;V29I;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1747;viral infection;rs139197368;A;1.0;0.0023086;0.00089111;0.0095776;V29I;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1747;viral infection;rs139197368;A;1.0;0.0023086;0.00089111;0.0095776;V60I;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1747;viral infection;rs139197368;A;1.0;0.0023086;0.00089111;0.0095776;V29I;ENST00000438013
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs34778053;A;0.997334;-0.010551999999999999;0.0036676;0.0040137;R125S;ENST00000319838
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs34778053;A;0.997334;-0.010551999999999999;0.0036676;0.0040137;R125S;ENST00000403859
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs34778053;A;0.997334;-0.010551999999999999;0.0036676;0.0040137;R125S;ENST00000407714
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs34778053;A;0.997334;-0.010551999999999999;0.0036676;0.0040137;R156S;ENST00000430267
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs34778053;A;0.997334;-0.010551999999999999;0.0036676;0.0040137;R125S;ENST00000438013
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs35146537;A;1.0;-0.013313;0.005118899999999999;0.0093012;A25T;ENST00000319838
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs35146537;A;1.0;-0.013313;0.005118899999999999;0.0093012;A25T;ENST00000403859
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs35146537;A;1.0;-0.013313;0.005118899999999999;0.0093012;A25T;ENST00000407714
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs35146537;A;1.0;-0.013313;0.005118899999999999;0.0093012;A56T;ENST00000430267
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs35146537;A;1.0;-0.013313;0.005118899999999999;0.0093012;A25T;ENST00000438013
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs3749172;C;1.0;-0.0038365;0.001263;0.0023851;S294R;ENST00000319838
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs3749172;C;1.0;-0.0038365;0.001263;0.0023851;S294R;ENST00000403859
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs3749172;C;1.0;-0.0038365;0.001263;0.0023851;S294R;ENST00000407714
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs3749172;C;1.0;-0.0038365;0.001263;0.0023851;S325R;ENST00000430267
CXCR8;ENSG00000178623;1687-0.0;Comparative body size at age 10;rs3749172;C;1.0;-0.0038365;0.001263;0.0023851;S294R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_N97;N97 Female infertility;rs115880579;T;0.9268069999999999;0.042612;0.011236;0.00014919;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_N97;N97 Female infertility;rs115880579;T;0.9268069999999999;0.042612;0.011236;0.00014919;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_N97;N97 Female infertility;rs115880579;T;0.9268069999999999;0.042612;0.011236;0.00014919;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_N97;N97 Female infertility;rs115880579;T;0.9268069999999999;0.042612;0.011236;0.00014919;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_N97;N97 Female infertility;rs115880579;T;0.9268069999999999;0.042612;0.011236;0.00014919;R56C;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1762;tropical & travel-related infections;rs115880579;T;0.9268069999999999;0.014367;0.0045886;0.0017418;R56C;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1762;tropical & travel-related infections;rs115880579;T;0.9268069999999999;0.014367;0.0045886;0.0017418;R56C;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1762;tropical & travel-related infections;rs115880579;T;0.9268069999999999;0.014367;0.0045886;0.0017418;R56C;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1762;tropical & travel-related infections;rs115880579;T;0.9268069999999999;0.014367;0.0045886;0.0017418;R87C;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1762;tropical & travel-related infections;rs115880579;T;0.9268069999999999;0.014367;0.0045886;0.0017418;R56C;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1762;tropical & travel-related infections;rs13387859;A;0.976353;0.013483000000000002;0.0032659;3.6556999999999996e-05;V76M;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1762;tropical & travel-related infections;rs13387859;A;0.976353;0.013483000000000002;0.0032659;3.6556999999999996e-05;V76M;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1762;tropical & travel-related infections;rs13387859;A;0.976353;0.013483000000000002;0.0032659;3.6556999999999996e-05;V76M;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1762;tropical & travel-related infections;rs13387859;A;0.976353;0.013483000000000002;0.0032659;3.6556999999999996e-05;V107M;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1762;tropical & travel-related infections;rs13387859;A;0.976353;0.013483000000000002;0.0032659;3.6556999999999996e-05;V76M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_G51;G51 Facial nerve disorders;rs61734452;G;1.0;0.0021892;0.00082053;0.007631399999999999;N169D;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_G51;G51 Facial nerve disorders;rs61734452;G;1.0;0.0021892;0.00082053;0.007631399999999999;N169D;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_G51;G51 Facial nerve disorders;rs61734452;G;1.0;0.0021892;0.00082053;0.007631399999999999;N169D;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_G51;G51 Facial nerve disorders;rs61734452;G;1.0;0.0021892;0.00082053;0.007631399999999999;N200D;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_G51;G51 Facial nerve disorders;rs61734452;G;1.0;0.0021892;0.00082053;0.007631399999999999;N169D;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_N45;N45 Orchitis and epididymitis;rs3749172;C;1.0;0.00053128;0.00020605;0.0099248;S294R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_N45;N45 Orchitis and epididymitis;rs3749172;C;1.0;0.00053128;0.00020605;0.0099248;S294R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_N45;N45 Orchitis and epididymitis;rs3749172;C;1.0;0.00053128;0.00020605;0.0099248;S294R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_N45;N45 Orchitis and epididymitis;rs3749172;C;1.0;0.00053128;0.00020605;0.0099248;S325R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_N45;N45 Orchitis and epididymitis;rs3749172;C;1.0;0.00053128;0.00020605;0.0099248;S294R;ENST00000438013
CXCR8;ENSG00000178623;23108-0.0;Impedance of leg (left);rs34778053;A;0.997334;0.48689;0.15875999999999998;0.0021631999999999997;R125S;ENST00000319838
CXCR8;ENSG00000178623;23108-0.0;Impedance of leg (left);rs34778053;A;0.997334;0.48689;0.15875999999999998;0.0021631999999999997;R125S;ENST00000403859
CXCR8;ENSG00000178623;23108-0.0;Impedance of leg (left);rs34778053;A;0.997334;0.48689;0.15875999999999998;0.0021631999999999997;R125S;ENST00000407714
CXCR8;ENSG00000178623;23108-0.0;Impedance of leg (left);rs34778053;A;0.997334;0.48689;0.15875999999999998;0.0021631999999999997;R156S;ENST00000430267
CXCR8;ENSG00000178623;23108-0.0;Impedance of leg (left);rs34778053;A;0.997334;0.48689;0.15875999999999998;0.0021631999999999997;R125S;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1537;hiatus hernia;rs34778053;A;0.997334;-0.0024749000000000004;0.00091144;0.0066197;R125S;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1537;hiatus hernia;rs34778053;A;0.997334;-0.0024749000000000004;0.00091144;0.0066197;R125S;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1537;hiatus hernia;rs34778053;A;0.997334;-0.0024749000000000004;0.00091144;0.0066197;R125S;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1537;hiatus hernia;rs34778053;A;0.997334;-0.0024749000000000004;0.00091144;0.0066197;R156S;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1537;hiatus hernia;rs34778053;A;0.997334;-0.0024749000000000004;0.00091144;0.0066197;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs115880579;T;0.9268069999999999;0.013878;0.0049838;0.005360899999999999;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs115880579;T;0.9268069999999999;0.013878;0.0049838;0.005360899999999999;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs115880579;T;0.9268069999999999;0.013878;0.0049838;0.005360899999999999;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs115880579;T;0.9268069999999999;0.013878;0.0049838;0.005360899999999999;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs115880579;T;0.9268069999999999;0.013878;0.0049838;0.005360899999999999;R56C;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_H43-H45;H43-H45 Disorders of vitreous body and globe;rs35146537;A;1.0;-0.0016779;0.00055024;0.0022929;A25T;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_H43-H45;H43-H45 Disorders of vitreous body and globe;rs35146537;A;1.0;-0.0016779;0.00055024;0.0022929;A25T;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_H43-H45;H43-H45 Disorders of vitreous body and globe;rs35146537;A;1.0;-0.0016779;0.00055024;0.0022929;A25T;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_H43-H45;H43-H45 Disorders of vitreous body and globe;rs35146537;A;1.0;-0.0016779;0.00055024;0.0022929;A56T;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_H43-H45;H43-H45 Disorders of vitreous body and globe;rs35146537;A;1.0;-0.0016779;0.00055024;0.0022929;A25T;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs139197368;A;1.0;0.0013109000000000003;0.00048905;0.007352199999999999;V29I;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs139197368;A;1.0;0.0013109000000000003;0.00048905;0.007352199999999999;V29I;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs139197368;A;1.0;0.0013109000000000003;0.00048905;0.007352199999999999;V29I;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs139197368;A;1.0;0.0013109000000000003;0.00048905;0.007352199999999999;V60I;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs139197368;A;1.0;0.0013109000000000003;0.00048905;0.007352199999999999;V29I;ENST00000438013
CXCR8;ENSG00000178623;49-0.0;Hip circumference;rs34778053;A;0.997334;-0.13425;0.046903;0.0042075;R125S;ENST00000319838
CXCR8;ENSG00000178623;49-0.0;Hip circumference;rs34778053;A;0.997334;-0.13425;0.046903;0.0042075;R125S;ENST00000403859
CXCR8;ENSG00000178623;49-0.0;Hip circumference;rs34778053;A;0.997334;-0.13425;0.046903;0.0042075;R125S;ENST00000407714
CXCR8;ENSG00000178623;49-0.0;Hip circumference;rs34778053;A;0.997334;-0.13425;0.046903;0.0042075;R156S;ENST00000430267
CXCR8;ENSG00000178623;49-0.0;Hip circumference;rs34778053;A;0.997334;-0.13425;0.046903;0.0042075;R125S;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1185;pancreatic disease;rs201441371;A;0.900618;0.0094581;0.0036248000000000005;0.009073600000000001;V206M;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1185;pancreatic disease;rs201441371;A;0.900618;0.0094581;0.0036248000000000005;0.009073600000000001;V206M;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1185;pancreatic disease;rs201441371;A;0.900618;0.0094581;0.0036248000000000005;0.009073600000000001;V206M;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1185;pancreatic disease;rs201441371;A;0.900618;0.0094581;0.0036248000000000005;0.009073600000000001;V237M;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1185;pancreatic disease;rs201441371;A;0.900618;0.0094581;0.0036248000000000005;0.009073600000000001;V206M;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1130;asthma;rs139197368;A;1.0;0.009402500000000001;0.0030643000000000003;0.0021519;V29I;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1130;asthma;rs139197368;A;1.0;0.009402500000000001;0.0030643000000000003;0.0021519;V29I;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1130;asthma;rs139197368;A;1.0;0.009402500000000001;0.0030643000000000003;0.0021519;V29I;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1130;asthma;rs139197368;A;1.0;0.009402500000000001;0.0030643000000000003;0.0021519;V60I;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1130;asthma;rs139197368;A;1.0;0.009402500000000001;0.0030643000000000003;0.0021519;V29I;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1130;asthma;rs3749171;T;1.0;-0.0025975;0.00081704;0.0014772000000000001;T108M;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1130;asthma;rs3749171;T;1.0;-0.0025975;0.00081704;0.0014772000000000001;T108M;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1130;asthma;rs3749171;T;1.0;-0.0025975;0.00081704;0.0014772000000000001;T108M;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1130;asthma;rs3749171;T;1.0;-0.0025975;0.00081704;0.0014772000000000001;T139M;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1130;asthma;rs3749171;T;1.0;-0.0025975;0.00081704;0.0014772000000000001;T108M;ENST00000438013
CXCR8;ENSG00000178623;23124-0.0;Arm fat mass (left);rs34778053;A;0.997334;-0.010794;0.0034771;0.001907;R125S;ENST00000319838
CXCR8;ENSG00000178623;23124-0.0;Arm fat mass (left);rs34778053;A;0.997334;-0.010794;0.0034771;0.001907;R125S;ENST00000403859
CXCR8;ENSG00000178623;23124-0.0;Arm fat mass (left);rs34778053;A;0.997334;-0.010794;0.0034771;0.001907;R125S;ENST00000407714
CXCR8;ENSG00000178623;23124-0.0;Arm fat mass (left);rs34778053;A;0.997334;-0.010794;0.0034771;0.001907;R156S;ENST00000430267
CXCR8;ENSG00000178623;23124-0.0;Arm fat mass (left);rs34778053;A;0.997334;-0.010794;0.0034771;0.001907;R125S;ENST00000438013
CXCR8;ENSG00000178623;30170-0.0;Nucleated red blood cell count;rs139042901;G;0.701167;0.006581999999999999;0.0015390999999999998;1.899e-05;E252G;ENST00000319838
CXCR8;ENSG00000178623;30170-0.0;Nucleated red blood cell count;rs139042901;G;0.701167;0.006581999999999999;0.0015390999999999998;1.899e-05;E252G;ENST00000403859
CXCR8;ENSG00000178623;30170-0.0;Nucleated red blood cell count;rs139042901;G;0.701167;0.006581999999999999;0.0015390999999999998;1.899e-05;E252G;ENST00000407714
CXCR8;ENSG00000178623;30170-0.0;Nucleated red blood cell count;rs139042901;G;0.701167;0.006581999999999999;0.0015390999999999998;1.899e-05;E283G;ENST00000430267
CXCR8;ENSG00000178623;30170-0.0;Nucleated red blood cell count;rs139042901;G;0.701167;0.006581999999999999;0.0015390999999999998;1.899e-05;E252G;ENST00000438013
CXCR8;ENSG00000178623;cancer_c_D41;D41 Neoplasm of uncertain or unknown behaviour of urinary organs;rs201441371;A;0.900618;0.008421099999999999;0.0029697;0.0045728;V206M;ENST00000319838
CXCR8;ENSG00000178623;cancer_c_D41;D41 Neoplasm of uncertain or unknown behaviour of urinary organs;rs201441371;A;0.900618;0.008421099999999999;0.0029697;0.0045728;V206M;ENST00000403859
CXCR8;ENSG00000178623;cancer_c_D41;D41 Neoplasm of uncertain or unknown behaviour of urinary organs;rs201441371;A;0.900618;0.008421099999999999;0.0029697;0.0045728;V206M;ENST00000407714
CXCR8;ENSG00000178623;cancer_c_D41;D41 Neoplasm of uncertain or unknown behaviour of urinary organs;rs201441371;A;0.900618;0.008421099999999999;0.0029697;0.0045728;V237M;ENST00000430267
CXCR8;ENSG00000178623;cancer_c_D41;D41 Neoplasm of uncertain or unknown behaviour of urinary organs;rs201441371;A;0.900618;0.008421099999999999;0.0029697;0.0045728;V206M;ENST00000438013
CXCR8;ENSG00000178623;23119-0.0;Arm fat percentage (right);rs34778053;A;0.997334;-0.13563;0.037939999999999995;0.0003506;R125S;ENST00000319838
CXCR8;ENSG00000178623;23119-0.0;Arm fat percentage (right);rs34778053;A;0.997334;-0.13563;0.037939999999999995;0.0003506;R125S;ENST00000403859
CXCR8;ENSG00000178623;23119-0.0;Arm fat percentage (right);rs34778053;A;0.997334;-0.13563;0.037939999999999995;0.0003506;R125S;ENST00000407714
CXCR8;ENSG00000178623;23119-0.0;Arm fat percentage (right);rs34778053;A;0.997334;-0.13563;0.037939999999999995;0.0003506;R156S;ENST00000430267
CXCR8;ENSG00000178623;23119-0.0;Arm fat percentage (right);rs34778053;A;0.997334;-0.13563;0.037939999999999995;0.0003506;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_M45-M49;M45-M49 Spondylopathies;rs3749172;C;1.0;0.00091703;0.00034675;0.0081782;S294R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_M45-M49;M45-M49 Spondylopathies;rs3749172;C;1.0;0.00091703;0.00034675;0.0081782;S294R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_M45-M49;M45-M49 Spondylopathies;rs3749172;C;1.0;0.00091703;0.00034675;0.0081782;S294R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_M45-M49;M45-M49 Spondylopathies;rs3749172;C;1.0;0.00091703;0.00034675;0.0081782;S325R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_M45-M49;M45-M49 Spondylopathies;rs3749172;C;1.0;0.00091703;0.00034675;0.0081782;S294R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs34778053;A;0.997334;0.00097133;0.00036296;0.007447800000000001;R125S;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs34778053;A;0.997334;0.00097133;0.00036296;0.007447800000000001;R125S;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs34778053;A;0.997334;0.00097133;0.00036296;0.007447800000000001;R125S;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs34778053;A;0.997334;0.00097133;0.00036296;0.007447800000000001;R156S;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs34778053;A;0.997334;0.00097133;0.00036296;0.007447800000000001;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_M50-M54;M50-M54 Other dorsopathies;rs6437353;A;1.0;0.001143;0.00044306;0.009885099999999999;R13H;ENST00000430267
CXCR8;ENSG00000178623;30010-0.0;Red blood cell (erythrocyte) count;rs6437353;A;1.0;-0.0016772000000000002;0.00059225;0.0046268;R13H;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_M07;M07 Psoriatic and enteropathic arthropathies;rs115880579;T;0.9268069999999999;0.013536000000000001;0.0051665;0.008796700000000001;R56C;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_M07;M07 Psoriatic and enteropathic arthropathies;rs115880579;T;0.9268069999999999;0.013536000000000001;0.0051665;0.008796700000000001;R56C;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_M07;M07 Psoriatic and enteropathic arthropathies;rs115880579;T;0.9268069999999999;0.013536000000000001;0.0051665;0.008796700000000001;R56C;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_M07;M07 Psoriatic and enteropathic arthropathies;rs115880579;T;0.9268069999999999;0.013536000000000001;0.0051665;0.008796700000000001;R87C;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_M07;M07 Psoriatic and enteropathic arthropathies;rs115880579;T;0.9268069999999999;0.013536000000000001;0.0051665;0.008796700000000001;R56C;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_M47;M47 Spondylosis;rs3749172;C;1.0;0.0007463999999999999;0.00028143;0.0079989;S294R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_M47;M47 Spondylosis;rs3749172;C;1.0;0.0007463999999999999;0.00028143;0.0079989;S294R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_M47;M47 Spondylosis;rs3749172;C;1.0;0.0007463999999999999;0.00028143;0.0079989;S294R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_M47;M47 Spondylosis;rs3749172;C;1.0;0.0007463999999999999;0.00028143;0.0079989;S325R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_M47;M47 Spondylosis;rs3749172;C;1.0;0.0007463999999999999;0.00028143;0.0079989;S294R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs3749172;C;1.0;0.0028386;0.00091595;0.0019411;S294R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs3749172;C;1.0;0.0028386;0.00091595;0.0019411;S294R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs3749172;C;1.0;0.0028386;0.00091595;0.0019411;S294R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs3749172;C;1.0;0.0028386;0.00091595;0.0019411;S325R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs3749172;C;1.0;0.0028386;0.00091595;0.0019411;S294R;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1616;cervical problem;rs139197368;A;1.0;0.0028527;0.00097356;0.0033882;V29I;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1616;cervical problem;rs139197368;A;1.0;0.0028527;0.00097356;0.0033882;V29I;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1616;cervical problem;rs139197368;A;1.0;0.0028527;0.00097356;0.0033882;V29I;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1616;cervical problem;rs139197368;A;1.0;0.0028527;0.00097356;0.0033882;V60I;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1616;cervical problem;rs139197368;A;1.0;0.0028527;0.00097356;0.0033882;V29I;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_G81;G81 Hemiplegia;rs12468485;T;1.0;-0.00059358;0.00022824;0.0093051;T253M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_G81;G81 Hemiplegia;rs12468485;T;1.0;-0.00059358;0.00022824;0.0093051;T253M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_G81;G81 Hemiplegia;rs12468485;T;1.0;-0.00059358;0.00022824;0.0093051;T253M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_G81;G81 Hemiplegia;rs12468485;T;1.0;-0.00059358;0.00022824;0.0093051;T284M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_G81;G81 Hemiplegia;rs12468485;T;1.0;-0.00059358;0.00022824;0.0093051;T253M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_G81;G81 Hemiplegia;rs35146537;A;1.0;0.0014177;0.00050984;0.0054246;A25T;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_G81;G81 Hemiplegia;rs35146537;A;1.0;0.0014177;0.00050984;0.0054246;A25T;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_G81;G81 Hemiplegia;rs35146537;A;1.0;0.0014177;0.00050984;0.0054246;A25T;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_G81;G81 Hemiplegia;rs35146537;A;1.0;0.0014177;0.00050984;0.0054246;A56T;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_G81;G81 Hemiplegia;rs35146537;A;1.0;0.0014177;0.00050984;0.0054246;A25T;ENST00000438013
CXCR8;ENSG00000178623;23123-0.0;Arm fat percentage (left);rs34778053;A;0.997334;-0.13827;0.038158;0.00029051;R125S;ENST00000319838
CXCR8;ENSG00000178623;23123-0.0;Arm fat percentage (left);rs34778053;A;0.997334;-0.13827;0.038158;0.00029051;R125S;ENST00000403859
CXCR8;ENSG00000178623;23123-0.0;Arm fat percentage (left);rs34778053;A;0.997334;-0.13827;0.038158;0.00029051;R125S;ENST00000407714
CXCR8;ENSG00000178623;23123-0.0;Arm fat percentage (left);rs34778053;A;0.997334;-0.13827;0.038158;0.00029051;R156S;ENST00000430267
CXCR8;ENSG00000178623;23123-0.0;Arm fat percentage (left);rs34778053;A;0.997334;-0.13827;0.038158;0.00029051;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_K82;K82 Other diseases of gallbladder;rs139197368;A;1.0;0.0023035;0.00066668;0.00054994;V29I;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_K82;K82 Other diseases of gallbladder;rs139197368;A;1.0;0.0023035;0.00066668;0.00054994;V29I;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_K82;K82 Other diseases of gallbladder;rs139197368;A;1.0;0.0023035;0.00066668;0.00054994;V29I;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_K82;K82 Other diseases of gallbladder;rs139197368;A;1.0;0.0023035;0.00066668;0.00054994;V60I;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_K82;K82 Other diseases of gallbladder;rs139197368;A;1.0;0.0023035;0.00066668;0.00054994;V29I;ENST00000438013
CXCR8;ENSG00000178623;23117-0.0;Leg fat-free mass (left);rs34778053;A;0.997334;-0.016237;0.0058841;0.0057902;R125S;ENST00000319838
CXCR8;ENSG00000178623;23117-0.0;Leg fat-free mass (left);rs34778053;A;0.997334;-0.016237;0.0058841;0.0057902;R125S;ENST00000403859
CXCR8;ENSG00000178623;23117-0.0;Leg fat-free mass (left);rs34778053;A;0.997334;-0.016237;0.0058841;0.0057902;R125S;ENST00000407714
CXCR8;ENSG00000178623;23117-0.0;Leg fat-free mass (left);rs34778053;A;0.997334;-0.016237;0.0058841;0.0057902;R156S;ENST00000430267
CXCR8;ENSG00000178623;23117-0.0;Leg fat-free mass (left);rs34778053;A;0.997334;-0.016237;0.0058841;0.0057902;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_G20;G20 Parkinson's disease;rs3749172;C;1.0;0.00030742;0.00011054;0.0054174;S294R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_G20;G20 Parkinson's disease;rs3749172;C;1.0;0.00030742;0.00011054;0.0054174;S294R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_G20;G20 Parkinson's disease;rs3749172;C;1.0;0.00030742;0.00011054;0.0054174;S294R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_G20;G20 Parkinson's disease;rs3749172;C;1.0;0.00030742;0.00011054;0.0054174;S325R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_G20;G20 Parkinson's disease;rs3749172;C;1.0;0.00030742;0.00011054;0.0054174;S294R;ENST00000438013
CXCR8;ENSG00000178623;1309-0.0;Fresh fruit intake;rs3749171;T;1.0;-0.011962;0.0037709;0.0015132;T108M;ENST00000319838
CXCR8;ENSG00000178623;1309-0.0;Fresh fruit intake;rs3749171;T;1.0;-0.011962;0.0037709;0.0015132;T108M;ENST00000403859
CXCR8;ENSG00000178623;1309-0.0;Fresh fruit intake;rs3749171;T;1.0;-0.011962;0.0037709;0.0015132;T108M;ENST00000407714
CXCR8;ENSG00000178623;1309-0.0;Fresh fruit intake;rs3749171;T;1.0;-0.011962;0.0037709;0.0015132;T139M;ENST00000430267
CXCR8;ENSG00000178623;1309-0.0;Fresh fruit intake;rs3749171;T;1.0;-0.011962;0.0037709;0.0015132;T108M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_K51;K51 Ulcerative colitis;rs34778053;A;0.997334;0.0014433;0.00053317;0.006790699999999999;R125S;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_K51;K51 Ulcerative colitis;rs34778053;A;0.997334;0.0014433;0.00053317;0.006790699999999999;R125S;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_K51;K51 Ulcerative colitis;rs34778053;A;0.997334;0.0014433;0.00053317;0.006790699999999999;R125S;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_K51;K51 Ulcerative colitis;rs34778053;A;0.997334;0.0014433;0.00053317;0.006790699999999999;R156S;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_K51;K51 Ulcerative colitis;rs34778053;A;0.997334;0.0014433;0.00053317;0.006790699999999999;R125S;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_K51;K51 Ulcerative colitis;rs3749171;T;1.0;0.00092065;0.00023507;8.9848e-05;T108M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_K51;K51 Ulcerative colitis;rs3749171;T;1.0;0.00092065;0.00023507;8.9848e-05;T108M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_K51;K51 Ulcerative colitis;rs3749171;T;1.0;0.00092065;0.00023507;8.9848e-05;T108M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_K51;K51 Ulcerative colitis;rs3749171;T;1.0;0.00092065;0.00023507;8.9848e-05;T139M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_K51;K51 Ulcerative colitis;rs3749171;T;1.0;0.00092065;0.00023507;8.9848e-05;T108M;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1623;miscarriage;rs139042901;G;0.701167;0.019147;0.0038976;8.990799999999998e-07;E252G;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1623;miscarriage;rs139042901;G;0.701167;0.019147;0.0038976;8.990799999999998e-07;E252G;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1623;miscarriage;rs139042901;G;0.701167;0.019147;0.0038976;8.990799999999998e-07;E252G;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1623;miscarriage;rs139042901;G;0.701167;0.019147;0.0038976;8.990799999999998e-07;E283G;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1623;miscarriage;rs139042901;G;0.701167;0.019147;0.0038976;8.990799999999998e-07;E252G;ENST00000438013
CXCR8;ENSG00000178623;1558-0.0;Alcohol intake frequency.;rs61734453;A;0.9567;-0.041774;0.015616999999999999;0.0074748;G126R;ENST00000319838
CXCR8;ENSG00000178623;1558-0.0;Alcohol intake frequency.;rs61734453;A;0.9567;-0.041774;0.015616999999999999;0.0074748;G126R;ENST00000403859
CXCR8;ENSG00000178623;1558-0.0;Alcohol intake frequency.;rs61734453;A;0.9567;-0.041774;0.015616999999999999;0.0074748;G126R;ENST00000407714
CXCR8;ENSG00000178623;1558-0.0;Alcohol intake frequency.;rs61734453;A;0.9567;-0.041774;0.015616999999999999;0.0074748;G157R;ENST00000430267
CXCR8;ENSG00000178623;1558-0.0;Alcohol intake frequency.;rs61734453;A;0.9567;-0.041774;0.015616999999999999;0.0074748;G126R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_L40;L40 Psoriasis;rs61734453;A;0.9567;0.0030361;0.00083514;0.00027753;G126R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_L40;L40 Psoriasis;rs61734453;A;0.9567;0.0030361;0.00083514;0.00027753;G126R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_L40;L40 Psoriasis;rs61734453;A;0.9567;0.0030361;0.00083514;0.00027753;G126R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_L40;L40 Psoriasis;rs61734453;A;0.9567;0.0030361;0.00083514;0.00027753;G157R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_L40;L40 Psoriasis;rs61734453;A;0.9567;0.0030361;0.00083514;0.00027753;G126R;ENST00000438013
CXCR8;ENSG00000178623;30110-0.0;Platelet distribution width;rs6437353;A;1.0;-0.0056478000000000006;0.0008654;6.7539e-11;R13H;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_B25-B34;B25-B34 Other viral diseases;rs13387859;A;0.976353;0.019244;0.006067;0.0015148;V76M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_B25-B34;B25-B34 Other viral diseases;rs13387859;A;0.976353;0.019244;0.006067;0.0015148;V76M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_B25-B34;B25-B34 Other viral diseases;rs13387859;A;0.976353;0.019244;0.006067;0.0015148;V76M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_B25-B34;B25-B34 Other viral diseases;rs13387859;A;0.976353;0.019244;0.006067;0.0015148;V107M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_B25-B34;B25-B34 Other viral diseases;rs13387859;A;0.976353;0.019244;0.006067;0.0015148;V76M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_M80-M85;M80-M85 Disorders of bone density and structure;rs139197368;A;1.0;-0.0047165;0.0014686;0.00132;V29I;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_M80-M85;M80-M85 Disorders of bone density and structure;rs139197368;A;1.0;-0.0047165;0.0014686;0.00132;V29I;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_M80-M85;M80-M85 Disorders of bone density and structure;rs139197368;A;1.0;-0.0047165;0.0014686;0.00132;V29I;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_M80-M85;M80-M85 Disorders of bone density and structure;rs139197368;A;1.0;-0.0047165;0.0014686;0.00132;V60I;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_M80-M85;M80-M85 Disorders of bone density and structure;rs139197368;A;1.0;-0.0047165;0.0014686;0.00132;V29I;ENST00000438013
CXCR8;ENSG00000178623;30050-0.0;Mean corpuscular haemoglobin;rs6437353;A;1.0;0.010426000000000001;0.0028884;0.00030687;R13H;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_H50;H50 Other strabismus;rs139197368;A;1.0;-0.0013193;0.00047949;0.0059341;V29I;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_H50;H50 Other strabismus;rs139197368;A;1.0;-0.0013193;0.00047949;0.0059341;V29I;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_H50;H50 Other strabismus;rs139197368;A;1.0;-0.0013193;0.00047949;0.0059341;V29I;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_H50;H50 Other strabismus;rs139197368;A;1.0;-0.0013193;0.00047949;0.0059341;V60I;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_H50;H50 Other strabismus;rs139197368;A;1.0;-0.0013193;0.00047949;0.0059341;V29I;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_N90;N90 Other noninflammatory disorders of vulva and perineum;rs61734452;G;1.0;0.006955500000000001;0.0022419;0.0019192;N169D;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_N90;N90 Other noninflammatory disorders of vulva and perineum;rs61734452;G;1.0;0.006955500000000001;0.0022419;0.0019192;N169D;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_N90;N90 Other noninflammatory disorders of vulva and perineum;rs61734452;G;1.0;0.006955500000000001;0.0022419;0.0019192;N169D;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_N90;N90 Other noninflammatory disorders of vulva and perineum;rs61734452;G;1.0;0.006955500000000001;0.0022419;0.0019192;N200D;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_N90;N90 Other noninflammatory disorders of vulva and perineum;rs61734452;G;1.0;0.006955500000000001;0.0022419;0.0019192;N169D;ENST00000438013
CXCR8;ENSG00000178623;cancer_c_Block_D10-D36;D10-D36 Benign neoplasms;rs3749171;T;1.0;0.00029494;0.00011021;0.007447199999999999;T108M;ENST00000319838
CXCR8;ENSG00000178623;cancer_c_Block_D10-D36;D10-D36 Benign neoplasms;rs3749171;T;1.0;0.00029494;0.00011021;0.007447199999999999;T108M;ENST00000403859
CXCR8;ENSG00000178623;cancer_c_Block_D10-D36;D10-D36 Benign neoplasms;rs3749171;T;1.0;0.00029494;0.00011021;0.007447199999999999;T108M;ENST00000407714
CXCR8;ENSG00000178623;cancer_c_Block_D10-D36;D10-D36 Benign neoplasms;rs3749171;T;1.0;0.00029494;0.00011021;0.007447199999999999;T139M;ENST00000430267
CXCR8;ENSG00000178623;cancer_c_Block_D10-D36;D10-D36 Benign neoplasms;rs3749171;T;1.0;0.00029494;0.00011021;0.007447199999999999;T108M;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs201441371;A;0.900618;0.009551700000000002;0.0031493000000000003;0.0024215;V206M;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs201441371;A;0.900618;0.009551700000000002;0.0031493000000000003;0.0024215;V206M;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs201441371;A;0.900618;0.009551700000000002;0.0031493000000000003;0.0024215;V206M;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs201441371;A;0.900618;0.009551700000000002;0.0031493000000000003;0.0024215;V237M;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs201441371;A;0.900618;0.009551700000000002;0.0031493000000000003;0.0024215;V206M;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1430;hayfever/allergic rhinitis;rs3749171;T;1.0;-0.0016637;0.00060761;0.0061798;T108M;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1430;hayfever/allergic rhinitis;rs3749171;T;1.0;-0.0016637;0.00060761;0.0061798;T108M;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1430;hayfever/allergic rhinitis;rs3749171;T;1.0;-0.0016637;0.00060761;0.0061798;T108M;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1430;hayfever/allergic rhinitis;rs3749171;T;1.0;-0.0016637;0.00060761;0.0061798;T139M;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1430;hayfever/allergic rhinitis;rs3749171;T;1.0;-0.0016637;0.00060761;0.0061798;T108M;ENST00000438013
CXCR8;ENSG00000178623;selfReported_n_1164;gastritis/gastric erosions;rs3749172;C;1.0;0.0002176;8.3644e-05;0.0092811;S294R;ENST00000319838
CXCR8;ENSG00000178623;selfReported_n_1164;gastritis/gastric erosions;rs3749172;C;1.0;0.0002176;8.3644e-05;0.0092811;S294R;ENST00000403859
CXCR8;ENSG00000178623;selfReported_n_1164;gastritis/gastric erosions;rs3749172;C;1.0;0.0002176;8.3644e-05;0.0092811;S294R;ENST00000407714
CXCR8;ENSG00000178623;selfReported_n_1164;gastritis/gastric erosions;rs3749172;C;1.0;0.0002176;8.3644e-05;0.0092811;S325R;ENST00000430267
CXCR8;ENSG00000178623;selfReported_n_1164;gastritis/gastric erosions;rs3749172;C;1.0;0.0002176;8.3644e-05;0.0092811;S294R;ENST00000438013
CXCR8;ENSG00000178623;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs3749172;C;1.0;0.00029206;0.00011064;0.0082989;S294R;ENST00000319838
CXCR8;ENSG00000178623;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs3749172;C;1.0;0.00029206;0.00011064;0.0082989;S294R;ENST00000403859
CXCR8;ENSG00000178623;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs3749172;C;1.0;0.00029206;0.00011064;0.0082989;S294R;ENST00000407714
CXCR8;ENSG00000178623;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs3749172;C;1.0;0.00029206;0.00011064;0.0082989;S325R;ENST00000430267
CXCR8;ENSG00000178623;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs3749172;C;1.0;0.00029206;0.00011064;0.0082989;S294R;ENST00000438013
CCRL2;ENSG00000121797;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs3204849;A;0.996653;-0.00035351;0.00012109;0.0035085999999999997;F179Y;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs3204849;A;0.996653;-0.00035351;0.00012109;0.0035085999999999997;F167Y;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs3204849;A;0.996653;-0.00035351;0.00012109;0.0035085999999999997;F167Y;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs3204849;A;0.996653;-0.00035351;0.00012109;0.0035085999999999997;F167Y;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs3204849;A;0.996653;-0.00035351;0.00012109;0.0035085999999999997;F167Y;ENST00000433848
CCRL2;ENSG00000121797;23104-0.0;Body mass index (BMI);rs6441977;A;1.0;0.034415;0.011038;0.0018218;V180M;ENST00000357392
CCRL2;ENSG00000121797;23104-0.0;Body mass index (BMI);rs6441977;A;1.0;0.034415;0.011038;0.0018218;V168M;ENST00000399036
CCRL2;ENSG00000121797;23104-0.0;Body mass index (BMI);rs6441977;A;1.0;0.034415;0.011038;0.0018218;V168M;ENST00000400880
CCRL2;ENSG00000121797;23104-0.0;Body mass index (BMI);rs6441977;A;1.0;0.034415;0.011038;0.0018218;V168M;ENST00000400882
CCRL2;ENSG00000121797;23104-0.0;Body mass index (BMI);rs6441977;A;1.0;0.034415;0.011038;0.0018218;V168M;ENST00000433848
CCRL2;ENSG00000121797;3079-0.0;Pace-maker;rs111863112;A;1.0;0.0012037;0.00044688;0.007069;G110E;ENST00000357392
CCRL2;ENSG00000121797;3079-0.0;Pace-maker;rs111863112;A;1.0;0.0012037;0.00044688;0.007069;G98E;ENST00000399036
CCRL2;ENSG00000121797;3079-0.0;Pace-maker;rs111863112;A;1.0;0.0012037;0.00044688;0.007069;G98E;ENST00000400880
CCRL2;ENSG00000121797;3079-0.0;Pace-maker;rs111863112;A;1.0;0.0012037;0.00044688;0.007069;G98E;ENST00000400882
CCRL2;ENSG00000121797;3079-0.0;Pace-maker;rs111863112;A;1.0;0.0012037;0.00044688;0.007069;G98E;ENST00000433848
CCRL2;ENSG00000121797;30160-0.0;Basophill count;rs11574443;G;1.0;0.00070687;0.00025383;0.0053568999999999995;Y16C;ENST00000357392
CCRL2;ENSG00000121797;30160-0.0;Basophill count;rs11574443;G;1.0;0.00070687;0.00025383;0.0053568999999999995;Y4C;ENST00000399036
CCRL2;ENSG00000121797;30160-0.0;Basophill count;rs11574443;G;1.0;0.00070687;0.00025383;0.0053568999999999995;Y4C;ENST00000400880
CCRL2;ENSG00000121797;30160-0.0;Basophill count;rs11574443;G;1.0;0.00070687;0.00025383;0.0053568999999999995;Y4C;ENST00000400882
CCRL2;ENSG00000121797;30160-0.0;Basophill count;rs11574443;G;1.0;0.00070687;0.00025383;0.0053568999999999995;Y4C;ENST00000433848
CCRL2;ENSG00000121797;30160-0.0;Basophill count;rs3204849;A;0.996653;-0.00044794;8.049399999999999e-05;2.6256e-08;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30160-0.0;Basophill count;rs3204849;A;0.996653;-0.00044794;8.049399999999999e-05;2.6256e-08;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30160-0.0;Basophill count;rs3204849;A;0.996653;-0.00044794;8.049399999999999e-05;2.6256e-08;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30160-0.0;Basophill count;rs3204849;A;0.996653;-0.00044794;8.049399999999999e-05;2.6256e-08;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30160-0.0;Basophill count;rs3204849;A;0.996653;-0.00044794;8.049399999999999e-05;2.6256e-08;F167Y;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1465;bronchitis;rs11574443;G;1.0;-0.0016007999999999999;0.00058029;0.0058065;Y16C;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1465;bronchitis;rs11574443;G;1.0;-0.0016007999999999999;0.00058029;0.0058065;Y4C;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1465;bronchitis;rs11574443;G;1.0;-0.0016007999999999999;0.00058029;0.0058065;Y4C;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1465;bronchitis;rs11574443;G;1.0;-0.0016007999999999999;0.00058029;0.0058065;Y4C;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1465;bronchitis;rs11574443;G;1.0;-0.0016007999999999999;0.00058029;0.0058065;Y4C;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1465;bronchitis;rs3204850;G;1.0;-0.00096082;0.0003182;0.0025318000000000003;I255V;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1465;bronchitis;rs3204850;G;1.0;-0.00096082;0.0003182;0.0025318000000000003;I243V;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1465;bronchitis;rs3204850;G;1.0;-0.00096082;0.0003182;0.0025318000000000003;I243V;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1465;bronchitis;rs3204850;G;1.0;-0.00096082;0.0003182;0.0025318000000000003;I243V;ENST00000400882
CCRL2;ENSG00000121797;cancer_c_Block_C15-C26;C15-C26 Malignant neoplasms of digestive organs;rs6441977;A;1.0;-0.0011304;0.00033156;0.00065114;V180M;ENST00000357392
CCRL2;ENSG00000121797;cancer_c_Block_C15-C26;C15-C26 Malignant neoplasms of digestive organs;rs6441977;A;1.0;-0.0011304;0.00033156;0.00065114;V168M;ENST00000399036
CCRL2;ENSG00000121797;cancer_c_Block_C15-C26;C15-C26 Malignant neoplasms of digestive organs;rs6441977;A;1.0;-0.0011304;0.00033156;0.00065114;V168M;ENST00000400880
CCRL2;ENSG00000121797;cancer_c_Block_C15-C26;C15-C26 Malignant neoplasms of digestive organs;rs6441977;A;1.0;-0.0011304;0.00033156;0.00065114;V168M;ENST00000400882
CCRL2;ENSG00000121797;cancer_c_Block_C15-C26;C15-C26 Malignant neoplasms of digestive organs;rs6441977;A;1.0;-0.0011304;0.00033156;0.00065114;V168M;ENST00000433848
CCRL2;ENSG00000121797;30210-0.0;Eosinophill percentage;rs11574443;G;1.0;0.036429;0.010088;0.00030477;Y16C;ENST00000357392
CCRL2;ENSG00000121797;30210-0.0;Eosinophill percentage;rs11574443;G;1.0;0.036429;0.010088;0.00030477;Y4C;ENST00000399036
CCRL2;ENSG00000121797;30210-0.0;Eosinophill percentage;rs11574443;G;1.0;0.036429;0.010088;0.00030477;Y4C;ENST00000400880
CCRL2;ENSG00000121797;30210-0.0;Eosinophill percentage;rs11574443;G;1.0;0.036429;0.010088;0.00030477;Y4C;ENST00000400882
CCRL2;ENSG00000121797;30210-0.0;Eosinophill percentage;rs11574443;G;1.0;0.036429;0.010088;0.00030477;Y4C;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1089;essential hypertension;rs6441977;A;1.0;0.00049975;0.00019216;0.009305299999999999;V180M;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1089;essential hypertension;rs6441977;A;1.0;0.00049975;0.00019216;0.009305299999999999;V168M;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1089;essential hypertension;rs6441977;A;1.0;0.00049975;0.00019216;0.009305299999999999;V168M;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1089;essential hypertension;rs6441977;A;1.0;0.00049975;0.00019216;0.009305299999999999;V168M;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1089;essential hypertension;rs6441977;A;1.0;0.00049975;0.00019216;0.009305299999999999;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1525;osteoarthritis;rs6441977;A;1.0;0.0021249000000000003;0.00076802;0.0056614;V180M;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1525;osteoarthritis;rs6441977;A;1.0;0.0021249000000000003;0.00076802;0.0056614;V168M;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1525;osteoarthritis;rs6441977;A;1.0;0.0021249000000000003;0.00076802;0.0056614;V168M;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1525;osteoarthritis;rs6441977;A;1.0;0.0021249000000000003;0.00076802;0.0056614;V168M;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1525;osteoarthritis;rs6441977;A;1.0;0.0021249000000000003;0.00076802;0.0056614;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_K35;K35 Acute appendicitis;rs3204849;A;0.996653;0.00059405;0.00017947;0.00093271;F179Y;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_K35;K35 Acute appendicitis;rs3204849;A;0.996653;0.00059405;0.00017947;0.00093271;F167Y;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_K35;K35 Acute appendicitis;rs3204849;A;0.996653;0.00059405;0.00017947;0.00093271;F167Y;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_K35;K35 Acute appendicitis;rs3204849;A;0.996653;0.00059405;0.00017947;0.00093271;F167Y;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_K35;K35 Acute appendicitis;rs3204849;A;0.996653;0.00059405;0.00017947;0.00093271;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30240-0.0;Reticulocyte percentage;rs3204849;A;0.996653;-0.0072612;0.00098789;1.9832e-13;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30240-0.0;Reticulocyte percentage;rs3204849;A;0.996653;-0.0072612;0.00098789;1.9832e-13;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30240-0.0;Reticulocyte percentage;rs3204849;A;0.996653;-0.0072612;0.00098789;1.9832e-13;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30240-0.0;Reticulocyte percentage;rs3204849;A;0.996653;-0.0072612;0.00098789;1.9832e-13;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30240-0.0;Reticulocyte percentage;rs3204849;A;0.996653;-0.0072612;0.00098789;1.9832e-13;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30240-0.0;Reticulocyte percentage;rs6441977;A;1.0;0.010665000000000001;0.0013253;8.4696e-16;V180M;ENST00000357392
CCRL2;ENSG00000121797;30240-0.0;Reticulocyte percentage;rs6441977;A;1.0;0.010665000000000001;0.0013253;8.4696e-16;V168M;ENST00000399036
CCRL2;ENSG00000121797;30240-0.0;Reticulocyte percentage;rs6441977;A;1.0;0.010665000000000001;0.0013253;8.4696e-16;V168M;ENST00000400880
CCRL2;ENSG00000121797;30240-0.0;Reticulocyte percentage;rs6441977;A;1.0;0.010665000000000001;0.0013253;8.4696e-16;V168M;ENST00000400882
CCRL2;ENSG00000121797;30240-0.0;Reticulocyte percentage;rs6441977;A;1.0;0.010665000000000001;0.0013253;8.4696e-16;V168M;ENST00000433848
CCRL2;ENSG00000121797;50-0.0;Standing height;rs3204850;G;1.0;0.039274;0.014794;0.0079364;I255V;ENST00000357392
CCRL2;ENSG00000121797;50-0.0;Standing height;rs3204850;G;1.0;0.039274;0.014794;0.0079364;I243V;ENST00000399036
CCRL2;ENSG00000121797;50-0.0;Standing height;rs3204850;G;1.0;0.039274;0.014794;0.0079364;I243V;ENST00000400880
CCRL2;ENSG00000121797;50-0.0;Standing height;rs3204850;G;1.0;0.039274;0.014794;0.0079364;I243V;ENST00000400882
CCRL2;ENSG00000121797;50-0.0;Standing height;rs6441977;A;1.0;-0.069172;0.011477;1.6741e-09;V180M;ENST00000357392
CCRL2;ENSG00000121797;50-0.0;Standing height;rs6441977;A;1.0;-0.069172;0.011477;1.6741e-09;V168M;ENST00000399036
CCRL2;ENSG00000121797;50-0.0;Standing height;rs6441977;A;1.0;-0.069172;0.011477;1.6741e-09;V168M;ENST00000400880
CCRL2;ENSG00000121797;50-0.0;Standing height;rs6441977;A;1.0;-0.069172;0.011477;1.6741e-09;V168M;ENST00000400882
CCRL2;ENSG00000121797;50-0.0;Standing height;rs6441977;A;1.0;-0.069172;0.011477;1.6741e-09;V168M;ENST00000433848
CCRL2;ENSG00000121797;30120-0.0;Lymphocyte count;rs3204849;A;0.996653;-0.0063566000000000004;0.0011246;1.5865e-08;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30120-0.0;Lymphocyte count;rs3204849;A;0.996653;-0.0063566000000000004;0.0011246;1.5865e-08;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30120-0.0;Lymphocyte count;rs3204849;A;0.996653;-0.0063566000000000004;0.0011246;1.5865e-08;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30120-0.0;Lymphocyte count;rs3204849;A;0.996653;-0.0063566000000000004;0.0011246;1.5865e-08;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30120-0.0;Lymphocyte count;rs3204849;A;0.996653;-0.0063566000000000004;0.0011246;1.5865e-08;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30120-0.0;Lymphocyte count;rs6441977;A;1.0;0.014851;0.0015087;7.3464e-23;V180M;ENST00000357392
CCRL2;ENSG00000121797;30120-0.0;Lymphocyte count;rs6441977;A;1.0;0.014851;0.0015087;7.3464e-23;V168M;ENST00000399036
CCRL2;ENSG00000121797;30120-0.0;Lymphocyte count;rs6441977;A;1.0;0.014851;0.0015087;7.3464e-23;V168M;ENST00000400880
CCRL2;ENSG00000121797;30120-0.0;Lymphocyte count;rs6441977;A;1.0;0.014851;0.0015087;7.3464e-23;V168M;ENST00000400882
CCRL2;ENSG00000121797;30120-0.0;Lymphocyte count;rs6441977;A;1.0;0.014851;0.0015087;7.3464e-23;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_I74;I74 Arterial embolism and thrombosis;rs143567349;A;1.0;0.0067801;0.0025369;0.007526899999999999;D35N;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_I74;I74 Arterial embolism and thrombosis;rs143567349;A;1.0;0.0067801;0.0025369;0.007526899999999999;D23N;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_I74;I74 Arterial embolism and thrombosis;rs143567349;A;1.0;0.0067801;0.0025369;0.007526899999999999;D23N;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_I74;I74 Arterial embolism and thrombosis;rs143567349;A;1.0;0.0067801;0.0025369;0.007526899999999999;D23N;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_I74;I74 Arterial embolism and thrombosis;rs143567349;A;1.0;0.0067801;0.0025369;0.007526899999999999;D23N;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_N17-N19;N17-N19 Renal failure;rs6441977;A;1.0;0.0013557;0.00040643;0.00085134;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_N17-N19;N17-N19 Renal failure;rs6441977;A;1.0;0.0013557;0.00040643;0.00085134;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_N17-N19;N17-N19 Renal failure;rs6441977;A;1.0;0.0013557;0.00040643;0.00085134;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_N17-N19;N17-N19 Renal failure;rs6441977;A;1.0;0.0013557;0.00040643;0.00085134;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_N17-N19;N17-N19 Renal failure;rs6441977;A;1.0;0.0013557;0.00040643;0.00085134;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_N00-N08;N00-N08 Glomerular diseases;rs11574441;A;1.0;0.008901000000000001;0.0029467;0.002522;R5H;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_N03;N03 Chronic nephritic syndrome;rs11574441;A;1.0;0.0064639;0.0018922999999999998;0.00063593;R5H;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_N03;N03 Chronic nephritic syndrome;rs11574443;G;1.0;-0.00080468;0.00030906;0.0092235;Y16C;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_N03;N03 Chronic nephritic syndrome;rs11574443;G;1.0;-0.00080468;0.00030906;0.0092235;Y4C;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_N03;N03 Chronic nephritic syndrome;rs11574443;G;1.0;-0.00080468;0.00030906;0.0092235;Y4C;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_N03;N03 Chronic nephritic syndrome;rs11574443;G;1.0;-0.00080468;0.00030906;0.0092235;Y4C;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_N03;N03 Chronic nephritic syndrome;rs11574443;G;1.0;-0.00080468;0.00030906;0.0092235;Y4C;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1293;spinal injury;rs6441977;A;1.0;-0.00037945;0.00011312;0.00079554;V180M;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1293;spinal injury;rs6441977;A;1.0;-0.00037945;0.00011312;0.00079554;V168M;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1293;spinal injury;rs6441977;A;1.0;-0.00037945;0.00011312;0.00079554;V168M;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1293;spinal injury;rs6441977;A;1.0;-0.00037945;0.00011312;0.00079554;V168M;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1293;spinal injury;rs6441977;A;1.0;-0.00037945;0.00011312;0.00079554;V168M;ENST00000433848
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs11574443;G;1.0;0.010864;0.0028252;0.00012027;Y16C;ENST00000357392
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs11574443;G;1.0;0.010864;0.0028252;0.00012027;Y4C;ENST00000399036
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs11574443;G;1.0;0.010864;0.0028252;0.00012027;Y4C;ENST00000400880
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs11574443;G;1.0;0.010864;0.0028252;0.00012027;Y4C;ENST00000400882
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs11574443;G;1.0;0.010864;0.0028252;0.00012027;Y4C;ENST00000433848
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs3204849;A;0.996653;-0.004486199999999999;0.00089591;5.5194e-07;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs3204849;A;0.996653;-0.004486199999999999;0.00089591;5.5194e-07;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs3204849;A;0.996653;-0.004486199999999999;0.00089591;5.5194e-07;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs3204849;A;0.996653;-0.004486199999999999;0.00089591;5.5194e-07;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs3204849;A;0.996653;-0.004486199999999999;0.00089591;5.5194e-07;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs6441977;A;1.0;-0.0044104999999999995;0.0012019;0.00024308;V180M;ENST00000357392
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs6441977;A;1.0;-0.0044104999999999995;0.0012019;0.00024308;V168M;ENST00000399036
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs6441977;A;1.0;-0.0044104999999999995;0.0012019;0.00024308;V168M;ENST00000400880
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs6441977;A;1.0;-0.0044104999999999995;0.0012019;0.00024308;V168M;ENST00000400882
CCRL2;ENSG00000121797;30220-0.0;Basophill percentage;rs6441977;A;1.0;-0.0044104999999999995;0.0012019;0.00024308;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_F10-F19;F10-F19 Mental and behavioural disorders due to psychoactive substance use;rs11574441;A;1.0;0.023358;0.007714399999999999;0.0024635;R5H;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_K66;K66 Other disorders of peritoneum;rs11574441;A;1.0;0.0098326;0.0035830999999999997;0.006067;R5H;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_M81;M81 Osteoporosis without pathological fracture;rs11574441;A;1.0;0.013613;0.0049126000000000005;0.0055887;R5H;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1565;appendicitis;rs3204850;G;1.0;0.000897;0.00033585;0.007567;I255V;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1565;appendicitis;rs3204850;G;1.0;0.000897;0.00033585;0.007567;I243V;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1565;appendicitis;rs3204850;G;1.0;0.000897;0.00033585;0.007567;I243V;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1565;appendicitis;rs3204850;G;1.0;0.000897;0.00033585;0.007567;I243V;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1524;rheumatoid arthritis;rs6441977;A;1.0;-0.00095555;0.00030082;0.001491;V180M;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1524;rheumatoid arthritis;rs6441977;A;1.0;-0.00095555;0.00030082;0.001491;V168M;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1524;rheumatoid arthritis;rs6441977;A;1.0;-0.00095555;0.00030082;0.001491;V168M;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1524;rheumatoid arthritis;rs6441977;A;1.0;-0.00095555;0.00030082;0.001491;V168M;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1524;rheumatoid arthritis;rs6441977;A;1.0;-0.00095555;0.00030082;0.001491;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1092;heart attack/myocardial infarction;rs6441977;A;1.0;0.0015723;0.00041846;0.00017175;V180M;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1092;heart attack/myocardial infarction;rs6441977;A;1.0;0.0015723;0.00041846;0.00017175;V168M;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1092;heart attack/myocardial infarction;rs6441977;A;1.0;0.0015723;0.00041846;0.00017175;V168M;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1092;heart attack/myocardial infarction;rs6441977;A;1.0;0.0015723;0.00041846;0.00017175;V168M;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1092;heart attack/myocardial infarction;rs6441977;A;1.0;0.0015723;0.00041846;0.00017175;V168M;ENST00000433848
CCRL2;ENSG00000121797;21001-0.0;Body mass index (BMI);rs6441977;A;1.0;0.035286;0.011124;0.0015134999999999999;V180M;ENST00000357392
CCRL2;ENSG00000121797;21001-0.0;Body mass index (BMI);rs6441977;A;1.0;0.035286;0.011124;0.0015134999999999999;V168M;ENST00000399036
CCRL2;ENSG00000121797;21001-0.0;Body mass index (BMI);rs6441977;A;1.0;0.035286;0.011124;0.0015134999999999999;V168M;ENST00000400880
CCRL2;ENSG00000121797;21001-0.0;Body mass index (BMI);rs6441977;A;1.0;0.035286;0.011124;0.0015134999999999999;V168M;ENST00000400882
CCRL2;ENSG00000121797;21001-0.0;Body mass index (BMI);rs6441977;A;1.0;0.035286;0.011124;0.0015134999999999999;V168M;ENST00000433848
CCRL2;ENSG00000121797;30290-0.0;High light scatter reticulocyte percentage;rs3204849;A;0.996653;-0.0030894000000000004;0.00036458;2.3804e-17;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30290-0.0;High light scatter reticulocyte percentage;rs3204849;A;0.996653;-0.0030894000000000004;0.00036458;2.3804e-17;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30290-0.0;High light scatter reticulocyte percentage;rs3204849;A;0.996653;-0.0030894000000000004;0.00036458;2.3804e-17;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30290-0.0;High light scatter reticulocyte percentage;rs3204849;A;0.996653;-0.0030894000000000004;0.00036458;2.3804e-17;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30290-0.0;High light scatter reticulocyte percentage;rs3204849;A;0.996653;-0.0030894000000000004;0.00036458;2.3804e-17;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30290-0.0;High light scatter reticulocyte percentage;rs6441977;A;1.0;0.004333699999999999;0.00048911;8.0035e-19;V180M;ENST00000357392
CCRL2;ENSG00000121797;30290-0.0;High light scatter reticulocyte percentage;rs6441977;A;1.0;0.004333699999999999;0.00048911;8.0035e-19;V168M;ENST00000399036
CCRL2;ENSG00000121797;30290-0.0;High light scatter reticulocyte percentage;rs6441977;A;1.0;0.004333699999999999;0.00048911;8.0035e-19;V168M;ENST00000400880
CCRL2;ENSG00000121797;30290-0.0;High light scatter reticulocyte percentage;rs6441977;A;1.0;0.004333699999999999;0.00048911;8.0035e-19;V168M;ENST00000400882
CCRL2;ENSG00000121797;30290-0.0;High light scatter reticulocyte percentage;rs6441977;A;1.0;0.004333699999999999;0.00048911;8.0035e-19;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1155;bowel problem;rs3204850;G;1.0;0.0033201;0.0009137;0.00027948;I255V;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1155;bowel problem;rs3204850;G;1.0;0.0033201;0.0009137;0.00027948;I243V;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1155;bowel problem;rs3204850;G;1.0;0.0033201;0.0009137;0.00027948;I243V;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1155;bowel problem;rs3204850;G;1.0;0.0033201;0.0009137;0.00027948;I243V;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_E78;E78 Disorders of lipoprotein metabolism and other lipidaemias;rs3204849;A;0.996653;0.0016344999999999999;0.00057065;0.004181100000000001;F179Y;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_E78;E78 Disorders of lipoprotein metabolism and other lipidaemias;rs3204849;A;0.996653;0.0016344999999999999;0.00057065;0.004181100000000001;F167Y;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_E78;E78 Disorders of lipoprotein metabolism and other lipidaemias;rs3204849;A;0.996653;0.0016344999999999999;0.00057065;0.004181100000000001;F167Y;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_E78;E78 Disorders of lipoprotein metabolism and other lipidaemias;rs3204849;A;0.996653;0.0016344999999999999;0.00057065;0.004181100000000001;F167Y;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_E78;E78 Disorders of lipoprotein metabolism and other lipidaemias;rs3204849;A;0.996653;0.0016344999999999999;0.00057065;0.004181100000000001;F167Y;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_J92;J92 Pleural plaque;rs111863112;A;1.0;-0.00093099;0.00034906;0.0076509;G110E;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_J92;J92 Pleural plaque;rs111863112;A;1.0;-0.00093099;0.00034906;0.0076509;G98E;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_J92;J92 Pleural plaque;rs111863112;A;1.0;-0.00093099;0.00034906;0.0076509;G98E;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_J92;J92 Pleural plaque;rs111863112;A;1.0;-0.00093099;0.00034906;0.0076509;G98E;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_J92;J92 Pleural plaque;rs111863112;A;1.0;-0.00093099;0.00034906;0.0076509;G98E;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1250;hyperthyroidism/thyrotoxicosis;rs6441977;A;1.0;-0.00067794;0.0002481;0.0062846;V180M;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1250;hyperthyroidism/thyrotoxicosis;rs6441977;A;1.0;-0.00067794;0.0002481;0.0062846;V168M;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1250;hyperthyroidism/thyrotoxicosis;rs6441977;A;1.0;-0.00067794;0.0002481;0.0062846;V168M;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1250;hyperthyroidism/thyrotoxicosis;rs6441977;A;1.0;-0.00067794;0.0002481;0.0062846;V168M;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1250;hyperthyroidism/thyrotoxicosis;rs6441977;A;1.0;-0.00067794;0.0002481;0.0062846;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1566;anal problem;rs143567349;A;1.0;0.008186;0.003057;0.0074111;D35N;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1566;anal problem;rs143567349;A;1.0;0.008186;0.003057;0.0074111;D23N;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1566;anal problem;rs143567349;A;1.0;0.008186;0.003057;0.0074111;D23N;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1566;anal problem;rs143567349;A;1.0;0.008186;0.003057;0.0074111;D23N;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1566;anal problem;rs143567349;A;1.0;0.008186;0.003057;0.0074111;D23N;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1527;other joint disorder;rs142950457;T;0.949018;0.022826;0.008768799999999998;0.0092374;L73F;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1527;other joint disorder;rs142950457;T;0.949018;0.022826;0.008768799999999998;0.0092374;L61F;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1527;other joint disorder;rs142950457;T;0.949018;0.022826;0.008768799999999998;0.0092374;L61F;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1527;other joint disorder;rs142950457;T;0.949018;0.022826;0.008768799999999998;0.0092374;L61F;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1527;other joint disorder;rs142950457;T;0.949018;0.022826;0.008768799999999998;0.0092374;L61F;ENST00000433848
CCRL2;ENSG00000121797;23107-0.0;Impedance of leg (right);rs11574443;G;1.0;0.49813;0.17425;0.0042537;Y16C;ENST00000357392
CCRL2;ENSG00000121797;23107-0.0;Impedance of leg (right);rs11574443;G;1.0;0.49813;0.17425;0.0042537;Y4C;ENST00000399036
CCRL2;ENSG00000121797;23107-0.0;Impedance of leg (right);rs11574443;G;1.0;0.49813;0.17425;0.0042537;Y4C;ENST00000400880
CCRL2;ENSG00000121797;23107-0.0;Impedance of leg (right);rs11574443;G;1.0;0.49813;0.17425;0.0042537;Y4C;ENST00000400882
CCRL2;ENSG00000121797;23107-0.0;Impedance of leg (right);rs11574443;G;1.0;0.49813;0.17425;0.0042537;Y4C;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_L60;L60 Nail disorders;rs142950457;T;0.949018;0.013751;0.0047482;0.003779;L73F;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_L60;L60 Nail disorders;rs142950457;T;0.949018;0.013751;0.0047482;0.003779;L61F;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_L60;L60 Nail disorders;rs142950457;T;0.949018;0.013751;0.0047482;0.003779;L61F;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_L60;L60 Nail disorders;rs142950457;T;0.949018;0.013751;0.0047482;0.003779;L61F;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_L60;L60 Nail disorders;rs142950457;T;0.949018;0.013751;0.0047482;0.003779;L61F;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1407;breast disease (not cancer);rs3204850;G;1.0;-0.0017127;0.00059713;0.0041283000000000005;I255V;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1407;breast disease (not cancer);rs3204850;G;1.0;-0.0017127;0.00059713;0.0041283000000000005;I243V;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1407;breast disease (not cancer);rs3204850;G;1.0;-0.0017127;0.00059713;0.0041283000000000005;I243V;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1407;breast disease (not cancer);rs3204850;G;1.0;-0.0017127;0.00059713;0.0041283000000000005;I243V;ENST00000400882
CCRL2;ENSG00000121797;1289-0.0;Cooked vegetable intake;rs6441977;A;1.0;-0.011879;0.0044876000000000004;0.0081185;V180M;ENST00000357392
CCRL2;ENSG00000121797;1289-0.0;Cooked vegetable intake;rs6441977;A;1.0;-0.011879;0.0044876000000000004;0.0081185;V168M;ENST00000399036
CCRL2;ENSG00000121797;1289-0.0;Cooked vegetable intake;rs6441977;A;1.0;-0.011879;0.0044876000000000004;0.0081185;V168M;ENST00000400880
CCRL2;ENSG00000121797;1289-0.0;Cooked vegetable intake;rs6441977;A;1.0;-0.011879;0.0044876000000000004;0.0081185;V168M;ENST00000400882
CCRL2;ENSG00000121797;1289-0.0;Cooked vegetable intake;rs6441977;A;1.0;-0.011879;0.0044876000000000004;0.0081185;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_K86;K86 Other diseases of pancreas;rs3204850;G;1.0;0.00057881;0.00019341;0.0027651999999999998;I255V;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_K86;K86 Other diseases of pancreas;rs3204850;G;1.0;0.00057881;0.00019341;0.0027651999999999998;I243V;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_K86;K86 Other diseases of pancreas;rs3204850;G;1.0;0.00057881;0.00019341;0.0027651999999999998;I243V;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_K86;K86 Other diseases of pancreas;rs3204850;G;1.0;0.00057881;0.00019341;0.0027651999999999998;I243V;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_L60-L75;L60-L75 Disorders of skin appendages;rs11574443;G;1.0;-0.0028913;0.0010509;0.005935899999999999;Y16C;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_L60-L75;L60-L75 Disorders of skin appendages;rs11574443;G;1.0;-0.0028913;0.0010509;0.005935899999999999;Y4C;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_L60-L75;L60-L75 Disorders of skin appendages;rs11574443;G;1.0;-0.0028913;0.0010509;0.005935899999999999;Y4C;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_L60-L75;L60-L75 Disorders of skin appendages;rs11574443;G;1.0;-0.0028913;0.0010509;0.005935899999999999;Y4C;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_L60-L75;L60-L75 Disorders of skin appendages;rs11574443;G;1.0;-0.0028913;0.0010509;0.005935899999999999;Y4C;ENST00000433848
CCRL2;ENSG00000121797;_48_49_-0.0;Waist circumference / Hip circumference;rs11574443;G;1.0;-0.0010169;0.00038866;0.0088845;Y16C;ENST00000357392
CCRL2;ENSG00000121797;_48_49_-0.0;Waist circumference / Hip circumference;rs11574443;G;1.0;-0.0010169;0.00038866;0.0088845;Y4C;ENST00000399036
CCRL2;ENSG00000121797;_48_49_-0.0;Waist circumference / Hip circumference;rs11574443;G;1.0;-0.0010169;0.00038866;0.0088845;Y4C;ENST00000400880
CCRL2;ENSG00000121797;_48_49_-0.0;Waist circumference / Hip circumference;rs11574443;G;1.0;-0.0010169;0.00038866;0.0088845;Y4C;ENST00000400882
CCRL2;ENSG00000121797;_48_49_-0.0;Waist circumference / Hip circumference;rs11574443;G;1.0;-0.0010169;0.00038866;0.0088845;Y4C;ENST00000433848
CCRL2;ENSG00000121797;_48_49_-0.0;Waist circumference / Hip circumference;rs6441977;A;1.0;0.00075961;0.00016535;4.3499000000000005e-06;V180M;ENST00000357392
CCRL2;ENSG00000121797;_48_49_-0.0;Waist circumference / Hip circumference;rs6441977;A;1.0;0.00075961;0.00016535;4.3499000000000005e-06;V168M;ENST00000399036
CCRL2;ENSG00000121797;_48_49_-0.0;Waist circumference / Hip circumference;rs6441977;A;1.0;0.00075961;0.00016535;4.3499000000000005e-06;V168M;ENST00000400880
CCRL2;ENSG00000121797;_48_49_-0.0;Waist circumference / Hip circumference;rs6441977;A;1.0;0.00075961;0.00016535;4.3499000000000005e-06;V168M;ENST00000400882
CCRL2;ENSG00000121797;_48_49_-0.0;Waist circumference / Hip circumference;rs6441977;A;1.0;0.00075961;0.00016535;4.3499000000000005e-06;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_I10-I15;I10-I15 Hypertensive diseases;rs6441977;A;1.0;0.0038783000000000003;0.0010073;0.00011801;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_I10-I15;I10-I15 Hypertensive diseases;rs6441977;A;1.0;0.0038783000000000003;0.0010073;0.00011801;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_I10-I15;I10-I15 Hypertensive diseases;rs6441977;A;1.0;0.0038783000000000003;0.0010073;0.00011801;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_I10-I15;I10-I15 Hypertensive diseases;rs6441977;A;1.0;0.0038783000000000003;0.0010073;0.00011801;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_I10-I15;I10-I15 Hypertensive diseases;rs6441977;A;1.0;0.0038783000000000003;0.0010073;0.00011801;V168M;ENST00000433848
CCRL2;ENSG00000121797;1777-0.0;Part of a multiple birth;rs142950457;T;0.949018;0.034453;0.013304;0.009604999999999999;L73F;ENST00000357392
CCRL2;ENSG00000121797;1777-0.0;Part of a multiple birth;rs142950457;T;0.949018;0.034453;0.013304;0.009604999999999999;L61F;ENST00000399036
CCRL2;ENSG00000121797;1777-0.0;Part of a multiple birth;rs142950457;T;0.949018;0.034453;0.013304;0.009604999999999999;L61F;ENST00000400880
CCRL2;ENSG00000121797;1777-0.0;Part of a multiple birth;rs142950457;T;0.949018;0.034453;0.013304;0.009604999999999999;L61F;ENST00000400882
CCRL2;ENSG00000121797;1777-0.0;Part of a multiple birth;rs142950457;T;0.949018;0.034453;0.013304;0.009604999999999999;L61F;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_K70;K70 Alcoholic liver disease;rs143567349;A;1.0;0.006819199999999999;0.0024316999999999997;0.005041899999999999;D35N;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_K70;K70 Alcoholic liver disease;rs143567349;A;1.0;0.006819199999999999;0.0024316999999999997;0.005041899999999999;D23N;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_K70;K70 Alcoholic liver disease;rs143567349;A;1.0;0.006819199999999999;0.0024316999999999997;0.005041899999999999;D23N;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_K70;K70 Alcoholic liver disease;rs143567349;A;1.0;0.006819199999999999;0.0024316999999999997;0.005041899999999999;D23N;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_K70;K70 Alcoholic liver disease;rs143567349;A;1.0;0.006819199999999999;0.0024316999999999997;0.005041899999999999;D23N;ENST00000433848
CCRL2;ENSG00000121797;30280-0.0;Immature reticulocyte fraction;rs3204849;A;0.996653;-0.00077039;0.00010966;2.1396e-12;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30280-0.0;Immature reticulocyte fraction;rs3204849;A;0.996653;-0.00077039;0.00010966;2.1396e-12;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30280-0.0;Immature reticulocyte fraction;rs3204849;A;0.996653;-0.00077039;0.00010966;2.1396e-12;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30280-0.0;Immature reticulocyte fraction;rs3204849;A;0.996653;-0.00077039;0.00010966;2.1396e-12;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30280-0.0;Immature reticulocyte fraction;rs3204849;A;0.996653;-0.00077039;0.00010966;2.1396e-12;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30280-0.0;Immature reticulocyte fraction;rs6441977;A;1.0;0.00082412;0.00014712;2.1244e-08;V180M;ENST00000357392
CCRL2;ENSG00000121797;30280-0.0;Immature reticulocyte fraction;rs6441977;A;1.0;0.00082412;0.00014712;2.1244e-08;V168M;ENST00000399036
CCRL2;ENSG00000121797;30280-0.0;Immature reticulocyte fraction;rs6441977;A;1.0;0.00082412;0.00014712;2.1244e-08;V168M;ENST00000400880
CCRL2;ENSG00000121797;30280-0.0;Immature reticulocyte fraction;rs6441977;A;1.0;0.00082412;0.00014712;2.1244e-08;V168M;ENST00000400882
CCRL2;ENSG00000121797;30280-0.0;Immature reticulocyte fraction;rs6441977;A;1.0;0.00082412;0.00014712;2.1244e-08;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_B35-B49;B35-B49 Mycoses;rs111863112;A;1.0;0.0018027000000000002;0.00065377;0.0058264;G110E;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_B35-B49;B35-B49 Mycoses;rs111863112;A;1.0;0.0018027000000000002;0.00065377;0.0058264;G98E;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_B35-B49;B35-B49 Mycoses;rs111863112;A;1.0;0.0018027000000000002;0.00065377;0.0058264;G98E;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_B35-B49;B35-B49 Mycoses;rs111863112;A;1.0;0.0018027000000000002;0.00065377;0.0058264;G98E;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_B35-B49;B35-B49 Mycoses;rs111863112;A;1.0;0.0018027000000000002;0.00065377;0.0058264;G98E;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_I21;I21 Acute myocardial infarction;rs6441977;A;1.0;0.0012052999999999999;0.00038941;0.0019665;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_I21;I21 Acute myocardial infarction;rs6441977;A;1.0;0.0012052999999999999;0.00038941;0.0019665;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_I21;I21 Acute myocardial infarction;rs6441977;A;1.0;0.0012052999999999999;0.00038941;0.0019665;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_I21;I21 Acute myocardial infarction;rs6441977;A;1.0;0.0012052999999999999;0.00038941;0.0019665;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_I21;I21 Acute myocardial infarction;rs6441977;A;1.0;0.0012052999999999999;0.00038941;0.0019665;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1457;muscle or soft tissue injuries;rs11574441;A;1.0;0.013640000000000001;0.0035077;0.00010083;R5H;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_M65-M68;M65-M68 Disorders of synovium and tendon;rs3204849;A;0.996653;-0.00089786;0.00031595;0.0044865;F179Y;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_M65-M68;M65-M68 Disorders of synovium and tendon;rs3204849;A;0.996653;-0.00089786;0.00031595;0.0044865;F167Y;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_M65-M68;M65-M68 Disorders of synovium and tendon;rs3204849;A;0.996653;-0.00089786;0.00031595;0.0044865;F167Y;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_M65-M68;M65-M68 Disorders of synovium and tendon;rs3204849;A;0.996653;-0.00089786;0.00031595;0.0044865;F167Y;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_M65-M68;M65-M68 Disorders of synovium and tendon;rs3204849;A;0.996653;-0.00089786;0.00031595;0.0044865;F167Y;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_O63;O63 Long labour;rs142950457;T;0.949018;0.049463;0.011603;2.0176e-05;L73F;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_O63;O63 Long labour;rs142950457;T;0.949018;0.049463;0.011603;2.0176e-05;L61F;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_O63;O63 Long labour;rs142950457;T;0.949018;0.049463;0.011603;2.0176e-05;L61F;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_O63;O63 Long labour;rs142950457;T;0.949018;0.049463;0.011603;2.0176e-05;L61F;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_O63;O63 Long labour;rs142950457;T;0.949018;0.049463;0.011603;2.0176e-05;L61F;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs142950457;T;0.949018;0.034926;0.011139;0.0017165;L73F;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs142950457;T;0.949018;0.034926;0.011139;0.0017165;L61F;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs142950457;T;0.949018;0.034926;0.011139;0.0017165;L61F;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs142950457;T;0.949018;0.034926;0.011139;0.0017165;L61F;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs142950457;T;0.949018;0.034926;0.011139;0.0017165;L61F;ENST00000433848
CCRL2;ENSG00000121797;30200-0.0;Neutrophill percentage;rs3204850;G;1.0;0.1316;0.026881;9.7972e-07;I255V;ENST00000357392
CCRL2;ENSG00000121797;30200-0.0;Neutrophill percentage;rs3204850;G;1.0;0.1316;0.026881;9.7972e-07;I243V;ENST00000399036
CCRL2;ENSG00000121797;30200-0.0;Neutrophill percentage;rs3204850;G;1.0;0.1316;0.026881;9.7972e-07;I243V;ENST00000400880
CCRL2;ENSG00000121797;30200-0.0;Neutrophill percentage;rs3204850;G;1.0;0.1316;0.026881;9.7972e-07;I243V;ENST00000400882
CCRL2;ENSG00000121797;30200-0.0;Neutrophill percentage;rs6441977;A;1.0;-0.1071;0.020855000000000002;2.8208e-07;V180M;ENST00000357392
CCRL2;ENSG00000121797;30200-0.0;Neutrophill percentage;rs6441977;A;1.0;-0.1071;0.020855000000000002;2.8208e-07;V168M;ENST00000399036
CCRL2;ENSG00000121797;30200-0.0;Neutrophill percentage;rs6441977;A;1.0;-0.1071;0.020855000000000002;2.8208e-07;V168M;ENST00000400880
CCRL2;ENSG00000121797;30200-0.0;Neutrophill percentage;rs6441977;A;1.0;-0.1071;0.020855000000000002;2.8208e-07;V168M;ENST00000400882
CCRL2;ENSG00000121797;30200-0.0;Neutrophill percentage;rs6441977;A;1.0;-0.1071;0.020855000000000002;2.8208e-07;V168M;ENST00000433848
CCRL2;ENSG00000121797;23106-0.0;Impedance of whole body;rs11574443;G;1.0;1.1562;0.35527;0.0011362;Y16C;ENST00000357392
CCRL2;ENSG00000121797;23106-0.0;Impedance of whole body;rs11574443;G;1.0;1.1562;0.35527;0.0011362;Y4C;ENST00000399036
CCRL2;ENSG00000121797;23106-0.0;Impedance of whole body;rs11574443;G;1.0;1.1562;0.35527;0.0011362;Y4C;ENST00000400880
CCRL2;ENSG00000121797;23106-0.0;Impedance of whole body;rs11574443;G;1.0;1.1562;0.35527;0.0011362;Y4C;ENST00000400882
CCRL2;ENSG00000121797;23106-0.0;Impedance of whole body;rs11574443;G;1.0;1.1562;0.35527;0.0011362;Y4C;ENST00000433848
CCRL2;ENSG00000121797;23106-0.0;Impedance of whole body;rs6441977;A;1.0;-0.39892;0.15115;0.0083083;V180M;ENST00000357392
CCRL2;ENSG00000121797;23106-0.0;Impedance of whole body;rs6441977;A;1.0;-0.39892;0.15115;0.0083083;V168M;ENST00000399036
CCRL2;ENSG00000121797;23106-0.0;Impedance of whole body;rs6441977;A;1.0;-0.39892;0.15115;0.0083083;V168M;ENST00000400880
CCRL2;ENSG00000121797;23106-0.0;Impedance of whole body;rs6441977;A;1.0;-0.39892;0.15115;0.0083083;V168M;ENST00000400882
CCRL2;ENSG00000121797;23106-0.0;Impedance of whole body;rs6441977;A;1.0;-0.39892;0.15115;0.0083083;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1750;measles / morbillivirus;rs3204850;G;1.0;-0.00067094;0.00021351;0.0016757000000000002;I255V;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1750;measles / morbillivirus;rs3204850;G;1.0;-0.00067094;0.00021351;0.0016757000000000002;I243V;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1750;measles / morbillivirus;rs3204850;G;1.0;-0.00067094;0.00021351;0.0016757000000000002;I243V;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1750;measles / morbillivirus;rs3204850;G;1.0;-0.00067094;0.00021351;0.0016757000000000002;I243V;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1503;clotting disorder/excessive bleeding;rs11574441;A;1.0;0.0048426;0.0018394000000000001;0.008471700000000002;R5H;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_L80-L99;L80-L99 Other disorders of the skin and subcutaneous tissue;rs6441977;A;1.0;-0.0014290999999999998;0.00055332;0.0097991;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_L80-L99;L80-L99 Other disorders of the skin and subcutaneous tissue;rs6441977;A;1.0;-0.0014290999999999998;0.00055332;0.0097991;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_L80-L99;L80-L99 Other disorders of the skin and subcutaneous tissue;rs6441977;A;1.0;-0.0014290999999999998;0.00055332;0.0097991;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_L80-L99;L80-L99 Other disorders of the skin and subcutaneous tissue;rs6441977;A;1.0;-0.0014290999999999998;0.00055332;0.0097991;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_L80-L99;L80-L99 Other disorders of the skin and subcutaneous tissue;rs6441977;A;1.0;-0.0014290999999999998;0.00055332;0.0097991;V168M;ENST00000433848
CCRL2;ENSG00000121797;30300-0.0;High light scatter reticulocyte count;rs3204849;A;0.996653;-0.00013784;1.6306e-05;2.8503000000000003e-17;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30300-0.0;High light scatter reticulocyte count;rs3204849;A;0.996653;-0.00013784;1.6306e-05;2.8503000000000003e-17;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30300-0.0;High light scatter reticulocyte count;rs3204849;A;0.996653;-0.00013784;1.6306e-05;2.8503000000000003e-17;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30300-0.0;High light scatter reticulocyte count;rs3204849;A;0.996653;-0.00013784;1.6306e-05;2.8503000000000003e-17;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30300-0.0;High light scatter reticulocyte count;rs3204849;A;0.996653;-0.00013784;1.6306e-05;2.8503000000000003e-17;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30300-0.0;High light scatter reticulocyte count;rs6441977;A;1.0;0.00020155;2.1876e-05;3.1671e-20;V180M;ENST00000357392
CCRL2;ENSG00000121797;30300-0.0;High light scatter reticulocyte count;rs6441977;A;1.0;0.00020155;2.1876e-05;3.1671e-20;V168M;ENST00000399036
CCRL2;ENSG00000121797;30300-0.0;High light scatter reticulocyte count;rs6441977;A;1.0;0.00020155;2.1876e-05;3.1671e-20;V168M;ENST00000400880
CCRL2;ENSG00000121797;30300-0.0;High light scatter reticulocyte count;rs6441977;A;1.0;0.00020155;2.1876e-05;3.1671e-20;V168M;ENST00000400882
CCRL2;ENSG00000121797;30300-0.0;High light scatter reticulocyte count;rs6441977;A;1.0;0.00020155;2.1876e-05;3.1671e-20;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs142950457;T;0.949018;0.04005;0.015196000000000001;0.008398200000000001;L73F;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs142950457;T;0.949018;0.04005;0.015196000000000001;0.008398200000000001;L61F;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs142950457;T;0.949018;0.04005;0.015196000000000001;0.008398200000000001;L61F;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs142950457;T;0.949018;0.04005;0.015196000000000001;0.008398200000000001;L61F;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs142950457;T;0.949018;0.04005;0.015196000000000001;0.008398200000000001;L61F;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1597;back pain;rs3204850;G;1.0;0.00071215;0.00026963;0.0082605;I255V;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1597;back pain;rs3204850;G;1.0;0.00071215;0.00026963;0.0082605;I243V;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1597;back pain;rs3204850;G;1.0;0.00071215;0.00026963;0.0082605;I243V;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1597;back pain;rs3204850;G;1.0;0.00071215;0.00026963;0.0082605;I243V;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_M06;M06 Other rheumatoid arthritis;rs6441977;A;1.0;-0.00076455;0.00029064;0.0085246;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_M06;M06 Other rheumatoid arthritis;rs6441977;A;1.0;-0.00076455;0.00029064;0.0085246;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_M06;M06 Other rheumatoid arthritis;rs6441977;A;1.0;-0.00076455;0.00029064;0.0085246;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_M06;M06 Other rheumatoid arthritis;rs6441977;A;1.0;-0.00076455;0.00029064;0.0085246;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_M06;M06 Other rheumatoid arthritis;rs6441977;A;1.0;-0.00076455;0.00029064;0.0085246;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_K35-K38;K35-K38 Diseases of appendix;rs3204849;A;0.996653;0.00077138;0.00019898;0.00010593;F179Y;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_K35-K38;K35-K38 Diseases of appendix;rs3204849;A;0.996653;0.00077138;0.00019898;0.00010593;F167Y;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_K35-K38;K35-K38 Diseases of appendix;rs3204849;A;0.996653;0.00077138;0.00019898;0.00010593;F167Y;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_K35-K38;K35-K38 Diseases of appendix;rs3204849;A;0.996653;0.00077138;0.00019898;0.00010593;F167Y;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_K35-K38;K35-K38 Diseases of appendix;rs3204849;A;0.996653;0.00077138;0.00019898;0.00010593;F167Y;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1081;hypertension;rs6441977;A;1.0;0.0037586;0.0011023;0.00065;V180M;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1081;hypertension;rs6441977;A;1.0;0.0037586;0.0011023;0.00065;V168M;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1081;hypertension;rs6441977;A;1.0;0.0037586;0.0011023;0.00065;V168M;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1081;hypertension;rs6441977;A;1.0;0.0037586;0.0011023;0.00065;V168M;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1081;hypertension;rs6441977;A;1.0;0.0037586;0.0011023;0.00065;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1266;neurological injury/trauma;rs6441977;A;1.0;-0.00059574;0.00021369;0.0053045;V180M;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1266;neurological injury/trauma;rs6441977;A;1.0;-0.00059574;0.00021369;0.0053045;V168M;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1266;neurological injury/trauma;rs6441977;A;1.0;-0.00059574;0.00021369;0.0053045;V168M;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1266;neurological injury/trauma;rs6441977;A;1.0;-0.00059574;0.00021369;0.0053045;V168M;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1266;neurological injury/trauma;rs6441977;A;1.0;-0.00059574;0.00021369;0.0053045;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1091;angina;rs6441977;A;1.0;0.0013349;0.00048829;0.006261600000000001;V180M;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1091;angina;rs6441977;A;1.0;0.0013349;0.00048829;0.006261600000000001;V168M;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1091;angina;rs6441977;A;1.0;0.0013349;0.00048829;0.006261600000000001;V168M;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1091;angina;rs6441977;A;1.0;0.0013349;0.00048829;0.006261600000000001;V168M;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1091;angina;rs6441977;A;1.0;0.0013349;0.00048829;0.006261600000000001;V168M;ENST00000433848
CCRL2;ENSG00000121797;30260-0.0;Mean reticulocyte volume;rs6441977;A;1.0;-0.11395999999999999;0.017911;1.9868e-10;V180M;ENST00000357392
CCRL2;ENSG00000121797;30260-0.0;Mean reticulocyte volume;rs6441977;A;1.0;-0.11395999999999999;0.017911;1.9868e-10;V168M;ENST00000399036
CCRL2;ENSG00000121797;30260-0.0;Mean reticulocyte volume;rs6441977;A;1.0;-0.11395999999999999;0.017911;1.9868e-10;V168M;ENST00000400880
CCRL2;ENSG00000121797;30260-0.0;Mean reticulocyte volume;rs6441977;A;1.0;-0.11395999999999999;0.017911;1.9868e-10;V168M;ENST00000400882
CCRL2;ENSG00000121797;30260-0.0;Mean reticulocyte volume;rs6441977;A;1.0;-0.11395999999999999;0.017911;1.9868e-10;V168M;ENST00000433848
CCRL2;ENSG00000121797;30000-0.0;White blood cell (leukocyte) count;rs3204849;A;0.996653;-0.016184999999999998;0.0031771;3.5028e-07;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30000-0.0;White blood cell (leukocyte) count;rs3204849;A;0.996653;-0.016184999999999998;0.0031771;3.5028e-07;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30000-0.0;White blood cell (leukocyte) count;rs3204849;A;0.996653;-0.016184999999999998;0.0031771;3.5028e-07;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30000-0.0;White blood cell (leukocyte) count;rs3204849;A;0.996653;-0.016184999999999998;0.0031771;3.5028e-07;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30000-0.0;White blood cell (leukocyte) count;rs3204849;A;0.996653;-0.016184999999999998;0.0031771;3.5028e-07;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30000-0.0;White blood cell (leukocyte) count;rs6441977;A;1.0;0.021962;0.0042623;2.5696e-07;V180M;ENST00000357392
CCRL2;ENSG00000121797;30000-0.0;White blood cell (leukocyte) count;rs6441977;A;1.0;0.021962;0.0042623;2.5696e-07;V168M;ENST00000399036
CCRL2;ENSG00000121797;30000-0.0;White blood cell (leukocyte) count;rs6441977;A;1.0;0.021962;0.0042623;2.5696e-07;V168M;ENST00000400880
CCRL2;ENSG00000121797;30000-0.0;White blood cell (leukocyte) count;rs6441977;A;1.0;0.021962;0.0042623;2.5696e-07;V168M;ENST00000400882
CCRL2;ENSG00000121797;30000-0.0;White blood cell (leukocyte) count;rs6441977;A;1.0;0.021962;0.0042623;2.5696e-07;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs11574443;G;1.0;-0.00085272;0.00030232;0.0047946;Y16C;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs11574443;G;1.0;-0.00085272;0.00030232;0.0047946;Y4C;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs11574443;G;1.0;-0.00085272;0.00030232;0.0047946;Y4C;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs11574443;G;1.0;-0.00085272;0.00030232;0.0047946;Y4C;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs11574443;G;1.0;-0.00085272;0.00030232;0.0047946;Y4C;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_B15-B19;B15-B19 Viral hepatitis;rs3204850;G;1.0;-0.00036321;0.00013843;0.0086939;I255V;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_B15-B19;B15-B19 Viral hepatitis;rs3204850;G;1.0;-0.00036321;0.00013843;0.0086939;I243V;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_B15-B19;B15-B19 Viral hepatitis;rs3204850;G;1.0;-0.00036321;0.00013843;0.0086939;I243V;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_B15-B19;B15-B19 Viral hepatitis;rs3204850;G;1.0;-0.00036321;0.00013843;0.0086939;I243V;ENST00000400882
CCRL2;ENSG00000121797;20015-0.0;Sitting height;rs3204849;A;0.996653;0.01712;0.005767100000000001;0.0029918;F179Y;ENST00000357392
CCRL2;ENSG00000121797;20015-0.0;Sitting height;rs3204849;A;0.996653;0.01712;0.005767100000000001;0.0029918;F167Y;ENST00000399036
CCRL2;ENSG00000121797;20015-0.0;Sitting height;rs3204849;A;0.996653;0.01712;0.005767100000000001;0.0029918;F167Y;ENST00000400880
CCRL2;ENSG00000121797;20015-0.0;Sitting height;rs3204849;A;0.996653;0.01712;0.005767100000000001;0.0029918;F167Y;ENST00000400882
CCRL2;ENSG00000121797;20015-0.0;Sitting height;rs3204849;A;0.996653;0.01712;0.005767100000000001;0.0029918;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs111863112;A;1.0;-0.054012;0.014704;0.00023941;G110E;ENST00000357392
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs111863112;A;1.0;-0.054012;0.014704;0.00023941;G98E;ENST00000399036
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs111863112;A;1.0;-0.054012;0.014704;0.00023941;G98E;ENST00000400880
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs111863112;A;1.0;-0.054012;0.014704;0.00023941;G98E;ENST00000400882
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs111863112;A;1.0;-0.054012;0.014704;0.00023941;G98E;ENST00000433848
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs3204849;A;0.996653;0.040538;0.0038674;1.0514000000000002e-25;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs3204849;A;0.996653;0.040538;0.0038674;1.0514000000000002e-25;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs3204849;A;0.996653;0.040538;0.0038674;1.0514000000000002e-25;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs3204849;A;0.996653;0.040538;0.0038674;1.0514000000000002e-25;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs3204849;A;0.996653;0.040538;0.0038674;1.0514000000000002e-25;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs3204850;G;1.0;-0.078311;0.0066871000000000005;1.1342e-31;I255V;ENST00000357392
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs3204850;G;1.0;-0.078311;0.0066871000000000005;1.1342e-31;I243V;ENST00000399036
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs3204850;G;1.0;-0.078311;0.0066871000000000005;1.1342e-31;I243V;ENST00000400880
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs3204850;G;1.0;-0.078311;0.0066871000000000005;1.1342e-31;I243V;ENST00000400882
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs6441977;A;1.0;-0.024380000000000002;0.0051889;2.6205e-06;V180M;ENST00000357392
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs6441977;A;1.0;-0.024380000000000002;0.0051889;2.6205e-06;V168M;ENST00000399036
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs6441977;A;1.0;-0.024380000000000002;0.0051889;2.6205e-06;V168M;ENST00000400880
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs6441977;A;1.0;-0.024380000000000002;0.0051889;2.6205e-06;V168M;ENST00000400882
CCRL2;ENSG00000121797;30190-0.0;Monocyte percentage;rs6441977;A;1.0;-0.024380000000000002;0.0051889;2.6205e-06;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_K21;K21 Gastro-oesophageal reflux disease;rs11574443;G;1.0;-0.004553100000000001;0.0015294;0.0029108;Y16C;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_K21;K21 Gastro-oesophageal reflux disease;rs11574443;G;1.0;-0.004553100000000001;0.0015294;0.0029108;Y4C;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_K21;K21 Gastro-oesophageal reflux disease;rs11574443;G;1.0;-0.004553100000000001;0.0015294;0.0029108;Y4C;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_K21;K21 Gastro-oesophageal reflux disease;rs11574443;G;1.0;-0.004553100000000001;0.0015294;0.0029108;Y4C;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_K21;K21 Gastro-oesophageal reflux disease;rs11574443;G;1.0;-0.004553100000000001;0.0015294;0.0029108;Y4C;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1131;chronic obstructive airways disease/copd;rs11574441;A;1.0;0.0070732;0.0024427;0.0037834;R5H;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_L00-L08;L00-L08 Infections of the skin and subcutaneous tissue;rs6441977;A;1.0;0.0012269;0.00045265;0.006719499999999999;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_L00-L08;L00-L08 Infections of the skin and subcutaneous tissue;rs6441977;A;1.0;0.0012269;0.00045265;0.006719499999999999;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_L00-L08;L00-L08 Infections of the skin and subcutaneous tissue;rs6441977;A;1.0;0.0012269;0.00045265;0.006719499999999999;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_L00-L08;L00-L08 Infections of the skin and subcutaneous tissue;rs6441977;A;1.0;0.0012269;0.00045265;0.006719499999999999;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_L00-L08;L00-L08 Infections of the skin and subcutaneous tissue;rs6441977;A;1.0;0.0012269;0.00045265;0.006719499999999999;V168M;ENST00000433848
CCRL2;ENSG00000121797;23110-0.0;Impedance of arm (left);rs11574443;G;1.0;0.64107;0.21118;0.0024005;Y16C;ENST00000357392
CCRL2;ENSG00000121797;23110-0.0;Impedance of arm (left);rs11574443;G;1.0;0.64107;0.21118;0.0024005;Y4C;ENST00000399036
CCRL2;ENSG00000121797;23110-0.0;Impedance of arm (left);rs11574443;G;1.0;0.64107;0.21118;0.0024005;Y4C;ENST00000400880
CCRL2;ENSG00000121797;23110-0.0;Impedance of arm (left);rs11574443;G;1.0;0.64107;0.21118;0.0024005;Y4C;ENST00000400882
CCRL2;ENSG00000121797;23110-0.0;Impedance of arm (left);rs11574443;G;1.0;0.64107;0.21118;0.0024005;Y4C;ENST00000433848
CCRL2;ENSG00000121797;23110-0.0;Impedance of arm (left);rs6441977;A;1.0;-0.30032;0.08984500000000001;0.00082999;V180M;ENST00000357392
CCRL2;ENSG00000121797;23110-0.0;Impedance of arm (left);rs6441977;A;1.0;-0.30032;0.08984500000000001;0.00082999;V168M;ENST00000399036
CCRL2;ENSG00000121797;23110-0.0;Impedance of arm (left);rs6441977;A;1.0;-0.30032;0.08984500000000001;0.00082999;V168M;ENST00000400880
CCRL2;ENSG00000121797;23110-0.0;Impedance of arm (left);rs6441977;A;1.0;-0.30032;0.08984500000000001;0.00082999;V168M;ENST00000400882
CCRL2;ENSG00000121797;23110-0.0;Impedance of arm (left);rs6441977;A;1.0;-0.30032;0.08984500000000001;0.00082999;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1160;oesophagitis/barretts oesophagus;rs3204850;G;1.0;0.00069395;0.00020577;0.00074502;I255V;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1160;oesophagitis/barretts oesophagus;rs3204850;G;1.0;0.00069395;0.00020577;0.00074502;I243V;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1160;oesophagitis/barretts oesophagus;rs3204850;G;1.0;0.00069395;0.00020577;0.00074502;I243V;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1160;oesophagitis/barretts oesophagus;rs3204850;G;1.0;0.00069395;0.00020577;0.00074502;I243V;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_M23;M23 Internal derangement of knee;rs3204849;A;0.996653;-0.0010783;0.00039868;0.006839100000000001;F179Y;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_M23;M23 Internal derangement of knee;rs3204849;A;0.996653;-0.0010783;0.00039868;0.006839100000000001;F167Y;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_M23;M23 Internal derangement of knee;rs3204849;A;0.996653;-0.0010783;0.00039868;0.006839100000000001;F167Y;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_M23;M23 Internal derangement of knee;rs3204849;A;0.996653;-0.0010783;0.00039868;0.006839100000000001;F167Y;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_M23;M23 Internal derangement of knee;rs3204849;A;0.996653;-0.0010783;0.00039868;0.006839100000000001;F167Y;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_L97;L97 Ulcer of lower limb, not elsewhere classified;rs6441977;A;1.0;0.00044262;0.00014521;0.0023019000000000004;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_L97;L97 Ulcer of lower limb, not elsewhere classified;rs6441977;A;1.0;0.00044262;0.00014521;0.0023019000000000004;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_L97;L97 Ulcer of lower limb, not elsewhere classified;rs6441977;A;1.0;0.00044262;0.00014521;0.0023019000000000004;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_L97;L97 Ulcer of lower limb, not elsewhere classified;rs6441977;A;1.0;0.00044262;0.00014521;0.0023019000000000004;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_L97;L97 Ulcer of lower limb, not elsewhere classified;rs6441977;A;1.0;0.00044262;0.00014521;0.0023019000000000004;V168M;ENST00000433848
CCRL2;ENSG00000121797;30270-0.0;Mean sphered cell volume;rs3204850;G;1.0;0.043904;0.015123;0.0036939;I255V;ENST00000357392
CCRL2;ENSG00000121797;30270-0.0;Mean sphered cell volume;rs3204850;G;1.0;0.043904;0.015123;0.0036939;I243V;ENST00000399036
CCRL2;ENSG00000121797;30270-0.0;Mean sphered cell volume;rs3204850;G;1.0;0.043904;0.015123;0.0036939;I243V;ENST00000400880
CCRL2;ENSG00000121797;30270-0.0;Mean sphered cell volume;rs3204850;G;1.0;0.043904;0.015123;0.0036939;I243V;ENST00000400882
CCRL2;ENSG00000121797;30270-0.0;Mean sphered cell volume;rs6441977;A;1.0;-0.056001;0.011733;1.815e-06;V180M;ENST00000357392
CCRL2;ENSG00000121797;30270-0.0;Mean sphered cell volume;rs6441977;A;1.0;-0.056001;0.011733;1.815e-06;V168M;ENST00000399036
CCRL2;ENSG00000121797;30270-0.0;Mean sphered cell volume;rs6441977;A;1.0;-0.056001;0.011733;1.815e-06;V168M;ENST00000400880
CCRL2;ENSG00000121797;30270-0.0;Mean sphered cell volume;rs6441977;A;1.0;-0.056001;0.011733;1.815e-06;V168M;ENST00000400882
CCRL2;ENSG00000121797;30270-0.0;Mean sphered cell volume;rs6441977;A;1.0;-0.056001;0.011733;1.815e-06;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_F10;F10 Mental and behavioural disorders due to use of alcohol;rs11574441;A;1.0;0.013803;0.0046356;0.0029058000000000005;R5H;ENST00000357392
CCRL2;ENSG00000121797;30150-0.0;Eosinophill count;rs11574443;G;1.0;0.0022864;0.00072595;0.0016355;Y16C;ENST00000357392
CCRL2;ENSG00000121797;30150-0.0;Eosinophill count;rs11574443;G;1.0;0.0022864;0.00072595;0.0016355;Y4C;ENST00000399036
CCRL2;ENSG00000121797;30150-0.0;Eosinophill count;rs11574443;G;1.0;0.0022864;0.00072595;0.0016355;Y4C;ENST00000400880
CCRL2;ENSG00000121797;30150-0.0;Eosinophill count;rs11574443;G;1.0;0.0022864;0.00072595;0.0016355;Y4C;ENST00000400882
CCRL2;ENSG00000121797;30150-0.0;Eosinophill count;rs11574443;G;1.0;0.0022864;0.00072595;0.0016355;Y4C;ENST00000433848
CCRL2;ENSG00000121797;30150-0.0;Eosinophill count;rs143567349;A;1.0;0.017971;0.0057806;0.0018784000000000003;D35N;ENST00000357392
CCRL2;ENSG00000121797;30150-0.0;Eosinophill count;rs143567349;A;1.0;0.017971;0.0057806;0.0018784000000000003;D23N;ENST00000399036
CCRL2;ENSG00000121797;30150-0.0;Eosinophill count;rs143567349;A;1.0;0.017971;0.0057806;0.0018784000000000003;D23N;ENST00000400880
CCRL2;ENSG00000121797;30150-0.0;Eosinophill count;rs143567349;A;1.0;0.017971;0.0057806;0.0018784000000000003;D23N;ENST00000400882
CCRL2;ENSG00000121797;30150-0.0;Eosinophill count;rs143567349;A;1.0;0.017971;0.0057806;0.0018784000000000003;D23N;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_I25;I25 Chronic ischaemic heart disease;rs6441977;A;1.0;0.0024739999999999996;0.00065265;0.00015023;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_I25;I25 Chronic ischaemic heart disease;rs6441977;A;1.0;0.0024739999999999996;0.00065265;0.00015023;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_I25;I25 Chronic ischaemic heart disease;rs6441977;A;1.0;0.0024739999999999996;0.00065265;0.00015023;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_I25;I25 Chronic ischaemic heart disease;rs6441977;A;1.0;0.0024739999999999996;0.00065265;0.00015023;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_I25;I25 Chronic ischaemic heart disease;rs6441977;A;1.0;0.0024739999999999996;0.00065265;0.00015023;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_H11;H11 Other disorders of conjunctiva;rs143567349;A;1.0;0.0070235;0.0023071;0.0023318;D35N;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_H11;H11 Other disorders of conjunctiva;rs143567349;A;1.0;0.0070235;0.0023071;0.0023318;D23N;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_H11;H11 Other disorders of conjunctiva;rs143567349;A;1.0;0.0070235;0.0023071;0.0023318;D23N;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_H11;H11 Other disorders of conjunctiva;rs143567349;A;1.0;0.0070235;0.0023071;0.0023318;D23N;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_H11;H11 Other disorders of conjunctiva;rs143567349;A;1.0;0.0070235;0.0023071;0.0023318;D23N;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_I34;I34 Nonrheumatic mitral valve disorders;rs142950457;T;0.949018;0.019115;0.0067396;0.0045646;L73F;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_I34;I34 Nonrheumatic mitral valve disorders;rs142950457;T;0.949018;0.019115;0.0067396;0.0045646;L61F;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_I34;I34 Nonrheumatic mitral valve disorders;rs142950457;T;0.949018;0.019115;0.0067396;0.0045646;L61F;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_I34;I34 Nonrheumatic mitral valve disorders;rs142950457;T;0.949018;0.019115;0.0067396;0.0045646;L61F;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_I34;I34 Nonrheumatic mitral valve disorders;rs142950457;T;0.949018;0.019115;0.0067396;0.0045646;L61F;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_L02;L02 Cutaneous abscess, furuncle and carbuncle;rs11574441;A;1.0;0.013179;0.0031063;2.2089e-05;R5H;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_L02;L02 Cutaneous abscess, furuncle and carbuncle;rs142950457;T;0.949018;0.042809;0.006737100000000001;2.0968999999999998e-10;L73F;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_L02;L02 Cutaneous abscess, furuncle and carbuncle;rs142950457;T;0.949018;0.042809;0.006737100000000001;2.0968999999999998e-10;L61F;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_L02;L02 Cutaneous abscess, furuncle and carbuncle;rs142950457;T;0.949018;0.042809;0.006737100000000001;2.0968999999999998e-10;L61F;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_L02;L02 Cutaneous abscess, furuncle and carbuncle;rs142950457;T;0.949018;0.042809;0.006737100000000001;2.0968999999999998e-10;L61F;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_L02;L02 Cutaneous abscess, furuncle and carbuncle;rs142950457;T;0.949018;0.042809;0.006737100000000001;2.0968999999999998e-10;L61F;ENST00000433848
CCRL2;ENSG00000121797;48-0.0;Waist circumference;rs6441977;A;1.0;0.084236;0.02875;0.0033909;V180M;ENST00000357392
CCRL2;ENSG00000121797;48-0.0;Waist circumference;rs6441977;A;1.0;0.084236;0.02875;0.0033909;V168M;ENST00000399036
CCRL2;ENSG00000121797;48-0.0;Waist circumference;rs6441977;A;1.0;0.084236;0.02875;0.0033909;V168M;ENST00000400880
CCRL2;ENSG00000121797;48-0.0;Waist circumference;rs6441977;A;1.0;0.084236;0.02875;0.0033909;V168M;ENST00000400882
CCRL2;ENSG00000121797;48-0.0;Waist circumference;rs6441977;A;1.0;0.084236;0.02875;0.0033909;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1132;emphysema/chronic bronchitis;rs11574443;G;1.0;-0.0026594;0.00097625;0.0064486000000000005;Y16C;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1132;emphysema/chronic bronchitis;rs11574443;G;1.0;-0.0026594;0.00097625;0.0064486000000000005;Y4C;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1132;emphysema/chronic bronchitis;rs11574443;G;1.0;-0.0026594;0.00097625;0.0064486000000000005;Y4C;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1132;emphysema/chronic bronchitis;rs11574443;G;1.0;-0.0026594;0.00097625;0.0064486000000000005;Y4C;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1132;emphysema/chronic bronchitis;rs11574443;G;1.0;-0.0026594;0.00097625;0.0064486000000000005;Y4C;ENST00000433848
CCRL2;ENSG00000121797;23109-0.0;Impedance of arm (right);rs11574443;G;1.0;0.5342;0.20329;0.0085945;Y16C;ENST00000357392
CCRL2;ENSG00000121797;23109-0.0;Impedance of arm (right);rs11574443;G;1.0;0.5342;0.20329;0.0085945;Y4C;ENST00000399036
CCRL2;ENSG00000121797;23109-0.0;Impedance of arm (right);rs11574443;G;1.0;0.5342;0.20329;0.0085945;Y4C;ENST00000400880
CCRL2;ENSG00000121797;23109-0.0;Impedance of arm (right);rs11574443;G;1.0;0.5342;0.20329;0.0085945;Y4C;ENST00000400882
CCRL2;ENSG00000121797;23109-0.0;Impedance of arm (right);rs11574443;G;1.0;0.5342;0.20329;0.0085945;Y4C;ENST00000433848
CCRL2;ENSG00000121797;23109-0.0;Impedance of arm (right);rs6441977;A;1.0;-0.26258000000000004;0.086487;0.0023968;V180M;ENST00000357392
CCRL2;ENSG00000121797;23109-0.0;Impedance of arm (right);rs6441977;A;1.0;-0.26258000000000004;0.086487;0.0023968;V168M;ENST00000399036
CCRL2;ENSG00000121797;23109-0.0;Impedance of arm (right);rs6441977;A;1.0;-0.26258000000000004;0.086487;0.0023968;V168M;ENST00000400880
CCRL2;ENSG00000121797;23109-0.0;Impedance of arm (right);rs6441977;A;1.0;-0.26258000000000004;0.086487;0.0023968;V168M;ENST00000400882
CCRL2;ENSG00000121797;23109-0.0;Impedance of arm (right);rs6441977;A;1.0;-0.26258000000000004;0.086487;0.0023968;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_H54;H54 Blindness and low vision;rs3204850;G;1.0;0.00048962;0.00017030000000000002;0.0040392;I255V;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_H54;H54 Blindness and low vision;rs3204850;G;1.0;0.00048962;0.00017030000000000002;0.0040392;I243V;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_H54;H54 Blindness and low vision;rs3204850;G;1.0;0.00048962;0.00017030000000000002;0.0040392;I243V;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_H54;H54 Blindness and low vision;rs3204850;G;1.0;0.00048962;0.00017030000000000002;0.0040392;I243V;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_D70;D70 Agranulocytosis;rs3204850;G;1.0;-0.0008481;0.00032692;0.0094821;I255V;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_D70;D70 Agranulocytosis;rs3204850;G;1.0;-0.0008481;0.00032692;0.0094821;I243V;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_D70;D70 Agranulocytosis;rs3204850;G;1.0;-0.0008481;0.00032692;0.0094821;I243V;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_D70;D70 Agranulocytosis;rs3204850;G;1.0;-0.0008481;0.00032692;0.0094821;I243V;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs111863112;A;1.0;0.0011259;0.00040411;0.005335800000000001;G110E;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs111863112;A;1.0;0.0011259;0.00040411;0.005335800000000001;G98E;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs111863112;A;1.0;0.0011259;0.00040411;0.005335800000000001;G98E;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs111863112;A;1.0;0.0011259;0.00040411;0.005335800000000001;G98E;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs111863112;A;1.0;0.0011259;0.00040411;0.005335800000000001;G98E;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1604;carpal tunnel syndrome;rs143567349;A;1.0;0.0070978000000000005;0.0021696;0.0010698;D35N;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1604;carpal tunnel syndrome;rs143567349;A;1.0;0.0070978000000000005;0.0021696;0.0010698;D23N;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1604;carpal tunnel syndrome;rs143567349;A;1.0;0.0070978000000000005;0.0021696;0.0010698;D23N;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1604;carpal tunnel syndrome;rs143567349;A;1.0;0.0070978000000000005;0.0021696;0.0010698;D23N;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1604;carpal tunnel syndrome;rs143567349;A;1.0;0.0070978000000000005;0.0021696;0.0010698;D23N;ENST00000433848
CCRL2;ENSG00000121797;1239-0.0;Current tobacco smoking;rs142950457;T;0.949018;0.14398;0.046874;0.0021295999999999997;L73F;ENST00000357392
CCRL2;ENSG00000121797;1239-0.0;Current tobacco smoking;rs142950457;T;0.949018;0.14398;0.046874;0.0021295999999999997;L61F;ENST00000399036
CCRL2;ENSG00000121797;1239-0.0;Current tobacco smoking;rs142950457;T;0.949018;0.14398;0.046874;0.0021295999999999997;L61F;ENST00000400880
CCRL2;ENSG00000121797;1239-0.0;Current tobacco smoking;rs142950457;T;0.949018;0.14398;0.046874;0.0021295999999999997;L61F;ENST00000400882
CCRL2;ENSG00000121797;1239-0.0;Current tobacco smoking;rs142950457;T;0.949018;0.14398;0.046874;0.0021295999999999997;L61F;ENST00000433848
CCRL2;ENSG00000121797;30140-0.0;Neutrophill count;rs3204849;A;0.996653;-0.010756;0.0025651;2.7521e-05;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30140-0.0;Neutrophill count;rs3204849;A;0.996653;-0.010756;0.0025651;2.7521e-05;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30140-0.0;Neutrophill count;rs3204849;A;0.996653;-0.010756;0.0025651;2.7521e-05;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30140-0.0;Neutrophill count;rs3204849;A;0.996653;-0.010756;0.0025651;2.7521e-05;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30140-0.0;Neutrophill count;rs3204849;A;0.996653;-0.010756;0.0025651;2.7521e-05;F167Y;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1752;varicella zoster virus;rs3204850;G;1.0;-0.00072525;0.00025116;0.0038814;I255V;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1752;varicella zoster virus;rs3204850;G;1.0;-0.00072525;0.00025116;0.0038814;I243V;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1752;varicella zoster virus;rs3204850;G;1.0;-0.00072525;0.00025116;0.0038814;I243V;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1752;varicella zoster virus;rs3204850;G;1.0;-0.00072525;0.00025116;0.0038814;I243V;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_I10;I10 Essential (primary) hypertension;rs6441977;A;1.0;0.0038325000000000004;0.0010062;0.00013965;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_I10;I10 Essential (primary) hypertension;rs6441977;A;1.0;0.0038325000000000004;0.0010062;0.00013965;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_I10;I10 Essential (primary) hypertension;rs6441977;A;1.0;0.0038325000000000004;0.0010062;0.00013965;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_I10;I10 Essential (primary) hypertension;rs6441977;A;1.0;0.0038325000000000004;0.0010062;0.00013965;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_I10;I10 Essential (primary) hypertension;rs6441977;A;1.0;0.0038325000000000004;0.0010062;0.00013965;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1545;chronic fatigue syndrome;rs143567349;A;1.0;0.010237000000000001;0.0035966;0.0044241;D35N;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1545;chronic fatigue syndrome;rs143567349;A;1.0;0.010237000000000001;0.0035966;0.0044241;D23N;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1545;chronic fatigue syndrome;rs143567349;A;1.0;0.010237000000000001;0.0035966;0.0044241;D23N;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1545;chronic fatigue syndrome;rs143567349;A;1.0;0.010237000000000001;0.0035966;0.0044241;D23N;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1545;chronic fatigue syndrome;rs143567349;A;1.0;0.010237000000000001;0.0035966;0.0044241;D23N;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1217;urinary tract infection/kidney infection;rs142950457;T;0.949018;0.01914;0.006756999999999999;0.0046177;L73F;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1217;urinary tract infection/kidney infection;rs142950457;T;0.949018;0.01914;0.006756999999999999;0.0046177;L61F;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1217;urinary tract infection/kidney infection;rs142950457;T;0.949018;0.01914;0.006756999999999999;0.0046177;L61F;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1217;urinary tract infection/kidney infection;rs142950457;T;0.949018;0.01914;0.006756999999999999;0.0046177;L61F;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1217;urinary tract infection/kidney infection;rs142950457;T;0.949018;0.01914;0.006756999999999999;0.0046177;L61F;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_M46;M46 Other inflammatory spondylopathies;rs3204849;A;0.996653;-0.00033608;0.00011873;0.0046454999999999995;F179Y;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_M46;M46 Other inflammatory spondylopathies;rs3204849;A;0.996653;-0.00033608;0.00011873;0.0046454999999999995;F167Y;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_M46;M46 Other inflammatory spondylopathies;rs3204849;A;0.996653;-0.00033608;0.00011873;0.0046454999999999995;F167Y;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_M46;M46 Other inflammatory spondylopathies;rs3204849;A;0.996653;-0.00033608;0.00011873;0.0046454999999999995;F167Y;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_M46;M46 Other inflammatory spondylopathies;rs3204849;A;0.996653;-0.00033608;0.00011873;0.0046454999999999995;F167Y;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1516;malabsorption/coeliac disease;rs3204850;G;1.0;0.0015075;0.00023905;2.8649e-10;I255V;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1516;malabsorption/coeliac disease;rs3204850;G;1.0;0.0015075;0.00023905;2.8649e-10;I243V;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1516;malabsorption/coeliac disease;rs3204850;G;1.0;0.0015075;0.00023905;2.8649e-10;I243V;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1516;malabsorption/coeliac disease;rs3204850;G;1.0;0.0015075;0.00023905;2.8649e-10;I243V;ENST00000400882
CCRL2;ENSG00000121797;30250-0.0;Reticulocyte count;rs3204849;A;0.996653;-0.00034007;4.488e-05;3.5315e-14;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30250-0.0;Reticulocyte count;rs3204849;A;0.996653;-0.00034007;4.488e-05;3.5315e-14;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30250-0.0;Reticulocyte count;rs3204849;A;0.996653;-0.00034007;4.488e-05;3.5315e-14;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30250-0.0;Reticulocyte count;rs3204849;A;0.996653;-0.00034007;4.488e-05;3.5315e-14;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30250-0.0;Reticulocyte count;rs3204849;A;0.996653;-0.00034007;4.488e-05;3.5315e-14;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30250-0.0;Reticulocyte count;rs6441977;A;1.0;0.00052744;6.0208000000000004e-05;1.9545e-18;V180M;ENST00000357392
CCRL2;ENSG00000121797;30250-0.0;Reticulocyte count;rs6441977;A;1.0;0.00052744;6.0208000000000004e-05;1.9545e-18;V168M;ENST00000399036
CCRL2;ENSG00000121797;30250-0.0;Reticulocyte count;rs6441977;A;1.0;0.00052744;6.0208000000000004e-05;1.9545e-18;V168M;ENST00000400880
CCRL2;ENSG00000121797;30250-0.0;Reticulocyte count;rs6441977;A;1.0;0.00052744;6.0208000000000004e-05;1.9545e-18;V168M;ENST00000400882
CCRL2;ENSG00000121797;30250-0.0;Reticulocyte count;rs6441977;A;1.0;0.00052744;6.0208000000000004e-05;1.9545e-18;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1352;ankylosing spondylitis;rs11574443;G;1.0;0.0012251;0.00035142;0.00049001;Y16C;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1352;ankylosing spondylitis;rs11574443;G;1.0;0.0012251;0.00035142;0.00049001;Y4C;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1352;ankylosing spondylitis;rs11574443;G;1.0;0.0012251;0.00035142;0.00049001;Y4C;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1352;ankylosing spondylitis;rs11574443;G;1.0;0.0012251;0.00035142;0.00049001;Y4C;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1352;ankylosing spondylitis;rs11574443;G;1.0;0.0012251;0.00035142;0.00049001;Y4C;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs6441977;A;1.0;-0.0013595;0.00052505;0.0096164;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs6441977;A;1.0;-0.0013595;0.00052505;0.0096164;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs6441977;A;1.0;-0.0013595;0.00052505;0.0096164;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs6441977;A;1.0;-0.0013595;0.00052505;0.0096164;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_N93;N93 Other abnormal uterine and vaginal bleeding;rs6441977;A;1.0;-0.0013595;0.00052505;0.0096164;V168M;ENST00000433848
CCRL2;ENSG00000121797;30040-0.0;Mean corpuscular volume;rs3204850;G;1.0;0.041958999999999996;0.012629999999999999;0.00089369;I255V;ENST00000357392
CCRL2;ENSG00000121797;30040-0.0;Mean corpuscular volume;rs3204850;G;1.0;0.041958999999999996;0.012629999999999999;0.00089369;I243V;ENST00000399036
CCRL2;ENSG00000121797;30040-0.0;Mean corpuscular volume;rs3204850;G;1.0;0.041958999999999996;0.012629999999999999;0.00089369;I243V;ENST00000400880
CCRL2;ENSG00000121797;30040-0.0;Mean corpuscular volume;rs3204850;G;1.0;0.041958999999999996;0.012629999999999999;0.00089369;I243V;ENST00000400882
CCRL2;ENSG00000121797;30040-0.0;Mean corpuscular volume;rs6441977;A;1.0;-0.033529;0.009799500000000001;0.00062284;V180M;ENST00000357392
CCRL2;ENSG00000121797;30040-0.0;Mean corpuscular volume;rs6441977;A;1.0;-0.033529;0.009799500000000001;0.00062284;V168M;ENST00000399036
CCRL2;ENSG00000121797;30040-0.0;Mean corpuscular volume;rs6441977;A;1.0;-0.033529;0.009799500000000001;0.00062284;V168M;ENST00000400880
CCRL2;ENSG00000121797;30040-0.0;Mean corpuscular volume;rs6441977;A;1.0;-0.033529;0.009799500000000001;0.00062284;V168M;ENST00000400882
CCRL2;ENSG00000121797;30040-0.0;Mean corpuscular volume;rs6441977;A;1.0;-0.033529;0.009799500000000001;0.00062284;V168M;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1270;infection of nervous system;rs142950457;T;0.949018;0.019389;0.0063857;0.0023951000000000003;L73F;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1270;infection of nervous system;rs142950457;T;0.949018;0.019389;0.0063857;0.0023951000000000003;L61F;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1270;infection of nervous system;rs142950457;T;0.949018;0.019389;0.0063857;0.0023951000000000003;L61F;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1270;infection of nervous system;rs142950457;T;0.949018;0.019389;0.0063857;0.0023951000000000003;L61F;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1270;infection of nervous system;rs142950457;T;0.949018;0.019389;0.0063857;0.0023951000000000003;L61F;ENST00000433848
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs111863112;A;1.0;-0.0032893;0.0011001;0.0027911;G110E;ENST00000357392
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs111863112;A;1.0;-0.0032893;0.0011001;0.0027911;G98E;ENST00000399036
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs111863112;A;1.0;-0.0032893;0.0011001;0.0027911;G98E;ENST00000400880
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs111863112;A;1.0;-0.0032893;0.0011001;0.0027911;G98E;ENST00000400882
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs111863112;A;1.0;-0.0032893;0.0011001;0.0027911;G98E;ENST00000433848
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs3204849;A;0.996653;0.0015895;0.00028938;3.9627e-08;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs3204849;A;0.996653;0.0015895;0.00028938;3.9627e-08;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs3204849;A;0.996653;0.0015895;0.00028938;3.9627e-08;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs3204849;A;0.996653;0.0015895;0.00028938;3.9627e-08;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs3204849;A;0.996653;0.0015895;0.00028938;3.9627e-08;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs3204850;G;1.0;-0.0054216;0.00050033;2.3434e-27;I255V;ENST00000357392
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs3204850;G;1.0;-0.0054216;0.00050033;2.3434e-27;I243V;ENST00000399036
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs3204850;G;1.0;-0.0054216;0.00050033;2.3434e-27;I243V;ENST00000400880
CCRL2;ENSG00000121797;30130-0.0;Monocyte count;rs3204850;G;1.0;-0.0054216;0.00050033;2.3434e-27;I243V;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1747;viral infection;rs3204850;G;1.0;-0.0009827;0.00032594;0.0025704;I255V;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1747;viral infection;rs3204850;G;1.0;-0.0009827;0.00032594;0.0025704;I243V;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1747;viral infection;rs3204850;G;1.0;-0.0009827;0.00032594;0.0025704;I243V;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1747;viral infection;rs3204850;G;1.0;-0.0009827;0.00032594;0.0025704;I243V;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_G51;G51 Facial nerve disorders;rs143567349;A;1.0;0.0067018;0.0024611999999999998;0.0064703;D35N;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_G51;G51 Facial nerve disorders;rs143567349;A;1.0;0.0067018;0.0024611999999999998;0.0064703;D23N;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_G51;G51 Facial nerve disorders;rs143567349;A;1.0;0.0067018;0.0024611999999999998;0.0064703;D23N;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_G51;G51 Facial nerve disorders;rs143567349;A;1.0;0.0067018;0.0024611999999999998;0.0064703;D23N;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_G51;G51 Facial nerve disorders;rs143567349;A;1.0;0.0067018;0.0024611999999999998;0.0064703;D23N;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1454;other renal/kidney problem;rs11574441;A;1.0;0.013597;0.0030485;8.1875e-06;R5H;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1454;other renal/kidney problem;rs142950457;T;0.949018;0.018823;0.006612000000000001;0.0044157;L73F;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1454;other renal/kidney problem;rs142950457;T;0.949018;0.018823;0.006612000000000001;0.0044157;L61F;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1454;other renal/kidney problem;rs142950457;T;0.949018;0.018823;0.006612000000000001;0.0044157;L61F;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1454;other renal/kidney problem;rs142950457;T;0.949018;0.018823;0.006612000000000001;0.0044157;L61F;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1454;other renal/kidney problem;rs142950457;T;0.949018;0.018823;0.006612000000000001;0.0044157;L61F;ENST00000433848
CCRL2;ENSG00000121797;23108-0.0;Impedance of leg (left);rs11574443;G;1.0;0.51484;0.17424;0.0031288;Y16C;ENST00000357392
CCRL2;ENSG00000121797;23108-0.0;Impedance of leg (left);rs11574443;G;1.0;0.51484;0.17424;0.0031288;Y4C;ENST00000399036
CCRL2;ENSG00000121797;23108-0.0;Impedance of leg (left);rs11574443;G;1.0;0.51484;0.17424;0.0031288;Y4C;ENST00000400880
CCRL2;ENSG00000121797;23108-0.0;Impedance of leg (left);rs11574443;G;1.0;0.51484;0.17424;0.0031288;Y4C;ENST00000400882
CCRL2;ENSG00000121797;23108-0.0;Impedance of leg (left);rs11574443;G;1.0;0.51484;0.17424;0.0031288;Y4C;ENST00000433848
CCRL2;ENSG00000121797;30170-0.0;Nucleated red blood cell count;rs6441977;A;1.0;0.0003097;9.1755e-05;0.00073729;V180M;ENST00000357392
CCRL2;ENSG00000121797;30170-0.0;Nucleated red blood cell count;rs6441977;A;1.0;0.0003097;9.1755e-05;0.00073729;V168M;ENST00000399036
CCRL2;ENSG00000121797;30170-0.0;Nucleated red blood cell count;rs6441977;A;1.0;0.0003097;9.1755e-05;0.00073729;V168M;ENST00000400880
CCRL2;ENSG00000121797;30170-0.0;Nucleated red blood cell count;rs6441977;A;1.0;0.0003097;9.1755e-05;0.00073729;V168M;ENST00000400882
CCRL2;ENSG00000121797;30170-0.0;Nucleated red blood cell count;rs6441977;A;1.0;0.0003097;9.1755e-05;0.00073729;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_O80;O80 Single spontaneous delivery;rs142950457;T;0.949018;0.03424;0.011835;0.0038152;L73F;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_O80;O80 Single spontaneous delivery;rs142950457;T;0.949018;0.03424;0.011835;0.0038152;L61F;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_O80;O80 Single spontaneous delivery;rs142950457;T;0.949018;0.03424;0.011835;0.0038152;L61F;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_O80;O80 Single spontaneous delivery;rs142950457;T;0.949018;0.03424;0.011835;0.0038152;L61F;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_O80;O80 Single spontaneous delivery;rs142950457;T;0.949018;0.03424;0.011835;0.0038152;L61F;ENST00000433848
CCRL2;ENSG00000121797;1707-0.0;Handedness (chirality/laterality);rs6441977;A;1.0;0.0022695;0.0008371;0.0067063;V180M;ENST00000357392
CCRL2;ENSG00000121797;1707-0.0;Handedness (chirality/laterality);rs6441977;A;1.0;0.0022695;0.0008371;0.0067063;V168M;ENST00000399036
CCRL2;ENSG00000121797;1707-0.0;Handedness (chirality/laterality);rs6441977;A;1.0;0.0022695;0.0008371;0.0067063;V168M;ENST00000400880
CCRL2;ENSG00000121797;1707-0.0;Handedness (chirality/laterality);rs6441977;A;1.0;0.0022695;0.0008371;0.0067063;V168M;ENST00000400882
CCRL2;ENSG00000121797;1707-0.0;Handedness (chirality/laterality);rs6441977;A;1.0;0.0022695;0.0008371;0.0067063;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_M45-M49;M45-M49 Spondylopathies;rs6441977;A;1.0;0.0018727;0.0004723;7.339e-05;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_M45-M49;M45-M49 Spondylopathies;rs6441977;A;1.0;0.0018727;0.0004723;7.339e-05;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_M45-M49;M45-M49 Spondylopathies;rs6441977;A;1.0;0.0018727;0.0004723;7.339e-05;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_M45-M49;M45-M49 Spondylopathies;rs6441977;A;1.0;0.0018727;0.0004723;7.339e-05;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_M45-M49;M45-M49 Spondylopathies;rs6441977;A;1.0;0.0018727;0.0004723;7.339e-05;V168M;ENST00000433848
CCRL2;ENSG00000121797;1697-0.0;Comparative height size at age 10;rs3204850;G;1.0;0.0062707;0.0020215999999999997;0.0019236000000000001;I255V;ENST00000357392
CCRL2;ENSG00000121797;1697-0.0;Comparative height size at age 10;rs3204850;G;1.0;0.0062707;0.0020215999999999997;0.0019236000000000001;I243V;ENST00000399036
CCRL2;ENSG00000121797;1697-0.0;Comparative height size at age 10;rs3204850;G;1.0;0.0062707;0.0020215999999999997;0.0019236000000000001;I243V;ENST00000400880
CCRL2;ENSG00000121797;1697-0.0;Comparative height size at age 10;rs3204850;G;1.0;0.0062707;0.0020215999999999997;0.0019236000000000001;I243V;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1348;osteoporosis;rs3204850;G;1.0;0.0012433;0.00046025;0.0069077;I255V;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1348;osteoporosis;rs3204850;G;1.0;0.0012433;0.00046025;0.0069077;I243V;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1348;osteoporosis;rs3204850;G;1.0;0.0012433;0.00046025;0.0069077;I243V;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1348;osteoporosis;rs3204850;G;1.0;0.0012433;0.00046025;0.0069077;I243V;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1417;allergy/hypersensitivity/anaphylaxis;rs143567349;A;1.0;0.039169999999999996;0.01375;0.0043903;D35N;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1417;allergy/hypersensitivity/anaphylaxis;rs143567349;A;1.0;0.039169999999999996;0.01375;0.0043903;D23N;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1417;allergy/hypersensitivity/anaphylaxis;rs143567349;A;1.0;0.039169999999999996;0.01375;0.0043903;D23N;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1417;allergy/hypersensitivity/anaphylaxis;rs143567349;A;1.0;0.039169999999999996;0.01375;0.0043903;D23N;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1417;allergy/hypersensitivity/anaphylaxis;rs143567349;A;1.0;0.039169999999999996;0.01375;0.0043903;D23N;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_G91;G91 Hydrocephalus;rs143567349;A;1.0;0.004739500000000001;0.0017797000000000002;0.007741199999999999;D35N;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_G91;G91 Hydrocephalus;rs143567349;A;1.0;0.004739500000000001;0.0017797000000000002;0.007741199999999999;D23N;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_G91;G91 Hydrocephalus;rs143567349;A;1.0;0.004739500000000001;0.0017797000000000002;0.007741199999999999;D23N;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_G91;G91 Hydrocephalus;rs143567349;A;1.0;0.004739500000000001;0.0017797000000000002;0.007741199999999999;D23N;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_G91;G91 Hydrocephalus;rs143567349;A;1.0;0.004739500000000001;0.0017797000000000002;0.007741199999999999;D23N;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_M35;M35 Other systemic involvement of connective tissue;rs11574441;A;1.0;0.0094556;0.0027945;0.00071543;R5H;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs111863112;A;1.0;-0.0014246999999999999;0.0004826000000000001;0.0031563000000000003;G110E;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs111863112;A;1.0;-0.0014246999999999999;0.0004826000000000001;0.0031563000000000003;G98E;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs111863112;A;1.0;-0.0014246999999999999;0.0004826000000000001;0.0031563000000000003;G98E;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs111863112;A;1.0;-0.0014246999999999999;0.0004826000000000001;0.0031563000000000003;G98E;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs111863112;A;1.0;-0.0014246999999999999;0.0004826000000000001;0.0031563000000000003;G98E;ENST00000433848
CCRL2;ENSG00000121797;30010-0.0;Red blood cell (erythrocyte) count;rs3204850;G;1.0;-0.0035957000000000003;0.0010402999999999999;0.00054738;I255V;ENST00000357392
CCRL2;ENSG00000121797;30010-0.0;Red blood cell (erythrocyte) count;rs3204850;G;1.0;-0.0035957000000000003;0.0010402999999999999;0.00054738;I243V;ENST00000399036
CCRL2;ENSG00000121797;30010-0.0;Red blood cell (erythrocyte) count;rs3204850;G;1.0;-0.0035957000000000003;0.0010402999999999999;0.00054738;I243V;ENST00000400880
CCRL2;ENSG00000121797;30010-0.0;Red blood cell (erythrocyte) count;rs3204850;G;1.0;-0.0035957000000000003;0.0010402999999999999;0.00054738;I243V;ENST00000400882
CCRL2;ENSG00000121797;30010-0.0;Red blood cell (erythrocyte) count;rs6441977;A;1.0;0.0030085;0.00080713;0.00019350000000000001;V180M;ENST00000357392
CCRL2;ENSG00000121797;30010-0.0;Red blood cell (erythrocyte) count;rs6441977;A;1.0;0.0030085;0.00080713;0.00019350000000000001;V168M;ENST00000399036
CCRL2;ENSG00000121797;30010-0.0;Red blood cell (erythrocyte) count;rs6441977;A;1.0;0.0030085;0.00080713;0.00019350000000000001;V168M;ENST00000400880
CCRL2;ENSG00000121797;30010-0.0;Red blood cell (erythrocyte) count;rs6441977;A;1.0;0.0030085;0.00080713;0.00019350000000000001;V168M;ENST00000400882
CCRL2;ENSG00000121797;30010-0.0;Red blood cell (erythrocyte) count;rs6441977;A;1.0;0.0030085;0.00080713;0.00019350000000000001;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_K90;K90 Intestinal malabsorption;rs3204850;G;1.0;0.0010465;0.00025953;5.5228999999999996e-05;I255V;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_K90;K90 Intestinal malabsorption;rs3204850;G;1.0;0.0010465;0.00025953;5.5228999999999996e-05;I243V;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_K90;K90 Intestinal malabsorption;rs3204850;G;1.0;0.0010465;0.00025953;5.5228999999999996e-05;I243V;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_K90;K90 Intestinal malabsorption;rs3204850;G;1.0;0.0010465;0.00025953;5.5228999999999996e-05;I243V;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_K90;K90 Intestinal malabsorption;rs6441977;A;1.0;-0.0006307;0.00020136;0.0017352999999999997;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_K90;K90 Intestinal malabsorption;rs6441977;A;1.0;-0.0006307;0.00020136;0.0017352999999999997;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_K90;K90 Intestinal malabsorption;rs6441977;A;1.0;-0.0006307;0.00020136;0.0017352999999999997;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_K90;K90 Intestinal malabsorption;rs6441977;A;1.0;-0.0006307;0.00020136;0.0017352999999999997;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_K90;K90 Intestinal malabsorption;rs6441977;A;1.0;-0.0006307;0.00020136;0.0017352999999999997;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_M47;M47 Spondylosis;rs6441977;A;1.0;0.0014088;0.00038347;0.00023893;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_M47;M47 Spondylosis;rs6441977;A;1.0;0.0014088;0.00038347;0.00023893;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_M47;M47 Spondylosis;rs6441977;A;1.0;0.0014088;0.00038347;0.00023893;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_M47;M47 Spondylosis;rs6441977;A;1.0;0.0014088;0.00038347;0.00023893;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_M47;M47 Spondylosis;rs6441977;A;1.0;0.0014088;0.00038347;0.00023893;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_G40;G40 Epilepsy;rs11574443;G;1.0;0.0022816;0.00063669;0.00033894;Y16C;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_G40;G40 Epilepsy;rs11574443;G;1.0;0.0022816;0.00063669;0.00033894;Y4C;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_G40;G40 Epilepsy;rs11574443;G;1.0;0.0022816;0.00063669;0.00033894;Y4C;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_G40;G40 Epilepsy;rs11574443;G;1.0;0.0022816;0.00063669;0.00033894;Y4C;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_G40;G40 Epilepsy;rs11574443;G;1.0;0.0022816;0.00063669;0.00033894;Y4C;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs11574443;G;1.0;-0.0077311;0.0029356;0.0084499;Y16C;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs11574443;G;1.0;-0.0077311;0.0029356;0.0084499;Y4C;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs11574443;G;1.0;-0.0077311;0.0029356;0.0084499;Y4C;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs11574443;G;1.0;-0.0077311;0.0029356;0.0084499;Y4C;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs11574443;G;1.0;-0.0077311;0.0029356;0.0084499;Y4C;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_K42;K42 Umbilical hernia;rs143567349;A;1.0;0.017093999999999998;0.005068199999999999;0.00074417;D35N;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_K42;K42 Umbilical hernia;rs143567349;A;1.0;0.017093999999999998;0.005068199999999999;0.00074417;D23N;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_K42;K42 Umbilical hernia;rs143567349;A;1.0;0.017093999999999998;0.005068199999999999;0.00074417;D23N;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_K42;K42 Umbilical hernia;rs143567349;A;1.0;0.017093999999999998;0.005068199999999999;0.00074417;D23N;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_K42;K42 Umbilical hernia;rs143567349;A;1.0;0.017093999999999998;0.005068199999999999;0.00074417;D23N;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1319;bone disorder;rs3204850;G;1.0;0.0014835999999999998;0.00053976;0.005984399999999999;I255V;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1319;bone disorder;rs3204850;G;1.0;0.0014835999999999998;0.00053976;0.005984399999999999;I243V;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1319;bone disorder;rs3204850;G;1.0;0.0014835999999999998;0.00053976;0.005984399999999999;I243V;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1319;bone disorder;rs3204850;G;1.0;0.0014835999999999998;0.00053976;0.005984399999999999;I243V;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1608;neck problem/injury;rs6441977;A;1.0;0.00069269;0.00025624;0.0068657;V180M;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1608;neck problem/injury;rs6441977;A;1.0;0.00069269;0.00025624;0.0068657;V168M;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1608;neck problem/injury;rs6441977;A;1.0;0.00069269;0.00025624;0.0068657;V168M;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1608;neck problem/injury;rs6441977;A;1.0;0.00069269;0.00025624;0.0068657;V168M;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1608;neck problem/injury;rs6441977;A;1.0;0.00069269;0.00025624;0.0068657;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_N43;N43 Hydrocele and spermatocele;rs111863112;A;1.0;0.0026309000000000003;0.0010145;0.009509;G110E;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_N43;N43 Hydrocele and spermatocele;rs111863112;A;1.0;0.0026309000000000003;0.0010145;0.009509;G98E;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_N43;N43 Hydrocele and spermatocele;rs111863112;A;1.0;0.0026309000000000003;0.0010145;0.009509;G98E;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_N43;N43 Hydrocele and spermatocele;rs111863112;A;1.0;0.0026309000000000003;0.0010145;0.009509;G98E;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_N43;N43 Hydrocele and spermatocele;rs111863112;A;1.0;0.0026309000000000003;0.0010145;0.009509;G98E;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_E10-E14;E10-E14 Diabetes mellitus;rs6441977;A;1.0;0.0015724;0.00058267;0.0069626;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_E10-E14;E10-E14 Diabetes mellitus;rs6441977;A;1.0;0.0015724;0.00058267;0.0069626;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_E10-E14;E10-E14 Diabetes mellitus;rs6441977;A;1.0;0.0015724;0.00058267;0.0069626;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_E10-E14;E10-E14 Diabetes mellitus;rs6441977;A;1.0;0.0015724;0.00058267;0.0069626;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_E10-E14;E10-E14 Diabetes mellitus;rs6441977;A;1.0;0.0015724;0.00058267;0.0069626;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_M17;M17 Gonarthrosis [arthrosis of knee];rs6441977;A;1.0;0.0021363000000000003;0.00060067;0.00037576;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_M17;M17 Gonarthrosis [arthrosis of knee];rs6441977;A;1.0;0.0021363000000000003;0.00060067;0.00037576;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_M17;M17 Gonarthrosis [arthrosis of knee];rs6441977;A;1.0;0.0021363000000000003;0.00060067;0.00037576;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_M17;M17 Gonarthrosis [arthrosis of knee];rs6441977;A;1.0;0.0021363000000000003;0.00060067;0.00037576;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_M17;M17 Gonarthrosis [arthrosis of knee];rs6441977;A;1.0;0.0021363000000000003;0.00060067;0.00037576;V168M;ENST00000433848
CCRL2;ENSG00000121797;23111-0.0;Leg fat percentage (right);rs143567349;A;1.0;-0.68202;0.24206;0.0048386;D35N;ENST00000357392
CCRL2;ENSG00000121797;23111-0.0;Leg fat percentage (right);rs143567349;A;1.0;-0.68202;0.24206;0.0048386;D23N;ENST00000399036
CCRL2;ENSG00000121797;23111-0.0;Leg fat percentage (right);rs143567349;A;1.0;-0.68202;0.24206;0.0048386;D23N;ENST00000400880
CCRL2;ENSG00000121797;23111-0.0;Leg fat percentage (right);rs143567349;A;1.0;-0.68202;0.24206;0.0048386;D23N;ENST00000400882
CCRL2;ENSG00000121797;23111-0.0;Leg fat percentage (right);rs143567349;A;1.0;-0.68202;0.24206;0.0048386;D23N;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_D70-D77;D70-D77 Other diseases of blood and blood-forming organs;rs3204850;G;1.0;-0.0011604;0.00039128;0.0030210999999999997;I255V;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_D70-D77;D70-D77 Other diseases of blood and blood-forming organs;rs3204850;G;1.0;-0.0011604;0.00039128;0.0030210999999999997;I243V;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_D70-D77;D70-D77 Other diseases of blood and blood-forming organs;rs3204850;G;1.0;-0.0011604;0.00039128;0.0030210999999999997;I243V;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_D70-D77;D70-D77 Other diseases of blood and blood-forming organs;rs3204850;G;1.0;-0.0011604;0.00039128;0.0030210999999999997;I243V;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1176;hepatitis;rs3204849;A;0.996653;0.00040837;0.00015109;0.0068763;F179Y;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1176;hepatitis;rs3204849;A;0.996653;0.00040837;0.00015109;0.0068763;F167Y;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1176;hepatitis;rs3204849;A;0.996653;0.00040837;0.00015109;0.0068763;F167Y;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1176;hepatitis;rs3204849;A;0.996653;0.00040837;0.00015109;0.0068763;F167Y;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1176;hepatitis;rs3204849;A;0.996653;0.00040837;0.00015109;0.0068763;F167Y;ENST00000433848
CCRL2;ENSG00000121797;30180-0.0;Lymphocyte percentage;rs6441977;A;1.0;0.14037;0.017869;3.988599999999999e-15;V180M;ENST00000357392
CCRL2;ENSG00000121797;30180-0.0;Lymphocyte percentage;rs6441977;A;1.0;0.14037;0.017869;3.988599999999999e-15;V168M;ENST00000399036
CCRL2;ENSG00000121797;30180-0.0;Lymphocyte percentage;rs6441977;A;1.0;0.14037;0.017869;3.988599999999999e-15;V168M;ENST00000400880
CCRL2;ENSG00000121797;30180-0.0;Lymphocyte percentage;rs6441977;A;1.0;0.14037;0.017869;3.988599999999999e-15;V168M;ENST00000400882
CCRL2;ENSG00000121797;30180-0.0;Lymphocyte percentage;rs6441977;A;1.0;0.14037;0.017869;3.988599999999999e-15;V168M;ENST00000433848
CCRL2;ENSG00000121797;30110-0.0;Platelet distribution width;rs3204849;A;0.996653;0.0028664000000000003;0.00087663;0.0010764000000000001;F179Y;ENST00000357392
CCRL2;ENSG00000121797;30110-0.0;Platelet distribution width;rs3204849;A;0.996653;0.0028664000000000003;0.00087663;0.0010764000000000001;F167Y;ENST00000399036
CCRL2;ENSG00000121797;30110-0.0;Platelet distribution width;rs3204849;A;0.996653;0.0028664000000000003;0.00087663;0.0010764000000000001;F167Y;ENST00000400880
CCRL2;ENSG00000121797;30110-0.0;Platelet distribution width;rs3204849;A;0.996653;0.0028664000000000003;0.00087663;0.0010764000000000001;F167Y;ENST00000400882
CCRL2;ENSG00000121797;30110-0.0;Platelet distribution width;rs3204849;A;0.996653;0.0028664000000000003;0.00087663;0.0010764000000000001;F167Y;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_I20-I25;I20-I25 Ischaemic heart diseases;rs11574443;G;1.0;-0.0048705;0.0016672999999999998;0.0034874000000000003;Y16C;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_I20-I25;I20-I25 Ischaemic heart diseases;rs11574443;G;1.0;-0.0048705;0.0016672999999999998;0.0034874000000000003;Y4C;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_I20-I25;I20-I25 Ischaemic heart diseases;rs11574443;G;1.0;-0.0048705;0.0016672999999999998;0.0034874000000000003;Y4C;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_I20-I25;I20-I25 Ischaemic heart diseases;rs11574443;G;1.0;-0.0048705;0.0016672999999999998;0.0034874000000000003;Y4C;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_I20-I25;I20-I25 Ischaemic heart diseases;rs11574443;G;1.0;-0.0048705;0.0016672999999999998;0.0034874000000000003;Y4C;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_Block_I20-I25;I20-I25 Ischaemic heart diseases;rs6441977;A;1.0;0.0023941999999999995;0.00070934;0.00073769;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_Block_I20-I25;I20-I25 Ischaemic heart diseases;rs6441977;A;1.0;0.0023941999999999995;0.00070934;0.00073769;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_Block_I20-I25;I20-I25 Ischaemic heart diseases;rs6441977;A;1.0;0.0023941999999999995;0.00070934;0.00073769;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_Block_I20-I25;I20-I25 Ischaemic heart diseases;rs6441977;A;1.0;0.0023941999999999995;0.00070934;0.00073769;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_Block_I20-I25;I20-I25 Ischaemic heart diseases;rs6441977;A;1.0;0.0023941999999999995;0.00070934;0.00073769;V168M;ENST00000433848
CCRL2;ENSG00000121797;30050-0.0;Mean corpuscular haemoglobin;rs3204850;G;1.0;0.017491999999999997;0.0051167;0.00062938;I255V;ENST00000357392
CCRL2;ENSG00000121797;30050-0.0;Mean corpuscular haemoglobin;rs3204850;G;1.0;0.017491999999999997;0.0051167;0.00062938;I243V;ENST00000399036
CCRL2;ENSG00000121797;30050-0.0;Mean corpuscular haemoglobin;rs3204850;G;1.0;0.017491999999999997;0.0051167;0.00062938;I243V;ENST00000400880
CCRL2;ENSG00000121797;30050-0.0;Mean corpuscular haemoglobin;rs3204850;G;1.0;0.017491999999999997;0.0051167;0.00062938;I243V;ENST00000400882
CCRL2;ENSG00000121797;30050-0.0;Mean corpuscular haemoglobin;rs6441977;A;1.0;-0.013072;0.0039699;0.0009919;V180M;ENST00000357392
CCRL2;ENSG00000121797;30050-0.0;Mean corpuscular haemoglobin;rs6441977;A;1.0;-0.013072;0.0039699;0.0009919;V168M;ENST00000399036
CCRL2;ENSG00000121797;30050-0.0;Mean corpuscular haemoglobin;rs6441977;A;1.0;-0.013072;0.0039699;0.0009919;V168M;ENST00000400880
CCRL2;ENSG00000121797;30050-0.0;Mean corpuscular haemoglobin;rs6441977;A;1.0;-0.013072;0.0039699;0.0009919;V168M;ENST00000400882
CCRL2;ENSG00000121797;30050-0.0;Mean corpuscular haemoglobin;rs6441977;A;1.0;-0.013072;0.0039699;0.0009919;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_N90;N90 Other noninflammatory disorders of vulva and perineum;rs11574441;A;1.0;0.014047;0.005172100000000001;0.0066078000000000005;R5H;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_I50;I50 Heart failure;rs6441977;A;1.0;0.00093596;0.00032433;0.0039037;V180M;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_I50;I50 Heart failure;rs6441977;A;1.0;0.00093596;0.00032433;0.0039037;V168M;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_I50;I50 Heart failure;rs6441977;A;1.0;0.00093596;0.00032433;0.0039037;V168M;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_I50;I50 Heart failure;rs6441977;A;1.0;0.00093596;0.00032433;0.0039037;V168M;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_I50;I50 Heart failure;rs6441977;A;1.0;0.00093596;0.00032433;0.0039037;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_B37;B37 Candidiasis;rs111863112;A;1.0;0.001698;0.00058803;0.0038823;G110E;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_B37;B37 Candidiasis;rs111863112;A;1.0;0.001698;0.00058803;0.0038823;G98E;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_B37;B37 Candidiasis;rs111863112;A;1.0;0.001698;0.00058803;0.0038823;G98E;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_B37;B37 Candidiasis;rs111863112;A;1.0;0.001698;0.00058803;0.0038823;G98E;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_B37;B37 Candidiasis;rs111863112;A;1.0;0.001698;0.00058803;0.0038823;G98E;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1430;hayfever/allergic rhinitis;rs143567349;A;1.0;0.03324;0.012089;0.0059676;D35N;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1430;hayfever/allergic rhinitis;rs143567349;A;1.0;0.03324;0.012089;0.0059676;D23N;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1430;hayfever/allergic rhinitis;rs143567349;A;1.0;0.03324;0.012089;0.0059676;D23N;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1430;hayfever/allergic rhinitis;rs143567349;A;1.0;0.03324;0.012089;0.0059676;D23N;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1430;hayfever/allergic rhinitis;rs143567349;A;1.0;0.03324;0.012089;0.0059676;D23N;ENST00000433848
CCRL2;ENSG00000121797;selfReported_n_1541;cervical spondylosis;rs6441977;A;1.0;0.00063917;0.00024235;0.008356200000000001;V180M;ENST00000357392
CCRL2;ENSG00000121797;selfReported_n_1541;cervical spondylosis;rs6441977;A;1.0;0.00063917;0.00024235;0.008356200000000001;V168M;ENST00000399036
CCRL2;ENSG00000121797;selfReported_n_1541;cervical spondylosis;rs6441977;A;1.0;0.00063917;0.00024235;0.008356200000000001;V168M;ENST00000400880
CCRL2;ENSG00000121797;selfReported_n_1541;cervical spondylosis;rs6441977;A;1.0;0.00063917;0.00024235;0.008356200000000001;V168M;ENST00000400882
CCRL2;ENSG00000121797;selfReported_n_1541;cervical spondylosis;rs6441977;A;1.0;0.00063917;0.00024235;0.008356200000000001;V168M;ENST00000433848
CCRL2;ENSG00000121797;clinical_c_L43;L43 Lichen planus;rs111863112;A;1.0;0.00091506;0.00029922;0.002227;G110E;ENST00000357392
CCRL2;ENSG00000121797;clinical_c_L43;L43 Lichen planus;rs111863112;A;1.0;0.00091506;0.00029922;0.002227;G98E;ENST00000399036
CCRL2;ENSG00000121797;clinical_c_L43;L43 Lichen planus;rs111863112;A;1.0;0.00091506;0.00029922;0.002227;G98E;ENST00000400880
CCRL2;ENSG00000121797;clinical_c_L43;L43 Lichen planus;rs111863112;A;1.0;0.00091506;0.00029922;0.002227;G98E;ENST00000400882
CCRL2;ENSG00000121797;clinical_c_L43;L43 Lichen planus;rs111863112;A;1.0;0.00091506;0.00029922;0.002227;G98E;ENST00000433848
CXCR3;ENSG00000186810;clinical_c_G93;G93 Other disorders of brain;rs778526136;C;0.47930200000000006;0.011668801194569587;0.004127849553358494;0.004700870867235815;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_G93;G93 Other disorders of brain;rs778526136;C;0.47930200000000006;0.011668801194569587;0.004127849553358494;0.004700870867235815;H155R;ENST00000373693
CXCR3;ENSG00000186810;23128-0.0;Trunk fat mass;rs778784936;C;0.189141;-3.761643892562961;1.450642838638961;0.009511855176149503;I235V;ENST00000373691
CXCR3;ENSG00000186810;23128-0.0;Trunk fat mass;rs778784936;C;0.189141;-3.761643892562961;1.450642838638961;0.009511855176149503;I188V;ENST00000373693
CXCR3;ENSG00000186810;cancer_c_Block_C30-C39;C30-C39 Malignant neoplasms of respiratory and intrathoracic organs;rs200615947;A;0.0291676;3.5087783640314716;0.813621650202125;1.613874712235198e-05;V63F;ENST00000373691
CXCR3;ENSG00000186810;cancer_c_Block_C30-C39;C30-C39 Malignant neoplasms of respiratory and intrathoracic organs;rs200615947;A;0.0291676;3.5087783640314716;0.813621650202125;1.613874712235198e-05;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N12;N12 Tubulo-interstitial nephritis, not specified as acute or chronic;rs767076510;G;0.173827;0.17433122871677545;0.03683408497092969;2.213585990299683e-06;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N12;N12 Tubulo-interstitial nephritis, not specified as acute or chronic;rs767076510;G;0.173827;0.17433122871677545;0.03683408497092969;2.213585990299683e-06;N340T;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K40;K40 Inguinal hernia;rs778784936;C;0.189141;0.16247650328038804;0.032532455805130096;5.905275256048328e-07;I235V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K40;K40 Inguinal hernia;rs778784936;C;0.189141;0.16247650328038804;0.032532455805130096;5.905275256048328e-07;I188V;ENST00000373693
CXCR3;ENSG00000186810;_46_47_-0.0;Hand grip strength (left) / Hand grip strength (right);rs778784936;C;0.189141;0.2853406414896867;0.06630848539084909;1.6832620100200688e-05;I235V;ENST00000373691
CXCR3;ENSG00000186810;_46_47_-0.0;Hand grip strength (left) / Hand grip strength (right);rs778784936;C;0.189141;0.2853406414896867;0.06630848539084909;1.6832620100200688e-05;I188V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs767076510;G;0.173827;0.20737301128220478;0.04143221561310827;5.582863875966066e-07;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs767076510;G;0.173827;0.20737301128220478;0.04143221561310827;5.582863875966066e-07;N340T;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_I60-I69;I60-I69 Cerebrovascular diseases;rs748585288;A;0.294724;0.4244283592318486;0.07424773097936202;1.0881626105408558e-08;S30L;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_F05;F05 Delirium, not induced by alcohol and other psychoactive substances;rs144267486;A;0.455006;0.014082990567215284;0.0039566491644651945;0.00037181266717917753;T248I;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_F05;F05 Delirium, not induced by alcohol and other psychoactive substances;rs144267486;A;0.455006;0.014082990567215284;0.0039566491644651945;0.00037181266717917753;T201I;ENST00000373693
CXCR3;ENSG00000186810;864-0.0;Number of days/week walked 10+ minutes;rs766391774;T;0.163976;-0.7797209024397727;0.25533183079526883;0.002259964229757166;R259H;ENST00000373691
CXCR3;ENSG00000186810;864-0.0;Number of days/week walked 10+ minutes;rs766391774;T;0.163976;-0.7797209024397727;0.25533183079526883;0.002259964229757166;R212H;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_M15-M19;M15-M19 Arthrosis;rs778526136;C;0.47930200000000006;0.05122667145340086;0.019767140165128476;0.009555674725710188;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_M15-M19;M15-M19 Arthrosis;rs778526136;C;0.47930200000000006;0.05122667145340086;0.019767140165128476;0.009555674725710188;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_M18;M18 Arthrosis of first carpometacarpal joint;rs778526136;C;0.47930200000000006;0.01208430713944683;0.003181386762800188;0.0001456095924446898;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_M18;M18 Arthrosis of first carpometacarpal joint;rs778526136;C;0.47930200000000006;0.01208430713944683;0.003181386762800188;0.0001456095924446898;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N19;N19 Unspecified renal failure;rs139226823;T;0.256869;0.14737882993208454;0.03883262528745784;0.00014750533754000097;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N19;N19 Unspecified renal failure;rs139226823;T;0.256869;0.14737882993208454;0.03883262528745784;0.00014750533754000097;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K35;K35 Acute appendicitis;rs139226823;T;0.256869;0.18461479972768863;0.056872042405635946;0.0011697993793055304;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K35;K35 Acute appendicitis;rs139226823;T;0.256869;0.18461479972768863;0.056872042405635946;0.0011697993793055304;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K85;K85 Acute pancreatitis;rs748102747;A;0.117718;0.09064735738065466;0.019894504500586743;5.203733450678184e-06;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K85;K85 Acute pancreatitis;rs748102747;A;0.117718;0.09064735738065466;0.019894504500586743;5.203733450678184e-06;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_J40-J47;J40-J47 Chronic lower respiratory diseases;rs748585288;A;0.294724;0.4894003613315778;0.12145766083959303;5.5921624400705736e-05;S30L;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_L82;L82 Seborrhoeic keratosis;rs200352503;T;0.501617;0.03389701388456915;0.006427316070922623;1.3355564415850664e-07;R373Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_L82;L82 Seborrhoeic keratosis;rs200352503;T;0.501617;0.03389701388456915;0.006427316070922623;1.3355564415850664e-07;R326Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_G95;G95 Other diseases of spinal cord;rs778526136;C;0.47930200000000006;0.011363643164383633;0.0024886229747485087;4.965565249664454e-06;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_G95;G95 Other diseases of spinal cord;rs778526136;C;0.47930200000000006;0.011363643164383633;0.0024886229747485087;4.965565249664454e-06;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_J40;J40 Bronchitis, not specified as acute or chronic;rs748102747;A;0.117718;0.0739841265106431;0.020194249268103166;0.00024867221605762635;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_J40;J40 Bronchitis, not specified as acute or chronic;rs748102747;A;0.117718;0.0739841265106431;0.020194249268103166;0.00024867221605762635;A76V;ENST00000373693
CXCR3;ENSG00000186810;23127-0.0;Trunk fat percentage;rs778784936;C;0.189141;-7.505285940178536;2.0450538106558898;0.00024257902586804914;I235V;ENST00000373691
CXCR3;ENSG00000186810;23127-0.0;Trunk fat percentage;rs778784936;C;0.189141;-7.505285940178536;2.0450538106558898;0.00024257902586804914;I188V;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1223;urinary frequency / incontinence;rs767076510;G;0.173827;0.17520731379194343;0.051774746346581885;0.0007143010287494297;N387T;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1223;urinary frequency / incontinence;rs767076510;G;0.173827;0.17520731379194343;0.051774746346581885;0.0007143010287494297;N340T;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N39;N39 Other disorders of urinary system;rs200615947;A;0.0291676;6.958503730189173;2.412722897621536;0.00392549777952964;V63F;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N39;N39 Other disorders of urinary system;rs200615947;A;0.0291676;6.958503730189173;2.412722897621536;0.00392549777952964;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs139226823;T;0.256869;0.21161333857238346;0.07496435962097074;0.004759844753895021;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs139226823;T;0.256869;0.21161333857238346;0.07496435962097074;0.004759844753895021;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs200615947;A;0.0291676;3.8748743586634538;1.3707391622732223;0.004700830353085543;V63F;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs200615947;A;0.0291676;3.8748743586634538;1.3707391622732223;0.004700830353085543;V16F;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1293;spinal injury;rs200352503;T;0.501617;0.0131414958350855;0.002930017082092388;7.287085528367222e-06;R373Q;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1293;spinal injury;rs200352503;T;0.501617;0.0131414958350855;0.002930017082092388;7.287085528367222e-06;R326Q;ENST00000373693
CXCR3;ENSG00000186810;cancer_c_C54;C54 Malignant neoplasm of corpus uteri;rs200352503;T;0.501617;0.027462;0.008657600000000001;0.0015140000000000002;R373Q;ENST00000373691
CXCR3;ENSG00000186810;cancer_c_C54;C54 Malignant neoplasm of corpus uteri;rs200352503;T;0.501617;0.027462;0.008657600000000001;0.0015140000000000002;R326Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K66;K66 Other disorders of peritoneum;rs139226823;T;0.256869;0.205697480716613;0.05534204040014464;0.00020173052020140608;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K66;K66 Other disorders of peritoneum;rs139226823;T;0.256869;0.205697480716613;0.05534204040014464;0.00020173052020140608;R292Q;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1265;neurology;rs748585288;A;0.294724;0.4473920988493611;0.10643683755301499;2.6298452467368465e-05;S30L;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1565;appendicitis;rs200615947;A;0.0291676;5.818245380553599;1.1280579166476397;2.4992950619374145e-07;V63F;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1565;appendicitis;rs200615947;A;0.0291676;5.818245380553599;1.1280579166476397;2.4992950619374145e-07;V16F;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1524;rheumatoid arthritis;rs200352503;T;0.501617;0.021486573988364437;0.007115442335695227;0.0025301663174065086;R373Q;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1524;rheumatoid arthritis;rs200352503;T;0.501617;0.021486573988364437;0.007115442335695227;0.0025301663174065086;R326Q;ENST00000373693
CXCR3;ENSG00000186810;23122-0.0;Arm predicted mass (right);rs778784936;C;0.189141;0.2671707786995414;0.09771707644225258;0.006254614515936175;I235V;ENST00000373691
CXCR3;ENSG00000186810;23122-0.0;Arm predicted mass (right);rs778784936;C;0.189141;0.2671707786995414;0.09771707644225258;0.006254614515936175;I188V;ENST00000373693
CXCR3;ENSG00000186810;30290-0.0;High light scatter reticulocyte percentage;rs139226823;T;0.256869;0.3349800825608494;0.11344803149285386;0.0031498922992774666;R339Q;ENST00000373691
CXCR3;ENSG00000186810;30290-0.0;High light scatter reticulocyte percentage;rs139226823;T;0.256869;0.3349800825608494;0.11344803149285386;0.0031498922992774666;R292Q;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1489;other neurological problem;rs748585288;A;0.294724;0.4756944630443365;0.05304167653557712;3.010849471752707e-19;S30L;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_K55-K64;K55-K64 Other diseases of intestines;rs767076510;G;0.173827;0.9359590544760776;0.32804051437082193;0.004328392238509535;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_K55-K64;K55-K64 Other diseases of intestines;rs767076510;G;0.173827;0.9359590544760776;0.32804051437082193;0.004328392238509535;N340T;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1155;bowel problem;rs200615947;A;0.0291676;9.126891175991265;2.982152987643599;0.00220964801988327;V63F;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1155;bowel problem;rs200615947;A;0.0291676;9.126891175991265;2.982152987643599;0.00220964801988327;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_E78;E78 Disorders of lipoprotein metabolism and other lipidaemias;rs759262878;G;0.348694;3.2594025160310385;1.1800726097590777;0.005744222112280346;I16T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_L20-L30;L20-L30 Dermatitis and eczema;rs778526136;C;0.47930200000000006;0.016016863365849884;0.005843864286084407;0.0061289797791148366;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_L20-L30;L20-L30 Dermatitis and eczema;rs778526136;C;0.47930200000000006;0.016016863365849884;0.005843864286084407;0.0061289797791148366;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_J93;J93 Pneumothorax;rs767076510;G;0.173827;0.1130586438116007;0.041420958187729826;0.006342980613132099;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_J93;J93 Pneumothorax;rs767076510;G;0.173827;0.1130586438116007;0.041420958187729826;0.006342980613132099;N340T;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1557;varicose veins;rs767076510;G;0.173827;0.16840687647777977;0.05178646086111588;0.0011461699944772486;N387T;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1557;varicose veins;rs767076510;G;0.173827;0.16840687647777977;0.05178646086111588;0.0011461699944772486;N340T;ENST00000373693
CXCR3;ENSG00000186810;1319-0.0;Dried fruit intake;rs139226823;T;0.256869;3.1102979747022377;0.9172066698794247;0.000696242075114866;R339Q;ENST00000373691
CXCR3;ENSG00000186810;1319-0.0;Dried fruit intake;rs139226823;T;0.256869;3.1102979747022377;0.9172066698794247;0.000696242075114866;R292Q;ENST00000373693
CXCR3;ENSG00000186810;1777-0.0;Part of a multiple birth;rs778784936;C;0.189141;0.15683938380582566;0.05237333476554609;0.0027476719808686685;I235V;ENST00000373691
CXCR3;ENSG00000186810;1777-0.0;Part of a multiple birth;rs778784936;C;0.189141;0.15683938380582566;0.05237333476554609;0.0027476719808686685;I188V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N76;N76 Other inflammation of vagina and vulva;rs144267486;A;0.455006;0.043469;0.010020000000000001;1.4369e-05;T248I;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N76;N76 Other inflammation of vagina and vulva;rs144267486;A;0.455006;0.043469;0.010020000000000001;1.4369e-05;T201I;ENST00000373693
CXCR3;ENSG00000186810;cancer_c_C34;C34 Malignant neoplasm of bronchus and lung;rs200615947;A;0.0291676;3.8956639908902906;0.7577674364921999;2.733153783494608e-07;V63F;ENST00000373691
CXCR3;ENSG00000186810;cancer_c_C34;C34 Malignant neoplasm of bronchus and lung;rs200615947;A;0.0291676;3.8956639908902906;0.7577674364921999;2.733153783494608e-07;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K70;K70 Alcoholic liver disease;rs139226823;T;0.256869;0.08069391440673054;0.026384090538434272;0.002224994809188933;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K70;K70 Alcoholic liver disease;rs139226823;T;0.256869;0.08069391440673054;0.026384090538434272;0.002224994809188933;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K70;K70 Alcoholic liver disease;rs748102747;A;0.117718;0.06589445276840168;0.021986751459101048;0.0027264426000239623;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K70;K70 Alcoholic liver disease;rs748102747;A;0.117718;0.06589445276840168;0.021986751459101048;0.0027264426000239623;A76V;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1556;other venous/lymphatic disease;rs767076510;G;0.173827;0.15891728027230814;0.054845258857270866;0.0037608102960201397;N387T;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1556;other venous/lymphatic disease;rs767076510;G;0.173827;0.15891728027230814;0.054845258857270866;0.0037608102960201397;N340T;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_B00-B09;B00-B09 Viral infections characterized by skin and mucous membrane lesions;rs759262878;G;0.348694;0.9327900015941516;0.27707623101795514;0.0007611576240152387;I16T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_I12;I12 Hypertensive renal disease;rs200352503;T;0.501617;0.011782115499619054;0.004521791632085345;0.009170549119735527;R373Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_I12;I12 Hypertensive renal disease;rs200352503;T;0.501617;0.011782115499619054;0.004521791632085345;0.009170549119735527;R326Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K20;K20 Oesophagitis;rs767076510;G;0.173827;0.8787175700941039;0.13802263012875443;1.9342230285025188e-10;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K20;K20 Oesophagitis;rs767076510;G;0.173827;0.8787175700941039;0.13802263012875443;1.9342230285025188e-10;N340T;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1513;blistering/desquamating skin disorder;rs778526136;C;0.47930200000000006;0.010247309283990197;0.002902996402273214;0.00041570470270828314;H202R;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1513;blistering/desquamating skin disorder;rs778526136;C;0.47930200000000006;0.010247309283990197;0.002902996402273214;0.00041570470270828314;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_J18;J18 Pneumonia, organism unspecified;rs200352503;T;0.501617;0.029386350519134935;0.010957584741104143;0.0073221236475056704;R373Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_J18;J18 Pneumonia, organism unspecified;rs200352503;T;0.501617;0.029386350519134935;0.010957584741104143;0.0073221236475056704;R326Q;ENST00000373693
CXCR3;ENSG00000186810;23106-0.0;Impedance of whole body;rs778784936;C;0.189141;-52.17734332216506;17.73885500081081;0.003267159518900271;I235V;ENST00000373691
CXCR3;ENSG00000186810;23106-0.0;Impedance of whole body;rs778784936;C;0.189141;-52.17734332216506;17.73885500081081;0.003267159518900271;I188V;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1750;measles / morbillivirus;rs759262878;G;0.348694;1.151341963631222;0.254940393735361;6.2982337768194584e-06;I16T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K76;K76 Other diseases of liver;rs139226823;T;0.256869;0.21901764136588647;0.06201931424709149;0.00041329972848278847;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K76;K76 Other diseases of liver;rs139226823;T;0.256869;0.21901764136588647;0.06201931424709149;0.00041329972848278847;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K76;K76 Other diseases of liver;rs200615947;A;0.0291676;3.6064838164177146;1.1358714733393258;0.001497947339404792;V63F;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K76;K76 Other diseases of liver;rs200615947;A;0.0291676;3.6064838164177146;1.1358714733393258;0.001497947339404792;V16F;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1347;osteomyelitis;rs200615947;A;0.0291676;3.594064375830736;0.4881902651117029;1.8115371621133786e-13;V63F;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1347;osteomyelitis;rs200615947;A;0.0291676;3.594064375830736;0.4881902651117029;1.8115371621133786e-13;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_L53;L53 Other erythematous conditions;rs766391774;T;0.163976;0.014915944677353866;0.004980828160583154;0.002747404590761585;R259H;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_L53;L53 Other erythematous conditions;rs766391774;T;0.163976;0.014915944677353866;0.004980828160583154;0.002747404590761585;R212H;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_L53;L53 Other erythematous conditions;rs778526136;C;0.47930200000000006;0.0070836545035454996;0.002433615303737855;0.003605582345058174;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_L53;L53 Other erythematous conditions;rs778526136;C;0.47930200000000006;0.0070836545035454996;0.002433615303737855;0.003605582345058174;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_M20;M20 Acquired deformities of fingers and toes;rs748102747;A;0.117718;0.16941240418271808;0.05151180178391679;0.0010061278306936973;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_M20;M20 Acquired deformities of fingers and toes;rs748102747;A;0.117718;0.16941240418271808;0.05151180178391679;0.0010061278306936973;A76V;ENST00000373693
CXCR3;ENSG00000186810;30300-0.0;High light scatter reticulocyte count;rs139226823;T;0.256869;0.014111860750536548;0.0051267761899580575;0.005912772814565763;R339Q;ENST00000373691
CXCR3;ENSG00000186810;30300-0.0;High light scatter reticulocyte count;rs139226823;T;0.256869;0.014111860750536548;0.0051267761899580575;0.005912772814565763;R292Q;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1597;back pain;rs200615947;A;0.0291676;3.004573355113509;0.907487037954362;0.000930057661035106;V63F;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1597;back pain;rs200615947;A;0.0291676;3.004573355113509;0.907487037954362;0.000930057661035106;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_K35-K38;K35-K38 Diseases of appendix;rs139226823;T;0.256869;0.17449724752062773;0.06287727817900692;0.005516716295031971;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_K35-K38;K35-K38 Diseases of appendix;rs139226823;T;0.256869;0.17449724752062773;0.06287727817900692;0.005516716295031971;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K75;K75 Other inflammatory liver diseases;rs139226823;T;0.256869;0.22432560449455052;0.027335914664555365;2.281862891427626e-16;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K75;K75 Other inflammatory liver diseases;rs139226823;T;0.256869;0.22432560449455052;0.027335914664555365;2.281862891427626e-16;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_F20-F29;F20-F29 Schizophrenia, schizotypal and delusional disorders;rs766391774;T;0.163976;0.022117369004728344;0.006810224907033152;0.0011635378000811726;R259H;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_F20-F29;F20-F29 Schizophrenia, schizotypal and delusional disorders;rs766391774;T;0.163976;0.022117369004728344;0.006810224907033152;0.0011635378000811726;R212H;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_F20-F29;F20-F29 Schizophrenia, schizotypal and delusional disorders;rs778526136;C;0.47930200000000006;0.012168641775646123;0.003286045045920914;0.00021295829576046608;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_F20-F29;F20-F29 Schizophrenia, schizotypal and delusional disorders;rs778526136;C;0.47930200000000006;0.012168641775646123;0.003286045045920914;0.00021295829576046608;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_F31;F31 Bipolar affective disorder;rs748102747;A;0.117718;0.07077183202241108;0.024745171874144368;0.0042360643408703505;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_F31;F31 Bipolar affective disorder;rs748102747;A;0.117718;0.07077183202241108;0.024745171874144368;0.0042360643408703505;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_J44;J44 Other chronic obstructive pulmonary disease;rs200615947;A;0.0291676;5.280902897634191;1.7341028477709879;0.002324307167064587;V63F;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_J44;J44 Other chronic obstructive pulmonary disease;rs200615947;A;0.0291676;5.280902897634191;1.7341028477709879;0.002324307167064587;V16F;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1468;throat or larynx disorder;rs767076510;G;0.173827;0.22762234431184802;0.08261773932798086;0.005866940089735603;N387T;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1468;throat or larynx disorder;rs767076510;G;0.173827;0.22762234431184802;0.08261773932798086;0.005866940089735603;N340T;ENST00000373693
CXCR3;ENSG00000186810;30070-0.0;Red blood cell (erythrocyte) distribution width;rs200352503;T;0.501617;0.14863648431649049;0.05601792709843122;0.007969163080987307;R373Q;ENST00000373691
CXCR3;ENSG00000186810;30070-0.0;Red blood cell (erythrocyte) distribution width;rs200352503;T;0.501617;0.14863648431649049;0.05601792709843122;0.007969163080987307;R326Q;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1211;peritonitis;rs139226823;T;0.256869;0.10928150083663128;0.039483668047182396;0.00564421978392419;R339Q;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1211;peritonitis;rs139226823;T;0.256869;0.10928150083663128;0.039483668047182396;0.00564421978392419;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_O48;O48 Prolonged pregnancy;rs139226823;T;0.256869;0.25461;0.081028;0.0016762999999999997;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_O48;O48 Prolonged pregnancy;rs139226823;T;0.256869;0.25461;0.081028;0.0016762999999999997;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs748102747;A;0.117718;0.1320981392401277;0.023949932443321293;3.4760095440527306e-08;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs748102747;A;0.117718;0.1320981392401277;0.023949932443321293;3.4760095440527306e-08;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_H92;H92 Otalgia and effusion of ear;rs200352503;T;0.501617;0.009894202907236027;0.0026767461903109075;0.00021871748824767322;R373Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_H92;H92 Otalgia and effusion of ear;rs200352503;T;0.501617;0.009894202907236027;0.0026767461903109075;0.00021871748824767322;R326Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_B15-B19;B15-B19 Viral hepatitis;rs200615947;A;0.0291676;3.314552782472046;0.45662621090664984;3.9057454733592647e-13;V63F;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_B15-B19;B15-B19 Viral hepatitis;rs200615947;A;0.0291676;3.314552782472046;0.45662621090664984;3.9057454733592647e-13;V16F;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1686;soft tissue inflammation;rs144267486;A;0.455006;0.014843821327878126;0.004349588728234871;0.0006432380087735484;T248I;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1686;soft tissue inflammation;rs144267486;A;0.455006;0.014843821327878126;0.004349588728234871;0.0006432380087735484;T201I;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N50;N50 Other disorders of male genital organs;rs139226823;T;0.256869;0.29933000000000004;0.10173;0.0032585;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N50;N50 Other disorders of male genital organs;rs139226823;T;0.256869;0.29933000000000004;0.10173;0.0032585;R292Q;ENST00000373693
CXCR3;ENSG00000186810;30190-0.0;Monocyte percentage;rs200352503;T;0.501617;0.5248850740869505;0.1343161415665055;9.312757018593882e-05;R373Q;ENST00000373691
CXCR3;ENSG00000186810;30190-0.0;Monocyte percentage;rs200352503;T;0.501617;0.5248850740869505;0.1343161415665055;9.312757018593882e-05;R326Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K21;K21 Gastro-oesophageal reflux disease;rs767076510;G;0.173827;0.6458013281182019;0.2089273927712353;0.0019946190716873006;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K21;K21 Gastro-oesophageal reflux disease;rs767076510;G;0.173827;0.6458013281182019;0.2089273927712353;0.0019946190716873006;N340T;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1251;hypothyroidism/myxoedema;rs200615947;A;0.0291676;4.844821647283054;1.826162937904259;0.007977839888110195;V63F;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1251;hypothyroidism/myxoedema;rs200615947;A;0.0291676;4.844821647283054;1.826162937904259;0.007977839888110195;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_G44;G44 Other headache syndromes;rs200615947;A;0.0291676;2.591751196298999;0.43572256042835145;2.711594297838452e-09;V63F;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_G44;G44 Other headache syndromes;rs200615947;A;0.0291676;2.591751196298999;0.43572256042835145;2.711594297838452e-09;V16F;ENST00000373693
CXCR3;ENSG00000186810;23099-0.0;Body fat percentage;rs778784936;C;0.189141;-5.432579823406703;1.7667322104275023;0.0021055118627138175;I235V;ENST00000373691
CXCR3;ENSG00000186810;23099-0.0;Body fat percentage;rs778784936;C;0.189141;-5.432579823406703;1.7667322104275023;0.0021055118627138175;I188V;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1160;oesophagitis/barretts oesophagus;rs767076510;G;0.173827;0.16081217843459322;0.05211934472443387;0.002032372304199254;N387T;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1160;oesophagitis/barretts oesophagus;rs767076510;G;0.173827;0.16081217843459322;0.05211934472443387;0.002032372304199254;N340T;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K83;K83 Other diseases of biliary tract;rs139226823;T;0.256869;0.22663574982417142;0.045292098345555414;5.61908018133904e-07;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K83;K83 Other diseases of biliary tract;rs139226823;T;0.256869;0.22663574982417142;0.045292098345555414;5.61908018133904e-07;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K61;K61 Abscess of anal and rectal regions;rs748102747;A;0.117718;0.08030074438832853;0.03047513901939513;0.00841474259320751;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K61;K61 Abscess of anal and rectal regions;rs748102747;A;0.117718;0.08030074438832853;0.03047513901939513;0.00841474259320751;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N73;N73 Other female pelvic inflammatory diseases;rs778784936;C;0.189141;0.16207;0.053672000000000004;0.0025313;I235V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N73;N73 Other female pelvic inflammatory diseases;rs778784936;C;0.189141;0.16207;0.053672000000000004;0.0025313;I188V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_H49-H52;H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction;rs144267486;A;0.455006;0.036629895627155004;0.008949947154262563;4.262873682248906e-05;T248I;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_H49-H52;H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction;rs144267486;A;0.455006;0.036629895627155004;0.008949947154262563;4.262873682248906e-05;T201I;ENST00000373693
CXCR3;ENSG00000186810;1070-0.0;Time spent watching television (TV);rs766391774;T;0.163976;0.596321651002953;0.20087552602057618;0.002991473161309956;R259H;ENST00000373691
CXCR3;ENSG00000186810;1070-0.0;Time spent watching television (TV);rs766391774;T;0.163976;0.596321651002953;0.20087552602057618;0.002991473161309956;R212H;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1313;anxiety/panic attacks;rs200352503;T;0.501617;0.02530227562607123;0.00829797206322407;0.0022944254032606403;R373Q;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1313;anxiety/panic attacks;rs200352503;T;0.501617;0.02530227562607123;0.00829797206322407;0.0022944254032606403;R326Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_I85;I85 Oesophageal varices;rs748102747;A;0.117718;0.1212223451539482;0.018988503954921226;1.725367678072244e-10;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_I85;I85 Oesophageal varices;rs748102747;A;0.117718;0.1212223451539482;0.018988503954921226;1.725367678072244e-10;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K01;K01 Embedded and impacted teeth;rs139226823;T;0.256869;0.2123365167134738;0.0448801661320559;2.232093551273837e-06;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K01;K01 Embedded and impacted teeth;rs139226823;T;0.256869;0.2123365167134738;0.0448801661320559;2.232093551273837e-06;R292Q;ENST00000373693
CXCR3;ENSG00000186810;cancer_c_C20;C20 Malignant neoplasm of rectum;rs144267486;A;0.455006;0.015331796285085327;0.005542748949226735;0.005673118489559432;T248I;ENST00000373691
CXCR3;ENSG00000186810;cancer_c_C20;C20 Malignant neoplasm of rectum;rs144267486;A;0.455006;0.015331796285085327;0.005542748949226735;0.005673118489559432;T201I;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_J33;J33 Nasal polyp;rs766391774;T;0.163976;0.03594867038408083;0.011938805453143167;0.0026032226366061516;R259H;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_J33;J33 Nasal polyp;rs766391774;T;0.163976;0.03594867038408083;0.011938805453143167;0.0026032226366061516;R212H;ENST00000373693
CXCR3;ENSG00000186810;23109-0.0;Impedance of arm (right);rs778784936;C;0.189141;-38.362171171365304;10.059501000519452;0.00013699796445170503;I235V;ENST00000373691
CXCR3;ENSG00000186810;23109-0.0;Impedance of arm (right);rs778784936;C;0.189141;-38.362171171365304;10.059501000519452;0.00013699796445170503;I188V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_L05;L05 Pilonidal cyst;rs748102747;A;0.117718;0.07884269699955108;0.017779196101463068;9.226569836746783e-06;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_L05;L05 Pilonidal cyst;rs748102747;A;0.117718;0.07884269699955108;0.017779196101463068;9.226569836746783e-06;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_O10-O16;O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium;rs748102747;A;0.117718;0.22002;0.075443;0.0035409999999999994;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_O10-O16;O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium;rs748102747;A;0.117718;0.22002;0.075443;0.0035409999999999994;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N36;N36 Other disorders of urethra;rs778526136;C;0.47930200000000006;0.008527511051120054;0.002861074417577765;0.002877523774234654;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N36;N36 Other disorders of urethra;rs778526136;C;0.47930200000000006;0.008527511051120054;0.002861074417577765;0.002877523774234654;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_D50;D50 Iron deficiency anaemia;rs200352503;T;0.501617;0.027787003781491616;0.009747435659941293;0.004362326186074417;R373Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_D50;D50 Iron deficiency anaemia;rs200352503;T;0.501617;0.027787003781491616;0.009747435659941293;0.004362326186074417;R326Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_I78;I78 Diseases of capillaries;rs200615947;A;0.0291676;2.3946754916786386;0.5043467314058522;2.0536312540413888e-06;V63F;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_I78;I78 Diseases of capillaries;rs200615947;A;0.0291676;2.3946754916786386;0.5043467314058522;2.0536312540413888e-06;V16F;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1416;connective tissue disorder;rs139226823;T;0.256869;0.2614671650216223;0.04506294527883207;6.542492394758429e-09;R339Q;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1416;connective tissue disorder;rs139226823;T;0.256869;0.2614671650216223;0.04506294527883207;6.542492394758429e-09;R292Q;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1416;connective tissue disorder;rs778526136;C;0.47930200000000006;0.012125889386823387;0.0046328846371480785;0.008861493420610916;H202R;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1416;connective tissue disorder;rs778526136;C;0.47930200000000006;0.012125889386823387;0.0046328846371480785;0.008861493420610916;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K25;K25 Gastric ulcer;rs759262878;G;0.348694;1.5398907443021197;0.4538693931818731;0.0006918064600212232;I16T;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1317;mania/bipolar disorder/manic depression;rs767076510;G;0.173827;0.15366319640625717;0.04851581843345232;0.001538719225300949;N387T;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1317;mania/bipolar disorder/manic depression;rs767076510;G;0.173827;0.15366319640625717;0.04851581843345232;0.001538719225300949;N340T;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N28;N28 Other disorders of kidney and ureter, not elsewhere classified;rs200615947;A;0.0291676;3.2985138788371695;0.9392126572132291;0.00044474973320767424;V63F;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N28;N28 Other disorders of kidney and ureter, not elsewhere classified;rs200615947;A;0.0291676;3.2985138788371695;0.9392126572132291;0.00044474973320767424;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_B96;B96 Other bacterial agents as the cause of diseases classified to other chapters;rs200615947;A;0.0291676;5.392865826709688;1.7965680815137632;0.0026842389301803644;V63F;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_B96;B96 Other bacterial agents as the cause of diseases classified to other chapters;rs200615947;A;0.0291676;5.392865826709688;1.7965680815137632;0.0026842389301803644;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_H00;H00 Hordeolum and chalazion;rs767076510;G;0.173827;0.322295460506519;0.06280469370097505;2.8712198701109306e-07;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_H00;H00 Hordeolum and chalazion;rs767076510;G;0.173827;0.322295460506519;0.06280469370097505;2.8712198701109306e-07;N340T;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1752;varicella zoster virus;rs759262878;G;0.348694;1.1232423454281468;0.2988265472485408;0.000170700289269444;I16T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N84;N84 Polyp of female genital tract;rs144267486;A;0.455006;0.11117;0.036239;0.0021578;T248I;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N84;N84 Polyp of female genital tract;rs144267486;A;0.455006;0.11117;0.036239;0.0021578;T201I;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N30;N30 Cystitis;rs767076510;G;0.173827;0.2166776233616464;0.07406700903931751;0.0034398394052215955;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N30;N30 Cystitis;rs767076510;G;0.173827;0.2166776233616464;0.07406700903931751;0.0034398394052215955;N340T;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_N80-N98;N80-N98 Noninflammatory disorders of female genital tract;rs144267486;A;0.455006;0.18487;0.068627;0.007065000000000001;T248I;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_N80-N98;N80-N98 Noninflammatory disorders of female genital tract;rs144267486;A;0.455006;0.18487;0.068627;0.007065000000000001;T201I;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_M89;M89 Other disorders of bone;rs778526136;C;0.47930200000000006;0.01416520515843733;0.003967257964637804;0.0003562625340921062;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_M89;M89 Other disorders of bone;rs778526136;C;0.47930200000000006;0.01416520515843733;0.003967257964637804;0.0003562625340921062;H155R;ENST00000373693
CXCR3;ENSG00000186810;30230-0.0;Nucleated red blood cell percentage;rs759262878;G;0.348694;4.85937387356946;1.737840988209849;0.005170528266941946;I16T;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1239;testicular problems (not cancer);rs200352503;T;0.501617;0.014597999999999998;0.0052716;0.005621899999999999;R373Q;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1239;testicular problems (not cancer);rs200352503;T;0.501617;0.014597999999999998;0.0052716;0.005621899999999999;R326Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_J20-J22;J20-J22 Other acute lower respiratory infections;rs748585288;A;0.294724;0.45451798446370834;0.06796875677293704;2.275423100359849e-11;S30L;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_I84;I84 Haemorrhoids;rs778526136;C;0.47930200000000006;0.042530946572755454;0.015532941896527935;0.00617928828678555;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_I84;I84 Haemorrhoids;rs778526136;C;0.47930200000000006;0.042530946572755454;0.015532941896527935;0.00617928828678555;H155R;ENST00000373693
CXCR3;ENSG00000186810;30040-0.0;Mean corpuscular volume;rs778526136;C;0.47930200000000006;-0.604505235521171;0.22404196569385837;0.006972002632181332;H202R;ENST00000373691
CXCR3;ENSG00000186810;30040-0.0;Mean corpuscular volume;rs778526136;C;0.47930200000000006;-0.604505235521171;0.22404196569385837;0.006972002632181332;H155R;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1270;infection of nervous system;rs766391774;T;0.163976;0.02682285672215372;0.00990158773310588;0.00674975250841066;R259H;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1270;infection of nervous system;rs766391774;T;0.163976;0.02682285672215372;0.00990158773310588;0.00674975250841066;R212H;ENST00000373693
CXCR3;ENSG00000186810;30130-0.0;Monocyte count;rs200352503;T;0.501617;0.031095622339076406;0.010034887773162122;0.001943380262143858;R373Q;ENST00000373691
CXCR3;ENSG00000186810;30130-0.0;Monocyte count;rs200352503;T;0.501617;0.031095622339076406;0.010034887773162122;0.001943380262143858;R326Q;ENST00000373693
CXCR3;ENSG00000186810;1687-0.0;Comparative body size at age 10;rs766391774;T;0.163976;0.24884718246246915;0.08079821751913019;0.0020709805361163055;R259H;ENST00000373691
CXCR3;ENSG00000186810;1687-0.0;Comparative body size at age 10;rs766391774;T;0.163976;0.24884718246246915;0.08079821751913019;0.0020709805361163055;R212H;ENST00000373693
CXCR3;ENSG00000186810;1687-0.0;Comparative body size at age 10;rs767076510;G;0.173827;1.5965615013882861;0.5437170251446628;0.003320639156913717;N387T;ENST00000373691
CXCR3;ENSG00000186810;1687-0.0;Comparative body size at age 10;rs767076510;G;0.173827;1.5965615013882861;0.5437170251446628;0.003320639156913717;N340T;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_K65-K67;K65-K67 Diseases of peritoneum;rs139226823;T;0.256869;0.18912151481032652;0.06240408727805911;0.0024407239245389416;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_K65-K67;K65-K67 Diseases of peritoneum;rs139226823;T;0.256869;0.18912151481032652;0.06240408727805911;0.0024407239245389416;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_G90-G99;G90-G99 Other disorders of the nervous system;rs778526136;C;0.47930200000000006;0.02201387549642513;0.00671634717113408;0.0010467287935591303;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_G90-G99;G90-G99 Other disorders of the nervous system;rs778526136;C;0.47930200000000006;0.02201387549642513;0.00671634717113408;0.0010467287935591303;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs200352503;T;0.501617;0.009416841059307526;0.002950619933142764;0.001415464823303128;R373Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs200352503;T;0.501617;0.009416841059307526;0.002950619933142764;0.001415464823303128;R326Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N23;N23 Unspecified renal colic;rs200352503;T;0.501617;0.012399120826050483;0.004787478321992688;0.00960020262356459;R373Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N23;N23 Unspecified renal colic;rs200352503;T;0.501617;0.012399120826050483;0.004787478321992688;0.00960020262356459;R326Q;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1142;sleep apnoea;rs778526136;C;0.47930200000000006;0.01269725820311432;0.0033309678221045283;0.00013791239337309434;H202R;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1142;sleep apnoea;rs778526136;C;0.47930200000000006;0.01269725820311432;0.0033309678221045283;0.00013791239337309434;H155R;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1720;fracture pelvis & lower limb;rs767076510;G;0.173827;0.3638270504878211;0.08544057708963283;2.0603655607751372e-05;N387T;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1720;fracture pelvis & lower limb;rs767076510;G;0.173827;0.3638270504878211;0.08544057708963283;2.0603655607751372e-05;N340T;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N13;N13 Obstructive and reflux uropathy;rs144267486;A;0.455006;0.02203769040439279;0.008511459214871071;0.009620510584555606;T248I;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N13;N13 Obstructive and reflux uropathy;rs144267486;A;0.455006;0.02203769040439279;0.008511459214871071;0.009620510584555606;T201I;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_O80-O84;O80-O84 Delivery;rs748102747;A;0.117718;0.30329;0.10689000000000001;0.0045479;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_O80-O84;O80-O84 Delivery;rs748102747;A;0.117718;0.30329;0.10689000000000001;0.0045479;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N70;N70 Salpingitis and oophoritis;rs767076510;G;0.173827;0.19165;0.073628;0.009243600000000001;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N70;N70 Salpingitis and oophoritis;rs767076510;G;0.173827;0.19165;0.073628;0.009243600000000001;N340T;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K41;K41 Femoral hernia;rs200352503;T;0.501617;0.006748884698361986;0.002551289068938129;0.00816223280884561;R373Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K41;K41 Femoral hernia;rs200352503;T;0.501617;0.006748884698361986;0.002551289068938129;0.00816223280884561;R326Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_J22;J22 Unspecified acute lower respiratory infection;rs748585288;A;0.294724;0.4560994546051723;0.0674210216716193;1.333605178080933e-11;S30L;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1130;asthma;rs748585288;A;0.294724;0.46367622704921935;0.13898891047612424;0.0008497288163234107;S30L;ENST00000373691
CXCR3;ENSG00000186810;30170-0.0;Nucleated red blood cell count;rs759262878;G;0.348694;0.40930895974115883;0.1407465830998529;0.0036360046689446024;I16T;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1517;duodenal ulcer;rs748102747;A;0.117718;0.097291607798413;0.0347111782996391;0.005064697077326202;A123V;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1517;duodenal ulcer;rs748102747;A;0.117718;0.097291607798413;0.0347111782996391;0.005064697077326202;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_O80;O80 Single spontaneous delivery;rs748102747;A;0.117718;0.26713000000000003;0.09325399999999999;0.004177;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_O80;O80 Single spontaneous delivery;rs748102747;A;0.117718;0.26713000000000003;0.09325399999999999;0.004177;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_N10-N16;N10-N16 Renal tubulo-interstitial diseases;rs144267486;A;0.455006;0.02641409616940637;0.010223698523069192;0.00977709962002549;T248I;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_N10-N16;N10-N16 Renal tubulo-interstitial diseases;rs144267486;A;0.455006;0.02641409616940637;0.010223698523069192;0.00977709962002549;T201I;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_N10-N16;N10-N16 Renal tubulo-interstitial diseases;rs200615947;A;0.0291676;3.683325011009337;1.1902997059747003;0.001971770019400618;V63F;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_N10-N16;N10-N16 Renal tubulo-interstitial diseases;rs200615947;A;0.0291676;3.683325011009337;1.1902997059747003;0.001971770019400618;V16F;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1469;ear/vestibular disorder;rs200352503;T;0.501617;0.02618168211080259;0.009108179951246704;0.0040463698157247;R373Q;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1469;ear/vestibular disorder;rs200352503;T;0.501617;0.02618168211080259;0.009108179951246704;0.0040463698157247;R326Q;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1536;high cholesterol;rs139226823;T;0.256869;0.773236781894579;0.20666405218321718;0.0001829137975095489;R339Q;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1536;high cholesterol;rs139226823;T;0.256869;0.773236781894579;0.20666405218321718;0.0001829137975095489;R292Q;ENST00000373693
CXCR3;ENSG00000186810;23119-0.0;Arm fat percentage (right);rs778784936;C;0.189141;-5.522377164544364;1.8507709293686045;0.0028466923551114754;I235V;ENST00000373691
CXCR3;ENSG00000186810;23119-0.0;Arm fat percentage (right);rs778784936;C;0.189141;-5.522377164544364;1.8507709293686045;0.0028466923551114754;I188V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_F40;F40 Phobic anxiety disorders;rs778526136;C;0.47930200000000006;0.009483867290442264;0.0023154525420986827;4.2052734417731616e-05;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_F40;F40 Phobic anxiety disorders;rs778526136;C;0.47930200000000006;0.009483867290442264;0.0023154525420986827;4.2052734417731616e-05;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_M86-M90;M86-M90 Other osteopathies;rs778526136;C;0.47930200000000006;0.0176191011926704;0.005823316560501949;0.0024812982178726646;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_M86-M90;M86-M90 Other osteopathies;rs778526136;C;0.47930200000000006;0.0176191011926704;0.005823316560501949;0.0024812982178726646;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_I61;I61 Intracerebral haemorrhage;rs748585288;A;0.294724;0.45104558709030285;0.022186480022544103;7.015934899574248e-92;S30L;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_G40-G47;G40-G47 Episodic and paroxysmal disorders;rs748585288;A;0.294724;0.40778764383096866;0.09328289101540672;1.2338684739477482e-05;S30L;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N21;N21 Calculus of lower urinary tract;rs766391774;T;0.163976;0.01767637687659641;0.004798082199777078;0.0002295567775994721;R259H;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N21;N21 Calculus of lower urinary tract;rs766391774;T;0.163976;0.01767637687659641;0.004798082199777078;0.0002295567775994721;R212H;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_M65;M65 Synovitis and tenosynovitis;rs139226823;T;0.256869;0.25771221971518465;0.07337452233209135;0.00044427163153005393;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_M65;M65 Synovitis and tenosynovitis;rs139226823;T;0.256869;0.25771221971518465;0.07337452233209135;0.00044427163153005393;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_G40;G40 Epilepsy;rs767076510;G;0.173827;0.23447664583210773;0.08824031242396621;0.007878079698999023;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_G40;G40 Epilepsy;rs767076510;G;0.173827;0.23447664583210773;0.08824031242396621;0.007878079698999023;N340T;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_J45;J45 Asthma;rs748585288;A;0.294724;0.4364691153621027;0.10512057854082045;3.294661688422467e-05;S30L;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_H04;H04 Disorders of lachrymal system;rs759262878;G;0.348694;1.1062891513842286;0.3008808018917958;0.000236145404211278;I16T;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1696;fracture head & neck;rs200615947;A;0.0291676;1.9382964273962378;0.5660131600900736;0.0006159944806012794;V63F;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1696;fracture head & neck;rs200615947;A;0.0291676;1.9382964273962378;0.5660131600900736;0.0006159944806012794;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K55;K55 Vascular disorders of intestine;rs139226823;T;0.256869;0.09189026614545885;0.033695523307651305;0.006389824378186641;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K55;K55 Vascular disorders of intestine;rs139226823;T;0.256869;0.09189026614545885;0.033695523307651305;0.006389824378186641;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K55;K55 Vascular disorders of intestine;rs766391774;T;0.163976;0.017814559420391493;0.006889787469299207;0.009719637105172044;R259H;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K55;K55 Vascular disorders of intestine;rs766391774;T;0.163976;0.017814559420391493;0.006889787469299207;0.009719637105172044;R212H;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1319;bone disorder;rs200615947;A;0.0291676;7.321530563381048;1.3471000897963292;5.4786948742757325e-08;V63F;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1319;bone disorder;rs200615947;A;0.0291676;7.321530563381048;1.3471000897963292;5.4786948742757325e-08;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K65;K65 Peritonitis;rs748102747;A;0.117718;0.12307317561102107;0.02395811569353601;2.791381756911155e-07;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K65;K65 Peritonitis;rs748102747;A;0.117718;0.12307317561102107;0.02395811569353601;2.791381756911155e-07;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_F20;F20 Schizophrenia;rs778526136;C;0.47930200000000006;0.011265012564451511;0.0023806496145831447;2.2242032352197744e-06;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_F20;F20 Schizophrenia;rs778526136;C;0.47930200000000006;0.011265012564451511;0.0023806496145831447;2.2242032352197744e-06;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_N43;N43 Hydrocele and spermatocele;rs748102747;A;0.117718;0.19471;0.051075;0.00013777;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_N43;N43 Hydrocele and spermatocele;rs748102747;A;0.117718;0.19471;0.051075;0.00013777;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K60;K60 Fissure and fistula of anal and rectal regions;rs767076510;G;0.173827;0.30782160992302654;0.08164644116646097;0.00016313120638699756;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K60;K60 Fissure and fistula of anal and rectal regions;rs767076510;G;0.173827;0.30782160992302654;0.08164644116646097;0.00016313120638699756;N340T;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1592;dry eyes;rs778784936;C;0.189141;0.044852267352644366;0.011695730465987712;0.00012560181989412742;I235V;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1592;dry eyes;rs778784936;C;0.189141;0.044852267352644366;0.011695730465987712;0.00012560181989412742;I188V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K31;K31 Other diseases of stomach and duodenum;rs767076510;G;0.173827;0.7989043647156975;0.11983029784159795;2.611478866057676e-11;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K31;K31 Other diseases of stomach and duodenum;rs767076510;G;0.173827;0.7989043647156975;0.11983029784159795;2.611478866057676e-11;N340T;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_G45;G45 Transient cerebral ischaemic attacks and related syndromes;rs748585288;A;0.294724;0.4364351149443332;0.041329739880565375;4.574792334544803e-26;S30L;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_H02;H02 Other disorders of eyelid;rs200352503;T;0.501617;0.02456316294322176;0.008635409307089567;0.00444853710222612;R373Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_H02;H02 Other disorders of eyelid;rs200352503;T;0.501617;0.02456316294322176;0.008635409307089567;0.00444853710222612;R326Q;ENST00000373693
CXCR3;ENSG00000186810;1389-0.0;Pork intake;rs200615947;A;0.0291676;25.381720393157398;8.511057794095853;0.002861801598352229;V63F;ENST00000373691
CXCR3;ENSG00000186810;1389-0.0;Pork intake;rs200615947;A;0.0291676;25.381720393157398;8.511057794095853;0.002861801598352229;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_N25-N29;N25-N29 Other disorders of kidney and ureter;rs200615947;A;0.0291676;3.3119938934054023;0.9830490493243503;0.0007541313288541527;V63F;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_N25-N29;N25-N29 Other disorders of kidney and ureter;rs200615947;A;0.0291676;3.3119938934054023;0.9830490493243503;0.0007541313288541527;V16F;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_M53;M53 Other dorsopathies, not elsewhere classified;rs778526136;C;0.47930200000000006;0.010570286082629839;0.0020907795266057747;4.2888802882755724e-07;H202R;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_M53;M53 Other dorsopathies, not elsewhere classified;rs778526136;C;0.47930200000000006;0.010570286082629839;0.0020907795266057747;4.2888802882755724e-07;H155R;ENST00000373693
CXCR3;ENSG00000186810;30050-0.0;Mean corpuscular haemoglobin;rs200352503;T;0.501617;-0.27715453537313545;0.10032592596198;0.005735326773362404;R373Q;ENST00000373691
CXCR3;ENSG00000186810;30050-0.0;Mean corpuscular haemoglobin;rs200352503;T;0.501617;-0.27715453537313545;0.10032592596198;0.005735326773362404;R326Q;ENST00000373693
CXCR3;ENSG00000186810;30050-0.0;Mean corpuscular haemoglobin;rs778526136;C;0.47930200000000006;-0.277762705269465;0.09073928382008355;0.0022051988030384723;H202R;ENST00000373691
CXCR3;ENSG00000186810;30050-0.0;Mean corpuscular haemoglobin;rs778526136;C;0.47930200000000006;-0.277762705269465;0.09073928382008355;0.0022051988030384723;H155R;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_H50;H50 Other strabismus;rs144267486;A;0.455006;0.032079665071511006;0.0049942282033980006;1.3330937109420743e-10;T248I;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_H50;H50 Other strabismus;rs144267486;A;0.455006;0.032079665071511006;0.0049942282033980006;1.3330937109420743e-10;T201I;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_K44;K44 Diaphragmatic hernia;rs767076510;G;0.173827;0.8844936197500038;0.2207045766291064;6.134129429205151e-05;N387T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_K44;K44 Diaphragmatic hernia;rs767076510;G;0.173827;0.8844936197500038;0.2207045766291064;6.134129429205151e-05;N340T;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1111;pulmonary embolism +/- dvt;rs778784936;C;0.189141;0.08337462628541362;0.03195249797848872;0.009071958712055536;I235V;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1111;pulmonary embolism +/- dvt;rs778784936;C;0.189141;0.08337462628541362;0.03195249797848872;0.009071958712055536;I188V;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1164;gastritis/gastric erosions;rs200352503;T;0.501617;0.017015387960015182;0.002942245219851754;7.3323153128127244e-09;R373Q;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1164;gastritis/gastric erosions;rs200352503;T;0.501617;0.017015387960015182;0.002942245219851754;7.3323153128127244e-09;R326Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_F00-F09;F00-F09 Organic, including symptomatic, mental disorders;rs144267486;A;0.455006;0.02225986645754201;0.006616625643153379;0.0007675687573834124;T248I;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_F00-F09;F00-F09 Organic, including symptomatic, mental disorders;rs144267486;A;0.455006;0.02225986645754201;0.006616625643153379;0.0007675687573834124;T201I;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_O69;O69 Labour and delivery complicated by umbilical cord complications;rs139226823;T;0.256869;0.2098;0.059023;0.00037871;R339Q;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_O69;O69 Labour and delivery complicated by umbilical cord complications;rs139226823;T;0.256869;0.2098;0.059023;0.00037871;R292Q;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_H55-H59;H55-H59 Other disorders of eye and adnexa;rs748102747;A;0.117718;0.07478748315458775;0.02595977230962092;0.003965426366871331;A123V;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_Block_H55-H59;H55-H59 Other disorders of eye and adnexa;rs748102747;A;0.117718;0.07478748315458775;0.02595977230962092;0.003965426366871331;A76V;ENST00000373693
CXCR3;ENSG00000186810;clinical_c_Block_H55-H59;H55-H59 Other disorders of eye and adnexa;rs759262878;G;0.348694;0.598389356123648;0.2185681679325846;0.006185733487021924;I16T;ENST00000373691
CXCR3;ENSG00000186810;clinical_c_E87;E87 Other disorders of fluid, electrolyte and acid-base balance;rs748585288;A;0.294724;0.438501772898269;0.05740554513612886;2.194842319531925e-14;S30L;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1542;rheumatic fever;rs139226823;T;0.256869;0.09561773239060391;0.03594006936363636;0.007803002756972596;R339Q;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1542;rheumatic fever;rs139226823;T;0.256869;0.09561773239060391;0.03594006936363636;0.007803002756972596;R292Q;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1542;rheumatic fever;rs144267486;A;0.455006;0.02110746531936242;0.005706010361429128;0.00021631121623742451;T248I;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1542;rheumatic fever;rs144267486;A;0.455006;0.02110746531936242;0.005706010361429128;0.00021631121623742451;T201I;ENST00000373693
CXCR3;ENSG00000186810;selfReported_n_1542;rheumatic fever;rs200615947;A;0.0291676;5.179347617387446;0.6698253020662406;1.0554953857480316e-14;V63F;ENST00000373691
CXCR3;ENSG00000186810;selfReported_n_1542;rheumatic fever;rs200615947;A;0.0291676;5.179347617387446;0.6698253020662406;1.0554953857480316e-14;V16F;ENST00000373693
ACKR3;ENSG00000144476;clinical_c_L30;L30 Other dermatitis;rs143408017;T;0.579412;0.012813;0.0029295000000000002;1.2207e-05;A336V;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_L30;L30 Other dermatitis;rs146407095;A;1.0;0.0026413;0.00084467;0.0017660999999999998;V42I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_L30;L30 Other dermatitis;rs146407095;A;1.0;0.0026413;0.00084467;0.0017660999999999998;V42I;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_G56;G56 Mononeuropathies of upper limb;rs114269199;C;0.8836350000000001;0.21474000000000001;0.08153200000000001;0.0084435;V64L;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_G56;G56 Mononeuropathies of upper limb;rs114269199;C;0.8836350000000001;0.21474000000000001;0.08153200000000001;0.0084435;V64L;ENST00000447924
ACKR3;ENSG00000144476;30090-0.0;Platelet crit;rs146407095;A;1.0;0.0014290999999999998;0.00050371;0.0045525;V42I;ENST00000272928
ACKR3;ENSG00000144476;30090-0.0;Platelet crit;rs146407095;A;1.0;0.0014290999999999998;0.00050371;0.0045525;V42I;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1245;diabetes;rs150632398;T;1.0;-0.013766999999999998;0.0047021;0.0034140999999999998;H298Y;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_I44;I44 Atrioventricular and left bundle-branch block;rs142678508;C;0.710155;0.027933;0.008231200000000001;0.00069011;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_I44;I44 Atrioventricular and left bundle-branch block;rs142678508;C;0.710155;0.027933;0.008231200000000001;0.00069011;V168A;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1740;benign breast lump;rs35095494;A;0.9021969999999999;0.032042;0.0098647;0.0011618;V230I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_E15-E16;E15-E16 Other disorders of glucose regulation and pancreatic internal secretion;rs142678508;C;0.710155;0.01445;0.0041912;0.00056544;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_E15-E16;E15-E16 Other disorders of glucose regulation and pancreatic internal secretion;rs142678508;C;0.710155;0.01445;0.0041912;0.00056544;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_N89;N89 Other noninflammatory disorders of vagina;rs771402831;A;0.155664;0.080785;0.028315;0.0043298;R251Q;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_K07;K07 Dentofacial anomalies [including malocclusion];rs142678508;C;0.710155;0.009549;0.0033722;0.0046303;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_K07;K07 Dentofacial anomalies [including malocclusion];rs142678508;C;0.710155;0.009549;0.0033722;0.0046303;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_K07;K07 Dentofacial anomalies [including malocclusion];rs143408017;T;0.579412;0.0048702;0.0018436;0.0082498;A336V;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_E16;E16 Other disorders of pancreatic internal secretion;rs142678508;C;0.710155;0.014458000000000002;0.0041849;0.00055047;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_E16;E16 Other disorders of pancreatic internal secretion;rs142678508;C;0.710155;0.014458000000000002;0.0041849;0.00055047;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_M71;M71 Other bursopathies;rs142678508;C;0.710155;0.010647;0.0039296;0.006740899999999999;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_M71;M71 Other bursopathies;rs142678508;C;0.710155;0.010647;0.0039296;0.006740899999999999;V168A;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1685;osteopenia;rs35095494;A;0.9021969999999999;0.014898;0.004635;0.0013083;V230I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_L50-L54;L50-L54 Urticaria and erythema;rs142678508;C;0.710155;0.012785;0.0044477;0.004045900000000001;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_L50-L54;L50-L54 Urticaria and erythema;rs142678508;C;0.710155;0.012785;0.0044477;0.004045900000000001;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_I74;I74 Arterial embolism and thrombosis;rs146407095;A;1.0;0.001719;0.00065762;0.008948399999999999;V42I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_I74;I74 Arterial embolism and thrombosis;rs146407095;A;1.0;0.001719;0.00065762;0.008948399999999999;V42I;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_I71;I71 Aortic aneurysm and dissection;rs142678508;C;0.710155;0.014865;0.0050332;0.0031435;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_I71;I71 Aortic aneurysm and dissection;rs142678508;C;0.710155;0.014865;0.0050332;0.0031435;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_N39;N39 Other disorders of urinary system;rs143408017;T;0.579412;0.029562;0.010103000000000001;0.0034341999999999997;A336V;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_H61;H61 Other disorders of external ear;rs35095494;A;0.9021969999999999;0.015236000000000001;0.0045433999999999995;0.00079826;V230I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_N80;N80 Endometriosis;rs114269199;C;0.8836350000000001;0.59526;0.1024;6.1412e-09;V64L;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_N80;N80 Endometriosis;rs114269199;C;0.8836350000000001;0.59526;0.1024;6.1412e-09;V64L;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs146407095;A;1.0;0.0014095999999999998;0.00047709;0.0031320000000000002;V42I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs146407095;A;1.0;0.0014095999999999998;0.00047709;0.0031320000000000002;V42I;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_K08;K08 Other disorders of teeth and supporting structures;rs143408017;T;0.579412;0.013546;0.0038658;0.0004584;A336V;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1504;anaemia;rs142678508;C;0.710155;0.025458;0.008881700000000001;0.0041530000000000004;V168A;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1504;anaemia;rs142678508;C;0.710155;0.025458;0.008881700000000001;0.0041530000000000004;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_N64;N64 Other disorders of breast;rs143408017;T;0.579412;0.016316999999999998;0.0048597;0.00078626;A336V;ENST00000272928
ACKR3;ENSG00000144476;1438-0.0;Bread intake;rs150632398;T;1.0;-0.64984;0.18269000000000002;0.00037502;H298Y;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_M62;M62 Other disorders of muscle;rs150632398;T;1.0;0.0028668;0.0010934;0.0087429;H298Y;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_N47;N47 Redundant prepuce, phimosis and paraphimosis;rs143408017;T;0.579412;0.021889;0.0074116;0.0031443;A336V;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_L20-L30;L20-L30 Dermatitis and eczema;rs143408017;T;0.579412;0.016094999999999998;0.004202399999999999;0.00012814;A336V;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_L20-L30;L20-L30 Dermatitis and eczema;rs146407095;A;1.0;0.0036709000000000004;0.0012117;0.0024494;V42I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_L20-L30;L20-L30 Dermatitis and eczema;rs146407095;A;1.0;0.0036709000000000004;0.0012117;0.0024494;V42I;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_N35;N35 Urethral stricture;rs143408017;T;0.579412;0.011779000000000001;0.004290100000000001;0.0060404;A336V;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs35095494;A;0.9021969999999999;0.014818000000000001;0.0047615;0.0018576;V230I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_H43;H43 Disorders of vitreous body;rs35095494;A;0.9021969999999999;0.014159999999999999;0.0053413;0.0080258;V230I;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1621;obstetric problem;rs142678508;C;0.710155;0.031718;0.0084435;0.00017236;V168A;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1621;obstetric problem;rs142678508;C;0.710155;0.031718;0.0084435;0.00017236;V168A;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1510;dermatology;rs771402831;A;0.155664;0.13435999999999998;0.046765;0.0040654;R251Q;ENST00000272928
ACKR3;ENSG00000144476;cancer_c_C67;C67 Malignant neoplasm of bladder;rs771402831;A;0.155664;0.03071;0.010176000000000001;0.0025441;R251Q;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_K70;K70 Alcoholic liver disease;rs142678508;C;0.710155;0.014147999999999999;0.0039977;0.00040177;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_K70;K70 Alcoholic liver disease;rs142678508;C;0.710155;0.014147999999999999;0.0039977;0.00040177;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_K70;K70 Alcoholic liver disease;rs771402831;A;0.155664;0.02935;0.010657999999999999;0.0058913;R251Q;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_B35-B49;B35-B49 Mycoses;rs142678508;C;0.710155;0.020733;0.0071006;0.0035018999999999996;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_B35-B49;B35-B49 Mycoses;rs142678508;C;0.710155;0.020733;0.0071006;0.0035018999999999996;V168A;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1526;gout;rs114269199;C;0.8836350000000001;0.25559;0.060077;2.0964e-05;V64L;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1526;gout;rs114269199;C;0.8836350000000001;0.25559;0.060077;2.0964e-05;V64L;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1750;measles / morbillivirus;rs114269199;C;0.8836350000000001;0.18022;0.030044;1.9925000000000003e-09;V64L;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1750;measles / morbillivirus;rs114269199;C;0.8836350000000001;0.18022;0.030044;1.9925000000000003e-09;V64L;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1750;measles / morbillivirus;rs771402831;A;0.155664;0.066664;0.013588999999999999;9.301600000000001e-07;R251Q;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1503;clotting disorder/excessive bleeding;rs142678508;C;0.710155;0.013749;0.003932199999999999;0.00047145;V168A;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1503;clotting disorder/excessive bleeding;rs142678508;C;0.710155;0.013749;0.003932199999999999;0.00047145;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_O42;O42 Premature rupture of membranes;rs142678508;C;0.710155;0.025135;0.0081295;0.0019897;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_O42;O42 Premature rupture of membranes;rs142678508;C;0.710155;0.025135;0.0081295;0.0019897;V168A;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1266;neurological injury/trauma;rs142678508;C;0.710155;0.022956999999999998;0.006573699999999999;0.00047895;V168A;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1266;neurological injury/trauma;rs142678508;C;0.710155;0.022956999999999998;0.006573699999999999;0.00047895;V168A;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1266;neurological injury/trauma;rs35095494;A;0.9021969999999999;0.023755000000000002;0.006935899999999999;0.00061505;V230I;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1468;throat or larynx disorder;rs114269199;C;0.8836350000000001;0.17351;0.047127999999999996;0.00023168;V64L;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1468;throat or larynx disorder;rs114269199;C;0.8836350000000001;0.17351;0.047127999999999996;0.00023168;V64L;ENST00000447924
ACKR3;ENSG00000144476;30260-0.0;Mean reticulocyte volume;rs771402831;A;0.155664;-3.935;1.4745;0.0076135000000000005;R251Q;ENST00000272928
ACKR3;ENSG00000144476;30080-0.0;Platelet count;rs146407095;A;1.0;1.9389;0.60807;0.0014297000000000001;V42I;ENST00000272928
ACKR3;ENSG00000144476;30080-0.0;Platelet count;rs146407095;A;1.0;1.9389;0.60807;0.0014297000000000001;V42I;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_O32;O32 Maternal care for known or suspected malpresentation of foetus;rs146407095;A;1.0;0.0036374;0.0012924000000000002;0.0048868;V42I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_O32;O32 Maternal care for known or suspected malpresentation of foetus;rs146407095;A;1.0;0.0036374;0.0012924000000000002;0.0048868;V42I;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_N32;N32 Other disorders of bladder;rs143408017;T;0.579412;0.01896;0.0069184;0.0061351999999999995;A336V;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_D63;D63 Anaemia in chronic diseases classified elsewhere;rs142678508;C;0.710155;0.013833000000000002;0.003653;0.00015267;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_D63;D63 Anaemia in chronic diseases classified elsewhere;rs142678508;C;0.710155;0.013833000000000002;0.003653;0.00015267;V168A;ENST00000447924
ACKR3;ENSG00000144476;cancer_c_Block_C64-C68;C64-C68 Malignant neoplasms of urinary tract;rs771402831;A;0.155664;0.046082;0.015033000000000001;0.0021739999999999997;R251Q;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_I95-I99;I95-I99 Other and unspecified disorders of the circulatory system;rs142678508;C;0.710155;0.028260000000000004;0.010136;0.0053018;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_I95-I99;I95-I99 Other and unspecified disorders of the circulatory system;rs142678508;C;0.710155;0.028260000000000004;0.010136;0.0053018;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_I85;I85 Oesophageal varices;rs771402831;A;0.155664;0.033214999999999995;0.008364100000000001;7.1552e-05;R251Q;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_L02;L02 Cutaneous abscess, furuncle and carbuncle;rs771402831;A;0.155664;0.065338;0.017715;0.0002258;R251Q;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_I35;I35 Nonrheumatic aortic valve disorders;rs771402831;A;0.155664;0.053041;0.018451;0.0040453;R251Q;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_I77;I77 Other disorders of arteries and arterioles;rs35095494;A;0.9021969999999999;0.014351;0.0054818;0.0088471;V230I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_H54;H54 Blindness and low vision;rs142678508;C;0.710155;0.011228;0.0040685;0.005783399999999999;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_H54;H54 Blindness and low vision;rs142678508;C;0.710155;0.011228;0.0040685;0.005783399999999999;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_I78;I78 Diseases of capillaries;rs142678508;C;0.710155;0.016787;0.0035968000000000003;3.0538e-06;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_I78;I78 Diseases of capillaries;rs142678508;C;0.710155;0.016787;0.0035968000000000003;3.0538e-06;V168A;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1466;ent disorder/not cancer;rs35095494;A;0.9021969999999999;0.045754;0.017446;0.008727500000000001;V230I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_H18;H18 Other disorders of cornea;rs771402831;A;0.155664;0.064139;0.009282700000000001;4.8702e-12;R251Q;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1752;varicella zoster virus;rs114269199;C;0.8836350000000001;0.17631;0.035339999999999996;6.0706e-07;V64L;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1752;varicella zoster virus;rs114269199;C;0.8836350000000001;0.17631;0.035339999999999996;6.0706e-07;V64L;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1752;varicella zoster virus;rs771402831;A;0.155664;0.07157000000000001;0.015984;7.5462e-06;R251Q;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_N84;N84 Polyp of female genital tract;rs114269199;C;0.8836350000000001;0.55088;0.16787;0.0010324000000000002;V64L;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_N84;N84 Polyp of female genital tract;rs114269199;C;0.8836350000000001;0.55088;0.16787;0.0010324000000000002;V64L;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1350;spine arthritis/spondylitis;rs771402831;A;0.155664;0.064235;0.022031;0.0035491999999999998;R251Q;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1158;other abdominal problem;rs146407095;A;1.0;0.0040997;0.0015755;0.0092619;V42I;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1158;other abdominal problem;rs146407095;A;1.0;0.0040997;0.0015755;0.0092619;V42I;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_K02;K02 Dental caries;rs143408017;T;0.579412;0.015778999999999998;0.0041799;0.0001601;A336V;ENST00000272928
ACKR3;ENSG00000144476;cancer_c_D06;D06 Carcinoma in situ of cervix uteri;rs771402831;A;0.155664;0.084297;0.030391;0.0055415;R251Q;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1747;viral infection;rs114269199;C;0.8836350000000001;0.16741;0.045856;0.00026153;V64L;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1747;viral infection;rs114269199;C;0.8836350000000001;0.16741;0.045856;0.00026153;V64L;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1747;viral infection;rs771402831;A;0.155664;0.067682;0.02074;0.0011010999999999998;R251Q;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1502;haematology;rs142678508;C;0.710155;0.036841000000000006;0.01039;0.00039126;V168A;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1502;haematology;rs142678508;C;0.710155;0.036841000000000006;0.01039;0.00039126;V168A;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1573;dyspepsia / indigestion;rs35095494;A;0.9021969999999999;0.016182;0.0033131;1.0394e-06;V230I;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1720;fracture pelvis & lower limb;rs142678508;C;0.710155;0.021491999999999997;0.0080929;0.0079146;V168A;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1720;fracture pelvis & lower limb;rs142678508;C;0.710155;0.021491999999999997;0.0080929;0.0079146;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_Block_O80-O84;O80-O84 Delivery;rs35095494;A;0.9021969999999999;0.060354999999999985;0.014658;3.8286e-05;V230I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_N70;N70 Salpingitis and oophoritis;rs142678508;C;0.710155;0.021227;0.0057589;0.00022797;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_N70;N70 Salpingitis and oophoritis;rs142678508;C;0.710155;0.021227;0.0057589;0.00022797;V168A;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1292;head injury;rs142678508;C;0.710155;0.016547;0.0050921000000000004;0.0011561;V168A;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1292;head injury;rs142678508;C;0.710155;0.016547;0.0050921000000000004;0.0011561;V168A;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1292;head injury;rs35095494;A;0.9021969999999999;0.016805;0.005372699999999999;0.0017609000000000001;V230I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs142678508;C;0.710155;0.017131999999999998;0.0063571;0.0070409999999999995;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs142678508;C;0.710155;0.017131999999999998;0.0063571;0.0070409999999999995;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_J32;J32 Chronic sinusitis;rs771402831;A;0.155664;0.058747;0.018184;0.0012353;R251Q;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_K11;K11 Diseases of salivary glands;rs142678508;C;0.710155;0.01179;0.004382;0.0071318;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_K11;K11 Diseases of salivary glands;rs142678508;C;0.710155;0.01179;0.004382;0.0071318;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_Block_N30-N39;N30-N39 Other diseases of urinary system;rs143408017;T;0.579412;0.043102;0.012293;0.00045460000000000005;A336V;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_O80;O80 Single spontaneous delivery;rs35095494;A;0.9021969999999999;0.064432;0.012784;4.6613e-07;V230I;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1469;ear/vestibular disorder;rs35095494;A;0.9021969999999999;0.034693;0.011362;0.0022622;V230I;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1511;eczema/dermatitis;rs771402831;A;0.155664;0.12809;0.036854000000000005;0.00050988;R251Q;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_F40;F40 Phobic anxiety disorders;rs143408017;T;0.579412;0.005231100000000001;0.0017828;0.0033450000000000003;A336V;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_H15-H22;H15-H22 Disorders of sclera, cornea, iris and ciliary body;rs771402831;A;0.155664;0.051515;0.014843;0.00051908;R251Q;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1348;osteoporosis;rs142678508;C;0.710155;0.030835;0.010993000000000001;0.0050313;V168A;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1348;osteoporosis;rs142678508;C;0.710155;0.030835;0.010993000000000001;0.0050313;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_Block_M50-M54;M50-M54 Other dorsopathies;rs35095494;A;0.9021969999999999;0.06679;0.019729;0.00071064;V230I;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1154;stomach disorder;rs35095494;A;0.9021969999999999;0.032632;0.009794;0.00086293;V230I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_N83;N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament;rs142678508;C;0.710155;0.047125;0.017765;0.007987600000000001;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_N83;N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament;rs142678508;C;0.710155;0.047125;0.017765;0.007987600000000001;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_Block_E10-E14;E10-E14 Diabetes mellitus;rs142678508;C;0.710155;0.048232;0.017945;0.007191899999999999;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_Block_E10-E14;E10-E14 Diabetes mellitus;rs142678508;C;0.710155;0.048232;0.017945;0.007191899999999999;V168A;ENST00000447924
ACKR3;ENSG00000144476;1160-0.0;Sleep duration;rs142678508;C;0.710155;0.25819000000000003;0.09063;0.0043875;V168A;ENST00000272928
ACKR3;ENSG00000144476;1160-0.0;Sleep duration;rs142678508;C;0.710155;0.25819000000000003;0.09063;0.0043875;V168A;ENST00000447924
ACKR3;ENSG00000144476;selfReported_n_1623;miscarriage;rs142678508;C;0.710155;0.01937;0.007251899999999999;0.0075631;V168A;ENST00000272928
ACKR3;ENSG00000144476;selfReported_n_1623;miscarriage;rs142678508;C;0.710155;0.01937;0.007251899999999999;0.0075631;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_H60;H60 Otitis externa;rs35095494;A;0.9021969999999999;0.016122;0.0033564999999999997;1.5619999999999998e-06;V230I;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_B37;B37 Candidiasis;rs142678508;C;0.710155;0.018313999999999997;0.0063857;0.0041317;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_B37;B37 Candidiasis;rs142678508;C;0.710155;0.018313999999999997;0.0063857;0.0041317;V168A;ENST00000447924
ACKR3;ENSG00000144476;clinical_c_E87;E87 Other disorders of fluid, electrolyte and acid-base balance;rs142678508;C;0.710155;0.042372;0.009945;2.0392e-05;V168A;ENST00000272928
ACKR3;ENSG00000144476;clinical_c_E87;E87 Other disorders of fluid, electrolyte and acid-base balance;rs142678508;C;0.710155;0.042372;0.009945;2.0392e-05;V168A;ENST00000447924
CCR7;ENSG00000126353;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs148614545;C;0.8422270000000001;0.010081;0.0029729;0.0006961000000000001;K339R;ENST00000246657
CCR7;ENSG00000126353;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs148614545;C;0.8422270000000001;0.010081;0.0029729;0.0006961000000000001;K333R;ENST00000579344
CCR7;ENSG00000126353;selfReported_n_1390;gynaecological disorder (not cancer);rs148614545;C;0.8422270000000001;0.080801;0.02788;0.0037535;K339R;ENST00000246657
CCR7;ENSG00000126353;selfReported_n_1390;gynaecological disorder (not cancer);rs148614545;C;0.8422270000000001;0.080801;0.02788;0.0037535;K333R;ENST00000579344
CCR7;ENSG00000126353;clinical_c_Block_N00-N08;N00-N08 Glomerular diseases;rs148614545;C;0.8422270000000001;0.015285;0.0054078;0.0047062;K339R;ENST00000246657
CCR7;ENSG00000126353;clinical_c_Block_N00-N08;N00-N08 Glomerular diseases;rs148614545;C;0.8422270000000001;0.015285;0.0054078;0.0047062;K333R;ENST00000579344
CCR7;ENSG00000126353;clinical_c_N03;N03 Chronic nephritic syndrome;rs148614545;C;0.8422270000000001;0.0091744;0.0034719;0.0082318;K339R;ENST00000246657
CCR7;ENSG00000126353;clinical_c_N03;N03 Chronic nephritic syndrome;rs148614545;C;0.8422270000000001;0.0091744;0.0034719;0.0082318;K333R;ENST00000579344
CCR7;ENSG00000126353;clinical_c_I51;I51 Complications and ill-defined descriptions of heart disease;rs148614545;C;0.8422270000000001;0.024135;0.007568200000000001;0.0014276;K339R;ENST00000246657
CCR7;ENSG00000126353;clinical_c_I51;I51 Complications and ill-defined descriptions of heart disease;rs148614545;C;0.8422270000000001;0.024135;0.007568200000000001;0.0014276;K333R;ENST00000579344
CCR7;ENSG00000126353;cancer_c_C34;C34 Malignant neoplasm of bronchus and lung;rs148614545;C;0.8422270000000001;0.012775;0.0045994;0.0054781000000000005;K339R;ENST00000246657
CCR7;ENSG00000126353;cancer_c_C34;C34 Malignant neoplasm of bronchus and lung;rs148614545;C;0.8422270000000001;0.012775;0.0045994;0.0054781000000000005;K333R;ENST00000579344
CCR7;ENSG00000126353;clinical_c_K70;K70 Alcoholic liver disease;rs148614545;C;0.8422270000000001;0.009621700000000002;0.0034316000000000004;0.0050501999999999995;K339R;ENST00000246657
CCR7;ENSG00000126353;clinical_c_K70;K70 Alcoholic liver disease;rs148614545;C;0.8422270000000001;0.009621700000000002;0.0034316000000000004;0.0050501999999999995;K333R;ENST00000579344
CCR7;ENSG00000126353;clinical_c_Block_K20-K31;K20-K31 Diseases of oesophagus, stomach and duodenum;rs148614545;C;0.8422270000000001;0.068647;0.02603;0.008359100000000001;K339R;ENST00000246657
CCR7;ENSG00000126353;clinical_c_Block_K20-K31;K20-K31 Diseases of oesophagus, stomach and duodenum;rs148614545;C;0.8422270000000001;0.068647;0.02603;0.008359100000000001;K333R;ENST00000579344
CCR7;ENSG00000126353;selfReported_n_1615;uterine problem;rs148614545;C;0.8422270000000001;0.06644;0.023211;0.004204;K339R;ENST00000246657
CCR7;ENSG00000126353;selfReported_n_1615;uterine problem;rs148614545;C;0.8422270000000001;0.06644;0.023211;0.004204;K333R;ENST00000579344
CCR7;ENSG00000126353;clinical_c_E27;E27 Other disorders of adrenal gland;rs148614545;C;0.8422270000000001;0.010181;0.0025545000000000003;6.732899999999999e-05;K339R;ENST00000246657
CCR7;ENSG00000126353;clinical_c_E27;E27 Other disorders of adrenal gland;rs148614545;C;0.8422270000000001;0.010181;0.0025545000000000003;6.732899999999999e-05;K333R;ENST00000579344
CCR7;ENSG00000126353;clinical_c_G57;G57 Mononeuropathies of lower limb;rs148614545;C;0.8422270000000001;0.012969;0.0048086000000000005;0.0069967;K339R;ENST00000246657
CCR7;ENSG00000126353;clinical_c_G57;G57 Mononeuropathies of lower limb;rs148614545;C;0.8422270000000001;0.012969;0.0048086000000000005;0.0069967;K333R;ENST00000579344
CCR7;ENSG00000126353;clinical_c_K29;K29 Gastritis and duodenitis;rs148614545;C;0.8422270000000001;0.05149600000000001;0.018576;0.005568399999999999;K339R;ENST00000246657
CCR7;ENSG00000126353;clinical_c_K29;K29 Gastritis and duodenitis;rs148614545;C;0.8422270000000001;0.05149600000000001;0.018576;0.005568399999999999;K333R;ENST00000579344
CCR7;ENSG00000126353;clinical_c_H65;H65 Nonsuppurative otitis media;rs148614545;C;0.8422270000000001;0.011375;0.0038242;0.0029356;K339R;ENST00000246657
CCR7;ENSG00000126353;clinical_c_H65;H65 Nonsuppurative otitis media;rs148614545;C;0.8422270000000001;0.011375;0.0038242;0.0029356;K333R;ENST00000579344
CCR7;ENSG00000126353;selfReported_n_1262;disorder or pituitary gland;rs148614545;C;0.8422270000000001;0.010116;0.0028445000000000002;0.00037626;K339R;ENST00000246657
CCR7;ENSG00000126353;selfReported_n_1262;disorder or pituitary gland;rs148614545;C;0.8422270000000001;0.010116;0.0028445000000000002;0.00037626;K333R;ENST00000579344
CCR7;ENSG00000126353;clinical_c_N21;N21 Calculus of lower urinary tract;rs148614545;C;0.8422270000000001;0.0092367;0.0032709;0.004744300000000001;K339R;ENST00000246657
CCR7;ENSG00000126353;clinical_c_N21;N21 Calculus of lower urinary tract;rs148614545;C;0.8422270000000001;0.0092367;0.0032709;0.004744300000000001;K333R;ENST00000579344
CCR7;ENSG00000126353;clinical_c_I83;I83 Varicose veins of lower extremities;rs148614545;C;0.8422270000000001;0.035457999999999996;0.01192;0.0029326;K339R;ENST00000246657
CCR7;ENSG00000126353;clinical_c_I83;I83 Varicose veins of lower extremities;rs148614545;C;0.8422270000000001;0.035457999999999996;0.01192;0.0029326;K333R;ENST00000579344
ACKR1;ENSG00000213088;selfReported_n_1099;transient ischaemic attack (tia);rs147620003;T;0.75856;0.011476;0.003944400000000001;0.0036214;S154F;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1099;transient ischaemic attack (tia);rs147620003;T;0.75856;0.011476;0.003944400000000001;0.0036214;S152F;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1099;transient ischaemic attack (tia);rs147620003;T;0.75856;0.011476;0.003944400000000001;0.0036214;S152F;ENST00000537147
ACKR1;ENSG00000213088;1299-0.0;Salad / raw vegetable intake;rs118062001;T;0.731923;0.76269;0.23158;0.00098975;L69F;ENST00000368121
ACKR1;ENSG00000213088;1299-0.0;Salad / raw vegetable intake;rs118062001;T;0.731923;0.76269;0.23158;0.00098975;L67F;ENST00000368122
ACKR1;ENSG00000213088;1299-0.0;Salad / raw vegetable intake;rs118062001;T;0.731923;0.76269;0.23158;0.00098975;L67F;ENST00000537147
ACKR1;ENSG00000213088;30160-0.0;Basophill count;rs12075;A;1.0;0.00087132;7.9617e-05;7.1625e-28;G44D;ENST00000368121
ACKR1;ENSG00000213088;30160-0.0;Basophill count;rs12075;A;1.0;0.00087132;7.9617e-05;7.1625e-28;G42D;ENST00000368122
ACKR1;ENSG00000213088;30160-0.0;Basophill count;rs12075;A;1.0;0.00087132;7.9617e-05;7.1625e-28;G42D;ENST00000537147
ACKR1;ENSG00000213088;30160-0.0;Basophill count;rs13962;A;0.9625;0.00065655;0.00010512;4.2174000000000003e-10;A102T;ENST00000368121
ACKR1;ENSG00000213088;30160-0.0;Basophill count;rs13962;A;0.9625;0.00065655;0.00010512;4.2174000000000003e-10;A100T;ENST00000368122
ACKR1;ENSG00000213088;30160-0.0;Basophill count;rs13962;A;0.9625;0.00065655;0.00010512;4.2174000000000003e-10;A100T;ENST00000537147
ACKR1;ENSG00000213088;30160-0.0;Basophill count;rs34599082;T;1.0;0.0014455;0.00033933;2.0455e-05;R91C;ENST00000368121
ACKR1;ENSG00000213088;30160-0.0;Basophill count;rs34599082;T;1.0;0.0014455;0.00033933;2.0455e-05;R89C;ENST00000368122
ACKR1;ENSG00000213088;30160-0.0;Basophill count;rs34599082;T;1.0;0.0014455;0.00033933;2.0455e-05;R89C;ENST00000537147
ACKR1;ENSG00000213088;30210-0.0;Eosinophill percentage;rs34599082;T;1.0;0.043578;0.013456999999999998;0.0012027000000000001;R91C;ENST00000368121
ACKR1;ENSG00000213088;30210-0.0;Eosinophill percentage;rs34599082;T;1.0;0.043578;0.013456999999999998;0.0012027000000000001;R89C;ENST00000368122
ACKR1;ENSG00000213088;30210-0.0;Eosinophill percentage;rs34599082;T;1.0;0.043578;0.013456999999999998;0.0012027000000000001;R89C;ENST00000537147
ACKR1;ENSG00000213088;1408-0.0;Cheese intake;rs13962;A;0.9625;-0.0085316;0.0027737;0.0020987;A102T;ENST00000368121
ACKR1;ENSG00000213088;1408-0.0;Cheese intake;rs13962;A;0.9625;-0.0085316;0.0027737;0.0020987;A100T;ENST00000368122
ACKR1;ENSG00000213088;1408-0.0;Cheese intake;rs13962;A;0.9625;-0.0085316;0.0027737;0.0020987;A100T;ENST00000537147
ACKR1;ENSG00000213088;1408-0.0;Cheese intake;rs147620003;T;0.75856;0.1681;0.064179;0.008814;S154F;ENST00000368121
ACKR1;ENSG00000213088;1408-0.0;Cheese intake;rs147620003;T;0.75856;0.1681;0.064179;0.008814;S152F;ENST00000368122
ACKR1;ENSG00000213088;1408-0.0;Cheese intake;rs147620003;T;0.75856;0.1681;0.064179;0.008814;S152F;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1410;breast cysts;rs118062001;T;0.731923;0.036037;0.013596;0.008034999999999999;L69F;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1410;breast cysts;rs118062001;T;0.731923;0.036037;0.013596;0.008034999999999999;L67F;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1410;breast cysts;rs118062001;T;0.731923;0.036037;0.013596;0.008034999999999999;L67F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs13962;A;0.9625;-0.00028492;0.00010929;0.009130200000000002;A102T;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs13962;A;0.9625;-0.00028492;0.00010929;0.009130200000000002;A100T;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs13962;A;0.9625;-0.00028492;0.00010929;0.009130200000000002;A100T;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_Block_J40-J47;J40-J47 Chronic lower respiratory diseases;rs12075;A;1.0;-0.00146;0.00055511;0.0085363;G44D;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_Block_J40-J47;J40-J47 Chronic lower respiratory diseases;rs12075;A;1.0;-0.00146;0.00055511;0.0085363;G42D;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_Block_J40-J47;J40-J47 Chronic lower respiratory diseases;rs12075;A;1.0;-0.00146;0.00055511;0.0085363;G42D;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_A08;A08 Viral and other specified intestinal infections;rs17851570;T;0.81896;0.0040229;0.0013243;0.0023833;S328F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_A08;A08 Viral and other specified intestinal infections;rs17851570;T;0.81896;0.0040229;0.0013243;0.0023833;S326F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_A08;A08 Viral and other specified intestinal infections;rs17851570;T;0.81896;0.0040229;0.0013243;0.0023833;S326F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_N89;N89 Other noninflammatory disorders of vagina;rs17851570;T;0.81896;0.012534;0.0033054;0.0001496;S328F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_N89;N89 Other noninflammatory disorders of vagina;rs17851570;T;0.81896;0.012534;0.0033054;0.0001496;S326F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_N89;N89 Other noninflammatory disorders of vagina;rs17851570;T;0.81896;0.012534;0.0033054;0.0001496;S326F;ENST00000537147
ACKR1;ENSG00000213088;30120-0.0;Lymphocyte count;rs118062001;T;0.731923;0.19227;0.066885;0.0040454;L69F;ENST00000368121
ACKR1;ENSG00000213088;30120-0.0;Lymphocyte count;rs118062001;T;0.731923;0.19227;0.066885;0.0040454;L67F;ENST00000368122
ACKR1;ENSG00000213088;30120-0.0;Lymphocyte count;rs118062001;T;0.731923;0.19227;0.066885;0.0040454;L67F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_K07;K07 Dentofacial anomalies [including malocclusion];rs118062001;T;0.731923;0.014339;0.004838800000000001;0.0030432;L69F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_K07;K07 Dentofacial anomalies [including malocclusion];rs118062001;T;0.731923;0.014339;0.004838800000000001;0.0030432;L67F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_K07;K07 Dentofacial anomalies [including malocclusion];rs118062001;T;0.731923;0.014339;0.004838800000000001;0.0030432;L67F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_J03;J03 Acute tonsillitis;rs118062001;T;0.731923;0.015319;0.0047069;0.0011361;L69F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_J03;J03 Acute tonsillitis;rs118062001;T;0.731923;0.015319;0.0047069;0.0011361;L67F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_J03;J03 Acute tonsillitis;rs118062001;T;0.731923;0.015319;0.0047069;0.0011361;L67F;ENST00000537147
ACKR1;ENSG00000213088;1369-0.0;Beef intake;rs12075;A;1.0;0.0049081;0.0016634;0.0031706;G44D;ENST00000368121
ACKR1;ENSG00000213088;1369-0.0;Beef intake;rs12075;A;1.0;0.0049081;0.0016634;0.0031706;G42D;ENST00000368122
ACKR1;ENSG00000213088;1369-0.0;Beef intake;rs12075;A;1.0;0.0049081;0.0016634;0.0031706;G42D;ENST00000537147
ACKR1;ENSG00000213088;30220-0.0;Basophill percentage;rs12075;A;1.0;0.0099757;0.00088697;2.4191999999999996e-29;G44D;ENST00000368121
ACKR1;ENSG00000213088;30220-0.0;Basophill percentage;rs12075;A;1.0;0.0099757;0.00088697;2.4191999999999996e-29;G42D;ENST00000368122
ACKR1;ENSG00000213088;30220-0.0;Basophill percentage;rs12075;A;1.0;0.0099757;0.00088697;2.4191999999999996e-29;G42D;ENST00000537147
ACKR1;ENSG00000213088;30220-0.0;Basophill percentage;rs13962;A;0.9625;0.010789;0.0011710000000000002;3.1729000000000003e-20;A102T;ENST00000368121
ACKR1;ENSG00000213088;30220-0.0;Basophill percentage;rs13962;A;0.9625;0.010789;0.0011710000000000002;3.1729000000000003e-20;A100T;ENST00000368122
ACKR1;ENSG00000213088;30220-0.0;Basophill percentage;rs13962;A;0.9625;0.010789;0.0011710000000000002;3.1729000000000003e-20;A100T;ENST00000537147
ACKR1;ENSG00000213088;30220-0.0;Basophill percentage;rs17851570;T;0.81896;0.036316;0.012327;0.0032186999999999997;S328F;ENST00000368121
ACKR1;ENSG00000213088;30220-0.0;Basophill percentage;rs17851570;T;0.81896;0.036316;0.012327;0.0032186999999999997;S326F;ENST00000368122
ACKR1;ENSG00000213088;30220-0.0;Basophill percentage;rs17851570;T;0.81896;0.036316;0.012327;0.0032186999999999997;S326F;ENST00000537147
ACKR1;ENSG00000213088;30220-0.0;Basophill percentage;rs34599082;T;1.0;0.037295;0.0037799999999999995;5.8492e-23;R91C;ENST00000368121
ACKR1;ENSG00000213088;30220-0.0;Basophill percentage;rs34599082;T;1.0;0.037295;0.0037799999999999995;5.8492e-23;R89C;ENST00000368122
ACKR1;ENSG00000213088;30220-0.0;Basophill percentage;rs34599082;T;1.0;0.037295;0.0037799999999999995;5.8492e-23;R89C;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_N88;N88 Other noninflammatory disorders of cervix uteri;rs17851570;T;0.81896;0.0092546;0.0035364000000000007;0.0088729;S328F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_N88;N88 Other noninflammatory disorders of cervix uteri;rs17851570;T;0.81896;0.0092546;0.0035364000000000007;0.0088729;S326F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_N88;N88 Other noninflammatory disorders of cervix uteri;rs17851570;T;0.81896;0.0092546;0.0035364000000000007;0.0088729;S326F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_N63;N63 Unspecified lump in breast;rs17851570;T;0.81896;0.004762;0.0018008;0.008186;S328F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_N63;N63 Unspecified lump in breast;rs17851570;T;0.81896;0.004762;0.0018008;0.008186;S326F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_N63;N63 Unspecified lump in breast;rs17851570;T;0.81896;0.004762;0.0018008;0.008186;S326F;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1619;menorrhagia (unknown cause);rs118062001;T;0.731923;0.048901;0.011275;1.4434e-05;L69F;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1619;menorrhagia (unknown cause);rs118062001;T;0.731923;0.048901;0.011275;1.4434e-05;L67F;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1619;menorrhagia (unknown cause);rs118062001;T;0.731923;0.048901;0.011275;1.4434e-05;L67F;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1619;menorrhagia (unknown cause);rs12075;A;1.0;0.00065764;0.00020032;0.0010276;G44D;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1619;menorrhagia (unknown cause);rs12075;A;1.0;0.00065764;0.00020032;0.0010276;G42D;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1619;menorrhagia (unknown cause);rs12075;A;1.0;0.00065764;0.00020032;0.0010276;G42D;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_N64;N64 Other disorders of breast;rs147620003;T;0.75856;0.017574;0.0064548;0.006478;S154F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_N64;N64 Other disorders of breast;rs147620003;T;0.75856;0.017574;0.0064548;0.006478;S152F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_N64;N64 Other disorders of breast;rs147620003;T;0.75856;0.017574;0.0064548;0.006478;S152F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_K52;K52 Other non-infective gastro-enteritis and colitis;rs12075;A;1.0;-0.0012790999999999998;0.00040892;0.0017605999999999998;G44D;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_K52;K52 Other non-infective gastro-enteritis and colitis;rs12075;A;1.0;-0.0012790999999999998;0.00040892;0.0017605999999999998;G42D;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_K52;K52 Other non-infective gastro-enteritis and colitis;rs12075;A;1.0;-0.0012790999999999998;0.00040892;0.0017605999999999998;G42D;ENST00000537147
ACKR1;ENSG00000213088;cancer_c_C61;C61 Malignant neoplasm of prostate;rs12075;A;1.0;0.0020546;0.00053772;0.00013292;G44D;ENST00000368121
ACKR1;ENSG00000213088;cancer_c_C61;C61 Malignant neoplasm of prostate;rs12075;A;1.0;0.0020546;0.00053772;0.00013292;G42D;ENST00000368122
ACKR1;ENSG00000213088;cancer_c_C61;C61 Malignant neoplasm of prostate;rs12075;A;1.0;0.0020546;0.00053772;0.00013292;G42D;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1429;allergy or anaphylactic reaction to drug;rs17851570;T;0.81896;0.00707;0.0027321999999999997;0.0096634;S328F;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1429;allergy or anaphylactic reaction to drug;rs17851570;T;0.81896;0.00707;0.0027321999999999997;0.0096634;S326F;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1429;allergy or anaphylactic reaction to drug;rs17851570;T;0.81896;0.00707;0.0027321999999999997;0.0096634;S326F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_Block_K40-K46;K40-K46 Hernia;rs12075;A;1.0;-0.0019273;0.0006483;0.0029505;G44D;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_Block_K40-K46;K40-K46 Hernia;rs12075;A;1.0;-0.0019273;0.0006483;0.0029505;G42D;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_Block_K40-K46;K40-K46 Hernia;rs12075;A;1.0;-0.0019273;0.0006483;0.0029505;G42D;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1144;pleurisy;rs13962;A;0.9625;-0.00043778;0.00016353;0.007428399999999999;A102T;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1144;pleurisy;rs13962;A;0.9625;-0.00043778;0.00016353;0.007428399999999999;A100T;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1144;pleurisy;rs13962;A;0.9625;-0.00043778;0.00016353;0.007428399999999999;A100T;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1460;substance abuse/dependency;rs13962;A;0.9625;0.00031061;0.00011382;0.0063526;A102T;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1460;substance abuse/dependency;rs13962;A;0.9625;0.00031061;0.00011382;0.0063526;A100T;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1460;substance abuse/dependency;rs13962;A;0.9625;0.00031061;0.00011382;0.0063526;A100T;ENST00000537147
ACKR1;ENSG00000213088;30200-0.0;Neutrophill percentage;rs12075;A;1.0;0.055261000000000005;0.015412;0.0003363;G44D;ENST00000368121
ACKR1;ENSG00000213088;30200-0.0;Neutrophill percentage;rs12075;A;1.0;0.055261000000000005;0.015412;0.0003363;G42D;ENST00000368122
ACKR1;ENSG00000213088;30200-0.0;Neutrophill percentage;rs12075;A;1.0;0.055261000000000005;0.015412;0.0003363;G42D;ENST00000537147
ACKR1;ENSG00000213088;30200-0.0;Neutrophill percentage;rs13962;A;0.9625;-0.082165;0.020346;5.3831999999999996e-05;A102T;ENST00000368121
ACKR1;ENSG00000213088;30200-0.0;Neutrophill percentage;rs13962;A;0.9625;-0.082165;0.020346;5.3831999999999996e-05;A100T;ENST00000368122
ACKR1;ENSG00000213088;30200-0.0;Neutrophill percentage;rs13962;A;0.9625;-0.082165;0.020346;5.3831999999999996e-05;A100T;ENST00000537147
ACKR1;ENSG00000213088;30200-0.0;Neutrophill percentage;rs34599082;T;1.0;-0.8848799999999999;0.065666;2.22e-41;R91C;ENST00000368121
ACKR1;ENSG00000213088;30200-0.0;Neutrophill percentage;rs34599082;T;1.0;-0.8848799999999999;0.065666;2.22e-41;R89C;ENST00000368122
ACKR1;ENSG00000213088;30200-0.0;Neutrophill percentage;rs34599082;T;1.0;-0.8848799999999999;0.065666;2.22e-41;R89C;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_G25;G25 Other extrapyramidal and movement disorders;rs13962;A;0.9625;0.00028401;0.00010765;0.008331999999999999;A102T;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_G25;G25 Other extrapyramidal and movement disorders;rs13962;A;0.9625;0.00028401;0.00010765;0.008331999999999999;A100T;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_G25;G25 Other extrapyramidal and movement disorders;rs13962;A;0.9625;0.00028401;0.00010765;0.008331999999999999;A100T;ENST00000537147
ACKR1;ENSG00000213088;137-0.0;Number of treatments/medications taken;rs12075;A;1.0;-0.014309;0.005019600000000001;0.0043638;G44D;ENST00000368121
ACKR1;ENSG00000213088;137-0.0;Number of treatments/medications taken;rs12075;A;1.0;-0.014309;0.005019600000000001;0.0043638;G42D;ENST00000368122
ACKR1;ENSG00000213088;137-0.0;Number of treatments/medications taken;rs12075;A;1.0;-0.014309;0.005019600000000001;0.0043638;G42D;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_N41;N41 Inflammatory diseases of prostate;rs17851570;T;0.81896;0.01044;0.003934900000000001;0.007976;S328F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_N41;N41 Inflammatory diseases of prostate;rs17851570;T;0.81896;0.01044;0.003934900000000001;0.007976;S326F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_N41;N41 Inflammatory diseases of prostate;rs17851570;T;0.81896;0.01044;0.003934900000000001;0.007976;S326F;ENST00000537147
ACKR1;ENSG00000213088;30070-0.0;Red blood cell (erythrocyte) distribution width;rs12075;A;1.0;0.0044243;0.0016773;0.008344200000000001;G44D;ENST00000368121
ACKR1;ENSG00000213088;30070-0.0;Red blood cell (erythrocyte) distribution width;rs12075;A;1.0;0.0044243;0.0016773;0.008344200000000001;G42D;ENST00000368122
ACKR1;ENSG00000213088;30070-0.0;Red blood cell (erythrocyte) distribution width;rs12075;A;1.0;0.0044243;0.0016773;0.008344200000000001;G42D;ENST00000537147
ACKR1;ENSG00000213088;30260-0.0;Mean reticulocyte volume;rs12075;A;1.0;0.045098;0.013366999999999999;0.00074176;G44D;ENST00000368121
ACKR1;ENSG00000213088;30260-0.0;Mean reticulocyte volume;rs12075;A;1.0;0.045098;0.013366999999999999;0.00074176;G42D;ENST00000368122
ACKR1;ENSG00000213088;30260-0.0;Mean reticulocyte volume;rs12075;A;1.0;0.045098;0.013366999999999999;0.00074176;G42D;ENST00000537147
ACKR1;ENSG00000213088;30260-0.0;Mean reticulocyte volume;rs34599082;T;1.0;0.17443;0.056965999999999996;0.0021985;R91C;ENST00000368121
ACKR1;ENSG00000213088;30260-0.0;Mean reticulocyte volume;rs34599082;T;1.0;0.17443;0.056965999999999996;0.0021985;R89C;ENST00000368122
ACKR1;ENSG00000213088;30260-0.0;Mean reticulocyte volume;rs34599082;T;1.0;0.17443;0.056965999999999996;0.0021985;R89C;ENST00000537147
ACKR1;ENSG00000213088;30000-0.0;White blood cell (leukocyte) count;rs12075;A;1.0;0.020655;0.0031565;6.014e-11;G44D;ENST00000368121
ACKR1;ENSG00000213088;30000-0.0;White blood cell (leukocyte) count;rs12075;A;1.0;0.020655;0.0031565;6.014e-11;G42D;ENST00000368122
ACKR1;ENSG00000213088;30000-0.0;White blood cell (leukocyte) count;rs12075;A;1.0;0.020655;0.0031565;6.014e-11;G42D;ENST00000537147
ACKR1;ENSG00000213088;30000-0.0;White blood cell (leukocyte) count;rs13962;A;0.9625;-0.022628;0.004167199999999999;5.6379e-08;A102T;ENST00000368121
ACKR1;ENSG00000213088;30000-0.0;White blood cell (leukocyte) count;rs13962;A;0.9625;-0.022628;0.004167199999999999;5.6379e-08;A100T;ENST00000368122
ACKR1;ENSG00000213088;30000-0.0;White blood cell (leukocyte) count;rs13962;A;0.9625;-0.022628;0.004167199999999999;5.6379e-08;A100T;ENST00000537147
ACKR1;ENSG00000213088;30000-0.0;White blood cell (leukocyte) count;rs17851570;T;0.81896;-0.12607000000000002;0.043866;0.0040533999999999995;S328F;ENST00000368121
ACKR1;ENSG00000213088;30000-0.0;White blood cell (leukocyte) count;rs17851570;T;0.81896;-0.12607000000000002;0.043866;0.0040533999999999995;S326F;ENST00000368122
ACKR1;ENSG00000213088;30000-0.0;White blood cell (leukocyte) count;rs17851570;T;0.81896;-0.12607000000000002;0.043866;0.0040533999999999995;S326F;ENST00000537147
ACKR1;ENSG00000213088;30000-0.0;White blood cell (leukocyte) count;rs34599082;T;1.0;-0.20864000000000002;0.013449000000000001;2.9005e-54;R91C;ENST00000368121
ACKR1;ENSG00000213088;30000-0.0;White blood cell (leukocyte) count;rs34599082;T;1.0;-0.20864000000000002;0.013449000000000001;2.9005e-54;R89C;ENST00000368122
ACKR1;ENSG00000213088;30000-0.0;White blood cell (leukocyte) count;rs34599082;T;1.0;-0.20864000000000002;0.013449000000000001;2.9005e-54;R89C;ENST00000537147
ACKR1;ENSG00000213088;30080-0.0;Platelet count;rs12075;A;1.0;-0.25675;0.092852;0.0056903;G44D;ENST00000368121
ACKR1;ENSG00000213088;30080-0.0;Platelet count;rs12075;A;1.0;-0.25675;0.092852;0.0056903;G42D;ENST00000368122
ACKR1;ENSG00000213088;30080-0.0;Platelet count;rs12075;A;1.0;-0.25675;0.092852;0.0056903;G42D;ENST00000537147
ACKR1;ENSG00000213088;30190-0.0;Monocyte percentage;rs12075;A;1.0;0.027076999999999997;0.0038277000000000003;1.5066e-12;G44D;ENST00000368121
ACKR1;ENSG00000213088;30190-0.0;Monocyte percentage;rs12075;A;1.0;0.027076999999999997;0.0038277000000000003;1.5066e-12;G42D;ENST00000368122
ACKR1;ENSG00000213088;30190-0.0;Monocyte percentage;rs12075;A;1.0;0.027076999999999997;0.0038277000000000003;1.5066e-12;G42D;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_Block_L00-L08;L00-L08 Infections of the skin and subcutaneous tissue;rs34599082;T;1.0;-0.0043966000000000005;0.0014194000000000001;0.0019523;R91C;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_Block_L00-L08;L00-L08 Infections of the skin and subcutaneous tissue;rs34599082;T;1.0;-0.0043966000000000005;0.0014194000000000001;0.0019523;R89C;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_Block_L00-L08;L00-L08 Infections of the skin and subcutaneous tissue;rs34599082;T;1.0;-0.0043966000000000005;0.0014194000000000001;0.0019523;R89C;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1153;oesophageal disorder;rs17851570;T;0.81896;0.020326;0.0071454;0.0044467;S328F;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1153;oesophageal disorder;rs17851570;T;0.81896;0.020326;0.0071454;0.0044467;S326F;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1153;oesophageal disorder;rs17851570;T;0.81896;0.020326;0.0071454;0.0044467;S326F;ENST00000537147
ACKR1;ENSG00000213088;30270-0.0;Mean sphered cell volume;rs12075;A;1.0;0.024755000000000003;0.0087584;0.0047073;G44D;ENST00000368121
ACKR1;ENSG00000213088;30270-0.0;Mean sphered cell volume;rs12075;A;1.0;0.024755000000000003;0.0087584;0.0047073;G42D;ENST00000368122
ACKR1;ENSG00000213088;30270-0.0;Mean sphered cell volume;rs12075;A;1.0;0.024755000000000003;0.0087584;0.0047073;G42D;ENST00000537147
ACKR1;ENSG00000213088;30150-0.0;Eosinophill count;rs12075;A;1.0;0.00087375;0.00022725;0.00012059999999999999;G44D;ENST00000368121
ACKR1;ENSG00000213088;30150-0.0;Eosinophill count;rs12075;A;1.0;0.00087375;0.00022725;0.00012059999999999999;G42D;ENST00000368122
ACKR1;ENSG00000213088;30150-0.0;Eosinophill count;rs12075;A;1.0;0.00087375;0.00022725;0.00012059999999999999;G42D;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_O70;O70 Perineal laceration during delivery;rs147620003;T;0.75856;0.033178;0.012756;0.009297;S154F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_O70;O70 Perineal laceration during delivery;rs147620003;T;0.75856;0.033178;0.012756;0.009297;S152F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_O70;O70 Perineal laceration during delivery;rs147620003;T;0.75856;0.033178;0.012756;0.009297;S152F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_Block_G70-G73;G70-G73 Diseases of myoneural junction and muscle;rs147620003;T;0.75856;0.006534100000000001;0.0023013;0.004521;S154F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_Block_G70-G73;G70-G73 Diseases of myoneural junction and muscle;rs147620003;T;0.75856;0.006534100000000001;0.0023013;0.004521;S152F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_Block_G70-G73;G70-G73 Diseases of myoneural junction and muscle;rs147620003;T;0.75856;0.006534100000000001;0.0023013;0.004521;S152F;ENST00000537147
ACKR1;ENSG00000213088;30140-0.0;Neutrophill count;rs12075;A;1.0;0.016156;0.0025489;2.3191999999999999e-10;G44D;ENST00000368121
ACKR1;ENSG00000213088;30140-0.0;Neutrophill count;rs12075;A;1.0;0.016156;0.0025489;2.3191999999999999e-10;G42D;ENST00000368122
ACKR1;ENSG00000213088;30140-0.0;Neutrophill count;rs12075;A;1.0;0.016156;0.0025489;2.3191999999999999e-10;G42D;ENST00000537147
ACKR1;ENSG00000213088;30140-0.0;Neutrophill count;rs13962;A;0.9625;-0.020158000000000002;0.0033649;2.0905999999999998e-09;A102T;ENST00000368121
ACKR1;ENSG00000213088;30140-0.0;Neutrophill count;rs13962;A;0.9625;-0.020158000000000002;0.0033649;2.0905999999999998e-09;A100T;ENST00000368122
ACKR1;ENSG00000213088;30140-0.0;Neutrophill count;rs13962;A;0.9625;-0.020158000000000002;0.0033649;2.0905999999999998e-09;A100T;ENST00000537147
ACKR1;ENSG00000213088;30140-0.0;Neutrophill count;rs34599082;T;1.0;-0.1874;0.010859;1.0343e-66;R91C;ENST00000368121
ACKR1;ENSG00000213088;30140-0.0;Neutrophill count;rs34599082;T;1.0;-0.1874;0.010859;1.0343e-66;R89C;ENST00000368122
ACKR1;ENSG00000213088;30140-0.0;Neutrophill count;rs34599082;T;1.0;-0.1874;0.010859;1.0343e-66;R89C;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_G35;G35 Multiple sclerosis;rs12075;A;1.0;-0.0003128;0.00011736;0.0076923;G44D;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_G35;G35 Multiple sclerosis;rs12075;A;1.0;-0.0003128;0.00011736;0.0076923;G42D;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_G35;G35 Multiple sclerosis;rs12075;A;1.0;-0.0003128;0.00011736;0.0076923;G42D;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_M89;M89 Other disorders of bone;rs12075;A;1.0;0.00036926;0.00012884;0.0041573999999999995;G44D;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_M89;M89 Other disorders of bone;rs12075;A;1.0;0.00036926;0.00012884;0.0041573999999999995;G42D;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_M89;M89 Other disorders of bone;rs12075;A;1.0;0.00036926;0.00012884;0.0041573999999999995;G42D;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1734;rosacea;rs17851570;T;0.81896;0.0032976999999999998;0.0011710999999999998;0.0048628;S328F;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1734;rosacea;rs17851570;T;0.81896;0.0032976999999999998;0.0011710999999999998;0.0048628;S326F;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1734;rosacea;rs17851570;T;0.81896;0.0032976999999999998;0.0011710999999999998;0.0048628;S326F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_K50;K50 Crohn's disease [regional enteritis];rs147620003;T;0.75856;0.012824;0.004153100000000001;0.0020159;S154F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_K50;K50 Crohn's disease [regional enteritis];rs147620003;T;0.75856;0.012824;0.004153100000000001;0.0020159;S152F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_K50;K50 Crohn's disease [regional enteritis];rs147620003;T;0.75856;0.012824;0.004153100000000001;0.0020159;S152F;ENST00000537147
ACKR1;ENSG00000213088;30130-0.0;Monocyte count;rs12075;A;1.0;0.0029305;0.00028606;1.2602e-24;G44D;ENST00000368121
ACKR1;ENSG00000213088;30130-0.0;Monocyte count;rs12075;A;1.0;0.0029305;0.00028606;1.2602e-24;G42D;ENST00000368122
ACKR1;ENSG00000213088;30130-0.0;Monocyte count;rs12075;A;1.0;0.0029305;0.00028606;1.2602e-24;G42D;ENST00000537147
ACKR1;ENSG00000213088;30130-0.0;Monocyte count;rs13962;A;0.9625;-0.0018475000000000002;0.00037768;9.9945e-07;A102T;ENST00000368121
ACKR1;ENSG00000213088;30130-0.0;Monocyte count;rs13962;A;0.9625;-0.0018475000000000002;0.00037768;9.9945e-07;A100T;ENST00000368122
ACKR1;ENSG00000213088;30130-0.0;Monocyte count;rs13962;A;0.9625;-0.0018475000000000002;0.00037768;9.9945e-07;A100T;ENST00000537147
ACKR1;ENSG00000213088;30130-0.0;Monocyte count;rs17851570;T;0.81896;-0.011676;0.0039756;0.0033137;S328F;ENST00000368121
ACKR1;ENSG00000213088;30130-0.0;Monocyte count;rs17851570;T;0.81896;-0.011676;0.0039756;0.0033137;S326F;ENST00000368122
ACKR1;ENSG00000213088;30130-0.0;Monocyte count;rs17851570;T;0.81896;-0.011676;0.0039756;0.0033137;S326F;ENST00000537147
ACKR1;ENSG00000213088;30130-0.0;Monocyte count;rs34599082;T;1.0;-0.012605;0.0012190999999999999;4.6667e-25;R91C;ENST00000368121
ACKR1;ENSG00000213088;30130-0.0;Monocyte count;rs34599082;T;1.0;-0.012605;0.0012190999999999999;4.6667e-25;R89C;ENST00000368122
ACKR1;ENSG00000213088;30130-0.0;Monocyte count;rs34599082;T;1.0;-0.012605;0.0012190999999999999;4.6667e-25;R89C;ENST00000537147
ACKR1;ENSG00000213088;1687-0.0;Comparative body size at age 10;rs13962;A;0.9625;0.0058548;0.0016699000000000002;0.00045489;A102T;ENST00000368121
ACKR1;ENSG00000213088;1687-0.0;Comparative body size at age 10;rs13962;A;0.9625;0.0058548;0.0016699000000000002;0.00045489;A100T;ENST00000368122
ACKR1;ENSG00000213088;1687-0.0;Comparative body size at age 10;rs13962;A;0.9625;0.0058548;0.0016699000000000002;0.00045489;A100T;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1762;tropical & travel-related infections;rs118062001;T;0.731923;0.013645;0.0046685;0.0034693000000000007;L69F;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1762;tropical & travel-related infections;rs118062001;T;0.731923;0.013645;0.0046685;0.0034693000000000007;L67F;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1762;tropical & travel-related infections;rs118062001;T;0.731923;0.013645;0.0046685;0.0034693000000000007;L67F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_Block_K50-K52;K50-K52 Noninfective enteritis and colitis;rs12075;A;1.0;-0.0013767999999999999;0.00044244;0.0018591999999999999;G44D;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_Block_K50-K52;K50-K52 Noninfective enteritis and colitis;rs12075;A;1.0;-0.0013767999999999999;0.00044244;0.0018591999999999999;G42D;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_Block_K50-K52;K50-K52 Noninfective enteritis and colitis;rs12075;A;1.0;-0.0013767999999999999;0.00044244;0.0018591999999999999;G42D;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs118062001;T;0.731923;0.013643;0.00507;0.007127;L69F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs118062001;T;0.731923;0.013643;0.00507;0.007127;L67F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs118062001;T;0.731923;0.013643;0.00507;0.007127;L67F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_O46;O46 Antepartum haemorrhage, not elsewhere classified;rs118062001;T;0.731923;0.024073;0.008610799999999998;0.0051793;L69F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_O46;O46 Antepartum haemorrhage, not elsewhere classified;rs118062001;T;0.731923;0.024073;0.008610799999999998;0.0051793;L67F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_O46;O46 Antepartum haemorrhage, not elsewhere classified;rs118062001;T;0.731923;0.024073;0.008610799999999998;0.0051793;L67F;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1720;fracture pelvis & lower limb;rs17851570;T;0.81896;0.0075903;0.0026877;0.0047418;S328F;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1720;fracture pelvis & lower limb;rs17851570;T;0.81896;0.0075903;0.0026877;0.0047418;S326F;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1720;fracture pelvis & lower limb;rs17851570;T;0.81896;0.0075903;0.0026877;0.0047418;S326F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs12075;A;1.0;0.00043256;0.00015196;0.0044191000000000005;G44D;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs12075;A;1.0;0.00043256;0.00015196;0.0044191000000000005;G42D;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs12075;A;1.0;0.00043256;0.00015196;0.0044191000000000005;G42D;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs147620003;T;0.75856;0.014275;0.0046418;0.0021023000000000005;S154F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs147620003;T;0.75856;0.014275;0.0046418;0.0021023000000000005;S152F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_Block_G80-G83;G80-G83 Cerebral palsy and other paralytic syndromes;rs147620003;T;0.75856;0.014275;0.0046418;0.0021023000000000005;S152F;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1130;asthma;rs12075;A;1.0;-0.0022586999999999998;0.00063923;0.00041023;G44D;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1130;asthma;rs12075;A;1.0;-0.0022586999999999998;0.00063923;0.00041023;G42D;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1130;asthma;rs12075;A;1.0;-0.0022586999999999998;0.00063923;0.00041023;G42D;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1130;asthma;rs13962;A;0.9625;-0.0022305999999999997;0.0008439;0.0082128;A102T;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1130;asthma;rs13962;A;0.9625;-0.0022305999999999997;0.0008439;0.0082128;A100T;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1130;asthma;rs13962;A;0.9625;-0.0022305999999999997;0.0008439;0.0082128;A100T;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1536;high cholesterol;rs118062001;T;0.731923;-0.10564000000000001;0.038521;0.0060986999999999994;L69F;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1536;high cholesterol;rs118062001;T;0.731923;-0.10564000000000001;0.038521;0.0060986999999999994;L67F;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1536;high cholesterol;rs118062001;T;0.731923;-0.10564000000000001;0.038521;0.0060986999999999994;L67F;ENST00000537147
ACKR1;ENSG00000213088;selfReported_n_1417;allergy/hypersensitivity/anaphylaxis;rs13962;A;0.9625;-0.0021205;0.00071382;0.0029712;A102T;ENST00000368121
ACKR1;ENSG00000213088;selfReported_n_1417;allergy/hypersensitivity/anaphylaxis;rs13962;A;0.9625;-0.0021205;0.00071382;0.0029712;A100T;ENST00000368122
ACKR1;ENSG00000213088;selfReported_n_1417;allergy/hypersensitivity/anaphylaxis;rs13962;A;0.9625;-0.0021205;0.00071382;0.0029712;A100T;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_G91;G91 Hydrocephalus;rs118062001;T;0.731923;0.016058000000000003;0.0041979;0.00013066;L69F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_G91;G91 Hydrocephalus;rs118062001;T;0.731923;0.016058000000000003;0.0041979;0.00013066;L67F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_G91;G91 Hydrocephalus;rs118062001;T;0.731923;0.016058000000000003;0.0041979;0.00013066;L67F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_K90;K90 Intestinal malabsorption;rs12075;A;1.0;-0.00041727;0.00014812;0.0048468999999999995;G44D;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_K90;K90 Intestinal malabsorption;rs12075;A;1.0;-0.00041727;0.00014812;0.0048468999999999995;G42D;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_K90;K90 Intestinal malabsorption;rs12075;A;1.0;-0.00041727;0.00014812;0.0048468999999999995;G42D;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_M65;M65 Synovitis and tenosynovitis;rs13962;A;0.9625;0.00081174;0.00031128;0.0091144;A102T;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_M65;M65 Synovitis and tenosynovitis;rs13962;A;0.9625;0.00081174;0.00031128;0.0091144;A100T;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_M65;M65 Synovitis and tenosynovitis;rs13962;A;0.9625;0.00081174;0.00031128;0.0091144;A100T;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_J35;J35 Chronic diseases of tonsils and adenoids;rs17851570;T;0.81896;0.0046612;0.0014494999999999998;0.0013009;S328F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_J35;J35 Chronic diseases of tonsils and adenoids;rs17851570;T;0.81896;0.0046612;0.0014494999999999998;0.0013009;S326F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_J35;J35 Chronic diseases of tonsils and adenoids;rs17851570;T;0.81896;0.0046612;0.0014494999999999998;0.0013009;S326F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_J45;J45 Asthma;rs12075;A;1.0;-0.0013985999999999998;0.00049814;0.004991399999999999;G44D;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_J45;J45 Asthma;rs12075;A;1.0;-0.0013985999999999998;0.00049814;0.004991399999999999;G42D;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_J45;J45 Asthma;rs12075;A;1.0;-0.0013985999999999998;0.00049814;0.004991399999999999;G42D;ENST00000537147
ACKR1;ENSG00000213088;1458-0.0;Cereal intake;rs13962;A;0.9625;-0.021053;0.007385300000000001;0.0043638;A102T;ENST00000368121
ACKR1;ENSG00000213088;1458-0.0;Cereal intake;rs13962;A;0.9625;-0.021053;0.007385300000000001;0.0043638;A100T;ENST00000368122
ACKR1;ENSG00000213088;1458-0.0;Cereal intake;rs13962;A;0.9625;-0.021053;0.007385300000000001;0.0043638;A100T;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_G81;G81 Hemiplegia;rs147620003;T;0.75856;0.01272;0.0038513000000000006;0.00095781;S154F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_G81;G81 Hemiplegia;rs147620003;T;0.75856;0.01272;0.0038513000000000006;0.00095781;S152F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_G81;G81 Hemiplegia;rs147620003;T;0.75856;0.01272;0.0038513000000000006;0.00095781;S152F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_K82;K82 Other diseases of gallbladder;rs147620003;T;0.75856;0.011578;0.0042493;0.006437600000000001;S154F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_K82;K82 Other diseases of gallbladder;rs147620003;T;0.75856;0.011578;0.0042493;0.006437600000000001;S152F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_K82;K82 Other diseases of gallbladder;rs147620003;T;0.75856;0.011578;0.0042493;0.006437600000000001;S152F;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_L40;L40 Psoriasis;rs34599082;T;1.0;-0.0017322;0.00065474;0.0081545;R91C;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_L40;L40 Psoriasis;rs34599082;T;1.0;-0.0017322;0.00065474;0.0081545;R89C;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_L40;L40 Psoriasis;rs34599082;T;1.0;-0.0017322;0.00065474;0.0081545;R89C;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_K56;K56 Paralytic ileus and intestinal obstruction without hernia;rs147620003;T;0.75856;0.019377000000000002;0.0062883999999999995;0.0020599;S154F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_K56;K56 Paralytic ileus and intestinal obstruction without hernia;rs147620003;T;0.75856;0.019377000000000002;0.0062883999999999995;0.0020599;S152F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_K56;K56 Paralytic ileus and intestinal obstruction without hernia;rs147620003;T;0.75856;0.019377000000000002;0.0062883999999999995;0.0020599;S152F;ENST00000537147
ACKR1;ENSG00000213088;30180-0.0;Lymphocyte percentage;rs12075;A;1.0;-0.097036;0.013208000000000001;2.0384000000000002e-13;G44D;ENST00000368121
ACKR1;ENSG00000213088;30180-0.0;Lymphocyte percentage;rs12075;A;1.0;-0.097036;0.013208000000000001;2.0384000000000002e-13;G42D;ENST00000368122
ACKR1;ENSG00000213088;30180-0.0;Lymphocyte percentage;rs12075;A;1.0;-0.097036;0.013208000000000001;2.0384000000000002e-13;G42D;ENST00000537147
ACKR1;ENSG00000213088;30180-0.0;Lymphocyte percentage;rs13962;A;0.9625;0.069868;0.017438;6.1597e-05;A102T;ENST00000368121
ACKR1;ENSG00000213088;30180-0.0;Lymphocyte percentage;rs13962;A;0.9625;0.069868;0.017438;6.1597e-05;A100T;ENST00000368122
ACKR1;ENSG00000213088;30180-0.0;Lymphocyte percentage;rs13962;A;0.9625;0.069868;0.017438;6.1597e-05;A100T;ENST00000537147
ACKR1;ENSG00000213088;30180-0.0;Lymphocyte percentage;rs34599082;T;1.0;0.77436;0.05628;4.5833e-43;R91C;ENST00000368121
ACKR1;ENSG00000213088;30180-0.0;Lymphocyte percentage;rs34599082;T;1.0;0.77436;0.05628;4.5833e-43;R89C;ENST00000368122
ACKR1;ENSG00000213088;30180-0.0;Lymphocyte percentage;rs34599082;T;1.0;0.77436;0.05628;4.5833e-43;R89C;ENST00000537147
ACKR1;ENSG00000213088;30110-0.0;Platelet distribution width;rs13962;A;0.9625;0.003833;0.0011634;0.00098582;A102T;ENST00000368121
ACKR1;ENSG00000213088;30110-0.0;Platelet distribution width;rs13962;A;0.9625;0.003833;0.0011634;0.00098582;A100T;ENST00000368122
ACKR1;ENSG00000213088;30110-0.0;Platelet distribution width;rs13962;A;0.9625;0.003833;0.0011634;0.00098582;A100T;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_M53;M53 Other dorsopathies, not elsewhere classified;rs118062001;T;0.731923;0.014357;0.0046178999999999994;0.0018777000000000002;L69F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_M53;M53 Other dorsopathies, not elsewhere classified;rs118062001;T;0.731923;0.014357;0.0046178999999999994;0.0018777000000000002;L67F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_M53;M53 Other dorsopathies, not elsewhere classified;rs118062001;T;0.731923;0.014357;0.0046178999999999994;0.0018777000000000002;L67F;ENST00000537147
ACKR1;ENSG00000213088;cancer_c_Block_C60-C63;C60-C63 Malignant neoplasms of male genital organs;rs12075;A;1.0;0.0022599;0.00055512;4.6817e-05;G44D;ENST00000368121
ACKR1;ENSG00000213088;cancer_c_Block_C60-C63;C60-C63 Malignant neoplasms of male genital organs;rs12075;A;1.0;0.0022599;0.00055512;4.6817e-05;G42D;ENST00000368122
ACKR1;ENSG00000213088;cancer_c_Block_C60-C63;C60-C63 Malignant neoplasms of male genital organs;rs12075;A;1.0;0.0022599;0.00055512;4.6817e-05;G42D;ENST00000537147
ACKR1;ENSG00000213088;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs147620003;T;0.75856;0.008741500000000001;0.0033859000000000003;0.0098307;S154F;ENST00000368121
ACKR1;ENSG00000213088;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs147620003;T;0.75856;0.008741500000000001;0.0033859000000000003;0.0098307;S152F;ENST00000368122
ACKR1;ENSG00000213088;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs147620003;T;0.75856;0.008741500000000001;0.0033859000000000003;0.0098307;S152F;ENST00000537147
CCR2;ENSG00000121807;23121-0.0;Arm fat-free mass (right);rs1799864;A;1.0;0.0039602;0.0013825999999999999;0.0041792;V64I;ENST00000292301
CCR2;ENSG00000121807;23121-0.0;Arm fat-free mass (right);rs1799864;A;1.0;0.0039602;0.0013825999999999999;0.0041792;V64I;ENST00000400888
CCR2;ENSG00000121807;23121-0.0;Arm fat-free mass (right);rs1799864;A;1.0;0.0039602;0.0013825999999999999;0.0041792;V64I;ENST00000421659
CCR2;ENSG00000121807;23121-0.0;Arm fat-free mass (right);rs1799864;A;1.0;0.0039602;0.0013825999999999999;0.0041792;V64I;ENST00000445132
CCR2;ENSG00000121807;23128-0.0;Trunk fat mass;rs3918387;A;0.944699;-3.4146;1.1829;0.0038933999999999996;G355E;ENST00000292301
CCR2;ENSG00000121807;23128-0.0;Trunk fat mass;rs3918387;A;0.944699;-3.4146;1.1829;0.0038933999999999996;G355E;ENST00000400888
CCR2;ENSG00000121807;clinical_c_E10;E10 Insulin-dependent diabetes mellitus;rs1799864;A;1.0;-0.00088416;0.00032275;0.0061551;V64I;ENST00000292301
CCR2;ENSG00000121807;clinical_c_E10;E10 Insulin-dependent diabetes mellitus;rs1799864;A;1.0;-0.00088416;0.00032275;0.0061551;V64I;ENST00000400888
CCR2;ENSG00000121807;clinical_c_E10;E10 Insulin-dependent diabetes mellitus;rs1799864;A;1.0;-0.00088416;0.00032275;0.0061551;V64I;ENST00000421659
CCR2;ENSG00000121807;clinical_c_E10;E10 Insulin-dependent diabetes mellitus;rs1799864;A;1.0;-0.00088416;0.00032275;0.0061551;V64I;ENST00000445132
CCR2;ENSG00000121807;864-0.0;Number of days/week walked 10+ minutes;rs1799864;A;1.0;-0.019894;0.0073441;0.006751600000000001;V64I;ENST00000292301
CCR2;ENSG00000121807;864-0.0;Number of days/week walked 10+ minutes;rs1799864;A;1.0;-0.019894;0.0073441;0.006751600000000001;V64I;ENST00000400888
CCR2;ENSG00000121807;864-0.0;Number of days/week walked 10+ minutes;rs1799864;A;1.0;-0.019894;0.0073441;0.006751600000000001;V64I;ENST00000421659
CCR2;ENSG00000121807;864-0.0;Number of days/week walked 10+ minutes;rs1799864;A;1.0;-0.019894;0.0073441;0.006751600000000001;V64I;ENST00000445132
CCR2;ENSG00000121807;30210-0.0;Eosinophill percentage;rs1799864;A;1.0;-0.016852000000000002;0.005956800000000001;0.0046696;V64I;ENST00000292301
CCR2;ENSG00000121807;30210-0.0;Eosinophill percentage;rs1799864;A;1.0;-0.016852000000000002;0.005956800000000001;0.0046696;V64I;ENST00000400888
CCR2;ENSG00000121807;30210-0.0;Eosinophill percentage;rs1799864;A;1.0;-0.016852000000000002;0.005956800000000001;0.0046696;V64I;ENST00000421659
CCR2;ENSG00000121807;30210-0.0;Eosinophill percentage;rs1799864;A;1.0;-0.016852000000000002;0.005956800000000001;0.0046696;V64I;ENST00000445132
CCR2;ENSG00000121807;30210-0.0;Eosinophill percentage;rs3918387;A;0.944699;1.1579;0.42265;0.0061512;G355E;ENST00000292301
CCR2;ENSG00000121807;30210-0.0;Eosinophill percentage;rs3918387;A;0.944699;1.1579;0.42265;0.0061512;G355E;ENST00000400888
CCR2;ENSG00000121807;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs1799864;A;1.0;-0.00040916;0.00015618;0.008800299999999999;V64I;ENST00000292301
CCR2;ENSG00000121807;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs1799864;A;1.0;-0.00040916;0.00015618;0.008800299999999999;V64I;ENST00000400888
CCR2;ENSG00000121807;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs1799864;A;1.0;-0.00040916;0.00015618;0.008800299999999999;V64I;ENST00000421659
CCR2;ENSG00000121807;clinical_c_H93;H93 Other disorders of ear, not elsewhere classified;rs1799864;A;1.0;-0.00040916;0.00015618;0.008800299999999999;V64I;ENST00000445132
CCR2;ENSG00000121807;cancer_c_C50;C50 Malignant neoplasm of breast;rs779248623;T;0.626741;0.094321;0.03019;0.001783;T348M;ENST00000445132
CCR2;ENSG00000121807;selfReported_n_1098;stroke;rs200491743;A;0.770844;0.013819999999999999;0.0053366;0.009606;M249K;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1098;stroke;rs200491743;A;0.770844;0.013819999999999999;0.0053366;0.009606;M249K;ENST00000400888
CCR2;ENSG00000121807;selfReported_n_1098;stroke;rs200491743;A;0.770844;0.013819999999999999;0.0053366;0.009606;M249K;ENST00000445132
CCR2;ENSG00000121807;50-0.0;Standing height;rs1799864;A;1.0;0.045651;0.015931;0.0041625;V64I;ENST00000292301
CCR2;ENSG00000121807;50-0.0;Standing height;rs1799864;A;1.0;0.045651;0.015931;0.0041625;V64I;ENST00000400888
CCR2;ENSG00000121807;50-0.0;Standing height;rs1799864;A;1.0;0.045651;0.015931;0.0041625;V64I;ENST00000421659
CCR2;ENSG00000121807;50-0.0;Standing height;rs1799864;A;1.0;0.045651;0.015931;0.0041625;V64I;ENST00000445132
CCR2;ENSG00000121807;clinical_c_L82;L82 Seborrhoeic keratosis;rs779248623;T;0.626741;0.031687;0.0092084;0.00057945;T348M;ENST00000445132
CCR2;ENSG00000121807;clinical_c_G95;G95 Other diseases of spinal cord;rs779248623;T;0.626741;0.010981999999999999;0.0039622;0.0055780000000000005;T348M;ENST00000445132
CCR2;ENSG00000121807;clinical_c_F41;F41 Other anxiety disorders;rs200491743;A;0.770844;0.013877;0.0053515;0.009513299999999999;M249K;ENST00000292301
CCR2;ENSG00000121807;clinical_c_F41;F41 Other anxiety disorders;rs200491743;A;0.770844;0.013877;0.0053515;0.009513299999999999;M249K;ENST00000400888
CCR2;ENSG00000121807;clinical_c_F41;F41 Other anxiety disorders;rs200491743;A;0.770844;0.013877;0.0053515;0.009513299999999999;M249K;ENST00000445132
CCR2;ENSG00000121807;23127-0.0;Trunk fat percentage;rs3918387;A;0.944699;-7.0659;1.6829;2.6849e-05;G355E;ENST00000292301
CCR2;ENSG00000121807;23127-0.0;Trunk fat percentage;rs3918387;A;0.944699;-7.0659;1.6829;2.6849e-05;G355E;ENST00000400888
CCR2;ENSG00000121807;selfReported_n_1280;peripheral nerve disorder;rs779248623;T;0.626741;0.026437000000000002;0.0078837;0.00079825;T348M;ENST00000445132
CCR2;ENSG00000121807;23113-0.0;Leg fat-free mass (right);rs1799864;A;1.0;0.013488;0.0037975;0.00038264;V64I;ENST00000292301
CCR2;ENSG00000121807;23113-0.0;Leg fat-free mass (right);rs1799864;A;1.0;0.013488;0.0037975;0.00038264;V64I;ENST00000400888
CCR2;ENSG00000121807;23113-0.0;Leg fat-free mass (right);rs1799864;A;1.0;0.013488;0.0037975;0.00038264;V64I;ENST00000421659
CCR2;ENSG00000121807;23113-0.0;Leg fat-free mass (right);rs1799864;A;1.0;0.013488;0.0037975;0.00038264;V64I;ENST00000445132
CCR2;ENSG00000121807;clinical_c_G55;G55 Nerve root and plexus compressions in diseases classified elsewhere;rs1799864;A;1.0;0.0010317;0.00038855;0.0079275;V64I;ENST00000292301
CCR2;ENSG00000121807;clinical_c_G55;G55 Nerve root and plexus compressions in diseases classified elsewhere;rs1799864;A;1.0;0.0010317;0.00038855;0.0079275;V64I;ENST00000400888
CCR2;ENSG00000121807;clinical_c_G55;G55 Nerve root and plexus compressions in diseases classified elsewhere;rs1799864;A;1.0;0.0010317;0.00038855;0.0079275;V64I;ENST00000421659
CCR2;ENSG00000121807;clinical_c_G55;G55 Nerve root and plexus compressions in diseases classified elsewhere;rs1799864;A;1.0;0.0010317;0.00038855;0.0079275;V64I;ENST00000445132
CCR2;ENSG00000121807;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs779248623;T;0.626741;0.013134999999999999;0.0036528;0.00032334;T348M;ENST00000445132
CCR2;ENSG00000121807;clinical_c_K66;K66 Other disorders of peritoneum;rs3918387;A;0.944699;0.070899;0.024518;0.0038311;G355E;ENST00000292301
CCR2;ENSG00000121807;clinical_c_K66;K66 Other disorders of peritoneum;rs3918387;A;0.944699;0.070899;0.024518;0.0038311;G355E;ENST00000400888
CCR2;ENSG00000121807;23122-0.0;Arm predicted mass (right);rs1799864;A;1.0;0.0035872;0.0013032999999999999;0.0059166;V64I;ENST00000292301
CCR2;ENSG00000121807;23122-0.0;Arm predicted mass (right);rs1799864;A;1.0;0.0035872;0.0013032999999999999;0.0059166;V64I;ENST00000400888
CCR2;ENSG00000121807;23122-0.0;Arm predicted mass (right);rs1799864;A;1.0;0.0035872;0.0013032999999999999;0.0059166;V64I;ENST00000421659
CCR2;ENSG00000121807;23122-0.0;Arm predicted mass (right);rs1799864;A;1.0;0.0035872;0.0013032999999999999;0.0059166;V64I;ENST00000445132
CCR2;ENSG00000121807;clinical_c_Block_L20-L30;L20-L30 Dermatitis and eczema;rs3918387;A;0.944699;0.075512;0.024598;0.0021416;G355E;ENST00000292301
CCR2;ENSG00000121807;clinical_c_Block_L20-L30;L20-L30 Dermatitis and eczema;rs3918387;A;0.944699;0.075512;0.024598;0.0021416;G355E;ENST00000400888
CCR2;ENSG00000121807;selfReported_n_1249;thyroid problem (not cancer);rs1799864;A;1.0;0.0031119;0.00087688;0.00038693;V64I;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1249;thyroid problem (not cancer);rs1799864;A;1.0;0.0031119;0.00087688;0.00038693;V64I;ENST00000400888
CCR2;ENSG00000121807;selfReported_n_1249;thyroid problem (not cancer);rs1799864;A;1.0;0.0031119;0.00087688;0.00038693;V64I;ENST00000421659
CCR2;ENSG00000121807;selfReported_n_1249;thyroid problem (not cancer);rs1799864;A;1.0;0.0031119;0.00087688;0.00038693;V64I;ENST00000445132
CCR2;ENSG00000121807;selfReported_n_1566;anal problem;rs3918387;A;0.944699;0.074787;0.016085;3.3269e-06;G355E;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1566;anal problem;rs3918387;A;0.944699;0.074787;0.016085;3.3269e-06;G355E;ENST00000400888
CCR2;ENSG00000121807;clinical_c_M24;M24 Other specific joint derangements;rs3918387;A;0.944699;0.07787000000000001;0.022421;0.00051464;G355E;ENST00000292301
CCR2;ENSG00000121807;clinical_c_M24;M24 Other specific joint derangements;rs3918387;A;0.944699;0.07787000000000001;0.022421;0.00051464;G355E;ENST00000400888
CCR2;ENSG00000121807;selfReported_n_1557;varicose veins;rs3918387;A;0.944699;0.078449;0.016855000000000002;3.2494e-06;G355E;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1557;varicose veins;rs3918387;A;0.944699;0.078449;0.016855000000000002;3.2494e-06;G355E;ENST00000400888
CCR2;ENSG00000121807;clinical_c_H43;H43 Disorders of vitreous body;rs3918387;A;0.944699;0.076752;0.016199;2.1593000000000002e-06;G355E;ENST00000292301
CCR2;ENSG00000121807;clinical_c_H43;H43 Disorders of vitreous body;rs3918387;A;0.944699;0.076752;0.016199;2.1593000000000002e-06;G355E;ENST00000400888
CCR2;ENSG00000121807;23101-0.0;Whole body fat-free mass;rs1799864;A;1.0;0.058204;0.019084;0.0022896;V64I;ENST00000292301
CCR2;ENSG00000121807;23101-0.0;Whole body fat-free mass;rs1799864;A;1.0;0.058204;0.019084;0.0022896;V64I;ENST00000400888
CCR2;ENSG00000121807;23101-0.0;Whole body fat-free mass;rs1799864;A;1.0;0.058204;0.019084;0.0022896;V64I;ENST00000421659
CCR2;ENSG00000121807;23101-0.0;Whole body fat-free mass;rs1799864;A;1.0;0.058204;0.019084;0.0022896;V64I;ENST00000445132
CCR2;ENSG00000121807;clinical_c_H81;H81 Disorders of vestibular function;rs200491743;A;0.770844;0.006775499999999999;0.0022017;0.0020885;M249K;ENST00000292301
CCR2;ENSG00000121807;clinical_c_H81;H81 Disorders of vestibular function;rs200491743;A;0.770844;0.006775499999999999;0.0022017;0.0020885;M249K;ENST00000400888
CCR2;ENSG00000121807;clinical_c_H81;H81 Disorders of vestibular function;rs200491743;A;0.770844;0.006775499999999999;0.0022017;0.0020885;M249K;ENST00000445132
CCR2;ENSG00000121807;selfReported_n_1556;other venous/lymphatic disease;rs3918387;A;0.944699;0.077677;0.018127;1.826e-05;G355E;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1556;other venous/lymphatic disease;rs3918387;A;0.944699;0.077677;0.018127;1.826e-05;G355E;ENST00000400888
CCR2;ENSG00000121807;clinical_c_Block_B00-B09;B00-B09 Viral infections characterized by skin and mucous membrane lesions;rs779248623;T;0.626741;0.018233000000000003;0.0066661;0.006234;T348M;ENST00000445132
CCR2;ENSG00000121807;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs1799864;A;1.0;0.002032;0.00076386;0.007809999999999999;V64I;ENST00000292301
CCR2;ENSG00000121807;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs1799864;A;1.0;0.002032;0.00076386;0.007809999999999999;V64I;ENST00000400888
CCR2;ENSG00000121807;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs1799864;A;1.0;0.002032;0.00076386;0.007809999999999999;V64I;ENST00000421659
CCR2;ENSG00000121807;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs1799864;A;1.0;0.002032;0.00076386;0.007809999999999999;V64I;ENST00000445132
CCR2;ENSG00000121807;23114-0.0;Leg predicted mass (right);rs1799864;A;1.0;0.012459;0.003561;0.00046737;V64I;ENST00000292301
CCR2;ENSG00000121807;23114-0.0;Leg predicted mass (right);rs1799864;A;1.0;0.012459;0.003561;0.00046737;V64I;ENST00000400888
CCR2;ENSG00000121807;23114-0.0;Leg predicted mass (right);rs1799864;A;1.0;0.012459;0.003561;0.00046737;V64I;ENST00000421659
CCR2;ENSG00000121807;23114-0.0;Leg predicted mass (right);rs1799864;A;1.0;0.012459;0.003561;0.00046737;V64I;ENST00000445132
CCR2;ENSG00000121807;30200-0.0;Neutrophill percentage;rs3918387;A;0.944699;-5.3839999999999995;2.0539;0.0087575;G355E;ENST00000292301
CCR2;ENSG00000121807;30200-0.0;Neutrophill percentage;rs3918387;A;0.944699;-5.3839999999999995;2.0539;0.0087575;G355E;ENST00000400888
CCR2;ENSG00000121807;clinical_c_L29;L29 Pruritus;rs3918387;A;0.944699;0.078817;0.012151;8.786799999999999e-11;G355E;ENST00000292301
CCR2;ENSG00000121807;clinical_c_L29;L29 Pruritus;rs3918387;A;0.944699;0.078817;0.012151;8.786799999999999e-11;G355E;ENST00000400888
CCR2;ENSG00000121807;clinical_c_N72;N72 Inflammatory disease of cervix uteri;rs200491743;A;0.770844;0.011443;0.004431;0.0098108;M249K;ENST00000292301
CCR2;ENSG00000121807;clinical_c_N72;N72 Inflammatory disease of cervix uteri;rs200491743;A;0.770844;0.011443;0.004431;0.0098108;M249K;ENST00000400888
CCR2;ENSG00000121807;clinical_c_N72;N72 Inflammatory disease of cervix uteri;rs200491743;A;0.770844;0.011443;0.004431;0.0098108;M249K;ENST00000445132
CCR2;ENSG00000121807;20015-0.0;Sitting height;rs1799864;A;1.0;0.030258999999999998;0.010739;0.0048359;V64I;ENST00000292301
CCR2;ENSG00000121807;20015-0.0;Sitting height;rs1799864;A;1.0;0.030258999999999998;0.010739;0.0048359;V64I;ENST00000400888
CCR2;ENSG00000121807;20015-0.0;Sitting height;rs1799864;A;1.0;0.030258999999999998;0.010739;0.0048359;V64I;ENST00000421659
CCR2;ENSG00000121807;20015-0.0;Sitting height;rs1799864;A;1.0;0.030258999999999998;0.010739;0.0048359;V64I;ENST00000445132
CCR2;ENSG00000121807;clinical_c_N50;N50 Other disorders of male genital organs;rs3918387;A;0.944699;0.33503;0.067635;7.2947e-07;G355E;ENST00000292301
CCR2;ENSG00000121807;clinical_c_N50;N50 Other disorders of male genital organs;rs3918387;A;0.944699;0.33503;0.067635;7.2947e-07;G355E;ENST00000400888
CCR2;ENSG00000121807;30190-0.0;Monocyte percentage;rs1799864;A;1.0;-0.081944;0.007201100000000001;5.3461e-30;V64I;ENST00000292301
CCR2;ENSG00000121807;30190-0.0;Monocyte percentage;rs1799864;A;1.0;-0.081944;0.007201100000000001;5.3461e-30;V64I;ENST00000400888
CCR2;ENSG00000121807;30190-0.0;Monocyte percentage;rs1799864;A;1.0;-0.081944;0.007201100000000001;5.3461e-30;V64I;ENST00000421659
CCR2;ENSG00000121807;30190-0.0;Monocyte percentage;rs1799864;A;1.0;-0.081944;0.007201100000000001;5.3461e-30;V64I;ENST00000445132
CCR2;ENSG00000121807;30190-0.0;Monocyte percentage;rs200491743;A;0.770844;-0.48146000000000005;0.081247;3.1098e-09;M249K;ENST00000292301
CCR2;ENSG00000121807;30190-0.0;Monocyte percentage;rs200491743;A;0.770844;-0.48146000000000005;0.081247;3.1098e-09;M249K;ENST00000400888
CCR2;ENSG00000121807;30190-0.0;Monocyte percentage;rs200491743;A;0.770844;-0.48146000000000005;0.081247;3.1098e-09;M249K;ENST00000445132
CCR2;ENSG00000121807;clinical_c_M50;M50 Cervical disk disorders;rs779248623;T;0.626741;0.019941999999999998;0.006444199999999999;0.0019714000000000003;T348M;ENST00000445132
CCR2;ENSG00000121807;selfReported_n_1251;hypothyroidism/myxoedema;rs1799864;A;1.0;0.003522;0.00080638;1.2557999999999999e-05;V64I;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1251;hypothyroidism/myxoedema;rs1799864;A;1.0;0.003522;0.00080638;1.2557999999999999e-05;V64I;ENST00000400888
CCR2;ENSG00000121807;selfReported_n_1251;hypothyroidism/myxoedema;rs1799864;A;1.0;0.003522;0.00080638;1.2557999999999999e-05;V64I;ENST00000421659
CCR2;ENSG00000121807;selfReported_n_1251;hypothyroidism/myxoedema;rs1799864;A;1.0;0.003522;0.00080638;1.2557999999999999e-05;V64I;ENST00000445132
CCR2;ENSG00000121807;23118-0.0;Leg predicted mass (left);rs1799864;A;1.0;0.012399;0.0035789000000000003;0.00053117;V64I;ENST00000292301
CCR2;ENSG00000121807;23118-0.0;Leg predicted mass (left);rs1799864;A;1.0;0.012399;0.0035789000000000003;0.00053117;V64I;ENST00000400888
CCR2;ENSG00000121807;23118-0.0;Leg predicted mass (left);rs1799864;A;1.0;0.012399;0.0035789000000000003;0.00053117;V64I;ENST00000421659
CCR2;ENSG00000121807;23118-0.0;Leg predicted mass (left);rs1799864;A;1.0;0.012399;0.0035789000000000003;0.00053117;V64I;ENST00000445132
CCR2;ENSG00000121807;cancer_c_Block_C50-C50;C50-C50 Malignant neoplasm of breast;rs779248623;T;0.626741;0.094321;0.03019;0.001783;T348M;ENST00000445132
CCR2;ENSG00000121807;23099-0.0;Body fat percentage;rs3918387;A;0.944699;-5.4879;1.4605;0.00017162;G355E;ENST00000292301
CCR2;ENSG00000121807;23099-0.0;Body fat percentage;rs3918387;A;0.944699;-5.4879;1.4605;0.00017162;G355E;ENST00000400888
CCR2;ENSG00000121807;21002-0.0;Weight;rs1799864;A;1.0;0.11642000000000001;0.045004;0.0096836;V64I;ENST00000292301
CCR2;ENSG00000121807;21002-0.0;Weight;rs1799864;A;1.0;0.11642000000000001;0.045004;0.0096836;V64I;ENST00000400888
CCR2;ENSG00000121807;21002-0.0;Weight;rs1799864;A;1.0;0.11642000000000001;0.045004;0.0096836;V64I;ENST00000421659
CCR2;ENSG00000121807;21002-0.0;Weight;rs1799864;A;1.0;0.11642000000000001;0.045004;0.0096836;V64I;ENST00000445132
CCR2;ENSG00000121807;30150-0.0;Eosinophill count;rs1799864;A;1.0;-0.0015065999999999999;0.00042867;0.00044044;V64I;ENST00000292301
CCR2;ENSG00000121807;30150-0.0;Eosinophill count;rs1799864;A;1.0;-0.0015065999999999999;0.00042867;0.00044044;V64I;ENST00000400888
CCR2;ENSG00000121807;30150-0.0;Eosinophill count;rs1799864;A;1.0;-0.0015065999999999999;0.00042867;0.00044044;V64I;ENST00000421659
CCR2;ENSG00000121807;30150-0.0;Eosinophill count;rs1799864;A;1.0;-0.0015065999999999999;0.00042867;0.00044044;V64I;ENST00000445132
CCR2;ENSG00000121807;30150-0.0;Eosinophill count;rs3918387;A;0.944699;0.079367;0.030414999999999998;0.0090694;G355E;ENST00000292301
CCR2;ENSG00000121807;30150-0.0;Eosinophill count;rs3918387;A;0.944699;0.079367;0.030414999999999998;0.0090694;G355E;ENST00000400888
CCR2;ENSG00000121807;23105-0.0;Basal metabolic rate;rs1799864;A;1.0;7.837000000000001;2.5947;0.0025245000000000003;V64I;ENST00000292301
CCR2;ENSG00000121807;23105-0.0;Basal metabolic rate;rs1799864;A;1.0;7.837000000000001;2.5947;0.0025245000000000003;V64I;ENST00000400888
CCR2;ENSG00000121807;23105-0.0;Basal metabolic rate;rs1799864;A;1.0;7.837000000000001;2.5947;0.0025245000000000003;V64I;ENST00000421659
CCR2;ENSG00000121807;23105-0.0;Basal metabolic rate;rs1799864;A;1.0;7.837000000000001;2.5947;0.0025245000000000003;V64I;ENST00000445132
CCR2;ENSG00000121807;clinical_c_I85;I85 Oesophageal varices;rs779248623;T;0.626741;0.01036;0.0037851;0.0062019;T348M;ENST00000445132
CCR2;ENSG00000121807;2277-0.0;Frequency of solarium/sunlamp use;rs3918387;A;0.944699;3.4088;1.2676;0.0071648;G355E;ENST00000292301
CCR2;ENSG00000121807;2277-0.0;Frequency of solarium/sunlamp use;rs3918387;A;0.944699;3.4088;1.2676;0.0071648;G355E;ENST00000400888
CCR2;ENSG00000121807;clinical_c_E03;E03 Other hypothyroidism;rs1799864;A;1.0;0.0019579000000000003;0.0006986000000000001;0.0050698;V64I;ENST00000292301
CCR2;ENSG00000121807;clinical_c_E03;E03 Other hypothyroidism;rs1799864;A;1.0;0.0019579000000000003;0.0006986000000000001;0.0050698;V64I;ENST00000400888
CCR2;ENSG00000121807;clinical_c_E03;E03 Other hypothyroidism;rs1799864;A;1.0;0.0019579000000000003;0.0006986000000000001;0.0050698;V64I;ENST00000421659
CCR2;ENSG00000121807;clinical_c_E03;E03 Other hypothyroidism;rs1799864;A;1.0;0.0019579000000000003;0.0006986000000000001;0.0050698;V64I;ENST00000445132
CCR2;ENSG00000121807;clinical_c_I78;I78 Diseases of capillaries;rs779248623;T;0.626741;0.011958;0.004342800000000001;0.0058974;T348M;ENST00000445132
CCR2;ENSG00000121807;clinical_c_K92;K92 Other diseases of digestive system;rs779248623;T;0.626741;0.050986000000000004;0.015823;0.0012714;T348M;ENST00000445132
CCR2;ENSG00000121807;clinical_c_Block_G60-G64;G60-G64 Polyneuropathies and other disorders of the peripheral nervous system;rs779248623;T;0.626741;0.019308000000000002;0.0069997;0.005809300000000001;T348M;ENST00000445132
CCR2;ENSG00000121807;clinical_c_M46;M46 Other inflammatory spondylopathies;rs200491743;A;0.770844;0.0066035;0.0024941;0.0081044;M249K;ENST00000292301
CCR2;ENSG00000121807;clinical_c_M46;M46 Other inflammatory spondylopathies;rs200491743;A;0.770844;0.0066035;0.0024941;0.0081044;M249K;ENST00000400888
CCR2;ENSG00000121807;clinical_c_M46;M46 Other inflammatory spondylopathies;rs200491743;A;0.770844;0.0066035;0.0024941;0.0081044;M249K;ENST00000445132
CCR2;ENSG00000121807;selfReported_n_1516;malabsorption/coeliac disease;rs1799864;A;1.0;-0.00085116;0.00025744;0.00094544;V64I;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1516;malabsorption/coeliac disease;rs1799864;A;1.0;-0.00085116;0.00025744;0.00094544;V64I;ENST00000400888
CCR2;ENSG00000121807;selfReported_n_1516;malabsorption/coeliac disease;rs1799864;A;1.0;-0.00085116;0.00025744;0.00094544;V64I;ENST00000421659
CCR2;ENSG00000121807;selfReported_n_1516;malabsorption/coeliac disease;rs1799864;A;1.0;-0.00085116;0.00025744;0.00094544;V64I;ENST00000445132
CCR2;ENSG00000121807;23126-0.0;Arm predicted mass (left);rs1799864;A;1.0;0.0037896;0.0013890999999999999;0.006370000000000001;V64I;ENST00000292301
CCR2;ENSG00000121807;23126-0.0;Arm predicted mass (left);rs1799864;A;1.0;0.0037896;0.0013890999999999999;0.006370000000000001;V64I;ENST00000400888
CCR2;ENSG00000121807;23126-0.0;Arm predicted mass (left);rs1799864;A;1.0;0.0037896;0.0013890999999999999;0.006370000000000001;V64I;ENST00000421659
CCR2;ENSG00000121807;23126-0.0;Arm predicted mass (left);rs1799864;A;1.0;0.0037896;0.0013890999999999999;0.006370000000000001;V64I;ENST00000445132
CCR2;ENSG00000121807;30130-0.0;Monocyte count;rs1799864;A;1.0;-0.0059079;0.00053879;5.668999999999999e-28;V64I;ENST00000292301
CCR2;ENSG00000121807;30130-0.0;Monocyte count;rs1799864;A;1.0;-0.0059079;0.00053879;5.668999999999999e-28;V64I;ENST00000400888
CCR2;ENSG00000121807;30130-0.0;Monocyte count;rs1799864;A;1.0;-0.0059079;0.00053879;5.668999999999999e-28;V64I;ENST00000421659
CCR2;ENSG00000121807;30130-0.0;Monocyte count;rs1799864;A;1.0;-0.0059079;0.00053879;5.668999999999999e-28;V64I;ENST00000445132
CCR2;ENSG00000121807;30130-0.0;Monocyte count;rs200491743;A;0.770844;-0.025172;0.006079;3.4624e-05;M249K;ENST00000292301
CCR2;ENSG00000121807;30130-0.0;Monocyte count;rs200491743;A;0.770844;-0.025172;0.006079;3.4624e-05;M249K;ENST00000400888
CCR2;ENSG00000121807;30130-0.0;Monocyte count;rs200491743;A;0.770844;-0.025172;0.006079;3.4624e-05;M249K;ENST00000445132
CCR2;ENSG00000121807;23102-0.0;Whole body water mass;rs1799864;A;1.0;0.044611000000000005;0.014063999999999998;0.0015142;V64I;ENST00000292301
CCR2;ENSG00000121807;23102-0.0;Whole body water mass;rs1799864;A;1.0;0.044611000000000005;0.014063999999999998;0.0015142;V64I;ENST00000400888
CCR2;ENSG00000121807;23102-0.0;Whole body water mass;rs1799864;A;1.0;0.044611000000000005;0.014063999999999998;0.0015142;V64I;ENST00000421659
CCR2;ENSG00000121807;23102-0.0;Whole body water mass;rs1799864;A;1.0;0.044611000000000005;0.014063999999999998;0.0015142;V64I;ENST00000445132
CCR2;ENSG00000121807;selfReported_n_1747;viral infection;rs3918387;A;0.944699;0.069185;0.024904;0.0054686000000000005;G355E;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1747;viral infection;rs3918387;A;0.944699;0.069185;0.024904;0.0054686000000000005;G355E;ENST00000400888
CCR2;ENSG00000121807;clinical_c_Block_J00-J06;J00-J06 Acute upper respiratory infections;rs779248623;T;0.626741;0.027852;0.009011499999999999;0.0019972;T348M;ENST00000445132
CCR2;ENSG00000121807;clinical_c_Block_H43-H45;H43-H45 Disorders of vitreous body and globe;rs3918387;A;0.944699;0.07535599999999999;0.018215000000000002;3.519e-05;G355E;ENST00000292301
CCR2;ENSG00000121807;clinical_c_Block_H43-H45;H43-H45 Disorders of vitreous body and globe;rs3918387;A;0.944699;0.07535599999999999;0.018215000000000002;3.519e-05;G355E;ENST00000400888
CCR2;ENSG00000121807;23115-0.0;Leg fat percentage (left);rs3918387;A;0.944699;-3.3205;1.2111;0.0061125;G355E;ENST00000292301
CCR2;ENSG00000121807;23115-0.0;Leg fat percentage (left);rs3918387;A;0.944699;-3.3205;1.2111;0.0061125;G355E;ENST00000400888
CCR2;ENSG00000121807;clinical_c_M21;M21 Other acquired deformities of limbs;rs1799864;A;1.0;0.00069637;0.00025552;0.006425;V64I;ENST00000292301
CCR2;ENSG00000121807;clinical_c_M21;M21 Other acquired deformities of limbs;rs1799864;A;1.0;0.00069637;0.00025552;0.006425;V64I;ENST00000400888
CCR2;ENSG00000121807;clinical_c_M21;M21 Other acquired deformities of limbs;rs1799864;A;1.0;0.00069637;0.00025552;0.006425;V64I;ENST00000421659
CCR2;ENSG00000121807;clinical_c_M21;M21 Other acquired deformities of limbs;rs1799864;A;1.0;0.00069637;0.00025552;0.006425;V64I;ENST00000445132
CCR2;ENSG00000121807;clinical_c_Block_K90-K93;K90-K93 Other diseases of the digestive system;rs779248623;T;0.626741;0.050527999999999997;0.018305000000000002;0.0057729;T348M;ENST00000445132
CCR2;ENSG00000121807;selfReported_n_1511;eczema/dermatitis;rs3918387;A;0.944699;0.13537000000000002;0.044226;0.0022061999999999997;G355E;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1511;eczema/dermatitis;rs3918387;A;0.944699;0.13537000000000002;0.044226;0.0022061999999999997;G355E;ENST00000400888
CCR2;ENSG00000121807;23119-0.0;Arm fat percentage (right);rs3918387;A;0.944699;-5.1732;1.7442;0.0030177;G355E;ENST00000292301
CCR2;ENSG00000121807;23119-0.0;Arm fat percentage (right);rs3918387;A;0.944699;-5.1732;1.7442;0.0030177;G355E;ENST00000400888
CCR2;ENSG00000121807;selfReported_n_1417;allergy/hypersensitivity/anaphylaxis;rs200491743;A;0.770844;-0.033035;0.011503;0.0040826000000000005;M249K;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1417;allergy/hypersensitivity/anaphylaxis;rs200491743;A;0.770844;-0.033035;0.011503;0.0040826000000000005;M249K;ENST00000400888
CCR2;ENSG00000121807;selfReported_n_1417;allergy/hypersensitivity/anaphylaxis;rs200491743;A;0.770844;-0.033035;0.011503;0.0040826000000000005;M249K;ENST00000445132
CCR2;ENSG00000121807;30010-0.0;Red blood cell (erythrocyte) count;rs1799864;A;1.0;0.0036821999999999996;0.0011202999999999999;0.001013;V64I;ENST00000292301
CCR2;ENSG00000121807;30010-0.0;Red blood cell (erythrocyte) count;rs1799864;A;1.0;0.0036821999999999996;0.0011202999999999999;0.001013;V64I;ENST00000400888
CCR2;ENSG00000121807;30010-0.0;Red blood cell (erythrocyte) count;rs1799864;A;1.0;0.0036821999999999996;0.0011202999999999999;0.001013;V64I;ENST00000421659
CCR2;ENSG00000121807;30010-0.0;Red blood cell (erythrocyte) count;rs1799864;A;1.0;0.0036821999999999996;0.0011202999999999999;0.001013;V64I;ENST00000445132
CCR2;ENSG00000121807;clinical_c_J35;J35 Chronic diseases of tonsils and adenoids;rs200491743;A;0.770844;0.0062046;0.0022205;0.0052033;M249K;ENST00000292301
CCR2;ENSG00000121807;clinical_c_J35;J35 Chronic diseases of tonsils and adenoids;rs200491743;A;0.770844;0.0062046;0.0022205;0.0052033;M249K;ENST00000400888
CCR2;ENSG00000121807;clinical_c_J35;J35 Chronic diseases of tonsils and adenoids;rs200491743;A;0.770844;0.0062046;0.0022205;0.0052033;M249K;ENST00000445132
CCR2;ENSG00000121807;clinical_c_F43;F43 Reaction to severe stress, and adjustment disorders;rs779248623;T;0.626741;0.011741;0.0037813;0.0019034000000000002;T348M;ENST00000445132
CCR2;ENSG00000121807;clinical_c_N17;N17 Acute renal failure;rs3918387;A;0.944699;0.081084;0.029375;0.0057757;G355E;ENST00000292301
CCR2;ENSG00000121807;clinical_c_N17;N17 Acute renal failure;rs3918387;A;0.944699;0.081084;0.029375;0.0057757;G355E;ENST00000400888
CCR2;ENSG00000121807;clinical_c_K42;K42 Umbilical hernia;rs779248623;T;0.626741;0.028074;0.010055;0.0052381;T348M;ENST00000445132
CCR2;ENSG00000121807;23123-0.0;Arm fat percentage (left);rs3918387;A;0.944699;-5.1503;1.7545;0.0033298000000000004;G355E;ENST00000292301
CCR2;ENSG00000121807;23123-0.0;Arm fat percentage (left);rs3918387;A;0.944699;-5.1503;1.7545;0.0033298000000000004;G355E;ENST00000400888
CCR2;ENSG00000121807;selfReported_n_1608;neck problem/injury;rs3918387;A;0.944699;0.07016599999999999;0.025234;0.0054265;G355E;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1608;neck problem/injury;rs3918387;A;0.944699;0.07016599999999999;0.025234;0.0054265;G355E;ENST00000400888
CCR2;ENSG00000121807;23117-0.0;Leg fat-free mass (left);rs1799864;A;1.0;0.013269999999999999;0.0038159;0.00050617;V64I;ENST00000292301
CCR2;ENSG00000121807;23117-0.0;Leg fat-free mass (left);rs1799864;A;1.0;0.013269999999999999;0.0038159;0.00050617;V64I;ENST00000400888
CCR2;ENSG00000121807;23117-0.0;Leg fat-free mass (left);rs1799864;A;1.0;0.013269999999999999;0.0038159;0.00050617;V64I;ENST00000421659
CCR2;ENSG00000121807;23117-0.0;Leg fat-free mass (left);rs1799864;A;1.0;0.013269999999999999;0.0038159;0.00050617;V64I;ENST00000445132
CCR2;ENSG00000121807;clinical_c_G45;G45 Transient cerebral ischaemic attacks and related syndromes;rs779248623;T;0.626741;0.030885000000000003;0.0083594;0.00022024;T348M;ENST00000445132
CCR2;ENSG00000121807;23125-0.0;Arm fat-free mass (left);rs1799864;A;1.0;0.0038591000000000003;0.0014734000000000001;0.008813;V64I;ENST00000292301
CCR2;ENSG00000121807;23125-0.0;Arm fat-free mass (left);rs1799864;A;1.0;0.0038591000000000003;0.0014734000000000001;0.008813;V64I;ENST00000400888
CCR2;ENSG00000121807;23125-0.0;Arm fat-free mass (left);rs1799864;A;1.0;0.0038591000000000003;0.0014734000000000001;0.008813;V64I;ENST00000421659
CCR2;ENSG00000121807;23125-0.0;Arm fat-free mass (left);rs1799864;A;1.0;0.0038591000000000003;0.0014734000000000001;0.008813;V64I;ENST00000445132
CCR2;ENSG00000121807;selfReported_n_1176;hepatitis;rs3918387;A;0.944699;0.071969;0.019962;0.00031176;G355E;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1176;hepatitis;rs3918387;A;0.944699;0.071969;0.019962;0.00031176;G355E;ENST00000400888
CCR2;ENSG00000121807;selfReported_n_1176;hepatitis;rs779248623;T;0.626741;0.019766;0.007526899999999999;0.0086398;T348M;ENST00000445132
CCR2;ENSG00000121807;30180-0.0;Lymphocyte percentage;rs3918387;A;0.944699;4.703;1.7598;0.0075287999999999996;G355E;ENST00000292301
CCR2;ENSG00000121807;30180-0.0;Lymphocyte percentage;rs3918387;A;0.944699;4.703;1.7598;0.0075287999999999996;G355E;ENST00000400888
CCR2;ENSG00000121807;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs779248623;T;0.626741;0.012208;0.0044451000000000004;0.006026300000000001;T348M;ENST00000445132
CCR2;ENSG00000121807;23129-0.0;Trunk fat-free mass;rs1799864;A;1.0;0.026167000000000003;0.0097629;0.007356399999999999;V64I;ENST00000292301
CCR2;ENSG00000121807;23129-0.0;Trunk fat-free mass;rs1799864;A;1.0;0.026167000000000003;0.0097629;0.007356399999999999;V64I;ENST00000400888
CCR2;ENSG00000121807;23129-0.0;Trunk fat-free mass;rs1799864;A;1.0;0.026167000000000003;0.0097629;0.007356399999999999;V64I;ENST00000421659
CCR2;ENSG00000121807;23129-0.0;Trunk fat-free mass;rs1799864;A;1.0;0.026167000000000003;0.0097629;0.007356399999999999;V64I;ENST00000445132
CCR2;ENSG00000121807;selfReported_n_1541;cervical spondylosis;rs3918387;A;0.944699;0.071658;0.023867;0.0026785999999999997;G355E;ENST00000292301
CCR2;ENSG00000121807;selfReported_n_1541;cervical spondylosis;rs3918387;A;0.944699;0.071658;0.023867;0.0026785999999999997;G355E;ENST00000400888
CX3CR1;ENSG00000168329;23121-0.0;Arm fat-free mass (right);rs147724093;C;1.0;0.013568;0.0040262;0.00075184;P4A;ENST00000358309
CX3CR1;ENSG00000168329;23128-0.0;Trunk fat mass;rs41535248;A;1.0;-0.10912999999999999;0.038362;0.0044456;E45D;ENST00000358309
CX3CR1;ENSG00000168329;23128-0.0;Trunk fat mass;rs41535248;A;1.0;-0.10912999999999999;0.038362;0.0044456;E13D;ENST00000399220
CX3CR1;ENSG00000168329;23128-0.0;Trunk fat mass;rs41535248;A;1.0;-0.10912999999999999;0.038362;0.0044456;E13D;ENST00000412814
CX3CR1;ENSG00000168329;23128-0.0;Trunk fat mass;rs41535248;A;1.0;-0.10912999999999999;0.038362;0.0044456;E13D;ENST00000435290
CX3CR1;ENSG00000168329;23128-0.0;Trunk fat mass;rs41535248;A;1.0;-0.10912999999999999;0.038362;0.0044456;E13D;ENST00000541347
CX3CR1;ENSG00000168329;23128-0.0;Trunk fat mass;rs41535248;A;1.0;-0.10912999999999999;0.038362;0.0044456;E13D;ENST00000542107
CX3CR1;ENSG00000168329;1883-0.0;Number of full sisters;rs3732380;T;0.720038;0.53833;0.15595;0.00055649;V179I;ENST00000358309
CX3CR1;ENSG00000168329;1883-0.0;Number of full sisters;rs3732380;T;0.720038;0.53833;0.15595;0.00055649;V147I;ENST00000399220
CX3CR1;ENSG00000168329;1883-0.0;Number of full sisters;rs3732380;T;0.720038;0.53833;0.15595;0.00055649;V147I;ENST00000435290
CX3CR1;ENSG00000168329;1883-0.0;Number of full sisters;rs3732380;T;0.720038;0.53833;0.15595;0.00055649;V147I;ENST00000541347
CX3CR1;ENSG00000168329;1883-0.0;Number of full sisters;rs3732380;T;0.720038;0.53833;0.15595;0.00055649;V147I;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1560;pneumothorax;rs150319988;A;0.526638;0.020911000000000003;0.0071569;0.0034795;R350C;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1560;pneumothorax;rs150319988;A;0.526638;0.020911000000000003;0.0071569;0.0034795;R318C;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1560;pneumothorax;rs150319988;A;0.526638;0.020911000000000003;0.0071569;0.0034795;R318C;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1560;pneumothorax;rs150319988;A;0.526638;0.020911000000000003;0.0071569;0.0034795;R318C;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1560;pneumothorax;rs41535248;A;1.0;-0.0014249;0.00048535;0.003327;E45D;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1560;pneumothorax;rs41535248;A;1.0;-0.0014249;0.00048535;0.003327;E13D;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1560;pneumothorax;rs41535248;A;1.0;-0.0014249;0.00048535;0.003327;E13D;ENST00000412814
CX3CR1;ENSG00000168329;selfReported_n_1560;pneumothorax;rs41535248;A;1.0;-0.0014249;0.00048535;0.003327;E13D;ENST00000435290
CX3CR1;ENSG00000168329;selfReported_n_1560;pneumothorax;rs41535248;A;1.0;-0.0014249;0.00048535;0.003327;E13D;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1560;pneumothorax;rs41535248;A;1.0;-0.0014249;0.00048535;0.003327;E13D;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs199811198;C;1.0;0.0036205;0.0013525;0.007432899999999998;T89A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs199811198;C;1.0;0.0036205;0.0013525;0.007432899999999998;T57A;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs199811198;C;1.0;0.0036205;0.0013525;0.007432899999999998;T57A;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs199811198;C;1.0;0.0036205;0.0013525;0.007432899999999998;T57A;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs199811198;C;1.0;0.0036205;0.0013525;0.007432899999999998;T57A;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs199811198;C;1.0;0.0036205;0.0013525;0.007432899999999998;T57A;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs3732380;T;0.720038;0.032901;0.011229;0.0033896;V179I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs3732380;T;0.720038;0.032901;0.011229;0.0033896;V147I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs3732380;T;0.720038;0.032901;0.011229;0.0033896;V147I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs3732380;T;0.720038;0.032901;0.011229;0.0033896;V147I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs3732380;T;0.720038;0.032901;0.011229;0.0033896;V147I;ENST00000542107
CX3CR1;ENSG00000168329;cancer_c_Block_D00-D09;D00-D09 In situ neoplasms;rs11715522;C;1.0;0.00073332;0.0002663;0.0058915;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs3732378;A;1.0;0.00047845;0.00015574;0.0021250999999999996;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs3732378;A;1.0;0.00047845;0.00015574;0.0021250999999999996;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs3732378;A;1.0;0.00047845;0.00015574;0.0021250999999999996;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs3732378;A;1.0;0.00047845;0.00015574;0.0021250999999999996;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_I42;I42 Cardiomyopathy;rs139019894;C;0.889349;0.0041642;0.001557;0.007484;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_I42;I42 Cardiomyopathy;rs139019894;C;0.889349;0.0041642;0.001557;0.007484;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_I42;I42 Cardiomyopathy;rs139019894;C;0.889349;0.0041642;0.001557;0.007484;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_I42;I42 Cardiomyopathy;rs139019894;C;0.889349;0.0041642;0.001557;0.007484;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_I42;I42 Cardiomyopathy;rs139019894;C;0.889349;0.0041642;0.001557;0.007484;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_I42;I42 Cardiomyopathy;rs139019894;C;0.889349;0.0041642;0.001557;0.007484;D25G;ENST00000542107
CX3CR1;ENSG00000168329;23104-0.0;Body mass index (BMI);rs41535248;A;1.0;-0.094111;0.035253;0.0075951000000000005;E45D;ENST00000358309
CX3CR1;ENSG00000168329;23104-0.0;Body mass index (BMI);rs41535248;A;1.0;-0.094111;0.035253;0.0075951000000000005;E13D;ENST00000399220
CX3CR1;ENSG00000168329;23104-0.0;Body mass index (BMI);rs41535248;A;1.0;-0.094111;0.035253;0.0075951000000000005;E13D;ENST00000412814
CX3CR1;ENSG00000168329;23104-0.0;Body mass index (BMI);rs41535248;A;1.0;-0.094111;0.035253;0.0075951000000000005;E13D;ENST00000435290
CX3CR1;ENSG00000168329;23104-0.0;Body mass index (BMI);rs41535248;A;1.0;-0.094111;0.035253;0.0075951000000000005;E13D;ENST00000541347
CX3CR1;ENSG00000168329;23104-0.0;Body mass index (BMI);rs41535248;A;1.0;-0.094111;0.035253;0.0075951000000000005;E13D;ENST00000542107
CX3CR1;ENSG00000168329;cancer_c_Block_C51-C58;C51-C58 Malignant neoplasms of female genital organs;rs150319988;A;0.526638;0.051308000000000006;0.018057;0.0044915;R350C;ENST00000358309
CX3CR1;ENSG00000168329;cancer_c_Block_C51-C58;C51-C58 Malignant neoplasms of female genital organs;rs150319988;A;0.526638;0.051308000000000006;0.018057;0.0044915;R318C;ENST00000399220
CX3CR1;ENSG00000168329;cancer_c_Block_C51-C58;C51-C58 Malignant neoplasms of female genital organs;rs150319988;A;0.526638;0.051308000000000006;0.018057;0.0044915;R318C;ENST00000541347
CX3CR1;ENSG00000168329;cancer_c_Block_C51-C58;C51-C58 Malignant neoplasms of female genital organs;rs150319988;A;0.526638;0.051308000000000006;0.018057;0.0044915;R318C;ENST00000542107
CX3CR1;ENSG00000168329;cancer_c_Block_C51-C58;C51-C58 Malignant neoplasms of female genital organs;rs3732380;T;0.720038;0.060954;0.019869;0.0021566;V179I;ENST00000358309
CX3CR1;ENSG00000168329;cancer_c_Block_C51-C58;C51-C58 Malignant neoplasms of female genital organs;rs3732380;T;0.720038;0.060954;0.019869;0.0021566;V147I;ENST00000399220
CX3CR1;ENSG00000168329;cancer_c_Block_C51-C58;C51-C58 Malignant neoplasms of female genital organs;rs3732380;T;0.720038;0.060954;0.019869;0.0021566;V147I;ENST00000435290
CX3CR1;ENSG00000168329;cancer_c_Block_C51-C58;C51-C58 Malignant neoplasms of female genital organs;rs3732380;T;0.720038;0.060954;0.019869;0.0021566;V147I;ENST00000541347
CX3CR1;ENSG00000168329;cancer_c_Block_C51-C58;C51-C58 Malignant neoplasms of female genital organs;rs3732380;T;0.720038;0.060954;0.019869;0.0021566;V147I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_E10;E10 Insulin-dependent diabetes mellitus;rs3732378;A;1.0;0.0006372000000000001;0.00022292;0.004257899999999999;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_E10;E10 Insulin-dependent diabetes mellitus;rs3732378;A;1.0;0.0006372000000000001;0.00022292;0.004257899999999999;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_E10;E10 Insulin-dependent diabetes mellitus;rs3732378;A;1.0;0.0006372000000000001;0.00022292;0.004257899999999999;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_E10;E10 Insulin-dependent diabetes mellitus;rs3732378;A;1.0;0.0006372000000000001;0.00022292;0.004257899999999999;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_I44;I44 Atrioventricular and left bundle-branch block;rs3732379;T;1.0;0.00055948;0.00021583;0.0095381;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_I44;I44 Atrioventricular and left bundle-branch block;rs3732379;T;1.0;0.00055948;0.00021583;0.0095381;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_I44;I44 Atrioventricular and left bundle-branch block;rs3732379;T;1.0;0.00055948;0.00021583;0.0095381;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_I44;I44 Atrioventricular and left bundle-branch block;rs3732379;T;1.0;0.00055948;0.00021583;0.0095381;V249I;ENST00000542107
CX3CR1;ENSG00000168329;30030-0.0;Haematocrit percentage;rs11715522;C;1.0;-0.017731;0.005220300000000001;0.00068223;F8L;ENST00000358309
CX3CR1;ENSG00000168329;30210-0.0;Eosinophill percentage;rs11715522;C;1.0;0.008792200000000002;0.0032066000000000004;0.0061082;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M18;M18 Arthrosis of first carpometacarpal joint;rs139019894;C;0.889349;0.0042563;0.0015907999999999999;0.0074597;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M18;M18 Arthrosis of first carpometacarpal joint;rs139019894;C;0.889349;0.0042563;0.0015907999999999999;0.0074597;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_M18;M18 Arthrosis of first carpometacarpal joint;rs139019894;C;0.889349;0.0042563;0.0015907999999999999;0.0074597;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_M18;M18 Arthrosis of first carpometacarpal joint;rs139019894;C;0.889349;0.0042563;0.0015907999999999999;0.0074597;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_M18;M18 Arthrosis of first carpometacarpal joint;rs139019894;C;0.889349;0.0042563;0.0015907999999999999;0.0074597;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_M18;M18 Arthrosis of first carpometacarpal joint;rs139019894;C;0.889349;0.0042563;0.0015907999999999999;0.0074597;D25G;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_E15-E16;E15-E16 Other disorders of glucose regulation and pancreatic internal secretion;rs150319988;A;0.526638;0.024443;0.0064148;0.00013874;R350C;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_E15-E16;E15-E16 Other disorders of glucose regulation and pancreatic internal secretion;rs150319988;A;0.526638;0.024443;0.0064148;0.00013874;R318C;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_E15-E16;E15-E16 Other disorders of glucose regulation and pancreatic internal secretion;rs150319988;A;0.526638;0.024443;0.0064148;0.00013874;R318C;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_E15-E16;E15-E16 Other disorders of glucose regulation and pancreatic internal secretion;rs150319988;A;0.526638;0.024443;0.0064148;0.00013874;R318C;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1410;breast cysts;rs3732378;A;1.0;0.00081324;0.00031484;0.0097932;T312M;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1410;breast cysts;rs3732378;A;1.0;0.00081324;0.00031484;0.0097932;T280M;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1410;breast cysts;rs3732378;A;1.0;0.00081324;0.00031484;0.0097932;T280M;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1410;breast cysts;rs3732378;A;1.0;0.00081324;0.00031484;0.0097932;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_I26;I26 Pulmonary embolism;rs3732378;A;1.0;0.00083333;0.00025614;0.0011402;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_I26;I26 Pulmonary embolism;rs3732378;A;1.0;0.00083333;0.00025614;0.0011402;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_I26;I26 Pulmonary embolism;rs3732378;A;1.0;0.00083333;0.00025614;0.0011402;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_I26;I26 Pulmonary embolism;rs3732378;A;1.0;0.00083333;0.00025614;0.0011402;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_I26;I26 Pulmonary embolism;rs3732379;T;1.0;0.00060419;0.00021542;0.005035899999999999;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_I26;I26 Pulmonary embolism;rs3732379;T;1.0;0.00060419;0.00021542;0.005035899999999999;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_I26;I26 Pulmonary embolism;rs3732379;T;1.0;0.00060419;0.00021542;0.005035899999999999;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_I26;I26 Pulmonary embolism;rs3732379;T;1.0;0.00060419;0.00021542;0.005035899999999999;V249I;ENST00000542107
CX3CR1;ENSG00000168329;cancer_c_C50;C50 Malignant neoplasm of breast;rs3732380;T;0.720038;0.12804;0.0382;0.00080267;V179I;ENST00000358309
CX3CR1;ENSG00000168329;cancer_c_C50;C50 Malignant neoplasm of breast;rs3732380;T;0.720038;0.12804;0.0382;0.00080267;V147I;ENST00000399220
CX3CR1;ENSG00000168329;cancer_c_C50;C50 Malignant neoplasm of breast;rs3732380;T;0.720038;0.12804;0.0382;0.00080267;V147I;ENST00000435290
CX3CR1;ENSG00000168329;cancer_c_C50;C50 Malignant neoplasm of breast;rs3732380;T;0.720038;0.12804;0.0382;0.00080267;V147I;ENST00000541347
CX3CR1;ENSG00000168329;cancer_c_C50;C50 Malignant neoplasm of breast;rs3732380;T;0.720038;0.12804;0.0382;0.00080267;V147I;ENST00000542107
CX3CR1;ENSG00000168329;30120-0.0;Lymphocyte count;rs11715522;C;1.0;-0.0050885;0.0011273;6.367e-06;F8L;ENST00000358309
CX3CR1;ENSG00000168329;30120-0.0;Lymphocyte count;rs3732378;A;1.0;0.016291999999999997;0.0014462;1.9626999999999998e-29;T312M;ENST00000358309
CX3CR1;ENSG00000168329;30120-0.0;Lymphocyte count;rs3732378;A;1.0;0.016291999999999997;0.0014462;1.9626999999999998e-29;T280M;ENST00000399220
CX3CR1;ENSG00000168329;30120-0.0;Lymphocyte count;rs3732378;A;1.0;0.016291999999999997;0.0014462;1.9626999999999998e-29;T280M;ENST00000541347
CX3CR1;ENSG00000168329;30120-0.0;Lymphocyte count;rs3732378;A;1.0;0.016291999999999997;0.0014462;1.9626999999999998e-29;T280M;ENST00000542107
CX3CR1;ENSG00000168329;30120-0.0;Lymphocyte count;rs3732379;T;1.0;0.0081142;0.0012164;2.5528e-11;V281I;ENST00000358309
CX3CR1;ENSG00000168329;30120-0.0;Lymphocyte count;rs3732379;T;1.0;0.0081142;0.0012164;2.5528e-11;V249I;ENST00000399220
CX3CR1;ENSG00000168329;30120-0.0;Lymphocyte count;rs3732379;T;1.0;0.0081142;0.0012164;2.5528e-11;V249I;ENST00000541347
CX3CR1;ENSG00000168329;30120-0.0;Lymphocyte count;rs3732379;T;1.0;0.0081142;0.0012164;2.5528e-11;V249I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs3732378;A;1.0;0.0005902;0.00017458;0.00072327;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs3732378;A;1.0;0.0005902;0.00017458;0.00072327;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs3732378;A;1.0;0.0005902;0.00017458;0.00072327;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs3732378;A;1.0;0.0005902;0.00017458;0.00072327;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs3732379;T;1.0;0.00038068;0.00014683;0.009522599999999999;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs3732379;T;1.0;0.00038068;0.00014683;0.009522599999999999;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs3732379;T;1.0;0.00038068;0.00014683;0.009522599999999999;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs3732379;T;1.0;0.00038068;0.00014683;0.009522599999999999;V249I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_E16;E16 Other disorders of pancreatic internal secretion;rs150319988;A;0.526638;0.024452;0.006405;0.0001347;R350C;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_E16;E16 Other disorders of pancreatic internal secretion;rs150319988;A;0.526638;0.024452;0.006405;0.0001347;R318C;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_E16;E16 Other disorders of pancreatic internal secretion;rs150319988;A;0.526638;0.024452;0.006405;0.0001347;R318C;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_E16;E16 Other disorders of pancreatic internal secretion;rs150319988;A;0.526638;0.024452;0.006405;0.0001347;R318C;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_I26-I28;I26-I28 Pulmonary heart disease and diseases of pulmonary circulation;rs3732378;A;1.0;0.00093093;0.0002821;0.00096709;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_I26-I28;I26-I28 Pulmonary heart disease and diseases of pulmonary circulation;rs3732378;A;1.0;0.00093093;0.0002821;0.00096709;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_I26-I28;I26-I28 Pulmonary heart disease and diseases of pulmonary circulation;rs3732378;A;1.0;0.00093093;0.0002821;0.00096709;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_I26-I28;I26-I28 Pulmonary heart disease and diseases of pulmonary circulation;rs3732378;A;1.0;0.00093093;0.0002821;0.00096709;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_I26-I28;I26-I28 Pulmonary heart disease and diseases of pulmonary circulation;rs3732379;T;1.0;0.00063478;0.00023726;0.0074621999999999996;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_I26-I28;I26-I28 Pulmonary heart disease and diseases of pulmonary circulation;rs3732379;T;1.0;0.00063478;0.00023726;0.0074621999999999996;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_I26-I28;I26-I28 Pulmonary heart disease and diseases of pulmonary circulation;rs3732379;T;1.0;0.00063478;0.00023726;0.0074621999999999996;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_I26-I28;I26-I28 Pulmonary heart disease and diseases of pulmonary circulation;rs3732379;T;1.0;0.00063478;0.00023726;0.0074621999999999996;V249I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_I74;I74 Arterial embolism and thrombosis;rs143001773;T;1.0;0.0036652;0.0013503;0.0066392;V154I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_I74;I74 Arterial embolism and thrombosis;rs143001773;T;1.0;0.0036652;0.0013503;0.0066392;V122I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_I74;I74 Arterial embolism and thrombosis;rs143001773;T;1.0;0.0036652;0.0013503;0.0066392;V122I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_I74;I74 Arterial embolism and thrombosis;rs143001773;T;1.0;0.0036652;0.0013503;0.0066392;V122I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_I74;I74 Arterial embolism and thrombosis;rs143001773;T;1.0;0.0036652;0.0013503;0.0066392;V122I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_J03;J03 Acute tonsillitis;rs150319988;A;0.526638;0.023740999999999998;0.0050206;2.2609000000000002e-06;R350C;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_J03;J03 Acute tonsillitis;rs150319988;A;0.526638;0.023740999999999998;0.0050206;2.2609000000000002e-06;R318C;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_J03;J03 Acute tonsillitis;rs150319988;A;0.526638;0.023740999999999998;0.0050206;2.2609000000000002e-06;R318C;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_J03;J03 Acute tonsillitis;rs150319988;A;0.526638;0.023740999999999998;0.0050206;2.2609000000000002e-06;R318C;ENST00000542107
CX3CR1;ENSG00000168329;23127-0.0;Trunk fat percentage;rs41535248;A;1.0;-0.15619;0.054577999999999995;0.0042122;E45D;ENST00000358309
CX3CR1;ENSG00000168329;23127-0.0;Trunk fat percentage;rs41535248;A;1.0;-0.15619;0.054577999999999995;0.0042122;E13D;ENST00000399220
CX3CR1;ENSG00000168329;23127-0.0;Trunk fat percentage;rs41535248;A;1.0;-0.15619;0.054577999999999995;0.0042122;E13D;ENST00000412814
CX3CR1;ENSG00000168329;23127-0.0;Trunk fat percentage;rs41535248;A;1.0;-0.15619;0.054577999999999995;0.0042122;E13D;ENST00000435290
CX3CR1;ENSG00000168329;23127-0.0;Trunk fat percentage;rs41535248;A;1.0;-0.15619;0.054577999999999995;0.0042122;E13D;ENST00000541347
CX3CR1;ENSG00000168329;23127-0.0;Trunk fat percentage;rs41535248;A;1.0;-0.15619;0.054577999999999995;0.0042122;E13D;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1280;peripheral nerve disorder;rs143001773;T;1.0;0.0062191;0.0021149999999999997;0.0032777;V154I;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1280;peripheral nerve disorder;rs143001773;T;1.0;0.0062191;0.0021149999999999997;0.0032777;V122I;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1280;peripheral nerve disorder;rs143001773;T;1.0;0.0062191;0.0021149999999999997;0.0032777;V122I;ENST00000435290
CX3CR1;ENSG00000168329;selfReported_n_1280;peripheral nerve disorder;rs143001773;T;1.0;0.0062191;0.0021149999999999997;0.0032777;V122I;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1280;peripheral nerve disorder;rs143001773;T;1.0;0.0062191;0.0021149999999999997;0.0032777;V122I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_N03;N03 Chronic nephritic syndrome;rs3732378;A;1.0;0.00037324;0.00012605;0.003065;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_N03;N03 Chronic nephritic syndrome;rs3732378;A;1.0;0.00037324;0.00012605;0.003065;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_N03;N03 Chronic nephritic syndrome;rs3732378;A;1.0;0.00037324;0.00012605;0.003065;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_N03;N03 Chronic nephritic syndrome;rs3732378;A;1.0;0.00037324;0.00012605;0.003065;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_N03;N03 Chronic nephritic syndrome;rs3732379;T;1.0;0.00028181;0.00010601;0.0078521;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_N03;N03 Chronic nephritic syndrome;rs3732379;T;1.0;0.00028181;0.00010601;0.0078521;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_N03;N03 Chronic nephritic syndrome;rs3732379;T;1.0;0.00028181;0.00010601;0.0078521;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_N03;N03 Chronic nephritic syndrome;rs3732379;T;1.0;0.00028181;0.00010601;0.0078521;V249I;ENST00000542107
CX3CR1;ENSG00000168329;23113-0.0;Leg fat-free mass (right);rs147724093;C;1.0;0.031261000000000004;0.011059000000000001;0.0047015;P4A;ENST00000358309
CX3CR1;ENSG00000168329;30220-0.0;Basophill percentage;rs3732378;A;1.0;-0.0040527;0.0011522;0.00043607;T312M;ENST00000358309
CX3CR1;ENSG00000168329;30220-0.0;Basophill percentage;rs3732378;A;1.0;-0.0040527;0.0011522;0.00043607;T280M;ENST00000399220
CX3CR1;ENSG00000168329;30220-0.0;Basophill percentage;rs3732378;A;1.0;-0.0040527;0.0011522;0.00043607;T280M;ENST00000541347
CX3CR1;ENSG00000168329;30220-0.0;Basophill percentage;rs3732378;A;1.0;-0.0040527;0.0011522;0.00043607;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs3732380;T;0.720038;0.019119;0.0049046;9.692799999999999e-05;V179I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs3732380;T;0.720038;0.019119;0.0049046;9.692799999999999e-05;V147I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs3732380;T;0.720038;0.019119;0.0049046;9.692799999999999e-05;V147I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs3732380;T;0.720038;0.019119;0.0049046;9.692799999999999e-05;V147I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs3732380;T;0.720038;0.019119;0.0049046;9.692799999999999e-05;V147I;ENST00000542107
CX3CR1;ENSG00000168329;23122-0.0;Arm predicted mass (right);rs147724093;C;1.0;0.013085;0.0037953;0.00056564;P4A;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1520;rectal or colon adenoma/polyps;rs11715522;C;1.0;0.00033701;0.00011871;0.004526;F8L;ENST00000358309
CX3CR1;ENSG00000168329;21001-0.0;Body mass index (BMI);rs41535248;A;1.0;-0.095978;0.035526999999999996;0.006901600000000001;E45D;ENST00000358309
CX3CR1;ENSG00000168329;21001-0.0;Body mass index (BMI);rs41535248;A;1.0;-0.095978;0.035526999999999996;0.006901600000000001;E13D;ENST00000399220
CX3CR1;ENSG00000168329;21001-0.0;Body mass index (BMI);rs41535248;A;1.0;-0.095978;0.035526999999999996;0.006901600000000001;E13D;ENST00000412814
CX3CR1;ENSG00000168329;21001-0.0;Body mass index (BMI);rs41535248;A;1.0;-0.095978;0.035526999999999996;0.006901600000000001;E13D;ENST00000435290
CX3CR1;ENSG00000168329;21001-0.0;Body mass index (BMI);rs41535248;A;1.0;-0.095978;0.035526999999999996;0.006901600000000001;E13D;ENST00000541347
CX3CR1;ENSG00000168329;21001-0.0;Body mass index (BMI);rs41535248;A;1.0;-0.095978;0.035526999999999996;0.006901600000000001;E13D;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_D64;D64 Other anaemias;rs143001773;T;1.0;0.014965000000000001;0.0047146;0.0015026;V154I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_D64;D64 Other anaemias;rs143001773;T;1.0;0.014965000000000001;0.0047146;0.0015026;V122I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_D64;D64 Other anaemias;rs143001773;T;1.0;0.014965000000000001;0.0047146;0.0015026;V122I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_D64;D64 Other anaemias;rs143001773;T;1.0;0.014965000000000001;0.0047146;0.0015026;V122I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_D64;D64 Other anaemias;rs143001773;T;1.0;0.014965000000000001;0.0047146;0.0015026;V122I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_M62;M62 Other disorders of muscle;rs199811198;C;1.0;0.0023285999999999997;0.0007978;0.0035137000000000002;T89A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M62;M62 Other disorders of muscle;rs199811198;C;1.0;0.0023285999999999997;0.0007978;0.0035137000000000002;T57A;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_M62;M62 Other disorders of muscle;rs199811198;C;1.0;0.0023285999999999997;0.0007978;0.0035137000000000002;T57A;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_M62;M62 Other disorders of muscle;rs199811198;C;1.0;0.0023285999999999997;0.0007978;0.0035137000000000002;T57A;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_M62;M62 Other disorders of muscle;rs199811198;C;1.0;0.0023285999999999997;0.0007978;0.0035137000000000002;T57A;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_M62;M62 Other disorders of muscle;rs199811198;C;1.0;0.0023285999999999997;0.0007978;0.0035137000000000002;T57A;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1155;bowel problem;rs11715522;C;1.0;0.0018375999999999998;0.00052965;0.00052144;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_D51;D51 Vitamin B12 deficiency anaemia;rs3732380;T;0.720038;0.023748;0.0066153;0.00033099;V179I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_D51;D51 Vitamin B12 deficiency anaemia;rs3732380;T;0.720038;0.023748;0.0066153;0.00033099;V147I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_D51;D51 Vitamin B12 deficiency anaemia;rs3732380;T;0.720038;0.023748;0.0066153;0.00033099;V147I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_D51;D51 Vitamin B12 deficiency anaemia;rs3732380;T;0.720038;0.023748;0.0066153;0.00033099;V147I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_D51;D51 Vitamin B12 deficiency anaemia;rs3732380;T;0.720038;0.023748;0.0066153;0.00033099;V147I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_L20-L30;L20-L30 Dermatitis and eczema;rs11715522;C;1.0;0.00053405;0.00018662;0.0042133000000000006;F8L;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1249;thyroid problem (not cancer);rs3732378;A;1.0;0.0033104999999999996;0.00060564;4.6029e-08;T312M;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1249;thyroid problem (not cancer);rs3732378;A;1.0;0.0033104999999999996;0.00060564;4.6029e-08;T280M;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1249;thyroid problem (not cancer);rs3732378;A;1.0;0.0033104999999999996;0.00060564;4.6029e-08;T280M;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1249;thyroid problem (not cancer);rs3732378;A;1.0;0.0033104999999999996;0.00060564;4.6029e-08;T280M;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1249;thyroid problem (not cancer);rs3732379;T;1.0;0.0027241999999999995;0.00050935;8.8788e-08;V281I;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1249;thyroid problem (not cancer);rs3732379;T;1.0;0.0027241999999999995;0.00050935;8.8788e-08;V249I;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1249;thyroid problem (not cancer);rs3732379;T;1.0;0.0027241999999999995;0.00050935;8.8788e-08;V249I;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1249;thyroid problem (not cancer);rs3732379;T;1.0;0.0027241999999999995;0.00050935;8.8788e-08;V249I;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1527;other joint disorder;rs150319988;A;0.526638;0.047445999999999995;0.013229;0.00033522;R350C;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1527;other joint disorder;rs150319988;A;0.526638;0.047445999999999995;0.013229;0.00033522;R318C;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1527;other joint disorder;rs150319988;A;0.526638;0.047445999999999995;0.013229;0.00033522;R318C;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1527;other joint disorder;rs150319988;A;0.526638;0.047445999999999995;0.013229;0.00033522;R318C;ENST00000542107
CX3CR1;ENSG00000168329;23107-0.0;Impedance of leg (right);rs11715522;C;1.0;-0.16932;0.055387;0.0022356999999999998;F8L;ENST00000358309
CX3CR1;ENSG00000168329;23112-0.0;Leg fat mass (right);rs41535248;A;1.0;-0.034437;0.011842;0.0036371000000000003;E45D;ENST00000358309
CX3CR1;ENSG00000168329;23112-0.0;Leg fat mass (right);rs41535248;A;1.0;-0.034437;0.011842;0.0036371000000000003;E13D;ENST00000399220
CX3CR1;ENSG00000168329;23112-0.0;Leg fat mass (right);rs41535248;A;1.0;-0.034437;0.011842;0.0036371000000000003;E13D;ENST00000412814
CX3CR1;ENSG00000168329;23112-0.0;Leg fat mass (right);rs41535248;A;1.0;-0.034437;0.011842;0.0036371000000000003;E13D;ENST00000435290
CX3CR1;ENSG00000168329;23112-0.0;Leg fat mass (right);rs41535248;A;1.0;-0.034437;0.011842;0.0036371000000000003;E13D;ENST00000541347
CX3CR1;ENSG00000168329;23112-0.0;Leg fat mass (right);rs41535248;A;1.0;-0.034437;0.011842;0.0036371000000000003;E13D;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs201179424;C;0.754391;0.0069183000000000005;0.0021693000000000003;0.0014271;I324M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs201179424;C;0.754391;0.0069183000000000005;0.0021693000000000003;0.0014271;I292M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs201179424;C;0.754391;0.0069183000000000005;0.0021693000000000003;0.0014271;I292M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs201179424;C;0.754391;0.0069183000000000005;0.0021693000000000003;0.0014271;I292M;ENST00000542107
CX3CR1;ENSG00000168329;23101-0.0;Whole body fat-free mass;rs147724093;C;1.0;0.18475999999999998;0.055574;0.00088575;P4A;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1407;breast disease (not cancer);rs147724093;C;1.0;-0.0050905;0.0018859;0.006950199999999999;P4A;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1407;breast disease (not cancer);rs3732378;A;1.0;0.0011584000000000002;0.00044393;0.009069;T312M;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1407;breast disease (not cancer);rs3732378;A;1.0;0.0011584000000000002;0.00044393;0.009069;T280M;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1407;breast disease (not cancer);rs3732378;A;1.0;0.0011584000000000002;0.00044393;0.009069;T280M;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1407;breast disease (not cancer);rs3732378;A;1.0;0.0011584000000000002;0.00044393;0.009069;T280M;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1159;gastro-oesophageal reflux (gord) / gastric reflux;rs3732378;A;1.0;0.0014697;0.00055104;0.0076487;T312M;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1159;gastro-oesophageal reflux (gord) / gastric reflux;rs3732378;A;1.0;0.0014697;0.00055104;0.0076487;T280M;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1159;gastro-oesophageal reflux (gord) / gastric reflux;rs3732378;A;1.0;0.0014697;0.00055104;0.0076487;T280M;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1159;gastro-oesophageal reflux (gord) / gastric reflux;rs3732378;A;1.0;0.0014697;0.00055104;0.0076487;T280M;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1510;dermatology;rs41535248;A;1.0;-0.0050627;0.0018198;0.0054016;E45D;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1510;dermatology;rs41535248;A;1.0;-0.0050627;0.0018198;0.0054016;E13D;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1510;dermatology;rs41535248;A;1.0;-0.0050627;0.0018198;0.0054016;E13D;ENST00000412814
CX3CR1;ENSG00000168329;selfReported_n_1510;dermatology;rs41535248;A;1.0;-0.0050627;0.0018198;0.0054016;E13D;ENST00000435290
CX3CR1;ENSG00000168329;selfReported_n_1510;dermatology;rs41535248;A;1.0;-0.0050627;0.0018198;0.0054016;E13D;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1510;dermatology;rs41535248;A;1.0;-0.0050627;0.0018198;0.0054016;E13D;ENST00000542107
CX3CR1;ENSG00000168329;cancer_c_C67;C67 Malignant neoplasm of bladder;rs41535248;A;1.0;0.0011344;0.0003963;0.0042031;E45D;ENST00000358309
CX3CR1;ENSG00000168329;cancer_c_C67;C67 Malignant neoplasm of bladder;rs41535248;A;1.0;0.0011344;0.0003963;0.0042031;E13D;ENST00000399220
CX3CR1;ENSG00000168329;cancer_c_C67;C67 Malignant neoplasm of bladder;rs41535248;A;1.0;0.0011344;0.0003963;0.0042031;E13D;ENST00000412814
CX3CR1;ENSG00000168329;cancer_c_C67;C67 Malignant neoplasm of bladder;rs41535248;A;1.0;0.0011344;0.0003963;0.0042031;E13D;ENST00000435290
CX3CR1;ENSG00000168329;cancer_c_C67;C67 Malignant neoplasm of bladder;rs41535248;A;1.0;0.0011344;0.0003963;0.0042031;E13D;ENST00000541347
CX3CR1;ENSG00000168329;cancer_c_C67;C67 Malignant neoplasm of bladder;rs41535248;A;1.0;0.0011344;0.0003963;0.0042031;E13D;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_I12;I12 Hypertensive renal disease;rs139019894;C;0.889349;0.0048503;0.0017127;0.0046272;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_I12;I12 Hypertensive renal disease;rs139019894;C;0.889349;0.0048503;0.0017127;0.0046272;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_I12;I12 Hypertensive renal disease;rs139019894;C;0.889349;0.0048503;0.0017127;0.0046272;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_I12;I12 Hypertensive renal disease;rs139019894;C;0.889349;0.0048503;0.0017127;0.0046272;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_I12;I12 Hypertensive renal disease;rs139019894;C;0.889349;0.0048503;0.0017127;0.0046272;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_I12;I12 Hypertensive renal disease;rs139019894;C;0.889349;0.0048503;0.0017127;0.0046272;D25G;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1144;pleurisy;rs11715522;C;1.0;0.00036902;0.00012584;0.0033638000000000006;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_I30-I52;I30-I52 Other forms of heart disease;rs3732379;T;1.0;0.0015710999999999998;0.00056842;0.0057098999999999995;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_I30-I52;I30-I52 Other forms of heart disease;rs3732379;T;1.0;0.0015710999999999998;0.00056842;0.0057098999999999995;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_I30-I52;I30-I52 Other forms of heart disease;rs3732379;T;1.0;0.0015710999999999998;0.00056842;0.0057098999999999995;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_I30-I52;I30-I52 Other forms of heart disease;rs3732379;T;1.0;0.0015710999999999998;0.00056842;0.0057098999999999995;V249I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs3732378;A;1.0;0.0023031999999999996;0.00052758;1.268e-05;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs3732378;A;1.0;0.0023031999999999996;0.00052758;1.268e-05;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs3732378;A;1.0;0.0023031999999999996;0.00052758;1.268e-05;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs3732378;A;1.0;0.0023031999999999996;0.00052758;1.268e-05;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs3732379;T;1.0;0.0017617000000000002;0.00044371;7.1777e-05;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs3732379;T;1.0;0.0017617000000000002;0.00044371;7.1777e-05;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs3732379;T;1.0;0.0017617000000000002;0.00044371;7.1777e-05;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_E00-E07;E00-E07 Disorders of thyroid gland;rs3732379;T;1.0;0.0017617000000000002;0.00044371;7.1777e-05;V249I;ENST00000542107
CX3CR1;ENSG00000168329;23114-0.0;Leg predicted mass (right);rs147724093;C;1.0;0.0293;0.01037;0.004721100000000001;P4A;ENST00000358309
CX3CR1;ENSG00000168329;30020-0.0;Haemoglobin concentration;rs11715522;C;1.0;-0.0049752;0.0017695999999999999;0.0049312;F8L;ENST00000358309
CX3CR1;ENSG00000168329;23100-0.0;Whole body fat mass;rs41535248;A;1.0;-0.19992000000000001;0.069082;0.0038043;E45D;ENST00000358309
CX3CR1;ENSG00000168329;23100-0.0;Whole body fat mass;rs41535248;A;1.0;-0.19992000000000001;0.069082;0.0038043;E13D;ENST00000399220
CX3CR1;ENSG00000168329;23100-0.0;Whole body fat mass;rs41535248;A;1.0;-0.19992000000000001;0.069082;0.0038043;E13D;ENST00000412814
CX3CR1;ENSG00000168329;23100-0.0;Whole body fat mass;rs41535248;A;1.0;-0.19992000000000001;0.069082;0.0038043;E13D;ENST00000435290
CX3CR1;ENSG00000168329;23100-0.0;Whole body fat mass;rs41535248;A;1.0;-0.19992000000000001;0.069082;0.0038043;E13D;ENST00000541347
CX3CR1;ENSG00000168329;23100-0.0;Whole body fat mass;rs41535248;A;1.0;-0.19992000000000001;0.069082;0.0038043;E13D;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_M16;M16 Coxarthrosis [arthrosis of hip];rs3732379;T;1.0;0.0010168;0.00037767;0.0070982;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M16;M16 Coxarthrosis [arthrosis of hip];rs3732379;T;1.0;0.0010168;0.00037767;0.0070982;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_M16;M16 Coxarthrosis [arthrosis of hip];rs3732379;T;1.0;0.0010168;0.00037767;0.0070982;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_M16;M16 Coxarthrosis [arthrosis of hip];rs3732379;T;1.0;0.0010168;0.00037767;0.0070982;V249I;ENST00000542107
CX3CR1;ENSG00000168329;30200-0.0;Neutrophill percentage;rs3732378;A;1.0;-0.17553;0.019992;1.6395e-18;T312M;ENST00000358309
CX3CR1;ENSG00000168329;30200-0.0;Neutrophill percentage;rs3732378;A;1.0;-0.17553;0.019992;1.6395e-18;T280M;ENST00000399220
CX3CR1;ENSG00000168329;30200-0.0;Neutrophill percentage;rs3732378;A;1.0;-0.17553;0.019992;1.6395e-18;T280M;ENST00000541347
CX3CR1;ENSG00000168329;30200-0.0;Neutrophill percentage;rs3732378;A;1.0;-0.17553;0.019992;1.6395e-18;T280M;ENST00000542107
CX3CR1;ENSG00000168329;30200-0.0;Neutrophill percentage;rs3732379;T;1.0;-0.10211;0.016814;1.2604000000000001e-09;V281I;ENST00000358309
CX3CR1;ENSG00000168329;30200-0.0;Neutrophill percentage;rs3732379;T;1.0;-0.10211;0.016814;1.2604000000000001e-09;V249I;ENST00000399220
CX3CR1;ENSG00000168329;30200-0.0;Neutrophill percentage;rs3732379;T;1.0;-0.10211;0.016814;1.2604000000000001e-09;V249I;ENST00000541347
CX3CR1;ENSG00000168329;30200-0.0;Neutrophill percentage;rs3732379;T;1.0;-0.10211;0.016814;1.2604000000000001e-09;V249I;ENST00000542107
CX3CR1;ENSG00000168329;23106-0.0;Impedance of whole body;rs11715522;C;1.0;-0.35279;0.11292999999999999;0.0017840999999999998;F8L;ENST00000358309
CX3CR1;ENSG00000168329;23106-0.0;Impedance of whole body;rs147724093;C;1.0;-1.7693;0.6109100000000001;0.0037786;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs150319988;A;0.526638;0.12044;0.038822;0.0019203;R350C;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs150319988;A;0.526638;0.12044;0.038822;0.0019203;R318C;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs150319988;A;0.526638;0.12044;0.038822;0.0019203;R318C;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs150319988;A;0.526638;0.12044;0.038822;0.0019203;R318C;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_G31;G31 Other degenerative diseases of nervous system, not elsewhere classified;rs150319988;A;0.526638;0.016174;0.0051994;0.0018667999999999998;R350C;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_G31;G31 Other degenerative diseases of nervous system, not elsewhere classified;rs150319988;A;0.526638;0.016174;0.0051994;0.0018667999999999998;R318C;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_G31;G31 Other degenerative diseases of nervous system, not elsewhere classified;rs150319988;A;0.526638;0.016174;0.0051994;0.0018667999999999998;R318C;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_G31;G31 Other degenerative diseases of nervous system, not elsewhere classified;rs150319988;A;0.526638;0.016174;0.0051994;0.0018667999999999998;R318C;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_G25;G25 Other extrapyramidal and movement disorders;rs147724093;C;1.0;0.0013825999999999999;0.00044803;0.0020295;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs147724093;C;1.0;0.0063063;0.0019675;0.00135;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M06;M06 Other rheumatoid arthritis;rs150319988;A;0.526638;0.050247;0.013687999999999999;0.00024163;R350C;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M06;M06 Other rheumatoid arthritis;rs150319988;A;0.526638;0.050247;0.013687999999999999;0.00024163;R318C;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_M06;M06 Other rheumatoid arthritis;rs150319988;A;0.526638;0.050247;0.013687999999999999;0.00024163;R318C;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_M06;M06 Other rheumatoid arthritis;rs150319988;A;0.526638;0.050247;0.013687999999999999;0.00024163;R318C;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1081;hypertension;rs11715522;C;1.0;-0.0023975000000000003;0.00082355;0.0036006999999999996;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_K80;K80 Cholelithiasis;rs143001773;T;1.0;0.016316999999999998;0.0051372;0.0014925999999999997;V154I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_K80;K80 Cholelithiasis;rs143001773;T;1.0;0.016316999999999998;0.0051372;0.0014925999999999997;V122I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_K80;K80 Cholelithiasis;rs143001773;T;1.0;0.016316999999999998;0.0051372;0.0014925999999999997;V122I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_K80;K80 Cholelithiasis;rs143001773;T;1.0;0.016316999999999998;0.0051372;0.0014925999999999997;V122I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_K80;K80 Cholelithiasis;rs143001773;T;1.0;0.016316999999999998;0.0051372;0.0014925999999999997;V122I;ENST00000542107
CX3CR1;ENSG00000168329;137-0.0;Number of treatments/medications taken;rs41535248;A;1.0;-0.057101;0.021765;0.0087029;E45D;ENST00000358309
CX3CR1;ENSG00000168329;137-0.0;Number of treatments/medications taken;rs41535248;A;1.0;-0.057101;0.021765;0.0087029;E13D;ENST00000399220
CX3CR1;ENSG00000168329;137-0.0;Number of treatments/medications taken;rs41535248;A;1.0;-0.057101;0.021765;0.0087029;E13D;ENST00000412814
CX3CR1;ENSG00000168329;137-0.0;Number of treatments/medications taken;rs41535248;A;1.0;-0.057101;0.021765;0.0087029;E13D;ENST00000435290
CX3CR1;ENSG00000168329;137-0.0;Number of treatments/medications taken;rs41535248;A;1.0;-0.057101;0.021765;0.0087029;E13D;ENST00000541347
CX3CR1;ENSG00000168329;137-0.0;Number of treatments/medications taken;rs41535248;A;1.0;-0.057101;0.021765;0.0087029;E13D;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_M70;M70 Soft tissue disorders related to use, overuse and pressure;rs139019894;C;0.889349;0.0046058;0.0017644000000000002;0.009045000000000001;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M70;M70 Soft tissue disorders related to use, overuse and pressure;rs139019894;C;0.889349;0.0046058;0.0017644000000000002;0.009045000000000001;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_M70;M70 Soft tissue disorders related to use, overuse and pressure;rs139019894;C;0.889349;0.0046058;0.0017644000000000002;0.009045000000000001;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_M70;M70 Soft tissue disorders related to use, overuse and pressure;rs139019894;C;0.889349;0.0046058;0.0017644000000000002;0.009045000000000001;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_M70;M70 Soft tissue disorders related to use, overuse and pressure;rs139019894;C;0.889349;0.0046058;0.0017644000000000002;0.009045000000000001;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_M70;M70 Soft tissue disorders related to use, overuse and pressure;rs139019894;C;0.889349;0.0046058;0.0017644000000000002;0.009045000000000001;D25G;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1540;psoriatic arthropathy;rs3732380;T;0.720038;0.01754;0.0063167;0.0054909;V179I;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1540;psoriatic arthropathy;rs3732380;T;0.720038;0.01754;0.0063167;0.0054909;V147I;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1540;psoriatic arthropathy;rs3732380;T;0.720038;0.01754;0.0063167;0.0054909;V147I;ENST00000435290
CX3CR1;ENSG00000168329;selfReported_n_1540;psoriatic arthropathy;rs3732380;T;0.720038;0.01754;0.0063167;0.0054909;V147I;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1540;psoriatic arthropathy;rs3732380;T;0.720038;0.01754;0.0063167;0.0054909;V147I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_K80-K87;K80-K87 Disorders of gallbladder, biliary tract and pancreas;rs143001773;T;1.0;0.018902000000000002;0.0057381;0.00098713;V154I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_K80-K87;K80-K87 Disorders of gallbladder, biliary tract and pancreas;rs143001773;T;1.0;0.018902000000000002;0.0057381;0.00098713;V122I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_K80-K87;K80-K87 Disorders of gallbladder, biliary tract and pancreas;rs143001773;T;1.0;0.018902000000000002;0.0057381;0.00098713;V122I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_Block_K80-K87;K80-K87 Disorders of gallbladder, biliary tract and pancreas;rs143001773;T;1.0;0.018902000000000002;0.0057381;0.00098713;V122I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_K80-K87;K80-K87 Disorders of gallbladder, biliary tract and pancreas;rs143001773;T;1.0;0.018902000000000002;0.0057381;0.00098713;V122I;ENST00000542107
CX3CR1;ENSG00000168329;23120-0.0;Arm fat mass (right);rs41535248;A;1.0;-0.012782;0.0046494;0.0059767;E45D;ENST00000358309
CX3CR1;ENSG00000168329;23120-0.0;Arm fat mass (right);rs41535248;A;1.0;-0.012782;0.0046494;0.0059767;E13D;ENST00000399220
CX3CR1;ENSG00000168329;23120-0.0;Arm fat mass (right);rs41535248;A;1.0;-0.012782;0.0046494;0.0059767;E13D;ENST00000412814
CX3CR1;ENSG00000168329;23120-0.0;Arm fat mass (right);rs41535248;A;1.0;-0.012782;0.0046494;0.0059767;E13D;ENST00000435290
CX3CR1;ENSG00000168329;23120-0.0;Arm fat mass (right);rs41535248;A;1.0;-0.012782;0.0046494;0.0059767;E13D;ENST00000541347
CX3CR1;ENSG00000168329;23120-0.0;Arm fat mass (right);rs41535248;A;1.0;-0.012782;0.0046494;0.0059767;E13D;ENST00000542107
CX3CR1;ENSG00000168329;30070-0.0;Red blood cell (erythrocyte) distribution width;rs3732380;T;0.720038;0.32569000000000004;0.11325;0.004028800000000001;V179I;ENST00000358309
CX3CR1;ENSG00000168329;30070-0.0;Red blood cell (erythrocyte) distribution width;rs3732380;T;0.720038;0.32569000000000004;0.11325;0.004028800000000001;V147I;ENST00000399220
CX3CR1;ENSG00000168329;30070-0.0;Red blood cell (erythrocyte) distribution width;rs3732380;T;0.720038;0.32569000000000004;0.11325;0.004028800000000001;V147I;ENST00000435290
CX3CR1;ENSG00000168329;30070-0.0;Red blood cell (erythrocyte) distribution width;rs3732380;T;0.720038;0.32569000000000004;0.11325;0.004028800000000001;V147I;ENST00000541347
CX3CR1;ENSG00000168329;30070-0.0;Red blood cell (erythrocyte) distribution width;rs3732380;T;0.720038;0.32569000000000004;0.11325;0.004028800000000001;V147I;ENST00000542107
CX3CR1;ENSG00000168329;30000-0.0;White blood cell (leukocyte) count;rs11715522;C;1.0;-0.010929000000000001;0.0031846;0.00059975;F8L;ENST00000358309
CX3CR1;ENSG00000168329;30000-0.0;White blood cell (leukocyte) count;rs3732378;A;1.0;0.029616000000000003;0.0040859;4.226e-13;T312M;ENST00000358309
CX3CR1;ENSG00000168329;30000-0.0;White blood cell (leukocyte) count;rs3732378;A;1.0;0.029616000000000003;0.0040859;4.226e-13;T280M;ENST00000399220
CX3CR1;ENSG00000168329;30000-0.0;White blood cell (leukocyte) count;rs3732378;A;1.0;0.029616000000000003;0.0040859;4.226e-13;T280M;ENST00000541347
CX3CR1;ENSG00000168329;30000-0.0;White blood cell (leukocyte) count;rs3732378;A;1.0;0.029616000000000003;0.0040859;4.226e-13;T280M;ENST00000542107
CX3CR1;ENSG00000168329;30000-0.0;White blood cell (leukocyte) count;rs3732379;T;1.0;0.014796;0.0034364000000000005;1.6666e-05;V281I;ENST00000358309
CX3CR1;ENSG00000168329;30000-0.0;White blood cell (leukocyte) count;rs3732379;T;1.0;0.014796;0.0034364000000000005;1.6666e-05;V249I;ENST00000399220
CX3CR1;ENSG00000168329;30000-0.0;White blood cell (leukocyte) count;rs3732379;T;1.0;0.014796;0.0034364000000000005;1.6666e-05;V249I;ENST00000541347
CX3CR1;ENSG00000168329;30000-0.0;White blood cell (leukocyte) count;rs3732379;T;1.0;0.014796;0.0034364000000000005;1.6666e-05;V249I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_H92;H92 Otalgia and effusion of ear;rs150319988;A;0.526638;0.016472;0.004857899999999999;0.00069681;R350C;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_H92;H92 Otalgia and effusion of ear;rs150319988;A;0.526638;0.016472;0.004857899999999999;0.00069681;R318C;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_H92;H92 Otalgia and effusion of ear;rs150319988;A;0.526638;0.016472;0.004857899999999999;0.00069681;R318C;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_H92;H92 Otalgia and effusion of ear;rs150319988;A;0.526638;0.016472;0.004857899999999999;0.00069681;R318C;ENST00000542107
CX3CR1;ENSG00000168329;20015-0.0;Sitting height;rs3732378;A;1.0;0.025523;0.007417;0.00057915;T312M;ENST00000358309
CX3CR1;ENSG00000168329;20015-0.0;Sitting height;rs3732378;A;1.0;0.025523;0.007417;0.00057915;T280M;ENST00000399220
CX3CR1;ENSG00000168329;20015-0.0;Sitting height;rs3732378;A;1.0;0.025523;0.007417;0.00057915;T280M;ENST00000541347
CX3CR1;ENSG00000168329;20015-0.0;Sitting height;rs3732378;A;1.0;0.025523;0.007417;0.00057915;T280M;ENST00000542107
CX3CR1;ENSG00000168329;30190-0.0;Monocyte percentage;rs3732378;A;1.0;0.076193;0.0049731;5.720199999999999e-53;T312M;ENST00000358309
CX3CR1;ENSG00000168329;30190-0.0;Monocyte percentage;rs3732378;A;1.0;0.076193;0.0049731;5.720199999999999e-53;T280M;ENST00000399220
CX3CR1;ENSG00000168329;30190-0.0;Monocyte percentage;rs3732378;A;1.0;0.076193;0.0049731;5.720199999999999e-53;T280M;ENST00000541347
CX3CR1;ENSG00000168329;30190-0.0;Monocyte percentage;rs3732378;A;1.0;0.076193;0.0049731;5.720199999999999e-53;T280M;ENST00000542107
CX3CR1;ENSG00000168329;30190-0.0;Monocyte percentage;rs3732379;T;1.0;0.047833;0.004183;2.8199999999999997e-30;V281I;ENST00000358309
CX3CR1;ENSG00000168329;30190-0.0;Monocyte percentage;rs3732379;T;1.0;0.047833;0.004183;2.8199999999999997e-30;V249I;ENST00000399220
CX3CR1;ENSG00000168329;30190-0.0;Monocyte percentage;rs3732379;T;1.0;0.047833;0.004183;2.8199999999999997e-30;V249I;ENST00000541347
CX3CR1;ENSG00000168329;30190-0.0;Monocyte percentage;rs3732379;T;1.0;0.047833;0.004183;2.8199999999999997e-30;V249I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_H35;H35 Other retinal disorders;rs3732379;T;1.0;0.00057482;0.00021142;0.006549800000000001;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_H35;H35 Other retinal disorders;rs3732379;T;1.0;0.00057482;0.00021142;0.006549800000000001;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_H35;H35 Other retinal disorders;rs3732379;T;1.0;0.00057482;0.00021142;0.006549800000000001;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_H35;H35 Other retinal disorders;rs3732379;T;1.0;0.00057482;0.00021142;0.006549800000000001;V249I;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1251;hypothyroidism/myxoedema;rs3732378;A;1.0;0.0033917;0.00055695;1.1313e-09;T312M;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1251;hypothyroidism/myxoedema;rs3732378;A;1.0;0.0033917;0.00055695;1.1313e-09;T280M;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1251;hypothyroidism/myxoedema;rs3732378;A;1.0;0.0033917;0.00055695;1.1313e-09;T280M;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1251;hypothyroidism/myxoedema;rs3732378;A;1.0;0.0033917;0.00055695;1.1313e-09;T280M;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1251;hypothyroidism/myxoedema;rs3732379;T;1.0;0.0027011;0.00046841;8.091000000000001e-09;V281I;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1251;hypothyroidism/myxoedema;rs3732379;T;1.0;0.0027011;0.00046841;8.091000000000001e-09;V249I;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1251;hypothyroidism/myxoedema;rs3732379;T;1.0;0.0027011;0.00046841;8.091000000000001e-09;V249I;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1251;hypothyroidism/myxoedema;rs3732379;T;1.0;0.0027011;0.00046841;8.091000000000001e-09;V249I;ENST00000542107
CX3CR1;ENSG00000168329;23118-0.0;Leg predicted mass (left);rs147724093;C;1.0;0.029469;0.010422;0.004691;P4A;ENST00000358309
CX3CR1;ENSG00000168329;23110-0.0;Impedance of arm (left);rs11715522;C;1.0;-0.19582;0.067128;0.0035321;F8L;ENST00000358309
CX3CR1;ENSG00000168329;cancer_c_Block_C50-C50;C50-C50 Malignant neoplasm of breast;rs3732380;T;0.720038;0.12804;0.0382;0.00080267;V179I;ENST00000358309
CX3CR1;ENSG00000168329;cancer_c_Block_C50-C50;C50-C50 Malignant neoplasm of breast;rs3732380;T;0.720038;0.12804;0.0382;0.00080267;V147I;ENST00000399220
CX3CR1;ENSG00000168329;cancer_c_Block_C50-C50;C50-C50 Malignant neoplasm of breast;rs3732380;T;0.720038;0.12804;0.0382;0.00080267;V147I;ENST00000435290
CX3CR1;ENSG00000168329;cancer_c_Block_C50-C50;C50-C50 Malignant neoplasm of breast;rs3732380;T;0.720038;0.12804;0.0382;0.00080267;V147I;ENST00000541347
CX3CR1;ENSG00000168329;cancer_c_Block_C50-C50;C50-C50 Malignant neoplasm of breast;rs3732380;T;0.720038;0.12804;0.0382;0.00080267;V147I;ENST00000542107
CX3CR1;ENSG00000168329;23099-0.0;Body fat percentage;rs41535248;A;1.0;-0.13875;0.047366000000000005;0.0033978999999999997;E45D;ENST00000358309
CX3CR1;ENSG00000168329;23099-0.0;Body fat percentage;rs41535248;A;1.0;-0.13875;0.047366000000000005;0.0033978999999999997;E13D;ENST00000399220
CX3CR1;ENSG00000168329;23099-0.0;Body fat percentage;rs41535248;A;1.0;-0.13875;0.047366000000000005;0.0033978999999999997;E13D;ENST00000412814
CX3CR1;ENSG00000168329;23099-0.0;Body fat percentage;rs41535248;A;1.0;-0.13875;0.047366000000000005;0.0033978999999999997;E13D;ENST00000435290
CX3CR1;ENSG00000168329;23099-0.0;Body fat percentage;rs41535248;A;1.0;-0.13875;0.047366000000000005;0.0033978999999999997;E13D;ENST00000541347
CX3CR1;ENSG00000168329;23099-0.0;Body fat percentage;rs41535248;A;1.0;-0.13875;0.047366000000000005;0.0033978999999999997;E13D;ENST00000542107
CX3CR1;ENSG00000168329;21002-0.0;Weight;rs147724093;C;1.0;0.3655;0.13105;0.005288899999999999;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M23;M23 Internal derangement of knee;rs11715522;C;1.0;0.0013038;0.00039961;0.0011034;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_F17;F17 Mental and behavioural disorders due to use of tobacco;rs3732380;T;0.720038;0.06807200000000001;0.02302;0.0031054000000000003;V179I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_F17;F17 Mental and behavioural disorders due to use of tobacco;rs3732380;T;0.720038;0.06807200000000001;0.02302;0.0031054000000000003;V147I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_F17;F17 Mental and behavioural disorders due to use of tobacco;rs3732380;T;0.720038;0.06807200000000001;0.02302;0.0031054000000000003;V147I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_F17;F17 Mental and behavioural disorders due to use of tobacco;rs3732380;T;0.720038;0.06807200000000001;0.02302;0.0031054000000000003;V147I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_F17;F17 Mental and behavioural disorders due to use of tobacco;rs3732380;T;0.720038;0.06807200000000001;0.02302;0.0031054000000000003;V147I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_M05;M05 Seropositive rheumatoid arthritis;rs150319988;A;0.526638;0.016553000000000002;0.0050699;0.0010952;R350C;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M05;M05 Seropositive rheumatoid arthritis;rs150319988;A;0.526638;0.016553000000000002;0.0050699;0.0010952;R318C;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_M05;M05 Seropositive rheumatoid arthritis;rs150319988;A;0.526638;0.016553000000000002;0.0050699;0.0010952;R318C;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_M05;M05 Seropositive rheumatoid arthritis;rs150319988;A;0.526638;0.016553000000000002;0.0050699;0.0010952;R318C;ENST00000542107
CX3CR1;ENSG00000168329;23105-0.0;Basal metabolic rate;rs147724093;C;1.0;25.016;7.5559;0.00093017;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_N32;N32 Other disorders of bladder;rs199811198;C;1.0;0.0074508;0.0024503;0.0023594;T89A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_N32;N32 Other disorders of bladder;rs199811198;C;1.0;0.0074508;0.0024503;0.0023594;T57A;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_N32;N32 Other disorders of bladder;rs199811198;C;1.0;0.0074508;0.0024503;0.0023594;T57A;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_N32;N32 Other disorders of bladder;rs199811198;C;1.0;0.0074508;0.0024503;0.0023594;T57A;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_N32;N32 Other disorders of bladder;rs199811198;C;1.0;0.0074508;0.0024503;0.0023594;T57A;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_N32;N32 Other disorders of bladder;rs199811198;C;1.0;0.0074508;0.0024503;0.0023594;T57A;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_O70;O70 Perineal laceration during delivery;rs3732378;A;1.0;0.0016067;0.00054424;0.0031561;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_O70;O70 Perineal laceration during delivery;rs3732378;A;1.0;0.0016067;0.00054424;0.0031561;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_O70;O70 Perineal laceration during delivery;rs3732378;A;1.0;0.0016067;0.00054424;0.0031561;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_O70;O70 Perineal laceration during delivery;rs3732378;A;1.0;0.0016067;0.00054424;0.0031561;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_H11;H11 Other disorders of conjunctiva;rs11715522;C;1.0;0.00025085;9.2095e-05;0.0064541;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_H11;H11 Other disorders of conjunctiva;rs201179424;C;0.754391;0.0054733;0.0018242;0.0026968000000000005;I324M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_H11;H11 Other disorders of conjunctiva;rs201179424;C;0.754391;0.0054733;0.0018242;0.0026968000000000005;I292M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_H11;H11 Other disorders of conjunctiva;rs201179424;C;0.754391;0.0054733;0.0018242;0.0026968000000000005;I292M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_H11;H11 Other disorders of conjunctiva;rs201179424;C;0.754391;0.0054733;0.0018242;0.0026968000000000005;I292M;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1094;heart arrhythmia;rs11715522;C;1.0;-0.0007273;0.00026139;0.0053956;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_I85;I85 Oesophageal varices;rs201179424;C;0.754391;0.0043467;0.0015086;0.003959900000000001;I324M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_I85;I85 Oesophageal varices;rs201179424;C;0.754391;0.0043467;0.0015086;0.003959900000000001;I292M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_I85;I85 Oesophageal varices;rs201179424;C;0.754391;0.0043467;0.0015086;0.003959900000000001;I292M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_I85;I85 Oesophageal varices;rs201179424;C;0.754391;0.0043467;0.0015086;0.003959900000000001;I292M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_K59;K59 Other functional intestinal disorders;rs201179424;C;0.754391;0.018795;0.0068929;0.0063964;I324M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_K59;K59 Other functional intestinal disorders;rs201179424;C;0.754391;0.018795;0.0068929;0.0063964;I292M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_K59;K59 Other functional intestinal disorders;rs201179424;C;0.754391;0.018795;0.0068929;0.0063964;I292M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_K59;K59 Other functional intestinal disorders;rs201179424;C;0.754391;0.018795;0.0068929;0.0063964;I292M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_J84;J84 Other interstitial pulmonary diseases;rs3732378;A;1.0;0.00040522;0.00013835;0.0034003;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_J84;J84 Other interstitial pulmonary diseases;rs3732378;A;1.0;0.00040522;0.00013835;0.0034003;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_J84;J84 Other interstitial pulmonary diseases;rs3732378;A;1.0;0.00040522;0.00013835;0.0034003;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_J84;J84 Other interstitial pulmonary diseases;rs3732378;A;1.0;0.00040522;0.00013835;0.0034003;T280M;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1760;helicobacter pylori;rs201179424;C;0.754391;0.006053899999999999;0.0022795000000000003;0.0079117;I324M;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1760;helicobacter pylori;rs201179424;C;0.754391;0.006053899999999999;0.0022795000000000003;0.0079117;I292M;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1760;helicobacter pylori;rs201179424;C;0.754391;0.006053899999999999;0.0022795000000000003;0.0079117;I292M;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1760;helicobacter pylori;rs201179424;C;0.754391;0.006053899999999999;0.0022795000000000003;0.0079117;I292M;ENST00000542107
CX3CR1;ENSG00000168329;23109-0.0;Impedance of arm (right);rs11715522;C;1.0;-0.18809;0.064618;0.0036056999999999994;F8L;ENST00000358309
CX3CR1;ENSG00000168329;23109-0.0;Impedance of arm (right);rs147724093;C;1.0;-0.97821;0.34957;0.005136600000000001;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_F32;F32 Depressive episode;rs139019894;C;0.889349;-0.012054;0.0046331;0.0092794;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_F32;F32 Depressive episode;rs139019894;C;0.889349;-0.012054;0.0046331;0.0092794;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_F32;F32 Depressive episode;rs139019894;C;0.889349;-0.012054;0.0046331;0.0092794;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_F32;F32 Depressive episode;rs139019894;C;0.889349;-0.012054;0.0046331;0.0092794;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_F32;F32 Depressive episode;rs139019894;C;0.889349;-0.012054;0.0046331;0.0092794;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_F32;F32 Depressive episode;rs139019894;C;0.889349;-0.012054;0.0046331;0.0092794;D25G;ENST00000542107
CX3CR1;ENSG00000168329;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs3732378;A;1.0;0.00044042;0.00012378;0.00037354;T312M;ENST00000358309
CX3CR1;ENSG00000168329;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs3732378;A;1.0;0.00044042;0.00012378;0.00037354;T280M;ENST00000399220
CX3CR1;ENSG00000168329;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs3732378;A;1.0;0.00044042;0.00012378;0.00037354;T280M;ENST00000541347
CX3CR1;ENSG00000168329;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs3732378;A;1.0;0.00044042;0.00012378;0.00037354;T280M;ENST00000542107
CX3CR1;ENSG00000168329;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs3732379;T;1.0;0.00034713;0.0001041;0.00085443;V281I;ENST00000358309
CX3CR1;ENSG00000168329;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs3732379;T;1.0;0.00034713;0.0001041;0.00085443;V249I;ENST00000399220
CX3CR1;ENSG00000168329;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs3732379;T;1.0;0.00034713;0.0001041;0.00085443;V249I;ENST00000541347
CX3CR1;ENSG00000168329;cancer_c_C64;C64 Malignant neoplasm of kidney, except renal pelvis;rs3732379;T;1.0;0.00034713;0.0001041;0.00085443;V249I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_D60-D64;D60-D64 Aplastic and other anaemias;rs143001773;T;1.0;0.014481;0.0048913;0.0030705;V154I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_D60-D64;D60-D64 Aplastic and other anaemias;rs143001773;T;1.0;0.014481;0.0048913;0.0030705;V122I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_D60-D64;D60-D64 Aplastic and other anaemias;rs143001773;T;1.0;0.014481;0.0048913;0.0030705;V122I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_Block_D60-D64;D60-D64 Aplastic and other anaemias;rs143001773;T;1.0;0.014481;0.0048913;0.0030705;V122I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_D60-D64;D60-D64 Aplastic and other anaemias;rs143001773;T;1.0;0.014481;0.0048913;0.0030705;V122I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_D60-D64;D60-D64 Aplastic and other anaemias;rs201179424;C;0.754391;-0.02034;0.0072665;0.0051235;I324M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_D60-D64;D60-D64 Aplastic and other anaemias;rs201179424;C;0.754391;-0.02034;0.0072665;0.0051235;I292M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_D60-D64;D60-D64 Aplastic and other anaemias;rs201179424;C;0.754391;-0.02034;0.0072665;0.0051235;I292M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_D60-D64;D60-D64 Aplastic and other anaemias;rs201179424;C;0.754391;-0.02034;0.0072665;0.0051235;I292M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_E27;E27 Other disorders of adrenal gland;rs139019894;C;0.889349;0.002587;0.0009488;0.0064003;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_E27;E27 Other disorders of adrenal gland;rs139019894;C;0.889349;0.002587;0.0009488;0.0064003;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_E27;E27 Other disorders of adrenal gland;rs139019894;C;0.889349;0.002587;0.0009488;0.0064003;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_E27;E27 Other disorders of adrenal gland;rs139019894;C;0.889349;0.002587;0.0009488;0.0064003;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_E27;E27 Other disorders of adrenal gland;rs139019894;C;0.889349;0.002587;0.0009488;0.0064003;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_E27;E27 Other disorders of adrenal gland;rs139019894;C;0.889349;0.002587;0.0009488;0.0064003;D25G;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_E27;E27 Other disorders of adrenal gland;rs199811198;C;1.0;0.0015332;0.00057651;0.0078261;T89A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_E27;E27 Other disorders of adrenal gland;rs199811198;C;1.0;0.0015332;0.00057651;0.0078261;T57A;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_E27;E27 Other disorders of adrenal gland;rs199811198;C;1.0;0.0015332;0.00057651;0.0078261;T57A;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_E27;E27 Other disorders of adrenal gland;rs199811198;C;1.0;0.0015332;0.00057651;0.0078261;T57A;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_E27;E27 Other disorders of adrenal gland;rs199811198;C;1.0;0.0015332;0.00057651;0.0078261;T57A;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_E27;E27 Other disorders of adrenal gland;rs199811198;C;1.0;0.0015332;0.00057651;0.0078261;T57A;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_E03;E03 Other hypothyroidism;rs3732378;A;1.0;0.0021536999999999997;0.0004825;8.0583e-06;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_E03;E03 Other hypothyroidism;rs3732378;A;1.0;0.0021536999999999997;0.0004825;8.0583e-06;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_E03;E03 Other hypothyroidism;rs3732378;A;1.0;0.0021536999999999997;0.0004825;8.0583e-06;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_E03;E03 Other hypothyroidism;rs3732378;A;1.0;0.0021536999999999997;0.0004825;8.0583e-06;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_E03;E03 Other hypothyroidism;rs3732379;T;1.0;0.0017614999999999998;0.0004058;1.419e-05;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_E03;E03 Other hypothyroidism;rs3732379;T;1.0;0.0017614999999999998;0.0004058;1.419e-05;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_E03;E03 Other hypothyroidism;rs3732379;T;1.0;0.0017614999999999998;0.0004058;1.419e-05;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_E03;E03 Other hypothyroidism;rs3732379;T;1.0;0.0017614999999999998;0.0004058;1.419e-05;V249I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_N36;N36 Other disorders of urethra;rs199811198;C;1.0;0.0026397;0.00074005;0.00036134;T89A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_N36;N36 Other disorders of urethra;rs199811198;C;1.0;0.0026397;0.00074005;0.00036134;T57A;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_N36;N36 Other disorders of urethra;rs199811198;C;1.0;0.0026397;0.00074005;0.00036134;T57A;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_N36;N36 Other disorders of urethra;rs199811198;C;1.0;0.0026397;0.00074005;0.00036134;T57A;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_N36;N36 Other disorders of urethra;rs199811198;C;1.0;0.0026397;0.00074005;0.00036134;T57A;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_N36;N36 Other disorders of urethra;rs199811198;C;1.0;0.0026397;0.00074005;0.00036134;T57A;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1428;allergy or anaphylactic reaction to food;rs143001773;T;1.0;0.0053303000000000005;0.0019245;0.0056096;V154I;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1428;allergy or anaphylactic reaction to food;rs143001773;T;1.0;0.0053303000000000005;0.0019245;0.0056096;V122I;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1428;allergy or anaphylactic reaction to food;rs143001773;T;1.0;0.0053303000000000005;0.0019245;0.0056096;V122I;ENST00000435290
CX3CR1;ENSG00000168329;selfReported_n_1428;allergy or anaphylactic reaction to food;rs143001773;T;1.0;0.0053303000000000005;0.0019245;0.0056096;V122I;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1428;allergy or anaphylactic reaction to food;rs143001773;T;1.0;0.0053303000000000005;0.0019245;0.0056096;V122I;ENST00000542107
CX3CR1;ENSG00000168329;135-0.0;Number of self-reported non-cancer illnesses;rs41535248;A;1.0;-0.044150999999999996;0.015455000000000002;0.0042793;E45D;ENST00000358309
CX3CR1;ENSG00000168329;135-0.0;Number of self-reported non-cancer illnesses;rs41535248;A;1.0;-0.044150999999999996;0.015455000000000002;0.0042793;E13D;ENST00000399220
CX3CR1;ENSG00000168329;135-0.0;Number of self-reported non-cancer illnesses;rs41535248;A;1.0;-0.044150999999999996;0.015455000000000002;0.0042793;E13D;ENST00000412814
CX3CR1;ENSG00000168329;135-0.0;Number of self-reported non-cancer illnesses;rs41535248;A;1.0;-0.044150999999999996;0.015455000000000002;0.0042793;E13D;ENST00000435290
CX3CR1;ENSG00000168329;135-0.0;Number of self-reported non-cancer illnesses;rs41535248;A;1.0;-0.044150999999999996;0.015455000000000002;0.0042793;E13D;ENST00000541347
CX3CR1;ENSG00000168329;135-0.0;Number of self-reported non-cancer illnesses;rs41535248;A;1.0;-0.044150999999999996;0.015455000000000002;0.0042793;E13D;ENST00000542107
CX3CR1;ENSG00000168329;1349-0.0;Processed meat intake;rs201179424;C;0.754391;0.11034000000000001;0.041103;0.007264100000000001;I324M;ENST00000358309
CX3CR1;ENSG00000168329;1349-0.0;Processed meat intake;rs201179424;C;0.754391;0.11034000000000001;0.041103;0.007264100000000001;I292M;ENST00000399220
CX3CR1;ENSG00000168329;1349-0.0;Processed meat intake;rs201179424;C;0.754391;0.11034000000000001;0.041103;0.007264100000000001;I292M;ENST00000541347
CX3CR1;ENSG00000168329;1349-0.0;Processed meat intake;rs201179424;C;0.754391;0.11034000000000001;0.041103;0.007264100000000001;I292M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_L72;L72 Follicular cysts of skin and subcutaneous tissue;rs3732378;A;1.0;0.0011501;0.0003857;0.0028643;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_L72;L72 Follicular cysts of skin and subcutaneous tissue;rs3732378;A;1.0;0.0011501;0.0003857;0.0028643;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_L72;L72 Follicular cysts of skin and subcutaneous tissue;rs3732378;A;1.0;0.0011501;0.0003857;0.0028643;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_L72;L72 Follicular cysts of skin and subcutaneous tissue;rs3732378;A;1.0;0.0011501;0.0003857;0.0028643;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs201179424;C;0.754391;0.0055355;0.0021105;0.008721099999999999;I324M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs201179424;C;0.754391;0.0055355;0.0021105;0.008721099999999999;I292M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs201179424;C;0.754391;0.0055355;0.0021105;0.008721099999999999;I292M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs201179424;C;0.754391;0.0055355;0.0021105;0.008721099999999999;I292M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_K25;K25 Gastric ulcer;rs41535248;A;1.0;-0.0038504;0.00093162;3.5807e-05;E45D;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_K25;K25 Gastric ulcer;rs41535248;A;1.0;-0.0038504;0.00093162;3.5807e-05;E13D;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_K25;K25 Gastric ulcer;rs41535248;A;1.0;-0.0038504;0.00093162;3.5807e-05;E13D;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_K25;K25 Gastric ulcer;rs41535248;A;1.0;-0.0038504;0.00093162;3.5807e-05;E13D;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_K25;K25 Gastric ulcer;rs41535248;A;1.0;-0.0038504;0.00093162;3.5807e-05;E13D;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_K25;K25 Gastric ulcer;rs41535248;A;1.0;-0.0038504;0.00093162;3.5807e-05;E13D;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_D50-D53;D50-D53 Nutritional anaemias;rs3732380;T;0.720038;0.059743;0.020405;0.0034135;V179I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_D50-D53;D50-D53 Nutritional anaemias;rs3732380;T;0.720038;0.059743;0.020405;0.0034135;V147I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_D50-D53;D50-D53 Nutritional anaemias;rs3732380;T;0.720038;0.059743;0.020405;0.0034135;V147I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_Block_D50-D53;D50-D53 Nutritional anaemias;rs3732380;T;0.720038;0.059743;0.020405;0.0034135;V147I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_D50-D53;D50-D53 Nutritional anaemias;rs3732380;T;0.720038;0.059743;0.020405;0.0034135;V147I;ENST00000542107
CX3CR1;ENSG00000168329;23116-0.0;Leg fat mass (left);rs41535248;A;1.0;-0.033618;0.011579;0.0036915;E45D;ENST00000358309
CX3CR1;ENSG00000168329;23116-0.0;Leg fat mass (left);rs41535248;A;1.0;-0.033618;0.011579;0.0036915;E13D;ENST00000399220
CX3CR1;ENSG00000168329;23116-0.0;Leg fat mass (left);rs41535248;A;1.0;-0.033618;0.011579;0.0036915;E13D;ENST00000412814
CX3CR1;ENSG00000168329;23116-0.0;Leg fat mass (left);rs41535248;A;1.0;-0.033618;0.011579;0.0036915;E13D;ENST00000435290
CX3CR1;ENSG00000168329;23116-0.0;Leg fat mass (left);rs41535248;A;1.0;-0.033618;0.011579;0.0036915;E13D;ENST00000541347
CX3CR1;ENSG00000168329;23116-0.0;Leg fat mass (left);rs41535248;A;1.0;-0.033618;0.011579;0.0036915;E13D;ENST00000542107
CX3CR1;ENSG00000168329;1239-0.0;Current tobacco smoking;rs3732378;A;1.0;-0.0049556999999999995;0.0014395;0.00057626;T312M;ENST00000358309
CX3CR1;ENSG00000168329;1239-0.0;Current tobacco smoking;rs3732378;A;1.0;-0.0049556999999999995;0.0014395;0.00057626;T280M;ENST00000399220
CX3CR1;ENSG00000168329;1239-0.0;Current tobacco smoking;rs3732378;A;1.0;-0.0049556999999999995;0.0014395;0.00057626;T280M;ENST00000541347
CX3CR1;ENSG00000168329;1239-0.0;Current tobacco smoking;rs3732378;A;1.0;-0.0049556999999999995;0.0014395;0.00057626;T280M;ENST00000542107
CX3CR1;ENSG00000168329;1239-0.0;Current tobacco smoking;rs3732379;T;1.0;-0.0043303000000000005;0.0012107;0.00034786;V281I;ENST00000358309
CX3CR1;ENSG00000168329;1239-0.0;Current tobacco smoking;rs3732379;T;1.0;-0.0043303000000000005;0.0012107;0.00034786;V249I;ENST00000399220
CX3CR1;ENSG00000168329;1239-0.0;Current tobacco smoking;rs3732379;T;1.0;-0.0043303000000000005;0.0012107;0.00034786;V249I;ENST00000541347
CX3CR1;ENSG00000168329;1239-0.0;Current tobacco smoking;rs3732379;T;1.0;-0.0043303000000000005;0.0012107;0.00034786;V249I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_I10;I10 Essential (primary) hypertension;rs11715522;C;1.0;-0.0020055999999999997;0.00075179;0.007636399999999999;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_I72;I72 Other aneurysm;rs139019894;C;0.889349;0.0034159;0.00095991;0.00037299;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_I72;I72 Other aneurysm;rs139019894;C;0.889349;0.0034159;0.00095991;0.00037299;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_I72;I72 Other aneurysm;rs139019894;C;0.889349;0.0034159;0.00095991;0.00037299;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_I72;I72 Other aneurysm;rs139019894;C;0.889349;0.0034159;0.00095991;0.00037299;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_I72;I72 Other aneurysm;rs139019894;C;0.889349;0.0034159;0.00095991;0.00037299;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_I72;I72 Other aneurysm;rs139019894;C;0.889349;0.0034159;0.00095991;0.00037299;D25G;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_M22;M22 Disorders of patella;rs150319988;A;0.526638;0.03792;0.0064399;3.905e-09;R350C;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M22;M22 Disorders of patella;rs150319988;A;0.526638;0.03792;0.0064399;3.905e-09;R318C;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_M22;M22 Disorders of patella;rs150319988;A;0.526638;0.03792;0.0064399;3.905e-09;R318C;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_M22;M22 Disorders of patella;rs150319988;A;0.526638;0.03792;0.0064399;3.905e-09;R318C;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_N30;N30 Cystitis;rs41535248;A;1.0;0.0023864;0.00077346;0.0020333;E45D;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_N30;N30 Cystitis;rs41535248;A;1.0;0.0023864;0.00077346;0.0020333;E13D;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_N30;N30 Cystitis;rs41535248;A;1.0;0.0023864;0.00077346;0.0020333;E13D;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_N30;N30 Cystitis;rs41535248;A;1.0;0.0023864;0.00077346;0.0020333;E13D;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_N30;N30 Cystitis;rs41535248;A;1.0;0.0023864;0.00077346;0.0020333;E13D;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_N30;N30 Cystitis;rs41535248;A;1.0;0.0023864;0.00077346;0.0020333;E13D;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_M89;M89 Other disorders of bone;rs147724093;C;1.0;0.0019182000000000001;0.00070794;0.0067388000000000005;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M46;M46 Other inflammatory spondylopathies;rs201179424;C;0.754391;0.0079386;0.0023573;0.00075804;I324M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M46;M46 Other inflammatory spondylopathies;rs201179424;C;0.754391;0.0079386;0.0023573;0.00075804;I292M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_M46;M46 Other inflammatory spondylopathies;rs201179424;C;0.754391;0.0079386;0.0023573;0.00075804;I292M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_M46;M46 Other inflammatory spondylopathies;rs201179424;C;0.754391;0.0079386;0.0023573;0.00075804;I292M;ENST00000542107
CX3CR1;ENSG00000168329;23130-0.0;Trunk predicted mass;rs147724093;C;1.0;0.087094;0.027284;0.0014122;P4A;ENST00000358309
CX3CR1;ENSG00000168329;23126-0.0;Arm predicted mass (left);rs147724093;C;1.0;0.013550999999999999;0.0040451;0.00080841;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_G57;G57 Mononeuropathies of lower limb;rs201179424;C;0.754391;0.007083;0.0026955;0.008596600000000001;I324M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_G57;G57 Mononeuropathies of lower limb;rs201179424;C;0.754391;0.007083;0.0026955;0.008596600000000001;I292M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_G57;G57 Mononeuropathies of lower limb;rs201179424;C;0.754391;0.007083;0.0026955;0.008596600000000001;I292M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_G57;G57 Mononeuropathies of lower limb;rs201179424;C;0.754391;0.007083;0.0026955;0.008596600000000001;I292M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_K29;K29 Gastritis and duodenitis;rs41535248;A;1.0;-0.0058598999999999995;0.0022482;0.0091489;E45D;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_K29;K29 Gastritis and duodenitis;rs41535248;A;1.0;-0.0058598999999999995;0.0022482;0.0091489;E13D;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_K29;K29 Gastritis and duodenitis;rs41535248;A;1.0;-0.0058598999999999995;0.0022482;0.0091489;E13D;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_K29;K29 Gastritis and duodenitis;rs41535248;A;1.0;-0.0058598999999999995;0.0022482;0.0091489;E13D;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_K29;K29 Gastritis and duodenitis;rs41535248;A;1.0;-0.0058598999999999995;0.0022482;0.0091489;E13D;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_K29;K29 Gastritis and duodenitis;rs41535248;A;1.0;-0.0058598999999999995;0.0022482;0.0091489;E13D;ENST00000542107
CX3CR1;ENSG00000168329;30130-0.0;Monocyte count;rs11715522;C;1.0;-0.00133;0.00029006;4.5365e-06;F8L;ENST00000358309
CX3CR1;ENSG00000168329;30130-0.0;Monocyte count;rs3732378;A;1.0;0.0070934;0.00037203;5.1526e-81;T312M;ENST00000358309
CX3CR1;ENSG00000168329;30130-0.0;Monocyte count;rs3732378;A;1.0;0.0070934;0.00037203;5.1526e-81;T280M;ENST00000399220
CX3CR1;ENSG00000168329;30130-0.0;Monocyte count;rs3732378;A;1.0;0.0070934;0.00037203;5.1526e-81;T280M;ENST00000541347
CX3CR1;ENSG00000168329;30130-0.0;Monocyte count;rs3732378;A;1.0;0.0070934;0.00037203;5.1526e-81;T280M;ENST00000542107
CX3CR1;ENSG00000168329;30130-0.0;Monocyte count;rs3732379;T;1.0;0.0042176;0.00031295;2.1811999999999999e-41;V281I;ENST00000358309
CX3CR1;ENSG00000168329;30130-0.0;Monocyte count;rs3732379;T;1.0;0.0042176;0.00031295;2.1811999999999999e-41;V249I;ENST00000399220
CX3CR1;ENSG00000168329;30130-0.0;Monocyte count;rs3732379;T;1.0;0.0042176;0.00031295;2.1811999999999999e-41;V249I;ENST00000541347
CX3CR1;ENSG00000168329;30130-0.0;Monocyte count;rs3732379;T;1.0;0.0042176;0.00031295;2.1811999999999999e-41;V249I;ENST00000542107
CX3CR1;ENSG00000168329;23102-0.0;Whole body water mass;rs147724093;C;1.0;0.13823;0.040956;0.00073766;P4A;ENST00000358309
CX3CR1;ENSG00000168329;cancer_c_D06;D06 Carcinoma in situ of cervix uteri;rs11715522;C;1.0;0.00071167;0.00026049;0.006294600000000001;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_H65;H65 Nonsuppurative otitis media;rs139019894;C;0.889349;0.0040774999999999995;0.0014208;0.004106;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_H65;H65 Nonsuppurative otitis media;rs139019894;C;0.889349;0.0040774999999999995;0.0014208;0.004106;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_H65;H65 Nonsuppurative otitis media;rs139019894;C;0.889349;0.0040774999999999995;0.0014208;0.004106;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_H65;H65 Nonsuppurative otitis media;rs139019894;C;0.889349;0.0040774999999999995;0.0014208;0.004106;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_H65;H65 Nonsuppurative otitis media;rs139019894;C;0.889349;0.0040774999999999995;0.0014208;0.004106;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_H65;H65 Nonsuppurative otitis media;rs139019894;C;0.889349;0.0040774999999999995;0.0014208;0.004106;D25G;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_H36;H36 Retinal disorders in diseases classified elsewhere;rs3732378;A;1.0;0.00046528;0.00015542;0.0027559;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_H36;H36 Retinal disorders in diseases classified elsewhere;rs3732378;A;1.0;0.00046528;0.00015542;0.0027559;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_H36;H36 Retinal disorders in diseases classified elsewhere;rs3732378;A;1.0;0.00046528;0.00015542;0.0027559;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_H36;H36 Retinal disorders in diseases classified elsewhere;rs3732378;A;1.0;0.00046528;0.00015542;0.0027559;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_H36;H36 Retinal disorders in diseases classified elsewhere;rs3732379;T;1.0;0.00040758;0.00013071;0.0018195999999999998;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_H36;H36 Retinal disorders in diseases classified elsewhere;rs3732379;T;1.0;0.00040758;0.00013071;0.0018195999999999998;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_H36;H36 Retinal disorders in diseases classified elsewhere;rs3732379;T;1.0;0.00040758;0.00013071;0.0018195999999999998;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_H36;H36 Retinal disorders in diseases classified elsewhere;rs3732379;T;1.0;0.00040758;0.00013071;0.0018195999999999998;V249I;ENST00000542107
CX3CR1;ENSG00000168329;23108-0.0;Impedance of leg (left);rs11715522;C;1.0;-0.16343;0.055384;0.0031694;F8L;ENST00000358309
CX3CR1;ENSG00000168329;23108-0.0;Impedance of leg (left);rs147724093;C;1.0;-0.7762100000000001;0.29961;0.009578;P4A;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1314;nervous breakdown;rs150319988;A;0.526638;0.017432;0.0052213;0.00084216;R350C;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1314;nervous breakdown;rs150319988;A;0.526638;0.017432;0.0052213;0.00084216;R318C;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1314;nervous breakdown;rs150319988;A;0.526638;0.017432;0.0052213;0.00084216;R318C;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1314;nervous breakdown;rs150319988;A;0.526638;0.017432;0.0052213;0.00084216;R318C;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1314;nervous breakdown;rs3732380;T;0.720038;0.018711000000000002;0.005527600000000001;0.00071162;V179I;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1314;nervous breakdown;rs3732380;T;0.720038;0.018711000000000002;0.005527600000000001;0.00071162;V147I;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1314;nervous breakdown;rs3732380;T;0.720038;0.018711000000000002;0.005527600000000001;0.00071162;V147I;ENST00000435290
CX3CR1;ENSG00000168329;selfReported_n_1314;nervous breakdown;rs3732380;T;0.720038;0.018711000000000002;0.005527600000000001;0.00071162;V147I;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1314;nervous breakdown;rs3732380;T;0.720038;0.018711000000000002;0.005527600000000001;0.00071162;V147I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs3732380;T;0.720038;0.026900999999999998;0.0057263;2.6308e-06;V179I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs3732380;T;0.720038;0.026900999999999998;0.0057263;2.6308e-06;V147I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs3732380;T;0.720038;0.026900999999999998;0.0057263;2.6308e-06;V147I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs3732380;T;0.720038;0.026900999999999998;0.0057263;2.6308e-06;V147I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_I89;I89 Other non-infective disorders of lymphatic vessels and lymph nodes;rs3732380;T;0.720038;0.026900999999999998;0.0057263;2.6308e-06;V147I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_N23;N23 Unspecified renal colic;rs143001773;T;1.0;0.0054434;0.0019329999999999998;0.004861600000000001;V154I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_N23;N23 Unspecified renal colic;rs143001773;T;1.0;0.0054434;0.0019329999999999998;0.004861600000000001;V122I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_N23;N23 Unspecified renal colic;rs143001773;T;1.0;0.0054434;0.0019329999999999998;0.004861600000000001;V122I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_N23;N23 Unspecified renal colic;rs143001773;T;1.0;0.0054434;0.0019329999999999998;0.004861600000000001;V122I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_N23;N23 Unspecified renal colic;rs143001773;T;1.0;0.0054434;0.0019329999999999998;0.004861600000000001;V122I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_J00-J06;J00-J06 Acute upper respiratory infections;rs150319988;A;0.526638;0.030712;0.011429;0.0072051;R350C;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_J00-J06;J00-J06 Acute upper respiratory infections;rs150319988;A;0.526638;0.030712;0.011429;0.0072051;R318C;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_J00-J06;J00-J06 Acute upper respiratory infections;rs150319988;A;0.526638;0.030712;0.011429;0.0072051;R318C;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_J00-J06;J00-J06 Acute upper respiratory infections;rs150319988;A;0.526638;0.030712;0.011429;0.0072051;R318C;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_N70;N70 Salpingitis and oophoritis;rs201179424;C;0.754391;0.010925;0.0029476;0.00021021;I324M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_N70;N70 Salpingitis and oophoritis;rs201179424;C;0.754391;0.010925;0.0029476;0.00021021;I292M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_N70;N70 Salpingitis and oophoritis;rs201179424;C;0.754391;0.010925;0.0029476;0.00021021;I292M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_N70;N70 Salpingitis and oophoritis;rs201179424;C;0.754391;0.010925;0.0029476;0.00021021;I292M;ENST00000542107
CX3CR1;ENSG00000168329;20117-0.0;Alcohol drinker status;rs143001773;T;1.0;-0.032131;0.01093;0.0032849000000000003;V154I;ENST00000358309
CX3CR1;ENSG00000168329;20117-0.0;Alcohol drinker status;rs143001773;T;1.0;-0.032131;0.01093;0.0032849000000000003;V122I;ENST00000399220
CX3CR1;ENSG00000168329;20117-0.0;Alcohol drinker status;rs143001773;T;1.0;-0.032131;0.01093;0.0032849000000000003;V122I;ENST00000435290
CX3CR1;ENSG00000168329;20117-0.0;Alcohol drinker status;rs143001773;T;1.0;-0.032131;0.01093;0.0032849000000000003;V122I;ENST00000541347
CX3CR1;ENSG00000168329;20117-0.0;Alcohol drinker status;rs143001773;T;1.0;-0.032131;0.01093;0.0032849000000000003;V122I;ENST00000542107
CX3CR1;ENSG00000168329;1478-0.0;Salt added to food;rs41535248;A;1.0;-0.034703;0.007298899999999999;1.9893e-06;E45D;ENST00000358309
CX3CR1;ENSG00000168329;1478-0.0;Salt added to food;rs41535248;A;1.0;-0.034703;0.007298899999999999;1.9893e-06;E13D;ENST00000399220
CX3CR1;ENSG00000168329;1478-0.0;Salt added to food;rs41535248;A;1.0;-0.034703;0.007298899999999999;1.9893e-06;E13D;ENST00000412814
CX3CR1;ENSG00000168329;1478-0.0;Salt added to food;rs41535248;A;1.0;-0.034703;0.007298899999999999;1.9893e-06;E13D;ENST00000435290
CX3CR1;ENSG00000168329;1478-0.0;Salt added to food;rs41535248;A;1.0;-0.034703;0.007298899999999999;1.9893e-06;E13D;ENST00000541347
CX3CR1;ENSG00000168329;1478-0.0;Salt added to food;rs41535248;A;1.0;-0.034703;0.007298899999999999;1.9893e-06;E13D;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_J32;J32 Chronic sinusitis;rs139019894;C;0.889349;0.0065896999999999996;0.0021738000000000005;0.002434;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_J32;J32 Chronic sinusitis;rs139019894;C;0.889349;0.0065896999999999996;0.0021738000000000005;0.002434;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_J32;J32 Chronic sinusitis;rs139019894;C;0.889349;0.0065896999999999996;0.0021738000000000005;0.002434;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_J32;J32 Chronic sinusitis;rs139019894;C;0.889349;0.0065896999999999996;0.0021738000000000005;0.002434;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_J32;J32 Chronic sinusitis;rs139019894;C;0.889349;0.0065896999999999996;0.0021738000000000005;0.002434;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_J32;J32 Chronic sinusitis;rs139019894;C;0.889349;0.0065896999999999996;0.0021738000000000005;0.002434;D25G;ENST00000542107
CX3CR1;ENSG00000168329;23124-0.0;Arm fat mass (left);rs41535248;A;1.0;-0.016287;0.0051916;0.0017057000000000003;E45D;ENST00000358309
CX3CR1;ENSG00000168329;23124-0.0;Arm fat mass (left);rs41535248;A;1.0;-0.016287;0.0051916;0.0017057000000000003;E13D;ENST00000399220
CX3CR1;ENSG00000168329;23124-0.0;Arm fat mass (left);rs41535248;A;1.0;-0.016287;0.0051916;0.0017057000000000003;E13D;ENST00000412814
CX3CR1;ENSG00000168329;23124-0.0;Arm fat mass (left);rs41535248;A;1.0;-0.016287;0.0051916;0.0017057000000000003;E13D;ENST00000435290
CX3CR1;ENSG00000168329;23124-0.0;Arm fat mass (left);rs41535248;A;1.0;-0.016287;0.0051916;0.0017057000000000003;E13D;ENST00000541347
CX3CR1;ENSG00000168329;23124-0.0;Arm fat mass (left);rs41535248;A;1.0;-0.016287;0.0051916;0.0017057000000000003;E13D;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_I20;I20 Angina pectoris;rs199811198;C;1.0;0.0088406;0.0033884;0.0090794;T89A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_I20;I20 Angina pectoris;rs199811198;C;1.0;0.0088406;0.0033884;0.0090794;T57A;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_I20;I20 Angina pectoris;rs199811198;C;1.0;0.0088406;0.0033884;0.0090794;T57A;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_I20;I20 Angina pectoris;rs199811198;C;1.0;0.0088406;0.0033884;0.0090794;T57A;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_I20;I20 Angina pectoris;rs199811198;C;1.0;0.0088406;0.0033884;0.0090794;T57A;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_I20;I20 Angina pectoris;rs199811198;C;1.0;0.0088406;0.0033884;0.0090794;T57A;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1517;duodenal ulcer;rs150319988;A;0.526638;0.025716000000000003;0.008705200000000001;0.0031364;R350C;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1517;duodenal ulcer;rs150319988;A;0.526638;0.025716000000000003;0.008705200000000001;0.0031364;R318C;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1517;duodenal ulcer;rs150319988;A;0.526638;0.025716000000000003;0.008705200000000001;0.0031364;R318C;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1517;duodenal ulcer;rs150319988;A;0.526638;0.025716000000000003;0.008705200000000001;0.0031364;R318C;ENST00000542107
CX3CR1;ENSG00000168329;cancer_c_D41;D41 Neoplasm of uncertain or unknown behaviour of urinary organs;rs139019894;C;0.889349;0.0032039;0.0011074000000000001;0.0038145;D57G;ENST00000358309
CX3CR1;ENSG00000168329;cancer_c_D41;D41 Neoplasm of uncertain or unknown behaviour of urinary organs;rs139019894;C;0.889349;0.0032039;0.0011074000000000001;0.0038145;D25G;ENST00000399220
CX3CR1;ENSG00000168329;cancer_c_D41;D41 Neoplasm of uncertain or unknown behaviour of urinary organs;rs139019894;C;0.889349;0.0032039;0.0011074000000000001;0.0038145;D25G;ENST00000412814
CX3CR1;ENSG00000168329;cancer_c_D41;D41 Neoplasm of uncertain or unknown behaviour of urinary organs;rs139019894;C;0.889349;0.0032039;0.0011074000000000001;0.0038145;D25G;ENST00000435290
CX3CR1;ENSG00000168329;cancer_c_D41;D41 Neoplasm of uncertain or unknown behaviour of urinary organs;rs139019894;C;0.889349;0.0032039;0.0011074000000000001;0.0038145;D25G;ENST00000541347
CX3CR1;ENSG00000168329;cancer_c_D41;D41 Neoplasm of uncertain or unknown behaviour of urinary organs;rs139019894;C;0.889349;0.0032039;0.0011074000000000001;0.0038145;D25G;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_J02;J02 Acute pharyngitis;rs150319988;A;0.526638;0.020737000000000002;0.006162;0.00076469;R350C;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_J02;J02 Acute pharyngitis;rs150319988;A;0.526638;0.020737000000000002;0.006162;0.00076469;R318C;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_J02;J02 Acute pharyngitis;rs150319988;A;0.526638;0.020737000000000002;0.006162;0.00076469;R318C;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_J02;J02 Acute pharyngitis;rs150319988;A;0.526638;0.020737000000000002;0.006162;0.00076469;R318C;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_N10-N16;N10-N16 Renal tubulo-interstitial diseases;rs147724093;C;1.0;0.0030313000000000002;0.0011054;0.0061042;P4A;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1469;ear/vestibular disorder;rs3732378;A;1.0;-0.00089249;0.00033555;0.007819;T312M;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1469;ear/vestibular disorder;rs3732378;A;1.0;-0.00089249;0.00033555;0.007819;T280M;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1469;ear/vestibular disorder;rs3732378;A;1.0;-0.00089249;0.00033555;0.007819;T280M;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1469;ear/vestibular disorder;rs3732378;A;1.0;-0.00089249;0.00033555;0.007819;T280M;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1511;eczema/dermatitis;rs41535248;A;1.0;-0.0040880000000000005;0.0014343;0.004368899999999999;E45D;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1511;eczema/dermatitis;rs41535248;A;1.0;-0.0040880000000000005;0.0014343;0.004368899999999999;E13D;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1511;eczema/dermatitis;rs41535248;A;1.0;-0.0040880000000000005;0.0014343;0.004368899999999999;E13D;ENST00000412814
CX3CR1;ENSG00000168329;selfReported_n_1511;eczema/dermatitis;rs41535248;A;1.0;-0.0040880000000000005;0.0014343;0.004368899999999999;E13D;ENST00000435290
CX3CR1;ENSG00000168329;selfReported_n_1511;eczema/dermatitis;rs41535248;A;1.0;-0.0040880000000000005;0.0014343;0.004368899999999999;E13D;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1511;eczema/dermatitis;rs41535248;A;1.0;-0.0040880000000000005;0.0014343;0.004368899999999999;E13D;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_I70-I79;I70-I79 Diseases of arteries, arterioles and capillaries;rs139019894;C;0.889349;0.011079;0.003742;0.0030698;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_I70-I79;I70-I79 Diseases of arteries, arterioles and capillaries;rs139019894;C;0.889349;0.011079;0.003742;0.0030698;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_I70-I79;I70-I79 Diseases of arteries, arterioles and capillaries;rs139019894;C;0.889349;0.011079;0.003742;0.0030698;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_Block_I70-I79;I70-I79 Diseases of arteries, arterioles and capillaries;rs139019894;C;0.889349;0.011079;0.003742;0.0030698;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_Block_I70-I79;I70-I79 Diseases of arteries, arterioles and capillaries;rs139019894;C;0.889349;0.011079;0.003742;0.0030698;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_I70-I79;I70-I79 Diseases of arteries, arterioles and capillaries;rs139019894;C;0.889349;0.011079;0.003742;0.0030698;D25G;ENST00000542107
CX3CR1;ENSG00000168329;1707-0.0;Handedness (chirality/laterality);rs11715522;C;1.0;0.0017054000000000001;0.00062544;0.0063967;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_M86-M90;M86-M90 Other osteopathies;rs147724093;C;1.0;0.0034952;0.0010102;0.00054063;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_F30-F39;F30-F39 Mood [affective] disorders;rs139019894;C;0.889349;-0.014449000000000002;0.004815;0.0026921999999999996;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_F30-F39;F30-F39 Mood [affective] disorders;rs139019894;C;0.889349;-0.014449000000000002;0.004815;0.0026921999999999996;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_F30-F39;F30-F39 Mood [affective] disorders;rs139019894;C;0.889349;-0.014449000000000002;0.004815;0.0026921999999999996;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_Block_F30-F39;F30-F39 Mood [affective] disorders;rs139019894;C;0.889349;-0.014449000000000002;0.004815;0.0026921999999999996;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_Block_F30-F39;F30-F39 Mood [affective] disorders;rs139019894;C;0.889349;-0.014449000000000002;0.004815;0.0026921999999999996;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_F30-F39;F30-F39 Mood [affective] disorders;rs139019894;C;0.889349;-0.014449000000000002;0.004815;0.0026921999999999996;D25G;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_G91;G91 Hydrocephalus;rs3732380;T;0.720038;0.028495999999999997;0.0047405;1.844e-09;V179I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_G91;G91 Hydrocephalus;rs3732380;T;0.720038;0.028495999999999997;0.0047405;1.844e-09;V147I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_G91;G91 Hydrocephalus;rs3732380;T;0.720038;0.028495999999999997;0.0047405;1.844e-09;V147I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_G91;G91 Hydrocephalus;rs3732380;T;0.720038;0.028495999999999997;0.0047405;1.844e-09;V147I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_G91;G91 Hydrocephalus;rs3732380;T;0.720038;0.028495999999999997;0.0047405;1.844e-09;V147I;ENST00000542107
CX3CR1;ENSG00000168329;30010-0.0;Red blood cell (erythrocyte) count;rs11715522;C;1.0;-0.0018944000000000003;0.00060304;0.0016819000000000003;F8L;ENST00000358309
CX3CR1;ENSG00000168329;30010-0.0;Red blood cell (erythrocyte) count;rs150319988;A;0.526638;0.11264;0.038011;0.0030428;R350C;ENST00000358309
CX3CR1;ENSG00000168329;30010-0.0;Red blood cell (erythrocyte) count;rs150319988;A;0.526638;0.11264;0.038011;0.0030428;R318C;ENST00000399220
CX3CR1;ENSG00000168329;30010-0.0;Red blood cell (erythrocyte) count;rs150319988;A;0.526638;0.11264;0.038011;0.0030428;R318C;ENST00000541347
CX3CR1;ENSG00000168329;30010-0.0;Red blood cell (erythrocyte) count;rs150319988;A;0.526638;0.11264;0.038011;0.0030428;R318C;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_M43;M43 Other deforming dorsopathies;rs41535248;A;1.0;-0.0017646;0.00059148;0.0028511999999999995;E45D;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M43;M43 Other deforming dorsopathies;rs41535248;A;1.0;-0.0017646;0.00059148;0.0028511999999999995;E13D;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_M43;M43 Other deforming dorsopathies;rs41535248;A;1.0;-0.0017646;0.00059148;0.0028511999999999995;E13D;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_M43;M43 Other deforming dorsopathies;rs41535248;A;1.0;-0.0017646;0.00059148;0.0028511999999999995;E13D;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_M43;M43 Other deforming dorsopathies;rs41535248;A;1.0;-0.0017646;0.00059148;0.0028511999999999995;E13D;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_M43;M43 Other deforming dorsopathies;rs41535248;A;1.0;-0.0017646;0.00059148;0.0028511999999999995;E13D;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_G50-G59;G50-G59 Nerve, nerve root and plexus disorders;rs139019894;C;0.889349;-0.015211;0.0056426;0.007023399999999999;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_G50-G59;G50-G59 Nerve, nerve root and plexus disorders;rs139019894;C;0.889349;-0.015211;0.0056426;0.007023399999999999;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_G50-G59;G50-G59 Nerve, nerve root and plexus disorders;rs139019894;C;0.889349;-0.015211;0.0056426;0.007023399999999999;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_Block_G50-G59;G50-G59 Nerve, nerve root and plexus disorders;rs139019894;C;0.889349;-0.015211;0.0056426;0.007023399999999999;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_Block_G50-G59;G50-G59 Nerve, nerve root and plexus disorders;rs139019894;C;0.889349;-0.015211;0.0056426;0.007023399999999999;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_G50-G59;G50-G59 Nerve, nerve root and plexus disorders;rs139019894;C;0.889349;-0.015211;0.0056426;0.007023399999999999;D25G;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_F43;F43 Reaction to severe stress, and adjustment disorders;rs3732380;T;0.720038;0.019076;0.005077;0.00017177;V179I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_F43;F43 Reaction to severe stress, and adjustment disorders;rs3732380;T;0.720038;0.019076;0.005077;0.00017177;V147I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_F43;F43 Reaction to severe stress, and adjustment disorders;rs3732380;T;0.720038;0.019076;0.005077;0.00017177;V147I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_F43;F43 Reaction to severe stress, and adjustment disorders;rs3732380;T;0.720038;0.019076;0.005077;0.00017177;V147I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_F43;F43 Reaction to severe stress, and adjustment disorders;rs3732380;T;0.720038;0.019076;0.005077;0.00017177;V147I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs3732378;A;1.0;-0.004213000000000001;0.0011973;0.00043366;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs3732378;A;1.0;-0.004213000000000001;0.0011973;0.00043366;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs3732378;A;1.0;-0.004213000000000001;0.0011973;0.00043366;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs3732378;A;1.0;-0.004213000000000001;0.0011973;0.00043366;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_H52;H52 Disorders of refraction and accommodation;rs3732379;T;1.0;0.00043279;0.00015355;0.0048244;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_H52;H52 Disorders of refraction and accommodation;rs3732379;T;1.0;0.00043279;0.00015355;0.0048244;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_H52;H52 Disorders of refraction and accommodation;rs3732379;T;1.0;0.00043279;0.00015355;0.0048244;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_H52;H52 Disorders of refraction and accommodation;rs3732379;T;1.0;0.00043279;0.00015355;0.0048244;V249I;ENST00000542107
CX3CR1;ENSG00000168329;23123-0.0;Arm fat percentage (left);rs41535248;A;1.0;-0.15008;0.056899;0.008349500000000001;E45D;ENST00000358309
CX3CR1;ENSG00000168329;23123-0.0;Arm fat percentage (left);rs41535248;A;1.0;-0.15008;0.056899;0.008349500000000001;E13D;ENST00000399220
CX3CR1;ENSG00000168329;23123-0.0;Arm fat percentage (left);rs41535248;A;1.0;-0.15008;0.056899;0.008349500000000001;E13D;ENST00000412814
CX3CR1;ENSG00000168329;23123-0.0;Arm fat percentage (left);rs41535248;A;1.0;-0.15008;0.056899;0.008349500000000001;E13D;ENST00000435290
CX3CR1;ENSG00000168329;23123-0.0;Arm fat percentage (left);rs41535248;A;1.0;-0.15008;0.056899;0.008349500000000001;E13D;ENST00000541347
CX3CR1;ENSG00000168329;23123-0.0;Arm fat percentage (left);rs41535248;A;1.0;-0.15008;0.056899;0.008349500000000001;E13D;ENST00000542107
CX3CR1;ENSG00000168329;23117-0.0;Leg fat-free mass (left);rs147724093;C;1.0;0.032335;0.011112;0.003616;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_N43;N43 Hydrocele and spermatocele;rs3732378;A;1.0;-0.00088995;0.00034189;0.0092421;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_N43;N43 Hydrocele and spermatocele;rs3732378;A;1.0;-0.00088995;0.00034189;0.0092421;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_N43;N43 Hydrocele and spermatocele;rs3732378;A;1.0;-0.00088995;0.00034189;0.0092421;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_N43;N43 Hydrocele and spermatocele;rs3732378;A;1.0;-0.00088995;0.00034189;0.0092421;T280M;ENST00000542107
CX3CR1;ENSG00000168329;1309-0.0;Fresh fruit intake;rs11715522;C;1.0;0.0088567;0.002991;0.0030653000000000004;F8L;ENST00000358309
CX3CR1;ENSG00000168329;1160-0.0;Sleep duration;rs3732378;A;1.0;0.0080771;0.0028199;0.0041797;T312M;ENST00000358309
CX3CR1;ENSG00000168329;1160-0.0;Sleep duration;rs3732378;A;1.0;0.0080771;0.0028199;0.0041797;T280M;ENST00000399220
CX3CR1;ENSG00000168329;1160-0.0;Sleep duration;rs3732378;A;1.0;0.0080771;0.0028199;0.0041797;T280M;ENST00000541347
CX3CR1;ENSG00000168329;1160-0.0;Sleep duration;rs3732378;A;1.0;0.0080771;0.0028199;0.0041797;T280M;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1623;miscarriage;rs11715522;C;1.0;0.00049111;0.00017816;0.0058407;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_H02;H02 Other disorders of eyelid;rs201179424;C;0.754391;0.014409;0.0049775;0.0037926;I324M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_H02;H02 Other disorders of eyelid;rs201179424;C;0.754391;0.014409;0.0049775;0.0037926;I292M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_H02;H02 Other disorders of eyelid;rs201179424;C;0.754391;0.014409;0.0049775;0.0037926;I292M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_H02;H02 Other disorders of eyelid;rs201179424;C;0.754391;0.014409;0.0049775;0.0037926;I292M;ENST00000542107
CX3CR1;ENSG00000168329;23125-0.0;Arm fat-free mass (left);rs147724093;C;1.0;0.013606;0.0042906;0.0015187000000000002;P4A;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1222;bladder problem (not cancer);rs143001773;T;1.0;-0.0074735;0.0027712;0.007000399999999999;V154I;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1222;bladder problem (not cancer);rs143001773;T;1.0;-0.0074735;0.0027712;0.007000399999999999;V122I;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1222;bladder problem (not cancer);rs143001773;T;1.0;-0.0074735;0.0027712;0.007000399999999999;V122I;ENST00000435290
CX3CR1;ENSG00000168329;selfReported_n_1222;bladder problem (not cancer);rs143001773;T;1.0;-0.0074735;0.0027712;0.007000399999999999;V122I;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1222;bladder problem (not cancer);rs143001773;T;1.0;-0.0074735;0.0027712;0.007000399999999999;V122I;ENST00000542107
CX3CR1;ENSG00000168329;30180-0.0;Lymphocyte percentage;rs3732378;A;1.0;0.10547000000000001;0.017130000000000003;7.4189e-10;T312M;ENST00000358309
CX3CR1;ENSG00000168329;30180-0.0;Lymphocyte percentage;rs3732378;A;1.0;0.10547000000000001;0.017130000000000003;7.4189e-10;T280M;ENST00000399220
CX3CR1;ENSG00000168329;30180-0.0;Lymphocyte percentage;rs3732378;A;1.0;0.10547000000000001;0.017130000000000003;7.4189e-10;T280M;ENST00000541347
CX3CR1;ENSG00000168329;30180-0.0;Lymphocyte percentage;rs3732378;A;1.0;0.10547000000000001;0.017130000000000003;7.4189e-10;T280M;ENST00000542107
CX3CR1;ENSG00000168329;30180-0.0;Lymphocyte percentage;rs3732379;T;1.0;0.05441;0.014407;0.00015901;V281I;ENST00000358309
CX3CR1;ENSG00000168329;30180-0.0;Lymphocyte percentage;rs3732379;T;1.0;0.05441;0.014407;0.00015901;V249I;ENST00000399220
CX3CR1;ENSG00000168329;30180-0.0;Lymphocyte percentage;rs3732379;T;1.0;0.05441;0.014407;0.00015901;V249I;ENST00000541347
CX3CR1;ENSG00000168329;30180-0.0;Lymphocyte percentage;rs3732379;T;1.0;0.05441;0.014407;0.00015901;V249I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_M70-M79;M70-M79 Other soft tissue disorders;rs147724093;C;1.0;0.007364;0.0028542;0.009877200000000001;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M53;M53 Other dorsopathies, not elsewhere classified;rs143001773;T;1.0;0.0028608;0.0010423;0.0060595;V154I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_M53;M53 Other dorsopathies, not elsewhere classified;rs143001773;T;1.0;0.0028608;0.0010423;0.0060595;V122I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_M53;M53 Other dorsopathies, not elsewhere classified;rs143001773;T;1.0;0.0028608;0.0010423;0.0060595;V122I;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_M53;M53 Other dorsopathies, not elsewhere classified;rs143001773;T;1.0;0.0028608;0.0010423;0.0060595;V122I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_M53;M53 Other dorsopathies, not elsewhere classified;rs143001773;T;1.0;0.0028608;0.0010423;0.0060595;V122I;ENST00000542107
CX3CR1;ENSG00000168329;30050-0.0;Mean corpuscular haemoglobin;rs199811198;C;1.0;0.061171;0.023662;0.0097336;T89A;ENST00000358309
CX3CR1;ENSG00000168329;30050-0.0;Mean corpuscular haemoglobin;rs199811198;C;1.0;0.061171;0.023662;0.0097336;T57A;ENST00000399220
CX3CR1;ENSG00000168329;30050-0.0;Mean corpuscular haemoglobin;rs199811198;C;1.0;0.061171;0.023662;0.0097336;T57A;ENST00000412814
CX3CR1;ENSG00000168329;30050-0.0;Mean corpuscular haemoglobin;rs199811198;C;1.0;0.061171;0.023662;0.0097336;T57A;ENST00000435290
CX3CR1;ENSG00000168329;30050-0.0;Mean corpuscular haemoglobin;rs199811198;C;1.0;0.061171;0.023662;0.0097336;T57A;ENST00000541347
CX3CR1;ENSG00000168329;30050-0.0;Mean corpuscular haemoglobin;rs199811198;C;1.0;0.061171;0.023662;0.0097336;T57A;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_L03;L03 Cellulitis;rs11715522;C;1.0;0.00076377;0.00027969;0.0063189;F8L;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_L03;L03 Cellulitis;rs3732379;T;1.0;0.0007875;0.00030182;0.0090752;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_L03;L03 Cellulitis;rs3732379;T;1.0;0.0007875;0.00030182;0.0090752;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_L03;L03 Cellulitis;rs3732379;T;1.0;0.0007875;0.00030182;0.0090752;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_L03;L03 Cellulitis;rs3732379;T;1.0;0.0007875;0.00030182;0.0090752;V249I;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1111;pulmonary embolism +/- dvt;rs3732378;A;1.0;0.00065604;0.00024929;0.008497;T312M;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1111;pulmonary embolism +/- dvt;rs3732378;A;1.0;0.00065604;0.00024929;0.008497;T280M;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1111;pulmonary embolism +/- dvt;rs3732378;A;1.0;0.00065604;0.00024929;0.008497;T280M;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1111;pulmonary embolism +/- dvt;rs3732378;A;1.0;0.00065604;0.00024929;0.008497;T280M;ENST00000542107
CX3CR1;ENSG00000168329;selfReported_n_1111;pulmonary embolism +/- dvt;rs3732379;T;1.0;0.00056733;0.00020966;0.0068107;V281I;ENST00000358309
CX3CR1;ENSG00000168329;selfReported_n_1111;pulmonary embolism +/- dvt;rs3732379;T;1.0;0.00056733;0.00020966;0.0068107;V249I;ENST00000399220
CX3CR1;ENSG00000168329;selfReported_n_1111;pulmonary embolism +/- dvt;rs3732379;T;1.0;0.00056733;0.00020966;0.0068107;V249I;ENST00000541347
CX3CR1;ENSG00000168329;selfReported_n_1111;pulmonary embolism +/- dvt;rs3732379;T;1.0;0.00056733;0.00020966;0.0068107;V249I;ENST00000542107
CX3CR1;ENSG00000168329;1329-0.0;Oily fish intake;rs199811198;C;1.0;0.038113;0.014727;0.0096561;T89A;ENST00000358309
CX3CR1;ENSG00000168329;1329-0.0;Oily fish intake;rs199811198;C;1.0;0.038113;0.014727;0.0096561;T57A;ENST00000399220
CX3CR1;ENSG00000168329;1329-0.0;Oily fish intake;rs199811198;C;1.0;0.038113;0.014727;0.0096561;T57A;ENST00000412814
CX3CR1;ENSG00000168329;1329-0.0;Oily fish intake;rs199811198;C;1.0;0.038113;0.014727;0.0096561;T57A;ENST00000435290
CX3CR1;ENSG00000168329;1329-0.0;Oily fish intake;rs199811198;C;1.0;0.038113;0.014727;0.0096561;T57A;ENST00000541347
CX3CR1;ENSG00000168329;1329-0.0;Oily fish intake;rs199811198;C;1.0;0.038113;0.014727;0.0096561;T57A;ENST00000542107
CX3CR1;ENSG00000168329;728-0.0;Number of vehicles in household;rs3732380;T;0.720038;-0.31461999999999996;0.11562;0.0065052999999999995;V179I;ENST00000358309
CX3CR1;ENSG00000168329;728-0.0;Number of vehicles in household;rs3732380;T;0.720038;-0.31461999999999996;0.11562;0.0065052999999999995;V147I;ENST00000399220
CX3CR1;ENSG00000168329;728-0.0;Number of vehicles in household;rs3732380;T;0.720038;-0.31461999999999996;0.11562;0.0065052999999999995;V147I;ENST00000435290
CX3CR1;ENSG00000168329;728-0.0;Number of vehicles in household;rs3732380;T;0.720038;-0.31461999999999996;0.11562;0.0065052999999999995;V147I;ENST00000541347
CX3CR1;ENSG00000168329;728-0.0;Number of vehicles in household;rs3732380;T;0.720038;-0.31461999999999996;0.11562;0.0065052999999999995;V147I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_B37;B37 Candidiasis;rs139019894;C;0.889349;0.0053142;0.0020356;0.0090369;D57G;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_B37;B37 Candidiasis;rs139019894;C;0.889349;0.0053142;0.0020356;0.0090369;D25G;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_B37;B37 Candidiasis;rs139019894;C;0.889349;0.0053142;0.0020356;0.0090369;D25G;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_B37;B37 Candidiasis;rs139019894;C;0.889349;0.0053142;0.0020356;0.0090369;D25G;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_B37;B37 Candidiasis;rs139019894;C;0.889349;0.0053142;0.0020356;0.0090369;D25G;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_B37;B37 Candidiasis;rs139019894;C;0.889349;0.0053142;0.0020356;0.0090369;D25G;ENST00000542107
CX3CR1;ENSG00000168329;23129-0.0;Trunk fat-free mass;rs147724093;C;1.0;0.098205;0.02843;0.00055184;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_J95-J99;J95-J99 Other diseases of the respiratory system;rs147724093;C;1.0;-0.0041099;0.0013135;0.0017542000000000002;P4A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_L91;L91 Hypertrophic disorders of skin;rs3732378;A;1.0;0.00037026;0.00014255;0.009391799999999999;T312M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_L91;L91 Hypertrophic disorders of skin;rs3732378;A;1.0;0.00037026;0.00014255;0.009391799999999999;T280M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_L91;L91 Hypertrophic disorders of skin;rs3732378;A;1.0;0.00037026;0.00014255;0.009391799999999999;T280M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_L91;L91 Hypertrophic disorders of skin;rs3732378;A;1.0;0.00037026;0.00014255;0.009391799999999999;T280M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_L91;L91 Hypertrophic disorders of skin;rs3732379;T;1.0;0.00035596;0.00011989;0.0029863000000000003;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_L91;L91 Hypertrophic disorders of skin;rs3732379;T;1.0;0.00035596;0.00011989;0.0029863000000000003;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_L91;L91 Hypertrophic disorders of skin;rs3732379;T;1.0;0.00035596;0.00011989;0.0029863000000000003;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_L91;L91 Hypertrophic disorders of skin;rs3732379;T;1.0;0.00035596;0.00011989;0.0029863000000000003;V249I;ENST00000542107
CX3CR1;ENSG00000168329;cancer_c_C56;C56 Malignant neoplasm of ovary;rs3732380;T;0.720038;0.033451;0.011366;0.0032494;V179I;ENST00000358309
CX3CR1;ENSG00000168329;cancer_c_C56;C56 Malignant neoplasm of ovary;rs3732380;T;0.720038;0.033451;0.011366;0.0032494;V147I;ENST00000399220
CX3CR1;ENSG00000168329;cancer_c_C56;C56 Malignant neoplasm of ovary;rs3732380;T;0.720038;0.033451;0.011366;0.0032494;V147I;ENST00000435290
CX3CR1;ENSG00000168329;cancer_c_C56;C56 Malignant neoplasm of ovary;rs3732380;T;0.720038;0.033451;0.011366;0.0032494;V147I;ENST00000541347
CX3CR1;ENSG00000168329;cancer_c_C56;C56 Malignant neoplasm of ovary;rs3732380;T;0.720038;0.033451;0.011366;0.0032494;V147I;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs199811198;C;1.0;0.0026583;0.00089801;0.0030749;T89A;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs199811198;C;1.0;0.0026583;0.00089801;0.0030749;T57A;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs199811198;C;1.0;0.0026583;0.00089801;0.0030749;T57A;ENST00000412814
CX3CR1;ENSG00000168329;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs199811198;C;1.0;0.0026583;0.00089801;0.0030749;T57A;ENST00000435290
CX3CR1;ENSG00000168329;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs199811198;C;1.0;0.0026583;0.00089801;0.0030749;T57A;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs199811198;C;1.0;0.0026583;0.00089801;0.0030749;T57A;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_L43;L43 Lichen planus;rs201179424;C;0.754391;0.0040292999999999995;0.0015627;0.0099258;I324M;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_L43;L43 Lichen planus;rs201179424;C;0.754391;0.0040292999999999995;0.0015627;0.0099258;I292M;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_L43;L43 Lichen planus;rs201179424;C;0.754391;0.0040292999999999995;0.0015627;0.0099258;I292M;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_L43;L43 Lichen planus;rs201179424;C;0.754391;0.0040292999999999995;0.0015627;0.0099258;I292M;ENST00000542107
CX3CR1;ENSG00000168329;clinical_c_Block_H30-H36;H30-H36 Disorders of choroid and retina;rs3732379;T;1.0;0.0010517;0.00030587;0.00058554;V281I;ENST00000358309
CX3CR1;ENSG00000168329;clinical_c_Block_H30-H36;H30-H36 Disorders of choroid and retina;rs3732379;T;1.0;0.0010517;0.00030587;0.00058554;V249I;ENST00000399220
CX3CR1;ENSG00000168329;clinical_c_Block_H30-H36;H30-H36 Disorders of choroid and retina;rs3732379;T;1.0;0.0010517;0.00030587;0.00058554;V249I;ENST00000541347
CX3CR1;ENSG00000168329;clinical_c_Block_H30-H36;H30-H36 Disorders of choroid and retina;rs3732379;T;1.0;0.0010517;0.00030587;0.00058554;V249I;ENST00000542107
CCR9;ENSG00000173585;selfReported_n_1560;pneumothorax;rs149156206;A;0.773465;0.016779;0.0053251999999999996;0.0016279;G324D;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1560;pneumothorax;rs149156206;A;0.773465;0.016779;0.0053251999999999996;0.0016279;G336D;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1560;pneumothorax;rs149156206;A;0.773465;0.016779;0.0053251999999999996;0.0016279;G324D;ENST00000395963
CCR9;ENSG00000173585;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs139107036;T;1.0;0.0099025;0.0028654;0.00054863;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs139107036;T;1.0;0.0099025;0.0028654;0.00054863;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_E89;E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified;rs139107036;T;1.0;0.0099025;0.0028654;0.00054863;P90S;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1245;diabetes;rs149156206;A;0.773465;0.059814;0.020166;0.0030171;G324D;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1245;diabetes;rs149156206;A;0.773465;0.059814;0.020166;0.0030171;G336D;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1245;diabetes;rs149156206;A;0.773465;0.059814;0.020166;0.0030171;G324D;ENST00000395963
CCR9;ENSG00000173585;1299-0.0;Salad / raw vegetable intake;rs149156206;A;0.773465;-0.49309;0.18382;0.0073068;G324D;ENST00000355983
CCR9;ENSG00000173585;1299-0.0;Salad / raw vegetable intake;rs149156206;A;0.773465;-0.49309;0.18382;0.0073068;G336D;ENST00000357632
CCR9;ENSG00000173585;1299-0.0;Salad / raw vegetable intake;rs149156206;A;0.773465;-0.49309;0.18382;0.0073068;G324D;ENST00000395963
CCR9;ENSG00000173585;30160-0.0;Basophill count;rs139107036;T;1.0;-0.0051426;0.0019048;0.0069373;P90S;ENST00000355983
CCR9;ENSG00000173585;30160-0.0;Basophill count;rs139107036;T;1.0;-0.0051426;0.0019048;0.0069373;P102S;ENST00000357632
CCR9;ENSG00000173585;30160-0.0;Basophill count;rs139107036;T;1.0;-0.0051426;0.0019048;0.0069373;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_N48;N48 Other disorders of penis;rs139107036;T;1.0;0.023015;0.007795699999999998;0.0031555;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_N48;N48 Other disorders of penis;rs139107036;T;1.0;0.023015;0.007795699999999998;0.0031555;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_N48;N48 Other disorders of penis;rs139107036;T;1.0;0.023015;0.007795699999999998;0.0031555;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_N48;N48 Other disorders of penis;rs149156206;A;0.773465;0.048469;0.014883;0.0011277;G324D;ENST00000355983
CCR9;ENSG00000173585;clinical_c_N48;N48 Other disorders of penis;rs149156206;A;0.773465;0.048469;0.014883;0.0011277;G336D;ENST00000357632
CCR9;ENSG00000173585;clinical_c_N48;N48 Other disorders of penis;rs149156206;A;0.773465;0.048469;0.014883;0.0011277;G324D;ENST00000395963
CCR9;ENSG00000173585;clinical_c_Block_E65-E68;E65-E68 Obesity and other hyperalimentation;rs149156206;A;0.773465;0.060503999999999995;0.015815;0.00013036;G324D;ENST00000355983
CCR9;ENSG00000173585;clinical_c_Block_E65-E68;E65-E68 Obesity and other hyperalimentation;rs149156206;A;0.773465;0.060503999999999995;0.015815;0.00013036;G336D;ENST00000357632
CCR9;ENSG00000173585;clinical_c_Block_E65-E68;E65-E68 Obesity and other hyperalimentation;rs149156206;A;0.773465;0.060503999999999995;0.015815;0.00013036;G324D;ENST00000395963
CCR9;ENSG00000173585;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs12721497;G;0.917794;0.011937999999999999;0.0045893999999999996;0.009291599999999999;M272V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs12721497;G;0.917794;0.011937999999999999;0.0045893999999999996;0.009291599999999999;M284V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs12721497;G;0.917794;0.011937999999999999;0.0045893999999999996;0.009291599999999999;M272V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_J40;J40 Bronchitis, not specified as acute or chronic;rs139107036;T;1.0;0.0087181;0.0019858000000000002;1.1325e-05;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_J40;J40 Bronchitis, not specified as acute or chronic;rs139107036;T;1.0;0.0087181;0.0019858000000000002;1.1325e-05;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_J40;J40 Bronchitis, not specified as acute or chronic;rs139107036;T;1.0;0.0087181;0.0019858000000000002;1.1325e-05;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_H61;H61 Other disorders of external ear;rs139107036;T;1.0;0.007923699999999999;0.0024684999999999998;0.0013274;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_H61;H61 Other disorders of external ear;rs139107036;T;1.0;0.007923699999999999;0.0024684999999999998;0.0013274;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_H61;H61 Other disorders of external ear;rs139107036;T;1.0;0.007923699999999999;0.0024684999999999998;0.0013274;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_Block_D80-D89;D80-D89 Certain disorders involving the immune mechanism;rs149156206;A;0.773465;0.016984;0.0050782;0.00082459;G324D;ENST00000355983
CCR9;ENSG00000173585;clinical_c_Block_D80-D89;D80-D89 Certain disorders involving the immune mechanism;rs149156206;A;0.773465;0.016984;0.0050782;0.00082459;G336D;ENST00000357632
CCR9;ENSG00000173585;clinical_c_Block_D80-D89;D80-D89 Certain disorders involving the immune mechanism;rs149156206;A;0.773465;0.016984;0.0050782;0.00082459;G324D;ENST00000395963
CCR9;ENSG00000173585;clinical_c_M81;M81 Osteoporosis without pathological fracture;rs12721497;G;0.917794;0.023333;0.008601799999999998;0.0066771;M272V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_M81;M81 Osteoporosis without pathological fracture;rs12721497;G;0.917794;0.023333;0.008601799999999998;0.0066771;M284V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_M81;M81 Osteoporosis without pathological fracture;rs12721497;G;0.917794;0.023333;0.008601799999999998;0.0066771;M272V;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1414;sarcoidosis;rs139107036;T;1.0;0.0058768;0.0022193;0.008096899999999999;P90S;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1414;sarcoidosis;rs139107036;T;1.0;0.0058768;0.0022193;0.008096899999999999;P102S;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1414;sarcoidosis;rs139107036;T;1.0;0.0058768;0.0022193;0.008096899999999999;P90S;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1619;menorrhagia (unknown cause);rs139107036;T;1.0;0.012799;0.0048117;0.007813299999999999;P90S;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1619;menorrhagia (unknown cause);rs139107036;T;1.0;0.012799;0.0048117;0.007813299999999999;P102S;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1619;menorrhagia (unknown cause);rs139107036;T;1.0;0.012799;0.0048117;0.007813299999999999;P90S;ENST00000395963
CCR9;ENSG00000173585;1438-0.0;Bread intake;rs149156206;A;0.773465;2.0365;0.78308;0.009304399999999999;G324D;ENST00000355983
CCR9;ENSG00000173585;1438-0.0;Bread intake;rs149156206;A;0.773465;2.0365;0.78308;0.009304399999999999;G336D;ENST00000357632
CCR9;ENSG00000173585;1438-0.0;Bread intake;rs149156206;A;0.773465;2.0365;0.78308;0.009304399999999999;G324D;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1527;other joint disorder;rs61751653;A;1.0;-0.0041709;0.0015802;0.0083026;A219T;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1527;other joint disorder;rs61751653;A;1.0;-0.0041709;0.0015802;0.0083026;A231T;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1527;other joint disorder;rs61751653;A;1.0;-0.0041709;0.0015802;0.0083026;A219T;ENST00000395963
CCR9;ENSG00000173585;clinical_c_I69;I69 Sequelae of cerebrovascular disease;rs149156206;A;0.773465;0.016819;0.0055419;0.0024056;G324D;ENST00000355983
CCR9;ENSG00000173585;clinical_c_I69;I69 Sequelae of cerebrovascular disease;rs149156206;A;0.773465;0.016819;0.0055419;0.0024056;G336D;ENST00000357632
CCR9;ENSG00000173585;clinical_c_I69;I69 Sequelae of cerebrovascular disease;rs149156206;A;0.773465;0.016819;0.0055419;0.0024056;G324D;ENST00000395963
CCR9;ENSG00000173585;clinical_c_Block_L60-L75;L60-L75 Disorders of skin appendages;rs45530037;G;1.0;-0.0045961000000000005;0.0015005;0.0021910999999999996;I80V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_Block_L60-L75;L60-L75 Disorders of skin appendages;rs45530037;G;1.0;-0.0045961000000000005;0.0015005;0.0021910999999999996;I92V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_Block_L60-L75;L60-L75 Disorders of skin appendages;rs45530037;G;1.0;-0.0045961000000000005;0.0015005;0.0021910999999999996;I80V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_K70;K70 Alcoholic liver disease;rs12721497;G;0.917794;0.0089693;0.0032741;0.0061533000000000004;M272V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_K70;K70 Alcoholic liver disease;rs12721497;G;0.917794;0.0089693;0.0032741;0.0061533000000000004;M284V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_K70;K70 Alcoholic liver disease;rs12721497;G;0.917794;0.0089693;0.0032741;0.0061533000000000004;M272V;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1457;muscle or soft tissue injuries;rs139107036;T;1.0;0.011329;0.0042988;0.008404700000000001;P90S;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1457;muscle or soft tissue injuries;rs139107036;T;1.0;0.011329;0.0042988;0.008404700000000001;P102S;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1457;muscle or soft tissue injuries;rs139107036;T;1.0;0.011329;0.0042988;0.008404700000000001;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_L57;L57 Skin changes due to chronic exposure to nonionising radiation;rs149156206;A;0.773465;0.019722999999999997;0.0076070999999999995;0.009523700000000001;G324D;ENST00000355983
CCR9;ENSG00000173585;clinical_c_L57;L57 Skin changes due to chronic exposure to nonionising radiation;rs149156206;A;0.773465;0.019722999999999997;0.0076070999999999995;0.009523700000000001;G336D;ENST00000357632
CCR9;ENSG00000173585;clinical_c_L57;L57 Skin changes due to chronic exposure to nonionising radiation;rs149156206;A;0.773465;0.019722999999999997;0.0076070999999999995;0.009523700000000001;G324D;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1660;respiratory infection;rs139107036;T;1.0;0.019134;0.006080899999999999;0.0016522000000000002;P90S;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1660;respiratory infection;rs139107036;T;1.0;0.019134;0.006080899999999999;0.0016522000000000002;P102S;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1660;respiratory infection;rs139107036;T;1.0;0.019134;0.006080899999999999;0.0016522000000000002;P90S;ENST00000395963
CCR9;ENSG00000173585;cancer_c_D04;D04 Carcinoma in situ of skin;rs45530037;G;1.0;0.0012582000000000001;0.00045248;0.005423300000000001;I80V;ENST00000355983
CCR9;ENSG00000173585;cancer_c_D04;D04 Carcinoma in situ of skin;rs45530037;G;1.0;0.0012582000000000001;0.00045248;0.005423300000000001;I92V;ENST00000357632
CCR9;ENSG00000173585;cancer_c_D04;D04 Carcinoma in situ of skin;rs45530037;G;1.0;0.0012582000000000001;0.00045248;0.005423300000000001;I80V;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1540;psoriatic arthropathy;rs61751653;A;1.0;0.0023423000000000003;0.00071268;0.0010142;A219T;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1540;psoriatic arthropathy;rs61751653;A;1.0;0.0023423000000000003;0.00071268;0.0010142;A231T;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1540;psoriatic arthropathy;rs61751653;A;1.0;0.0023423000000000003;0.00071268;0.0010142;A219T;ENST00000395963
CCR9;ENSG00000173585;clinical_c_J44;J44 Other chronic obstructive pulmonary disease;rs149156206;A;0.773465;0.054644000000000005;0.014006999999999999;9.576200000000001e-05;G324D;ENST00000355983
CCR9;ENSG00000173585;clinical_c_J44;J44 Other chronic obstructive pulmonary disease;rs149156206;A;0.773465;0.054644000000000005;0.014006999999999999;9.576200000000001e-05;G336D;ENST00000357632
CCR9;ENSG00000173585;clinical_c_J44;J44 Other chronic obstructive pulmonary disease;rs149156206;A;0.773465;0.054644000000000005;0.014006999999999999;9.576200000000001e-05;G324D;ENST00000395963
CCR9;ENSG00000173585;30100-0.0;Mean platelet (thrombocyte) volume;rs149156206;A;0.773465;-0.22401;0.07720199999999999;0.0037135999999999996;G324D;ENST00000355983
CCR9;ENSG00000173585;30100-0.0;Mean platelet (thrombocyte) volume;rs149156206;A;0.773465;-0.22401;0.07720199999999999;0.0037135999999999996;G336D;ENST00000357632
CCR9;ENSG00000173585;30100-0.0;Mean platelet (thrombocyte) volume;rs149156206;A;0.773465;-0.22401;0.07720199999999999;0.0037135999999999996;G324D;ENST00000395963
CCR9;ENSG00000173585;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs45530037;G;1.0;0.0011243;0.00043166;0.0091987;I80V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs45530037;G;1.0;0.0011243;0.00043166;0.0091987;I92V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_K74;K74 Fibrosis and cirrhosis of liver;rs45530037;G;1.0;0.0011243;0.00043166;0.0091987;I80V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs139107036;T;1.0;0.0064786;0.0018367999999999998;0.00042008;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs139107036;T;1.0;0.0064786;0.0018367999999999998;0.00042008;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs139107036;T;1.0;0.0064786;0.0018367999999999998;0.00042008;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_E66;E66 Obesity;rs149156206;A;0.773465;0.06065;0.01577;0.00012016;G324D;ENST00000355983
CCR9;ENSG00000173585;clinical_c_E66;E66 Obesity;rs149156206;A;0.773465;0.06065;0.01577;0.00012016;G336D;ENST00000357632
CCR9;ENSG00000173585;clinical_c_E66;E66 Obesity;rs149156206;A;0.773465;0.06065;0.01577;0.00012016;G324D;ENST00000395963
CCR9;ENSG00000173585;clinical_c_N32;N32 Other disorders of bladder;rs139107036;T;1.0;0.02017;0.0072509;0.005407199999999999;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_N32;N32 Other disorders of bladder;rs139107036;T;1.0;0.02017;0.0072509;0.005407199999999999;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_N32;N32 Other disorders of bladder;rs139107036;T;1.0;0.02017;0.0072509;0.005407199999999999;P90S;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1443;pneumonia;rs139107036;T;1.0;0.019472;0.0060217;0.0012220999999999998;P90S;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1443;pneumonia;rs139107036;T;1.0;0.019472;0.0060217;0.0012220999999999998;P102S;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1443;pneumonia;rs139107036;T;1.0;0.019472;0.0060217;0.0012220999999999998;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_I35;I35 Nonrheumatic aortic valve disorders;rs12721497;G;0.917794;0.015156999999999999;0.005668899999999999;0.007500499999999999;M272V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_I35;I35 Nonrheumatic aortic valve disorders;rs12721497;G;0.917794;0.015156999999999999;0.005668899999999999;0.007500499999999999;M284V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_I35;I35 Nonrheumatic aortic valve disorders;rs12721497;G;0.917794;0.015156999999999999;0.005668899999999999;0.007500499999999999;M272V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_F32;F32 Depressive episode;rs12721497;G;0.917794;0.034427;0.011903;0.0038238;M272V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_F32;F32 Depressive episode;rs12721497;G;0.917794;0.034427;0.011903;0.0038238;M284V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_F32;F32 Depressive episode;rs12721497;G;0.917794;0.034427;0.011903;0.0038238;M272V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_E83;E83 Disorders of mineral metabolism;rs61751653;A;1.0;0.004508399999999999;0.0011524;9.1477e-05;A219T;ENST00000355983
CCR9;ENSG00000173585;clinical_c_E83;E83 Disorders of mineral metabolism;rs61751653;A;1.0;0.004508399999999999;0.0011524;9.1477e-05;A231T;ENST00000357632
CCR9;ENSG00000173585;clinical_c_E83;E83 Disorders of mineral metabolism;rs61751653;A;1.0;0.004508399999999999;0.0011524;9.1477e-05;A219T;ENST00000395963
CCR9;ENSG00000173585;clinical_c_N36;N36 Other disorders of urethra;rs139107036;T;1.0;0.0085554;0.0021899999999999997;9.3622e-05;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_N36;N36 Other disorders of urethra;rs139107036;T;1.0;0.0085554;0.0021899999999999997;9.3622e-05;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_N36;N36 Other disorders of urethra;rs139107036;T;1.0;0.0085554;0.0021899999999999997;9.3622e-05;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_K25;K25 Gastric ulcer;rs12721497;G;0.917794;0.019499000000000002;0.007351000000000001;0.0079889;M272V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_K25;K25 Gastric ulcer;rs12721497;G;0.917794;0.019499000000000002;0.007351000000000001;0.0079889;M284V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_K25;K25 Gastric ulcer;rs12721497;G;0.917794;0.019499000000000002;0.007351000000000001;0.0079889;M272V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_N40;N40 Hyperplasia of prostate;rs45530037;G;1.0;0.009003299999999999;0.0032123000000000004;0.0050668;I80V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_N40;N40 Hyperplasia of prostate;rs45530037;G;1.0;0.009003299999999999;0.0032123000000000004;0.0050668;I92V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_N40;N40 Hyperplasia of prostate;rs45530037;G;1.0;0.009003299999999999;0.0032123000000000004;0.0050668;I80V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_M19;M19 Other arthrosis;rs139107036;T;1.0;0.025522;0.0097881;0.0091234;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_M19;M19 Other arthrosis;rs139107036;T;1.0;0.025522;0.0097881;0.0091234;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_M19;M19 Other arthrosis;rs139107036;T;1.0;0.025522;0.0097881;0.0091234;P90S;ENST00000395963
CCR9;ENSG00000173585;cancer_c_Block_D37-D48;D37-D48 Neoplasms of uncertain or unknown behaviour;rs149156206;A;0.773465;0.02036;0.0066443;0.0021818000000000002;G324D;ENST00000355983
CCR9;ENSG00000173585;cancer_c_Block_D37-D48;D37-D48 Neoplasms of uncertain or unknown behaviour;rs149156206;A;0.773465;0.02036;0.0066443;0.0021818000000000002;G336D;ENST00000357632
CCR9;ENSG00000173585;cancer_c_Block_D37-D48;D37-D48 Neoplasms of uncertain or unknown behaviour;rs149156206;A;0.773465;0.02036;0.0066443;0.0021818000000000002;G324D;ENST00000395963
CCR9;ENSG00000173585;20116-0.0;Smoking status;rs12721497;G;0.917794;0.12053;0.044496;0.006755199999999999;M272V;ENST00000355983
CCR9;ENSG00000173585;20116-0.0;Smoking status;rs12721497;G;0.917794;0.12053;0.044496;0.006755199999999999;M284V;ENST00000357632
CCR9;ENSG00000173585;20116-0.0;Smoking status;rs12721497;G;0.917794;0.12053;0.044496;0.006755199999999999;M272V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_M84;M84 Disorders of continuity of bone;rs12721497;G;0.917794;0.022991;0.004365600000000001;1.3917e-07;M272V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_M84;M84 Disorders of continuity of bone;rs12721497;G;0.917794;0.022991;0.004365600000000001;1.3917e-07;M284V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_M84;M84 Disorders of continuity of bone;rs12721497;G;0.917794;0.022991;0.004365600000000001;1.3917e-07;M272V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_N30;N30 Cystitis;rs139107036;T;1.0;0.013708000000000001;0.0042716;0.0013319;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_N30;N30 Cystitis;rs139107036;T;1.0;0.013708000000000001;0.0042716;0.0013319;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_N30;N30 Cystitis;rs139107036;T;1.0;0.013708000000000001;0.0042716;0.0013319;P90S;ENST00000395963
CCR9;ENSG00000173585;30230-0.0;Nucleated red blood cell percentage;rs12721497;G;0.917794;0.080062;0.028747;0.0053521;M272V;ENST00000355983
CCR9;ENSG00000173585;30230-0.0;Nucleated red blood cell percentage;rs12721497;G;0.917794;0.080062;0.028747;0.0053521;M284V;ENST00000357632
CCR9;ENSG00000173585;30230-0.0;Nucleated red blood cell percentage;rs12721497;G;0.917794;0.080062;0.028747;0.0053521;M272V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_K02;K02 Dental caries;rs12721497;G;0.917794;0.023247999999999998;0.006261399999999999;0.00020495;M272V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_K02;K02 Dental caries;rs12721497;G;0.917794;0.023247999999999998;0.006261399999999999;0.00020495;M284V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_K02;K02 Dental caries;rs12721497;G;0.917794;0.023247999999999998;0.006261399999999999;0.00020495;M272V;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1454;other renal/kidney problem;rs45530037;G;1.0;0.0018341999999999998;0.00071088;0.0098774;I80V;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1454;other renal/kidney problem;rs45530037;G;1.0;0.0018341999999999998;0.00071088;0.0098774;I92V;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1454;other renal/kidney problem;rs45530037;G;1.0;0.0018341999999999998;0.00071088;0.0098774;I80V;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1314;nervous breakdown;rs139107036;T;1.0;0.0062347999999999995;0.0019554999999999998;0.0014314;P90S;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1314;nervous breakdown;rs139107036;T;1.0;0.0062347999999999995;0.0019554999999999998;0.0014314;P102S;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1314;nervous breakdown;rs139107036;T;1.0;0.0062347999999999995;0.0019554999999999998;0.0014314;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_H66;H66 Suppurative and unspecified otitis media;rs149156206;A;0.773465;0.01296;0.0043981;0.0032115000000000004;G324D;ENST00000355983
CCR9;ENSG00000173585;clinical_c_H66;H66 Suppurative and unspecified otitis media;rs149156206;A;0.773465;0.01296;0.0043981;0.0032115000000000004;G336D;ENST00000357632
CCR9;ENSG00000173585;clinical_c_H66;H66 Suppurative and unspecified otitis media;rs149156206;A;0.773465;0.01296;0.0043981;0.0032115000000000004;G324D;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1517;duodenal ulcer;rs149156206;A;0.773465;0.020008;0.006477299999999999;0.0020090999999999998;G324D;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1517;duodenal ulcer;rs149156206;A;0.773465;0.020008;0.006477299999999999;0.0020090999999999998;G336D;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1517;duodenal ulcer;rs149156206;A;0.773465;0.020008;0.006477299999999999;0.0020090999999999998;G324D;ENST00000395963
CCR9;ENSG00000173585;clinical_c_K11;K11 Diseases of salivary glands;rs139107036;T;1.0;0.0078243;0.0025118000000000002;0.0018395;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_K11;K11 Diseases of salivary glands;rs139107036;T;1.0;0.0078243;0.0025118000000000002;0.0018395;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_K11;K11 Diseases of salivary glands;rs139107036;T;1.0;0.0078243;0.0025118000000000002;0.0018395;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_Block_N30-N39;N30-N39 Other diseases of urinary system;rs139107036;T;1.0;0.047527;0.012888;0.00022631;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_Block_N30-N39;N30-N39 Other diseases of urinary system;rs139107036;T;1.0;0.047527;0.012888;0.00022631;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_Block_N30-N39;N30-N39 Other diseases of urinary system;rs139107036;T;1.0;0.047527;0.012888;0.00022631;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_Block_F30-F39;F30-F39 Mood [affective] disorders;rs12721497;G;0.917794;0.032064999999999996;0.01237;0.009537;M272V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_Block_F30-F39;F30-F39 Mood [affective] disorders;rs12721497;G;0.917794;0.032064999999999996;0.01237;0.009537;M284V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_Block_F30-F39;F30-F39 Mood [affective] disorders;rs12721497;G;0.917794;0.032064999999999996;0.01237;0.009537;M272V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs139107036;T;1.0;0.0092883;0.0030039999999999997;0.0019882000000000003;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs139107036;T;1.0;0.0092883;0.0030039999999999997;0.0019882000000000003;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_Block_H60-H62;H60-H62 Diseases of external ear;rs139107036;T;1.0;0.0092883;0.0030039999999999997;0.0019882000000000003;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_M07;M07 Psoriatic and enteropathic arthropathies;rs139107036;T;1.0;0.0086435;0.0021006;3.8751e-05;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_M07;M07 Psoriatic and enteropathic arthropathies;rs139107036;T;1.0;0.0086435;0.0021006;3.8751e-05;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_M07;M07 Psoriatic and enteropathic arthropathies;rs139107036;T;1.0;0.0086435;0.0021006;3.8751e-05;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_G81;G81 Hemiplegia;rs149156206;A;0.773465;0.016314;0.006005699999999999;0.0065994;G324D;ENST00000355983
CCR9;ENSG00000173585;clinical_c_G81;G81 Hemiplegia;rs149156206;A;0.773465;0.016314;0.006005699999999999;0.0065994;G336D;ENST00000357632
CCR9;ENSG00000173585;clinical_c_G81;G81 Hemiplegia;rs149156206;A;0.773465;0.016314;0.006005699999999999;0.0065994;G324D;ENST00000395963
CCR9;ENSG00000173585;clinical_c_F20;F20 Schizophrenia;rs12721497;G;0.917794;0.0094952;0.0026274000000000002;0.00030166;M272V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_F20;F20 Schizophrenia;rs12721497;G;0.917794;0.0094952;0.0026274000000000002;0.00030166;M284V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_F20;F20 Schizophrenia;rs12721497;G;0.917794;0.0094952;0.0026274000000000002;0.00030166;M272V;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1608;neck problem/injury;rs61751653;A;1.0;0.0044383;0.0014414000000000002;0.0020761;A219T;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1608;neck problem/injury;rs61751653;A;1.0;0.0044383;0.0014414000000000002;0.0020761;A231T;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1608;neck problem/injury;rs61751653;A;1.0;0.0044383;0.0014414000000000002;0.0020761;A219T;ENST00000395963
CCR9;ENSG00000173585;clinical_c_Block_E10-E14;E10-E14 Diabetes mellitus;rs139107036;T;1.0;0.02825;0.010277;0.005982;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_Block_E10-E14;E10-E14 Diabetes mellitus;rs139107036;T;1.0;0.02825;0.010277;0.005982;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_Block_E10-E14;E10-E14 Diabetes mellitus;rs139107036;T;1.0;0.02825;0.010277;0.005982;P90S;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1176;hepatitis;rs12721497;G;0.917794;0.018968000000000002;0.0051081;0.00020459;M272V;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1176;hepatitis;rs12721497;G;0.917794;0.018968000000000002;0.0051081;0.00020459;M284V;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1176;hepatitis;rs12721497;G;0.917794;0.018968000000000002;0.0051081;0.00020459;M272V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_Block_M80-M85;M80-M85 Disorders of bone density and structure;rs12721497;G;0.917794;0.051519;0.010501;9.2919e-07;M272V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_Block_M80-M85;M80-M85 Disorders of bone density and structure;rs12721497;G;0.917794;0.051519;0.010501;9.2919e-07;M284V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_Block_M80-M85;M80-M85 Disorders of bone density and structure;rs12721497;G;0.917794;0.051519;0.010501;9.2919e-07;M272V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_M25;M25 Other joint disorders, not elsewhere classified;rs139107036;T;1.0;0.026524000000000002;0.0088489;0.002723;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_M25;M25 Other joint disorders, not elsewhere classified;rs139107036;T;1.0;0.026524000000000002;0.0088489;0.002723;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_M25;M25 Other joint disorders, not elsewhere classified;rs139107036;T;1.0;0.026524000000000002;0.0088489;0.002723;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_L03;L03 Cellulitis;rs139107036;T;1.0;0.02159;0.006602899999999999;0.0010765999999999998;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_L03;L03 Cellulitis;rs139107036;T;1.0;0.02159;0.006602899999999999;0.0010765999999999998;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_L03;L03 Cellulitis;rs139107036;T;1.0;0.02159;0.006602899999999999;0.0010765999999999998;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_M13;M13 Other arthritis;rs139107036;T;1.0;0.023747;0.0082825;0.0041424;P90S;ENST00000355983
CCR9;ENSG00000173585;clinical_c_M13;M13 Other arthritis;rs139107036;T;1.0;0.023747;0.0082825;0.0041424;P102S;ENST00000357632
CCR9;ENSG00000173585;clinical_c_M13;M13 Other arthritis;rs139107036;T;1.0;0.023747;0.0082825;0.0041424;P90S;ENST00000395963
CCR9;ENSG00000173585;clinical_c_I50;I50 Heart failure;rs12721497;G;0.917794;0.026258;0.0081732;0.001315;M272V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_I50;I50 Heart failure;rs12721497;G;0.917794;0.026258;0.0081732;0.001315;M284V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_I50;I50 Heart failure;rs12721497;G;0.917794;0.026258;0.0081732;0.001315;M272V;ENST00000395963
CCR9;ENSG00000173585;clinical_c_L91;L91 Hypertrophic disorders of skin;rs149156206;A;0.773465;0.022226;0.0052105;1.9946e-05;G324D;ENST00000355983
CCR9;ENSG00000173585;clinical_c_L91;L91 Hypertrophic disorders of skin;rs149156206;A;0.773465;0.022226;0.0052105;1.9946e-05;G336D;ENST00000357632
CCR9;ENSG00000173585;clinical_c_L91;L91 Hypertrophic disorders of skin;rs149156206;A;0.773465;0.022226;0.0052105;1.9946e-05;G324D;ENST00000395963
CCR9;ENSG00000173585;selfReported_n_1541;cervical spondylosis;rs61751653;A;1.0;0.0039653;0.0013633;0.0036301000000000003;A219T;ENST00000355983
CCR9;ENSG00000173585;selfReported_n_1541;cervical spondylosis;rs61751653;A;1.0;0.0039653;0.0013633;0.0036301000000000003;A231T;ENST00000357632
CCR9;ENSG00000173585;selfReported_n_1541;cervical spondylosis;rs61751653;A;1.0;0.0039653;0.0013633;0.0036301000000000003;A219T;ENST00000395963
CCR9;ENSG00000173585;clinical_c_E87;E87 Other disorders of fluid, electrolyte and acid-base balance;rs45530037;G;1.0;-0.0028488000000000003;0.0010849;0.0086446;I80V;ENST00000355983
CCR9;ENSG00000173585;clinical_c_E87;E87 Other disorders of fluid, electrolyte and acid-base balance;rs45530037;G;1.0;-0.0028488000000000003;0.0010849;0.0086446;I92V;ENST00000357632
CCR9;ENSG00000173585;clinical_c_E87;E87 Other disorders of fluid, electrolyte and acid-base balance;rs45530037;G;1.0;-0.0028488000000000003;0.0010849;0.0086446;I80V;ENST00000395963
CCR5;ENSG00000160791;23121-0.0;Arm fat-free mass (right);rs371598347;T;0.852922;-0.072628;0.027847000000000004;0.0091054;G216V;ENST00000292303
CCR5;ENSG00000160791;23121-0.0;Arm fat-free mass (right);rs371598347;T;0.852922;-0.072628;0.027847000000000004;0.0091054;G216V;ENST00000445772
CCR5;ENSG00000160791;23128-0.0;Trunk fat mass;rs1799863;A;1.0;-0.08981900000000001;0.028341;0.0015286;L55Q;ENST00000292303
CCR5;ENSG00000160791;23128-0.0;Trunk fat mass;rs1799863;A;1.0;-0.08981900000000001;0.028341;0.0015286;L55Q;ENST00000445772
CCR5;ENSG00000160791;23128-0.0;Trunk fat mass;rs56198941;T;1.0;-0.26825;0.09500800000000001;0.004751699999999999;A73V;ENST00000292303
CCR5;ENSG00000160791;23128-0.0;Trunk fat mass;rs56198941;T;1.0;-0.26825;0.09500800000000001;0.004751699999999999;A73V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_L08;L08 Other local infections of skin and subcutaneous tissue;rs56198941;T;1.0;0.0032493;0.001245;0.009056;A73V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_L08;L08 Other local infections of skin and subcutaneous tissue;rs56198941;T;1.0;0.0032493;0.001245;0.009056;A73V;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1245;diabetes;rs1799863;A;1.0;-0.0039784;0.0013579;0.0033915;L55Q;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1245;diabetes;rs1799863;A;1.0;-0.0039784;0.0013579;0.0033915;L55Q;ENST00000445772
CCR5;ENSG00000160791;23104-0.0;Body mass index (BMI);rs1799863;A;1.0;-0.072187;0.026044;0.005576;L55Q;ENST00000292303
CCR5;ENSG00000160791;23104-0.0;Body mass index (BMI);rs1799863;A;1.0;-0.072187;0.026044;0.005576;L55Q;ENST00000445772
CCR5;ENSG00000160791;23104-0.0;Body mass index (BMI);rs56198941;T;1.0;-0.27671999999999997;0.08730700000000001;0.0015272;A73V;ENST00000292303
CCR5;ENSG00000160791;23104-0.0;Body mass index (BMI);rs56198941;T;1.0;-0.27671999999999997;0.08730700000000001;0.0015272;A73V;ENST00000445772
CCR5;ENSG00000160791;30160-0.0;Basophill count;rs1799863;A;1.0;0.00075416;0.0002548;0.0030788;L55Q;ENST00000292303
CCR5;ENSG00000160791;30160-0.0;Basophill count;rs1799863;A;1.0;0.00075416;0.0002548;0.0030788;L55Q;ENST00000445772
CCR5;ENSG00000160791;30160-0.0;Basophill count;rs1800944;T;0.974492;0.021698;0.005021899999999999;1.5564000000000002e-05;A335V;ENST00000292303
CCR5;ENSG00000160791;30160-0.0;Basophill count;rs1800944;T;0.974492;0.021698;0.005021899999999999;1.5564000000000002e-05;A335V;ENST00000445772
CCR5;ENSG00000160791;cancer_c_Block_C15-C26;C15-C26 Malignant neoplasms of digestive organs;rs1800945;T;0.961098;0.029310000000000003;0.0079369;0.00022175;Y339F;ENST00000292303
CCR5;ENSG00000160791;cancer_c_Block_C15-C26;C15-C26 Malignant neoplasms of digestive organs;rs1800945;T;0.961098;0.029310000000000003;0.0079369;0.00022175;Y339F;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1268;eye/eyelid problem;rs1799863;A;1.0;-0.004261600000000001;0.0013142999999999998;0.0011852;L55Q;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1268;eye/eyelid problem;rs1799863;A;1.0;-0.004261600000000001;0.0013142999999999998;0.0011852;L55Q;ENST00000445772
CCR5;ENSG00000160791;clinical_c_N48;N48 Other disorders of penis;rs1800944;T;0.974492;0.096743;0.019876;1.1324e-06;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_N48;N48 Other disorders of penis;rs1800944;T;0.974492;0.096743;0.019876;1.1324e-06;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_N02;N02 Recurrent and persistent haematuria;rs150497029;G;0.93589;0.0093374;0.0021519;1.4302e-05;L121R;ENST00000292303
CCR5;ENSG00000160791;clinical_c_N02;N02 Recurrent and persistent haematuria;rs150497029;G;0.93589;0.0093374;0.0021519;1.4302e-05;L121R;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1163;gastric/stomach ulcers;rs371598347;T;0.852922;0.018838;0.0068081999999999995;0.0056595;G216V;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1163;gastric/stomach ulcers;rs371598347;T;0.852922;0.018838;0.0068081999999999995;0.0056595;G216V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_O30-O48;O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems;rs1800944;T;0.974492;0.088402;0.029633;0.0028527;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_O30-O48;O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems;rs1800944;T;0.974492;0.088402;0.029633;0.0028527;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_J40-J47;J40-J47 Chronic lower respiratory diseases;rs1800944;T;0.974492;0.09846;0.035086;0.005012399999999999;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_J40-J47;J40-J47 Chronic lower respiratory diseases;rs1800944;T;0.974492;0.09846;0.035086;0.005012399999999999;A335V;ENST00000445772
CCR5;ENSG00000160791;30240-0.0;Reticulocyte percentage;rs142829420;T;0.795295;0.068088;0.019977;0.00065373;S63C;ENST00000292303
CCR5;ENSG00000160791;30240-0.0;Reticulocyte percentage;rs142829420;T;0.795295;0.068088;0.019977;0.00065373;S63C;ENST00000445772
CCR5;ENSG00000160791;30240-0.0;Reticulocyte percentage;rs1799863;A;1.0;-0.008363899999999999;0.0031271999999999997;0.0074835;L55Q;ENST00000292303
CCR5;ENSG00000160791;30240-0.0;Reticulocyte percentage;rs1799863;A;1.0;-0.008363899999999999;0.0031271999999999997;0.0074835;L55Q;ENST00000445772
CCR5;ENSG00000160791;30240-0.0;Reticulocyte percentage;rs62625034;T;0.5037470000000001;0.021271;0.004190999999999999;3.8714e-07;Q194H;ENST00000292303
CCR5;ENSG00000160791;30240-0.0;Reticulocyte percentage;rs62625034;T;0.5037470000000001;0.021271;0.004190999999999999;3.8714e-07;Q194H;ENST00000445772
CCR5;ENSG00000160791;50-0.0;Standing height;rs62625034;T;0.5037470000000001;-0.10627;0.036295;0.0034129;Q194H;ENST00000292303
CCR5;ENSG00000160791;50-0.0;Standing height;rs62625034;T;0.5037470000000001;-0.10627;0.036295;0.0034129;Q194H;ENST00000445772
CCR5;ENSG00000160791;30120-0.0;Lymphocyte count;rs1800452;A;1.0;-0.054827;0.019565;0.0050745;R223Q;ENST00000292303
CCR5;ENSG00000160791;30120-0.0;Lymphocyte count;rs1800452;A;1.0;-0.054827;0.019565;0.0050745;R223Q;ENST00000445772
CCR5;ENSG00000160791;30120-0.0;Lymphocyte count;rs62625034;T;0.5037470000000001;0.035177;0.004771;1.6687e-13;Q194H;ENST00000292303
CCR5;ENSG00000160791;30120-0.0;Lymphocyte count;rs62625034;T;0.5037470000000001;0.035177;0.004771;1.6687e-13;Q194H;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs56198941;T;1.0;0.0039271;0.0014405;0.0064059;A73V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_J80-J84;J80-J84 Other respiratory diseases principally affecting the interstitium;rs56198941;T;1.0;0.0039271;0.0014405;0.0064059;A73V;ENST00000445772
CCR5;ENSG00000160791;1359-0.0;Poultry intake;rs62625034;T;0.5037470000000001;0.019822;0.0076950000000000005;0.0099984;Q194H;ENST00000292303
CCR5;ENSG00000160791;1359-0.0;Poultry intake;rs62625034;T;0.5037470000000001;0.019822;0.0076950000000000005;0.0099984;Q194H;ENST00000445772
CCR5;ENSG00000160791;clinical_c_K13;K13 Other diseases of lip and oral mucosa;rs1800944;T;0.974492;0.028848000000000002;0.011123000000000001;0.009498999999999999;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_K13;K13 Other diseases of lip and oral mucosa;rs1800944;T;0.974492;0.028848000000000002;0.011123000000000001;0.009498999999999999;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_L50-L54;L50-L54 Urticaria and erythema;rs56198941;T;1.0;0.0032796;0.0011435;0.004130399999999999;A73V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_L50-L54;L50-L54 Urticaria and erythema;rs56198941;T;1.0;0.0032796;0.0011435;0.004130399999999999;A73V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_H26;H26 Other cataract;rs1799863;A;1.0;-0.0034353;0.0012135;0.0046435;L55Q;ENST00000292303
CCR5;ENSG00000160791;clinical_c_H26;H26 Other cataract;rs1799863;A;1.0;-0.0034353;0.0012135;0.0046435;L55Q;ENST00000445772
CCR5;ENSG00000160791;clinical_c_J03;J03 Acute tonsillitis;rs1800944;T;0.974492;0.01584;0.0049577;0.0013981;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_J03;J03 Acute tonsillitis;rs1800944;T;0.974492;0.01584;0.0049577;0.0013981;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_K58;K58 Irritable bowel syndrome;rs1800940;T;0.922702;-0.0072226;0.0027134;0.0077708;R60S;ENST00000292303
CCR5;ENSG00000160791;clinical_c_K58;K58 Irritable bowel syndrome;rs1800940;T;0.922702;-0.0072226;0.0027134;0.0077708;R60S;ENST00000445772
CCR5;ENSG00000160791;23113-0.0;Leg fat-free mass (right);rs1799863;A;1.0;-0.018044;0.0064556;0.0051883;L55Q;ENST00000292303
CCR5;ENSG00000160791;23113-0.0;Leg fat-free mass (right);rs1799863;A;1.0;-0.018044;0.0064556;0.0051883;L55Q;ENST00000445772
CCR5;ENSG00000160791;23113-0.0;Leg fat-free mass (right);rs371598347;T;0.852922;-0.20122;0.076486;0.008518099999999999;G216V;ENST00000292303
CCR5;ENSG00000160791;23113-0.0;Leg fat-free mass (right);rs371598347;T;0.852922;-0.20122;0.076486;0.008518099999999999;G216V;ENST00000445772
CCR5;ENSG00000160791;30220-0.0;Basophill percentage;rs1799863;A;1.0;0.0094413;0.002836;0.00087121;L55Q;ENST00000292303
CCR5;ENSG00000160791;30220-0.0;Basophill percentage;rs1799863;A;1.0;0.0094413;0.002836;0.00087121;L55Q;ENST00000445772
CCR5;ENSG00000160791;30220-0.0;Basophill percentage;rs1800944;T;0.974492;0.20528000000000002;0.05589500000000001;0.00024009;A335V;ENST00000292303
CCR5;ENSG00000160791;30220-0.0;Basophill percentage;rs1800944;T;0.974492;0.20528000000000002;0.05589500000000001;0.00024009;A335V;ENST00000445772
CCR5;ENSG00000160791;30220-0.0;Basophill percentage;rs62625034;T;0.5037470000000001;-0.011569;0.0038006999999999997;0.0023349;Q194H;ENST00000292303
CCR5;ENSG00000160791;30220-0.0;Basophill percentage;rs62625034;T;0.5037470000000001;-0.011569;0.0038006999999999997;0.0023349;Q194H;ENST00000445772
CCR5;ENSG00000160791;46-0.0;Hand grip strength (left);rs142829420;T;0.795295;-0.77728;0.28996;0.0073484;S63C;ENST00000292303
CCR5;ENSG00000160791;46-0.0;Hand grip strength (left);rs142829420;T;0.795295;-0.77728;0.28996;0.0073484;S63C;ENST00000445772
CCR5;ENSG00000160791;clinical_c_K26;K26 Duodenal ulcer;rs34418657;T;0.453617;0.030614;0.011506;0.0078;V131F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_K26;K26 Duodenal ulcer;rs34418657;T;0.453617;0.030614;0.011506;0.0078;V131F;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1524;rheumatoid arthritis;rs1800944;T;0.974492;0.041267;0.01399;0.0031793000000000004;A335V;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1524;rheumatoid arthritis;rs1800944;T;0.974492;0.041267;0.01399;0.0031793000000000004;A335V;ENST00000445772
CCR5;ENSG00000160791;23122-0.0;Arm predicted mass (right);rs371598347;T;0.852922;-0.069063;0.02625;0.0085137;G216V;ENST00000292303
CCR5;ENSG00000160791;23122-0.0;Arm predicted mass (right);rs371598347;T;0.852922;-0.069063;0.02625;0.0085137;G216V;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1520;rectal or colon adenoma/polyps;rs34418657;T;0.453617;0.022713;0.0073468000000000006;0.001991;V131F;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1520;rectal or colon adenoma/polyps;rs34418657;T;0.453617;0.022713;0.0073468000000000006;0.001991;V131F;ENST00000445772
CCR5;ENSG00000160791;21001-0.0;Body mass index (BMI);rs1799863;A;1.0;-0.074451;0.026246;0.0045593000000000005;L55Q;ENST00000292303
CCR5;ENSG00000160791;21001-0.0;Body mass index (BMI);rs1799863;A;1.0;-0.074451;0.026246;0.0045593000000000005;L55Q;ENST00000445772
CCR5;ENSG00000160791;21001-0.0;Body mass index (BMI);rs56198941;T;1.0;-0.28534;0.08798500000000001;0.0011828;A73V;ENST00000292303
CCR5;ENSG00000160791;21001-0.0;Body mass index (BMI);rs56198941;T;1.0;-0.28534;0.08798500000000001;0.0011828;A73V;ENST00000445772
CCR5;ENSG00000160791;30290-0.0;High light scatter reticulocyte percentage;rs142829420;T;0.795295;0.026222000000000002;0.0073727;0.00037567;S63C;ENST00000292303
CCR5;ENSG00000160791;30290-0.0;High light scatter reticulocyte percentage;rs142829420;T;0.795295;0.026222000000000002;0.0073727;0.00037567;S63C;ENST00000445772
CCR5;ENSG00000160791;30290-0.0;High light scatter reticulocyte percentage;rs1799863;A;1.0;-0.0031842;0.0011541;0.0057985;L55Q;ENST00000292303
CCR5;ENSG00000160791;30290-0.0;High light scatter reticulocyte percentage;rs1799863;A;1.0;-0.0031842;0.0011541;0.0057985;L55Q;ENST00000445772
CCR5;ENSG00000160791;30290-0.0;High light scatter reticulocyte percentage;rs62625034;T;0.5037470000000001;0.008663200000000001;0.0015467;2.1328e-08;Q194H;ENST00000292303
CCR5;ENSG00000160791;30290-0.0;High light scatter reticulocyte percentage;rs62625034;T;0.5037470000000001;0.008663200000000001;0.0015467;2.1328e-08;Q194H;ENST00000445772
CCR5;ENSG00000160791;clinical_c_J93;J93 Pneumothorax;rs1800452;A;1.0;0.0050661000000000005;0.0016823;0.0026011;R223Q;ENST00000292303
CCR5;ENSG00000160791;clinical_c_J93;J93 Pneumothorax;rs1800452;A;1.0;0.0050661000000000005;0.0016823;0.0026011;R223Q;ENST00000445772
CCR5;ENSG00000160791;23107-0.0;Impedance of leg (right);rs1799863;A;1.0;0.46025;0.17490999999999998;0.008505799999999999;L55Q;ENST00000292303
CCR5;ENSG00000160791;23107-0.0;Impedance of leg (right);rs1799863;A;1.0;0.46025;0.17490999999999998;0.008505799999999999;L55Q;ENST00000445772
CCR5;ENSG00000160791;23107-0.0;Impedance of leg (right);rs371598347;T;0.852922;5.6225;2.0723;0.006666;G216V;ENST00000292303
CCR5;ENSG00000160791;23107-0.0;Impedance of leg (right);rs371598347;T;0.852922;5.6225;2.0723;0.006666;G216V;ENST00000445772
CCR5;ENSG00000160791;23112-0.0;Leg fat mass (right);rs56198941;T;1.0;-0.07950299999999999;0.029327;0.0067111;A73V;ENST00000292303
CCR5;ENSG00000160791;23112-0.0;Leg fat mass (right);rs56198941;T;1.0;-0.07950299999999999;0.029327;0.0067111;A73V;ENST00000445772
CCR5;ENSG00000160791;23101-0.0;Whole body fat-free mass;rs371598347;T;0.852922;-1.1413;0.38437;0.0029861999999999996;G216V;ENST00000292303
CCR5;ENSG00000160791;23101-0.0;Whole body fat-free mass;rs371598347;T;0.852922;-1.1413;0.38437;0.0029861999999999996;G216V;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1621;obstetric problem;rs1800944;T;0.974492;0.06579299999999999;0.013324;7.893399999999998e-07;A335V;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1621;obstetric problem;rs1800944;T;0.974492;0.06579299999999999;0.013324;7.893399999999998e-07;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_I10-I15;I10-I15 Hypertensive diseases;rs62625034;T;0.5037470000000001;0.010588;0.0031851999999999996;0.00088687;Q194H;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_I10-I15;I10-I15 Hypertensive diseases;rs62625034;T;0.5037470000000001;0.010588;0.0031851999999999996;0.00088687;Q194H;ENST00000445772
CCR5;ENSG00000160791;1777-0.0;Part of a multiple birth;rs1800945;T;0.961098;0.032591;0.010202;0.0014006;Y339F;ENST00000292303
CCR5;ENSG00000160791;1777-0.0;Part of a multiple birth;rs1800945;T;0.961098;0.032591;0.010202;0.0014006;Y339F;ENST00000445772
CCR5;ENSG00000160791;clinical_c_K70;K70 Alcoholic liver disease;rs1800940;T;0.922702;0.0029256;0.0010694;0.0062254;R60S;ENST00000292303
CCR5;ENSG00000160791;clinical_c_K70;K70 Alcoholic liver disease;rs1800940;T;0.922702;0.0029256;0.0010694;0.0062254;R60S;ENST00000445772
CCR5;ENSG00000160791;30280-0.0;Immature reticulocyte fraction;rs62625034;T;0.5037470000000001;0.0020167;0.00046523;1.4582999999999999e-05;Q194H;ENST00000292303
CCR5;ENSG00000160791;30280-0.0;Immature reticulocyte fraction;rs62625034;T;0.5037470000000001;0.0020167;0.00046523;1.4582999999999999e-05;Q194H;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1513;blistering/desquamating skin disorder;rs150497029;G;0.93589;0.0082881;0.0022268;0.00019772;L121R;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1513;blistering/desquamating skin disorder;rs150497029;G;0.93589;0.0082881;0.0022268;0.00019772;L121R;ENST00000445772
CCR5;ENSG00000160791;clinical_c_O63;O63 Long labour;rs1800945;T;0.961098;0.022619;0.008520200000000002;0.007936499999999999;Y339F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_O63;O63 Long labour;rs1800945;T;0.961098;0.022619;0.008520200000000002;0.007936499999999999;Y339F;ENST00000445772
CCR5;ENSG00000160791;23114-0.0;Leg predicted mass (right);rs1799863;A;1.0;-0.016708;0.0060536;0.0057799;L55Q;ENST00000292303
CCR5;ENSG00000160791;23114-0.0;Leg predicted mass (right);rs1799863;A;1.0;-0.016708;0.0060536;0.0057799;L55Q;ENST00000445772
CCR5;ENSG00000160791;23114-0.0;Leg predicted mass (right);rs371598347;T;0.852922;-0.193;0.07172200000000001;0.0071255;G216V;ENST00000292303
CCR5;ENSG00000160791;23114-0.0;Leg predicted mass (right);rs371598347;T;0.852922;-0.193;0.07172200000000001;0.0071255;G216V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs1800944;T;0.974492;0.056033000000000006;0.016457;0.00066202;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs1800944;T;0.974492;0.056033000000000006;0.016457;0.00066202;A335V;ENST00000445772
CCR5;ENSG00000160791;23100-0.0;Whole body fat mass;rs1799863;A;1.0;-0.14492;0.051036;0.0045185;L55Q;ENST00000292303
CCR5;ENSG00000160791;23100-0.0;Whole body fat mass;rs1799863;A;1.0;-0.14492;0.051036;0.0045185;L55Q;ENST00000445772
CCR5;ENSG00000160791;23100-0.0;Whole body fat mass;rs56198941;T;1.0;-0.4869;0.17109000000000002;0.0044288999999999995;A73V;ENST00000292303
CCR5;ENSG00000160791;23100-0.0;Whole body fat mass;rs56198941;T;1.0;-0.4869;0.17109000000000002;0.0044288999999999995;A73V;ENST00000445772
CCR5;ENSG00000160791;30200-0.0;Neutrophill percentage;rs62625034;T;0.5037470000000001;-0.20955;0.06595;0.0014862;Q194H;ENST00000292303
CCR5;ENSG00000160791;30200-0.0;Neutrophill percentage;rs62625034;T;0.5037470000000001;-0.20955;0.06595;0.0014862;Q194H;ENST00000445772
CCR5;ENSG00000160791;47-0.0;Hand grip strength (right);rs142829420;T;0.795295;-0.87564;0.29001;0.0025329000000000003;S63C;ENST00000292303
CCR5;ENSG00000160791;47-0.0;Hand grip strength (right);rs142829420;T;0.795295;-0.87564;0.29001;0.0025329000000000003;S63C;ENST00000445772
CCR5;ENSG00000160791;23106-0.0;Impedance of whole body;rs371598347;T;0.852922;13.585999999999999;4.2253;0.0013031;G216V;ENST00000292303
CCR5;ENSG00000160791;23106-0.0;Impedance of whole body;rs371598347;T;0.852922;13.585999999999999;4.2253;0.0013031;G216V;ENST00000445772
CCR5;ENSG00000160791;23106-0.0;Impedance of whole body;rs56198941;T;1.0;3.8608;1.1955;0.0012408;A73V;ENST00000292303
CCR5;ENSG00000160791;23106-0.0;Impedance of whole body;rs56198941;T;1.0;3.8608;1.1955;0.0012408;A73V;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1503;clotting disorder/excessive bleeding;rs1800944;T;0.974492;0.015772;0.0059435;0.0079616;A335V;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1503;clotting disorder/excessive bleeding;rs1800944;T;0.974492;0.015772;0.0059435;0.0079616;A335V;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1503;clotting disorder/excessive bleeding;rs371598347;T;0.852922;0.010828;0.0035728;0.0024399;G216V;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1503;clotting disorder/excessive bleeding;rs371598347;T;0.852922;0.010828;0.0035728;0.0024399;G216V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_O42;O42 Premature rupture of membranes;rs1800944;T;0.974492;0.095292;0.012821;1.0705e-13;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_O42;O42 Premature rupture of membranes;rs1800944;T;0.974492;0.095292;0.012821;1.0705e-13;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_O03;O03 Spontaneous abortion;rs150497029;G;0.93589;0.015426;0.0055222000000000005;0.005215999999999999;L121R;ENST00000292303
CCR5;ENSG00000160791;clinical_c_O03;O03 Spontaneous abortion;rs150497029;G;0.93589;0.015426;0.0055222000000000005;0.005215999999999999;L121R;ENST00000445772
CCR5;ENSG00000160791;clinical_c_O03;O03 Spontaneous abortion;rs1800944;T;0.974492;0.094577;0.014451;5.9798e-11;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_O03;O03 Spontaneous abortion;rs1800944;T;0.974492;0.094577;0.014451;5.9798e-11;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs371598347;T;0.852922;0.0093961;0.0036382;0.0098053;G216V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs371598347;T;0.852922;0.0093961;0.0036382;0.0098053;G216V;ENST00000445772
CCR5;ENSG00000160791;30300-0.0;High light scatter reticulocyte count;rs142829420;T;0.795295;0.0010584000000000001;0.00032976;0.0013291;S63C;ENST00000292303
CCR5;ENSG00000160791;30300-0.0;High light scatter reticulocyte count;rs142829420;T;0.795295;0.0010584000000000001;0.00032976;0.0013291;S63C;ENST00000445772
CCR5;ENSG00000160791;30300-0.0;High light scatter reticulocyte count;rs1799863;A;1.0;-0.00014058;5.162e-05;0.006461399999999999;L55Q;ENST00000292303
CCR5;ENSG00000160791;30300-0.0;High light scatter reticulocyte count;rs1799863;A;1.0;-0.00014058;5.162e-05;0.006461399999999999;L55Q;ENST00000445772
CCR5;ENSG00000160791;30300-0.0;High light scatter reticulocyte count;rs62625034;T;0.5037470000000001;0.00041960000000000006;6.9179e-05;1.3165e-09;Q194H;ENST00000292303
CCR5;ENSG00000160791;30300-0.0;High light scatter reticulocyte count;rs62625034;T;0.5037470000000001;0.00041960000000000006;6.9179e-05;1.3165e-09;Q194H;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1595;disc problem;rs62625034;T;0.5037470000000001;0.0033753999999999998;0.0012418;0.0065643;Q194H;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1595;disc problem;rs62625034;T;0.5037470000000001;0.0033753999999999998;0.0012418;0.0065643;Q194H;ENST00000445772
CCR5;ENSG00000160791;clinical_c_M06;M06 Other rheumatoid arthritis;rs1800944;T;0.974492;0.04158;0.013516;0.0020954999999999997;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_M06;M06 Other rheumatoid arthritis;rs1800944;T;0.974492;0.04158;0.013516;0.0020954999999999997;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_N99-N99;N99-N99 Other disorders of the genitourinary system;rs150497029;G;0.93589;0.0080184;0.0027708000000000003;0.0038048;L121R;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_N99-N99;N99-N99 Other disorders of the genitourinary system;rs150497029;G;0.93589;0.0080184;0.0027708000000000003;0.0038048;L121R;ENST00000445772
CCR5;ENSG00000160791;clinical_c_K75;K75 Other inflammatory liver diseases;rs142829420;T;0.795295;0.0046299;0.0017539;0.0082978;S63C;ENST00000292303
CCR5;ENSG00000160791;clinical_c_K75;K75 Other inflammatory liver diseases;rs142829420;T;0.795295;0.0046299;0.0017539;0.0082978;S63C;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1081;hypertension;rs1799863;A;1.0;-0.0070453;0.0026008000000000003;0.006750399999999999;L55Q;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1081;hypertension;rs1799863;A;1.0;-0.0070453;0.0026008000000000003;0.006750399999999999;L55Q;ENST00000445772
CCR5;ENSG00000160791;137-0.0;Number of treatments/medications taken;rs1799863;A;1.0;-0.041745;0.016079;0.009426799999999999;L55Q;ENST00000292303
CCR5;ENSG00000160791;137-0.0;Number of treatments/medications taken;rs1799863;A;1.0;-0.041745;0.016079;0.009426799999999999;L55Q;ENST00000445772
CCR5;ENSG00000160791;clinical_c_I65;I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction;rs34418657;T;0.453617;0.022233000000000003;0.0065935;0.0007462999999999999;V131F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_I65;I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction;rs34418657;T;0.453617;0.022233000000000003;0.0065935;0.0007462999999999999;V131F;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1540;psoriatic arthropathy;rs1800944;T;0.974492;0.015384;0.0058918;0.0090279;A335V;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1540;psoriatic arthropathy;rs1800944;T;0.974492;0.015384;0.0058918;0.0090279;A335V;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1540;psoriatic arthropathy;rs371598347;T;0.852922;0.010323;0.0035418;0.0035609;G216V;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1540;psoriatic arthropathy;rs371598347;T;0.852922;0.010323;0.0035418;0.0035609;G216V;ENST00000445772
CCR5;ENSG00000160791;23120-0.0;Arm fat mass (right);rs1799863;A;1.0;-0.009537299999999999;0.0034349000000000003;0.005493100000000001;L55Q;ENST00000292303
CCR5;ENSG00000160791;23120-0.0;Arm fat mass (right);rs1799863;A;1.0;-0.009537299999999999;0.0034349000000000003;0.005493100000000001;L55Q;ENST00000445772
CCR5;ENSG00000160791;23120-0.0;Arm fat mass (right);rs56198941;T;1.0;-0.031792;0.011515000000000001;0.0057625;A73V;ENST00000292303
CCR5;ENSG00000160791;23120-0.0;Arm fat mass (right);rs56198941;T;1.0;-0.031792;0.011515000000000001;0.0057625;A73V;ENST00000445772
CCR5;ENSG00000160791;30000-0.0;White blood cell (leukocyte) count;rs62625034;T;0.5037470000000001;0.048948;0.013478;0.00028167;Q194H;ENST00000292303
CCR5;ENSG00000160791;30000-0.0;White blood cell (leukocyte) count;rs62625034;T;0.5037470000000001;0.048948;0.013478;0.00028167;Q194H;ENST00000445772
CCR5;ENSG00000160791;clinical_c_H92;H92 Otalgia and effusion of ear;rs34418657;T;0.453617;0.015688;0.0047697;0.0010054999999999999;V131F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_H92;H92 Otalgia and effusion of ear;rs34418657;T;0.453617;0.015688;0.0047697;0.0010054999999999999;V131F;ENST00000445772
CCR5;ENSG00000160791;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs1800944;T;0.974492;0.016872;0.0048427;0.0004942;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_B97;B97 Viral agents as the cause of diseases classified to other chapters;rs1800944;T;0.974492;0.016872;0.0048427;0.0004942;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_N50;N50 Other disorders of male genital organs;rs1800452;A;1.0;0.026156;0.006712999999999999;9.7711e-05;R223Q;ENST00000292303
CCR5;ENSG00000160791;clinical_c_N50;N50 Other disorders of male genital organs;rs1800452;A;1.0;0.026156;0.006712999999999999;9.7711e-05;R223Q;ENST00000445772
CCR5;ENSG00000160791;30190-0.0;Monocyte percentage;rs62625034;T;0.5037470000000001;-0.074943;0.016408000000000002;4.9395e-06;Q194H;ENST00000292303
CCR5;ENSG00000160791;30190-0.0;Monocyte percentage;rs62625034;T;0.5037470000000001;-0.074943;0.016408000000000002;4.9395e-06;Q194H;ENST00000445772
CCR5;ENSG00000160791;23118-0.0;Leg predicted mass (left);rs1799863;A;1.0;-0.017248;0.006084;0.004582899999999999;L55Q;ENST00000292303
CCR5;ENSG00000160791;23118-0.0;Leg predicted mass (left);rs1799863;A;1.0;-0.017248;0.006084;0.004582899999999999;L55Q;ENST00000445772
CCR5;ENSG00000160791;23118-0.0;Leg predicted mass (left);rs371598347;T;0.852922;-0.19857;0.07208300000000001;0.005873399999999999;G216V;ENST00000292303
CCR5;ENSG00000160791;23118-0.0;Leg predicted mass (left);rs371598347;T;0.852922;-0.19857;0.07208300000000001;0.005873399999999999;G216V;ENST00000445772
CCR5;ENSG00000160791;23110-0.0;Impedance of arm (left);rs371598347;T;0.852922;6.653;2.5116;0.0080765;G216V;ENST00000292303
CCR5;ENSG00000160791;23110-0.0;Impedance of arm (left);rs371598347;T;0.852922;6.653;2.5116;0.0080765;G216V;ENST00000445772
CCR5;ENSG00000160791;23110-0.0;Impedance of arm (left);rs56198941;T;1.0;2.1358;0.71065;0.0026521;A73V;ENST00000292303
CCR5;ENSG00000160791;23110-0.0;Impedance of arm (left);rs56198941;T;1.0;2.1358;0.71065;0.0026521;A73V;ENST00000445772
CCR5;ENSG00000160791;1548-0.0;Variation in diet;rs1799863;A;1.0;-0.01031;0.0038732;0.007770399999999999;L55Q;ENST00000292303
CCR5;ENSG00000160791;1548-0.0;Variation in diet;rs1799863;A;1.0;-0.01031;0.0038732;0.007770399999999999;L55Q;ENST00000445772
CCR5;ENSG00000160791;1548-0.0;Variation in diet;rs62625034;T;0.5037470000000001;0.014625;0.0051909;0.0048426;Q194H;ENST00000292303
CCR5;ENSG00000160791;1548-0.0;Variation in diet;rs62625034;T;0.5037470000000001;0.014625;0.0051909;0.0048426;Q194H;ENST00000445772
CCR5;ENSG00000160791;23099-0.0;Body fat percentage;rs56198941;T;1.0;-0.31504;0.11731;0.007240100000000001;A73V;ENST00000292303
CCR5;ENSG00000160791;23099-0.0;Body fat percentage;rs56198941;T;1.0;-0.31504;0.11731;0.007240100000000001;A73V;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1160;oesophagitis/barretts oesophagus;rs1799863;A;1.0;0.0010267000000000002;0.00037669;0.0064168;L55Q;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1160;oesophagitis/barretts oesophagus;rs1799863;A;1.0;0.0010267000000000002;0.00037669;0.0064168;L55Q;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1160;oesophagitis/barretts oesophagus;rs34418657;T;0.453617;0.024730000000000002;0.0073822;0.00080827;V131F;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1160;oesophagitis/barretts oesophagus;rs34418657;T;0.453617;0.024730000000000002;0.0073822;0.00080827;V131F;ENST00000445772
CCR5;ENSG00000160791;21002-0.0;Weight;rs1799863;A;1.0;-0.23371;0.07650499999999999;0.0022521;L55Q;ENST00000292303
CCR5;ENSG00000160791;21002-0.0;Weight;rs1799863;A;1.0;-0.23371;0.07650499999999999;0.0022521;L55Q;ENST00000445772
CCR5;ENSG00000160791;21002-0.0;Weight;rs56198941;T;1.0;-0.71031;0.25647;0.0056135;A73V;ENST00000292303
CCR5;ENSG00000160791;21002-0.0;Weight;rs56198941;T;1.0;-0.71031;0.25647;0.0056135;A73V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_N99;N99 Postprocedural disorders of genito-urinary system, not elsewhere classified;rs150497029;G;0.93589;0.0080184;0.0027708000000000003;0.0038048;L121R;ENST00000292303
CCR5;ENSG00000160791;clinical_c_N99;N99 Postprocedural disorders of genito-urinary system, not elsewhere classified;rs150497029;G;0.93589;0.0080184;0.0027708000000000003;0.0038048;L121R;ENST00000445772
CCR5;ENSG00000160791;clinical_c_M05;M05 Seropositive rheumatoid arthritis;rs1800944;T;0.974492;0.016063;0.0050063;0.0013342;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_M05;M05 Seropositive rheumatoid arthritis;rs1800944;T;0.974492;0.016063;0.0050063;0.0013342;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_N73;N73 Other female pelvic inflammatory diseases;rs1800940;T;0.922702;0.012123;0.003545599999999999;0.00062841;R60S;ENST00000292303
CCR5;ENSG00000160791;clinical_c_N73;N73 Other female pelvic inflammatory diseases;rs1800940;T;0.922702;0.012123;0.003545599999999999;0.00062841;R60S;ENST00000445772
CCR5;ENSG00000160791;23105-0.0;Basal metabolic rate;rs371598347;T;0.852922;-144.35;52.26;0.0057408;G216V;ENST00000292303
CCR5;ENSG00000160791;23105-0.0;Basal metabolic rate;rs371598347;T;0.852922;-144.35;52.26;0.0057408;G216V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_I64;I64 Stroke, not specified as haemorrhage or infarction;rs142829420;T;0.795295;0.0089351;0.0021941999999999994;4.658e-05;S63C;ENST00000292303
CCR5;ENSG00000160791;clinical_c_I64;I64 Stroke, not specified as haemorrhage or infarction;rs142829420;T;0.795295;0.0089351;0.0021941999999999994;4.658e-05;S63C;ENST00000445772
CCR5;ENSG00000160791;clinical_c_H11;H11 Other disorders of conjunctiva;rs150497029;G;0.93589;0.0062907;0.0022302;0.0047925;L121R;ENST00000292303
CCR5;ENSG00000160791;clinical_c_H11;H11 Other disorders of conjunctiva;rs150497029;G;0.93589;0.0062907;0.0022302;0.0047925;L121R;ENST00000445772
CCR5;ENSG00000160791;clinical_c_H11;H11 Other disorders of conjunctiva;rs56198941;T;1.0;0.0029281;0.00097497;0.002671;A73V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_H11;H11 Other disorders of conjunctiva;rs56198941;T;1.0;0.0029281;0.00097497;0.002671;A73V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_I85;I85 Oesophageal varices;rs1800452;A;1.0;0.0043596;0.0013218;0.00097299;R223Q;ENST00000292303
CCR5;ENSG00000160791;clinical_c_I85;I85 Oesophageal varices;rs1800452;A;1.0;0.0043596;0.0013218;0.00097299;R223Q;ENST00000445772
CCR5;ENSG00000160791;clinical_c_I85;I85 Oesophageal varices;rs1800944;T;0.974492;0.016736;0.0047403;0.00041476;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_I85;I85 Oesophageal varices;rs1800944;T;0.974492;0.016736;0.0047403;0.00041476;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_L02;L02 Cutaneous abscess, furuncle and carbuncle;rs1800945;T;0.961098;0.02758;0.0051666;9.3963e-08;Y339F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_L02;L02 Cutaneous abscess, furuncle and carbuncle;rs1800945;T;0.961098;0.02758;0.0051666;9.3963e-08;Y339F;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1574;abdominal hernia;rs1800940;T;0.922702;0.0065741;0.0017816;0.00022433;R60S;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1574;abdominal hernia;rs1800940;T;0.922702;0.0065741;0.0017816;0.00022433;R60S;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1304;cataract;rs142829420;T;0.795295;-0.013503999999999999;0.005017100000000001;0.007109899999999999;S63C;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1304;cataract;rs142829420;T;0.795295;-0.013503999999999999;0.005017100000000001;0.007109899999999999;S63C;ENST00000445772
CCR5;ENSG00000160791;23109-0.0;Impedance of arm (right);rs371598347;T;0.852922;6.5127;2.4177;0.007066299999999999;G216V;ENST00000292303
CCR5;ENSG00000160791;23109-0.0;Impedance of arm (right);rs371598347;T;0.852922;6.5127;2.4177;0.007066299999999999;G216V;ENST00000445772
CCR5;ENSG00000160791;23109-0.0;Impedance of arm (right);rs56198941;T;1.0;1.8848;0.68409;0.0058652;A73V;ENST00000292303
CCR5;ENSG00000160791;23109-0.0;Impedance of arm (right);rs56198941;T;1.0;1.8848;0.68409;0.0058652;A73V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_O10-O16;O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium;rs56198941;T;1.0;0.0065033;0.00232;0.005061199999999999;A73V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_O10-O16;O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium;rs56198941;T;1.0;0.0065033;0.00232;0.005061199999999999;A73V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_D60-D64;D60-D64 Aplastic and other anaemias;rs1800940;T;0.922702;0.011578;0.004041599999999999;0.0041732;R60S;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_D60-D64;D60-D64 Aplastic and other anaemias;rs1800940;T;0.922702;0.011578;0.004041599999999999;0.0041732;R60S;ENST00000445772
CCR5;ENSG00000160791;clinical_c_H54;H54 Blindness and low vision;rs150497029;G;0.93589;0.014284;0.0023905000000000003;2.2968e-09;L121R;ENST00000292303
CCR5;ENSG00000160791;clinical_c_H54;H54 Blindness and low vision;rs150497029;G;0.93589;0.014284;0.0023905000000000003;2.2968e-09;L121R;ENST00000445772
CCR5;ENSG00000160791;clinical_c_O36;O36 Maternal care for other known or suspected foetal problems;rs1800944;T;0.974492;0.056217;0.016802;0.00082045;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_O36;O36 Maternal care for other known or suspected foetal problems;rs1800944;T;0.974492;0.056217;0.016802;0.00082045;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_O36;O36 Maternal care for other known or suspected foetal problems;rs371598347;T;0.852922;0.036916;0.0097008;0.00014161;G216V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_O36;O36 Maternal care for other known or suspected foetal problems;rs371598347;T;0.852922;0.036916;0.0097008;0.00014161;G216V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs1800945;T;0.961098;0.011922;0.0034138000000000007;0.00047875;Y339F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs1800945;T;0.961098;0.011922;0.0034138000000000007;0.00047875;Y339F;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1416;connective tissue disorder;rs1800944;T;0.974492;0.027884;0.010801999999999999;0.009841599999999999;A335V;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1416;connective tissue disorder;rs1800944;T;0.974492;0.027884;0.010801999999999999;0.009841599999999999;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_N28;N28 Other disorders of kidney and ureter, not elsewhere classified;rs142829420;T;0.795295;0.0091624;0.0032840000000000005;0.0052714;S63C;ENST00000292303
CCR5;ENSG00000160791;clinical_c_N28;N28 Other disorders of kidney and ureter, not elsewhere classified;rs142829420;T;0.795295;0.0091624;0.0032840000000000005;0.0052714;S63C;ENST00000445772
CCR5;ENSG00000160791;23116-0.0;Leg fat mass (left);rs56198941;T;1.0;-0.081259;0.028676;0.004601600000000001;A73V;ENST00000292303
CCR5;ENSG00000160791;23116-0.0;Leg fat mass (left);rs56198941;T;1.0;-0.081259;0.028676;0.004601600000000001;A73V;ENST00000445772
CCR5;ENSG00000160791;1239-0.0;Current tobacco smoking;rs1800945;T;0.961098;0.11355;0.035947;0.0015833;Y339F;ENST00000292303
CCR5;ENSG00000160791;1239-0.0;Current tobacco smoking;rs1800945;T;0.961098;0.11355;0.035947;0.0015833;Y339F;ENST00000445772
CCR5;ENSG00000160791;23098-0.0;Weight;rs1799863;A;1.0;-0.22639;0.075949;0.0028749;L55Q;ENST00000292303
CCR5;ENSG00000160791;23098-0.0;Weight;rs1799863;A;1.0;-0.22639;0.075949;0.0028749;L55Q;ENST00000445772
CCR5;ENSG00000160791;23098-0.0;Weight;rs56198941;T;1.0;-0.71668;0.2546;0.0048797;A73V;ENST00000292303
CCR5;ENSG00000160791;23098-0.0;Weight;rs56198941;T;1.0;-0.71668;0.2546;0.0048797;A73V;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1321;joint disorder;rs1800944;T;0.974492;0.11222;0.04295;0.008982899999999999;A335V;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1321;joint disorder;rs1800944;T;0.974492;0.11222;0.04295;0.008982899999999999;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_M31;M31 Other necrotising vasculopathies;rs1800944;T;0.974492;0.016074;0.005021899999999999;0.0013709000000000002;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_M31;M31 Other necrotising vasculopathies;rs1800944;T;0.974492;0.016074;0.005021899999999999;0.0013709000000000002;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_B07;B07 Viral warts;rs1800945;T;0.961098;0.0078167;0.0028596999999999997;0.0062683999999999995;Y339F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_B07;B07 Viral warts;rs1800945;T;0.961098;0.0078167;0.0028596999999999997;0.0062683999999999995;Y339F;ENST00000445772
CCR5;ENSG00000160791;clinical_c_H18;H18 Other disorders of cornea;rs150497029;G;0.93589;0.0060128000000000004;0.0020471;0.0033116;L121R;ENST00000292303
CCR5;ENSG00000160791;clinical_c_H18;H18 Other disorders of cornea;rs150497029;G;0.93589;0.0060128000000000004;0.0020471;0.0033116;L121R;ENST00000445772
CCR5;ENSG00000160791;clinical_c_I10;I10 Essential (primary) hypertension;rs62625034;T;0.5037470000000001;0.010284999999999999;0.0031818000000000003;0.0012277999999999998;Q194H;ENST00000292303
CCR5;ENSG00000160791;clinical_c_I10;I10 Essential (primary) hypertension;rs62625034;T;0.5037470000000001;0.010284999999999999;0.0031818000000000003;0.0012277999999999998;Q194H;ENST00000445772
CCR5;ENSG00000160791;1717-0.0;Skin colour;rs1800944;T;0.974492;-0.19422999999999999;0.06451799999999999;0.0026088;A335V;ENST00000292303
CCR5;ENSG00000160791;1717-0.0;Skin colour;rs1800944;T;0.974492;-0.19422999999999999;0.06451799999999999;0.0026088;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_O04;O04 Medical abortion;rs142829420;T;0.795295;0.011193;0.0040036;0.0051774;S63C;ENST00000292303
CCR5;ENSG00000160791;clinical_c_O04;O04 Medical abortion;rs142829420;T;0.795295;0.011193;0.0040036;0.0051774;S63C;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1217;urinary tract infection/kidney infection;rs1800940;T;0.922702;0.0046991;0.0017817999999999998;0.008357;R60S;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1217;urinary tract infection/kidney infection;rs1800940;T;0.922702;0.0046991;0.0017817999999999998;0.008357;R60S;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1217;urinary tract infection/kidney infection;rs1800945;T;0.961098;0.01339;0.0051818;0.0097636;Y339F;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1217;urinary tract infection/kidney infection;rs1800945;T;0.961098;0.01339;0.0051818;0.0097636;Y339F;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1217;urinary tract infection/kidney infection;rs62625034;T;0.5037470000000001;-0.0018304999999999999;0.00068449;0.007491800000000001;Q194H;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1217;urinary tract infection/kidney infection;rs62625034;T;0.5037470000000001;-0.0018304999999999999;0.00068449;0.007491800000000001;Q194H;ENST00000445772
CCR5;ENSG00000160791;clinical_c_M10;M10 Gout;rs34418657;T;0.453617;0.041297;0.011604000000000001;0.00037251;V131F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_M10;M10 Gout;rs34418657;T;0.453617;0.041297;0.011604000000000001;0.00037251;V131F;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1734;rosacea;rs1800452;A;1.0;0.0043002;0.0014857000000000002;0.0038001999999999997;R223Q;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1734;rosacea;rs1800452;A;1.0;0.0043002;0.0014857000000000002;0.0038001999999999997;R223Q;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1734;rosacea;rs1800945;T;0.961098;0.0079547;0.0027428;0.003729;Y339F;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1734;rosacea;rs1800945;T;0.961098;0.0079547;0.0027428;0.003729;Y339F;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1605;fibromyalgia;rs1800945;T;0.961098;0.007936499999999999;0.002625;0.0024989;Y339F;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1605;fibromyalgia;rs1800945;T;0.961098;0.007936499999999999;0.002625;0.0024989;Y339F;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_F40-F48;F40-F48 Neurotic, stress-related and somatoform disorders;rs1800940;T;0.922702;-0.0087695;0.0031252;0.005015100000000001;R60S;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_F40-F48;F40-F48 Neurotic, stress-related and somatoform disorders;rs1800940;T;0.922702;-0.0087695;0.0031252;0.005015100000000001;R60S;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1158;other abdominal problem;rs1800940;T;0.922702;0.010882;0.0026735;4.6912e-05;R60S;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1158;other abdominal problem;rs1800940;T;0.922702;0.010882;0.0026735;4.6912e-05;R60S;ENST00000445772
CCR5;ENSG00000160791;23130-0.0;Trunk predicted mass;rs371598347;T;0.852922;-0.55125;0.1887;0.0034869;G216V;ENST00000292303
CCR5;ENSG00000160791;23130-0.0;Trunk predicted mass;rs371598347;T;0.852922;-0.55125;0.1887;0.0034869;G216V;ENST00000445772
CCR5;ENSG00000160791;30250-0.0;Reticulocyte count;rs142829420;T;0.795295;0.0029005;0.00090756;0.001394;S63C;ENST00000292303
CCR5;ENSG00000160791;30250-0.0;Reticulocyte count;rs142829420;T;0.795295;0.0029005;0.00090756;0.001394;S63C;ENST00000445772
CCR5;ENSG00000160791;30250-0.0;Reticulocyte count;rs62625034;T;0.5037470000000001;0.0010554;0.00019040000000000002;2.9686e-08;Q194H;ENST00000292303
CCR5;ENSG00000160791;30250-0.0;Reticulocyte count;rs62625034;T;0.5037470000000001;0.0010554;0.00019040000000000002;2.9686e-08;Q194H;ENST00000445772
CCR5;ENSG00000160791;clinical_c_I84;I84 Haemorrhoids;rs1799863;A;1.0;0.004234;0.0015561;0.006512;L55Q;ENST00000292303
CCR5;ENSG00000160791;clinical_c_I84;I84 Haemorrhoids;rs1799863;A;1.0;0.004234;0.0015561;0.006512;L55Q;ENST00000445772
CCR5;ENSG00000160791;23126-0.0;Arm predicted mass (left);rs371598347;T;0.852922;-0.07725800000000001;0.027977999999999996;0.0057555;G216V;ENST00000292303
CCR5;ENSG00000160791;23126-0.0;Arm predicted mass (left);rs371598347;T;0.852922;-0.07725800000000001;0.027977999999999996;0.0057555;G216V;ENST00000445772
CCR5;ENSG00000160791;30040-0.0;Mean corpuscular volume;rs62625034;T;0.5037470000000001;-0.08769099999999999;0.030987999999999998;0.004657;Q194H;ENST00000292303
CCR5;ENSG00000160791;30040-0.0;Mean corpuscular volume;rs62625034;T;0.5037470000000001;-0.08769099999999999;0.030987999999999998;0.004657;Q194H;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1270;infection of nervous system;rs1800945;T;0.961098;0.014097;0.004897;0.0039924999999999995;Y339F;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1270;infection of nervous system;rs1800945;T;0.961098;0.014097;0.004897;0.0039924999999999995;Y339F;ENST00000445772
CCR5;ENSG00000160791;23102-0.0;Whole body water mass;rs371598347;T;0.852922;-0.85339;0.28326999999999997;0.0025897;G216V;ENST00000292303
CCR5;ENSG00000160791;23102-0.0;Whole body water mass;rs371598347;T;0.852922;-0.85339;0.28326999999999997;0.0025897;G216V;ENST00000445772
CCR5;ENSG00000160791;cancer_c_D06;D06 Carcinoma in situ of cervix uteri;rs1800944;T;0.974492;0.057126;0.016732;0.00063977;A335V;ENST00000292303
CCR5;ENSG00000160791;cancer_c_D06;D06 Carcinoma in situ of cervix uteri;rs1800944;T;0.974492;0.057126;0.016732;0.00063977;A335V;ENST00000445772
CCR5;ENSG00000160791;1687-0.0;Comparative body size at age 10;rs62625034;T;0.5037470000000001;0.015833;0.0054151;0.0034571;Q194H;ENST00000292303
CCR5;ENSG00000160791;1687-0.0;Comparative body size at age 10;rs62625034;T;0.5037470000000001;0.015833;0.0054151;0.0034571;Q194H;ENST00000445772
CCR5;ENSG00000160791;clinical_c_M66;M66 Spontaneous rupture of synovium and tendon;rs56198941;T;1.0;0.0029100000000000003;0.00081404;0.00035062;A73V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_M66;M66 Spontaneous rupture of synovium and tendon;rs56198941;T;1.0;0.0029100000000000003;0.00081404;0.00035062;A73V;ENST00000445772
CCR5;ENSG00000160791;1518-0.0;Hot drink temperature;rs150497029;G;0.93589;0.073931;0.027612;0.007417399999999999;L121R;ENST00000292303
CCR5;ENSG00000160791;1518-0.0;Hot drink temperature;rs150497029;G;0.93589;0.073931;0.027612;0.007417399999999999;L121R;ENST00000445772
CCR5;ENSG00000160791;clinical_c_G51;G51 Facial nerve disorders;rs34418657;T;0.453617;0.01821;0.0060806;0.0027471;V131F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_G51;G51 Facial nerve disorders;rs34418657;T;0.453617;0.01821;0.0060806;0.0027471;V131F;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1454;other renal/kidney problem;rs1800945;T;0.961098;0.013640000000000001;0.005070600000000001;0.0071464;Y339F;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1454;other renal/kidney problem;rs1800945;T;0.961098;0.013640000000000001;0.005070600000000001;0.0071464;Y339F;ENST00000445772
CCR5;ENSG00000160791;23108-0.0;Impedance of leg (left);rs1799863;A;1.0;0.51883;0.1749;0.0030135;L55Q;ENST00000292303
CCR5;ENSG00000160791;23108-0.0;Impedance of leg (left);rs1799863;A;1.0;0.51883;0.1749;0.0030135;L55Q;ENST00000445772
CCR5;ENSG00000160791;23108-0.0;Impedance of leg (left);rs371598347;T;0.852922;7.4574;2.0722;0.00031979;G216V;ENST00000292303
CCR5;ENSG00000160791;23108-0.0;Impedance of leg (left);rs371598347;T;0.852922;7.4574;2.0722;0.00031979;G216V;ENST00000445772
CCR5;ENSG00000160791;1873-0.0;Number of full brothers;rs1800945;T;0.961098;0.26808000000000004;0.07823200000000001;0.00061083;Y339F;ENST00000292303
CCR5;ENSG00000160791;1873-0.0;Number of full brothers;rs1800945;T;0.961098;0.26808000000000004;0.07823200000000001;0.00061083;Y339F;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1314;nervous breakdown;rs142829420;T;0.795295;0.004799899999999999;0.0016710999999999998;0.0040751;S63C;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1314;nervous breakdown;rs142829420;T;0.795295;0.004799899999999999;0.0016710999999999998;0.0040751;S63C;ENST00000445772
CCR5;ENSG00000160791;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs150497029;G;0.93589;0.013787;0.0026023000000000005;1.1709000000000001e-07;L121R;ENST00000292303
CCR5;ENSG00000160791;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs150497029;G;0.93589;0.013787;0.0026023000000000005;1.1709000000000001e-07;L121R;ENST00000445772
CCR5;ENSG00000160791;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs62625034;T;0.5037470000000001;-0.0013138;0.00045481;0.0038696;Q194H;ENST00000292303
CCR5;ENSG00000160791;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs62625034;T;0.5037470000000001;-0.0013138;0.00045481;0.0038696;Q194H;ENST00000445772
CCR5;ENSG00000160791;clinical_c_H66;H66 Suppurative and unspecified otitis media;rs1800944;T;0.974492;0.015691999999999998;0.0058368000000000005;0.0071792;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_H66;H66 Suppurative and unspecified otitis media;rs1800944;T;0.974492;0.015691999999999998;0.0058368000000000005;0.0071792;A335V;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1720;fracture pelvis & lower limb;rs1799863;A;1.0;-0.001801;0.00062037;0.0036943000000000006;L55Q;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1720;fracture pelvis & lower limb;rs1799863;A;1.0;-0.001801;0.00062037;0.0036943000000000006;L55Q;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_H43-H45;H43-H45 Disorders of vitreous body and globe;rs371598347;T;0.852922;0.016587;0.0051706;0.0013368;G216V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_H43-H45;H43-H45 Disorders of vitreous body and globe;rs371598347;T;0.852922;0.016587;0.0051706;0.0013368;G216V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs62625034;T;0.5037470000000001;-0.0011958000000000001;0.00043886;0.006436;Q194H;ENST00000292303
CCR5;ENSG00000160791;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs62625034;T;0.5037470000000001;-0.0011958000000000001;0.00043886;0.006436;Q194H;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1175;irritable bowel syndrome;rs1800944;T;0.974492;0.06410700000000001;0.020219;0.0015215;A335V;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1175;irritable bowel syndrome;rs1800944;T;0.974492;0.06410700000000001;0.020219;0.0015215;A335V;ENST00000445772
CCR5;ENSG00000160791;49-0.0;Hip circumference;rs56198941;T;1.0;-0.5152;0.17342;0.0029708;A73V;ENST00000292303
CCR5;ENSG00000160791;49-0.0;Hip circumference;rs56198941;T;1.0;-0.5152;0.17342;0.0029708;A73V;ENST00000445772
CCR5;ENSG00000160791;23115-0.0;Leg fat percentage (left);rs56198941;T;1.0;-0.27991;0.097273;0.0040070999999999996;A73V;ENST00000292303
CCR5;ENSG00000160791;23115-0.0;Leg fat percentage (left);rs56198941;T;1.0;-0.27991;0.097273;0.0040070999999999996;A73V;ENST00000445772
CCR5;ENSG00000160791;23124-0.0;Arm fat mass (left);rs1799863;A;1.0;-0.011064000000000001;0.0038354;0.003918199999999999;L55Q;ENST00000292303
CCR5;ENSG00000160791;23124-0.0;Arm fat mass (left);rs1799863;A;1.0;-0.011064000000000001;0.0038354;0.003918199999999999;L55Q;ENST00000445772
CCR5;ENSG00000160791;23124-0.0;Arm fat mass (left);rs56198941;T;1.0;-0.035013999999999997;0.012856999999999999;0.006465;A73V;ENST00000292303
CCR5;ENSG00000160791;23124-0.0;Arm fat mass (left);rs56198941;T;1.0;-0.035013999999999997;0.012856999999999999;0.006465;A73V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_L81;L81 Other disorders of pigmentation;rs1800452;A;1.0;0.0052309;0.0016292000000000001;0.0013245999999999998;R223Q;ENST00000292303
CCR5;ENSG00000160791;clinical_c_L81;L81 Other disorders of pigmentation;rs1800452;A;1.0;0.0052309;0.0016292000000000001;0.0013245999999999998;R223Q;ENST00000445772
CCR5;ENSG00000160791;clinical_c_I22;I22 Subsequent myocardial infarction;rs150497029;G;0.93589;0.0066495;0.0021734000000000002;0.0022171;L121R;ENST00000292303
CCR5;ENSG00000160791;clinical_c_I22;I22 Subsequent myocardial infarction;rs150497029;G;0.93589;0.0066495;0.0021734000000000002;0.0022171;L121R;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1469;ear/vestibular disorder;rs34418657;T;0.453617;0.050193;0.016184999999999998;0.0019277;V131F;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1469;ear/vestibular disorder;rs34418657;T;0.453617;0.050193;0.016184999999999998;0.0019277;V131F;ENST00000445772
CCR5;ENSG00000160791;23119-0.0;Arm fat percentage (right);rs56198941;T;1.0;-0.38654;0.14009000000000002;0.0057944;A73V;ENST00000292303
CCR5;ENSG00000160791;23119-0.0;Arm fat percentage (right);rs56198941;T;1.0;-0.38654;0.14009000000000002;0.0057944;A73V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_M80;M80 Osteoporosis with pathological fracture;rs1799863;A;1.0;-0.00082162;0.00031588;0.009295;L55Q;ENST00000292303
CCR5;ENSG00000160791;clinical_c_M80;M80 Osteoporosis with pathological fracture;rs1799863;A;1.0;-0.00082162;0.00031588;0.009295;L55Q;ENST00000445772
CCR5;ENSG00000160791;cancer_c_C43;C43 Malignant melanoma of skin;rs34418657;T;0.453617;0.03147;0.0098024;0.0013252000000000001;V131F;ENST00000292303
CCR5;ENSG00000160791;cancer_c_C43;C43 Malignant melanoma of skin;rs34418657;T;0.453617;0.03147;0.0098024;0.0013252000000000001;V131F;ENST00000445772
CCR5;ENSG00000160791;30010-0.0;Red blood cell (erythrocyte) count;rs62625034;T;0.5037470000000001;0.0089409;0.0025523000000000004;0.00045995;Q194H;ENST00000292303
CCR5;ENSG00000160791;30010-0.0;Red blood cell (erythrocyte) count;rs62625034;T;0.5037470000000001;0.0089409;0.0025523000000000004;0.00045995;Q194H;ENST00000445772
CCR5;ENSG00000160791;clinical_c_I60;I60 Subarachnoid haemorrhage;rs371598347;T;0.852922;0.0099366;0.0035715000000000005;0.0053988;G216V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_I60;I60 Subarachnoid haemorrhage;rs371598347;T;0.852922;0.0099366;0.0035715000000000005;0.0053988;G216V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs1800452;A;1.0;0.045217;0.016319999999999998;0.005595;R223Q;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_N40-N51;N40-N51 Diseases of male genital organs;rs1800452;A;1.0;0.045217;0.016319999999999998;0.005595;R223Q;ENST00000445772
CCR5;ENSG00000160791;1458-0.0;Cereal intake;rs371598347;T;0.852922;0.6059100000000001;0.21243;0.004340600000000001;G216V;ENST00000292303
CCR5;ENSG00000160791;1458-0.0;Cereal intake;rs371598347;T;0.852922;0.6059100000000001;0.21243;0.004340600000000001;G216V;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1616;cervical problem;rs34418657;T;0.453617;0.0433;0.013302;0.0011331;V131F;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1616;cervical problem;rs34418657;T;0.453617;0.0433;0.013302;0.0011331;V131F;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1616;cervical problem;rs371598347;T;0.852922;0.042382;0.0076377;2.8745e-08;G216V;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1616;cervical problem;rs371598347;T;0.852922;0.042382;0.0076377;2.8745e-08;G216V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_M41;M41 Scoliosis;rs34418657;T;0.453617;0.017834;0.006690100000000001;0.0076818;V131F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_M41;M41 Scoliosis;rs34418657;T;0.453617;0.017834;0.006690100000000001;0.0076818;V131F;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_O00-O08;O00-O08 Pregnancy with abortive outcome;rs1800944;T;0.974492;0.08781699999999999;0.023179;0.00015154;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_O00-O08;O00-O08 Pregnancy with abortive outcome;rs1800944;T;0.974492;0.08781699999999999;0.023179;0.00015154;A335V;ENST00000445772
CCR5;ENSG00000160791;23123-0.0;Arm fat percentage (left);rs56198941;T;1.0;-0.37394;0.14092000000000002;0.007962100000000001;A73V;ENST00000292303
CCR5;ENSG00000160791;23123-0.0;Arm fat percentage (left);rs56198941;T;1.0;-0.37394;0.14092000000000002;0.007962100000000001;A73V;ENST00000445772
CCR5;ENSG00000160791;23117-0.0;Leg fat-free mass (left);rs1799863;A;1.0;-0.018708000000000002;0.006487000000000001;0.0039271;L55Q;ENST00000292303
CCR5;ENSG00000160791;23117-0.0;Leg fat-free mass (left);rs1799863;A;1.0;-0.018708000000000002;0.006487000000000001;0.0039271;L55Q;ENST00000445772
CCR5;ENSG00000160791;23117-0.0;Leg fat-free mass (left);rs371598347;T;0.852922;-0.21204;0.07685700000000001;0.0057994;G216V;ENST00000292303
CCR5;ENSG00000160791;23117-0.0;Leg fat-free mass (left);rs371598347;T;0.852922;-0.21204;0.07685700000000001;0.0057994;G216V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_N70-N77;N70-N77 Inflammatory diseases of female pelvic organs;rs1800940;T;0.922702;0.015939;0.0051742;0.0020666;R60S;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_N70-N77;N70-N77 Inflammatory diseases of female pelvic organs;rs1800940;T;0.922702;0.015939;0.0051742;0.0020666;R60S;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1623;miscarriage;rs1800944;T;0.974492;0.033131;0.011443;0.0037899;A335V;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1623;miscarriage;rs1800944;T;0.974492;0.033131;0.011443;0.0037899;A335V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_G45;G45 Transient cerebral ischaemic attacks and related syndromes;rs56198941;T;1.0;0.005543;0.0017805999999999998;0.0018526;A73V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_G45;G45 Transient cerebral ischaemic attacks and related syndromes;rs56198941;T;1.0;0.005543;0.0017805999999999998;0.0018526;A73V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_N92;N92 Excessive, frequent and irregular menstruation;rs1800945;T;0.961098;0.062128;0.021282;0.0035092;Y339F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_N92;N92 Excessive, frequent and irregular menstruation;rs1800945;T;0.961098;0.062128;0.021282;0.0035092;Y339F;ENST00000445772
CCR5;ENSG00000160791;clinical_c_N92;N92 Excessive, frequent and irregular menstruation;rs62625034;T;0.5037470000000001;-0.007395;0.0028328000000000003;0.0090412;Q194H;ENST00000292303
CCR5;ENSG00000160791;clinical_c_N92;N92 Excessive, frequent and irregular menstruation;rs62625034;T;0.5037470000000001;-0.007395;0.0028328000000000003;0.0090412;Q194H;ENST00000445772
CCR5;ENSG00000160791;23125-0.0;Arm fat-free mass (left);rs371598347;T;0.852922;-0.086016;0.029675;0.0037488;G216V;ENST00000292303
CCR5;ENSG00000160791;23125-0.0;Arm fat-free mass (left);rs371598347;T;0.852922;-0.086016;0.029675;0.0037488;G216V;ENST00000445772
CCR5;ENSG00000160791;23111-0.0;Leg fat percentage (right);rs56198941;T;1.0;-0.27443;0.10228999999999999;0.007301;A73V;ENST00000292303
CCR5;ENSG00000160791;23111-0.0;Leg fat percentage (right);rs56198941;T;1.0;-0.27443;0.10228999999999999;0.007301;A73V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_H53-H54;H53-H54 Visual disturbances and blindness;rs150497029;G;0.93589;0.023272;0.0049602;2.7098000000000003e-06;L121R;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_H53-H54;H53-H54 Visual disturbances and blindness;rs150497029;G;0.93589;0.023272;0.0049602;2.7098000000000003e-06;L121R;ENST00000445772
CCR5;ENSG00000160791;clinical_c_H60;H60 Otitis externa;rs1800944;T;0.974492;0.015403;0.0048078;0.0013564;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_H60;H60 Otitis externa;rs1800944;T;0.974492;0.015403;0.0048078;0.0013564;A335V;ENST00000445772
CCR5;ENSG00000160791;30180-0.0;Lymphocyte percentage;rs62625034;T;0.5037470000000001;0.32293;0.05650499999999999;1.0971e-08;Q194H;ENST00000292303
CCR5;ENSG00000160791;30180-0.0;Lymphocyte percentage;rs62625034;T;0.5037470000000001;0.32293;0.05650499999999999;1.0971e-08;Q194H;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1695;fracture;rs62625034;T;0.5037470000000001;0.0034508000000000004;0.0012032;0.004131;Q194H;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1695;fracture;rs62625034;T;0.5037470000000001;0.0034508000000000004;0.0012032;0.004131;Q194H;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_N25-N29;N25-N29 Other disorders of kidney and ureter;rs142829420;T;0.795295;0.010445;0.0034311999999999997;0.0023337;S63C;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_N25-N29;N25-N29 Other disorders of kidney and ureter;rs142829420;T;0.795295;0.010445;0.0034311999999999997;0.0023337;S63C;ENST00000445772
CCR5;ENSG00000160791;clinical_c_J98;J98 Other respiratory disorders;rs1800945;T;0.961098;0.030646;0.0060515000000000005;4.1039999999999997e-07;Y339F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_J98;J98 Other respiratory disorders;rs1800945;T;0.961098;0.030646;0.0060515000000000005;4.1039999999999997e-07;Y339F;ENST00000445772
CCR5;ENSG00000160791;30050-0.0;Mean corpuscular haemoglobin;rs62625034;T;0.5037470000000001;-0.039086;0.012553;0.0018484000000000003;Q194H;ENST00000292303
CCR5;ENSG00000160791;30050-0.0;Mean corpuscular haemoglobin;rs62625034;T;0.5037470000000001;-0.039086;0.012553;0.0018484000000000003;Q194H;ENST00000445772
CCR5;ENSG00000160791;selfReported_n_1111;pulmonary embolism +/- dvt;rs62625034;T;0.5037470000000001;0.0021801999999999998;0.0008222999999999999;0.0080184;Q194H;ENST00000292303
CCR5;ENSG00000160791;selfReported_n_1111;pulmonary embolism +/- dvt;rs62625034;T;0.5037470000000001;0.0021801999999999998;0.0008222999999999999;0.0080184;Q194H;ENST00000445772
CCR5;ENSG00000160791;1329-0.0;Oily fish intake;rs1799863;A;1.0;0.017568;0.0058299;0.0025833;L55Q;ENST00000292303
CCR5;ENSG00000160791;1329-0.0;Oily fish intake;rs1799863;A;1.0;0.017568;0.0058299;0.0025833;L55Q;ENST00000445772
CCR5;ENSG00000160791;728-0.0;Number of vehicles in household;rs56198941;T;1.0;-0.050546;0.018343;0.0058571000000000005;A73V;ENST00000292303
CCR5;ENSG00000160791;728-0.0;Number of vehicles in household;rs56198941;T;1.0;-0.050546;0.018343;0.0058571000000000005;A73V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_L85;L85 Other epidermal thickening;rs1800944;T;0.974492;0.015832;0.0054555;0.0037070000000000002;A335V;ENST00000292303
CCR5;ENSG00000160791;clinical_c_L85;L85 Other epidermal thickening;rs1800944;T;0.974492;0.015832;0.0054555;0.0037070000000000002;A335V;ENST00000445772
CCR5;ENSG00000160791;23129-0.0;Trunk fat-free mass;rs371598347;T;0.852922;-0.56996;0.19663;0.0037486999999999993;G216V;ENST00000292303
CCR5;ENSG00000160791;23129-0.0;Trunk fat-free mass;rs371598347;T;0.852922;-0.56996;0.19663;0.0037486999999999993;G216V;ENST00000445772
CCR5;ENSG00000160791;clinical_c_Block_J95-J99;J95-J99 Other diseases of the respiratory system;rs1800945;T;0.961098;0.03573;0.0077794;4.3713e-06;Y339F;ENST00000292303
CCR5;ENSG00000160791;clinical_c_Block_J95-J99;J95-J99 Other diseases of the respiratory system;rs1800945;T;0.961098;0.03573;0.0077794;4.3713e-06;Y339F;ENST00000445772
CCR5;ENSG00000160791;clinical_c_N86;N86 Erosion and ectropion of cervix uteri;rs150497029;G;0.93589;0.014136;0.004559399999999999;0.0019327;L121R;ENST00000292303
CCR5;ENSG00000160791;clinical_c_N86;N86 Erosion and ectropion of cervix uteri;rs150497029;G;0.93589;0.014136;0.004559399999999999;0.0019327;L121R;ENST00000445772
CCR5;ENSG00000160791;clinical_c_I83;I83 Varicose veins of lower extremities;rs1800940;T;0.922702;0.0097841;0.0037185;0.008508799999999999;R60S;ENST00000292303
CCR5;ENSG00000160791;clinical_c_I83;I83 Varicose veins of lower extremities;rs1800940;T;0.922702;0.0097841;0.0037185;0.008508799999999999;R60S;ENST00000445772
CCR6;ENSG00000112486;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs145112098;A;0.477627;0.060164;0.010954;3.9671e-08;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs145112098;A;0.477627;0.060164;0.010954;3.9671e-08;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs145112098;A;0.477627;0.060164;0.010954;3.9671e-08;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs145112098;A;0.477627;0.060164;0.010954;3.9671e-08;A364T;ENST00000643861
CCR6;ENSG00000112486;cancer_c_Block_D00-D09;D00-D09 In situ neoplasms;rs111321050;A;0.936054;0.12423;0.046380000000000005;0.0073934;G345S;ENST00000341935
CCR6;ENSG00000112486;cancer_c_Block_D00-D09;D00-D09 In situ neoplasms;rs111321050;A;0.936054;0.12423;0.046380000000000005;0.0073934;G345S;ENST00000349984
CCR6;ENSG00000112486;cancer_c_Block_D00-D09;D00-D09 In situ neoplasms;rs111321050;A;0.936054;0.12423;0.046380000000000005;0.0073934;G345S;ENST00000400926
CCR6;ENSG00000112486;cancer_c_Block_D00-D09;D00-D09 In situ neoplasms;rs111321050;A;0.936054;0.12423;0.046380000000000005;0.0073934;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_L30;L30 Other dermatitis;rs149593498;T;0.755602;0.011218;0.0034159;0.001024;A150V;ENST00000341935
CCR6;ENSG00000112486;clinical_c_L30;L30 Other dermatitis;rs149593498;T;0.755602;0.011218;0.0034159;0.001024;A150V;ENST00000349984
CCR6;ENSG00000112486;clinical_c_L30;L30 Other dermatitis;rs149593498;T;0.755602;0.011218;0.0034159;0.001024;A150V;ENST00000400926
CCR6;ENSG00000112486;clinical_c_L30;L30 Other dermatitis;rs149593498;T;0.755602;0.011218;0.0034159;0.001024;A150V;ENST00000643861
CCR6;ENSG00000112486;clinical_c_L30;L30 Other dermatitis;rs149593498;T;0.755602;0.011218;0.0034159;0.001024;A150V;ENST00000646493
CCR6;ENSG00000112486;selfReported_n_1410;breast cysts;rs145112098;A;0.477627;0.054104999999999986;0.01586;0.00064625;A364T;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1410;breast cysts;rs145112098;A;0.477627;0.054104999999999986;0.01586;0.00064625;A364T;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1410;breast cysts;rs145112098;A;0.477627;0.054104999999999986;0.01586;0.00064625;A364T;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1410;breast cysts;rs145112098;A;0.477627;0.054104999999999986;0.01586;0.00064625;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_O30-O48;O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems;rs145112098;A;0.477627;0.081093;0.029844;0.006583100000000001;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_O30-O48;O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems;rs145112098;A;0.477627;0.081093;0.029844;0.006583100000000001;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_O30-O48;O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems;rs145112098;A;0.477627;0.081093;0.029844;0.006583100000000001;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_O30-O48;O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems;rs145112098;A;0.477627;0.081093;0.029844;0.006583100000000001;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_M71;M71 Other bursopathies;rs145112098;A;0.477627;0.019306999999999998;0.0063527;0.0023721999999999997;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_M71;M71 Other bursopathies;rs145112098;A;0.477627;0.019306999999999998;0.0063527;0.0023721999999999997;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_M71;M71 Other bursopathies;rs145112098;A;0.477627;0.019306999999999998;0.0063527;0.0023721999999999997;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_M71;M71 Other bursopathies;rs145112098;A;0.477627;0.019306999999999998;0.0063527;0.0023721999999999997;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_O16;O16 Unspecified maternal hypertension;rs145112098;A;0.477627;0.055649;0.0096946;9.4629e-09;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_O16;O16 Unspecified maternal hypertension;rs145112098;A;0.477627;0.055649;0.0096946;9.4629e-09;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_O16;O16 Unspecified maternal hypertension;rs145112098;A;0.477627;0.055649;0.0096946;9.4629e-09;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_O16;O16 Unspecified maternal hypertension;rs145112098;A;0.477627;0.055649;0.0096946;9.4629e-09;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_M95-M99;M95-M99 Other disorders of the musculoskeletal system and connective tissue;rs145112098;A;0.477627;0.025887999999999998;0.006647;9.8325e-05;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_M95-M99;M95-M99 Other disorders of the musculoskeletal system and connective tissue;rs145112098;A;0.477627;0.025887999999999998;0.006647;9.8325e-05;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_M95-M99;M95-M99 Other disorders of the musculoskeletal system and connective tissue;rs145112098;A;0.477627;0.025887999999999998;0.006647;9.8325e-05;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_M95-M99;M95-M99 Other disorders of the musculoskeletal system and connective tissue;rs145112098;A;0.477627;0.025887999999999998;0.006647;9.8325e-05;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs111321050;A;0.936054;0.12969;0.040971;0.001549;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs111321050;A;0.936054;0.12969;0.040971;0.001549;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs111321050;A;0.936054;0.12969;0.040971;0.001549;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_K70-K77;K70-K77 Diseases of liver;rs111321050;A;0.936054;0.12969;0.040971;0.001549;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_N00-N08;N00-N08 Glomerular diseases;rs111321050;A;0.936054;0.13746;0.026654;2.5079e-07;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_N00-N08;N00-N08 Glomerular diseases;rs111321050;A;0.936054;0.13746;0.026654;2.5079e-07;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_N00-N08;N00-N08 Glomerular diseases;rs111321050;A;0.936054;0.13746;0.026654;2.5079e-07;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_N00-N08;N00-N08 Glomerular diseases;rs111321050;A;0.936054;0.13746;0.026654;2.5079e-07;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_N03;N03 Chronic nephritic syndrome;rs111321050;A;0.936054;0.1397;0.017099;3.0859e-16;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_N03;N03 Chronic nephritic syndrome;rs111321050;A;0.936054;0.1397;0.017099;3.0859e-16;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_N03;N03 Chronic nephritic syndrome;rs111321050;A;0.936054;0.1397;0.017099;3.0859e-16;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_N03;N03 Chronic nephritic syndrome;rs111321050;A;0.936054;0.1397;0.017099;3.0859e-16;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K81;K81 Cholecystitis;rs111321050;A;0.936054;0.13402;0.030001;7.9354e-06;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K81;K81 Cholecystitis;rs111321050;A;0.936054;0.13402;0.030001;7.9354e-06;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K81;K81 Cholecystitis;rs111321050;A;0.936054;0.13402;0.030001;7.9354e-06;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K81;K81 Cholecystitis;rs111321050;A;0.936054;0.13402;0.030001;7.9354e-06;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs56304535;C;0.93806;0.015515000000000001;0.003145;8.0961e-07;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs56304535;C;0.93806;0.015515000000000001;0.003145;8.0961e-07;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs56304535;C;0.93806;0.015515000000000001;0.003145;8.0961e-07;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs56304535;C;0.93806;0.015515000000000001;0.003145;8.0961e-07;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K66;K66 Other disorders of peritoneum;rs111321050;A;0.936054;0.1319;0.032365;4.5908e-05;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K66;K66 Other disorders of peritoneum;rs111321050;A;0.936054;0.1319;0.032365;4.5908e-05;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K66;K66 Other disorders of peritoneum;rs111321050;A;0.936054;0.1319;0.032365;4.5908e-05;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K66;K66 Other disorders of peritoneum;rs111321050;A;0.936054;0.1319;0.032365;4.5908e-05;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K66;K66 Other disorders of peritoneum;rs56304535;C;0.93806;0.03445;0.0079503;1.47e-05;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K66;K66 Other disorders of peritoneum;rs56304535;C;0.93806;0.03445;0.0079503;1.47e-05;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K66;K66 Other disorders of peritoneum;rs56304535;C;0.93806;0.03445;0.0079503;1.47e-05;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K66;K66 Other disorders of peritoneum;rs56304535;C;0.93806;0.03445;0.0079503;1.47e-05;F236L;ENST00000643861
CCR6;ENSG00000112486;46-0.0;Hand grip strength (left);rs56304535;C;0.93806;-2.1458;0.61495;0.00048423;F236L;ENST00000341935
CCR6;ENSG00000112486;46-0.0;Hand grip strength (left);rs56304535;C;0.93806;-2.1458;0.61495;0.00048423;F236L;ENST00000349984
CCR6;ENSG00000112486;46-0.0;Hand grip strength (left);rs56304535;C;0.93806;-2.1458;0.61495;0.00048423;F236L;ENST00000400926
CCR6;ENSG00000112486;46-0.0;Hand grip strength (left);rs56304535;C;0.93806;-2.1458;0.61495;0.00048423;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K26;K26 Duodenal ulcer;rs56304535;C;0.93806;0.025948000000000002;0.0079484;0.0010963;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K26;K26 Duodenal ulcer;rs56304535;C;0.93806;0.025948000000000002;0.0079484;0.0010963;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K26;K26 Duodenal ulcer;rs56304535;C;0.93806;0.025948000000000002;0.0079484;0.0010963;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K26;K26 Duodenal ulcer;rs56304535;C;0.93806;0.025948000000000002;0.0079484;0.0010963;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_O34;O34 Maternal care for known or suspected abnormality of pelvic organs;rs111321050;A;0.936054;0.17629;0.035802999999999995;8.489200000000002e-07;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_O34;O34 Maternal care for known or suspected abnormality of pelvic organs;rs111321050;A;0.936054;0.17629;0.035802999999999995;8.489200000000002e-07;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_O34;O34 Maternal care for known or suspected abnormality of pelvic organs;rs111321050;A;0.936054;0.17629;0.035802999999999995;8.489200000000002e-07;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_O34;O34 Maternal care for known or suspected abnormality of pelvic organs;rs111321050;A;0.936054;0.17629;0.035802999999999995;8.489200000000002e-07;G345S;ENST00000643861
CCR6;ENSG00000112486;selfReported_n_1520;rectal or colon adenoma/polyps;rs149593498;T;0.755602;0.011562000000000001;0.0031149999999999997;0.00020577;A150V;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1520;rectal or colon adenoma/polyps;rs149593498;T;0.755602;0.011562000000000001;0.0031149999999999997;0.00020577;A150V;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1520;rectal or colon adenoma/polyps;rs149593498;T;0.755602;0.011562000000000001;0.0031149999999999997;0.00020577;A150V;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1520;rectal or colon adenoma/polyps;rs149593498;T;0.755602;0.011562000000000001;0.0031149999999999997;0.00020577;A150V;ENST00000643861
CCR6;ENSG00000112486;selfReported_n_1520;rectal or colon adenoma/polyps;rs149593498;T;0.755602;0.011562000000000001;0.0031149999999999997;0.00020577;A150V;ENST00000646493
CCR6;ENSG00000112486;selfReported_n_1489;other neurological problem;rs56304535;C;0.93806;0.032935;0.010879999999999999;0.0024689;F236L;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1489;other neurological problem;rs56304535;C;0.93806;0.032935;0.010879999999999999;0.0024689;F236L;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1489;other neurological problem;rs56304535;C;0.93806;0.032935;0.010879999999999999;0.0024689;F236L;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1489;other neurological problem;rs56304535;C;0.93806;0.032935;0.010879999999999999;0.0024689;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_H65-H75;H65-H75 Diseases of middle ear and mastoid;rs145112098;A;0.477627;0.03746;0.01258;0.002904;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_H65-H75;H65-H75 Diseases of middle ear and mastoid;rs145112098;A;0.477627;0.03746;0.01258;0.002904;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_H65-H75;H65-H75 Diseases of middle ear and mastoid;rs145112098;A;0.477627;0.03746;0.01258;0.002904;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_H65-H75;H65-H75 Diseases of middle ear and mastoid;rs145112098;A;0.477627;0.03746;0.01258;0.002904;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_H65-H75;H65-H75 Diseases of middle ear and mastoid;rs56304535;C;0.93806;0.025833;0.0080794;0.0013868;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_H65-H75;H65-H75 Diseases of middle ear and mastoid;rs56304535;C;0.93806;0.025833;0.0080794;0.0013868;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_H65-H75;H65-H75 Diseases of middle ear and mastoid;rs56304535;C;0.93806;0.025833;0.0080794;0.0013868;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_H65-H75;H65-H75 Diseases of middle ear and mastoid;rs56304535;C;0.93806;0.025833;0.0080794;0.0013868;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs111321050;A;0.936054;0.17381;0.038688;7.0361e-06;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs111321050;A;0.936054;0.17381;0.038688;7.0361e-06;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs111321050;A;0.936054;0.17381;0.038688;7.0361e-06;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs111321050;A;0.936054;0.17381;0.038688;7.0361e-06;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs145112098;A;0.477627;0.10516;0.016492;1.8136000000000003e-10;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs145112098;A;0.477627;0.10516;0.016492;1.8136000000000003e-10;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs145112098;A;0.477627;0.10516;0.016492;1.8136000000000003e-10;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs145112098;A;0.477627;0.10516;0.016492;1.8136000000000003e-10;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_M62;M62 Other disorders of muscle;rs56304535;C;0.93806;0.014855000000000002;0.004275899999999999;0.00051248;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_M62;M62 Other disorders of muscle;rs56304535;C;0.93806;0.014855000000000002;0.004275899999999999;0.00051248;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_M62;M62 Other disorders of muscle;rs56304535;C;0.93806;0.014855000000000002;0.004275899999999999;0.00051248;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_M62;M62 Other disorders of muscle;rs56304535;C;0.93806;0.014855000000000002;0.004275899999999999;0.00051248;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_N47;N47 Redundant prepuce, phimosis and paraphimosis;rs56304535;C;0.93806;0.045006;0.014321;0.0016748000000000002;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_N47;N47 Redundant prepuce, phimosis and paraphimosis;rs56304535;C;0.93806;0.045006;0.014321;0.0016748000000000002;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_N47;N47 Redundant prepuce, phimosis and paraphimosis;rs56304535;C;0.93806;0.045006;0.014321;0.0016748000000000002;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_N47;N47 Redundant prepuce, phimosis and paraphimosis;rs56304535;C;0.93806;0.045006;0.014321;0.0016748000000000002;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_J93;J93 Pneumothorax;rs149593498;T;0.755602;0.0067931;0.0025421;0.0075358000000000005;A150V;ENST00000341935
CCR6;ENSG00000112486;clinical_c_J93;J93 Pneumothorax;rs149593498;T;0.755602;0.0067931;0.0025421;0.0075358000000000005;A150V;ENST00000349984
CCR6;ENSG00000112486;clinical_c_J93;J93 Pneumothorax;rs149593498;T;0.755602;0.0067931;0.0025421;0.0075358000000000005;A150V;ENST00000400926
CCR6;ENSG00000112486;clinical_c_J93;J93 Pneumothorax;rs149593498;T;0.755602;0.0067931;0.0025421;0.0075358000000000005;A150V;ENST00000643861
CCR6;ENSG00000112486;clinical_c_J93;J93 Pneumothorax;rs149593498;T;0.755602;0.0067931;0.0025421;0.0075358000000000005;A150V;ENST00000646493
CCR6;ENSG00000112486;selfReported_n_1566;anal problem;rs17860852;T;1.0;0.0017166;0.00059512;0.0039213;A369V;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1566;anal problem;rs17860852;T;1.0;0.0017166;0.00059512;0.0039213;A369V;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1566;anal problem;rs17860852;T;1.0;0.0017166;0.00059512;0.0039213;A369V;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1566;anal problem;rs17860852;T;1.0;0.0017166;0.00059512;0.0039213;A369V;ENST00000643861
CCR6;ENSG00000112486;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs111321050;A;0.936054;0.18746;0.028146;2.7369e-11;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs111321050;A;0.936054;0.18746;0.028146;2.7369e-11;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs111321050;A;0.936054;0.18746;0.028146;2.7369e-11;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs111321050;A;0.936054;0.18746;0.028146;2.7369e-11;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs145112098;A;0.477627;0.053013;0.011999;9.9653e-06;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs145112098;A;0.477627;0.053013;0.011999;9.9653e-06;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs145112098;A;0.477627;0.053013;0.011999;9.9653e-06;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_O20;O20 Haemorrhage in early pregnancy;rs145112098;A;0.477627;0.053013;0.011999;9.9653e-06;A364T;ENST00000643861
CCR6;ENSG00000112486;cancer_c_C61;C61 Malignant neoplasm of prostate;rs111321050;A;0.936054;0.45395;0.12015;0.00015794;G345S;ENST00000341935
CCR6;ENSG00000112486;cancer_c_C61;C61 Malignant neoplasm of prostate;rs111321050;A;0.936054;0.45395;0.12015;0.00015794;G345S;ENST00000349984
CCR6;ENSG00000112486;cancer_c_C61;C61 Malignant neoplasm of prostate;rs111321050;A;0.936054;0.45395;0.12015;0.00015794;G345S;ENST00000400926
CCR6;ENSG00000112486;cancer_c_C61;C61 Malignant neoplasm of prostate;rs111321050;A;0.936054;0.45395;0.12015;0.00015794;G345S;ENST00000643861
CCR6;ENSG00000112486;cancer_c_C67;C67 Malignant neoplasm of bladder;rs56304535;C;0.93806;0.018195;0.0039643000000000005;4.4388e-06;F236L;ENST00000341935
CCR6;ENSG00000112486;cancer_c_C67;C67 Malignant neoplasm of bladder;rs56304535;C;0.93806;0.018195;0.0039643000000000005;4.4388e-06;F236L;ENST00000349984
CCR6;ENSG00000112486;cancer_c_C67;C67 Malignant neoplasm of bladder;rs56304535;C;0.93806;0.018195;0.0039643000000000005;4.4388e-06;F236L;ENST00000400926
CCR6;ENSG00000112486;cancer_c_C67;C67 Malignant neoplasm of bladder;rs56304535;C;0.93806;0.018195;0.0039643000000000005;4.4388e-06;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs111321050;A;0.936054;0.17440999999999998;0.038189;4.9483e-06;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs111321050;A;0.936054;0.17440999999999998;0.038189;4.9483e-06;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs111321050;A;0.936054;0.17440999999999998;0.038189;4.9483e-06;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs111321050;A;0.936054;0.17440999999999998;0.038189;4.9483e-06;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs145112098;A;0.477627;0.1055;0.016279;9.147e-11;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs145112098;A;0.477627;0.1055;0.016279;9.147e-11;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs145112098;A;0.477627;0.1055;0.016279;9.147e-11;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs145112098;A;0.477627;0.1055;0.016279;9.147e-11;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_D68;D68 Other coagulation defects;rs145112098;A;0.477627;0.026782;0.006779899999999999;7.8094e-05;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_D68;D68 Other coagulation defects;rs145112098;A;0.477627;0.026782;0.006779899999999999;7.8094e-05;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_D68;D68 Other coagulation defects;rs145112098;A;0.477627;0.026782;0.006779899999999999;7.8094e-05;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_D68;D68 Other coagulation defects;rs145112098;A;0.477627;0.026782;0.006779899999999999;7.8094e-05;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_O68;O68 Labour and delivery complicated by foetal stress [distress];rs111321050;A;0.936054;0.14359;0.05206;0.005812100000000001;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_O68;O68 Labour and delivery complicated by foetal stress [distress];rs111321050;A;0.936054;0.14359;0.05206;0.005812100000000001;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_O68;O68 Labour and delivery complicated by foetal stress [distress];rs111321050;A;0.936054;0.14359;0.05206;0.005812100000000001;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_O68;O68 Labour and delivery complicated by foetal stress [distress];rs111321050;A;0.936054;0.14359;0.05206;0.005812100000000001;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_A09;A09 Diarrhoea and gastro-enteritis of presumed infectious origin;rs111321050;A;0.936054;0.12742;0.041369;0.0020694000000000003;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_A09;A09 Diarrhoea and gastro-enteritis of presumed infectious origin;rs111321050;A;0.936054;0.12742;0.041369;0.0020694000000000003;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_A09;A09 Diarrhoea and gastro-enteritis of presumed infectious origin;rs111321050;A;0.936054;0.12742;0.041369;0.0020694000000000003;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_A09;A09 Diarrhoea and gastro-enteritis of presumed infectious origin;rs111321050;A;0.936054;0.12742;0.041369;0.0020694000000000003;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs145112098;A;0.477627;0.045822;0.016582;0.0057215;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs145112098;A;0.477627;0.045822;0.016582;0.0057215;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs145112098;A;0.477627;0.045822;0.016582;0.0057215;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_O26;O26 Maternal care for other conditions predominantly related to pregnancy;rs145112098;A;0.477627;0.045822;0.016582;0.0057215;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K76;K76 Other diseases of liver;rs111321050;A;0.936054;0.13201;0.033943;0.0001006;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K76;K76 Other diseases of liver;rs111321050;A;0.936054;0.13201;0.033943;0.0001006;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K76;K76 Other diseases of liver;rs111321050;A;0.936054;0.13201;0.033943;0.0001006;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K76;K76 Other diseases of liver;rs111321050;A;0.936054;0.13201;0.033943;0.0001006;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K14;K14 Diseases of tongue;rs149593498;T;0.755602;0.0085659;0.0030583000000000003;0.0050971;A150V;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K14;K14 Diseases of tongue;rs149593498;T;0.755602;0.0085659;0.0030583000000000003;0.0050971;A150V;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K14;K14 Diseases of tongue;rs149593498;T;0.755602;0.0085659;0.0030583000000000003;0.0050971;A150V;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K14;K14 Diseases of tongue;rs149593498;T;0.755602;0.0085659;0.0030583000000000003;0.0050971;A150V;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K14;K14 Diseases of tongue;rs149593498;T;0.755602;0.0085659;0.0030583000000000003;0.0050971;A150V;ENST00000646493
CCR6;ENSG00000112486;clinical_c_O47;O47 False labour;rs111321050;A;0.936054;0.18101;0.030047000000000008;1.6997e-09;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_O47;O47 False labour;rs111321050;A;0.936054;0.18101;0.030047000000000008;1.6997e-09;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_O47;O47 False labour;rs111321050;A;0.936054;0.18101;0.030047000000000008;1.6997e-09;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_O47;O47 False labour;rs111321050;A;0.936054;0.18101;0.030047000000000008;1.6997e-09;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K80;K80 Cholelithiasis;rs111321050;A;0.936054;0.24165999999999999;0.06704600000000001;0.00031285;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K80;K80 Cholelithiasis;rs111321050;A;0.936054;0.24165999999999999;0.06704600000000001;0.00031285;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K80;K80 Cholelithiasis;rs111321050;A;0.936054;0.24165999999999999;0.06704600000000001;0.00031285;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K80;K80 Cholelithiasis;rs111321050;A;0.936054;0.24165999999999999;0.06704600000000001;0.00031285;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_K80-K87;K80-K87 Disorders of gallbladder, biliary tract and pancreas;rs111321050;A;0.936054;0.23464000000000002;0.074875;0.0017262;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_K80-K87;K80-K87 Disorders of gallbladder, biliary tract and pancreas;rs111321050;A;0.936054;0.23464000000000002;0.074875;0.0017262;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_K80-K87;K80-K87 Disorders of gallbladder, biliary tract and pancreas;rs111321050;A;0.936054;0.23464000000000002;0.074875;0.0017262;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_K80-K87;K80-K87 Disorders of gallbladder, biliary tract and pancreas;rs111321050;A;0.936054;0.23464000000000002;0.074875;0.0017262;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K43;K43 Ventral hernia;rs111321050;A;0.936054;0.13310999999999998;0.033708;7.8564e-05;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K43;K43 Ventral hernia;rs111321050;A;0.936054;0.13310999999999998;0.033708;7.8564e-05;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K43;K43 Ventral hernia;rs111321050;A;0.936054;0.13310999999999998;0.033708;7.8564e-05;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K43;K43 Ventral hernia;rs111321050;A;0.936054;0.13310999999999998;0.033708;7.8564e-05;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_G00-G09;G00-G09 Inflammatory diseases of the central nervous system;rs145112098;A;0.477627;0.017747;0.0055363999999999995;0.0013481;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_G00-G09;G00-G09 Inflammatory diseases of the central nervous system;rs145112098;A;0.477627;0.017747;0.0055363999999999995;0.0013481;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_G00-G09;G00-G09 Inflammatory diseases of the central nervous system;rs145112098;A;0.477627;0.017747;0.0055363999999999995;0.0013481;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_G00-G09;G00-G09 Inflammatory diseases of the central nervous system;rs145112098;A;0.477627;0.017747;0.0055363999999999995;0.0013481;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K21;K21 Gastro-oesophageal reflux disease;rs111321050;A;0.936054;0.231;0.084632;0.006345399999999999;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K21;K21 Gastro-oesophageal reflux disease;rs111321050;A;0.936054;0.231;0.084632;0.006345399999999999;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K21;K21 Gastro-oesophageal reflux disease;rs111321050;A;0.936054;0.231;0.084632;0.006345399999999999;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K21;K21 Gastro-oesophageal reflux disease;rs111321050;A;0.936054;0.231;0.084632;0.006345399999999999;G345S;ENST00000643861
CCR6;ENSG00000112486;selfReported_n_1131;chronic obstructive airways disease/copd;rs17860852;T;1.0;-0.0017659000000000002;0.00061844;0.004298;A369V;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1131;chronic obstructive airways disease/copd;rs17860852;T;1.0;-0.0017659000000000002;0.00061844;0.004298;A369V;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1131;chronic obstructive airways disease/copd;rs17860852;T;1.0;-0.0017659000000000002;0.00061844;0.004298;A369V;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1131;chronic obstructive airways disease/copd;rs17860852;T;1.0;-0.0017659000000000002;0.00061844;0.004298;A369V;ENST00000643861
CCR6;ENSG00000112486;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs145112098;A;0.477627;0.022775999999999998;0.0055907;4.6259e-05;A364T;ENST00000341935
CCR6;ENSG00000112486;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs145112098;A;0.477627;0.022775999999999998;0.0055907;4.6259e-05;A364T;ENST00000349984
CCR6;ENSG00000112486;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs145112098;A;0.477627;0.022775999999999998;0.0055907;4.6259e-05;A364T;ENST00000400926
CCR6;ENSG00000112486;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs145112098;A;0.477627;0.022775999999999998;0.0055907;4.6259e-05;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_O20-O29;O20-O29 Other maternal disorders predominantly related to pregnancy;rs111321050;A;0.936054;0.15461;0.050003;0.0019878;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_O20-O29;O20-O29 Other maternal disorders predominantly related to pregnancy;rs111321050;A;0.936054;0.15461;0.050003;0.0019878;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_O20-O29;O20-O29 Other maternal disorders predominantly related to pregnancy;rs111321050;A;0.936054;0.15461;0.050003;0.0019878;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_O20-O29;O20-O29 Other maternal disorders predominantly related to pregnancy;rs111321050;A;0.936054;0.15461;0.050003;0.0019878;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K61;K61 Abscess of anal and rectal regions;rs17860852;T;1.0;0.0020784;0.00059967;0.00052836;A369V;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K61;K61 Abscess of anal and rectal regions;rs17860852;T;1.0;0.0020784;0.00059967;0.00052836;A369V;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K61;K61 Abscess of anal and rectal regions;rs17860852;T;1.0;0.0020784;0.00059967;0.00052836;A369V;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K61;K61 Abscess of anal and rectal regions;rs17860852;T;1.0;0.0020784;0.00059967;0.00052836;A369V;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_H49-H52;H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction;rs145112098;A;0.477627;0.039599;0.012093000000000001;0.0010585999999999998;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_H49-H52;H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction;rs145112098;A;0.477627;0.039599;0.012093000000000001;0.0010585999999999998;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_H49-H52;H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction;rs145112098;A;0.477627;0.039599;0.012093000000000001;0.0010585999999999998;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_H49-H52;H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction;rs145112098;A;0.477627;0.039599;0.012093000000000001;0.0010585999999999998;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_O02;O02 Other abnormal products of conception;rs145112098;A;0.477627;0.037332;0.014161000000000003;0.0083847;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_O02;O02 Other abnormal products of conception;rs145112098;A;0.477627;0.037332;0.014161000000000003;0.0083847;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_O02;O02 Other abnormal products of conception;rs145112098;A;0.477627;0.037332;0.014161000000000003;0.0083847;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_O02;O02 Other abnormal products of conception;rs145112098;A;0.477627;0.037332;0.014161000000000003;0.0083847;A364T;ENST00000643861
CCR6;ENSG00000112486;cancer_c_Block_C64-C68;C64-C68 Malignant neoplasms of urinary tract;rs56304535;C;0.93806;0.015897;0.005853199999999999;0.0066077;F236L;ENST00000341935
CCR6;ENSG00000112486;cancer_c_Block_C64-C68;C64-C68 Malignant neoplasms of urinary tract;rs56304535;C;0.93806;0.015897;0.005853199999999999;0.0066077;F236L;ENST00000349984
CCR6;ENSG00000112486;cancer_c_Block_C64-C68;C64-C68 Malignant neoplasms of urinary tract;rs56304535;C;0.93806;0.015897;0.005853199999999999;0.0066077;F236L;ENST00000400926
CCR6;ENSG00000112486;cancer_c_Block_C64-C68;C64-C68 Malignant neoplasms of urinary tract;rs56304535;C;0.93806;0.015897;0.005853199999999999;0.0066077;F236L;ENST00000643861
CCR6;ENSG00000112486;selfReported_n_1521;inflammatory bowel disease;rs56304535;C;0.93806;0.032909;0.008412600000000001;9.1587e-05;F236L;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1521;inflammatory bowel disease;rs56304535;C;0.93806;0.032909;0.008412600000000001;9.1587e-05;F236L;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1521;inflammatory bowel disease;rs56304535;C;0.93806;0.032909;0.008412600000000001;9.1587e-05;F236L;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1521;inflammatory bowel disease;rs56304535;C;0.93806;0.032909;0.008412600000000001;9.1587e-05;F236L;ENST00000643861
CCR6;ENSG00000112486;selfReported_n_1574;abdominal hernia;rs111321050;A;0.936054;0.13723;0.028133;1.0733e-06;G345S;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1574;abdominal hernia;rs111321050;A;0.936054;0.13723;0.028133;1.0733e-06;G345S;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1574;abdominal hernia;rs111321050;A;0.936054;0.13723;0.028133;1.0733e-06;G345S;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1574;abdominal hernia;rs111321050;A;0.936054;0.13723;0.028133;1.0733e-06;G345S;ENST00000643861
CCR6;ENSG00000112486;cancer_c_C20;C20 Malignant neoplasm of rectum;rs56304535;C;0.93806;0.022696;0.004829399999999999;2.6074000000000002e-06;F236L;ENST00000341935
CCR6;ENSG00000112486;cancer_c_C20;C20 Malignant neoplasm of rectum;rs56304535;C;0.93806;0.022696;0.004829399999999999;2.6074000000000002e-06;F236L;ENST00000349984
CCR6;ENSG00000112486;cancer_c_C20;C20 Malignant neoplasm of rectum;rs56304535;C;0.93806;0.022696;0.004829399999999999;2.6074000000000002e-06;F236L;ENST00000400926
CCR6;ENSG00000112486;cancer_c_C20;C20 Malignant neoplasm of rectum;rs56304535;C;0.93806;0.022696;0.004829399999999999;2.6074000000000002e-06;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_L05;L05 Pilonidal cyst;rs145112098;A;0.477627;0.015259;0.004920399999999999;0.0019283000000000002;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_L05;L05 Pilonidal cyst;rs145112098;A;0.477627;0.015259;0.004920399999999999;0.0019283000000000002;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_L05;L05 Pilonidal cyst;rs145112098;A;0.477627;0.015259;0.004920399999999999;0.0019283000000000002;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_L05;L05 Pilonidal cyst;rs145112098;A;0.477627;0.015259;0.004920399999999999;0.0019283000000000002;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_O10-O16;O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium;rs145112098;A;0.477627;0.048918;0.014238;0.0005909;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_O10-O16;O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium;rs145112098;A;0.477627;0.048918;0.014238;0.0005909;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_O10-O16;O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium;rs145112098;A;0.477627;0.048918;0.014238;0.0005909;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_O10-O16;O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium;rs145112098;A;0.477627;0.048918;0.014238;0.0005909;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_J34;J34 Other disorders of nose and nasal sinuses;rs111321050;A;0.936054;0.12452;0.046816;0.0078191;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_J34;J34 Other disorders of nose and nasal sinuses;rs111321050;A;0.936054;0.12452;0.046816;0.0078191;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_J34;J34 Other disorders of nose and nasal sinuses;rs111321050;A;0.936054;0.12452;0.046816;0.0078191;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_J34;J34 Other disorders of nose and nasal sinuses;rs111321050;A;0.936054;0.12452;0.046816;0.0078191;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_N36;N36 Other disorders of urethra;rs56304535;C;0.93806;0.015172999999999999;0.0039683999999999995;0.00013163;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_N36;N36 Other disorders of urethra;rs56304535;C;0.93806;0.015172999999999999;0.0039683999999999995;0.00013163;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_N36;N36 Other disorders of urethra;rs56304535;C;0.93806;0.015172999999999999;0.0039683999999999995;0.00013163;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_N36;N36 Other disorders of urethra;rs56304535;C;0.93806;0.015172999999999999;0.0039683999999999995;0.00013163;F236L;ENST00000643861
CCR6;ENSG00000112486;selfReported_n_1467;nasal/sinus disorder;rs111321050;A;0.936054;0.12671;0.044237;0.0041776;G345S;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1467;nasal/sinus disorder;rs111321050;A;0.936054;0.12671;0.044237;0.0041776;G345S;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1467;nasal/sinus disorder;rs111321050;A;0.936054;0.12671;0.044237;0.0041776;G345S;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1467;nasal/sinus disorder;rs111321050;A;0.936054;0.12671;0.044237;0.0041776;G345S;ENST00000643861
CCR6;ENSG00000112486;selfReported_n_1467;nasal/sinus disorder;rs145112098;A;0.477627;0.07066599999999999;0.016919999999999998;2.9603e-05;A364T;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1467;nasal/sinus disorder;rs145112098;A;0.477627;0.07066599999999999;0.016919999999999998;2.9603e-05;A364T;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1467;nasal/sinus disorder;rs145112098;A;0.477627;0.07066599999999999;0.016919999999999998;2.9603e-05;A364T;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1467;nasal/sinus disorder;rs145112098;A;0.477627;0.07066599999999999;0.016919999999999998;2.9603e-05;A364T;ENST00000643861
CCR6;ENSG00000112486;selfReported_n_1231;other urological problem (male);rs111321050;A;0.936054;0.4381;0.13824;0.0015289;G345S;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1231;other urological problem (male);rs111321050;A;0.936054;0.4381;0.13824;0.0015289;G345S;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1231;other urological problem (male);rs111321050;A;0.936054;0.4381;0.13824;0.0015289;G345S;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1231;other urological problem (male);rs111321050;A;0.936054;0.4381;0.13824;0.0015289;G345S;ENST00000643861
CCR6;ENSG00000112486;selfReported_n_1466;ent disorder/not cancer;rs145112098;A;0.477627;0.082396;0.026728;0.0020510999999999997;A364T;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1466;ent disorder/not cancer;rs145112098;A;0.477627;0.082396;0.026728;0.0020510999999999997;A364T;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1466;ent disorder/not cancer;rs145112098;A;0.477627;0.082396;0.026728;0.0020510999999999997;A364T;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1466;ent disorder/not cancer;rs145112098;A;0.477627;0.082396;0.026728;0.0020510999999999997;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_M10;M10 Gout;rs56304535;C;0.93806;0.023829;0.0080162;0.0029524;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_M10;M10 Gout;rs56304535;C;0.93806;0.023829;0.0080162;0.0029524;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_M10;M10 Gout;rs56304535;C;0.93806;0.023829;0.0080162;0.0029524;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_M10;M10 Gout;rs56304535;C;0.93806;0.023829;0.0080162;0.0029524;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_H72;H72 Perforation of tympanic membrane;rs145112098;A;0.477627;0.024041;0.0069777;0.00057025;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_H72;H72 Perforation of tympanic membrane;rs145112098;A;0.477627;0.024041;0.0069777;0.00057025;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_H72;H72 Perforation of tympanic membrane;rs145112098;A;0.477627;0.024041;0.0069777;0.00057025;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_H72;H72 Perforation of tympanic membrane;rs145112098;A;0.477627;0.024041;0.0069777;0.00057025;A364T;ENST00000643861
CCR6;ENSG00000112486;selfReported_n_1239;testicular problems (not cancer);rs111321050;A;0.936054;0.4914600000000001;0.038481;2.4495e-37;G345S;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1239;testicular problems (not cancer);rs111321050;A;0.936054;0.4914600000000001;0.038481;2.4495e-37;G345S;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1239;testicular problems (not cancer);rs111321050;A;0.936054;0.4914600000000001;0.038481;2.4495e-37;G345S;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1239;testicular problems (not cancer);rs111321050;A;0.936054;0.4914600000000001;0.038481;2.4495e-37;G345S;ENST00000643861
CCR6;ENSG00000112486;selfReported_n_1158;other abdominal problem;rs111321050;A;0.936054;0.13033;0.042244;0.0020340999999999996;G345S;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1158;other abdominal problem;rs111321050;A;0.936054;0.13033;0.042244;0.0020340999999999996;G345S;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1158;other abdominal problem;rs111321050;A;0.936054;0.13033;0.042244;0.0020340999999999996;G345S;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1158;other abdominal problem;rs111321050;A;0.936054;0.13033;0.042244;0.0020340999999999996;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_J09-J18;J09-J18 Influenza and pneumonia;rs149593498;T;0.755602;0.022163;0.0085691;0.0097;A150V;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_J09-J18;J09-J18 Influenza and pneumonia;rs149593498;T;0.755602;0.022163;0.0085691;0.0097;A150V;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_J09-J18;J09-J18 Influenza and pneumonia;rs149593498;T;0.755602;0.022163;0.0085691;0.0097;A150V;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_J09-J18;J09-J18 Influenza and pneumonia;rs149593498;T;0.755602;0.022163;0.0085691;0.0097;A150V;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_J09-J18;J09-J18 Influenza and pneumonia;rs149593498;T;0.755602;0.022163;0.0085691;0.0097;A150V;ENST00000646493
CCR6;ENSG00000112486;clinical_c_I80;I80 Phlebitis and thrombophlebitis;rs17860852;T;1.0;0.0030471;0.00099781;0.0022596;A369V;ENST00000341935
CCR6;ENSG00000112486;clinical_c_I80;I80 Phlebitis and thrombophlebitis;rs17860852;T;1.0;0.0030471;0.00099781;0.0022596;A369V;ENST00000349984
CCR6;ENSG00000112486;clinical_c_I80;I80 Phlebitis and thrombophlebitis;rs17860852;T;1.0;0.0030471;0.00099781;0.0022596;A369V;ENST00000400926
CCR6;ENSG00000112486;clinical_c_I80;I80 Phlebitis and thrombophlebitis;rs17860852;T;1.0;0.0030471;0.00099781;0.0022596;A369V;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_K65-K67;K65-K67 Diseases of peritoneum;rs111321050;A;0.936054;0.13009;0.035588;0.00025668;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_K65-K67;K65-K67 Diseases of peritoneum;rs111321050;A;0.936054;0.13009;0.035588;0.00025668;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_K65-K67;K65-K67 Diseases of peritoneum;rs111321050;A;0.936054;0.13009;0.035588;0.00025668;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_K65-K67;K65-K67 Diseases of peritoneum;rs111321050;A;0.936054;0.13009;0.035588;0.00025668;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_K65-K67;K65-K67 Diseases of peritoneum;rs56304535;C;0.93806;0.032809;0.008742100000000001;0.00017475;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_K65-K67;K65-K67 Diseases of peritoneum;rs56304535;C;0.93806;0.032809;0.008742100000000001;0.00017475;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_K65-K67;K65-K67 Diseases of peritoneum;rs56304535;C;0.93806;0.032809;0.008742100000000001;0.00017475;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_K65-K67;K65-K67 Diseases of peritoneum;rs56304535;C;0.93806;0.032809;0.008742100000000001;0.00017475;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_H65;H65 Nonsuppurative otitis media;rs56304535;C;0.93806;0.014384000000000001;0.0046262000000000005;0.0018762;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_H65;H65 Nonsuppurative otitis media;rs56304535;C;0.93806;0.014384000000000001;0.0046262000000000005;0.0018762;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_H65;H65 Nonsuppurative otitis media;rs56304535;C;0.93806;0.014384000000000001;0.0046262000000000005;0.0018762;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_H65;H65 Nonsuppurative otitis media;rs56304535;C;0.93806;0.014384000000000001;0.0046262000000000005;0.0018762;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_K50-K52;K50-K52 Noninfective enteritis and colitis;rs56304535;C;0.93806;0.056251999999999996;0.019214;0.0034156;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_K50-K52;K50-K52 Noninfective enteritis and colitis;rs56304535;C;0.93806;0.056251999999999996;0.019214;0.0034156;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_K50-K52;K50-K52 Noninfective enteritis and colitis;rs56304535;C;0.93806;0.056251999999999996;0.019214;0.0034156;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_K50-K52;K50-K52 Noninfective enteritis and colitis;rs56304535;C;0.93806;0.056251999999999996;0.019214;0.0034156;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_O46;O46 Antepartum haemorrhage, not elsewhere classified;rs145112098;A;0.477627;0.028723;0.010064;0.0043153;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_O46;O46 Antepartum haemorrhage, not elsewhere classified;rs145112098;A;0.477627;0.028723;0.010064;0.0043153;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_O46;O46 Antepartum haemorrhage, not elsewhere classified;rs145112098;A;0.477627;0.028723;0.010064;0.0043153;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_O46;O46 Antepartum haemorrhage, not elsewhere classified;rs145112098;A;0.477627;0.028723;0.010064;0.0043153;A364T;ENST00000643861
CCR6;ENSG00000112486;selfReported_n_1218;kidney stone/ureter stone/bladder stone;rs145112098;A;0.477627;0.032461000000000004;0.012516;0.0094964;A364T;ENST00000341935
CCR6;ENSG00000112486;selfReported_n_1218;kidney stone/ureter stone/bladder stone;rs145112098;A;0.477627;0.032461000000000004;0.012516;0.0094964;A364T;ENST00000349984
CCR6;ENSG00000112486;selfReported_n_1218;kidney stone/ureter stone/bladder stone;rs145112098;A;0.477627;0.032461000000000004;0.012516;0.0094964;A364T;ENST00000400926
CCR6;ENSG00000112486;selfReported_n_1218;kidney stone/ureter stone/bladder stone;rs145112098;A;0.477627;0.032461000000000004;0.012516;0.0094964;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_N70;N70 Salpingitis and oophoritis;rs17860852;T;1.0;0.0021189;0.00068719;0.0020462;A369V;ENST00000341935
CCR6;ENSG00000112486;clinical_c_N70;N70 Salpingitis and oophoritis;rs17860852;T;1.0;0.0021189;0.00068719;0.0020462;A369V;ENST00000349984
CCR6;ENSG00000112486;clinical_c_N70;N70 Salpingitis and oophoritis;rs17860852;T;1.0;0.0021189;0.00068719;0.0020462;A369V;ENST00000400926
CCR6;ENSG00000112486;clinical_c_N70;N70 Salpingitis and oophoritis;rs17860852;T;1.0;0.0021189;0.00068719;0.0020462;A369V;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K41;K41 Femoral hernia;rs56304535;C;0.93806;0.014752000000000001;0.0035909999999999996;3.9896e-05;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K41;K41 Femoral hernia;rs56304535;C;0.93806;0.014752000000000001;0.0035909999999999996;3.9896e-05;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K41;K41 Femoral hernia;rs56304535;C;0.93806;0.014752000000000001;0.0035909999999999996;3.9896e-05;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K41;K41 Femoral hernia;rs56304535;C;0.93806;0.014752000000000001;0.0035909999999999996;3.9896e-05;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K11;K11 Diseases of salivary glands;rs111321050;A;0.936054;0.13896;0.018521;6.2601e-14;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K11;K11 Diseases of salivary glands;rs111321050;A;0.936054;0.13896;0.018521;6.2601e-14;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K11;K11 Diseases of salivary glands;rs111321050;A;0.936054;0.13896;0.018521;6.2601e-14;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K11;K11 Diseases of salivary glands;rs111321050;A;0.936054;0.13896;0.018521;6.2601e-14;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_H04;H04 Disorders of lachrymal system;rs56304535;C;0.93806;0.019079;0.006711399999999999;0.0044723;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_H04;H04 Disorders of lachrymal system;rs56304535;C;0.93806;0.019079;0.006711399999999999;0.0044723;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_H04;H04 Disorders of lachrymal system;rs56304535;C;0.93806;0.019079;0.006711399999999999;0.0044723;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_H04;H04 Disorders of lachrymal system;rs56304535;C;0.93806;0.019079;0.006711399999999999;0.0044723;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K42;K42 Umbilical hernia;rs145112098;A;0.477627;0.04029;0.013471;0.0027833000000000003;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K42;K42 Umbilical hernia;rs145112098;A;0.477627;0.04029;0.013471;0.0027833000000000003;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K42;K42 Umbilical hernia;rs145112098;A;0.477627;0.04029;0.013471;0.0027833000000000003;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K42;K42 Umbilical hernia;rs145112098;A;0.477627;0.04029;0.013471;0.0027833000000000003;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_H52;H52 Disorders of refraction and accommodation;rs145112098;A;0.477627;0.031702;0.009465600000000001;0.00081046;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_H52;H52 Disorders of refraction and accommodation;rs145112098;A;0.477627;0.031702;0.009465600000000001;0.00081046;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_H52;H52 Disorders of refraction and accommodation;rs145112098;A;0.477627;0.031702;0.009465600000000001;0.00081046;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_H52;H52 Disorders of refraction and accommodation;rs145112098;A;0.477627;0.031702;0.009465600000000001;0.00081046;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_O00-O08;O00-O08 Pregnancy with abortive outcome;rs145112098;A;0.477627;0.060567;0.023362;0.0095285;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_O00-O08;O00-O08 Pregnancy with abortive outcome;rs145112098;A;0.477627;0.060567;0.023362;0.0095285;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_O00-O08;O00-O08 Pregnancy with abortive outcome;rs145112098;A;0.477627;0.060567;0.023362;0.0095285;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_O00-O08;O00-O08 Pregnancy with abortive outcome;rs145112098;A;0.477627;0.060567;0.023362;0.0095285;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_L92;L92 Granulomatous disorders of skin and subcutaneous tissue;rs56304535;C;0.93806;0.015683000000000002;0.0034563000000000003;5.6917999999999994e-06;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_L92;L92 Granulomatous disorders of skin and subcutaneous tissue;rs56304535;C;0.93806;0.015683000000000002;0.0034563000000000003;5.6917999999999994e-06;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_L92;L92 Granulomatous disorders of skin and subcutaneous tissue;rs56304535;C;0.93806;0.015683000000000002;0.0034563000000000003;5.6917999999999994e-06;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_L92;L92 Granulomatous disorders of skin and subcutaneous tissue;rs56304535;C;0.93806;0.015683000000000002;0.0034563000000000003;5.6917999999999994e-06;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_G62;G62 Other polyneuropathies;rs145112098;A;0.477627;0.019677;0.007602500000000001;0.0096479;A364T;ENST00000341935
CCR6;ENSG00000112486;clinical_c_G62;G62 Other polyneuropathies;rs145112098;A;0.477627;0.019677;0.007602500000000001;0.0096479;A364T;ENST00000349984
CCR6;ENSG00000112486;clinical_c_G62;G62 Other polyneuropathies;rs145112098;A;0.477627;0.019677;0.007602500000000001;0.0096479;A364T;ENST00000400926
CCR6;ENSG00000112486;clinical_c_G62;G62 Other polyneuropathies;rs145112098;A;0.477627;0.019677;0.007602500000000001;0.0096479;A364T;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K51;K51 Ulcerative colitis;rs56304535;C;0.93806;0.041294;0.008000799999999999;2.4546e-07;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K51;K51 Ulcerative colitis;rs56304535;C;0.93806;0.041294;0.008000799999999999;2.4546e-07;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K51;K51 Ulcerative colitis;rs56304535;C;0.93806;0.041294;0.008000799999999999;2.4546e-07;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K51;K51 Ulcerative colitis;rs56304535;C;0.93806;0.041294;0.008000799999999999;2.4546e-07;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_I47;I47 Paroxysmal tachycardia;rs56304535;C;0.93806;0.025509999999999998;0.0080999;0.0016359999999999999;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_I47;I47 Paroxysmal tachycardia;rs56304535;C;0.93806;0.025509999999999998;0.0080999;0.0016359999999999999;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_I47;I47 Paroxysmal tachycardia;rs56304535;C;0.93806;0.025509999999999998;0.0080999;0.0016359999999999999;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_I47;I47 Paroxysmal tachycardia;rs56304535;C;0.93806;0.025509999999999998;0.0080999;0.0016359999999999999;F236L;ENST00000643861
CCR6;ENSG00000112486;1558-0.0;Alcohol intake frequency.;rs17860852;T;1.0;-0.04832;0.014180000000000002;0.00065559;A369V;ENST00000341935
CCR6;ENSG00000112486;1558-0.0;Alcohol intake frequency.;rs17860852;T;1.0;-0.04832;0.014180000000000002;0.00065559;A369V;ENST00000349984
CCR6;ENSG00000112486;1558-0.0;Alcohol intake frequency.;rs17860852;T;1.0;-0.04832;0.014180000000000002;0.00065559;A369V;ENST00000400926
CCR6;ENSG00000112486;1558-0.0;Alcohol intake frequency.;rs17860852;T;1.0;-0.04832;0.014180000000000002;0.00065559;A369V;ENST00000643861
CCR6;ENSG00000112486;clinical_c_K56;K56 Paralytic ileus and intestinal obstruction without hernia;rs111321050;A;0.936054;0.13432;0.036381000000000004;0.00022243;G345S;ENST00000341935
CCR6;ENSG00000112486;clinical_c_K56;K56 Paralytic ileus and intestinal obstruction without hernia;rs111321050;A;0.936054;0.13432;0.036381000000000004;0.00022243;G345S;ENST00000349984
CCR6;ENSG00000112486;clinical_c_K56;K56 Paralytic ileus and intestinal obstruction without hernia;rs111321050;A;0.936054;0.13432;0.036381000000000004;0.00022243;G345S;ENST00000400926
CCR6;ENSG00000112486;clinical_c_K56;K56 Paralytic ileus and intestinal obstruction without hernia;rs111321050;A;0.936054;0.13432;0.036381000000000004;0.00022243;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_H53-H54;H53-H54 Visual disturbances and blindness;rs149593498;T;0.755602;0.013926;0.0053756;0.0095801;A150V;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_H53-H54;H53-H54 Visual disturbances and blindness;rs149593498;T;0.755602;0.013926;0.0053756;0.0095801;A150V;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_H53-H54;H53-H54 Visual disturbances and blindness;rs149593498;T;0.755602;0.013926;0.0053756;0.0095801;A150V;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_H53-H54;H53-H54 Visual disturbances and blindness;rs149593498;T;0.755602;0.013926;0.0053756;0.0095801;A150V;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_H53-H54;H53-H54 Visual disturbances and blindness;rs149593498;T;0.755602;0.013926;0.0053756;0.0095801;A150V;ENST00000646493
CCR6;ENSG00000112486;1329-0.0;Oily fish intake;rs149593498;T;0.755602;0.14461;0.048378;0.0027965999999999998;A150V;ENST00000341935
CCR6;ENSG00000112486;1329-0.0;Oily fish intake;rs149593498;T;0.755602;0.14461;0.048378;0.0027965999999999998;A150V;ENST00000349984
CCR6;ENSG00000112486;1329-0.0;Oily fish intake;rs149593498;T;0.755602;0.14461;0.048378;0.0027965999999999998;A150V;ENST00000400926
CCR6;ENSG00000112486;1329-0.0;Oily fish intake;rs149593498;T;0.755602;0.14461;0.048378;0.0027965999999999998;A150V;ENST00000643861
CCR6;ENSG00000112486;1329-0.0;Oily fish intake;rs149593498;T;0.755602;0.14461;0.048378;0.0027965999999999998;A150V;ENST00000646493
CCR6;ENSG00000112486;cancer_c_Block_C60-C63;C60-C63 Malignant neoplasms of male genital organs;rs111321050;A;0.936054;0.45635;0.12405;0.00023436;G345S;ENST00000341935
CCR6;ENSG00000112486;cancer_c_Block_C60-C63;C60-C63 Malignant neoplasms of male genital organs;rs111321050;A;0.936054;0.45635;0.12405;0.00023436;G345S;ENST00000349984
CCR6;ENSG00000112486;cancer_c_Block_C60-C63;C60-C63 Malignant neoplasms of male genital organs;rs111321050;A;0.936054;0.45635;0.12405;0.00023436;G345S;ENST00000400926
CCR6;ENSG00000112486;cancer_c_Block_C60-C63;C60-C63 Malignant neoplasms of male genital organs;rs111321050;A;0.936054;0.45635;0.12405;0.00023436;G345S;ENST00000643861
CCR6;ENSG00000112486;cancer_c_D05;D05 Carcinoma in situ of breast;rs111321050;A;0.936054;0.19277;0.038199;4.5026e-07;G345S;ENST00000341935
CCR6;ENSG00000112486;cancer_c_D05;D05 Carcinoma in situ of breast;rs111321050;A;0.936054;0.19277;0.038199;4.5026e-07;G345S;ENST00000349984
CCR6;ENSG00000112486;cancer_c_D05;D05 Carcinoma in situ of breast;rs111321050;A;0.936054;0.19277;0.038199;4.5026e-07;G345S;ENST00000400926
CCR6;ENSG00000112486;cancer_c_D05;D05 Carcinoma in situ of breast;rs111321050;A;0.936054;0.19277;0.038199;4.5026e-07;G345S;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs56304535;C;0.93806;0.014287000000000001;0.0048137;0.0029975;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs56304535;C;0.93806;0.014287000000000001;0.0048137;0.0029975;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs56304535;C;0.93806;0.014287000000000001;0.0048137;0.0029975;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_M60-M63;M60-M63 Disorders of muscles;rs56304535;C;0.93806;0.014287000000000001;0.0048137;0.0029975;F236L;ENST00000643861
CCR6;ENSG00000112486;clinical_c_Block_H55-H59;H55-H59 Other disorders of eye and adnexa;rs56304535;C;0.93806;0.014325;0.0044873000000000005;0.0014112999999999999;F236L;ENST00000341935
CCR6;ENSG00000112486;clinical_c_Block_H55-H59;H55-H59 Other disorders of eye and adnexa;rs56304535;C;0.93806;0.014325;0.0044873000000000005;0.0014112999999999999;F236L;ENST00000349984
CCR6;ENSG00000112486;clinical_c_Block_H55-H59;H55-H59 Other disorders of eye and adnexa;rs56304535;C;0.93806;0.014325;0.0044873000000000005;0.0014112999999999999;F236L;ENST00000400926
CCR6;ENSG00000112486;clinical_c_Block_H55-H59;H55-H59 Other disorders of eye and adnexa;rs56304535;C;0.93806;0.014325;0.0044873000000000005;0.0014112999999999999;F236L;ENST00000643861
CCR3;ENSG00000183625;clinical_c_G93;G93 Other disorders of brain;rs145141172;A;1.0;0.008471600000000001;0.0027657;0.0021906;V139M;ENST00000357422
CCR3;ENSG00000183625;clinical_c_G93;G93 Other disorders of brain;rs145141172;A;1.0;0.008471600000000001;0.0027657;0.0021906;V139M;ENST00000395940
CCR3;ENSG00000183625;clinical_c_G93;G93 Other disorders of brain;rs145141172;A;1.0;0.008471600000000001;0.0027657;0.0021906;V139M;ENST00000395942
CCR3;ENSG00000183625;clinical_c_G93;G93 Other disorders of brain;rs145141172;A;1.0;0.008471600000000001;0.0027657;0.0021906;V160M;ENST00000545097
CCR3;ENSG00000183625;clinical_c_M85;M85 Other disorders of bone density and structure;rs138346219;G;1.0;0.0041272;0.0015880999999999998;0.009354600000000001;I222V;ENST00000357422
CCR3;ENSG00000183625;clinical_c_M85;M85 Other disorders of bone density and structure;rs138346219;G;1.0;0.0041272;0.0015880999999999998;0.009354600000000001;I222V;ENST00000395940
CCR3;ENSG00000183625;clinical_c_M85;M85 Other disorders of bone density and structure;rs138346219;G;1.0;0.0041272;0.0015880999999999998;0.009354600000000001;I222V;ENST00000395942
CCR3;ENSG00000183625;clinical_c_M85;M85 Other disorders of bone density and structure;rs138346219;G;1.0;0.0041272;0.0015880999999999998;0.009354600000000001;I243V;ENST00000545097
CCR3;ENSG00000183625;clinical_c_M85;M85 Other disorders of bone density and structure;rs142051640;A;0.845935;0.008069499999999999;0.0028175;0.004183;R239Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_M85;M85 Other disorders of bone density and structure;rs142051640;A;0.845935;0.008069499999999999;0.0028175;0.004183;R239Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_M85;M85 Other disorders of bone density and structure;rs142051640;A;0.845935;0.008069499999999999;0.0028175;0.004183;R239Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_M85;M85 Other disorders of bone density and structure;rs142051640;A;0.845935;0.008069499999999999;0.0028175;0.004183;R260Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_A04;A04 Other bacterial intestinal infections;rs41409552;A;1.0;0.0021462;0.00063322;0.00070074;R275Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_A04;A04 Other bacterial intestinal infections;rs41409552;A;1.0;0.0021462;0.00063322;0.00070074;R275Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_A04;A04 Other bacterial intestinal infections;rs41409552;A;1.0;0.0021462;0.00063322;0.00070074;R275Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_A04;A04 Other bacterial intestinal infections;rs41409552;A;1.0;0.0021462;0.00063322;0.00070074;R296Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_L30;L30 Other dermatitis;rs142051640;A;0.845935;0.0095574;0.0033236;0.0040325000000000005;R239Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_L30;L30 Other dermatitis;rs142051640;A;0.845935;0.0095574;0.0033236;0.0040325000000000005;R239Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_L30;L30 Other dermatitis;rs142051640;A;0.845935;0.0095574;0.0033236;0.0040325000000000005;R239Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_L30;L30 Other dermatitis;rs142051640;A;0.845935;0.0095574;0.0033236;0.0040325000000000005;R260Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_I60-I69;I60-I69 Cerebrovascular diseases;rs201916744;C;0.395741;0.0303;0.011548000000000001;0.008692700000000001;L117F;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_I60-I69;I60-I69 Cerebrovascular diseases;rs201916744;C;0.395741;0.0303;0.011548000000000001;0.008692700000000001;L117F;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_I60-I69;I60-I69 Cerebrovascular diseases;rs201916744;C;0.395741;0.0303;0.011548000000000001;0.008692700000000001;L117F;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_I60-I69;I60-I69 Cerebrovascular diseases;rs201916744;C;0.395741;0.0303;0.011548000000000001;0.008692700000000001;L138F;ENST00000545097
CCR3;ENSG00000183625;clinical_c_M51;M51 Other intervertebral disk disorders;rs111826278;T;1.0;0.015113;0.004792800000000001;0.0016146;P349L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_M51;M51 Other intervertebral disk disorders;rs111826278;T;1.0;0.015113;0.004792800000000001;0.0016146;P349L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_M51;M51 Other intervertebral disk disorders;rs111826278;T;1.0;0.015113;0.004792800000000001;0.0016146;P349L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_M51;M51 Other intervertebral disk disorders;rs111826278;T;1.0;0.015113;0.004792800000000001;0.0016146;P370L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_M15-M19;M15-M19 Arthrosis;rs41409552;A;1.0;0.008274;0.0023577;0.0004493;R275Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_M15-M19;M15-M19 Arthrosis;rs41409552;A;1.0;0.008274;0.0023577;0.0004493;R275Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_M15-M19;M15-M19 Arthrosis;rs41409552;A;1.0;0.008274;0.0023577;0.0004493;R275Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_M15-M19;M15-M19 Arthrosis;rs41409552;A;1.0;0.008274;0.0023577;0.0004493;R296Q;ENST00000545097
CCR3;ENSG00000183625;3079-0.0;Pace-maker;rs147670448;C;0.9169010000000001;0.029320999999999996;0.009856;0.0029306;L351P;ENST00000357422
CCR3;ENSG00000183625;3079-0.0;Pace-maker;rs147670448;C;0.9169010000000001;0.029320999999999996;0.009856;0.0029306;L351P;ENST00000395940
CCR3;ENSG00000183625;3079-0.0;Pace-maker;rs147670448;C;0.9169010000000001;0.029320999999999996;0.009856;0.0029306;L351P;ENST00000395942
CCR3;ENSG00000183625;3079-0.0;Pace-maker;rs147670448;C;0.9169010000000001;0.029320999999999996;0.009856;0.0029306;L372P;ENST00000545097
CCR3;ENSG00000183625;30160-0.0;Basophill count;rs41409552;A;1.0;-0.0010487;0.00029978;0.00046834;R275Q;ENST00000357422
CCR3;ENSG00000183625;30160-0.0;Basophill count;rs41409552;A;1.0;-0.0010487;0.00029978;0.00046834;R275Q;ENST00000395940
CCR3;ENSG00000183625;30160-0.0;Basophill count;rs41409552;A;1.0;-0.0010487;0.00029978;0.00046834;R275Q;ENST00000395942
CCR3;ENSG00000183625;30160-0.0;Basophill count;rs41409552;A;1.0;-0.0010487;0.00029978;0.00046834;R296Q;ENST00000545097
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs138346219;G;1.0;0.32855;0.046183999999999996;1.1299e-12;I222V;ENST00000357422
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs138346219;G;1.0;0.32855;0.046183999999999996;1.1299e-12;I222V;ENST00000395940
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs138346219;G;1.0;0.32855;0.046183999999999996;1.1299e-12;I222V;ENST00000395942
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs138346219;G;1.0;0.32855;0.046183999999999996;1.1299e-12;I243V;ENST00000545097
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs145141172;A;1.0;0.25304;0.066884;0.00015479;V139M;ENST00000357422
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs145141172;A;1.0;0.25304;0.066884;0.00015479;V139M;ENST00000395940
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs145141172;A;1.0;0.25304;0.066884;0.00015479;V139M;ENST00000395942
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs145141172;A;1.0;0.25304;0.066884;0.00015479;V160M;ENST00000545097
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs5742906;T;1.0;0.14326;0.03053;2.7005000000000002e-06;P39L;ENST00000357422
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs5742906;T;1.0;0.14326;0.03053;2.7005000000000002e-06;P39L;ENST00000395940
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs5742906;T;1.0;0.14326;0.03053;2.7005000000000002e-06;P39L;ENST00000395942
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs5742906;T;1.0;0.14326;0.03053;2.7005000000000002e-06;P39L;ENST00000452454
CCR3;ENSG00000183625;30210-0.0;Eosinophill percentage;rs5742906;T;1.0;0.14326;0.03053;2.7005000000000002e-06;P60L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_E15-E16;E15-E16 Other disorders of glucose regulation and pancreatic internal secretion;rs147670448;C;0.9169010000000001;0.026282;0.0085128;0.0020199000000000003;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_E15-E16;E15-E16 Other disorders of glucose regulation and pancreatic internal secretion;rs147670448;C;0.9169010000000001;0.026282;0.0085128;0.0020199000000000003;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_E15-E16;E15-E16 Other disorders of glucose regulation and pancreatic internal secretion;rs147670448;C;0.9169010000000001;0.026282;0.0085128;0.0020199000000000003;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_E15-E16;E15-E16 Other disorders of glucose regulation and pancreatic internal secretion;rs147670448;C;0.9169010000000001;0.026282;0.0085128;0.0020199000000000003;L372P;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1163;gastric/stomach ulcers;rs61738836;C;0.848311;0.032443;0.0092881;0.00047772;V147A;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1163;gastric/stomach ulcers;rs61738836;C;0.848311;0.032443;0.0092881;0.00047772;V147A;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1163;gastric/stomach ulcers;rs61738836;C;0.848311;0.032443;0.0092881;0.00047772;V147A;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1163;gastric/stomach ulcers;rs61738836;C;0.848311;0.032443;0.0092881;0.00047772;V168A;ENST00000545097
CCR3;ENSG00000183625;30240-0.0;Reticulocyte percentage;rs147670448;C;0.9169010000000001;0.22371;0.082833;0.0069193;L351P;ENST00000357422
CCR3;ENSG00000183625;30240-0.0;Reticulocyte percentage;rs147670448;C;0.9169010000000001;0.22371;0.082833;0.0069193;L351P;ENST00000395940
CCR3;ENSG00000183625;30240-0.0;Reticulocyte percentage;rs147670448;C;0.9169010000000001;0.22371;0.082833;0.0069193;L351P;ENST00000395942
CCR3;ENSG00000183625;30240-0.0;Reticulocyte percentage;rs147670448;C;0.9169010000000001;0.22371;0.082833;0.0069193;L372P;ENST00000545097
CCR3;ENSG00000183625;50-0.0;Standing height;rs201916744;C;0.395741;-0.86745;0.33405999999999997;0.0094125;L117F;ENST00000357422
CCR3;ENSG00000183625;50-0.0;Standing height;rs201916744;C;0.395741;-0.86745;0.33405999999999997;0.0094125;L117F;ENST00000395940
CCR3;ENSG00000183625;50-0.0;Standing height;rs201916744;C;0.395741;-0.86745;0.33405999999999997;0.0094125;L117F;ENST00000395942
CCR3;ENSG00000183625;50-0.0;Standing height;rs201916744;C;0.395741;-0.86745;0.33405999999999997;0.0094125;L138F;ENST00000545097
CCR3;ENSG00000183625;50-0.0;Standing height;rs574114165;G;0.6003029999999999;0.73664;0.27815;0.008088600000000001;I5V;ENST00000545097
CCR3;ENSG00000183625;clinical_c_N75;N75 Diseases of Bartholin's gland;rs4987124;A;0.955318;0.016031;0.0055756;0.0040388;R19K;ENST00000545097
CCR3;ENSG00000183625;clinical_c_N89;N89 Other noninflammatory disorders of vagina;rs111826278;T;1.0;0.018538;0.004174000000000001;8.9426e-06;P349L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_N89;N89 Other noninflammatory disorders of vagina;rs111826278;T;1.0;0.018538;0.004174000000000001;8.9426e-06;P349L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_N89;N89 Other noninflammatory disorders of vagina;rs111826278;T;1.0;0.018538;0.004174000000000001;8.9426e-06;P349L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_N89;N89 Other noninflammatory disorders of vagina;rs111826278;T;1.0;0.018538;0.004174000000000001;8.9426e-06;P370L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_E16;E16 Other disorders of pancreatic internal secretion;rs147670448;C;0.9169010000000001;0.026294;0.008499799999999998;0.0019784000000000004;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_E16;E16 Other disorders of pancreatic internal secretion;rs147670448;C;0.9169010000000001;0.026294;0.008499799999999998;0.0019784000000000004;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_E16;E16 Other disorders of pancreatic internal secretion;rs147670448;C;0.9169010000000001;0.026294;0.008499799999999998;0.0019784000000000004;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_E16;E16 Other disorders of pancreatic internal secretion;rs147670448;C;0.9169010000000001;0.026294;0.008499799999999998;0.0019784000000000004;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_G95;G95 Other diseases of spinal cord;rs201774652;T;0.47502700000000003;0.011396;0.0039092;0.0035561;T148I;ENST00000357422
CCR3;ENSG00000183625;clinical_c_G95;G95 Other diseases of spinal cord;rs201774652;T;0.47502700000000003;0.011396;0.0039092;0.0035561;T148I;ENST00000395940
CCR3;ENSG00000183625;clinical_c_G95;G95 Other diseases of spinal cord;rs201774652;T;0.47502700000000003;0.011396;0.0039092;0.0035561;T148I;ENST00000395942
CCR3;ENSG00000183625;clinical_c_G95;G95 Other diseases of spinal cord;rs201774652;T;0.47502700000000003;0.011396;0.0039092;0.0035561;T169I;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1223;urinary frequency / incontinence;rs61738836;C;0.848311;0.020645;0.0064793;0.0014412000000000001;V147A;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1223;urinary frequency / incontinence;rs61738836;C;0.848311;0.020645;0.0064793;0.0014412000000000001;V147A;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1223;urinary frequency / incontinence;rs61738836;C;0.848311;0.020645;0.0064793;0.0014412000000000001;V147A;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1223;urinary frequency / incontinence;rs61738836;C;0.848311;0.020645;0.0064793;0.0014412000000000001;V168A;ENST00000545097
CCR3;ENSG00000183625;clinical_c_K58;K58 Irritable bowel syndrome;rs5742906;T;1.0;0.006093899999999999;0.002345;0.009357899999999999;P39L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_K58;K58 Irritable bowel syndrome;rs5742906;T;1.0;0.006093899999999999;0.002345;0.009357899999999999;P39L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_K58;K58 Irritable bowel syndrome;rs5742906;T;1.0;0.006093899999999999;0.002345;0.009357899999999999;P39L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_K58;K58 Irritable bowel syndrome;rs5742906;T;1.0;0.006093899999999999;0.002345;0.009357899999999999;P39L;ENST00000452454
CCR3;ENSG00000183625;clinical_c_K58;K58 Irritable bowel syndrome;rs5742906;T;1.0;0.006093899999999999;0.002345;0.009357899999999999;P60L;ENST00000545097
CCR3;ENSG00000183625;1369-0.0;Beef intake;rs5742906;T;1.0;0.042178;0.016077;0.0087045;P39L;ENST00000357422
CCR3;ENSG00000183625;1369-0.0;Beef intake;rs5742906;T;1.0;0.042178;0.016077;0.0087045;P39L;ENST00000395940
CCR3;ENSG00000183625;1369-0.0;Beef intake;rs5742906;T;1.0;0.042178;0.016077;0.0087045;P39L;ENST00000395942
CCR3;ENSG00000183625;1369-0.0;Beef intake;rs5742906;T;1.0;0.042178;0.016077;0.0087045;P39L;ENST00000452454
CCR3;ENSG00000183625;1369-0.0;Beef intake;rs5742906;T;1.0;0.042178;0.016077;0.0087045;P60L;ENST00000545097
CCR3;ENSG00000183625;30220-0.0;Basophill percentage;rs41409552;A;1.0;-0.012434;0.0033365;0.00019413;R275Q;ENST00000357422
CCR3;ENSG00000183625;30220-0.0;Basophill percentage;rs41409552;A;1.0;-0.012434;0.0033365;0.00019413;R275Q;ENST00000395940
CCR3;ENSG00000183625;30220-0.0;Basophill percentage;rs41409552;A;1.0;-0.012434;0.0033365;0.00019413;R275Q;ENST00000395942
CCR3;ENSG00000183625;30220-0.0;Basophill percentage;rs41409552;A;1.0;-0.012434;0.0033365;0.00019413;R296Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs145141172;A;1.0;0.004872100000000001;0.0015331;0.0014832;V139M;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs145141172;A;1.0;0.004872100000000001;0.0015331;0.0014832;V139M;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs145141172;A;1.0;0.004872100000000001;0.0015331;0.0014832;V139M;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_M00-M03;M00-M03 Infectious arthropathies;rs145141172;A;1.0;0.004872100000000001;0.0015331;0.0014832;V160M;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1504;anaemia;rs147670448;C;0.9169010000000001;0.05177999999999999;0.018035;0.0040906;L351P;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1504;anaemia;rs147670448;C;0.9169010000000001;0.05177999999999999;0.018035;0.0040906;L351P;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1504;anaemia;rs147670448;C;0.9169010000000001;0.05177999999999999;0.018035;0.0040906;L351P;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1504;anaemia;rs147670448;C;0.9169010000000001;0.05177999999999999;0.018035;0.0040906;L372P;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1275;cranial nerve problem/palsy;rs4987124;A;0.955318;0.009077;0.0033181999999999994;0.0062282;R19K;ENST00000545097
CCR3;ENSG00000183625;clinical_c_N64;N64 Other disorders of breast;rs61738836;C;0.848311;0.046313;0.010286;6.7196e-06;V147A;ENST00000357422
CCR3;ENSG00000183625;clinical_c_N64;N64 Other disorders of breast;rs61738836;C;0.848311;0.046313;0.010286;6.7196e-06;V147A;ENST00000395940
CCR3;ENSG00000183625;clinical_c_N64;N64 Other disorders of breast;rs61738836;C;0.848311;0.046313;0.010286;6.7196e-06;V147A;ENST00000395942
CCR3;ENSG00000183625;clinical_c_N64;N64 Other disorders of breast;rs61738836;C;0.848311;0.046313;0.010286;6.7196e-06;V168A;ENST00000545097
CCR3;ENSG00000183625;30290-0.0;High light scatter reticulocyte percentage;rs147670448;C;0.9169010000000001;0.08212;0.03057;0.007225199999999999;L351P;ENST00000357422
CCR3;ENSG00000183625;30290-0.0;High light scatter reticulocyte percentage;rs147670448;C;0.9169010000000001;0.08212;0.03057;0.007225199999999999;L351P;ENST00000395940
CCR3;ENSG00000183625;30290-0.0;High light scatter reticulocyte percentage;rs147670448;C;0.9169010000000001;0.08212;0.03057;0.007225199999999999;L351P;ENST00000395942
CCR3;ENSG00000183625;30290-0.0;High light scatter reticulocyte percentage;rs147670448;C;0.9169010000000001;0.08212;0.03057;0.007225199999999999;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_N47;N47 Redundant prepuce, phimosis and paraphimosis;rs201774652;T;0.47502700000000003;0.043619;0.016608;0.0086325;T148I;ENST00000357422
CCR3;ENSG00000183625;clinical_c_N47;N47 Redundant prepuce, phimosis and paraphimosis;rs201774652;T;0.47502700000000003;0.043619;0.016608;0.0086325;T148I;ENST00000395940
CCR3;ENSG00000183625;clinical_c_N47;N47 Redundant prepuce, phimosis and paraphimosis;rs201774652;T;0.47502700000000003;0.043619;0.016608;0.0086325;T148I;ENST00000395942
CCR3;ENSG00000183625;clinical_c_N47;N47 Redundant prepuce, phimosis and paraphimosis;rs201774652;T;0.47502700000000003;0.043619;0.016608;0.0086325;T169I;ENST00000545097
CCR3;ENSG00000183625;clinical_c_E78;E78 Disorders of lipoprotein metabolism and other lipidaemias;rs201774652;T;0.47502700000000003;0.073228;0.028048000000000003;0.0090326;T148I;ENST00000357422
CCR3;ENSG00000183625;clinical_c_E78;E78 Disorders of lipoprotein metabolism and other lipidaemias;rs201774652;T;0.47502700000000003;0.073228;0.028048000000000003;0.0090326;T148I;ENST00000395940
CCR3;ENSG00000183625;clinical_c_E78;E78 Disorders of lipoprotein metabolism and other lipidaemias;rs201774652;T;0.47502700000000003;0.073228;0.028048000000000003;0.0090326;T148I;ENST00000395942
CCR3;ENSG00000183625;clinical_c_E78;E78 Disorders of lipoprotein metabolism and other lipidaemias;rs201774652;T;0.47502700000000003;0.073228;0.028048000000000003;0.0090326;T169I;ENST00000545097
CCR3;ENSG00000183625;clinical_c_J93;J93 Pneumothorax;rs201916744;C;0.395741;0.013619;0.003776;0.00031022;L117F;ENST00000357422
CCR3;ENSG00000183625;clinical_c_J93;J93 Pneumothorax;rs201916744;C;0.395741;0.013619;0.003776;0.00031022;L117F;ENST00000395940
CCR3;ENSG00000183625;clinical_c_J93;J93 Pneumothorax;rs201916744;C;0.395741;0.013619;0.003776;0.00031022;L117F;ENST00000395942
CCR3;ENSG00000183625;clinical_c_J93;J93 Pneumothorax;rs201916744;C;0.395741;0.013619;0.003776;0.00031022;L138F;ENST00000545097
CCR3;ENSG00000183625;clinical_c_N95;N95 Menopausal and other perimenopausal disorders;rs142051640;A;0.845935;0.047373;0.015291;0.0019483;R239Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_N95;N95 Menopausal and other perimenopausal disorders;rs142051640;A;0.845935;0.047373;0.015291;0.0019483;R239Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_N95;N95 Menopausal and other perimenopausal disorders;rs142051640;A;0.845935;0.047373;0.015291;0.0019483;R239Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_N95;N95 Menopausal and other perimenopausal disorders;rs142051640;A;0.845935;0.047373;0.015291;0.0019483;R260Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_J92;J92 Pleural plaque;rs147670448;C;0.9169010000000001;0.030525;0.0076985;7.3401e-05;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_J92;J92 Pleural plaque;rs147670448;C;0.9169010000000001;0.030525;0.0076985;7.3401e-05;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_J92;J92 Pleural plaque;rs147670448;C;0.9169010000000001;0.030525;0.0076985;7.3401e-05;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_J92;J92 Pleural plaque;rs147670448;C;0.9169010000000001;0.030525;0.0076985;7.3401e-05;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_J92;J92 Pleural plaque;rs4987124;A;0.955318;0.0096034;0.0031996;0.002687;R19K;ENST00000545097
CCR3;ENSG00000183625;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs201774652;T;0.47502700000000003;0.017664;0.005370300000000001;0.0010046;T148I;ENST00000357422
CCR3;ENSG00000183625;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs201774652;T;0.47502700000000003;0.017664;0.005370300000000001;0.0010046;T148I;ENST00000395940
CCR3;ENSG00000183625;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs201774652;T;0.47502700000000003;0.017664;0.005370300000000001;0.0010046;T148I;ENST00000395942
CCR3;ENSG00000183625;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs201774652;T;0.47502700000000003;0.017664;0.005370300000000001;0.0010046;T169I;ENST00000545097
CCR3;ENSG00000183625;clinical_c_I69;I69 Sequelae of cerebrovascular disease;rs142051640;A;0.845935;0.008648399999999999;0.0030195;0.004181300000000001;R239Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_I69;I69 Sequelae of cerebrovascular disease;rs142051640;A;0.845935;0.008648399999999999;0.0030195;0.004181300000000001;R239Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_I69;I69 Sequelae of cerebrovascular disease;rs142051640;A;0.845935;0.008648399999999999;0.0030195;0.004181300000000001;R239Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_I69;I69 Sequelae of cerebrovascular disease;rs142051640;A;0.845935;0.008648399999999999;0.0030195;0.004181300000000001;R260Q;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1621;obstetric problem;rs41409552;A;1.0;0.0027031;0.00077005;0.00044774;R275Q;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1621;obstetric problem;rs41409552;A;1.0;0.0027031;0.00077005;0.00044774;R275Q;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1621;obstetric problem;rs41409552;A;1.0;0.0027031;0.00077005;0.00044774;R275Q;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1621;obstetric problem;rs41409552;A;1.0;0.0027031;0.00077005;0.00044774;R296Q;ENST00000545097
CCR3;ENSG00000183625;1777-0.0;Part of a multiple birth;rs147670448;C;0.9169010000000001;0.071633;0.026635000000000002;0.0071573999999999995;L351P;ENST00000357422
CCR3;ENSG00000183625;1777-0.0;Part of a multiple birth;rs147670448;C;0.9169010000000001;0.071633;0.026635000000000002;0.0071573999999999995;L351P;ENST00000395940
CCR3;ENSG00000183625;1777-0.0;Part of a multiple birth;rs147670448;C;0.9169010000000001;0.071633;0.026635000000000002;0.0071573999999999995;L351P;ENST00000395942
CCR3;ENSG00000183625;1777-0.0;Part of a multiple birth;rs147670448;C;0.9169010000000001;0.071633;0.026635000000000002;0.0071573999999999995;L372P;ENST00000545097
CCR3;ENSG00000183625;1777-0.0;Part of a multiple birth;rs4987124;A;0.955318;0.030718000000000002;0.01107;0.0055198999999999995;R19K;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_B00-B09;B00-B09 Viral infections characterized by skin and mucous membrane lesions;rs61738836;C;0.848311;0.020163999999999998;0.0068465;0.0032289000000000003;V147A;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_B00-B09;B00-B09 Viral infections characterized by skin and mucous membrane lesions;rs61738836;C;0.848311;0.020163999999999998;0.0068465;0.0032289000000000003;V147A;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_B00-B09;B00-B09 Viral infections characterized by skin and mucous membrane lesions;rs61738836;C;0.848311;0.020163999999999998;0.0068465;0.0032289000000000003;V147A;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_B00-B09;B00-B09 Viral infections characterized by skin and mucous membrane lesions;rs61738836;C;0.848311;0.020163999999999998;0.0068465;0.0032289000000000003;V168A;ENST00000545097
CCR3;ENSG00000183625;30280-0.0;Immature reticulocyte fraction;rs142051640;A;0.845935;-0.0080753;0.002809;0.0040428;R239Q;ENST00000357422
CCR3;ENSG00000183625;30280-0.0;Immature reticulocyte fraction;rs142051640;A;0.845935;-0.0080753;0.002809;0.0040428;R239Q;ENST00000395940
CCR3;ENSG00000183625;30280-0.0;Immature reticulocyte fraction;rs142051640;A;0.845935;-0.0080753;0.002809;0.0040428;R239Q;ENST00000395942
CCR3;ENSG00000183625;30280-0.0;Immature reticulocyte fraction;rs142051640;A;0.845935;-0.0080753;0.002809;0.0040428;R260Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_K40-K46;K40-K46 Hernia;rs5742906;T;1.0;0.017961;0.0062601;0.0041169;P39L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_K40-K46;K40-K46 Hernia;rs5742906;T;1.0;0.017961;0.0062601;0.0041169;P39L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_K40-K46;K40-K46 Hernia;rs5742906;T;1.0;0.017961;0.0062601;0.0041169;P39L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_K40-K46;K40-K46 Hernia;rs5742906;T;1.0;0.017961;0.0062601;0.0041169;P39L;ENST00000452454
CCR3;ENSG00000183625;clinical_c_Block_K40-K46;K40-K46 Hernia;rs5742906;T;1.0;0.017961;0.0062601;0.0041169;P60L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_O68;O68 Labour and delivery complicated by foetal stress [distress];rs147670448;C;0.9169010000000001;0.098137;0.02928;0.00080339;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_O68;O68 Labour and delivery complicated by foetal stress [distress];rs147670448;C;0.9169010000000001;0.098137;0.02928;0.00080339;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_O68;O68 Labour and delivery complicated by foetal stress [distress];rs147670448;C;0.9169010000000001;0.098137;0.02928;0.00080339;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_O68;O68 Labour and delivery complicated by foetal stress [distress];rs147670448;C;0.9169010000000001;0.098137;0.02928;0.00080339;L372P;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1303;glaucoma;rs147670448;C;0.9169010000000001;0.052305;0.017899;0.0034762;L351P;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1303;glaucoma;rs147670448;C;0.9169010000000001;0.052305;0.017899;0.0034762;L351P;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1303;glaucoma;rs147670448;C;0.9169010000000001;0.052305;0.017899;0.0034762;L351P;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1303;glaucoma;rs147670448;C;0.9169010000000001;0.052305;0.017899;0.0034762;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs201774652;T;0.47502700000000003;0.082772;0.030201;0.0061313999999999995;T148I;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs201774652;T;0.47502700000000003;0.082772;0.030201;0.0061313999999999995;T148I;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs201774652;T;0.47502700000000003;0.082772;0.030201;0.0061313999999999995;T148I;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs201774652;T;0.47502700000000003;0.082772;0.030201;0.0061313999999999995;T169I;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs5742906;T;1.0;-0.015472999999999999;0.0058642;0.008326700000000001;P39L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs5742906;T;1.0;-0.015472999999999999;0.0058642;0.008326700000000001;P39L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs5742906;T;1.0;-0.015472999999999999;0.0058642;0.008326700000000001;P39L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs5742906;T;1.0;-0.015472999999999999;0.0058642;0.008326700000000001;P39L;ENST00000452454
CCR3;ENSG00000183625;clinical_c_Block_I80-I89;I80-I89 Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified;rs5742906;T;1.0;-0.015472999999999999;0.0058642;0.008326700000000001;P60L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_G31;G31 Other degenerative diseases of nervous system, not elsewhere classified;rs41409552;A;1.0;0.00085907;0.00030648;0.0050631999999999995;R275Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_G31;G31 Other degenerative diseases of nervous system, not elsewhere classified;rs41409552;A;1.0;0.00085907;0.00030648;0.0050631999999999995;R275Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_G31;G31 Other degenerative diseases of nervous system, not elsewhere classified;rs41409552;A;1.0;0.00085907;0.00030648;0.0050631999999999995;R275Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_G31;G31 Other degenerative diseases of nervous system, not elsewhere classified;rs41409552;A;1.0;0.00085907;0.00030648;0.0050631999999999995;R296Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_G25;G25 Other extrapyramidal and movement disorders;rs201916744;C;0.395741;0.010690999999999999;0.0032262000000000002;0.00092036;L117F;ENST00000357422
CCR3;ENSG00000183625;clinical_c_G25;G25 Other extrapyramidal and movement disorders;rs201916744;C;0.395741;0.010690999999999999;0.0032262000000000002;0.00092036;L117F;ENST00000395940
CCR3;ENSG00000183625;clinical_c_G25;G25 Other extrapyramidal and movement disorders;rs201916744;C;0.395741;0.010690999999999999;0.0032262000000000002;0.00092036;L117F;ENST00000395942
CCR3;ENSG00000183625;clinical_c_G25;G25 Other extrapyramidal and movement disorders;rs201916744;C;0.395741;0.010690999999999999;0.0032262000000000002;0.00092036;L138F;ENST00000545097
CCR3;ENSG00000183625;clinical_c_G25;G25 Other extrapyramidal and movement disorders;rs574114165;G;0.6003029999999999;0.0096549;0.0026861999999999997;0.00032539;I5V;ENST00000545097
CCR3;ENSG00000183625;clinical_c_O42;O42 Premature rupture of membranes;rs574114165;G;0.6003029999999999;0.018092;0.0065566;0.0057912;I5V;ENST00000545097
CCR3;ENSG00000183625;clinical_c_A49;A49 Bacterial infection of unspecified site;rs147670448;C;0.9169010000000001;0.03069;0.0076715;6.322399999999999e-05;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_A49;A49 Bacterial infection of unspecified site;rs147670448;C;0.9169010000000001;0.03069;0.0076715;6.322399999999999e-05;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_A49;A49 Bacterial infection of unspecified site;rs147670448;C;0.9169010000000001;0.03069;0.0076715;6.322399999999999e-05;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_A49;A49 Bacterial infection of unspecified site;rs147670448;C;0.9169010000000001;0.03069;0.0076715;6.322399999999999e-05;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_A49;A49 Bacterial infection of unspecified site;rs4987124;A;0.955318;0.009438;0.0031883000000000002;0.0030749;R19K;ENST00000545097
CCR3;ENSG00000183625;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs142051640;A;0.845935;0.0083778;0.0024848;0.00074725;R239Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs142051640;A;0.845935;0.0083778;0.0024848;0.00074725;R239Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs142051640;A;0.845935;0.0083778;0.0024848;0.00074725;R239Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs142051640;A;0.845935;0.0083778;0.0024848;0.00074725;R260Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs201916744;C;0.395741;0.010195000000000001;0.0037878;0.0071134;L117F;ENST00000357422
CCR3;ENSG00000183625;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs201916744;C;0.395741;0.010195000000000001;0.0037878;0.0071134;L117F;ENST00000395940
CCR3;ENSG00000183625;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs201916744;C;0.395741;0.010195000000000001;0.0037878;0.0071134;L117F;ENST00000395942
CCR3;ENSG00000183625;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs201916744;C;0.395741;0.010195000000000001;0.0037878;0.0071134;L138F;ENST00000545097
CCR3;ENSG00000183625;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs574114165;G;0.6003029999999999;0.0094729;0.0031539000000000003;0.0026683;I5V;ENST00000545097
CCR3;ENSG00000183625;30300-0.0;High light scatter reticulocyte count;rs142051640;A;0.845935;-0.0010890999999999997;0.00041769999999999996;0.0091265;R239Q;ENST00000357422
CCR3;ENSG00000183625;30300-0.0;High light scatter reticulocyte count;rs142051640;A;0.845935;-0.0010890999999999997;0.00041769999999999996;0.0091265;R239Q;ENST00000395940
CCR3;ENSG00000183625;30300-0.0;High light scatter reticulocyte count;rs142051640;A;0.845935;-0.0010890999999999997;0.00041769999999999996;0.0091265;R239Q;ENST00000395942
CCR3;ENSG00000183625;30300-0.0;High light scatter reticulocyte count;rs142051640;A;0.845935;-0.0010890999999999997;0.00041769999999999996;0.0091265;R260Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs138346219;G;1.0;0.017646000000000002;0.0052387;0.00075619;I222V;ENST00000357422
CCR3;ENSG00000183625;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs138346219;G;1.0;0.017646000000000002;0.0052387;0.00075619;I222V;ENST00000395940
CCR3;ENSG00000183625;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs138346219;G;1.0;0.017646000000000002;0.0052387;0.00075619;I222V;ENST00000395942
CCR3;ENSG00000183625;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs138346219;G;1.0;0.017646000000000002;0.0052387;0.00075619;I243V;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1081;hypertension;rs145141172;A;1.0;0.052128;0.017178;0.0024091;V139M;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1081;hypertension;rs145141172;A;1.0;0.052128;0.017178;0.0024091;V139M;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1081;hypertension;rs145141172;A;1.0;0.052128;0.017178;0.0024091;V139M;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1081;hypertension;rs145141172;A;1.0;0.052128;0.017178;0.0024091;V160M;ENST00000545097
CCR3;ENSG00000183625;clinical_c_I08;I08 Multiple valve diseases;rs4987124;A;0.955318;0.012725;0.0047273;0.0071068;R19K;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_F20-F29;F20-F29 Schizophrenia, schizotypal and delusional disorders;rs201774652;T;0.47502700000000003;0.014428999999999999;0.00512;0.0048295000000000005;T148I;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_F20-F29;F20-F29 Schizophrenia, schizotypal and delusional disorders;rs201774652;T;0.47502700000000003;0.014428999999999999;0.00512;0.0048295000000000005;T148I;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_F20-F29;F20-F29 Schizophrenia, schizotypal and delusional disorders;rs201774652;T;0.47502700000000003;0.014428999999999999;0.00512;0.0048295000000000005;T148I;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_F20-F29;F20-F29 Schizophrenia, schizotypal and delusional disorders;rs201774652;T;0.47502700000000003;0.014428999999999999;0.00512;0.0048295000000000005;T169I;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_M20-M25;M20-M25 Other joint disorders;rs111826278;T;1.0;-0.031085;0.010472;0.0029939;P349L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_M20-M25;M20-M25 Other joint disorders;rs111826278;T;1.0;-0.031085;0.010472;0.0029939;P349L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_M20-M25;M20-M25 Other joint disorders;rs111826278;T;1.0;-0.031085;0.010472;0.0029939;P349L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_M20-M25;M20-M25 Other joint disorders;rs111826278;T;1.0;-0.031085;0.010472;0.0029939;P370L;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1540;psoriatic arthropathy;rs4987124;A;0.955318;0.0092219;0.0032908;0.0050736999999999996;R19K;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1290;epilepsy;rs145141172;A;1.0;0.012089;0.0040658000000000005;0.0029465999999999997;V139M;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1290;epilepsy;rs145141172;A;1.0;0.012089;0.0040658000000000005;0.0029465999999999997;V139M;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1290;epilepsy;rs145141172;A;1.0;0.012089;0.0040658000000000005;0.0029465999999999997;V139M;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1290;epilepsy;rs145141172;A;1.0;0.012089;0.0040658000000000005;0.0029465999999999997;V160M;ENST00000545097
CCR3;ENSG00000183625;clinical_c_D73;D73 Diseases of spleen;rs4987124;A;0.955318;0.0098669;0.0026765;0.00022741;R19K;ENST00000545097
CCR3;ENSG00000183625;30000-0.0;White blood cell (leukocyte) count;rs145141172;A;1.0;0.22554000000000002;0.066426;0.00068564;V139M;ENST00000357422
CCR3;ENSG00000183625;30000-0.0;White blood cell (leukocyte) count;rs145141172;A;1.0;0.22554000000000002;0.066426;0.00068564;V139M;ENST00000395940
CCR3;ENSG00000183625;30000-0.0;White blood cell (leukocyte) count;rs145141172;A;1.0;0.22554000000000002;0.066426;0.00068564;V139M;ENST00000395942
CCR3;ENSG00000183625;30000-0.0;White blood cell (leukocyte) count;rs145141172;A;1.0;0.22554000000000002;0.066426;0.00068564;V160M;ENST00000545097
CCR3;ENSG00000183625;30000-0.0;White blood cell (leukocyte) count;rs5742906;T;1.0;0.09122000000000001;0.030320999999999997;0.0026261;P39L;ENST00000357422
CCR3;ENSG00000183625;30000-0.0;White blood cell (leukocyte) count;rs5742906;T;1.0;0.09122000000000001;0.030320999999999997;0.0026261;P39L;ENST00000395940
CCR3;ENSG00000183625;30000-0.0;White blood cell (leukocyte) count;rs5742906;T;1.0;0.09122000000000001;0.030320999999999997;0.0026261;P39L;ENST00000395942
CCR3;ENSG00000183625;30000-0.0;White blood cell (leukocyte) count;rs5742906;T;1.0;0.09122000000000001;0.030320999999999997;0.0026261;P39L;ENST00000452454
CCR3;ENSG00000183625;30000-0.0;White blood cell (leukocyte) count;rs5742906;T;1.0;0.09122000000000001;0.030320999999999997;0.0026261;P60L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_E21;E21 Hyperparathyroidism and other disorders of parathyroid gland;rs138346219;G;1.0;0.0049427;0.0013687999999999999;0.00030499;I222V;ENST00000357422
CCR3;ENSG00000183625;clinical_c_E21;E21 Hyperparathyroidism and other disorders of parathyroid gland;rs138346219;G;1.0;0.0049427;0.0013687999999999999;0.00030499;I222V;ENST00000395940
CCR3;ENSG00000183625;clinical_c_E21;E21 Hyperparathyroidism and other disorders of parathyroid gland;rs138346219;G;1.0;0.0049427;0.0013687999999999999;0.00030499;I222V;ENST00000395942
CCR3;ENSG00000183625;clinical_c_E21;E21 Hyperparathyroidism and other disorders of parathyroid gland;rs138346219;G;1.0;0.0049427;0.0013687999999999999;0.00030499;I243V;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1686;soft tissue inflammation;rs201916744;C;0.395741;0.011692000000000001;0.0034453;0.00069007;L117F;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1686;soft tissue inflammation;rs201916744;C;0.395741;0.011692000000000001;0.0034453;0.00069007;L117F;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1686;soft tissue inflammation;rs201916744;C;0.395741;0.011692000000000001;0.0034453;0.00069007;L117F;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1686;soft tissue inflammation;rs201916744;C;0.395741;0.011692000000000001;0.0034453;0.00069007;L138F;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1136;other respiratory problems;rs147670448;C;0.9169010000000001;0.048922;0.018953;0.009844499999999999;L351P;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1136;other respiratory problems;rs147670448;C;0.9169010000000001;0.048922;0.018953;0.009844499999999999;L351P;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1136;other respiratory problems;rs147670448;C;0.9169010000000001;0.048922;0.018953;0.009844499999999999;L351P;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1136;other respiratory problems;rs147670448;C;0.9169010000000001;0.048922;0.018953;0.009844499999999999;L372P;ENST00000545097
CCR3;ENSG00000183625;20015-0.0;Sitting height;rs574114165;G;0.6003029999999999;0.50608;0.18749000000000002;0.0069514;I5V;ENST00000545097
CCR3;ENSG00000183625;clinical_c_N62;N62 Hypertrophy of breast;rs147670448;C;0.9169010000000001;0.026613;0.0080176;0.00090233;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_N62;N62 Hypertrophy of breast;rs147670448;C;0.9169010000000001;0.026613;0.0080176;0.00090233;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_N62;N62 Hypertrophy of breast;rs147670448;C;0.9169010000000001;0.026613;0.0080176;0.00090233;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_N62;N62 Hypertrophy of breast;rs147670448;C;0.9169010000000001;0.026613;0.0080176;0.00090233;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_N62;N62 Hypertrophy of breast;rs201916744;C;0.395741;0.009793000000000001;0.0037338000000000002;0.0087217;L117F;ENST00000357422
CCR3;ENSG00000183625;clinical_c_N62;N62 Hypertrophy of breast;rs201916744;C;0.395741;0.009793000000000001;0.0037338000000000002;0.0087217;L117F;ENST00000395940
CCR3;ENSG00000183625;clinical_c_N62;N62 Hypertrophy of breast;rs201916744;C;0.395741;0.009793000000000001;0.0037338000000000002;0.0087217;L117F;ENST00000395942
CCR3;ENSG00000183625;clinical_c_N62;N62 Hypertrophy of breast;rs201916744;C;0.395741;0.009793000000000001;0.0037338000000000002;0.0087217;L138F;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1131;chronic obstructive airways disease/copd;rs147670448;C;0.9169010000000001;0.02868;0.010607;0.006853799999999999;L351P;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1131;chronic obstructive airways disease/copd;rs147670448;C;0.9169010000000001;0.02868;0.010607;0.006853799999999999;L351P;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1131;chronic obstructive airways disease/copd;rs147670448;C;0.9169010000000001;0.02868;0.010607;0.006853799999999999;L351P;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1131;chronic obstructive airways disease/copd;rs147670448;C;0.9169010000000001;0.02868;0.010607;0.006853799999999999;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_H35;H35 Other retinal disorders;rs201774652;T;0.47502700000000003;0.035479000000000004;0.0096069;0.00022158;T148I;ENST00000357422
CCR3;ENSG00000183625;clinical_c_H35;H35 Other retinal disorders;rs201774652;T;0.47502700000000003;0.035479000000000004;0.0096069;0.00022158;T148I;ENST00000395940
CCR3;ENSG00000183625;clinical_c_H35;H35 Other retinal disorders;rs201774652;T;0.47502700000000003;0.035479000000000004;0.0096069;0.00022158;T148I;ENST00000395942
CCR3;ENSG00000183625;clinical_c_H35;H35 Other retinal disorders;rs201774652;T;0.47502700000000003;0.035479000000000004;0.0096069;0.00022158;T169I;ENST00000545097
CCR3;ENSG00000183625;clinical_c_D69;D69 Purpura and other haemorrhagic conditions;rs4987124;A;0.955318;0.012659;0.0047317;0.0074652;R19K;ENST00000545097
CCR3;ENSG00000183625;clinical_c_G44;G44 Other headache syndromes;rs61738836;C;0.848311;0.010745999999999999;0.0039071;0.005954999999999999;V147A;ENST00000357422
CCR3;ENSG00000183625;clinical_c_G44;G44 Other headache syndromes;rs61738836;C;0.848311;0.010745999999999999;0.0039071;0.005954999999999999;V147A;ENST00000395940
CCR3;ENSG00000183625;clinical_c_G44;G44 Other headache syndromes;rs61738836;C;0.848311;0.010745999999999999;0.0039071;0.005954999999999999;V147A;ENST00000395942
CCR3;ENSG00000183625;clinical_c_G44;G44 Other headache syndromes;rs61738836;C;0.848311;0.010745999999999999;0.0039071;0.005954999999999999;V168A;ENST00000545097
CCR3;ENSG00000183625;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs201774652;T;0.47502700000000003;0.012744;0.0041168;0.0019644000000000003;T148I;ENST00000357422
CCR3;ENSG00000183625;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs201774652;T;0.47502700000000003;0.012744;0.0041168;0.0019644000000000003;T148I;ENST00000395940
CCR3;ENSG00000183625;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs201774652;T;0.47502700000000003;0.012744;0.0041168;0.0019644000000000003;T148I;ENST00000395942
CCR3;ENSG00000183625;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs201774652;T;0.47502700000000003;0.012744;0.0041168;0.0019644000000000003;T169I;ENST00000545097
CCR3;ENSG00000183625;clinical_c_K83;K83 Other diseases of biliary tract;rs201774652;T;0.47502700000000003;0.020725;0.0071792;0.0038909999999999995;T148I;ENST00000357422
CCR3;ENSG00000183625;clinical_c_K83;K83 Other diseases of biliary tract;rs201774652;T;0.47502700000000003;0.020725;0.0071792;0.0038909999999999995;T148I;ENST00000395940
CCR3;ENSG00000183625;clinical_c_K83;K83 Other diseases of biliary tract;rs201774652;T;0.47502700000000003;0.020725;0.0071792;0.0038909999999999995;T148I;ENST00000395942
CCR3;ENSG00000183625;clinical_c_K83;K83 Other diseases of biliary tract;rs201774652;T;0.47502700000000003;0.020725;0.0071792;0.0038909999999999995;T169I;ENST00000545097
CCR3;ENSG00000183625;clinical_c_M23;M23 Internal derangement of knee;rs111826278;T;1.0;-0.017802000000000002;0.0068031;0.0088771;P349L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_M23;M23 Internal derangement of knee;rs111826278;T;1.0;-0.017802000000000002;0.0068031;0.0088771;P349L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_M23;M23 Internal derangement of knee;rs111826278;T;1.0;-0.017802000000000002;0.0068031;0.0088771;P349L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_M23;M23 Internal derangement of knee;rs111826278;T;1.0;-0.017802000000000002;0.0068031;0.0088771;P370L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_K61;K61 Abscess of anal and rectal regions;rs145141172;A;1.0;0.0067736;0.0025663;0.008303;V139M;ENST00000357422
CCR3;ENSG00000183625;clinical_c_K61;K61 Abscess of anal and rectal regions;rs145141172;A;1.0;0.0067736;0.0025663;0.008303;V139M;ENST00000395940
CCR3;ENSG00000183625;clinical_c_K61;K61 Abscess of anal and rectal regions;rs145141172;A;1.0;0.0067736;0.0025663;0.008303;V139M;ENST00000395942
CCR3;ENSG00000183625;clinical_c_K61;K61 Abscess of anal and rectal regions;rs145141172;A;1.0;0.0067736;0.0025663;0.008303;V160M;ENST00000545097
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs138346219;G;1.0;0.024756;0.0033235;9.4345e-14;I222V;ENST00000357422
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs138346219;G;1.0;0.024756;0.0033235;9.4345e-14;I222V;ENST00000395940
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs138346219;G;1.0;0.024756;0.0033235;9.4345e-14;I222V;ENST00000395942
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs138346219;G;1.0;0.024756;0.0033235;9.4345e-14;I243V;ENST00000545097
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs145141172;A;1.0;0.025289;0.0048131;1.4883e-07;V139M;ENST00000357422
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs145141172;A;1.0;0.025289;0.0048131;1.4883e-07;V139M;ENST00000395940
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs145141172;A;1.0;0.025289;0.0048131;1.4883e-07;V139M;ENST00000395942
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs145141172;A;1.0;0.025289;0.0048131;1.4883e-07;V160M;ENST00000545097
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs5742906;T;1.0;0.012385;0.0021969999999999997;1.7282e-08;P39L;ENST00000357422
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs5742906;T;1.0;0.012385;0.0021969999999999997;1.7282e-08;P39L;ENST00000395940
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs5742906;T;1.0;0.012385;0.0021969999999999997;1.7282e-08;P39L;ENST00000395942
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs5742906;T;1.0;0.012385;0.0021969999999999997;1.7282e-08;P39L;ENST00000452454
CCR3;ENSG00000183625;30150-0.0;Eosinophill count;rs5742906;T;1.0;0.012385;0.0021969999999999997;1.7282e-08;P60L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_I05-I09;I05-I09 Chronic rheumatic heart diseases;rs4987124;A;0.955318;0.016906;0.0054402999999999995;0.0018862000000000002;R19K;ENST00000545097
CCR3;ENSG00000183625;clinical_c_O70;O70 Perineal laceration during delivery;rs147670448;C;0.9169010000000001;0.15270999999999998;0.03615;2.3972e-05;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_O70;O70 Perineal laceration during delivery;rs147670448;C;0.9169010000000001;0.15270999999999998;0.03615;2.3972e-05;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_O70;O70 Perineal laceration during delivery;rs147670448;C;0.9169010000000001;0.15270999999999998;0.03615;2.3972e-05;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_O70;O70 Perineal laceration during delivery;rs147670448;C;0.9169010000000001;0.15270999999999998;0.03615;2.3972e-05;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_K01;K01 Embedded and impacted teeth;rs61738836;C;0.848311;0.026088;0.0074042000000000005;0.00042607;V147A;ENST00000357422
CCR3;ENSG00000183625;clinical_c_K01;K01 Embedded and impacted teeth;rs61738836;C;0.848311;0.026088;0.0074042000000000005;0.00042607;V147A;ENST00000395940
CCR3;ENSG00000183625;clinical_c_K01;K01 Embedded and impacted teeth;rs61738836;C;0.848311;0.026088;0.0074042000000000005;0.00042607;V147A;ENST00000395942
CCR3;ENSG00000183625;clinical_c_K01;K01 Embedded and impacted teeth;rs61738836;C;0.848311;0.026088;0.0074042000000000005;0.00042607;V168A;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1760;helicobacter pylori;rs142051640;A;0.845935;0.010775;0.0029406999999999997;0.00024827;R239Q;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1760;helicobacter pylori;rs142051640;A;0.845935;0.010775;0.0029406999999999997;0.00024827;R239Q;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1760;helicobacter pylori;rs142051640;A;0.845935;0.010775;0.0029406999999999997;0.00024827;R239Q;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1760;helicobacter pylori;rs142051640;A;0.845935;0.010775;0.0029406999999999997;0.00024827;R260Q;ENST00000545097
CCR3;ENSG00000183625;cancer_c_C20;C20 Malignant neoplasm of rectum;rs147670448;C;0.9169010000000001;0.029604000000000002;0.009449700000000002;0.0017315000000000002;L351P;ENST00000357422
CCR3;ENSG00000183625;cancer_c_C20;C20 Malignant neoplasm of rectum;rs147670448;C;0.9169010000000001;0.029604000000000002;0.009449700000000002;0.0017315000000000002;L351P;ENST00000395940
CCR3;ENSG00000183625;cancer_c_C20;C20 Malignant neoplasm of rectum;rs147670448;C;0.9169010000000001;0.029604000000000002;0.009449700000000002;0.0017315000000000002;L351P;ENST00000395942
CCR3;ENSG00000183625;cancer_c_C20;C20 Malignant neoplasm of rectum;rs147670448;C;0.9169010000000001;0.029604000000000002;0.009449700000000002;0.0017315000000000002;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_J33;J33 Nasal polyp;rs4987124;A;0.955318;0.019805;0.0065206000000000005;0.0023868;R19K;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1213;renal/kidney failure;rs147670448;C;0.9169010000000001;0.040761;0.007386399999999999;3.4246e-08;L351P;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1213;renal/kidney failure;rs147670448;C;0.9169010000000001;0.040761;0.007386399999999999;3.4246e-08;L351P;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1213;renal/kidney failure;rs147670448;C;0.9169010000000001;0.040761;0.007386399999999999;3.4246e-08;L351P;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1213;renal/kidney failure;rs147670448;C;0.9169010000000001;0.040761;0.007386399999999999;3.4246e-08;L372P;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1213;renal/kidney failure;rs4987124;A;0.955318;0.014956;0.0030699;1.1061e-06;R19K;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1213;renal/kidney failure;rs61738836;C;0.848311;0.018396;0.0045075;4.483e-05;V147A;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1213;renal/kidney failure;rs61738836;C;0.848311;0.018396;0.0045075;4.483e-05;V147A;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1213;renal/kidney failure;rs61738836;C;0.848311;0.018396;0.0045075;4.483e-05;V147A;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1213;renal/kidney failure;rs61738836;C;0.848311;0.018396;0.0045075;4.483e-05;V168A;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_H10-H13;H10-H13 Disorders of conjunctiva;rs4987124;A;0.955318;0.014422999999999998;0.0037040999999999997;9.8724e-05;R19K;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1317;mania/bipolar disorder/manic depression;rs147670448;C;0.9169010000000001;0.028595999999999996;0.009481299999999998;0.0025612;L351P;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1317;mania/bipolar disorder/manic depression;rs147670448;C;0.9169010000000001;0.028595999999999996;0.009481299999999998;0.0025612;L351P;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1317;mania/bipolar disorder/manic depression;rs147670448;C;0.9169010000000001;0.028595999999999996;0.009481299999999998;0.0025612;L351P;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1317;mania/bipolar disorder/manic depression;rs147670448;C;0.9169010000000001;0.028595999999999996;0.009481299999999998;0.0025612;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_K22;K22 Other diseases of oesophagus;rs5742906;T;1.0;0.008176600000000001;0.003091;0.008162;P39L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_K22;K22 Other diseases of oesophagus;rs5742906;T;1.0;0.008176600000000001;0.003091;0.008162;P39L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_K22;K22 Other diseases of oesophagus;rs5742906;T;1.0;0.008176600000000001;0.003091;0.008162;P39L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_K22;K22 Other diseases of oesophagus;rs5742906;T;1.0;0.008176600000000001;0.003091;0.008162;P39L;ENST00000452454
CCR3;ENSG00000183625;clinical_c_K22;K22 Other diseases of oesophagus;rs5742906;T;1.0;0.008176600000000001;0.003091;0.008162;P60L;ENST00000545097
CCR3;ENSG00000183625;1239-0.0;Current tobacco smoking;rs111826278;T;1.0;-0.053196;0.0191;0.0053506;P349L;ENST00000357422
CCR3;ENSG00000183625;1239-0.0;Current tobacco smoking;rs111826278;T;1.0;-0.053196;0.0191;0.0053506;P349L;ENST00000395940
CCR3;ENSG00000183625;1239-0.0;Current tobacco smoking;rs111826278;T;1.0;-0.053196;0.0191;0.0053506;P349L;ENST00000395942
CCR3;ENSG00000183625;1239-0.0;Current tobacco smoking;rs111826278;T;1.0;-0.053196;0.0191;0.0053506;P370L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_M19;M19 Other arthrosis;rs41409552;A;1.0;0.0042163999999999995;0.0015405;0.0061996;R275Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_M19;M19 Other arthrosis;rs41409552;A;1.0;0.0042163999999999995;0.0015405;0.0061996;R275Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_M19;M19 Other arthrosis;rs41409552;A;1.0;0.0042163999999999995;0.0015405;0.0061996;R275Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_M19;M19 Other arthrosis;rs41409552;A;1.0;0.0042163999999999995;0.0015405;0.0061996;R296Q;ENST00000545097
CCR3;ENSG00000183625;cancer_c_Block_D37-D48;D37-D48 Neoplasms of uncertain or unknown behaviour;rs138346219;G;1.0;0.005529;0.0020405;0.006737699999999999;I222V;ENST00000357422
CCR3;ENSG00000183625;cancer_c_Block_D37-D48;D37-D48 Neoplasms of uncertain or unknown behaviour;rs138346219;G;1.0;0.005529;0.0020405;0.006737699999999999;I222V;ENST00000395940
CCR3;ENSG00000183625;cancer_c_Block_D37-D48;D37-D48 Neoplasms of uncertain or unknown behaviour;rs138346219;G;1.0;0.005529;0.0020405;0.006737699999999999;I222V;ENST00000395942
CCR3;ENSG00000183625;cancer_c_Block_D37-D48;D37-D48 Neoplasms of uncertain or unknown behaviour;rs138346219;G;1.0;0.005529;0.0020405;0.006737699999999999;I243V;ENST00000545097
CCR3;ENSG00000183625;709-0.0;Number in household;rs142051640;A;0.845935;0.1807;0.055408000000000006;0.0011092;R239Q;ENST00000357422
CCR3;ENSG00000183625;709-0.0;Number in household;rs142051640;A;0.845935;0.1807;0.055408000000000006;0.0011092;R239Q;ENST00000395940
CCR3;ENSG00000183625;709-0.0;Number in household;rs142051640;A;0.845935;0.1807;0.055408000000000006;0.0011092;R239Q;ENST00000395942
CCR3;ENSG00000183625;709-0.0;Number in household;rs142051640;A;0.845935;0.1807;0.055408000000000006;0.0011092;R260Q;ENST00000545097
CCR3;ENSG00000183625;709-0.0;Number in household;rs147670448;C;0.9169010000000001;0.48157;0.18137;0.007927199999999999;L351P;ENST00000357422
CCR3;ENSG00000183625;709-0.0;Number in household;rs147670448;C;0.9169010000000001;0.48157;0.18137;0.007927199999999999;L351P;ENST00000395940
CCR3;ENSG00000183625;709-0.0;Number in household;rs147670448;C;0.9169010000000001;0.48157;0.18137;0.007927199999999999;L351P;ENST00000395942
CCR3;ENSG00000183625;709-0.0;Number in household;rs147670448;C;0.9169010000000001;0.48157;0.18137;0.007927199999999999;L372P;ENST00000545097
CCR3;ENSG00000183625;20116-0.0;Smoking status;rs111826278;T;1.0;-0.093046;0.022458000000000002;3.4282e-05;P349L;ENST00000357422
CCR3;ENSG00000183625;20116-0.0;Smoking status;rs111826278;T;1.0;-0.093046;0.022458000000000002;3.4282e-05;P349L;ENST00000395940
CCR3;ENSG00000183625;20116-0.0;Smoking status;rs111826278;T;1.0;-0.093046;0.022458000000000002;3.4282e-05;P349L;ENST00000395942
CCR3;ENSG00000183625;20116-0.0;Smoking status;rs111826278;T;1.0;-0.093046;0.022458000000000002;3.4282e-05;P370L;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1133;bronchiectasis;rs201916744;C;0.395741;0.010995;0.004046;0.0065757;L117F;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1133;bronchiectasis;rs201916744;C;0.395741;0.010995;0.004046;0.0065757;L117F;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1133;bronchiectasis;rs201916744;C;0.395741;0.010995;0.004046;0.0065757;L117F;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1133;bronchiectasis;rs201916744;C;0.395741;0.010995;0.004046;0.0065757;L138F;ENST00000545097
CCR3;ENSG00000183625;clinical_c_M84;M84 Disorders of continuity of bone;rs147670448;C;0.9169010000000001;0.028845999999999997;0.010827;0.0077161999999999994;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_M84;M84 Disorders of continuity of bone;rs147670448;C;0.9169010000000001;0.028845999999999997;0.010827;0.0077161999999999994;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_M84;M84 Disorders of continuity of bone;rs147670448;C;0.9169010000000001;0.028845999999999997;0.010827;0.0077161999999999994;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_M84;M84 Disorders of continuity of bone;rs147670448;C;0.9169010000000001;0.028845999999999997;0.010827;0.0077161999999999994;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_J30-J39;J30-J39 Other diseases of upper respiratory tract;rs574114165;G;0.6003029999999999;0.038084;0.012740000000000001;0.0027962;I5V;ENST00000545097
CCR3;ENSG00000183625;clinical_c_N30;N30 Cystitis;rs147670448;C;0.9169010000000001;0.053857;0.015135;0.00037317;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_N30;N30 Cystitis;rs147670448;C;0.9169010000000001;0.053857;0.015135;0.00037317;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_N30;N30 Cystitis;rs147670448;C;0.9169010000000001;0.053857;0.015135;0.00037317;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_N30;N30 Cystitis;rs147670448;C;0.9169010000000001;0.053857;0.015135;0.00037317;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_I24;I24 Other acute ischaemic heart diseases;rs147670448;C;0.9169010000000001;0.029149;0.010373;0.0049527;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_I24;I24 Other acute ischaemic heart diseases;rs147670448;C;0.9169010000000001;0.029149;0.010373;0.0049527;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_I24;I24 Other acute ischaemic heart diseases;rs147670448;C;0.9169010000000001;0.029149;0.010373;0.0049527;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_I24;I24 Other acute ischaemic heart diseases;rs147670448;C;0.9169010000000001;0.029149;0.010373;0.0049527;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_H72;H72 Perforation of tympanic membrane;rs138346219;G;1.0;0.0043648;0.0015107;0.0038624;I222V;ENST00000357422
CCR3;ENSG00000183625;clinical_c_H72;H72 Perforation of tympanic membrane;rs138346219;G;1.0;0.0043648;0.0015107;0.0038624;I222V;ENST00000395940
CCR3;ENSG00000183625;clinical_c_H72;H72 Perforation of tympanic membrane;rs138346219;G;1.0;0.0043648;0.0015107;0.0038624;I222V;ENST00000395942
CCR3;ENSG00000183625;clinical_c_H72;H72 Perforation of tympanic membrane;rs138346219;G;1.0;0.0043648;0.0015107;0.0038624;I243V;ENST00000545097
CCR3;ENSG00000183625;clinical_c_H72;H72 Perforation of tympanic membrane;rs5742906;T;1.0;0.0027234000000000004;0.00099864;0.0063901;P39L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_H72;H72 Perforation of tympanic membrane;rs5742906;T;1.0;0.0027234000000000004;0.00099864;0.0063901;P39L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_H72;H72 Perforation of tympanic membrane;rs5742906;T;1.0;0.0027234000000000004;0.00099864;0.0063901;P39L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_H72;H72 Perforation of tympanic membrane;rs5742906;T;1.0;0.0027234000000000004;0.00099864;0.0063901;P39L;ENST00000452454
CCR3;ENSG00000183625;clinical_c_H72;H72 Perforation of tympanic membrane;rs5742906;T;1.0;0.0027234000000000004;0.00099864;0.0063901;P60L;ENST00000545097
CCR3;ENSG00000183625;23130-0.0;Trunk predicted mass;rs138346219;G;1.0;0.19913;0.072644;0.0061232;I222V;ENST00000357422
CCR3;ENSG00000183625;23130-0.0;Trunk predicted mass;rs138346219;G;1.0;0.19913;0.072644;0.0061232;I222V;ENST00000395940
CCR3;ENSG00000183625;23130-0.0;Trunk predicted mass;rs138346219;G;1.0;0.19913;0.072644;0.0061232;I222V;ENST00000395942
CCR3;ENSG00000183625;23130-0.0;Trunk predicted mass;rs138346219;G;1.0;0.19913;0.072644;0.0061232;I243V;ENST00000545097
CCR3;ENSG00000183625;30040-0.0;Mean corpuscular volume;rs41409552;A;1.0;0.072542;0.027202999999999998;0.0076613;R275Q;ENST00000357422
CCR3;ENSG00000183625;30040-0.0;Mean corpuscular volume;rs41409552;A;1.0;0.072542;0.027202999999999998;0.0076613;R275Q;ENST00000395940
CCR3;ENSG00000183625;30040-0.0;Mean corpuscular volume;rs41409552;A;1.0;0.072542;0.027202999999999998;0.0076613;R275Q;ENST00000395942
CCR3;ENSG00000183625;30040-0.0;Mean corpuscular volume;rs41409552;A;1.0;0.072542;0.027202999999999998;0.0076613;R296Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_K50;K50 Crohn's disease [regional enteritis];rs4987124;A;0.955318;0.012742;0.0047948999999999995;0.0078759;R19K;ENST00000545097
CCR3;ENSG00000183625;30130-0.0;Monocyte count;rs145141172;A;1.0;0.019709;0.0060504;0.0011241;V139M;ENST00000357422
CCR3;ENSG00000183625;30130-0.0;Monocyte count;rs145141172;A;1.0;0.019709;0.0060504;0.0011241;V139M;ENST00000395940
CCR3;ENSG00000183625;30130-0.0;Monocyte count;rs145141172;A;1.0;0.019709;0.0060504;0.0011241;V139M;ENST00000395942
CCR3;ENSG00000183625;30130-0.0;Monocyte count;rs145141172;A;1.0;0.019709;0.0060504;0.0011241;V160M;ENST00000545097
CCR3;ENSG00000183625;cancer_c_D06;D06 Carcinoma in situ of cervix uteri;rs5742906;T;1.0;0.0068402;0.0025022;0.006264100000000001;P39L;ENST00000357422
CCR3;ENSG00000183625;cancer_c_D06;D06 Carcinoma in situ of cervix uteri;rs5742906;T;1.0;0.0068402;0.0025022;0.006264100000000001;P39L;ENST00000395940
CCR3;ENSG00000183625;cancer_c_D06;D06 Carcinoma in situ of cervix uteri;rs5742906;T;1.0;0.0068402;0.0025022;0.006264100000000001;P39L;ENST00000395942
CCR3;ENSG00000183625;cancer_c_D06;D06 Carcinoma in situ of cervix uteri;rs5742906;T;1.0;0.0068402;0.0025022;0.006264100000000001;P39L;ENST00000452454
CCR3;ENSG00000183625;cancer_c_D06;D06 Carcinoma in situ of cervix uteri;rs5742906;T;1.0;0.0068402;0.0025022;0.006264100000000001;P60L;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1502;haematology;rs147670448;C;0.9169010000000001;0.057674;0.021097;0.006261399999999999;L351P;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1502;haematology;rs147670448;C;0.9169010000000001;0.057674;0.021097;0.006261399999999999;L351P;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1502;haematology;rs147670448;C;0.9169010000000001;0.057674;0.021097;0.006261399999999999;L351P;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1502;haematology;rs147670448;C;0.9169010000000001;0.057674;0.021097;0.006261399999999999;L372P;ENST00000545097
CCR3;ENSG00000183625;1518-0.0;Hot drink temperature;rs5742906;T;1.0;-0.037405;0.010856000000000001;0.00057003;P39L;ENST00000357422
CCR3;ENSG00000183625;1518-0.0;Hot drink temperature;rs5742906;T;1.0;-0.037405;0.010856000000000001;0.00057003;P39L;ENST00000395940
CCR3;ENSG00000183625;1518-0.0;Hot drink temperature;rs5742906;T;1.0;-0.037405;0.010856000000000001;0.00057003;P39L;ENST00000395942
CCR3;ENSG00000183625;1518-0.0;Hot drink temperature;rs5742906;T;1.0;-0.037405;0.010856000000000001;0.00057003;P39L;ENST00000452454
CCR3;ENSG00000183625;1518-0.0;Hot drink temperature;rs5742906;T;1.0;-0.037405;0.010856000000000001;0.00057003;P60L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_N45;N45 Orchitis and epididymitis;rs145141172;A;1.0;0.012306999999999998;0.0042381;0.0036863;V139M;ENST00000357422
CCR3;ENSG00000183625;clinical_c_N45;N45 Orchitis and epididymitis;rs145141172;A;1.0;0.012306999999999998;0.0042381;0.0036863;V139M;ENST00000395940
CCR3;ENSG00000183625;clinical_c_N45;N45 Orchitis and epididymitis;rs145141172;A;1.0;0.012306999999999998;0.0042381;0.0036863;V139M;ENST00000395942
CCR3;ENSG00000183625;clinical_c_N45;N45 Orchitis and epididymitis;rs145141172;A;1.0;0.012306999999999998;0.0042381;0.0036863;V160M;ENST00000545097
CCR3;ENSG00000183625;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs61738836;C;0.848311;0.015821;0.0054853;0.0039234000000000005;V147A;ENST00000357422
CCR3;ENSG00000183625;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs61738836;C;0.848311;0.015821;0.0054853;0.0039234000000000005;V147A;ENST00000395940
CCR3;ENSG00000183625;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs61738836;C;0.848311;0.015821;0.0054853;0.0039234000000000005;V147A;ENST00000395942
CCR3;ENSG00000183625;clinical_c_J30;J30 Vasomotor and allergic rhinitis;rs61738836;C;0.848311;0.015821;0.0054853;0.0039234000000000005;V168A;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1142;sleep apnoea;rs147670448;C;0.9169010000000001;0.057467;0.010222;1.8875e-08;L351P;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1142;sleep apnoea;rs147670448;C;0.9169010000000001;0.057467;0.010222;1.8875e-08;L351P;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1142;sleep apnoea;rs147670448;C;0.9169010000000001;0.057467;0.010222;1.8875e-08;L351P;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1142;sleep apnoea;rs147670448;C;0.9169010000000001;0.057467;0.010222;1.8875e-08;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs201774652;T;0.47502700000000003;0.016644;0.005084600000000001;0.0010625;T148I;ENST00000357422
CCR3;ENSG00000183625;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs201774652;T;0.47502700000000003;0.016644;0.005084600000000001;0.0010625;T148I;ENST00000395940
CCR3;ENSG00000183625;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs201774652;T;0.47502700000000003;0.016644;0.005084600000000001;0.0010625;T148I;ENST00000395942
CCR3;ENSG00000183625;clinical_c_H90;H90 Conductive and sensorineural hearing loss;rs201774652;T;0.47502700000000003;0.016644;0.005084600000000001;0.0010625;T169I;ENST00000545097
CCR3;ENSG00000183625;20117-0.0;Alcohol drinker status;rs145141172;A;1.0;-0.065972;0.017099;0.00011418;V139M;ENST00000357422
CCR3;ENSG00000183625;20117-0.0;Alcohol drinker status;rs145141172;A;1.0;-0.065972;0.017099;0.00011418;V139M;ENST00000395940
CCR3;ENSG00000183625;20117-0.0;Alcohol drinker status;rs145141172;A;1.0;-0.065972;0.017099;0.00011418;V139M;ENST00000395942
CCR3;ENSG00000183625;20117-0.0;Alcohol drinker status;rs145141172;A;1.0;-0.065972;0.017099;0.00011418;V160M;ENST00000545097
CCR3;ENSG00000183625;23115-0.0;Leg fat percentage (left);rs41409552;A;1.0;-0.09159099999999999;0.034138999999999996;0.0072994;R275Q;ENST00000357422
CCR3;ENSG00000183625;23115-0.0;Leg fat percentage (left);rs41409552;A;1.0;-0.09159099999999999;0.034138999999999996;0.0072994;R275Q;ENST00000395940
CCR3;ENSG00000183625;23115-0.0;Leg fat percentage (left);rs41409552;A;1.0;-0.09159099999999999;0.034138999999999996;0.0072994;R275Q;ENST00000395942
CCR3;ENSG00000183625;23115-0.0;Leg fat percentage (left);rs41409552;A;1.0;-0.09159099999999999;0.034138999999999996;0.0072994;R296Q;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1130;asthma;rs574114165;G;0.6003029999999999;0.05948;0.021043;0.0047037;I5V;ENST00000545097
CCR3;ENSG00000183625;30170-0.0;Nucleated red blood cell count;rs41409552;A;1.0;0.00088018;0.00025471;0.00054911;R275Q;ENST00000357422
CCR3;ENSG00000183625;30170-0.0;Nucleated red blood cell count;rs41409552;A;1.0;0.00088018;0.00025471;0.00054911;R275Q;ENST00000395940
CCR3;ENSG00000183625;30170-0.0;Nucleated red blood cell count;rs41409552;A;1.0;0.00088018;0.00025471;0.00054911;R275Q;ENST00000395942
CCR3;ENSG00000183625;30170-0.0;Nucleated red blood cell count;rs41409552;A;1.0;0.00088018;0.00025471;0.00054911;R296Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_K11;K11 Diseases of salivary glands;rs142051640;A;0.845935;0.009178799999999999;0.0027189;0.00073576;R239Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_K11;K11 Diseases of salivary glands;rs142051640;A;0.845935;0.009178799999999999;0.0027189;0.00073576;R239Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_K11;K11 Diseases of salivary glands;rs142051640;A;0.845935;0.009178799999999999;0.0027189;0.00073576;R239Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_K11;K11 Diseases of salivary glands;rs142051640;A;0.845935;0.009178799999999999;0.0027189;0.00073576;R260Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_N60;N60 Benign mammary dysplasia;rs111826278;T;1.0;0.014776;0.0044464;0.00089054;P349L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_N60;N60 Benign mammary dysplasia;rs111826278;T;1.0;0.014776;0.0044464;0.00089054;P349L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_N60;N60 Benign mammary dysplasia;rs111826278;T;1.0;0.014776;0.0044464;0.00089054;P349L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_N60;N60 Benign mammary dysplasia;rs111826278;T;1.0;0.014776;0.0044464;0.00089054;P370L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_N60;N60 Benign mammary dysplasia;rs147670448;C;0.9169010000000001;0.06278500000000001;0.022059;0.0044238;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_N60;N60 Benign mammary dysplasia;rs147670448;C;0.9169010000000001;0.06278500000000001;0.022059;0.0044238;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_N60;N60 Benign mammary dysplasia;rs147670448;C;0.9169010000000001;0.06278500000000001;0.022059;0.0044238;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_N60;N60 Benign mammary dysplasia;rs147670448;C;0.9169010000000001;0.06278500000000001;0.022059;0.0044238;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_N10-N16;N10-N16 Renal tubulo-interstitial diseases;rs145141172;A;1.0;0.015438999999999998;0.0042623999999999995;0.00029226;V139M;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_N10-N16;N10-N16 Renal tubulo-interstitial diseases;rs145141172;A;1.0;0.015438999999999998;0.0042623999999999995;0.00029226;V139M;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_N10-N16;N10-N16 Renal tubulo-interstitial diseases;rs145141172;A;1.0;0.015438999999999998;0.0042623999999999995;0.00029226;V139M;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_N10-N16;N10-N16 Renal tubulo-interstitial diseases;rs145141172;A;1.0;0.015438999999999998;0.0042623999999999995;0.00029226;V160M;ENST00000545097
CCR3;ENSG00000183625;clinical_c_F40;F40 Phobic anxiety disorders;rs138346219;G;1.0;0.0035376999999999995;0.0011403;0.0019198;I222V;ENST00000357422
CCR3;ENSG00000183625;clinical_c_F40;F40 Phobic anxiety disorders;rs138346219;G;1.0;0.0035376999999999995;0.0011403;0.0019198;I222V;ENST00000395940
CCR3;ENSG00000183625;clinical_c_F40;F40 Phobic anxiety disorders;rs138346219;G;1.0;0.0035376999999999995;0.0011403;0.0019198;I222V;ENST00000395942
CCR3;ENSG00000183625;clinical_c_F40;F40 Phobic anxiety disorders;rs138346219;G;1.0;0.0035376999999999995;0.0011403;0.0019198;I243V;ENST00000545097
CCR3;ENSG00000183625;clinical_c_F40;F40 Phobic anxiety disorders;rs142051640;A;0.845935;0.0053666;0.0020231;0.0079864;R239Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_F40;F40 Phobic anxiety disorders;rs142051640;A;0.845935;0.0053666;0.0020231;0.0079864;R239Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_F40;F40 Phobic anxiety disorders;rs142051640;A;0.845935;0.0053666;0.0020231;0.0079864;R239Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_F40;F40 Phobic anxiety disorders;rs142051640;A;0.845935;0.0053666;0.0020231;0.0079864;R260Q;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1348;osteoporosis;rs142051640;A;0.845935;0.017572;0.0068178;0.009956999999999999;R239Q;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1348;osteoporosis;rs142051640;A;0.845935;0.017572;0.0068178;0.009956999999999999;R239Q;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1348;osteoporosis;rs142051640;A;0.845935;0.017572;0.0068178;0.009956999999999999;R239Q;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1348;osteoporosis;rs142051640;A;0.845935;0.017572;0.0068178;0.009956999999999999;R260Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_G91;G91 Hydrocephalus;rs142051640;A;0.845935;0.0068622;0.0018154;0.00015684;R239Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_G91;G91 Hydrocephalus;rs142051640;A;0.845935;0.0068622;0.0018154;0.00015684;R239Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_G91;G91 Hydrocephalus;rs142051640;A;0.845935;0.0068622;0.0018154;0.00015684;R239Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_G91;G91 Hydrocephalus;rs142051640;A;0.845935;0.0068622;0.0018154;0.00015684;R260Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_M50-M54;M50-M54 Other dorsopathies;rs111826278;T;1.0;0.021146;0.0077266;0.006204;P349L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_M50-M54;M50-M54 Other dorsopathies;rs111826278;T;1.0;0.021146;0.0077266;0.006204;P349L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_M50-M54;M50-M54 Other dorsopathies;rs111826278;T;1.0;0.021146;0.0077266;0.006204;P349L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_M50-M54;M50-M54 Other dorsopathies;rs111826278;T;1.0;0.021146;0.0077266;0.006204;P370L;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1154;stomach disorder;rs142051640;A;0.845935;0.015699;0.0057619;0.0064391000000000006;R239Q;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1154;stomach disorder;rs142051640;A;0.845935;0.015699;0.0057619;0.0064391000000000006;R239Q;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1154;stomach disorder;rs142051640;A;0.845935;0.015699;0.0057619;0.0064391000000000006;R239Q;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1154;stomach disorder;rs142051640;A;0.845935;0.015699;0.0057619;0.0064391000000000006;R260Q;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1154;stomach disorder;rs61738836;C;0.848311;0.052649;0.011509;4.7754e-06;V147A;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1154;stomach disorder;rs61738836;C;0.848311;0.052649;0.011509;4.7754e-06;V147A;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1154;stomach disorder;rs61738836;C;0.848311;0.052649;0.011509;4.7754e-06;V147A;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1154;stomach disorder;rs61738836;C;0.848311;0.052649;0.011509;4.7754e-06;V168A;ENST00000545097
CCR3;ENSG00000183625;clinical_c_G40;G40 Epilepsy;rs145141172;A;1.0;0.017575;0.0042214;3.1361999999999996e-05;V139M;ENST00000357422
CCR3;ENSG00000183625;clinical_c_G40;G40 Epilepsy;rs145141172;A;1.0;0.017575;0.0042214;3.1361999999999996e-05;V139M;ENST00000395940
CCR3;ENSG00000183625;clinical_c_G40;G40 Epilepsy;rs145141172;A;1.0;0.017575;0.0042214;3.1361999999999996e-05;V139M;ENST00000395942
CCR3;ENSG00000183625;clinical_c_G40;G40 Epilepsy;rs145141172;A;1.0;0.017575;0.0042214;3.1361999999999996e-05;V160M;ENST00000545097
CCR3;ENSG00000183625;clinical_c_J35;J35 Chronic diseases of tonsils and adenoids;rs201774652;T;0.47502700000000003;0.014141999999999998;0.0051955;0.006490899999999999;T148I;ENST00000357422
CCR3;ENSG00000183625;clinical_c_J35;J35 Chronic diseases of tonsils and adenoids;rs201774652;T;0.47502700000000003;0.014141999999999998;0.0051955;0.006490899999999999;T148I;ENST00000395940
CCR3;ENSG00000183625;clinical_c_J35;J35 Chronic diseases of tonsils and adenoids;rs201774652;T;0.47502700000000003;0.014141999999999998;0.0051955;0.006490899999999999;T148I;ENST00000395942
CCR3;ENSG00000183625;clinical_c_J35;J35 Chronic diseases of tonsils and adenoids;rs201774652;T;0.47502700000000003;0.014141999999999998;0.0051955;0.006490899999999999;T169I;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_K00-K14;K00-K14 Diseases of oral cavity, salivary glands and jaws;rs142051640;A;0.845935;0.038116000000000004;0.010445999999999999;0.00026331;R239Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_K00-K14;K00-K14 Diseases of oral cavity, salivary glands and jaws;rs142051640;A;0.845935;0.038116000000000004;0.010445999999999999;0.00026331;R239Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_K00-K14;K00-K14 Diseases of oral cavity, salivary glands and jaws;rs142051640;A;0.845935;0.038116000000000004;0.010445999999999999;0.00026331;R239Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_K00-K14;K00-K14 Diseases of oral cavity, salivary glands and jaws;rs142051640;A;0.845935;0.038116000000000004;0.010445999999999999;0.00026331;R260Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_H04;H04 Disorders of lachrymal system;rs138346219;G;1.0;0.0070985;0.002262;0.0017001999999999998;I222V;ENST00000357422
CCR3;ENSG00000183625;clinical_c_H04;H04 Disorders of lachrymal system;rs138346219;G;1.0;0.0070985;0.002262;0.0017001999999999998;I222V;ENST00000395940
CCR3;ENSG00000183625;clinical_c_H04;H04 Disorders of lachrymal system;rs138346219;G;1.0;0.0070985;0.002262;0.0017001999999999998;I222V;ENST00000395942
CCR3;ENSG00000183625;clinical_c_H04;H04 Disorders of lachrymal system;rs138346219;G;1.0;0.0070985;0.002262;0.0017001999999999998;I243V;ENST00000545097
CCR3;ENSG00000183625;clinical_c_H04;H04 Disorders of lachrymal system;rs5742906;T;1.0;0.005257100000000001;0.0014952;0.00043833;P39L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_H04;H04 Disorders of lachrymal system;rs5742906;T;1.0;0.005257100000000001;0.0014952;0.00043833;P39L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_H04;H04 Disorders of lachrymal system;rs5742906;T;1.0;0.005257100000000001;0.0014952;0.00043833;P39L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_H04;H04 Disorders of lachrymal system;rs5742906;T;1.0;0.005257100000000001;0.0014952;0.00043833;P39L;ENST00000452454
CCR3;ENSG00000183625;clinical_c_H04;H04 Disorders of lachrymal system;rs5742906;T;1.0;0.005257100000000001;0.0014952;0.00043833;P60L;ENST00000545097
CCR3;ENSG00000183625;1458-0.0;Cereal intake;rs201916744;C;0.395741;-0.6046199999999999;0.22116999999999998;0.006261500000000001;L117F;ENST00000357422
CCR3;ENSG00000183625;1458-0.0;Cereal intake;rs201916744;C;0.395741;-0.6046199999999999;0.22116999999999998;0.006261500000000001;L117F;ENST00000395940
CCR3;ENSG00000183625;1458-0.0;Cereal intake;rs201916744;C;0.395741;-0.6046199999999999;0.22116999999999998;0.006261500000000001;L117F;ENST00000395942
CCR3;ENSG00000183625;1458-0.0;Cereal intake;rs201916744;C;0.395741;-0.6046199999999999;0.22116999999999998;0.006261500000000001;L138F;ENST00000545097
CCR3;ENSG00000183625;clinical_c_G81;G81 Hemiplegia;rs147670448;C;0.9169010000000001;0.028573;0.010711;0.007640100000000001;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_G81;G81 Hemiplegia;rs147670448;C;0.9169010000000001;0.028573;0.010711;0.007640100000000001;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_G81;G81 Hemiplegia;rs147670448;C;0.9169010000000001;0.028573;0.010711;0.007640100000000001;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_G81;G81 Hemiplegia;rs147670448;C;0.9169010000000001;0.028573;0.010711;0.007640100000000001;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_O60-O75;O60-O75 Complications of labour and delivery;rs147670448;C;0.9169010000000001;0.18543;0.044926;3.6702e-05;L351P;ENST00000357422
CCR3;ENSG00000183625;clinical_c_Block_O60-O75;O60-O75 Complications of labour and delivery;rs147670448;C;0.9169010000000001;0.18543;0.044926;3.6702e-05;L351P;ENST00000395940
CCR3;ENSG00000183625;clinical_c_Block_O60-O75;O60-O75 Complications of labour and delivery;rs147670448;C;0.9169010000000001;0.18543;0.044926;3.6702e-05;L351P;ENST00000395942
CCR3;ENSG00000183625;clinical_c_Block_O60-O75;O60-O75 Complications of labour and delivery;rs147670448;C;0.9169010000000001;0.18543;0.044926;3.6702e-05;L372P;ENST00000545097
CCR3;ENSG00000183625;clinical_c_K82;K82 Other diseases of gallbladder;rs41409552;A;1.0;0.0017066;0.00052492;0.0011493;R275Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_K82;K82 Other diseases of gallbladder;rs41409552;A;1.0;0.0017066;0.00052492;0.0011493;R275Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_K82;K82 Other diseases of gallbladder;rs41409552;A;1.0;0.0017066;0.00052492;0.0011493;R275Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_K82;K82 Other diseases of gallbladder;rs41409552;A;1.0;0.0017066;0.00052492;0.0011493;R296Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_K82;K82 Other diseases of gallbladder;rs4987124;A;0.955318;0.018363;0.0049115;0.000185;R19K;ENST00000545097
CCR3;ENSG00000183625;clinical_c_F20;F20 Schizophrenia;rs201774652;T;0.47502700000000003;0.014191;0.0038196999999999997;0.0002031;T148I;ENST00000357422
CCR3;ENSG00000183625;clinical_c_F20;F20 Schizophrenia;rs201774652;T;0.47502700000000003;0.014191;0.0038196999999999997;0.0002031;T148I;ENST00000395940
CCR3;ENSG00000183625;clinical_c_F20;F20 Schizophrenia;rs201774652;T;0.47502700000000003;0.014191;0.0038196999999999997;0.0002031;T148I;ENST00000395942
CCR3;ENSG00000183625;clinical_c_F20;F20 Schizophrenia;rs201774652;T;0.47502700000000003;0.014191;0.0038196999999999997;0.0002031;T169I;ENST00000545097
CCR3;ENSG00000183625;1309-0.0;Fresh fruit intake;rs111826278;T;1.0;0.14273;0.05092;0.005063300000000001;P349L;ENST00000357422
CCR3;ENSG00000183625;1309-0.0;Fresh fruit intake;rs111826278;T;1.0;0.14273;0.05092;0.005063300000000001;P349L;ENST00000395940
CCR3;ENSG00000183625;1309-0.0;Fresh fruit intake;rs111826278;T;1.0;0.14273;0.05092;0.005063300000000001;P349L;ENST00000395942
CCR3;ENSG00000183625;1309-0.0;Fresh fruit intake;rs111826278;T;1.0;0.14273;0.05092;0.005063300000000001;P370L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_M17;M17 Gonarthrosis [arthrosis of knee];rs41409552;A;1.0;0.0055598999999999996;0.0016673999999999999;0.00085496;R275Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_M17;M17 Gonarthrosis [arthrosis of knee];rs41409552;A;1.0;0.0055598999999999996;0.0016673999999999999;0.00085496;R275Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_M17;M17 Gonarthrosis [arthrosis of knee];rs41409552;A;1.0;0.0055598999999999996;0.0016673999999999999;0.00085496;R275Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_M17;M17 Gonarthrosis [arthrosis of knee];rs41409552;A;1.0;0.0055598999999999996;0.0016673999999999999;0.00085496;R296Q;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1305;eye trauma;rs61738836;C;0.848311;0.022928999999999998;0.004105;2.3313000000000002e-08;V147A;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1305;eye trauma;rs61738836;C;0.848311;0.022928999999999998;0.004105;2.3313000000000002e-08;V147A;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1305;eye trauma;rs61738836;C;0.848311;0.022928999999999998;0.004105;2.3313000000000002e-08;V147A;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1305;eye trauma;rs61738836;C;0.848311;0.022928999999999998;0.004105;2.3313000000000002e-08;V168A;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1623;miscarriage;rs41409552;A;1.0;0.0022370000000000003;0.00066137;0.00071869;R275Q;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1623;miscarriage;rs41409552;A;1.0;0.0022370000000000003;0.00066137;0.00071869;R275Q;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1623;miscarriage;rs41409552;A;1.0;0.0022370000000000003;0.00066137;0.00071869;R275Q;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1623;miscarriage;rs41409552;A;1.0;0.0022370000000000003;0.00066137;0.00071869;R296Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_M54;M54 Dorsalgia;rs111826278;T;1.0;0.018096;0.0066253;0.006307899999999999;P349L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_M54;M54 Dorsalgia;rs111826278;T;1.0;0.018096;0.0066253;0.006307899999999999;P349L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_M54;M54 Dorsalgia;rs111826278;T;1.0;0.018096;0.0066253;0.006307899999999999;P349L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_M54;M54 Dorsalgia;rs111826278;T;1.0;0.018096;0.0066253;0.006307899999999999;P370L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_M67;M67 Other disorders of synovium and tendon;rs145141172;A;1.0;0.011217;0.0042912;0.0089512;V139M;ENST00000357422
CCR3;ENSG00000183625;clinical_c_M67;M67 Other disorders of synovium and tendon;rs145141172;A;1.0;0.011217;0.0042912;0.0089512;V139M;ENST00000395940
CCR3;ENSG00000183625;clinical_c_M67;M67 Other disorders of synovium and tendon;rs145141172;A;1.0;0.011217;0.0042912;0.0089512;V139M;ENST00000395942
CCR3;ENSG00000183625;clinical_c_M67;M67 Other disorders of synovium and tendon;rs145141172;A;1.0;0.011217;0.0042912;0.0089512;V160M;ENST00000545097
CCR3;ENSG00000183625;clinical_c_J98;J98 Other respiratory disorders;rs4987124;A;0.955318;0.036735000000000004;0.006566;2.2112e-08;R19K;ENST00000545097
CCR3;ENSG00000183625;30050-0.0;Mean corpuscular haemoglobin;rs41409552;A;1.0;0.033777999999999996;0.01102;0.0021763999999999998;R275Q;ENST00000357422
CCR3;ENSG00000183625;30050-0.0;Mean corpuscular haemoglobin;rs41409552;A;1.0;0.033777999999999996;0.01102;0.0021763999999999998;R275Q;ENST00000395940
CCR3;ENSG00000183625;30050-0.0;Mean corpuscular haemoglobin;rs41409552;A;1.0;0.033777999999999996;0.01102;0.0021763999999999998;R275Q;ENST00000395942
CCR3;ENSG00000183625;30050-0.0;Mean corpuscular haemoglobin;rs41409552;A;1.0;0.033777999999999996;0.01102;0.0021763999999999998;R296Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_K44;K44 Diaphragmatic hernia;rs5742906;T;1.0;0.012828999999999998;0.0049207999999999995;0.0091314;P39L;ENST00000357422
CCR3;ENSG00000183625;clinical_c_K44;K44 Diaphragmatic hernia;rs5742906;T;1.0;0.012828999999999998;0.0049207999999999995;0.0091314;P39L;ENST00000395940
CCR3;ENSG00000183625;clinical_c_K44;K44 Diaphragmatic hernia;rs5742906;T;1.0;0.012828999999999998;0.0049207999999999995;0.0091314;P39L;ENST00000395942
CCR3;ENSG00000183625;clinical_c_K44;K44 Diaphragmatic hernia;rs5742906;T;1.0;0.012828999999999998;0.0049207999999999995;0.0091314;P39L;ENST00000452454
CCR3;ENSG00000183625;clinical_c_K44;K44 Diaphragmatic hernia;rs5742906;T;1.0;0.012828999999999998;0.0049207999999999995;0.0091314;P60L;ENST00000545097
CCR3;ENSG00000183625;clinical_c_K04;K04 Diseases of pulp and periapical tissues;rs142051640;A;0.845935;0.011001;0.0041134;0.0074851;R239Q;ENST00000357422
CCR3;ENSG00000183625;clinical_c_K04;K04 Diseases of pulp and periapical tissues;rs142051640;A;0.845935;0.011001;0.0041134;0.0074851;R239Q;ENST00000395940
CCR3;ENSG00000183625;clinical_c_K04;K04 Diseases of pulp and periapical tissues;rs142051640;A;0.845935;0.011001;0.0041134;0.0074851;R239Q;ENST00000395942
CCR3;ENSG00000183625;clinical_c_K04;K04 Diseases of pulp and periapical tissues;rs142051640;A;0.845935;0.011001;0.0041134;0.0074851;R260Q;ENST00000545097
CCR3;ENSG00000183625;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs201916744;C;0.395741;0.013055;0.0034840000000000006;0.00017899;L117F;ENST00000357422
CCR3;ENSG00000183625;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs201916744;C;0.395741;0.013055;0.0034840000000000006;0.00017899;L117F;ENST00000395940
CCR3;ENSG00000183625;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs201916744;C;0.395741;0.013055;0.0034840000000000006;0.00017899;L117F;ENST00000395942
CCR3;ENSG00000183625;clinical_c_J39;J39 Other diseases of upper respiratory tract;rs201916744;C;0.395741;0.013055;0.0034840000000000006;0.00017899;L138F;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1713;other fractures;rs201774652;T;0.47502700000000003;0.022357;0.0042608;1.5455e-07;T148I;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1713;other fractures;rs201774652;T;0.47502700000000003;0.022357;0.0042608;1.5455e-07;T148I;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1713;other fractures;rs201774652;T;0.47502700000000003;0.022357;0.0042608;1.5455e-07;T148I;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1713;other fractures;rs201774652;T;0.47502700000000003;0.022357;0.0042608;1.5455e-07;T169I;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1164;gastritis/gastric erosions;rs142051640;A;0.845935;0.0071297;0.0021755;0.0010482000000000002;R239Q;ENST00000357422
CCR3;ENSG00000183625;selfReported_n_1164;gastritis/gastric erosions;rs142051640;A;0.845935;0.0071297;0.0021755;0.0010482000000000002;R239Q;ENST00000395940
CCR3;ENSG00000183625;selfReported_n_1164;gastritis/gastric erosions;rs142051640;A;0.845935;0.0071297;0.0021755;0.0010482000000000002;R239Q;ENST00000395942
CCR3;ENSG00000183625;selfReported_n_1164;gastritis/gastric erosions;rs142051640;A;0.845935;0.0071297;0.0021755;0.0010482000000000002;R260Q;ENST00000545097
CCR3;ENSG00000183625;selfReported_n_1164;gastritis/gastric erosions;rs574114165;G;0.6003029999999999;0.007662;0.0027613000000000004;0.0055238;I5V;ENST00000545097
CCR3;ENSG00000183625;23129-0.0;Trunk fat-free mass;rs138346219;G;1.0;0.20669;0.075697;0.0063238999999999995;I222V;ENST00000357422
CCR3;ENSG00000183625;23129-0.0;Trunk fat-free mass;rs138346219;G;1.0;0.20669;0.075697;0.0063238999999999995;I222V;ENST00000395940
CCR3;ENSG00000183625;23129-0.0;Trunk fat-free mass;rs138346219;G;1.0;0.20669;0.075697;0.0063238999999999995;I222V;ENST00000395942
CCR3;ENSG00000183625;23129-0.0;Trunk fat-free mass;rs138346219;G;1.0;0.20669;0.075697;0.0063238999999999995;I243V;ENST00000545097
CCR3;ENSG00000183625;clinical_c_Block_J95-J99;J95-J99 Other diseases of the respiratory system;rs4987124;A;0.955318;0.033955;0.0084409;5.7548e-05;R19K;ENST00000545097
CCR3;ENSG00000183625;clinical_c_I83;I83 Varicose veins of lower extremities;rs138346219;G;1.0;-0.013234000000000001;0.0048615;0.0064872;I222V;ENST00000357422
CCR3;ENSG00000183625;clinical_c_I83;I83 Varicose veins of lower extremities;rs138346219;G;1.0;-0.013234000000000001;0.0048615;0.0064872;I222V;ENST00000395940
CCR3;ENSG00000183625;clinical_c_I83;I83 Varicose veins of lower extremities;rs138346219;G;1.0;-0.013234000000000001;0.0048615;0.0064872;I222V;ENST00000395942
CCR3;ENSG00000183625;clinical_c_I83;I83 Varicose veins of lower extremities;rs138346219;G;1.0;-0.013234000000000001;0.0048615;0.0064872;I243V;ENST00000545097
CCR4;ENSG00000183813;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs148935732;A;0.87987;0.012423;0.004299600000000001;0.003861;L21Q;ENST00000330953
CCR4;ENSG00000183813;selfReported_n_1089;essential hypertension;rs61736865;A;0.732596;0.38308000000000003;0.048966;5.1509999999999995e-15;G324S;ENST00000330953
CCR4;ENSG00000183813;clinical_c_N75;N75 Diseases of Bartholin's gland;rs148935732;A;0.87987;0.011607;0.0042077;0.005806899999999999;L21Q;ENST00000330953
CCR4;ENSG00000183813;clinical_c_N75;N75 Diseases of Bartholin's gland;rs61736865;A;0.732596;0.56633;0.042968;1.1750999999999997e-39;G324S;ENST00000330953
CCR4;ENSG00000183813;clinical_c_K58;K58 Irritable bowel syndrome;rs148935732;A;0.87987;0.016294;0.0058568000000000005;0.0054003;L21Q;ENST00000330953
CCR4;ENSG00000183813;clinical_c_Block_M40-M43;M40-M43 Deforming dorsopathies;rs148935732;A;0.87987;0.011014;0.004195399999999999;0.008656700000000002;L21Q;ENST00000330953
CCR4;ENSG00000183813;clinical_c_I51;I51 Complications and ill-defined descriptions of heart disease;rs61736865;A;0.732596;0.42021000000000003;0.073064;8.8623e-09;G324S;ENST00000330953
CCR4;ENSG00000183813;clinical_c_O68;O68 Labour and delivery complicated by foetal stress [distress];rs148935732;A;0.87987;0.02524;0.0087242;0.0038148;L21Q;ENST00000330953
CCR4;ENSG00000183813;clinical_c_G25;G25 Other extrapyramidal and movement disorders;rs148935732;A;0.87987;0.0060525;0.0019695;0.0021183000000000005;L21Q;ENST00000330953
CCR4;ENSG00000183813;clinical_c_M79;M79 Other soft tissue disorders, not elsewhere classified;rs61736865;A;0.732596;0.42638000000000004;0.12405;0.00058786;G324S;ENST00000330953
CCR4;ENSG00000183813;cancer_c_D04;D04 Carcinoma in situ of skin;rs148935732;A;0.87987;0.0099363;0.0023954000000000002;3.3537e-05;L21Q;ENST00000330953
CCR4;ENSG00000183813;selfReported_n_1443;pneumonia;rs148935732;A;0.87987;0.015776;0.0060658000000000005;0.0093009;L21Q;ENST00000330953
CCR4;ENSG00000183813;selfReported_n_1313;anxiety/panic attacks;rs148935732;A;0.87987;0.015888;0.0059715;0.007801300000000001;L21Q;ENST00000330953
CCR4;ENSG00000183813;clinical_c_H18;H18 Other disorders of cornea;rs148935732;A;0.87987;0.008802299999999999;0.0020102;1.1935999999999999e-05;L21Q;ENST00000330953
CCR4;ENSG00000183813;clinical_c_I20;I20 Angina pectoris;rs61736865;A;0.732596;0.43512;0.14487;0.0026685;G324S;ENST00000330953
CCR4;ENSG00000183813;clinical_c_I22;I22 Subsequent myocardial infarction;rs148935732;A;0.87987;0.0083769;0.0021341999999999997;8.6734e-05;L21Q;ENST00000330953
CCR4;ENSG00000183813;clinical_c_Block_H15-H22;H15-H22 Disorders of sclera, cornea, iris and ciliary body;rs148935732;A;0.87987;0.011784000000000001;0.0032156;0.0002478;L21Q;ENST00000330953
CCR4;ENSG00000183813;clinical_c_E14;E14 Unspecified diabetes mellitus;rs148935732;A;0.87987;0.016176;0.0038139000000000003;2.2222e-05;L21Q;ENST00000330953
CCR4;ENSG00000183813;clinical_c_M17;M17 Gonarthrosis [arthrosis of knee];rs148935732;A;0.87987;0.027493;0.010672;0.009992399999999999;L21Q;ENST00000330953
CCR4;ENSG00000183813;clinical_c_Block_N70-N77;N70-N77 Inflammatory diseases of female pelvic organs;rs61736865;A;0.732596;0.72206;0.12195;3.2065e-09;G324S;ENST00000330953
XCR1;ENSG00000173578;clinical_c_O75;O75 Other complications of labour and delivery, not elsewhere classified;rs200700108;A;0.171851;0.07087;0.015331;3.7887e-06;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_K40;K40 Inguinal hernia;rs78405233;A;0.9442729999999999;-0.00672;0.0022655;0.0030146;S173L;ENST00000309285
XCR1;ENSG00000173578;clinical_c_L30;L30 Other dermatitis;rs138429796;C;0.851565;0.141;0.033054;1.9917e-05;I255S;ENST00000309285
XCR1;ENSG00000173578;30160-0.0;Basophill count;rs78405233;A;0.9442729999999999;0.0017195;0.00046231;0.00019977;S173L;ENST00000309285
XCR1;ENSG00000173578;clinical_c_Block_O30-O48;O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems;rs200700108;A;0.171851;0.14109000000000002;0.041778;0.00073255;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_O72;O72 Postpartum haemorrhage;rs200700108;A;0.171851;0.064196;0.019969;0.0013055;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_K13;K13 Other diseases of lip and oral mucosa;rs138429796;C;0.851565;0.18209;0.045417;6.0908e-05;I255S;ENST00000309285
XCR1;ENSG00000173578;clinical_c_G95;G95 Other diseases of spinal cord;rs200700108;A;0.171851;0.032159;0.0070039;4.4013e-06;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_Block_L50-L54;L50-L54 Urticaria and erythema;rs200700108;A;0.171851;0.038561;0.009489399999999999;4.8337e-05;Q254H;ENST00000309285
XCR1;ENSG00000173578;cancer_c_D03;D03 Melanoma in situ;rs200700108;A;0.171851;0.032747000000000005;0.0086675;0.00015801;Q254H;ENST00000309285
XCR1;ENSG00000173578;cancer_c_D03;D03 Melanoma in situ;rs78405233;A;0.9442729999999999;0.0015179;0.00056529;0.0072475;S173L;ENST00000309285
XCR1;ENSG00000173578;30220-0.0;Basophill percentage;rs78405233;A;0.9442729999999999;0.022422;0.0051455;1.3148e-05;S173L;ENST00000309285
XCR1;ENSG00000173578;clinical_c_K66;K66 Other disorders of peritoneum;rs78405233;A;0.9442729999999999;0.0028881999999999996;0.0010658;0.0067318;S173L;ENST00000309285
XCR1;ENSG00000173578;clinical_c_O34;O34 Maternal care for known or suspected abnormality of pelvic organs;rs200700108;A;0.171851;0.10105;0.021387;2.3072e-06;Q254H;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1504;anaemia;rs78405233;A;0.9442729999999999;-0.0032118000000000003;0.0012354;0.0093272;S173L;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1275;cranial nerve problem/palsy;rs200700108;A;0.171851;0.028861;0.008385600000000002;0.00057813;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_Block_O94-O99;O94-O99 Other obstetric conditions, not elsewhere classified;rs200700108;A;0.171851;0.07334;0.02309;0.001492;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_Block_L20-L30;L20-L30 Dermatitis and eczema;rs138429796;C;0.851565;0.13347;0.047428;0.0048903;I255S;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1249;thyroid problem (not cancer);rs78405233;A;0.9442729999999999;-0.007228;0.0027046999999999996;0.0075304000000000005;S173L;ENST00000309285
XCR1;ENSG00000173578;clinical_c_G99;G99 Other disorders of nervous system in diseases classified elsewhere;rs200700108;A;0.171851;0.03275;0.0096218;0.00066482;Q254H;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1159;gastro-oesophageal reflux (gord) / gastric reflux;rs200700108;A;0.171851;0.11395999999999999;0.037731;0.0025263;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_I12;I12 Hypertensive renal disease;rs138429796;C;0.851565;0.11189;0.033154;0.00073821;I255S;ENST00000309285
XCR1;ENSG00000173578;clinical_c_O99;O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium;rs200700108;A;0.171851;0.07256;0.022797;0.0014587;Q254H;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1513;blistering/desquamating skin disorder;rs138429796;C;0.851565;0.19022999999999998;0.023369;3.9554e-16;I255S;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1144;pleurisy;rs200700108;A;0.171851;0.031883;0.011056;0.0039294;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_K62;K62 Other diseases of anus and rectum;rs138429796;C;0.851565;0.37218;0.12536;0.0029892;I255S;ENST00000309285
XCR1;ENSG00000173578;clinical_c_L57;L57 Skin changes due to chronic exposure to nonionising radiation;rs138429796;C;0.851565;0.14292;0.041222;0.00052615;I255S;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1750;measles / morbillivirus;rs78405233;A;0.9442729999999999;0.0019764;0.00070917;0.0053212;S173L;ENST00000309285
XCR1;ENSG00000173578;clinical_c_O42;O42 Premature rupture of membranes;rs200700108;A;0.171851;0.060953;0.018078;0.00074702;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_B98;B98 Other specified infectious agents as the cause of diseases classified to other chapters;rs200700108;A;0.171851;0.033886;0.0085427;7.2909e-05;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_K14;K14 Diseases of tongue;rs200700108;A;0.171851;0.034287;0.010242;0.00081499;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_Block_N99-N99;N99-N99 Other disorders of the genitourinary system;rs78405233;A;0.9442729999999999;-0.0019116;0.00065559;0.0035472;S173L;ENST00000309285
XCR1;ENSG00000173578;clinical_c_K43;K43 Ventral hernia;rs78405233;A;0.9442729999999999;0.003243;0.0011092;0.0034580999999999995;S173L;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1211;peritonitis;rs200700108;A;0.171851;0.064541;0.010971999999999999;4.053e-09;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_O48;O48 Prolonged pregnancy;rs200700108;A;0.171851;0.061305999999999986;0.019094;0.0013243;Q254H;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1251;hypothyroidism/myxoedema;rs78405233;A;0.9442729999999999;-0.0068994;0.0024872;0.0055385;S173L;ENST00000309285
XCR1;ENSG00000173578;cancer_c_C83;C83 Diffuse non-Hodgkin's lymphoma;rs138429796;C;0.851565;0.11154000000000001;0.021337000000000002;1.7180999999999997e-07;I255S;ENST00000309285
XCR1;ENSG00000173578;clinical_c_N99;N99 Postprocedural disorders of genito-urinary system, not elsewhere classified;rs78405233;A;0.9442729999999999;-0.0019116;0.00065559;0.0035472;S173L;ENST00000309285
XCR1;ENSG00000173578;clinical_c_J33;J33 Nasal polyp;rs200700108;A;0.171851;0.053894000000000004;0.016479;0.0010735;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_F32;F32 Depressive episode;rs78405233;A;0.9442729999999999;-0.0062882;0.002022;0.0018716999999999998;S173L;ENST00000309285
XCR1;ENSG00000173578;clinical_c_O36;O36 Maternal care for other known or suspected foetal problems;rs200700108;A;0.171851;0.10044;0.023688;2.2337e-05;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_N30;N30 Cystitis;rs138429796;C;0.851565;0.13976;0.045985000000000005;0.0023723000000000004;I255S;ENST00000309285
XCR1;ENSG00000173578;clinical_c_N30;N30 Cystitis;rs200700108;A;0.171851;0.061683;0.015896;0.00010435;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_M10;M10 Gout;rs78405233;A;0.9442729999999999;-0.0028340999999999996;0.0010743;0.00834;S173L;ENST00000309285
XCR1;ENSG00000173578;30230-0.0;Nucleated red blood cell percentage;rs200700108;A;0.171851;0.22548;0.074878;0.0026014;Q254H;ENST00000309285
XCR1;ENSG00000173578;30040-0.0;Mean corpuscular volume;rs138429796;C;0.851565;6.0839;1.8608;0.0010772;I255S;ENST00000309285
XCR1;ENSG00000173578;clinical_c_G51;G51 Facial nerve disorders;rs200700108;A;0.171851;0.038196;0.0086316;9.6381e-06;Q254H;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1454;other renal/kidney problem;rs138429796;C;0.851565;0.13444;0.040221;0.00083041;I255S;ENST00000309285
XCR1;ENSG00000173578;clinical_c_Block_G90-G99;G90-G99 Other disorders of the nervous system;rs200700108;A;0.171851;0.065817;0.018694;0.00043027;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_Block_L55-L59;L55-L59 Radiation-related disorders of the skin and subcutaneous tissue;rs138429796;C;0.851565;0.14262;0.042247;0.0007362;I255S;ENST00000309285
XCR1;ENSG00000173578;clinical_c_K11;K11 Diseases of salivary glands;rs200700108;A;0.171851;0.031902;0.0093477;0.0006429;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_I22;I22 Subsequent myocardial infarction;rs200700108;A;0.171851;0.035375;0.0078847;7.241900000000001e-06;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_Block_F30-F39;F30-F39 Mood [affective] disorders;rs78405233;A;0.9442729999999999;-0.0064997;0.0021014;0.0019812000000000002;S173L;ENST00000309285
XCR1;ENSG00000173578;cancer_c_C43;C43 Malignant melanoma of skin;rs200700108;A;0.171851;0.036574;0.013915;0.008580599999999999;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_I61;I61 Intracerebral haemorrhage;rs78405233;A;0.9442729999999999;0.0021958000000000004;0.00051092;1.7254e-05;S173L;ENST00000309285
XCR1;ENSG00000173578;clinical_c_Block_O85-O92;O85-O92 Complications predominantly related to the puerperium;rs200700108;A;0.171851;0.065232;0.013888;2.6414e-06;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_Block_O60-O75;O60-O75 Complications of labour and delivery;rs200700108;A;0.171851;0.13902;0.047731;0.0035844;Q254H;ENST00000309285
XCR1;ENSG00000173578;clinical_c_K60;K60 Fissure and fistula of anal and rectal regions;rs138429796;C;0.851565;0.25715;0.047582;6.5086e-08;I255S;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1592;dry eyes;rs200700108;A;0.171851;0.029977999999999998;0.007181999999999999;2.9922e-05;Q254H;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1176;hepatitis;rs78405233;A;0.9442729999999999;0.0025116;0.00086776;0.0037994;S173L;ENST00000309285
XCR1;ENSG00000173578;selfReported_n_1222;bladder problem (not cancer);rs78405233;A;0.9442729999999999;0.0033458;0.0011909000000000002;0.0049619;S173L;ENST00000309285
XCR1;ENSG00000173578;30050-0.0;Mean corpuscular haemoglobin;rs138429796;C;0.851565;1.9893;0.7538199999999999;0.008317;I255S;ENST00000309285
